A . . . E> A . . . E> A MONTELUKAST d04289A C J30.9 J45 Allergic rhinitis, unspecified Asthma A E>0 A METOPROLOL d00134A Dc I10 Essential (primary) hypertension A E>@ A . . . E>P A . . . E>` A . . . E>p A ALBUTEROL d00749A CDp J44.9 Chronic obstructive pulmonary disease, unspecified Ap E>p A FLUTICASONE; SALMETEROL d04611A CDp J44.9 Chronic obstructive pulmonary disease, unspecified Ap E>p A HYDROCHLOROTHIAZIDE d00253A CDp I10 Essential (primary) hypertension Ap E>p A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension Ap E>p A METOPROLOL d00134A CDp I10 Essential (primary) hypertension Ap E>p A ROSUVASTATIN d04851A B E78.0 Pure hypercholesterolemia Ap E>p A UMECLIDINIUM d08187A CDp J44.9 Chronic obstructive pulmonary disease, unspecified Ap E> A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E> A DEXTROMETHORPHAN; QUINIDINE d07707A C G31.9 Degenerative disease of nervous system, unspecified A E> A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A E> A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A E> A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A E> A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease A E> A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia A E> A QUETIAPINE d04220A C G31.9 Degenerative disease of nervous system, unspecified A E> A WARFARIN d00022A C D75.9P I63 Prevent blood clots Cerebral infarction A E> A . . . E> A ETHINYL ESTRADIOL; NORGESTIMATE d03781A Cr Z79.3 Long term (current) use of hormonal contraceptives A E> A . . . E> A . . . E> A . . . E> A . . . E? A GEMFIBROZIL d00245A C[@ E78.0 Pure hypercholesterolemia A E? A . . . E? A IMIQUIMOD TOPICAL d04125A B B34.9 Viral infection, unspecified A E?0 A . . . E?@ A CELECOXIB d04380A B G99.8 Other specified disorders of nervous system in diseases classified elsewhere A0 E?@ A CYANOCOBALAMIN d00413A B A0 E?@ A OMEPRAZOLE d00325A C R12 Heartburn A0 E?P A . . . E?` A ASPIRIN d00170A Cr 99999 A E?` A GABAPENTIN d03182A C R52 Pain, unspecified A E?` A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A CDp I10 Essential (primary) hypertension A E?` A HYDROXYCHLOROQUINE d00817A C M06.9 Rheumatoid arthritis, unspecified A E?` A MELOXICAM d04532A Cr M06.9 Rheumatoid arthritis, unspecified A E?` A METHOTREXATE d00060A C M06.9 Rheumatoid arthritis, unspecified A E?` A METOPROLOL d00134A CDp R00 Abnormalities of heart beat A E?` A PANTOPRAZOLE d04514A C- K21 Gastro-esophageal reflux disease A E?` A PREDNISONE d00350A C M06.9 Rheumatoid arthritis, unspecified A E?p A . . . E? A TRIAMCINOLONE TOPICAL d03206A C- L40 Psoriasis A E? A . . . E? A . . . E? A . . . E? A . . . E? A ESOMEPRAZOLE d04749A B* K21 Gastro-esophageal reflux disease A E? A RANITIDINE d00021A B K21 Gastro-esophageal reflux disease A E? A HYDROCORTISONE TOPICAL d03205A B= R21 Rash and other nonspecific skin eruption A E? A . . . E@ A IBUPROFEN d00015A C N94 Pain and other conditions associated with female genital organs and menstrual cycle A E@ A . . . E@ A . . . E@0 A . . . E@@ A CLONAZEPAM d00197A CDp F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A0 E@@ A MECLIZINE d00859A C- R42 Dizziness and giddiness A0 E@@ A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease A0 E@P A CLONAZEPAM d00197A CDp F41.9 Anxiety disorder, unspecified A E@P A ESCITALOPRAM d04812A CDp F90 Attention-deficit hyperactivity disorders A E@` A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A E@` A HYDRALAZINE d00132A CDp I10 Essential (primary) hypertension A E@p A . . . E@ A . . . E@ A . . . E@ A FUROSEMIDE d00070A Cr I10 Essential (primary) hypertension A E@ A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E@ A ALENDRONATE d03849A C[@ M81 Osteoporosis without current pathological fracture AP E@ A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia AP E@ A CETIRIZINE d03827A C L50 Urticaria AP E@ A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease AP E@ A RANITIDINE d00021A B K21 Gastro-esophageal reflux disease AP E@ A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A B= I10 Essential (primary) hypertension A E@ A RANITIDINE d00021A B= K21 Gastro-esophageal reflux disease A E@ A OXCARBAZEPINE d04513A C G40 Epilepsy and recurrent seizures A E@ A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A A L08.9 Local infection of the skin and subcutaneous tissue, unspecified A E@ A . . . E@ A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus A0 E@ A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A B* I10 Essential (primary) hypertension A0 E@ A METFORMIN d03807A C E11 Type 2 diabetes mellitus A0 EA A RANITIDINE d00021A B[ K21 Gastro-esophageal reflux disease A EA A ATENOLOL d00004A D I10 Essential (primary) hypertension A EA A BUPRENORPHINE d00840A Bz R52 Pain, unspecified A EA A CANAGLIFLOZIN d08080A Cr E11 Type 2 diabetes mellitus A EA A CLOPIDOGREL d04258A D= D75.9P Prevent blood clots A EA A GLIMEPIRIDE d03864A D E11 Type 2 diabetes mellitus A EA A LEVOTHYROXINE d00278A D* E03.9 Hypothyroidism, unspecified A EA A LISINOPRIL d00732A D= I51.9P Prevent heart disease A EA A PREGABALIN d05508A C M79.7 Fibromyalgia A EA A ROPINIROLE d04215A B R25.2 Cramp and spasm A EA A ROSUVASTATIN d04851A C M79.6 Pain in limb, hand, foot, fingers and toes A EA A SERTRALINE d00880A C- F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A EA A SITAGLIPTIN d05896A C E11 Type 2 diabetes mellitus A EA A TRAZODONE d00395A B= G47.9 Sleep disorder, unspecified A EA A . . . EA0 A ALBUTEROL d00749A Cr J45 Asthma AP EA0 A CYCLOBENZAPRINE d00963A C[@ M19.9 M79.1 Osteoarthritis, unspecified site Myalgia AP EA0 A GABAPENTIN d03182A C[@ G25.81 Restless legs syndrome AP EA0 A METHYLPREDNISOLONE d00293A A` R52 Z79 Pain, unspecified Long term (current) drug therapy AP EA0 A PIROXICAM d00343A B= M19.9 Osteoarthritis, unspecified site AP EA@ A CELECOXIB d04380A C M13 M79.1 Other arthritis Myalgia A` EA@ A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A` EA@ A GLIMEPIRIDE d03864A C R73 Elevated blood glucose level A` EA@ A PIOGLITAZONE d04442A C E11 Type 2 diabetes mellitus A` EA@ A RAMIPRIL d00728A C E11.2 Type 2 diabetes mellitus with kidney complications A` EA@ A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A` EAP A . . . EA` A . . . EAp A DOXYCYCLINE d00037A B L70 Acne A EA A CITALOPRAM d04332A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A EA A VARENICLINE d05807A B8 F17.2 Nicotine dependence A EA A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C Z79.3 Long term (current) use of hormonal contraceptives A EA A BACLOFEN d00967A0 CDp M62.83 Muscle spasm B EA A CAPSAICIN TOPICAL d01321A0 C M54 Dorsalgia B EA A CETIRIZINE d03827A0 C T78.40 Allergy, unspecified B EA A FINASTERIDE d00563A0 C N40 Enlarged prostate B EA A FLUTICASONE NASAL d04283A0 C J30.9 Allergic rhinitis, unspecified B EA A GABAPENTIN d03182A0 C M79.2 Neuralgia and neuritis, unspecified B EA A GLIPIZIDE d00246A0 C E11 Type 2 diabetes mellitus B EA A MELOXICAM d04532A0 C- M54 Dorsalgia B EA A OMEPRAZOLE d00325A0 C K30 Functional dyspepsia B EA A QUETIAPINE d04220A0 C F41.9 Anxiety disorder, unspecified B EA A RANITIDINE d00021A0 C K30 Functional dyspepsia B EA A RISPERIDONE d03180A0 C- F91 Conduct disorders B EA A SERTRALINE d00880A0 C F32.9 Major depressive disorder, single episode, unspecified B EA A SIMVASTATIN d00746A0 C E78.0 Pure hypercholesterolemia B EA A TERAZOSIN d00386A0 C N40 Enlarged prostate B EA A UREA TOPICAL d00651A0 C[@ R21 Rash and other nonspecific skin eruption B EA A RIVAROXABAN d07356A B[ I48.9 Unspecified atrial fibrillation and atrial flutter A EA A . . . EA A . . . EA A . . . EA A ALBUTEROL d00749A A R06.2 Wheezing A EA A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A EB A . . . EB A ATORVASTATIN d04105A B E11 Type 2 diabetes mellitus AP EB A GLIPIZIDE d00246A B E11 Type 2 diabetes mellitus AP EB A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus AP EB A NITROFURANTOIN d00112A B N39.0P Prevent urinary tract infection AP EB A TRAMADOL d03826A C G89 Pain, not elsewhere classified AP EB A DICLOFENAC d00848A D M19.9 Osteoarthritis, unspecified site A EB A SIMVASTATIN d00746A B E78.0 Pure hypercholesterolemia A EB0 A . . . EB@ A CLONAZEPAM d00197A D F41.9 Anxiety disorder, unspecified AP EB@ A DEXTROMETHORPHAN; QUINIDINE d07707A D R52 Pain, unspecified AP EB@ A HYDROCODONE d03075A D R52 Pain, unspecified AP EB@ A LIDOCAINE TOPICAL d00683A D R52 Pain, unspecified AP EB@ A OXYCODONE d00329A D R52 Pain, unspecified AP EBP A . . . EB` A . . . EBp A . . . EB A FLUTICASONE d01296A C J45 Asthma A EB A . . . EB A BUSPIRONE d00182A C F43.9 Reaction to severe stress, unspecified A EB A ESCITALOPRAM d04812A C F41.9 F43.9 Anxiety disorder, unspecified Reaction to severe stress, unspecified A EB A GABAPENTIN d03182A Cr M54 M79.2 Dorsalgia Neuralgia and neuritis, unspecified A EB A INSULIN ASPART d04697A C E11 Type 2 diabetes mellitus A EB A INSULIN GLARGINE d04538A CDp E11 Type 2 diabetes mellitus A EB A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A EB A LINAGLIPTIN; METFORMIN d07825A CDp E11 Type 2 diabetes mellitus A EB A PANTOPRAZOLE d04514A C R12 Heartburn A EB A RAMIPRIL d00728A Cr I10 Essential (primary) hypertension A EB A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A EB A CONTRACEPTIVES - UNSPECIFIED c00102A Dc N92 Z79.3 Excessive, frequent and irregular menstruation Long term (current) use of hormonal contraceptives A EB A MONTELUKAST d04289A C J45 Asthma A EB A FINASTERIDE d00563A B[ L65.9 Nonscarring hair loss, unspecified A EB A MINOCYCLINE d00110A C L71 Rosacea A EB A . . . EB A . . . EB A . . . EC A . . . EC A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A` EC A INSULIN LISPRO d04373A C[@ E11 Type 2 diabetes mellitus A` EC A LOSARTAN d03821A C N28.9 Disorder of kidney and ureter, unspecified A` EC A METOPROLOL d00134A C I10 Essential (primary) hypertension A` EC A NIFEDIPINE d00051A C- I10 Essential (primary) hypertension A` EC A TRIAMTERENE d00396A C I10 Essential (primary) hypertension A` EC A . . . EC0 A ALBUTEROL d00749A C J45 Asthma A0 EC0 A FLUTICASONE d01296A C J45 Asthma A0 EC0 A MONTELUKAST d04289A C J45 Asthma A0 EC@ A . . . ECP A . . . EC` A . . . ECp A . . . EC A METOPROLOL d00134A Cr R00 Abnormalities of heart beat A EC A ALPRAZOLAM d00168A C F41.0 F41.9 Panic disorder [episodic paroxysmal anxiety] without agoraphobia Anxiety disorder, unspecified A0 EC A MELOXICAM d04532A B[ T14.9 Unspecified injury A0 EC A TAMOXIFEN d00381A C[@ C50 Malignant neoplasm of breast A0 EC A . . . EC A . . . EC A . . . EC A . . . EC A . . . EC A . . . ED A BECLOMETHASONE d00760A Bz R06.2 Wheezing A ED A . . . ED A ASPIRIN d00170A C Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A ED A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A ED0 A . . . ED@ A . . . EDP A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C[@ Z79.3 Long term (current) use of hormonal contraceptives A ED` A . . . EDp A ALBUTEROL d00749A B J45 Asthma A` EDp A ALBUTEROL d00749A C J45 Asthma A` EDp A BECLOMETHASONE d00760A C J45 Asthma A` EDp A CETIRIZINE d03827A C T78.40 Allergy, unspecified A` EDp A MONTELUKAST d04289A C J45 T78.40 Asthma Allergy, unspecified A` EDp A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A` ED A . . . ED A . . . ED A . . . ED A . . . ED A . . . ED A . . . ED A METFORMIN d03807A C R73 Elevated blood glucose level A ED A . . . EE A . . . EE A . . . EE A . . . EE0 A ACETAMINOPHEN; CODEINE d03423A A M25.5 Pain in joint A0 EE0 A CEPHALEXIN d00096A0 Ap T14.9 Unspecified injury A0 EE0 A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A0 A A49.9P Prevent bacterial infection A0 EE@ A ACETAMINOPHEN; CODEINE d03423A C M54 Dorsalgia A EEP A . . . EE` A LETROZOLE d04156A A0 C50 Malignant neoplasm of breast A EE` A VENLAFAXINE d03181A CDp F32.9 Major depressive disorder, single episode, unspecified A EEp A GEMFIBROZIL d00245A Dc E78.0 Pure hypercholesterolemia A EE A . . . EE A AMITRIPTYLINE d00146A CDp M62.83 Muscle spasm AP EE A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia AP EE A CHLORTHALIDONE d00192A CDp I10 Essential (primary) hypertension AP EE A PREGABALIN d05508A CDp F41.9 Anxiety disorder, unspecified AP EE A TIZANIDINE d04102A C- M54 Dorsalgia AP EE A AMLODIPINE d00689A C I10 Essential (primary) hypertension A EE A CYCLOBENZAPRINE d00963A C R52 Pain, unspecified A EE A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A EE A METOPROLOL d00134A C I10 Essential (primary) hypertension A EE A NAPROXEN d00019A C M54 Dorsalgia A EE A NIACIN d00314A Cr I21.P Prevent heart attack/myocardial infarction A EE A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia A EE A RANITIDINE d00021A B[ K21 Gastro-esophageal reflux disease A EE A . . . EE A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia A@ EE A INSULIN GLARGINE d04538A Dc E11 Type 2 diabetes mellitus A@ EE A INSULIN LISPRO d04373A D E11 Type 2 diabetes mellitus A@ EE A RAMIPRIL d00728A Dc I10 Essential (primary) hypertension A@ EE A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A` EE A CANAGLIFLOZIN d08080A C- E11 Type 2 diabetes mellitus A` EE A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A` EE A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A` EE A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` EE A RAMIPRIL d00728A C I10 Essential (primary) hypertension A` EE A AMLODIPINE d00689A C I10 Essential (primary) hypertension Ap EE A GLIMEPIRIDE d03864A C[@ E11 Type 2 diabetes mellitus Ap EE A LISINOPRIL d00732A C I10 Essential (primary) hypertension Ap EE A METFORMIN d03807A C E11 Type 2 diabetes mellitus Ap EE A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension Ap EE A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia Ap EE A VENLAFAXINE d03181A D F32.9 Major depressive disorder, single episode, unspecified Ap EE A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A EF A . . . EF A . . . EF A ATORVASTATIN d04105A Ei 99999 A EF A CLOPIDOGREL d04258A Ei 99999 A EF A FUROSEMIDE d00070A Ei 99999 A EF A GABAPENTIN d03182A Ei 99999 A EF A GLIMEPIRIDE d03864A Ei 99999 A EF A INSULIN GLARGINE d04538A Ei 99999 A EF A LOSARTAN d03821A Ei 99999 A EF A METOPROLOL d00134A Ei 99999 A EF A SITAGLIPTIN d05896A Ei 99999 A EF0 A CETIRIZINE d03827A CDp T78.40 Allergy, unspecified A EF@ A EVOLOCUMAB d08383A B E78.0 Pure hypercholesterolemia A` EF@ A GABAPENTIN d03182A C E11.4 Type 2 diabetes mellitus with neurological complications A` EF@ A INSULIN LISPRO d04373A C E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A` EF@ A LETROZOLE d04156A CDp C50 Malignant neoplasm of breast A` EF@ A LOSARTAN d03821A Ap I10 Essential (primary) hypertension A` EF@ A PREGABALIN d05508A C- E11.4 Type 2 diabetes mellitus with neurological complications A` EFP A ATENOLOL d00004A B= I10 Essential (primary) hypertension A EF` A ATORVASTATIN d04105A0 B= E78.0 Pure hypercholesterolemia A EF` A FLUOXETINE d00236A0 Bz 99999 A EF` A GABAPENTIN d03182A0 B= G40 Epilepsy and recurrent seizures A EF` A IBUPROFEN d00015A0 B M19.9 Osteoarthritis, unspecified site A EF` A LISINOPRIL d00732A0 C[@ I10 Essential (primary) hypertension A EF` A MELOXICAM d04532A0 B M13 Other arthritis A EF` A PANTOPRAZOLE d04514A0 B K21 Gastro-esophageal reflux disease A EF` A PREGABALIN d05508A0 B E11.4 G40 Type 2 diabetes mellitus with neurological complications Epilepsy and recurrent seizures A EFp A . . . EF A . . . EF A . . . EF A INSULIN GLARGINE d04538A D# E11 Type 2 diabetes mellitus A EF A LEVOFLOXACIN d04109A AP N42.9 Disorder of prostate, unspecified A EF A LISINOPRIL d00732A C- K76.9P Prevent liver disease A EF A METFORMIN d03807A D E11 Type 2 diabetes mellitus A EF A OMEPRAZOLE d00325A C K31.9 Disease of stomach and duodenum, unspecified A EF A PREGABALIN d05508A C M79.6 Pain in limb, hand, foot, fingers and toes A EF A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A EF A SUCRALFATE d00377A AP N42.9 Disorder of prostate, unspecified A EF A . . . EF A . . . EF A . . . EF A . . . EF A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A C I10 Essential (primary) hypertension A EG A . . . EG A . . . EG A . . . EG0 A . . . EG@ A . . . EGP A LEVETIRACETAM d04499A D G40 Epilepsy and recurrent seizures A EGP A PHENOBARBITAL d00340A D G40 Epilepsy and recurrent seizures A EG` A . . . EGp A . . . EG A . . . EG A . . . EG A MONTELUKAST d04289A C J30.9 R06.2 Allergic rhinitis, unspecified Wheezing A EG A . . . EG A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A0 EG A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A0 EG A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 EG A ACETAMINOPHEN; HYDROCODONE d03428A C- M79.7 Fibromyalgia AP EG A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Cr I10 Essential (primary) hypertension AP EG A NAPROXEN d00019A C Z79.1 Long term (current) use of non-steroidal anti-inflammatories (NSAID) AP EG A TERBINAFINE d04012A A B35 Dermatophytosis AP EG A TIZANIDINE d04102A B M62.83 Muscle spasm AP EG A ALBUTEROL d00749A C R06.02 Shortness of breath A EG A ALLOPURINOL d00023A Cr M10.9P Prevent gout A EG A CARVEDILOL d03847A Cr R60.9 Edema, unspecified A EG A DIGOXIN d00210A Cr I50.9 Heart failure, unspecified A EG A FUROSEMIDE d00070A Cr R60.9 Edema, unspecified A EG A INSULIN GLARGINE d04538A C- E11 Type 2 diabetes mellitus A EG A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A EG A OXYGEN a54115A C J43 Emphysema A EG A SPIRONOLACTONE d00373A Cr I51.9 Heart disease, unspecified A EG A WARFARIN d00022A Cr D75.9P Prevent blood clots A EG A . . . EH A . . . EH A . . . EH A . . . EH0 A . . . EH@ A 99999 . . A EHP A . . . EH` A HYDROXYZINE d00907A B[ F41.9 Anxiety disorder, unspecified A0 EH` A METOPROLOL d00134A B I49.9 Cardiac arrhythmia, unspecified A0 EH` A PAROXETINE d03157A B[ F32.9 Major depressive disorder, single episode, unspecified A0 EHp A ALBUTEROL d00749A B[ J45 Asthma A` EHp A FLUTICASONE NASAL d04283A B[ J30.9 Allergic rhinitis, unspecified A` EHp A FLUTICASONE; SALMETEROL d04611A C J45 Asthma A` EHp A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A` EHp A MONTELUKAST d04289A B[ J45 Asthma A` EHp A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease A` EH A . . . EH A . . . EH A DEXTROMETHORPHAN; PROMETHAZINE d03360A C- R05 Cough A0 EH A IBUPROFEN d00015A C[@ R50.9 Fever, unspecified A0 EH A TOBRAMYCIN d00069A A H57.9 Unspecified disorder of eye and adnexa A0 EH A . . . EH A ALBUTEROL d00749A D J44.9 Chronic obstructive pulmonary disease, unspecified A EH A BUDESONIDE; FORMOTEROL d04795A D J44.9 Chronic obstructive pulmonary disease, unspecified A EH A ENALAPRIL d00013A D I10 Essential (primary) hypertension A EH A FLUTICASONE NASAL d04283A D J30.2 Other seasonal allergic rhinitis A EH A FUROSEMIDE d00070A D R60.9 Edema, unspecified A EH A GUAIFENESIN d00797A D R09.3 Abnormal sputum A EH A IPRATROPIUM NASAL d04235A D R09.81 Nasal congestion A EH A POTASSIUM CHLORIDE d00345A D E87.6 Hypokalemia A EH A SPIRONOLACTONE d00373A D I10 Essential (primary) hypertension A EH A TAMSULOSIN d04121A D N40 R35 Enlarged prostate Polyuria A EH A WARFARIN d00022A D Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A EH A ALBUTEROL d00749A Cr J45 Asthma A0 EH A BECLOMETHASONE d00760A Cr J45 Asthma A0 EH A MONTELUKAST d04289A C J45 Asthma A0 EH A . . . EH A . . . EI A . . . EI A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A EI A METOPROLOL d00134A C E07.9 Disorder of thyroid, unspecified A EI A AMLODIPINE; OLMESARTAN d06905A D* I10 Essential (primary) hypertension A@ EI A LEVOTHYROXINE d00278A D6. E03.9 Hypothyroidism, unspecified A@ EI A RISEDRONATE d04300A D M81 Osteoporosis without current pathological fracture A@ EI A ROSUVASTATIN d04851A D E78.0 Pure hypercholesterolemia A@ EI0 A OLANZAPINE d04050A B G47.0 Insomnia A EI@ A CIPROFLOXACIN d00011A Ap N30 Cystitis A EIP A . . . EI` A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A EIp A . . . EI A . . . EI A . . . EI A . . . EI A . . . EI A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C F90 Attention-deficit hyperactivity disorders A EI A . . . EI A . . . EI A . . . EJ A . . . EJ A . . . EJ A . . . EJ0 A . . . EJ@ A . . . EJP A AMIODARONE d00002A CDp I10 Essential (primary) hypertension A EJP A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A EJP A APIXABAN d07804A B D75.9P Prevent blood clots A EJP A CLOPIDOGREL d04258A C I70.P Prevent atherosclerosis A EJP A FUROSEMIDE d00070A B[ I48.9 Unspecified atrial fibrillation and atrial flutter A EJP A ISOSORBIDE DINITRATE d00268A Cr I10 Essential (primary) hypertension A EJP A LOSARTAN d03821A B= I10 Essential (primary) hypertension A EJP A NITROGLYCERIN d00321A D R07.9 Chest pain, unspecified A EJP A PRAVASTATIN d00348A D E78.0 Pure hypercholesterolemia A EJ` A . . . EJp A . . . EJ A AMOXICILLIN d00088A Ap H66.9 Otitis media, unspecified A EJ A METOPROLOL d00134A Dc I10 Essential (primary) hypertension A EJ A . . . EJ A BUPROPION d00181A C F39 Unspecified mood [affective] disorder A0 EJ A CLONIDINE d00044A C F41.9 Anxiety disorder, unspecified A0 EJ A LURASIDONE d07705A Cr F20 Schizophrenia A0 EJ A . . . EJ A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A@ EJ A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A@ EJ A LISINOPRIL d00732A D= I10 Essential (primary) hypertension A@ EJ A RIVAROXABAN d07356A C I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified A@ EJ A FAMOTIDINE d00141A Cr K21 Gastro-esophageal reflux disease AP EJ A FINASTERIDE d00563A C N40 Enlarged prostate AP EJ A FUROSEMIDE d00070A C- I51.9 Heart disease, unspecified AP EJ A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia AP EJ A WARFARIN d00022A C I48.9 Unspecified atrial fibrillation and atrial flutter AP EJ A . . . EK A . . . EK A . . . EK A ACYCLOVIR d00001A D* A60.9 Anogenital herpesviral infection, unspecified A@ EK A CARVEDILOL d03847A D I49.9 Cardiac arrhythmia, unspecified A@ EK A FOSINOPRIL d00242A C I51.9 Heart disease, unspecified A@ EK A TAMSULOSIN d04121A D1 N42.9 Disorder of prostate, unspecified A@ EK0 A ACETAMINOPHEN; TRAMADOL d04766A A M79.1 Myalgia Ap EK0 A ALLOPURINOL d00023A B[ M10.9P Prevent gout Ap EK0 A FUROSEMIDE d00070A B R60.9 Edema, unspecified Ap EK0 A INSULIN LISPRO d04373A C[@ E11 Type 2 diabetes mellitus Ap EK0 A METOPROLOL d00134A C I10 Essential (primary) hypertension Ap EK0 A MONTELUKAST d04289A C- J45 Asthma Ap EK0 A PANTOPRAZOLE d04514A B[ K30 Functional dyspepsia Ap EK@ A AMOXICILLIN d00088A B K05.6 Periodontal disease, unspecified A` EK@ A CLOPIDOGREL d04258A B I51.9 Heart disease, unspecified A` EK@ A CLOTRIMAZOLE TOPICAL d04395A C R21 Rash and other nonspecific skin eruption A` EK@ A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A` EK@ A OXYCODONE d00329A C- M25.5 M54 Pain in joint Dorsalgia A` EK@ A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A` EKP A . . . EK` A . . . EKp A TERCONAZOLE TOPICAL d01238A A` B37 Candidiasis A EK A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C- Z79.3 Long term (current) use of hormonal contraceptives A EK A ALOGLIPTIN; PIOGLITAZONE d07965A C R73 Elevated blood glucose level AP EK A ATORVASTATIN d04105A C"0 E78.0 Pure hypercholesterolemia AP EK A GLIPIZIDE d00246A B E11 Type 2 diabetes mellitus AP EK A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension AP EK A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus AP EK A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 EK A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A0 EK A ZONISAMIDE d04527A C R51 Headache A0 EK A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP EK A DABIGATRAN d07137A C- D75.9P I49.9 Prevent blood clots Cardiac arrhythmia, unspecified AP EK A FINASTERIDE d00563A Cr N40 Enlarged prostate AP EK A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP EK A PANTOPRAZOLE d04514A B= K30 Functional dyspepsia AP EK A CITALOPRAM d04332A C F32.9 Major depressive disorder, single episode, unspecified A EK A ELETRIPTAN d04849A C"0 G43 Migraine A EK A GABAPENTIN d03182A C"0 M79.2 Neuralgia and neuritis, unspecified A EK A NAPROXEN d00019A C"0 G43 Migraine A EK A NORTRIPTYLINE d00144A B= G43 Migraine A EK A PROPRANOLOL d00032A C"0 G43 I10 Migraine Essential (primary) hypertension A EK A SUMATRIPTAN d03160A C G43 Migraine A EK A TIZANIDINE d04102A C"0 G43 G47.9 Migraine Sleep disorder, unspecified A EK A TOPIRAMATE d04115A C"0 G43 Migraine A EK A ATORVASTATIN d04105A C[@ I10 Essential (primary) hypertension AP EK A CLOPIDOGREL d04258A C I10 Essential (primary) hypertension AP EK A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified AP EK A METOPROLOL d00134A C- I10 Essential (primary) hypertension AP EK A RAMIPRIL d00728A C- I10 Essential (primary) hypertension AP EK A . . . EK A NAPROXEN d00019A B G43 Migraine A EL A DICLOFENAC d00848A C- M25.5 Pain in joint A EL A . . . EL A . . . EL0 A AMITRIPTYLINE d00146A C M79.2 Neuralgia and neuritis, unspecified Ap EL0 A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia Ap EL0 A BACLOFEN d00967A C M62.83 Muscle spasm Ap EL0 A COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR d07899A D B20 Human immunodeficiency virus [HIV] disease Ap EL0 A DARUNAVIR d05825A D B20 Human immunodeficiency virus [HIV] disease Ap EL0 A METOPROLOL d00134A C I10 Essential (primary) hypertension Ap EL0 A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease Ap EL@ A FUROSEMIDE d00070A B[ I51.9 Heart disease, unspecified A ELP A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A` ELP A INSULIN ASPART d04697A CDp E11 Type 2 diabetes mellitus A` ELP A INSULIN DETEMIR d05436A CDp E11 Type 2 diabetes mellitus A` ELP A LISINOPRIL d00732A C I10 Essential (primary) hypertension A` ELP A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` ELP A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia A` EL` A . . . ELp A ACETAMINOPHEN; CODEINE d03423A B K87 Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere A ELp A ALBUTEROL d00749A D J45 R06.02 R06.2 Asthma Shortness of breath Wheezing A ELp A AMITRIPTYLINE d00146A B F32.9 G47.0 Major depressive disorder, single episode, unspecified Insomnia A ELp A ATORVASTATIN d04105A B[ E78.0 Pure hypercholesterolemia A ELp A FLUTICASONE; VILANTEROL d08100A C- R06.2 Wheezing A ELp A FUROSEMIDE d00070A C I50.9 Heart failure, unspecified A ELp A GABAPENTIN d03182A D= M79.2 Neuralgia and neuritis, unspecified A ELp A INSULIN ASPART d04697A D= E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A ELp A INSULIN DETEMIR d05436A D= E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A ELp A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A ELp A METFORMIN d03807A Bz R73 Elevated blood glucose level A ELp A METOPROLOL d00134A C"0 I10 R00 Essential (primary) hypertension Abnormalities of heart beat A ELp A PROMETHAZINE d00787A B R11 Nausea and vomiting A EL A . . . EL A . . . EL A AMLODIPINE d00689A Dc I10 Essential (primary) hypertension A EL A CHLORTHALIDONE d00192A C I10 Essential (primary) hypertension A EL A CLONIDINE d00044A C I10 Essential (primary) hypertension A EL A DOCUSATE d01021A C K59.0 Constipation A EL A GABAPENTIN d03182A C- E11.4 Type 2 diabetes mellitus with neurological complications A EL A INSULIN ASPART d04697A C E11 Type 2 diabetes mellitus A EL A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A EL A ISOSORBIDE MONONITRATE d00269A C I51.9P Prevent heart disease A EL A LISINOPRIL d00732A Ap I10 N19 Essential (primary) hypertension Unspecified kidney failure A EL A METOPROLOL d00134A D= I10 Essential (primary) hypertension A EL A NITROGLYCERIN d00321A D= I20.9 Angina pectoris, unspecified A EL A OMEPRAZOLE d00325A C[@ K21 Gastro-esophageal reflux disease A EL A ROSUVASTATIN d04851A Cr E78.0 Pure hypercholesterolemia A EL A SERTRALINE d00880A C- F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A EL A . . . EL A . . . EL A . . . EL A . . . EL A . . . EM A DONEPEZIL d04099A C R41 Other symptoms and signs involving cognitive functions and awareness A0 EM A FUROSEMIDE d00070A C 99999 A0 EM A LOVASTATIN d00280A C I21.P Prevent heart attack/myocardial infarction A0 EM A . . . EM A . . . EM0 A . . . EM@ A . . . EMP A . . . EM` A . . . EMp A LEVOTHYROXINE d00278A D=O E03.9 Hypothyroidism, unspecified A0 EMp A LISINOPRIL d00732A CP I10 Essential (primary) hypertension A0 EMp A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia A0 EM A ALLOPURINOL d00023A B E79.9 Disorder of purine and pyrimidine metabolism, unspecified A` EM A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A` EM A GLIMEPIRIDE d03864A CDp R73 Elevated blood glucose level A` EM A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A` EM A LISINOPRIL d00732A C I10 Essential (primary) hypertension A` EM A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A` EM A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A@ EM A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ EM A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A@ EM A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A@ EM A . . . EM A . . . EM A AMLODIPINE; BENAZEPRIL d03829A Bz I10 Essential (primary) hypertension A EM A ATENOLOL; CHLORTHALIDONE d03258A Bz I10 Essential (primary) hypertension A EM A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A0 EM A CHLORTHALIDONE d00192A C- I10 Essential (primary) hypertension A0 EM A FENOFIBRATE d04286A C- E78.0 Pure hypercholesterolemia A0 EM A ALLOPURINOL d00023A Cr M10.9 Gout, unspecified AP EM A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia AP EM A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension AP EM A METFORMIN d03807A Cr R73 Elevated blood glucose level AP EM A METOPROLOL d00134A Cr I10 Essential (primary) hypertension AP EM A . . . EN A . . . EN A . . . EN A . . . EN0 A . . . EN@ A . . . ENP A ALBUTEROL d00749A Ap J45 Asthma A ENP A CETIRIZINE d03827A Ap T78.40 Allergy, unspecified A EN` A . . . ENp A . . . EN A . . . EN A AMLODIPINE d00689A C I10 Essential (primary) hypertension A EN A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A EN A FLECAINIDE d00234A C I49.9 Cardiac arrhythmia, unspecified A EN A BENZONATATE d00796A C 99999 B EN A CONJUGATED ESTROGENS d00541A Cr Z79.890 Hormone replacement therapy B EN A CYCLOBENZAPRINE d00963A D* M62.83 Muscle spasm B EN A FESOTERODINE d07162A Cr N32.81 Overactive bladder B EN A FORMOTEROL; MOMETASONE d07660A CDp J45 Asthma B EN A FUROSEMIDE d00070A D1 I10 I51.9 Essential (primary) hypertension Heart disease, unspecified B EN A HYDROXYZINE d00907A Dc L23 Allergic contact dermatitis B EN A LAMOTRIGINE d03809A C 99999 B EN A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified B EN A LIDOCAINE TOPICAL d00683A D M62.83 Muscle spasm B EN A LORAZEPAM d00149A D* G47.0 Insomnia B EN A MEMANTINE d04899A C G40 Epilepsy and recurrent seizures B EN A OLMESARTAN d04801A C I10 Essential (primary) hypertension B EN A OLOPATADINE OPHTHALMIC d04117A CDp H10 H57.9 Conjunctivitis Unspecified disorder of eye and adnexa B EN A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease B EN A PROMETHAZINE d00787A Dc R11 Nausea and vomiting B EN A PROPRANOLOL d00032A D# I10 R25.1 Essential (primary) hypertension Tremor, unspecified B EN A RIVASTIGMINE d04537A C R41 Other symptoms and signs involving cognitive functions and awareness B EN A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia B EN A ACETAMINOPHEN; BUTALBITAL; CAFFEINE d03455A0 C[@ G43 Migraine A EN A TOPIRAMATE d04115A0 C[@ G43 Migraine A EN A AMOXICILLIN; CLAVULANATE d00089A AP 55555 A EN A . . . EN A ATENOLOL d00004A D= I10 Essential (primary) hypertension A` EN A FINASTERIDE d00563A C[@ N40 Enlarged prostate A` EN A ISOSORBIDE MONONITRATE d00269A D= I99.9 Unspecified disorder of circulatory system A` EN A LISINOPRIL d00732A D= I10 Essential (primary) hypertension A` EN A SIMVASTATIN d00746A D= E78.0 Pure hypercholesterolemia A` EN A TAMSULOSIN d04121A C[@ N40 Enlarged prostate A` EO A . . . EO A . . . EO A . . . EO0 A . . . EO@ A . . . EOP A CLINDAMYCIN TOPICAL d01241A B L70 Acne A EOP A TRETINOIN TOPICAL d01244A C L70 Acne A EO` A . . . EOp A . . . EO A . . . EO A . . . EO A . . . EO A . . . EO A CYANOCOBALAMIN d00413A C A EO A DONEPEZIL d04099A Bz R41 Other symptoms and signs involving cognitive functions and awareness A EO A CETIRIZINE d03827A Cr T78.40 Allergy, unspecified A EO A LABETALOL d00016A C[@ I10 Essential (primary) hypertension A EO A NIFEDIPINE d00051A C- I10 Essential (primary) hypertension A EO A . . . EP A METFORMIN d03807A B R73 Elevated blood glucose level A EP A . . . EP A . . . EP0 A . . . EP@ A AMLODIPINE d00689A D* I10 Essential (primary) hypertension A EP@ A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A EP@ A FUROSEMIDE d00070A D* R60.9 Edema, unspecified A EP@ A LEVETIRACETAM d04499A D# G40 Epilepsy and recurrent seizures A EP@ A LOSARTAN d03821A C I10 Essential (primary) hypertension A EP@ A METHYLPHENIDATE d00900A B G47.9 Sleep disorder, unspecified A EP@ A METOPROLOL d00134A D* I10 Essential (primary) hypertension A EP@ A VENLAFAXINE d03181A C- G47.9 Sleep disorder, unspecified A EP@ A WARFARIN d00022A D# I63 Cerebral infarction A EPP A . . . EP` A . . . EPp A . . . EP A . . . EP A . . . EP A . . . EP A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A EP A DIVALPROEX SODIUM d03833A Dc G40 Epilepsy and recurrent seizures A EP A ESCITALOPRAM d04812A Dc F32.9 Major depressive disorder, single episode, unspecified A EP A FUROSEMIDE d00070A Dc R60.9 Edema, unspecified A EP A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension A EP A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus A EP A METOPROLOL d00134A Dc I10 Essential (primary) hypertension A EP A POTASSIUM CHLORIDE d00345A Dc E87.6 Hypokalemia A EP A SITAGLIPTIN d05896A Dc E11 Type 2 diabetes mellitus A EP A SPIRONOLACTONE d00373A Dc R60.9 Edema, unspecified A EP A TRAMADOL d03826A Dc M62.83 Muscle spasm A EP A . . . EP A . . . EP A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A@ EP A CLOPIDOGREL d04258A Cr D75.9P Prevent blood clots A@ EP A LISINOPRIL d00732A Cr I21.P Prevent heart attack/myocardial infarction A@ EP A ROSUVASTATIN d04851A C- E78.0 Pure hypercholesterolemia A@ EQ A FUROSEMIDE d00070A B R60.9 Edema, unspecified A EQ A PREDNISONE d00350A B 99999 A EQ A . . . EQ A . . . EQ0 A . . . EQ@ A AMLODIPINE d00689A B[ I10 Essential (primary) hypertension A EQP A CARVEDILOL d03847A C[@ I10 I99.9 Essential (primary) hypertension Unspecified disorder of circulatory system A EQP A DULOXETINE d05355A C[@ F41.9 Anxiety disorder, unspecified A EQ` A 99999 . . A EQ` A ESOMEPRAZOLE d04749A B[ K30 Functional dyspepsia A EQp A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension AP EQp A CANAGLIFLOZIN d08080A CDp E11 Type 2 diabetes mellitus AP EQp A METFORMIN; SITAGLIPTIN d06720A C- E11 Type 2 diabetes mellitus AP EQp A RAMIPRIL d00728A C E11.2P Prevent diabetic kidney disease AP EQp A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia AP EQ A . . . EQ A . . . EQ A . . . EQ Ap . . . EQ A . . . EQ A . . . EQ A CETIRIZINE d03827A CDp R09.81 Nasal congestion A0 EQ A FLUTICASONE NASAL d04283A C J34.9 Unspecified disorder of nose and nasal sinuses A0 EQ A RISPERIDONE d03180A Cr F31.9 R45 Bipolar disorder, unspecified Symptoms and signs involving emotional state A0 EQ A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Cr I10 Essential (primary) hypertension AP EQ A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified AP EQ A MECLIZINE d00859A D= R42 Dizziness and giddiness AP EQ A ONDANSETRON d00867A Cr R11 Nausea and vomiting AP EQ A PAROXETINE d03157A D= F32.9 Major depressive disorder, single episode, unspecified AP ER A . . . ER A . . . ER A LEVONORGESTREL d00557A B Z79.3 Long term (current) use of hormonal contraceptives A ER0 A . . . ER@ A ATORVASTATIN d04105A CDp 99999 A@ ER@ A GLIMEPIRIDE d03864A CDp E11 Type 2 diabetes mellitus A@ ER@ A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A CDp 99999 A@ ER@ A METFORMIN d03807A D E11 Type 2 diabetes mellitus A@ ERP A HYDROXYCHLOROQUINE d00817A Dc D89.9 Disorder involving the immune mechanism, unspecified A0 ERP A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 ERP A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A0 ER` A ALBUTEROL d00749A C J42 Unspecified chronic bronchitis A ER` A ALBUTEROL; IPRATROPIUM d04066A C J42 Unspecified chronic bronchitis A ER` A ASPIRIN; DIPYRIDAMOLE d04497A CDp I63.P Prevent stroke A ER` A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A ER` A CARVEDILOL d03847A C I10 Essential (primary) hypertension A ER` A DICLOFENAC d00848A C- M79.2 Neuralgia and neuritis, unspecified A ER` A DONEPEZIL d04099A C R41 Other symptoms and signs involving cognitive functions and awareness A ER` A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A ER` A HYDROCORTISONE d00254A D E27.9 Disorder of adrenal gland, unspecified A ER` A NITROGLYCERIN d00321A D I50.9 Heart failure, unspecified A ER` A SPIRONOLACTONE d00373A C I10 Essential (primary) hypertension A ERp A DOCUSATE d01021A A K59.0 Constipation A` ERp A FLUCONAZOLE d00071A C- N28.9 Disorder of kidney and ureter, unspecified A` ERp A FUROSEMIDE d00070A C 99999 A` ERp A MORPHINE d00308A C G89 Pain, not elsewhere classified A` ERp A POTASSIUM CHLORIDE d00345A Ap 99999 A` ERp A PREDNISONE d00350A C C80.1 Malignant (primary) neoplasm, unspecified A` ER A ACETAMINOPHEN; HYDROCODONE d03428A B T14.9 Unspecified injury A ER A . . . ER A AMOXICILLIN d00088A A@ H66.9 J02 Otitis media, unspecified Acute pharyngitis A ER A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A ER A . . . ER A ACETAMINOPHEN; HYDROCODONE d03428A Cr M54 Dorsalgia A ER A ALLOPURINOL d00023A Ei M1A Chronic gout A ER A ALPRAZOLAM d00168A C G47.0 Insomnia A ER A ATORVASTATIN d04105A Ei 99999 A ER A DOXAZOSIN d00726A Cr I10 R35 Essential (primary) hypertension Polyuria A ER A FUROSEMIDE d00070A Ei I51.9 R60.9 Heart disease, unspecified Edema, unspecified A ER A LEVOTHYROXINE d00278A Ei 99999 A ER A MEMANTINE d04899A B R41 Other symptoms and signs involving cognitive functions and awareness A ER A METOPROLOL d00134A Ei 99999 A ER A RIVAROXABAN d07356A C I48.9 Unspecified atrial fibrillation and atrial flutter A ER A LISINOPRIL d00732A D* I10 Essential (primary) hypertension A ER A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A ER A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A0 ER A CITALOPRAM d04332A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A0 ER A LORAZEPAM d00149A C F41.0 Panic disorder [episodic paroxysmal anxiety] without agoraphobia A0 ES A . . . ES A ATENOLOL d00004A A I10 Essential (primary) hypertension A ES A NAPROXEN d00019A B R51 Headache A ES A . . . ES0 A ATENOLOL d00004A D& I10 Essential (primary) hypertension A` ES0 A GABAPENTIN d03182A Cr M79.2 Neuralgia and neuritis, unspecified A` ES0 A HYDROCHLOROTHIAZIDE d00253A D& I10 Essential (primary) hypertension A` ES0 A LISINOPRIL d00732A D& I10 Essential (primary) hypertension A` ES0 A TRAZODONE d00395A C G47.0 Insomnia A` ES0 A ZOLPIDEM d00910A CDp G47.9 Sleep disorder, unspecified A` ES@ A AMLODIPINE d00689A0 Cr I10 Essential (primary) hypertension A@ ES@ A BENAZEPRIL; HYDROCHLOROTHIAZIDE d03265A0 C I10 Essential (primary) hypertension A@ ES@ A CIPROFLOXACIN d00011A0 B N30 N39.0 Cystitis Urinary tract infection, site not specified A@ ES@ A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease A@ ESP A HYDROXYZINE d00907A C- I10 Essential (primary) hypertension A@ ESP A IBUPROFEN d00015A C R51 Headache A@ ESP A NITROFURANTOIN d00112A A J02 Acute pharyngitis A@ ESP A ONDANSETRON d00867A A R11 Nausea and vomiting A@ ES` A . . . ESp A . . . ES A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A ES A . . . ES A ALBUTEROL d00749A Dc J45 R06.2 R07.9 Asthma Wheezing Chest pain, unspecified A ES A METFORMIN d03807A D1 R73 Elevated blood glucose level A ES A CEPHALEXIN d00096A A K08.8 Other specified disorders of teeth and supporting structures A ES A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A ES A METFORMIN d03807A C E11 Type 2 diabetes mellitus A ES A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A` ES A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A` ES A GLIPIZIDE d00246A Cr E11 Type 2 diabetes mellitus A` ES A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A` ES A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A` ES A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A` ES A . . . ET A . . . ET A METFORMIN d03807A B= E11 Type 2 diabetes mellitus A0 ET A METOPROLOL d00134A Dc I10 Essential (primary) hypertension A0 ET A VALSARTAN d04113A Dc I10 Essential (primary) hypertension A0 ET A . . . ET0 A . . . ET@ A . . . ETP A LOSARTAN d03821A C I10 Essential (primary) hypertension A0 ETP A METOPROLOL d00134A D I10 Essential (primary) hypertension A0 ETP A NIFEDIPINE d00051A C I10 Essential (primary) hypertension A0 ET` A LINAGLIPTIN; METFORMIN d07825A Bz E11 E78.0 Type 2 diabetes mellitus Pure hypercholesterolemia A ETp A PAROXETINE d03157A D F41.9 Anxiety disorder, unspecified A ETp A USTEKINUMAB d07396A B L40 Psoriasis A ET A . . . ET A . . . ET A . . . ET A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A ET A LISINOPRIL d00732A C I10 Essential (primary) hypertension A ET A . . . ET A . . . ET A CITALOPRAM d04332A C M79.2 Neuralgia and neuritis, unspecified A@ ET A LEVOTHYROXINE d00278A CDp E07.9 Disorder of thyroid, unspecified A@ ET A METOPROLOL d00134A C I10 Essential (primary) hypertension A@ ET A WARFARIN d00022A C D75.9P Prevent blood clots A@ ET A . . . EU A . . . EU A 99999 . . A EU A AMOXICILLIN d00088A A J18.9 Pneumonia, unspecified organism A EU0 A ACETAMINOPHEN; HYDROCODONE d03428A C- M13 M54 M79.1 Other arthritis Dorsalgia Myalgia A0 EU0 A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Cr I10 Essential (primary) hypertension A0 EU0 A METHOTREXATE d00060A C M06.9 Rheumatoid arthritis, unspecified A0 EU@ A METFORMIN d03807A D E11 Type 2 diabetes mellitus A0 EU@ A OMEPRAZOLE d00325A D K30 Functional dyspepsia A0 EU@ A PRAVASTATIN d00348A D E78.0 Pure hypercholesterolemia A0 EUP A . . . EU` A . . . EUp A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A` EUp A LISINOPRIL d00732A B I10 Essential (primary) hypertension A` EUp A METHOCARBAMOL d00965A D M62.83 Muscle spasm A` EUp A MONTELUKAST d04289A Bz H04 J30.9 R05 Disorders of lacrimal system Allergic rhinitis, unspecified Cough A` EUp A TAMSULOSIN d04121A Bz R35 Polyuria A` EUp A TRAMADOL d03826A D M54 T14.9 Dorsalgia Unspecified injury A` EU A ESCITALOPRAM d04812A CDp F32.9 Major depressive disorder, single episode, unspecified A@ EU A LOSARTAN d03821A C- I10 Essential (primary) hypertension A@ EU A METOPROLOL d00134A C G43.P R42 Prevent migraine Dizziness and giddiness A@ EU A OMEPRAZOLE d00325A CDp K30 Functional dyspepsia A@ EU A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A0 EU A LORAZEPAM d00149A C[@ F41.9 Anxiety disorder, unspecified A0 EU A TIOTROPIUM d04829A C- J44.9 Chronic obstructive pulmonary disease, unspecified A0 EU A . . . EU A AMLODIPINE d00689A B I10 Essential (primary) hypertension A EU A BACLOFEN d00967A C M62.83 Muscle spasm A EU A DULOXETINE d05355A C R07.9 Chest pain, unspecified A EU A GABAPENTIN d03182A C M54 Dorsalgia A EU A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A EU A TAMSULOSIN d04121A C R35 Polyuria A EU A TRAMADOL d03826A C R51 Headache A EU A VALACYCLOVIR d03838A C R52 Pain, unspecified A EU A ZOLPIDEM d00910A Cr G47.0 Insomnia A EU A . . . EU A . . . EU A . . . EU A ACETAMINOPHEN; HYDROCODONE d03428A C M54 M79.1 M79.6 Dorsalgia Myalgia Pain in limb, hand, foot, fingers and toes A0 EU A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 EU A ZOLPIDEM d00910A Cr G47.0 Insomnia A0 EV A . . . EV A . . . EV A . . . EV0 A ACETAMINOPHEN; BUTALBITAL; CAFFEINE d03455A C- R51 Headache A0 EV0 A CYCLOBENZAPRINE d00963A D M54 Dorsalgia A0 EV0 A IBUPROFEN d00015A C- M54 Dorsalgia A0 EV@ A METHYLPREDNISOLONE d00293A B M10.9 Gout, unspecified A EVP A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A EVP A METFORMIN d03807A Dc R73 Elevated blood glucose level A EV` A ALLOPURINOL d00023A D M10.9P Prevent gout AP EV` A AMLODIPINE d00689A D 99999 AP EV` A LISINOPRIL d00732A D 99999 AP EV` A METOPROLOL d00134A D I10 Essential (primary) hypertension AP EV` A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease AP EVp A . . . EV A . . . EV A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A EV A EMPAGLIFLOZIN; METFORMIN d08384A B[ E11 Type 2 diabetes mellitus A EV A AMITRIPTYLINE d00146A C G43 Migraine A` EV A BACLOFEN d00967A B M54 Dorsalgia A` EV A METOPROLOL d00134A B= R00 Abnormalities of heart beat A` EV A PANTOPRAZOLE d04514A C K21 R12 Gastro-esophageal reflux disease Heartburn A` EV A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A` EV A VENLAFAXINE d03181A C F32.9 Major depressive disorder, single episode, unspecified A` EV A ALBUTEROL d00749A A` J20.9 Acute bronchitis, unspecified Ap EV A ALBUTEROL d00749A A` J20.9 Acute bronchitis, unspecified Ap EV A AZITHROMYCIN d00091A AP J20.9 J42 Acute bronchitis, unspecified Unspecified chronic bronchitis Ap EV A DEXTROMETHORPHAN; PROMETHAZINE d03360A A` J20.9 R05 R09.81 Acute bronchitis, unspecified Cough Nasal congestion Ap EV A FLUTICASONE d01296A A` J20.9 Acute bronchitis, unspecified Ap EV A IBUPROFEN d00015A A0 R50.9 Fever, unspecified Ap EV A MONTELUKAST d04289A A` J42 Unspecified chronic bronchitis Ap EV A . . . EV A . . . EV A . . . EW A CINACALCET d05218A0 CP 55555 A EW A EZETIMIBE d04824A0 Dc E78.0 Pure hypercholesterolemia A EW A FLUCONAZOLE d00071A0 D B35 Dermatophytosis A EW A FUROSEMIDE d00070A0 D N28.9 Disorder of kidney and ureter, unspecified A EW A LISINOPRIL d00732A0 CP I10 Essential (primary) hypertension A EW A LORAZEPAM d00149A0 D* F41.9 Anxiety disorder, unspecified A EW A METFORMIN d03807A0 D- E11 Type 2 diabetes mellitus A EW A METOPROLOL d00134A0 D I10 Essential (primary) hypertension A EW A MIRTAZAPINE d04025A0 C F41.9 G47.0 Anxiety disorder, unspecified Insomnia A EW A MYCOPHENOLATE MOFETIL d03839A0 CP T86.9P Prevent transplanted organ and tissue rejection A EW A PARICALCITOL d04312A0 CP 55555 A EW A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A0 CP A49.9P Prevent bacterial infection A EW A TACROLIMUS d03752A0 CP T86.9P Prevent transplanted organ and tissue rejection A EW A TRAMADOL d03826A0 B[ M25.5 Pain in joint A EW A PREDNISONE d00350A B R52 Pain, unspecified A EW A . . . EW0 A . . . EW@ A . . . EWP A AZITHROMYCIN d00091A AP J40 Bronchitis, not specified as acute or chronic A EW` A . . . EWp A TADALAFIL d04896A C- N52.9 Male erectile dysfunction, unspecified A EW A ATENOLOL d00004A A I10 Essential (primary) hypertension A0 EW A CLONAZEPAM d00197A C G47.0 Insomnia A0 EW A DILTIAZEM d00045A Dc I10 Essential (primary) hypertension A0 EW A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C Z79.3 Long term (current) use of hormonal contraceptives A EW A LISDEXAMFETAMINE d06663A C F90 Attention-deficit hyperactivity disorders A EW A . . . EW A . . . EW A . . . EW A . . . EW A . . . EW A ISOSORBIDE d00653A C H40 Glaucoma A` EW A LEVOTHYROXINE d00278A C 99999 A` EW A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` EW A METOPROLOL d00134A C I10 Essential (primary) hypertension A` EW A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A` EW A SITAGLIPTIN d05896A C E11 Type 2 diabetes mellitus A` EX A ALBUTEROL d00749A Ap R05 Cough A0 EX A CODEINE; GUAIFENESIN d03393A Ap J00 Acute nasopharyngitis [common cold] A0 EX A ETHINYL ESTRADIOL; NORELGESTROMIN d04779A B= Z79.3 Long term (current) use of hormonal contraceptives A0 EX A . . . EX A . . . EX0 A . . . EX@ A . . . EXP A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A Bz I10 Essential (primary) hypertension A EXP A METFORMIN d03807A B= R73 Elevated blood glucose level A EX` A . . . EXp A HYDROCHLOROTHIAZIDE d00253A C"0 I10 Essential (primary) hypertension A EXp A LOSARTAN d03821A C"0 I10 Essential (primary) hypertension A EX A . . . EX A . . . EX A AMLODIPINE d00689A0 D I10 Essential (primary) hypertension A EX A ASPIRIN d00170A0 C- 99999 A EX A CARVEDILOL d03847A0 D I10 Essential (primary) hypertension A EX A FAMOTIDINE d00141A0 D K21 Gastro-esophageal reflux disease A EX A FUROSEMIDE d00070A0 D 99999 A EX A INSULIN ISOPHANE (NPH) d04370A0 D* E11 Type 2 diabetes mellitus A EX A ISOSORBIDE MONONITRATE d00269A0 Dc 99999 A EX A SIMVASTATIN d00746A0 D E78.0 Pure hypercholesterolemia A EX A CLONAZEPAM d00197A D F32.9 F41.9 G47.0 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Insomnia A EX A RANITIDINE d00021A C K25 Gastric ulcer A EX A . . . EX A ALPRAZOLAM d00168A D9 F41.9 Anxiety disorder, unspecified A EX A AMLODIPINE d00689A C I10 Essential (primary) hypertension A EX A BACLOFEN d00967A CDp M54 Dorsalgia A EX A FENOFIBRATE d04286A C- E78.1 Pure hyperglyceridemia A EX A FUROSEMIDE d00070A D J98.9 Respiratory disorder, unspecified A EX A GABAPENTIN d03182A B M79.2 Neuralgia and neuritis, unspecified A EX A HYDROCODONE d03075A C[@ M54 Dorsalgia A EX A MONTELUKAST d04289A C J44.9 Chronic obstructive pulmonary disease, unspecified A EX A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A EX A PRAVASTATIN d00348A B= E78.0 Pure hypercholesterolemia A EX A RANITIDINE d00021A C K30 Functional dyspepsia A EX A WARFARIN d00022A CDp I48.9 Unspecified atrial fibrillation and atrial flutter A EX A ALLOPURINOL d00023A Dc M10.9 Gout, unspecified AP EX A CHLORTHALIDONE d00192A Dc I10 Essential (primary) hypertension AP EX A GABAPENTIN d03182A B[ M79.2 Neuralgia and neuritis, unspecified AP EX A LISINOPRIL d00732A D I10 Essential (primary) hypertension AP EX A LOVASTATIN d00280A C- E78.0 Pure hypercholesterolemia AP EX A . . . EY A . . . EY A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A C R60.9 Edema, unspecified A0 EY A METFORMIN; SITAGLIPTIN d06720A C E11 Type 2 diabetes mellitus A0 EY A METOPROLOL d00134A C I10 Essential (primary) hypertension A0 EY A ACETAMINOPHEN; HYDROCODONE d03428A Bz M25.5 Pain in joint A EY0 A . . . EY@ A . . . EYP A FUROSEMIDE d00070A C- I50.9 Heart failure, unspecified A` EYP A GLIMEPIRIDE d03864A C- R73 Elevated blood glucose level A` EYP A LISINOPRIL d00732A Cr I21.P Prevent heart attack/myocardial infarction A` EYP A METFORMIN d03807A D R73 Elevated blood glucose level A` EYP A METOPROLOL d00134A D I10 Essential (primary) hypertension A` EYP A POTASSIUM CHLORIDE d00345A C- E87.6 Hypokalemia A` EY` A . . . EYp A DICLOFENAC TOPICAL d04722A A M79.6 Pain in limb, hand, foot, fingers and toes A EY A . . . EY A ACETAMINOPHEN; OXYCODONE d03431A Cr M25.5 M54 M79.2 Pain in joint Dorsalgia Neuralgia and neuritis, unspecified B EY A ALBUTEROL d00749A Cr J42 Unspecified chronic bronchitis B EY A AMITRIPTYLINE d00146A CDp G47.0 Insomnia B EY A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia B EY A CLOPIDOGREL d04258A Cr D75.9P Prevent blood clots B EY A DEXLANSOPRAZOLE d07395A Cr R10 Abdominal and pelvic pain B EY A DULOXETINE d05355A Dc F32.9 Major depressive disorder, single episode, unspecified B EY A FUROSEMIDE d00070A Cr I51.9 N28.9 Heart disease, unspecified Disorder of kidney and ureter, unspecified B EY A GABAPENTIN d03182A Cr M79.2 Neuralgia and neuritis, unspecified B EY A GLUCAGON d00593A CDp 55555 B EY A INSULIN ASPART d04697A Cr R73 Elevated blood glucose level B EY A INSULIN GLARGINE d04538A D E11 Type 2 diabetes mellitus B EY A LISINOPRIL d00732A Ei E11.2P I10 Prevent diabetic kidney disease Essential (primary) hypertension B EY A METFORMIN d03807A D E11 Type 2 diabetes mellitus B EY A METOPROLOL d00134A Cr I10 Essential (primary) hypertension B EY A PIOGLITAZONE d04442A Dc E11.2P E11.P R73 Prevent diabetic kidney disease Prevent diabetes Elevated blood glucose level B EY A PROMETHAZINE d00787A Cr K30 Functional dyspepsia B EY A ROPINIROLE d04215A Cr G25.81 Restless legs syndrome B EY A SUMATRIPTAN d03160A C- G43 Migraine B EY A . . . EY A . . . EY A ALBUTEROL d00749A0 C R05 Cough A EY A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A EY A CLOPIDOGREL d04258A CDp I21.P Prevent heart attack/myocardial infarction A EY A ESCITALOPRAM d04812A C- E07.9 Disorder of thyroid, unspecified A EY A INSULIN REGULAR d04369A0 C- E11 Type 2 diabetes mellitus A EY A KETOCONAZOLE TOPICAL d03202A0 B B35 Dermatophytosis A EY A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A EY A LISINOPRIL d00732A0 C I10 Essential (primary) hypertension A EY A METFORMIN d03807A0 C E11 Type 2 diabetes mellitus A EY A METOPROLOL d00134A0 CDp I10 Essential (primary) hypertension A EY A OMEPRAZOLE d00325A0 B= K21 Gastro-esophageal reflux disease A EY A OXYBUTYNIN d00328A0 A0 R32 Unspecified urinary incontinence A EY A . . . EY A RANITIDINE d00021A B K21 Gastro-esophageal reflux disease A EY A . . . EZ A . . . EZ A METFORMIN; SITAGLIPTIN d06720A B E11 Type 2 diabetes mellitus A EZ A METOPROLOL d00134A C I10 Essential (primary) hypertension A EZ A ALBUTEROL d00749A Ap J42 Unspecified chronic bronchitis A EZ A BECLOMETHASONE d00760A Ap J42 Unspecified chronic bronchitis A EZ0 A BENAZEPRIL d00730A D E11.2P Prevent diabetic kidney disease A` EZ0 A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus A` EZ0 A HYDROCHLOROTHIAZIDE d00253A Dc 99999 A` EZ0 A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A` EZ0 A METFORMIN; SITAGLIPTIN d06720A C E11 Type 2 diabetes mellitus A` EZ0 A TAMSULOSIN d04121A C R39.1 Other difficulties with micturition A` EZ@ A . . . EZP A . . . EZ` A AMLODIPINE d00689A0 C- I10 Essential (primary) hypertension Ap EZ` A AMOXICILLIN d00088A0 CDp K04.7P Prevent tooth infection Ap EZ` A FLUDROCORTISONE d00608A0 C- E87.6 Hypokalemia Ap EZ` A PRAVASTATIN d00348A0 C9 E78.0 Pure hypercholesterolemia Ap EZ` A SIROLIMUS d04453A0 C- T86.9P Prevent transplanted organ and tissue rejection Ap EZ` A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A0 CDp J18.9 Pneumonia, unspecified organism Ap EZ` A TACROLIMUS d03752A0 CDp T86.9P Prevent transplanted organ and tissue rejection Ap EZp A . . . EZ A ACETAMINOPHEN; OXYCODONE d03431A0 C M54 Dorsalgia A EZ A ALBUTEROL d00749A0 D J45 Asthma A EZ A AMITRIPTYLINE d00146A0 D F41.9 Anxiety disorder, unspecified A EZ A AMLODIPINE d00689A0 C- I10 Essential (primary) hypertension A EZ A ATORVASTATIN d04105A0 C E78.0 Pure hypercholesterolemia A EZ A GABAPENTIN d03182A0 B M54 Dorsalgia A EZ A INSULIN GLARGINE d04538A0 Cr E11 Type 2 diabetes mellitus A EZ A INSULIN LISPRO d04373A0 Cr E11 Type 2 diabetes mellitus A EZ A LANSOPRAZOLE d03828A0 C R12 Heartburn A EZ A METFORMIN d03807A0 C E11 Type 2 diabetes mellitus A EZ A . . . EZ A . . . EZ A . . . EZ A . . . EZ A . . . EZ A . . . EZ A . . . E[ A . . . E[ A CITALOPRAM d04332A C F32.9 Major depressive disorder, single episode, unspecified A E[ A . . . E[0 A . . . E[@ A ACETAMINOPHEN; HYDROCODONE d03428A C M25.5 M54 Pain in joint Dorsalgia A` E[@ A ALBUTEROL d00749A C R06.02 Shortness of breath A` E[@ A CONJUGATED ESTROGENS; MEDROXYPROGESTERONE d03819A C Z79.890 Hormone replacement therapy A` E[@ A DICLOFENAC d00848A Cr Z79.1 Long term (current) use of non-steroidal anti-inflammatories (NSAID) A` E[@ A OXYBUTYNIN d00328A C N32.81 Overactive bladder A` E[@ A TRIAMCINOLONE d00620A Cr M06.9 Rheumatoid arthritis, unspecified A` E[P A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A E[` A . . . E[p A ALBUTEROL d00749A C J45 Asthma A` E[p A BECLOMETHASONE d00760A C J44.9 J45 R06.2 Chronic obstructive pulmonary disease, unspecified Asthma Wheezing A` E[p A DIAZEPAM d00148A D F41.9 G47.0 Anxiety disorder, unspecified Insomnia A` E[p A MONTELUKAST d04289A C J42 J44.9 J45 Unspecified chronic bronchitis Chronic obstructive pulmonary disease, unspecified Asthma A` E[p A OXYBUTYNIN d00328A D= R32 Unspecified urinary incontinence A` E[p A PAROXETINE d03157A C F32.9 F41.9 F43.1 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Post-traumatic stress disorder (PTSD) A` E[ A APIXABAN d07804A Cr I48.9 Unspecified atrial fibrillation and atrial flutter A E[ A GABAPENTIN d03182A D M79.2 Neuralgia and neuritis, unspecified A E[ A GLYBURIDE d00248A Dc E11 Type 2 diabetes mellitus A E[ A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension A E[ A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus A E[ A SIMVASTATIN d00746A Dc E78.0 Pure hypercholesterolemia A E[ A SITAGLIPTIN d05896A Dc E11 Type 2 diabetes mellitus A E[ A TRIAMTERENE d00396A D I10 Essential (primary) hypertension A E[ A AMLODIPINE; BENAZEPRIL d03829A C[@ I10 Essential (primary) hypertension AP E[ A LABETALOL d00016A C[@ I10 Essential (primary) hypertension AP E[ A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia AP E[ A SOLIFENACIN d05413A Cr N32.81 Overactive bladder AP E[ A TAMSULOSIN d04121A Cr N40 Enlarged prostate AP E[ A CLONIDINE d00044A C I10 Essential (primary) hypertension A0 E[ A HYDROCODONE d03075A C- M54 Dorsalgia A0 E[ A OLMESARTAN d04801A CDp I10 Essential (primary) hypertension A0 E[ A . . . E[ A . . . E[ A FLUTICASONE NASAL d04283A CDp J30.2 Other seasonal allergic rhinitis A E[ A . . . E[ A . . . E\ A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A E\ A BROMFENAC OPHTHALMIC d05518A0 C- H57.9 Unspecified disorder of eye and adnexa A` E\ A FLUTICASONE NASAL d04283A0 C T78.40 Allergy, unspecified A` E\ A FUROSEMIDE d00070A0 C R60.9 Edema, unspecified A` E\ A LEVOTHYROXINE d00278A0 D# E03.9 Hypothyroidism, unspecified A` E\ A PANTOPRAZOLE d04514A0 C"0 K25.P K30 Prevent gastric ulcer Functional dyspepsia A` E\ A PRAVASTATIN d00348A0 CL E78.0 Pure hypercholesterolemia A` E\ A . . . E\0 A AZITHROMYCIN d00091A AP J40 Bronchitis, not specified as acute or chronic A E\@ A . . . E\P A IBUPROFEN d00015A Bz M54 Dorsalgia A E\` A ALBUTEROL d00749A D J45 Asthma A E\` A IPRATROPIUM d00265A D J45 Asthma A E\p A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia B E\p A CARVEDILOL d03847A C[@ I10 Essential (primary) hypertension B E\p A CILOSTAZOL d04382A Cr I51.9P Prevent heart disease B E\p A DOCUSATE d01021A C K59.0 Constipation B E\p A FINASTERIDE d00563A C 99999 B E\p A FUROSEMIDE d00070A C R60.9 Edema, unspecified B E\p A INSULIN ASPART d04697A CDp E11 Type 2 diabetes mellitus B E\p A INSULIN GLARGINE d04538A CDp E11 Type 2 diabetes mellitus B E\p A LEVETIRACETAM d04499A Bz I63 Cerebral infarction B E\p A LISINOPRIL d00732A Cr I10 I50.9 Essential (primary) hypertension Heart failure, unspecified B E\p A PANTOPRAZOLE d04514A B K92.9 Disease of digestive system, unspecified B E\p A PREGABALIN d05508A C[@ E11.4 Type 2 diabetes mellitus with neurological complications B E\p A SAXAGLIPTIN d07467A B E11 Type 2 diabetes mellitus B E\p A TERAZOSIN d00386A CDp I10 Essential (primary) hypertension B E\p A TRAMADOL d03826A Cr M79.6 Pain in limb, hand, foot, fingers and toes B E\p A TRAZODONE d00395A C[@ G47.0 Insomnia B E\ A CLOTRIMAZOLE TOPICAL d04395A A B35 Dermatophytosis A E\ A . . . E\ A . . . E\ A . . . E\ A DULOXETINE d05355A C M79.7 Fibromyalgia Ap E\ A HYDROCODONE d03075A C M54 M79.2 Dorsalgia Neuralgia and neuritis, unspecified Ap E\ A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified Ap E\ A METHOCARBAMOL d00965A C M62.83 Muscle spasm Ap E\ A OMEPRAZOLE d00325A AP K30 Functional dyspepsia Ap E\ A PANCRELIPASE d01002A Cr K87 Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere Ap E\ A PREGABALIN d05508A C M79.7 Fibromyalgia Ap E\ A . . . E\ A ATORVASTATIN d04105A A E78.0 Pure hypercholesterolemia A E\ A CITALOPRAM d04332A C F41.9 Anxiety disorder, unspecified A E\ A . . . E] A . . . E] A . . . E] A CLOMIPRAMINE d00876A A F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E] A PAROXETINE d03157A Bz F90 Attention-deficit hyperactivity disorders A E]0 A . . . E]@ A . . . E]P A MONTELUKAST d04289A Cr J30.9 Allergic rhinitis, unspecified A E]` A . . . E]p A . . . E] A INSULIN ISOPHANE (NPH) d04370A CDp E11 Type 2 diabetes mellitus A@ E] A LOSARTAN d03821A CP I10 Essential (primary) hypertension A@ E] A METFORMIN d03807A CP E11 Type 2 diabetes mellitus A@ E] A SIMVASTATIN d00746A CP E78.0 Pure hypercholesterolemia A@ E] A . . . E] A . . . E] A . . . E] A . . . E] A . . . E] A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A E] A METFORMIN d03807A C- R73 Elevated blood glucose level A E] A . . . E^ A . . . E^ A AMLODIPINE d00689A C- I10 Essential (primary) hypertension AP E^ A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia AP E^ A DOXAZOSIN d00726A C- N40 Enlarged prostate AP E^ A GLIPIZIDE d00246A B R73 Elevated blood glucose level AP E^ A METFORMIN d03807A CDp R73 Elevated blood glucose level AP E^ A IBUPROFEN d00015A B= M79.1 Myalgia A E^0 A . . . E^@ A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E^P A AMLODIPINE d00689A C 99999 A` E^P A BICALUTAMIDE d03850A C- C61 Malignant neoplasm of prostate A` E^P A CLONAZEPAM d00197A Dc G47.0 G47.9 Insomnia Sleep disorder, unspecified A` E^P A GABAPENTIN d03182A D 55555 A` E^P A SERTRALINE d00880A C F41.9 Anxiety disorder, unspecified A` E^P A TRAMADOL d03826A C G47.0 M54 Insomnia Dorsalgia A` E^` A . . . E^p A LAMOTRIGINE d03809A Cr F39 Unspecified mood [affective] disorder A E^p A SERTRALINE d00880A Cr F32.9 Major depressive disorder, single episode, unspecified A E^ A CONJUGATED ESTROGENS; MEDROXYPROGESTERONE d03819A CDp N95 Menopausal and other perimenopausal disorders A E^ A . . . E^ A . . . E^ A CLONIDINE d00044A C I10 Essential (primary) hypertension A E^ A LOSARTAN d03821A C I10 Essential (primary) hypertension A E^ A METHENAMINE d00106A Cr N39.0 Urinary tract infection, site not specified A E^ A METOPROLOL d00134A Cr I49.9 Cardiac arrhythmia, unspecified A E^ A MIRTAZAPINE d04025A Cr F32.9 Major depressive disorder, single episode, unspecified A E^ A OMEPRAZOLE d00325A Cr K30 Functional dyspepsia A E^ A ONDANSETRON d00867A Cr R11 Nausea and vomiting A E^ A VENLAFAXINE d03181A Cr F32.9 Major depressive disorder, single episode, unspecified A E^ A . . . E^ A ALLOPURINOL d00023A C- M10.9P Prevent gout AP E^ A ATORVASTATIN d04105A C- I63.P Prevent stroke AP E^ A CITALOPRAM d04332A C- F41.9 Anxiety disorder, unspecified AP E^ A GLIMEPIRIDE d03864A C- E11 Type 2 diabetes mellitus AP E^ A METOPROLOL d00134A C- I10 Essential (primary) hypertension AP E^ A . . . E^ A BUSPIRONE d00182A D F41.9 Anxiety disorder, unspecified A@ E^ A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A@ E^ A MONTELUKAST d04289A D# J30.9 Allergic rhinitis, unspecified A@ E^ A OMEPRAZOLE d00325A D= K21 Gastro-esophageal reflux disease A@ E_ A . . . E_ A ATENOLOL d00004A C I10 Essential (primary) hypertension A` E_ A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia A` E_ A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified A` E_ A LISINOPRIL d00732A C I10 Essential (primary) hypertension A` E_ A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A` E_ A SERTRALINE d00880A C F41.9 Anxiety disorder, unspecified A` E_ A . . . E_0 A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E_@ A . . . E_P A . . . E_` A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A E_` A HYDROCHLOROTHIAZIDE d00253A Cr I10 Essential (primary) hypertension A E_` A LANSOPRAZOLE d03828A D K30 Functional dyspepsia A E_` A LORAZEPAM d00149A D G47.9 Sleep disorder, unspecified A E_` A OLMESARTAN d04801A CDp I10 Essential (primary) hypertension A E_` A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A E_` A RIVAROXABAN d07356A C I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified A E_` A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified A E_p A . . . E_ A . . . E_ A CIPROFLOXACIN; DEXAMETHASONE OTIC d04890A A H60 Otitis externa A E_ A ACETAMINOPHEN; CODEINE d03423A B M25.5 Pain in joint A0 E_ A AMLODIPINE d00689A C I10 Essential (primary) hypertension A0 E_ A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease A0 E_ A . . . E_ A AMOXICILLIN d00088A A J02 Acute pharyngitis A E_ A OSELTAMIVIR d04462A AP J09 Influenza due to certain identified influenza viruses A E_ A . . . E_ A . . . E_ A . . . E` A . . . E` A ALPRAZOLAM d00168A CDp F41.9 Anxiety disorder, unspecified AP E` A CARISOPRODOL d00960A CDp M54 Dorsalgia AP E` A HYDROCHLOROTHIAZIDE d00253A Dc I10 Essential (primary) hypertension AP E` A IBUPROFEN d00015A CDp R52 Pain, unspecified AP E` A NIFEDIPINE d00051A Dc I10 Essential (primary) hypertension AP E` A . . . E`0 A . . . E`@ A . . . E`P A . . . E`` A BRIMONIDINE OPHTHALMIC d04048A Cr H40 Glaucoma A0 E`` A DORZOLAMIDE; TIMOLOL OPHTHALMIC d04303A Cr H40 Glaucoma A0 E`` A LATANOPROST OPHTHALMIC d04017A Cr H40 Glaucoma A0 E`p A . . . E` A 55555 A C I51.9P Prevent heart disease A E` A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A E` A . . . E` A . . . E` A . . . E` A . . . E` A . . . E` A . . . E` A BETAMETHASONE; CLOTRIMAZOLE TOPICAL d03561A Bz R21 Rash and other nonspecific skin eruption AP E` A BUMETANIDE d00179A B R60.9 Edema, unspecified AP E` A LEFLUNOMIDE d04349A D M06.9 Rheumatoid arthritis, unspecified AP E` A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia AP E` A TRAMADOL d03826A B M13 Other arthritis AP Ea A . . . Ea A . . . Ea A . . . Ea0 A FENOFIBRATE d04286A0 Ei 99999 A0 Ea0 A METOPROLOL d00134A0 Ei 99999 A0 Ea0 A SERTRALINE d00880A0 Ei 99999 A0 Ea@ A . . . EaP A . . . Ea` A . . . Eap A ATORVASTATIN d04105A C"0 E78.0 Pure hypercholesterolemia A Eap A DABIGATRAN d07137A C- D75.9P Prevent blood clots A Eap A DOCUSATE d01021A C"0 K59.0 Constipation A Eap A GABAPENTIN d03182A B M54 Dorsalgia A Eap A INSULIN GLARGINE d04538A C- R73 Elevated blood glucose level A Eap A LISINOPRIL d00732A C I10 Essential (primary) hypertension A Eap A METFORMIN d03807A C- R73 Elevated blood glucose level A Eap A METHOCARBAMOL d00965A B M62.83 Muscle spasm A Eap A METOPROLOL d00134A C- I10 Essential (primary) hypertension A Eap A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A Eap A SILDENAFIL d04299A Bz N52.9 Male erectile dysfunction, unspecified A Ea A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C F90 Attention-deficit hyperactivity disorders A Ea Ap . . . Ea A ALBUTEROL d00749A C J44.9 J45 Chronic obstructive pulmonary disease, unspecified Asthma Ap Ea A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia Ap Ea A BUSPIRONE d00182A B= F41.9 Anxiety disorder, unspecified Ap Ea A METFORMIN d03807A C- E11 Type 2 diabetes mellitus Ap Ea A MIRTAZAPINE d04025A B= F32.9 G47.0 Major depressive disorder, single episode, unspecified Insomnia Ap Ea A PANTOPRAZOLE d04514A C R12 Heartburn Ap Ea A TOPIRAMATE d04115A B= F41.9 Anxiety disorder, unspecified Ap Ea A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C[@ R60.9 Edema, unspecified A0 Ea A METOPROLOL d00134A C I10 Essential (primary) hypertension A0 Ea A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A0 Ea A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A@ Ea A BUSPIRONE d00182A B F41.9 Anxiety disorder, unspecified A@ Ea A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A@ Ea A METOPROLOL d00134A C- I10 Essential (primary) hypertension A@ Ea A ALBUTEROL d00749A C J45 Asthma A Ea A ASPIRIN d00170A C I50.9 Heart failure, unspecified A Ea A ATORVASTATIN d04105A CDp E63.9 Nutritional deficiency, unspecified A Ea A BUDESONIDE; FORMOTEROL d04795A C[@ J45 Asthma A Ea A CLONIDINE d00044A C[@ I10 Essential (primary) hypertension A Ea A GABAPENTIN d03182A Cr E11.4 Type 2 diabetes mellitus with neurological complications A Ea A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A Ea A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A Ea A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease A Ea A . . . Ea A . . . Eb A . . . Eb A CLOPIDOGREL d04258A0 C I63.P Prevent stroke B Eb A CLOPIDOGREL d04258A0 Cr I63 Cerebral infarction B Eb A EZETIMIBE d04824A0 C E78.0 Pure hypercholesterolemia B Eb A HYDROCHLOROTHIAZIDE d00253A0 C R60.9 Edema, unspecified B Eb A HYDROXYZINE d00907A0 C- L23 Allergic contact dermatitis B Eb A INSULIN ASPART d04697A0 Cr E11 Type 2 diabetes mellitus B Eb A INSULIN DETEMIR d05436A0 C E11 Type 2 diabetes mellitus B Eb A LINAGLIPTIN d07767A0 C R73 Elevated blood glucose level B Eb A LOPERAMIDE d01025A0 Dc N39.4 Other specified urinary incontinence B Eb A LOVASTATIN d00280A0 Cr E78.0 I63.P Pure hypercholesterolemia Prevent stroke B Eb A METOPROLOL d00134A0 D I10 Essential (primary) hypertension B Eb A MIRTAZAPINE d04025A0 C G47.0 Insomnia B Eb A OXYBUTYNIN d00328A0 C N32.81 Overactive bladder B Eb A PANTOPRAZOLE d04514A0 Cr K21 Gastro-esophageal reflux disease B Eb A SAXAGLIPTIN d07467A0 C E11 Type 2 diabetes mellitus B Eb A TEMAZEPAM d00384A0 C G47.0 Insomnia B Eb A . . . Eb0 A AMOXICILLIN d00088A A N30 Cystitis A Eb@ A ALBUTEROL d00749A C J45 Asthma Ap Eb@ A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension Ap Eb@ A ATENOLOL d00004A D I10 Essential (primary) hypertension Ap Eb@ A FLUTICASONE d01296A C R06.2 Wheezing Ap Eb@ A LATANOPROST OPHTHALMIC d04017A C H40 Glaucoma Ap Eb@ A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease Ap Eb@ A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease Ap EbP A . . . Eb` A . . . Ebp A . . . Eb A . . . Eb A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A CDp I10 Essential (primary) hypertension A Eb A OLODATEROL; TIOTROPIUM d08362A A J44.9 Chronic obstructive pulmonary disease, unspecified A Eb A . . . Eb A . . . Eb A . . . Eb A TRAMADOL d03826A C M54 Dorsalgia A Eb A . . . Eb A . . . Ec A AMPHETAMINE; DEXTROAMPHETAMINE d04035A0 B F90 Attention-deficit hyperactivity disorders A Ec A . . . Ec A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A Ec0 A RAMIPRIL d00728A B 99999 A Ec@ A . . . EcP A . . . Ec` A ACETAMINOPHEN; TRAMADOL d04766A DO M79.1 Myalgia A Ec` A CARVEDILOL d03847A D I21.P Prevent heart attack/myocardial infarction A Ec` A CIPROFLOXACIN d00011A C"@ A49.9P Prevent bacterial infection A Ec` A CLOPIDOGREL d04258A D I21 ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction A Ec` A DULOXETINE d05355A C- F32.9 Major depressive disorder, single episode, unspecified A Ec` A GABAPENTIN d03182A D M79.2 Neuralgia and neuritis, unspecified A Ec` A INSULIN ASPART d04697A B E11 Type 2 diabetes mellitus A Ec` A INSULIN ISOPHANE (NPH) d04370A B E11 Type 2 diabetes mellitus A Ec` A METFORMIN d03807A D# R73 Elevated blood glucose level A Ec` A NITROGLYCERIN d00321A C R07.9 Chest pain, unspecified A Ec` A OMEPRAZOLE d00325A Dc K21 Gastro-esophageal reflux disease A Ec` A PRAVASTATIN d00348A Dc E78.0 Pure hypercholesterolemia A Ec` A RALOXIFENE d04261A D* C50.P prevent breast cancer A Ec` A VALSARTAN d04113A C- I10 Essential (primary) hypertension A Ecp A . . . Ec A . . . Ec A ALBUTEROL d00749A C J45.P Prevent asthma A Ec A FLUTICASONE d01296A C J45 Asthma A Ec A DULOXETINE d05355A Cr F32.9 Major depressive disorder, single episode, unspecified A` Ec A LISINOPRIL d00732A D I10 Essential (primary) hypertension A` Ec A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus A` Ec A PIOGLITAZONE d04442A C E11 Type 2 diabetes mellitus A` Ec A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A` Ec A VARENICLINE d05807A B= F17.2 Nicotine dependence A` Ec A CITALOPRAM d04332A CDp F41.9 Anxiety disorder, unspecified AP Ec A FENOFIBRATE d04286A B E78.0 Pure hypercholesterolemia AP Ec A FINASTERIDE d00563A CDp L65.9 Nonscarring hair loss, unspecified AP Ec A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP Ec A OMEPRAZOLE d00325A C- K92.9 Disease of digestive system, unspecified AP Ec A . . . Ec A ALBUTEROL d00749A C- J45 Asthma A0 Ec A CETIRIZINE d03827A C- H10.1 J45 Acute atopic conjunctivitis Asthma A0 Ec A FLUTICASONE NASAL d04283A C- J30.9 Allergic rhinitis, unspecified A0 Ec A . . . Ec A . . . Ed A ACETAMINOPHEN; HYDROCODONE d03428A A G89 Pain, not elsewhere classified A@ Ed A DICLOFENAC d00848A Ap T14.9 Unspecified injury A@ Ed A DROSPIRENONE; ETHINYL ESTRADIOL d04760A B N94 Pain and other conditions associated with female genital organs and menstrual cycle A@ Ed A SERTRALINE d00880A0 CDp F41.9 Anxiety disorder, unspecified A@ Ed A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A B[ I10 Essential (primary) hypertension A0 Ed A LEVOTHYROXINE d00278A C E07.9 Disorder of thyroid, unspecified A0 Ed A METFORMIN d03807A C R73 Elevated blood glucose level A0 Ed A . . . Ed0 A . . . Ed@ A . . . EdP A HALOPERIDOL d00027A D# F29 Unspecified psychosis not due to a substance or known physiological condition A0 EdP A OMEPRAZOLE d00325A B= K46 Unspecified abdominal hernia A0 EdP A SUCRALFATE d00377A B= K22 Other diseases of esophagus A0 Ed` A LEVETIRACETAM d04499A B G40 Epilepsy and recurrent seizures A@ Ed` A LOSARTAN d03821A B I10 Essential (primary) hypertension A@ Ed` A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A@ Ed` A OMEPRAZOLE d00325A C"0 K25 Gastric ulcer A@ Edp A AMOXICILLIN; CLAVULANATE d00089A A J01.9 Acute sinusitis, unspecified A Ed A DEXMETHYLPHENIDATE d04777A CDp F90 Attention-deficit hyperactivity disorders A Ed A . . . Ed A . . . Ed A APIXABAN d07804A C[@ I48.9 Unspecified atrial fibrillation and atrial flutter AP Ed A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP Ed A CHLORTHALIDONE d00192A C R60.9 Edema, unspecified AP Ed A METOPROLOL d00134A C I48.9 Unspecified atrial fibrillation and atrial flutter AP Ed A OMEPRAZOLE d00325A C K21 R12 Gastro-esophageal reflux disease Heartburn AP Ed A . . . Ed A . . . Ed A . . . Ed A . . . Ee A 99999 . . Ap Ee A MECLIZINE d00859A CDp R42 Dizziness and giddiness Ap Ee A MELOXICAM d04532A C M19.9 Osteoarthritis, unspecified site Ap Ee A METFORMIN; SITAGLIPTIN d06720A D ^ E11 Type 2 diabetes mellitus Ap Ee A OMEPRAZOLE d00325A D ^ K21 Gastro-esophageal reflux disease Ap Ee A RAMIPRIL d00728A D"8 I10 Essential (primary) hypertension Ap Ee A TAMSULOSIN d04121A D ^ N40 Enlarged prostate Ap Ee A ABATACEPT d05694A C M06.9 Rheumatoid arthritis, unspecified A@ Ee A HYDROXYCHLOROQUINE d00817A CDp M06.9 Rheumatoid arthritis, unspecified A@ Ee A LEFLUNOMIDE d04349A CDp M06.9 Rheumatoid arthritis, unspecified A@ Ee A SULFASALAZINE d00379A CDp M06.9 Rheumatoid arthritis, unspecified A@ Ee A . . . Ee0 A . . . Ee@ A ATORVASTATIN d04105A B[ E78.0 Pure hypercholesterolemia A@ Ee@ A DONEPEZIL d04099A Ei 99999 A@ Ee@ A LISINOPRIL d00732A B[ I10 Essential (primary) hypertension A@ Ee@ A TRAMADOL d03826A C 99999 A@ EeP A ESCITALOPRAM d04812A CDp F32.9 Major depressive disorder, single episode, unspecified A` EeP A EZETIMIBE d04824A B E78.0 Pure hypercholesterolemia A` EeP A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A` EeP A LANSOPRAZOLE d03828A D K21 Gastro-esophageal reflux disease A` EeP A LISINOPRIL d00732A B I10 Essential (primary) hypertension A` EeP A POTASSIUM CHLORIDE d00345A B E87.6 Hypokalemia A` Ee` A RANITIDINE d00021A B K21 Gastro-esophageal reflux disease A Eep A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia AP Eep A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus AP Eep A LEVOTHYROXINE d00278A B 55555 AP Eep A METOPROLOL d00134A CDp I20.9 I25.9 I50.9 Angina pectoris, unspecified Chronic ischemic heart disease, unspecified Heart failure, unspecified AP Eep A VALSARTAN d04113A CDp I10 I50.9 Essential (primary) hypertension Heart failure, unspecified AP Ee A . . . Ee A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A B I10 Essential (primary) hypertension A Ee A METOPROLOL d00134A B I10 I50.9 Essential (primary) hypertension Heart failure, unspecified A Ee A AMOXICILLIN; CLAVULANATE d00089A A0 H66.9 Otitis media, unspecified A Ee A CODEINE; PROMETHAZINE d03357A A0 R05 Cough A Ee A ATORVASTATIN d04105A B[ E78.0 Pure hypercholesterolemia A Ee A CLOPIDOGREL d04258A C[@ D75.9P Prevent blood clots A Ee A PAROXETINE d03157A B F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A Ee A GRISEOFULVIN d00100A B B35 Dermatophytosis A Ee A ALLOPURINOL d00023A C- M1A Chronic gout A Ee A ASPIRIN d00170A C I51.9P Prevent heart disease A Ee A CABERGOLINE d04112A E 77777 A Ee A CINACALCET d05218A C N19 Unspecified kidney failure A Ee A DORZOLAMIDE OPHTHALMIC d03805A CDp H40 Glaucoma A Ee A FLUOXETINE d00236A C F41.9 Anxiety disorder, unspecified A Ee A INSULIN ISOPHANE (NPH) d04370A D E11 Type 2 diabetes mellitus A Ee A INSULIN REGULAR d04369A D E11 Type 2 diabetes mellitus A Ee A LATANOPROST OPHTHALMIC d04017A Cr H40 Glaucoma A Ee A LEVOTHYROXINE d00278A E E03.9 Hypothyroidism, unspecified A Ee A LISINOPRIL d00732A C 77777 A Ee A METOPROLOL d00134A E 77777 A Ee A SIMVASTATIN d00746A C 77777 A Ee A TAMSULOSIN d04121A E N40 Enlarged prostate A Ee A . . . Ef A . . . Ef A . . . Ef A IBUPROFEN d00015A A0 M54 Dorsalgia A Ef0 A CEPHALEXIN d00096A B M25.9 Joint disorder, unspecified A Ef@ A BUSPIRONE d00182A B F41.9 Anxiety disorder, unspecified Ap Ef@ A DULOXETINE d05355A C M79.7 Fibromyalgia Ap Ef@ A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension Ap Ef@ A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified Ap Ef@ A METHOTREXATE d00060A CO M35 Other systemic involvement of connective tissue Ap Ef@ A PREDNISONE d00350A CO M35 Other systemic involvement of connective tissue Ap Ef@ A PREGABALIN d05508A CDp M79.2 Neuralgia and neuritis, unspecified Ap EfP A . . . Ef` A MECLIZINE d00859A C R42 Dizziness and giddiness A Efp A . . . Ef A . . . Ef A . . . Ef A . . . Ef A . . . Ef A . . . Ef A DROSPIRENONE; ETHINYL ESTRADIOL d04760A C Z79.3 Long term (current) use of hormonal contraceptives A Ef A . . . Ef A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A Ef A LISINOPRIL d00732A C I10 Essential (primary) hypertension A Eg A . . . Eg A . . . Eg A . . . Eg0 A . . . Eg@ A ALPRAZOLAM d00168A C- F41.0 Panic disorder [episodic paroxysmal anxiety] without agoraphobia Ap Eg@ A DIVALPROEX SODIUM d03833A C G40 Epilepsy and recurrent seizures Ap Eg@ A ESCITALOPRAM d04812A Cr F32.9 Major depressive disorder, single episode, unspecified Ap Eg@ A LAMOTRIGINE d03809A C G40 Epilepsy and recurrent seizures Ap Eg@ A LEVETIRACETAM d04499A D G40 Epilepsy and recurrent seizures Ap Eg@ A PRIMIDONE d00352A C R06.9 R25.1 Unspecified abnormalities of breathing Tremor, unspecified Ap Eg@ A PROMETHAZINE d00787A B R11 Nausea and vomiting Ap EgP A . . . Eg` A ACETAMINOPHEN; HYDROCODONE d03428A C M54 Dorsalgia A Eg` A CHLORZOXAZONE d00962A B[ M62.83 Muscle spasm A Eg` A NEBIVOLOL d05265A B[ I10 Essential (primary) hypertension A Eg` A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease A Eg` A PAROXETINE d03157A B= F32.9 R52 Major depressive disorder, single episode, unspecified Pain, unspecified A Eg` A PREDNISONE d00350A C- M85.9 Disorder of bone density and structure, unspecified A Eg` A PRIMIDONE d00352A A R25.1 Tremor, unspecified A Eg` A RISEDRONATE d04300A C- M81 Osteoporosis without current pathological fracture A Eg` A TAMSULOSIN d04121A C N40 Enlarged prostate A Egp A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP Egp A CLONIDINE d00044A C I10 Essential (primary) hypertension AP Egp A LOSARTAN d03821A C I10 Essential (primary) hypertension AP Egp A PRAVASTATIN d00348A C 99999 AP Egp A SERTRALINE d00880A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified AP Eg A AMLODIPINE d00689A D"8 I10 Essential (primary) hypertension AP Eg A CODEINE d00012A D M79.1 Myalgia AP Eg A DEXLANSOPRAZOLE d07395A D"8 K27 K30 R12 Peptic ulcer, site unspecified Functional dyspepsia Heartburn AP Eg A LISINOPRIL d00732A D"8 I10 Essential (primary) hypertension AP Eg A METHOCARBAMOL d00965A D"8 M79.1 Myalgia AP Eg A ESOMEPRAZOLE d04749A CDp K30 Functional dyspepsia A Eg A DILTIAZEM d00045A C I10 Essential (primary) hypertension A0 Eg A LEVOTHYROXINE d00278A C 55555 A0 Eg A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A0 Eg A ALBUTEROL d00749A CP J45 Asthma A@ Eg A ALPRAZOLAM d00168A CP F41.9 Anxiety disorder, unspecified A@ Eg A FLUTICASONE; SALMETEROL d04611A B= R07.9 Chest pain, unspecified A@ Eg A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A@ Eg A DOXAZOSIN d00726A D* N40 Enlarged prostate A Eg A FUROSEMIDE d00070A D I51.9 Heart disease, unspecified A Eg A POTASSIUM CHLORIDE d00345A D E87.6 Hypokalemia A Eg A SERTRALINE d00880A C F41.9 Anxiety disorder, unspecified A Eg A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A Eg A SOTALOL d00371A B= I49.9 Cardiac arrhythmia, unspecified A Eg A TELMISARTAN d04364A C I10 Essential (primary) hypertension A Eg A WARFARIN d00022A B= I49.9 Cardiac arrhythmia, unspecified A Eg A . . . Eg A . . . Eg A CYPROHEPTADINE d00790A A R63 Symptoms and signs concerning food and fluid intake A@ Eg A FLUTICASONE NASAL d04283A CDp J30.9 Allergic rhinitis, unspecified A@ Eg A METHYLPHENIDATE d00900A B F90 Attention-deficit hyperactivity disorders A@ Eg A MONTELUKAST d04289A CDp J45 R06.9 Asthma Unspecified abnormalities of breathing A@ Eh A . . . Eh A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP Eh A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP Eh A METOPROLOL d00134A C I10 Essential (primary) hypertension AP Eh A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease AP Eh A TRAMADOL d03826A C- M79.1 Myalgia AP Eh A . . . Eh0 A AMLODIPINE; BENAZEPRIL d03829A B I10 Essential (primary) hypertension A Eh@ A . . . EhP A . . . Eh` A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A Eh` A IBUPROFEN d00015A B R50.9 Fever, unspecified A Ehp A . . . Eh A ALLOPURINOL d00023A CDp M10.9P Prevent gout A0 Eh A CEPHALEXIN d00096A Ap N30 Cystitis A0 Eh A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A A N39.0 Urinary tract infection, site not specified A0 Eh A FLUOXETINE d00236A D"8 F33.9 Major depressive disorder, recurrent, unspecified A@ Eh A HYDROXYZINE d00907A B= G47.0 Insomnia A@ Eh A PROGESTERONE d00550A C[@ N95 Menopausal and other perimenopausal disorders A@ Eh A SEX HORMONES COMBINATION - UNSPECIFIED c00186A C[@ N95 Menopausal and other perimenopausal disorders A@ Eh A . . . Eh A . . . Eh A . . . Eh A . . . Eh A 99999 . . A Eh A . . . Ei A . . . Ei A . . . Ei A . . . Ei0 A CARBIDOPA d00184A C G20 Parkinson's disease A0 Ei0 A CYCLOBENZAPRINE d00963A C M79.1 Myalgia A0 Ei0 A HYDROCODONE d03075A C M25.5 M54 Pain in joint Dorsalgia A0 Ei@ A . . . EiP A . . . Ei` A NYSTATIN d01233A B B37 Candidiasis A Eip A . . . Ei A BUSPIRONE d00182A CDp F41.9 Anxiety disorder, unspecified A@ Ei A FLUOXETINE d00236A CDp F32.9 Major depressive disorder, single episode, unspecified A@ Ei A LITHIUM d00061A CDp F31.9 Bipolar disorder, unspecified A@ Ei A QUETIAPINE d04220A CDp G47.9 Sleep disorder, unspecified A@ Ei A BROMPHENIRAMINE; DEXTROMETHORPHAN; PSEUDOEPHEDRINE d03368A Ap R05 R09.81 Cough Nasal congestion A0 Ei A CETIRIZINE d03827A C- T78.40 Allergy, unspecified A0 Ei A MONTELUKAST d04289A C- T78.40 Allergy, unspecified A0 Ei A . . . Ei A . . . Ei A . . . Ei A AMOXICILLIN d00088A A@ A49.9P J01.9 Prevent bacterial infection Acute sinusitis, unspecified A0 Ei A CETIRIZINE d03827A A H10.1 J30.9 T78.40 Acute atopic conjunctivitis Allergic rhinitis, unspecified Allergy, unspecified A0 Ei A POLYETHYLENE GLYCOL 3350 d05350A A K59.0 Constipation A0 Ei A AMLODIPINE d00689A A I10 Essential (primary) hypertension A Ei A CLINDAMYCIN d00043A A K04.7 Periapical abscess without sinus A Ei A . . . Ej A . . . Ej A 99999 . . A Ej A AMITRIPTYLINE d00146A A G47.0 R51 Insomnia Headache A Ej A DULOXETINE d05355A B F41.9 Anxiety disorder, unspecified A Ej0 A . . . Ej@ A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ Ej@ A DICLOFENAC d00848A B R52 Pain, unspecified A@ Ej@ A DULOXETINE d05355A A M62.83 M79.2 Muscle spasm Neuralgia and neuritis, unspecified A@ Ej@ A TIZANIDINE d04102A B M54 Dorsalgia A@ EjP A . . . Ej` A . . . Ejp A . . . Ej A MELOXICAM d04532A C- M79.1 Myalgia A Ej A ALENDRONATE d03849A C"0 M81 Osteoporosis without current pathological fracture A Ej A BUMETANIDE d00179A C R60.9 Edema, unspecified A@ Ej A FLUOXETINE d00236A C F32.9 Major depressive disorder, single episode, unspecified A@ Ej A MELOXICAM d04532A C"0 M13 Other arthritis A@ Ej A VERAPAMIL d00048A D I10 Essential (primary) hypertension A@ Ej A . . . Ej A COLCHICINE d00150A C M1A Chronic gout A Ej A TRAMADOL d03826A C- M10.9 M25.5 Gout, unspecified Pain in joint A Ej A CARVEDILOL d03847A C I10 Essential (primary) hypertension A` Ej A HYDROCHLOROTHIAZIDE d00253A Cr I10 Essential (primary) hypertension A` Ej A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A` Ej A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A` Ej A POTASSIUM CHLORIDE d00345A C"0 E87.6 Hypokalemia A` Ej A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia A` Ej A . . . Ej A ATORVASTATIN d04105A C E78.0P Prevent high cholesterol AP Ej A CHLORTHALIDONE d00192A C R60.9 Edema, unspecified AP Ej A LABETALOL d00016A C I50.9 Heart failure, unspecified AP Ej A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP Ej A PRASUGREL d07409A C I21 ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction AP Ek A . . . Ek A . . . Ek A . . . Ek0 A . . . Ek@ A . . . EkP A . . . Ek` A . . . Ekp A . . . Ek A VALSARTAN d04113A C I10 Essential (primary) hypertension A Ek A . . . Ek A . . . Ek A BUPROPION d00181A C F41.9 Anxiety disorder, unspecified Ap Ek A HYDROCHLOROTHIAZIDE d00253A C[@ I10 Essential (primary) hypertension Ap Ek A LOSARTAN d03821A C I10 Essential (primary) hypertension Ap Ek A MELOXICAM d04532A C M25.5 Pain in joint Ap Ek A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease Ap Ek A SERTRALINE d00880A CDp F41.9 Anxiety disorder, unspecified Ap Ek A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia Ap Ek A ALBUTEROL d00749A B J45 Asthma A0 Ek A AMOXICILLIN d00088A A` H66.9 Otitis media, unspecified A0 Ek A BECLOMETHASONE d00760A BT J45 Asthma A0 Ek A LANSOPRAZOLE d03828A B= R10 Abdominal and pelvic pain A0 Ek A OMEPRAZOLE d00325A B= R10 Abdominal and pelvic pain A0 Ek A OXCARBAZEPINE d04513A C F99 Mental disorder, not otherwise specified A0 Ek A GUANFACINE d00717A CDp F90 Attention-deficit hyperactivity disorders A Ek A METHYLPHENIDATE d00900A CDp F90 Attention-deficit hyperactivity disorders A Ek A . . . El A . . . El A . . . El A . . . El0 A DICLOFENAC d00848A0 B M25.5 Pain in joint A` El0 A LISINOPRIL d00732A0 Cr I10 Essential (primary) hypertension A` El0 A MELOXICAM d04532A0 C M25.5 M79.1 Pain in joint Myalgia A` El0 A SIMVASTATIN d00746A0 Cr E78.0P Prevent high cholesterol A` El0 A TEMAZEPAM d00384A0 C G47.0 Insomnia A` El0 A TRIAMCINOLONE TOPICAL d03206A0 C B35 Dermatophytosis A` El@ A . . . ElP A . . . El` A DIVALPROEX SODIUM d03833A C[@ G40 Epilepsy and recurrent seizures A Elp A . . . El A CARVEDILOL d03847A C E78.0 Pure hypercholesterolemia AP El A GLIPIZIDE d00246A Cr E11 Type 2 diabetes mellitus AP El A LISINOPRIL d00732A D I10 Essential (primary) hypertension AP El A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus AP El A ROSUVASTATIN d04851A C I21.P I63.P Prevent heart attack/myocardial infarction Prevent stroke AP El A ALENDRONATE d03849A B[ M81 Osteoporosis without current pathological fracture A El A ARIPIPRAZOLE d04825A C F32.9 Major depressive disorder, single episode, unspecified A El A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A El A DEXLANSOPRAZOLE d07395A C R12 Heartburn A El A MELOXICAM d04532A CDp M13 Other arthritis A El A METOPROLOL d00134A B[ I10 Essential (primary) hypertension A El A TOPIRAMATE d04115A Bz R25.1 Tremor, unspecified A El A VENLAFAXINE d03181A Dc F32.9 Major depressive disorder, single episode, unspecified A El A . . . El A ALBUTEROL d00749A B R05 Cough A El A . . . El A . . . El A VALACYCLOVIR d03838A C B00.1 Herpesviral vesicular dermatitis A El A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C F90 Attention-deficit hyperactivity disorders A Em A . . . Em A METHOTREXATE d00060A C- M06.9 Rheumatoid arthritis, unspecified A Em A . . . Em0 A POLYMYXIN B; TRIMETHOPRIM OPHTHALMIC d03529A Ap H10 Conjunctivitis A Em@ A . . . EmP A . . . Em` A . . . Emp A . . . Em A AMOXICILLIN d00088A A J40 Bronchitis, not specified as acute or chronic A Em A . . . Em A DOXYCYCLINE d00037A Ap L08.9 Local infection of the skin and subcutaneous tissue, unspecified A Em A . . . Em A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A Em A AMOXICILLIN; CLAVULANATE d00089A A J42 Unspecified chronic bronchitis A Em A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A Em A . . . En A LEVOTHYROXINE d00278A D E06 Thyroiditis A En A VALACYCLOVIR d03838A D B00.9 Herpesviral infection, unspecified A En A METOPROLOL d00134A0 B= I10 Essential (primary) hypertension A0 En A NAPROXEN d00019A B M54 Dorsalgia A0 En A RANITIDINE d00021A C- K21 Gastro-esophageal reflux disease A0 En A . . . En0 A FUROSEMIDE d00070A D9 R60.9 Edema, unspecified A@ En0 A METFORMIN d03807A Cr E11.P Prevent diabetes A@ En0 A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A@ En0 A SPIRONOLACTONE d00373A D I10 Essential (primary) hypertension A@ En@ A . . . EnP A . . . En` A . . . Enp A . . . En A ALPRAZOLAM d00168A C- F41.9 Anxiety disorder, unspecified A En A CLONIDINE d00044A C[@ I10 Essential (primary) hypertension A En A HYDROCODONE d03075A C- M54 Dorsalgia A En A LABETALOL d00016A C[@ I10 Essential (primary) hypertension A En A METFORMIN d03807A C E11 Type 2 diabetes mellitus A En A METHOCARBAMOL d00965A C"@ M54 M79.1 Dorsalgia Myalgia A En A QUETIAPINE d04220A0 C- F31.9 Bipolar disorder, unspecified A En A VORTIOXETINE d08125A0 C- F32.9 Major depressive disorder, single episode, unspecified A En A . . . En A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A@ En A GLIPIZIDE d00246A B E11 Type 2 diabetes mellitus A@ En A LOSARTAN d03821A B I10 Essential (primary) hypertension A@ En A SITAGLIPTIN d05896A B E11 Type 2 diabetes mellitus A@ En A AMLODIPINE d00689A C- K21 Gastro-esophageal reflux disease A` En A CHOLESTYRAMINE d00193A C- E78.0 Pure hypercholesterolemia A` En A DICYCLOMINE d00999A Cr R10 Abdominal and pelvic pain A` En A NAPROXEN d00019A C M19.9 Osteoarthritis, unspecified site A` En A PANTOPRAZOLE d04514A C[@ K22 Other diseases of esophagus A` En A SUCRALFATE d00377A CDp K31.9 Disease of stomach and duodenum, unspecified A` En A . . . En A ALLOPURINOL d00023A C M1A Chronic gout AP En A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP En A AMOXICILLIN; CLAVULANATE d00089A AP J02 Acute pharyngitis AP En A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus AP En A OMEPRAZOLE d00325A C- K30 Functional dyspepsia AP En A . . . En A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A@ En A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A@ En A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ En A METOPROLOL d00134A C I48.9 Unspecified atrial fibrillation and atrial flutter A@ Eo A . . . Eo A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A Eo A CITALOPRAM d04332A C F32.9 Major depressive disorder, single episode, unspecified A Eo A FEXOFENADINE d04040A CDp R09.81 Nasal congestion A Eo A GLIPIZIDE d00246A Cr E11 Type 2 diabetes mellitus A Eo A LISINOPRIL d00732A Cr I51.9P Prevent heart disease A Eo A LORAZEPAM d00149A C- F41.9 Anxiety disorder, unspecified A Eo A MELOXICAM d04532A C M79.1 Myalgia A Eo A METFORMIN; SITAGLIPTIN d06720A CDp E11 Type 2 diabetes mellitus A Eo A METOPROLOL d00134A B[ I25.9 Chronic ischemic heart disease, unspecified A Eo A OMEPRAZOLE d00325A CDp K21 R12 Gastro-esophageal reflux disease Heartburn A Eo A . . . Eo0 A 77777 . . A Eo@ A . . . EoP A . . . Eo` A . . . Eop A . . . Eo A CLOPIDOGREL d04258A C E11 Type 2 diabetes mellitus A` Eo A FUROSEMIDE d00070A C R60.9 Edema, unspecified A` Eo A INSULIN DETEMIR d05436A C E11 Type 2 diabetes mellitus A` Eo A LOSARTAN d03821A C E11 Type 2 diabetes mellitus A` Eo A METOPROLOL d00134A C I50.9 Heart failure, unspecified A` Eo A SITAGLIPTIN d05896A C E11 Type 2 diabetes mellitus A` Eo A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A0 Eo A HYDROCHLOROTHIAZIDE d00253A Cr R60.9 Edema, unspecified A0 Eo A PRAVASTATIN d00348A CDp E78.0 Pure hypercholesterolemia A0 Eo A . . . Eo A CLONAZEPAM d00197A B G40 Epilepsy and recurrent seizures A@ Eo A LEVETIRACETAM d04499A C[@ G40 Epilepsy and recurrent seizures A@ Eo A LOSARTAN d03821A C[@ G40 I10 Epilepsy and recurrent seizures Essential (primary) hypertension A@ Eo A OXCARBAZEPINE d04513A C[@ G40 Epilepsy and recurrent seizures A@ Eo A . . . Eo A BRIMONIDINE; BRINZOLAMIDE OPHTHALMIC d08086A C H57.9 Unspecified disorder of eye and adnexa A0 Eo A CANDESARTAN; HYDROCHLOROTHIAZIDE d04711A C I10 Essential (primary) hypertension A0 Eo A DIFLUPREDNATE OPHTHALMIC d07298A C H57.9 Unspecified disorder of eye and adnexa A0 Eo A . . . Eo A . . . Ep A . . . Ep A GABAPENTIN d03182A Cr M54 Dorsalgia A Ep A TRAMADOL d03826A Cr M13 M25.5 M54 Other arthritis Pain in joint Dorsalgia A Ep A INSULIN ISOPHANE (NPH) d04370A Bz E11 Type 2 diabetes mellitus A Ep A INSULIN LISPRO d04373A Bz 55555 A Ep0 A . . . Ep@ A . . . EpP A . . . Ep` A . . . Epp A . . . Ep A . . . Ep A . . . Ep A ATAZANAVIR d04882A0 D# B20 Human immunodeficiency virus [HIV] disease A0 Ep A EMTRICITABINE; TENOFOVIR d05352A0 D# B20 Human immunodeficiency virus [HIV] disease A0 Ep A RITONAVIR d03984A0 D# B20 Human immunodeficiency virus [HIV] disease A0 Ep A . . . Ep A . . . Ep A . . . Ep A . . . Ep A . . . Eq A ACETAMINOPHEN; HYDROCODONE d03428A D M54 Dorsalgia A Eq A AMLODIPINE d00689A0 C 99999 A Eq A ATORVASTATIN d04105A0 C E78.0 Pure hypercholesterolemia A Eq A CLONIDINE d00044A0 Cr I10 Essential (primary) hypertension A Eq A FUROSEMIDE d00070A C- R60.9 Edema, unspecified A Eq A LEVOTHYROXINE d00278A0 D9 E03.9 Hypothyroidism, unspecified A Eq A METOPROLOL d00134A0 C I10 Essential (primary) hypertension A Eq A NITROGLYCERIN d00321A D R07.9 Chest pain, unspecified A Eq A SEVELAMER d04363A C N19 Unspecified kidney failure A Eq A TADALAFIL d04896A C N52.9 Male erectile dysfunction, unspecified A Eq A . . . Eq0 A FENOFIBRATE d04286A B E78.0 E78.1 Pure hypercholesterolemia Pure hyperglyceridemia Ap Eq0 A FLUTICASONE NASAL d04283A B J30.2 Other seasonal allergic rhinitis Ap Eq0 A GABAPENTIN d03182A C[@ G25.81 Restless legs syndrome Ap Eq0 A LOSARTAN d03821A C I10 Essential (primary) hypertension Ap Eq0 A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension Ap Eq0 A SERTRALINE d00880A C[@ R10 Abdominal and pelvic pain Ap Eq0 A SITAGLIPTIN d05896A C R73 Elevated blood glucose level Ap Eq@ A CARVEDILOL d03847A D I48.9 Unspecified atrial fibrillation and atrial flutter Ap Eq@ A CLOPIDOGREL d04258A C I48.9 I50.9 Unspecified atrial fibrillation and atrial flutter Heart failure, unspecified Ap Eq@ A DIGOXIN d00210A D I48.9 Unspecified atrial fibrillation and atrial flutter Ap Eq@ A FUROSEMIDE d00070A D R60.9 Edema, unspecified Ap Eq@ A POTASSIUM CHLORIDE d00345A D E87.6 Hypokalemia Ap Eq@ A PRAVASTATIN d00348A D E78.0 Pure hypercholesterolemia Ap Eq@ A QUINAPRIL d00365A D I50.9 Heart failure, unspecified Ap EqP A . . . Eq` A . . . Eqp A ALENDRONATE d03849A0 B M81 Osteoporosis without current pathological fracture Ap Eqp A BACLOFEN d00967A0 C M62.83 Muscle spasm Ap Eqp A FENOFIBRATE d04286A0 C E78.0 Pure hypercholesterolemia Ap Eqp A MECLIZINE d00859A0 C R42 Dizziness and giddiness Ap Eqp A MELOXICAM d04532A0 C M19.9 Osteoarthritis, unspecified site Ap Eqp A POLYETHYLENE GLYCOL 3350 d05350A0 C K59.0 Constipation Ap Eqp A ROPINIROLE d04215A0 C G25.81 Restless legs syndrome Ap Eq A . . . Eq A ALLOPURINOL d00023A C E79.9 Disorder of purine and pyrimidine metabolism, unspecified A Eq A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A Eq A . . . Eq A ESOMEPRAZOLE d04749A Ap 55555 A@ Eq A FLECAINIDE d00234A C I48.9 Unspecified atrial fibrillation and atrial flutter A@ Eq A LEVOTHYROXINE d00278A DK E03.9 Hypothyroidism, unspecified A@ Eq A PAROXETINE d03157A C F32.9 G47.9 Major depressive disorder, single episode, unspecified Sleep disorder, unspecified A@ Eq A . . . Eq A . . . Eq A . . . Eq A NAPROXEN d00019A C- N94 Pain and other conditions associated with female genital organs and menstrual cycle A Er A . . . Er A ACETAMINOPHEN; HYDROCODONE d03428A Cr M54 Dorsalgia A0 Er A DIURETICS - UNSPECIFIED c00049A Dc R60.9 Edema, unspecified A0 Er A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension A0 Er A . . . Er0 A . . . Er@ A . . . ErP A BUMETANIDE d00179A B R60.9 Edema, unspecified A ErP A CARVEDILOL d03847A Cr I50.9 Heart failure, unspecified A ErP A FUROSEMIDE d00070A Dc R60.9 Edema, unspecified A ErP A GABAPENTIN d03182A Dc M79.2 Neuralgia and neuritis, unspecified A ErP A INSULIN ISOPHANE; INSULIN REGULAR d04374A C E11 Type 2 diabetes mellitus A ErP A ISOSORBIDE d00653A C 99999 A ErP A LISINOPRIL d00732A D I10 Essential (primary) hypertension A ErP A METFORMIN d03807A D> E11 Type 2 diabetes mellitus A ErP A PHENYTOIN d00143A Cr G40 Epilepsy and recurrent seizures A ErP A SERTRALINE d00880A Dc F32.9 Major depressive disorder, single episode, unspecified A ErP A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A C L08.9 Local infection of the skin and subcutaneous tissue, unspecified A ErP A TRAZODONE d00395A D= G47.9 Sleep disorder, unspecified A Er` A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A Erp A . . . Er A . . . Er A AMLODIPINE d00689A C- I10 Essential (primary) hypertension AP Er A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia AP Er A LISINOPRIL d00732A C- I10 Essential (primary) hypertension AP Er A PANTOPRAZOLE d04514A C- K31.9 Disease of stomach and duodenum, unspecified AP Er A SITAGLIPTIN d05896A C- E11 Type 2 diabetes mellitus AP Er A . . . Er A ALBUTEROL d00749A Cr J45 Asthma A0 Er A FLUTICASONE NASAL d04283A C- J30.2 Other seasonal allergic rhinitis A0 Er A LISDEXAMFETAMINE d06663A C9 F90 Attention-deficit hyperactivity disorders A0 Er A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A0 Er A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A0 Er A HYDROCHLOROTHIAZIDE d00253A C- R60.9 Edema, unspecified A0 Er A . . . Er A . . . Er A . . . Es A . . . Es A LISINOPRIL d00732A D I10 Essential (primary) hypertension A Es A TAMSULOSIN d04121A C N42.9 Disorder of prostate, unspecified A Es A VALSARTAN d04113A B I10 Essential (primary) hypertension A Es0 A . . . Es@ A DAPSONE TOPICAL d05543A B L70 Acne A EsP A . . . Es` A . . . Esp A . . . Es A BUDESONIDE; FORMOTEROL d04795A C J45 Asthma A Es A . . . Es A . . . Es A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A B* R19.7 Diarrhea, unspecified A Es A . . . Es A . . . Es A . . . Es A . . . Et A OLANZAPINE d04050A C[@ F31.9 Bipolar disorder, unspecified A Et A VALPROIC ACID d00083A Cr F31.9 Bipolar disorder, unspecified A Et A . . . Et A . . . Et0 A HYDROXYCHLOROQUINE d00817A C- M06.9 Rheumatoid arthritis, unspecified AP Et0 A METHOTREXATE d00060A CDp M06.9 Rheumatoid arthritis, unspecified AP Et0 A METRONIDAZOLE TOPICAL d03208A A L71 Rosacea AP Et0 A MINOCYCLINE d00110A C L08.9 L71 Local infection of the skin and subcutaneous tissue, unspecified Rosacea AP Et0 A SULFASALAZINE d00379A CDp M06.9 Rheumatoid arthritis, unspecified AP Et@ A . . . EtP A . . . Et` A GLIPIZIDE; METFORMIN d04823A C E11 Type 2 diabetes mellitus AP Et` A LOSARTAN d03821A CP N28.9P Prevent kidney disease AP Et` A PIOGLITAZONE d04442A CP E11 Type 2 diabetes mellitus AP Et` A PRAVASTATIN d00348A CP E78.0P Prevent high cholesterol AP Et` A SITAGLIPTIN d05896A CP E11 Type 2 diabetes mellitus AP Etp A . . . Et A . . . Et A . . . Et A . . . Et A . . . Et A . . . Et A . . . Et A . . . Et A . . . Eu A . . . Eu A . . . Eu A ACETAMINOPHEN; CODEINE d03423A C- M54 Dorsalgia A Eu A METOPROLOL d00134A C R00 Abnormalities of heart beat A Eu0 A . . . Eu@ A . . . EuP A . . . Eu` A ALLOPURINOL d00023A B M10.9 Gout, unspecified A@ Eu` A COLCHICINE d00150A C M10.9 Gout, unspecified A@ Eu` A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A@ Eu` A VALSARTAN d04113A D I10 Essential (primary) hypertension A@ Eup A ATENOLOL d00004A D I21.P Prevent heart attack/myocardial infarction A@ Eup A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A@ Eup A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A@ Eup A LISINOPRIL d00732A D I21.P Prevent heart attack/myocardial infarction A@ Eu A . . . Eu A ALLOPURINOL d00023A C M10.9P Prevent gout A Eu A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A Eu A CARVEDILOL d03847A C I10 Essential (primary) hypertension A Eu A DIGOXIN d00210A C I50.9 Heart failure, unspecified A Eu A FUROSEMIDE d00070A C I51.9 Heart disease, unspecified A Eu A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A Eu A LISINOPRIL d00732A C I10 Essential (primary) hypertension A Eu A NITROGLYCERIN d00321A C R07.9 Chest pain, unspecified A Eu A WARFARIN d00022A C D75.9P Prevent blood clots A Eu A . . . Eu A . . . Eu A . . . Eu A . . . Eu A . . . Eu A . . . Ev A . . . Ev A . . . Ev A AMLODIPINE d00689A B I10 Essential (primary) hypertension A0 Ev A CALCIUM ACETATE d03689A B E63.9 Nutritional deficiency, unspecified A0 Ev A FUROSEMIDE d00070A B 99999 A0 Ev0 A . . . Ev@ A AMLODIPINE d00689A B I10 Essential (primary) hypertension AP Ev@ A APIXABAN d07804A B D75.9P I21.P I63.P Prevent blood clots Prevent heart attack/myocardial infarction Prevent stroke AP Ev@ A CARVEDILOL d03847A B Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets AP Ev@ A DIVALPROEX SODIUM d03833A B F32.9 Major depressive disorder, single episode, unspecified AP Ev@ A LISINOPRIL d00732A B I10 Essential (primary) hypertension AP EvP A . . . Ev` A . . . Evp A . . . Ev A . . . Ev A ALPRAZOLAM d00168A B F41.9 Anxiety disorder, unspecified A Ev A AMOXICILLIN d00088A A J02 Acute pharyngitis A Ev A . . . Ev A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A Ev A ETHOSUXIMIDE d00227A C[@ G40 Epilepsy and recurrent seizures A Ev A GLIPIZIDE d00246A C[@ E11 Type 2 diabetes mellitus A@ Ev A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C[@ I10 Essential (primary) hypertension A@ Ev A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A@ Ev A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A@ Ev A . . . Ew A 77777 . . A Ew A . . . Ew A BACLOFEN d00967A D)Y M62.83 Muscle spasm A Ew A METHOCARBAMOL d00965A B8 T14.9 Unspecified injury A Ew0 A ACETAMINOPHEN; HYDROCODONE d03428A C- M54 Dorsalgia B Ew0 A ALBUTEROL d00749A D* J45 Asthma B Ew0 A ALPRAZOLAM d00168A C- F41.9 Anxiety disorder, unspecified B Ew0 A ESCITALOPRAM d04812A CP F41.9 Anxiety disorder, unspecified B Ew0 A FLUTICASONE; SALMETEROL d04611A C[@ J45 Asthma B Ew0 A GABAPENTIN d03182A C- M54 Dorsalgia B Ew0 A GLIMEPIRIDE d03864A D E11 Type 2 diabetes mellitus B Ew0 A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus B Ew0 A METOPROLOL d00134A Cr I10 Essential (primary) hypertension B Ew0 A MONTELUKAST d04289A C- J45 Asthma B Ew0 A PREDNISONE d00350A D; J45 Asthma B Ew0 A RAMIPRIL d00728A CP I10 Essential (primary) hypertension B Ew0 A RANITIDINE d00021A CP K21 Gastro-esophageal reflux disease B Ew0 A SIMVASTATIN d00746A Cr E78.1 Pure hyperglyceridemia B Ew0 A THEOPHYLLINE d00142A D* J45 Asthma B Ew0 A TIOTROPIUM d04829A C[@ Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets B Ew@ A NAPROXEN d00019A D% G43 M25.5 T14.9 Migraine Pain in joint Unspecified injury A EwP A ATORVASTATIN d04105A Cr E78.0P Prevent high cholesterol A0 EwP A DILTIAZEM d00045A CDp I21 ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction A0 EwP A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A0 Ew` A . . . Ewp A . . . Ew A ALBUTEROL d00749A D# J98.9 Respiratory disorder, unspecified A Ew A BECLOMETHASONE d00760A D# R06.9 Unspecified abnormalities of breathing A Ew A CONJUGATED ESTROGENS d00541A D= Z79.890 Hormone replacement therapy A Ew A PROGESTERONE d00550A D= Z79.890 Hormone replacement therapy A Ew A FEXOFENADINE d04040A C R06.2 Wheezing A@ Ew A IBANDRONATE d05357A C M81 M85.9 Osteoporosis without current pathological fracture Disorder of bone density and structure, unspecified A@ Ew A MONTELUKAST d04289A C E07.9 Disorder of thyroid, unspecified A@ Ew A MONTELUKAST d04289A C R06.2 Wheezing A@ Ew A SERTRALINE d00880A B N94 Pain and other conditions associated with female genital organs and menstrual cycle A Ew A INSULIN ASPART; INSULIN ASPART PROTAMINE d04839A C- E11 Type 2 diabetes mellitus A Ew A . . . Ew A . . . Ew A . . . Ex A . . . Ex A AMOXICILLIN d00088A A K04.7 Periapical abscess without sinus A Ex A . . . Ex0 A . . . Ex@ A . . . ExP A . . . Ex` A ALENDRONATE d03849A C M81 Osteoporosis without current pathological fracture Ap Ex` A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia Ap Ex` A DILTIAZEM d00045A Cr I10 Essential (primary) hypertension Ap Ex` A FAMOTIDINE d00141A Cr K30 Functional dyspepsia Ap Ex` A LOSARTAN d03821A C I10 Essential (primary) hypertension Ap Ex` A METFORMIN d03807A C E11 Type 2 diabetes mellitus Ap Ex` A OMEPRAZOLE d00325A C K30 Functional dyspepsia Ap Exp A ALLOPURINOL d00023A B M10.9P Prevent gout AP Exp A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension AP Exp A HYDROXYCHLOROQUINE d00817A Cr M06.9 Rheumatoid arthritis, unspecified AP Exp A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP Exp A NABUMETONE d00310A Cr M19.9 Osteoarthritis, unspecified site AP Ex A . . . Ex A AMITRIPTYLINE d00146A C G47.0 Insomnia A Ex A BUPROPION d00181A C F32.9 Major depressive disorder, single episode, unspecified A Ex A CYCLOBENZAPRINE d00963A C M79.7 Fibromyalgia A Ex A DICLOFENAC d00848A C M79.7 Fibromyalgia A Ex A DULOXETINE d05355A Bz F32.9 Major depressive disorder, single episode, unspecified A Ex A LISINOPRIL d00732A C I10 Essential (primary) hypertension A Ex A METFORMIN d03807A C E11 Type 2 diabetes mellitus A Ex A OMEPRAZOLE d00325A C K30 Functional dyspepsia A Ex A OXCARBAZEPINE d04513A C M79.7 Fibromyalgia A Ex A ARIPIPRAZOLE d04825A C F32.9 Major depressive disorder, single episode, unspecified A` Ex A CITALOPRAM d04332A Dc F32.9 Major depressive disorder, single episode, unspecified A` Ex A FENOFIBRATE d04286A D E78.1 Pure hyperglyceridemia A` Ex A HYDROCHLOROTHIAZIDE d00253A C[@ N28.9 Disorder of kidney and ureter, unspecified A` Ex A OMEPRAZOLE d00325A C R12 Heartburn A` Ex A RISPERIDONE d03180A Dc F31.9 R45 Bipolar disorder, unspecified Symptoms and signs involving emotional state A` Ex A . . . Ex A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A0 Ex A RAMIPRIL d00728A B 55555 A0 Ex A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A0 Ex A . . . Ex A . . . Ex A ALPRAZOLAM d00168A CDp F41.9 Anxiety disorder, unspecified A@ Ex A METOPROLOL d00134A C I10 Essential (primary) hypertension A@ Ex A PRAVASTATIN d00348A B E78.0 Pure hypercholesterolemia A@ Ex A TAMSULOSIN d04121A B[ R35 Polyuria A@ Ey A FAMOTIDINE d00141A B K21 Gastro-esophageal reflux disease A Ey A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A C I10 Essential (primary) hypertension A Ey A LORAZEPAM d00149A B F41.9 Anxiety disorder, unspecified A Ey A METHIMAZOLE d00290A Bz E05 Thyrotoxicosis [hyperthyroidism] A Ey A MONTELUKAST d04289A C[@ J30.9 Allergic rhinitis, unspecified A Ey A OLMESARTAN d04801A B[ I10 Essential (primary) hypertension A Ey A OMEGA-3 POLYUNSATURATED FATTY ACIDS d00497A C E78.1 Pure hyperglyceridemia A Ey A PROPRANOLOL d00032A D& I99.9 Unspecified disorder of circulatory system A Ey A TRAMADOL d03826A C- R51 Headache A Ey A CLONAZEPAM d00197A D% G47.0 Insomnia Ap Ey A ESCITALOPRAM d04812A D F41.9 Anxiety disorder, unspecified Ap Ey A METOPROLOL d00134A C I49.9 Cardiac arrhythmia, unspecified Ap Ey A OMEPRAZOLE d00325A C- K30 Functional dyspepsia Ap Ey A PROPAFENONE d00358A CDp I49.9 Cardiac arrhythmia, unspecified Ap Ey A TORSEMIDE d03189A C[@ I50.9 Heart failure, unspecified Ap Ey A WARFARIN d00022A C D75.9P I80.3 Z95 Prevent blood clots Phlebitis and thrombophlebitis of lower extremities, unspecified Presence of cardiac and vascular implants and grafts Ap Ey A . . . Ey0 A METOPROLOL d00134A Cr I50.9 N28.9 Heart failure, unspecified Disorder of kidney and ureter, unspecified A Ey@ A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A A R19.7 Diarrhea, unspecified A EyP A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A@ EyP A GLIPIZIDE d00246A C[@ E11 Type 2 diabetes mellitus A@ EyP A LOSARTAN d03821A C[@ I10 Essential (primary) hypertension A@ EyP A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A@ Ey` A . . . Eyp A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A0 Eyp A OLMESARTAN d04801A C I10 Essential (primary) hypertension A0 Eyp A RANITIDINE d00021A C- K30 Functional dyspepsia A0 Ey A . . . Ey A AMOXICILLIN d00088A A J02 Acute pharyngitis A Ey A LACTULOSE d01024A B K59.0 Constipation A Ey A ALBUTEROL d00749A Ap J20.9 J42 Acute bronchitis, unspecified Unspecified chronic bronchitis A Ey A AZELASTINE; FLUTICASONE NASAL d07868A C& J30.2 Other seasonal allergic rhinitis A Ey A . . . Ey A . . . Ey A FUROSEMIDE d00070A D* R60.9 Edema, unspecified A0 Ey A METOPROLOL d00134A B I10 Essential (primary) hypertension A0 Ey A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A0 Ez A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A Ez A . . . Ez A AMITRIPTYLINE d00146A C R51 Headache A Ez0 A . . . Ez@ A METFORMIN d03807A C[@ R73 Elevated blood glucose level A Ez@ A PRAVASTATIN d00348A CDp E78.0 Pure hypercholesterolemia A EzP A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A0 EzP A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension A0 EzP A PRAVASTATIN d00348A C[@ E78.0 Pure hypercholesterolemia A0 Ez` A . . . Ezp A LISINOPRIL d00732A C I10 Essential (primary) hypertension A Ezp A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A Ez A . . . Ez A ATENOLOL d00004A D# I10 Essential (primary) hypertension A Ez A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A Ez A CITALOPRAM d04332A C"0 F32.9 Major depressive disorder, single episode, unspecified A Ez A GLIMEPIRIDE d03864A CDp I10 Essential (primary) hypertension A Ez A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A Ez A LISINOPRIL d00732A D# I10 Essential (primary) hypertension A Ez A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A Ez A ZOLPIDEM d00910A B[ G47.0 Insomnia A Ez A CARVEDILOL d03847A0 CDp I10 Essential (primary) hypertension A Ez A GABAPENTIN d03182A CDp K92.9 Disease of digestive system, unspecified A Ez A HYDRALAZINE d00132A0 CDp I10 Essential (primary) hypertension A Ez A LEVOTHYROXINE d00278A0 D' E07.9 Disorder of thyroid, unspecified A Ez A LOSARTAN d03821A C I10 Essential (primary) hypertension A Ez A METFORMIN d03807A0 D E11 Type 2 diabetes mellitus A Ez A MONTELUKAST d04289A0 C- R06.2 Wheezing A Ez A PANTOPRAZOLE d04514A0 CDp K21 Gastro-esophageal reflux disease A Ez A PRAVASTATIN d00348A0 D& E78.0 Pure hypercholesterolemia A Ez A 99999 . . A Ez A CEFUROXIME d00056A A0 J01.9 Acute sinusitis, unspecified A Ez A MUPIROCIN TOPICAL d01267A A0 L08.9 Local infection of the skin and subcutaneous tissue, unspecified A Ez A . . . Ez A . . . Ez A . . . E{ A GUANFACINE d00717A B F90 Attention-deficit hyperactivity disorders A E{ A TRIAMCINOLONE TOPICAL d03206A B= L40 Psoriasis A E{ A AMLODIPINE; BENAZEPRIL d03829A Cr I10 Essential (primary) hypertension A@ E{ A ASPIRIN d00170A Cr I21.P Prevent heart attack/myocardial infarction A@ E{ A HYDROCHLOROTHIAZIDE d00253A C- I10 Essential (primary) hypertension A@ E{ A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A@ E{0 A . . . E{@ A . . . E{P A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A0 E{P A CLOPIDOGREL d04258A C- D75.9P Prevent blood clots A0 E{P A GLIPIZIDE; METFORMIN d04823A C- E11 Type 2 diabetes mellitus A0 E{` A . . . E{p A . . . E{ A ALLOPURINOL d00023A D M10.9P Prevent gout A` E{ A CARVEDILOL d03847A C I10 Essential (primary) hypertension A` E{ A CHOLESTYRAMINE d00193A C E78.0 Pure hypercholesterolemia A` E{ A CLOPIDOGREL d04258A C D75.9P Prevent blood clots A` E{ A GEMFIBROZIL d00245A C[@ E78.1 Pure hyperglyceridemia A` E{ A LOSARTAN d03821A C- I10 Essential (primary) hypertension A` E{ A AMLODIPINE d00689A C I10 Essential (primary) hypertension Ap E{ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia Ap E{ A FLUTICASONE NASAL d04283A C J30.9 Allergic rhinitis, unspecified Ap E{ A GLYBURIDE d00248A C E11 Type 2 diabetes mellitus Ap E{ A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A D I10 Essential (primary) hypertension Ap E{ A METFORMIN d03807A D E11 Type 2 diabetes mellitus Ap E{ A MONTELUKAST d04289A CDp J30.9 Allergic rhinitis, unspecified Ap E{ A . . . E{ A . . . E{ A ALBUTEROL d00749A D J45 Asthma A0 E{ A MONTELUKAST d04289A C J45 Asthma A0 E{ A TIZANIDINE d04102A B M54 M79.6 Dorsalgia Pain in limb, hand, foot, fingers and toes A0 E{ A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A E{ A METFORMIN d03807A C[@ R73 Elevated blood glucose level A E{ A . . . E{ A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus AP E{ A INSULIN ASPART d04697A C E11 Type 2 diabetes mellitus AP E{ A INSULIN DETEMIR d05436A C E11 Type 2 diabetes mellitus AP E{ A METFORMIN d03807A CP E11 Type 2 diabetes mellitus AP E{ A SERTRALINE d00880A B[ F41.9 F43.9 Anxiety disorder, unspecified Reaction to severe stress, unspecified AP E| A . . . E| A . . . E| A ALBUTEROL d00749A CDp J45 Asthma A E| A TRIAMCINOLONE TOPICAL d03206A B L20.9 Atopic dermatitis, unspecified A E|0 A ALLOPURINOL d00023A D M10.9P Prevent gout Ap E|0 A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia Ap E|0 A FUROSEMIDE d00070A D I10 Essential (primary) hypertension Ap E|0 A LISINOPRIL d00732A D I10 Essential (primary) hypertension Ap E|0 A METOPROLOL d00134A D I10 Essential (primary) hypertension Ap E|0 A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease Ap E|0 A PHENYTOIN d00143A C G40 Epilepsy and recurrent seizures Ap E|@ A CLONAZEPAM d00197A A` F41.9 Anxiety disorder, unspecified A0 E|@ A DULOXETINE d05355A A` F32.9 Major depressive disorder, single episode, unspecified A0 E|@ A TRAZODONE d00395A A` G47.0 Insomnia A0 E|P A . . . E|` A . . . E|p A . . . E| A . . . E| A . . . E| A . . . E| A . . . E| A . . . E| A . . . E| A . . . E| A ONDANSETRON d00867A C- R11 Nausea and vomiting A E} A . . . E} A . . . E} A DILTIAZEM d00045A Dc I10 Essential (primary) hypertension A0 E} A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A Dc I10 Essential (primary) hypertension A0 E} A METFORMIN d03807A Ei E11 Type 2 diabetes mellitus A0 E}0 A CITALOPRAM d04332A C F41.9 Anxiety disorder, unspecified A E}0 A LORAZEPAM d00149A C F41.9 Anxiety disorder, unspecified A E}@ A . . . E}P A . . . E}` A . . . E}p A . . . E} A LEVOTHYROXINE d00278A D- E03.9 Hypothyroidism, unspecified A E} A ALLOPURINOL d00023A C- M10.9 Gout, unspecified AP E} A FAMOTIDINE d00141A Bz K30 Functional dyspepsia AP E} A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension AP E} A PRAVASTATIN d00348A C[@ E78.0 Pure hypercholesterolemia AP E} A TESTOSTERONE d00558A0 C[@ E29.1 Testicular hypofunction AP E} A ACETAMINOPHEN; HYDROCODONE d03428A CP M25.9 Joint disorder, unspecified A E} A 77777 . . A E} A . . . E} A GABAPENTIN d03182A B[ M79.2 Neuralgia and neuritis, unspecified A@ E} A HYDROCHLOROTHIAZIDE d00253A CDp I10 Essential (primary) hypertension A@ E} A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A@ E} A NAPROXEN d00019A B- M54 Dorsalgia A@ E} A . . . E} A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 E} A METFORMIN d03807A C E11 Type 2 diabetes mellitus A0 E} A NIFEDIPINE d00051A C I10 Essential (primary) hypertension A0 E~ A . . . E~ A . . . E~ A . . . E~0 A LISDEXAMFETAMINE d06663A B F90 Attention-deficit hyperactivity disorders A0 E~0 A METHYLPHENIDATE d00900A B F31.9 F90 Bipolar disorder, unspecified Attention-deficit hyperactivity disorders A0 E~0 A RISPERIDONE d03180A B F31.9 F90 Bipolar disorder, unspecified Attention-deficit hyperactivity disorders A0 E~@ A . . . E~P A . . . E~` A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A E~` A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A E~p A . . . E~ A . . . E~ A . . . E~ A . . . E~ A . . . E~ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ E~ A GLIPIZIDE d00246A Cr E11 Type 2 diabetes mellitus A@ E~ A LOSARTAN d03821A C I10 Essential (primary) hypertension A@ E~ A METFORMIN d03807A D E11 Type 2 diabetes mellitus A@ E~ A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified AP E~ A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A D I51.9 Heart disease, unspecified AP E~ A NIFEDIPINE d00051A D I10 Essential (primary) hypertension AP E~ A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia AP E~ A TRAZODONE d00395A D# G47.9 Sleep disorder, unspecified AP E~ A FLUTICASONE NASAL d04283A C J30.2 Other seasonal allergic rhinitis A E~ A PAROXETINE d03157A C F41.9 Anxiety disorder, unspecified A E~ A . . . E A . . . E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A TOFACITINIB d07925A B= L65.9 Nonscarring hair loss, unspecified A E A . . . E0 A . . . E@ A ETHINYL ESTRADIOL; NORGESTREL d03241A C Z79.3 Long term (current) use of hormonal contraceptives A EP A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ EP A CHLORTHALIDONE d00192A C[@ I10 Essential (primary) hypertension A@ EP A METFORMIN d03807A C R73 Elevated blood glucose level A@ EP A METOPROLOL d00134A C I10 Essential (primary) hypertension A@ E` A . . . Ep A . . . E A . . . E A GLIPIZIDE d00246A D E11 Type 2 diabetes mellitus A E A . . . E A . . . E A ASPIRIN d00170A C D75.9P Prevent blood clots B E A CARVEDILOL d03847A Cr I10 Essential (primary) hypertension B E A CLOPIDOGREL d04258A B D75.9P I21.P Prevent blood clots Prevent heart attack/myocardial infarction B E A FLUCONAZOLE d00071A C 99999 B E A LEVOTHYROXINE d00278A C E07.9 Disorder of thyroid, unspecified B E A METOCLOPRAMIDE d00298A B K21 K30 R11 Gastro-esophageal reflux disease Functional dyspepsia Nausea and vomiting B E A MIRTAZAPINE d04025A C9 R63 Symptoms and signs concerning food and fluid intake B E A MYCOPHENOLIC ACID d05217A C9 T86.9P Prevent transplanted organ and tissue rejection B E A ONDANSETRON d00867A B I99.9 Unspecified disorder of circulatory system B E A PRAVASTATIN d00348A B 99999 B E A PREDNISONE d00350A D T86.9P Prevent transplanted organ and tissue rejection B E A RABEPRAZOLE d04448A C K21 K30 Gastro-esophageal reflux disease Functional dyspepsia B E A TACROLIMUS d03752A D T86.9P Prevent transplanted organ and tissue rejection B E A TEMAZEPAM d00384A C G47.0 Insomnia B E A TERIPARATIDE d04828A C- M81 Osteoporosis without current pathological fracture B E A VALGANCICLOVIR d04755A B A49.9 Bacterial infection, unspecified B E A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A C Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A . . . E A ALBUTEROL d00749A B[ J45 Asthma A E A TIMOLOL OPHTHALMIC d04037A C 55555 A E A GLYBURIDE d00248A B E11 Type 2 diabetes mellitus A E A METFORMIN d03807A B E11 Type 2 diabetes mellitus A E A . . . E0 A DEXMETHYLPHENIDATE d04777A B F90 Attention-deficit hyperactivity disorders A E@ A . . . EP A . . . E` A . . . Ep A DEXAMETHASONE; TOBRAMYCIN OPHTHALMIC d03536A A H66.9 Otitis media, unspecified A E A . . . E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A` E A DILTIAZEM d00045A C[@ I49.9 Cardiac arrhythmia, unspecified A` E A GLIPIZIDE d00246A B 99999 A` E A LEVOFLOXACIN d04109A B 99999 A` E A METFORMIN d03807A B E11 Type 2 diabetes mellitus A` E A TAMSULOSIN d04121A B N40 Enlarged prostate A` E A . . . E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A ATENOLOL d00004A C I10 Essential (primary) hypertension A E A CLONIDINE d00044A C I10 Essential (primary) hypertension A E A GABAPENTIN d03182A C E11.4 Type 2 diabetes mellitus with neurological complications A E A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus A E A LEVOTHYROXINE d00278A C E05 Thyrotoxicosis [hyperthyroidism] A E A LISINOPRIL d00732A C I21.P Prevent heart attack/myocardial infarction A E A METFORMIN d03807A C R73 Elevated blood glucose level A E A NAPROXEN d00019A B M19.9 Osteoarthritis, unspecified site A E A TAMSULOSIN d04121A C R35 Polyuria A E A ACETAMINOPHEN; HYDROCODONE d03428A A M54 Dorsalgia A E A IBUPROFEN d00015A A M54 Dorsalgia A E A . . . E A FENOFIBRATE d04286A CDp E78.0 Pure hypercholesterolemia A0 E A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A0 E A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A0 E A . . . E A . . . E A . . . E0 A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A C Z79.3 Long term (current) use of hormonal contraceptives A E@ A INSULIN ISOPHANE; INSULIN REGULAR d04374A B E11 Type 2 diabetes mellitus A EP A . . . E` A . . . Ep A GABAPENTIN d03182A B< M79.2 Neuralgia and neuritis, unspecified A Ep A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A E A DOXYCYCLINE d00037A B A49.9 Bacterial infection, unspecified A E A . . . E A . . . E A . . . E A CYCLOBENZAPRINE d00963A A M62.83 Muscle spasm A` E A GABAPENTIN d03182A C- M54 Dorsalgia A` E A NITROGLYCERIN d00321A C I20.9 Angina pectoris, unspecified A` E A RAMIPRIL d00728A Cr I10 Essential (primary) hypertension A` E A TAMSULOSIN d04121A Cr R35 Polyuria A` E A VENLAFAXINE d03181A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A` E A . . . E A . . . E A AMLODIPINE d00689A Bz I10 Essential (primary) hypertension A` E A ATENOLOL d00004A D ^ I10 Essential (primary) hypertension A` E A LEVOTHYROXINE d00278A D ^ E03.9 Hypothyroidism, unspecified A` E A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A` E A METFORMIN d03807A A E11 Type 2 diabetes mellitus A` E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A` E A . . . E A . . . E A IBUPROFEN d00015A B K08.4 Partial loss of teeth A E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A BUPRENORPHINE; NALOXONE d04819A B= F11.23 Opioid dependence with withdrawal A0 Ep A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 Ep A QUETIAPINE d04220A D F31.9 Bipolar disorder, unspecified A0 E A . . . E A ETHINYL ESTRADIOL; NORGESTREL d03241A B Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A IBUPROFEN d00015A A K08.8 Other specified disorders of teeth and supporting structures A0 E A METHADONE d00050A Bz F11.23 M54 M79.2 Opioid dependence with withdrawal Dorsalgia Neuralgia and neuritis, unspecified A0 E A PENICILLIN d00116A Ap K08.4 Partial loss of teeth A0 E A LEVOCETIRIZINE d05851A A T78.40 Allergy, unspecified A E A RIVAROXABAN d07356A C[@ D75.9P Prevent blood clots A E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A0 E A LORAZEPAM d00149A D# F41.9 Anxiety disorder, unspecified A0 E A TAMSULOSIN d04121A C- N40 Enlarged prostate A0 E A . . . E A METOPROLOL d00134A C I10 Essential (primary) hypertension A E A VERAPAMIL d00048A C- I10 Essential (primary) hypertension A E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP E A CITALOPRAM d04332A Cr F32.9 Major depressive disorder, single episode, unspecified AP E A DONEPEZIL d04099A Cr G31.9 Degenerative disease of nervous system, unspecified AP E A ESOMEPRAZOLE d04749A C K21 Gastro-esophageal reflux disease AP E A ROSUVASTATIN d04851A Cr E78.0 Pure hypercholesterolemia AP E0 A AMOXICILLIN d00088A Ap H66.9 J01.9 Otitis media, unspecified Acute sinusitis, unspecified A E@ A . . . EP A ALENDRONATE d03849A0 C- M81 Osteoporosis without current pathological fracture Ap EP A ATORVASTATIN d04105A0 C- E78.0 Pure hypercholesterolemia Ap EP A BENAZEPRIL d00730A0 C- I10 Essential (primary) hypertension Ap EP A GLIPIZIDE d00246A0 Cr E11 Type 2 diabetes mellitus Ap EP A LABETALOL d00016A0 C- I10 Essential (primary) hypertension Ap EP A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus Ap EP A SITAGLIPTIN d05896A0 Cr E11 Type 2 diabetes mellitus Ap E` A . . . Ep A . . . E A ATENOLOL d00004A B= I10 Essential (primary) hypertension A E A LABETALOL d00016A B I10 Essential (primary) hypertension A E A DOXYLAMINE; PYRIDOXINE d04654A B[ R11 Nausea and vomiting A0 E A LEVOTHYROXINE d00278A B E03.9 Hypothyroidism, unspecified A0 E A PROGESTERONE d00550A A Z79.890 Hormone replacement therapy A0 E A . . . E A PROMETHAZINE d00787A B R05 Cough A E A . . . E A LISINOPRIL d00732A Dc I10.P Prevent hypertension A E A PHENDIMETRAZINE d00809A Cr E66 Overweight and obesity A E A TRAZODONE d00395A CDp G47.0 Insomnia A E A ALPRAZOLAM d00168A C- F41.0 F41.9 Panic disorder [episodic paroxysmal anxiety] without agoraphobia Anxiety disorder, unspecified A E A ATORVASTATIN d04105A CDp E78.0 I70.P Pure hypercholesterolemia Prevent atherosclerosis A E A DILTIAZEM d00045A D# I10 Essential (primary) hypertension A E A IBUPROFEN d00015A D M19.9 Osteoarthritis, unspecified site A E A LISINOPRIL d00732A D# I10 Essential (primary) hypertension A E A OXYCODONE d00329A B G89 Pain, not elsewhere classified A E A PANTOPRAZOLE d04514A D K21 Gastro-esophageal reflux disease A E A VENLAFAXINE d03181A C- F32.9 Major depressive disorder, single episode, unspecified A E A . . . E A APIXABAN d07804A C D75.9P Prevent blood clots AP E A CLARITHROMYCIN d00097A B J18.9 Pneumonia, unspecified organism AP E A METOPROLOL d00134A C- R00 Abnormalities of heart beat AP E A SACUBITRIL; VALSARTAN d08369A C- I49.9 Cardiac arrhythmia, unspecified AP E A TAMSULOSIN d04121A B R35 Polyuria AP E A . . . E0 A AMLODIPINE d00689A B= I10 Essential (primary) hypertension A E0 A LOSARTAN d03821A B= I10 Essential (primary) hypertension A E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A Cr M54 Dorsalgia Ap E A AMITRIPTYLINE d00146A Cr G47.0 Insomnia Ap E A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension Ap E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension Ap E A METOPROLOL d00134A Cr I10 Essential (primary) hypertension Ap E A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia Ap E A TAMSULOSIN d04121A Cr N40 Enlarged prostate Ap E A CETIRIZINE d03827A C9 T78.40 Allergy, unspecified A E A . . . E A GLIPIZIDE; METFORMIN d04823A B R73 Elevated blood glucose level A@ E A LISINOPRIL d00732A B I10 Essential (primary) hypertension A@ E A METFORMIN d03807A B R73 Elevated blood glucose level A@ E A PRAVASTATIN d00348A B 99999 A@ E A . . . E A ALBUTEROL d00749A C J45 Asthma A E A ALLOPURINOL d00023A Dc M1A Chronic gout A E A CARVEDILOL d03847A C- I50.9 Heart failure, unspecified A E A CHLORZOXAZONE d00962A DGJ M79.1 Myalgia A E A CLOBETASOL TOPICAL d01288A Dc L40 Psoriasis A E A FLUTICASONE NASAL d04283A Cr J30.9 Allergic rhinitis, unspecified A E A FLUTICASONE; SALMETEROL d04611A B- J45 Asthma A E A HYDROCHLOROTHIAZIDE; OLMESARTAN d04878A C I10 Essential (primary) hypertension A E A LATANOPROST OPHTHALMIC d04017A C H40 Glaucoma A E A METFORMIN d03807A C R73 Elevated blood glucose level A E A NIACIN d00314A C E78.0 Pure hypercholesterolemia A E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E A AMLODIPINE d00689A Ei I10 Essential (primary) hypertension B E A ATORVASTATIN d04105A Ei E78.0 Pure hypercholesterolemia B E A BRIMONIDINE OPHTHALMIC d04048A Ei H57.9 Unspecified disorder of eye and adnexa B E A BUDESONIDE; FORMOTEROL d04795A Ei J45 Asthma B E A CLONIDINE d00044A Ei I10 Essential (primary) hypertension B E A DORZOLAMIDE OPHTHALMIC d03805A Ei H57.9 Unspecified disorder of eye and adnexa B E A FINASTERIDE d00563A Ei R39.9 Unspecified symptoms and signs involving the genitourinary system B E A GLIPIZIDE d00246A Ei E11 Type 2 diabetes mellitus B E A GUAIFENESIN; PSEUDOEPHEDRINE d03379A Ei R09.3 Abnormal sputum B E A HYDRALAZINE; HYDROCHLOROTHIAZIDE d03257A Ei I10 Essential (primary) hypertension B E A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A Ei R60.9 Edema, unspecified B E A INSULIN GLARGINE d04538A Ei E11 Type 2 diabetes mellitus B E A INSULIN LISPRO d04373A Ei E11 Type 2 diabetes mellitus B E A LINACLOTIDE d07902A Ei K59.0 Constipation B E A OMEPRAZOLE d00325A Ei K21 Gastro-esophageal reflux disease B E A TAMSULOSIN d04121A Ei R39.9 Unspecified symptoms and signs involving the genitourinary system B E A . . . E A . . . E0 A AMLODIPINE d00689A Ap I10 Essential (primary) hypertension A@ E0 A CARVEDILOL d03847A B= I10 Essential (primary) hypertension A@ E0 A CHLORTHALIDONE d00192A B I10 Essential (primary) hypertension A@ E0 A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A@ E@ A DOXYCYCLINE d00037A B R60.9 Edema, unspecified Ap E@ A HYDROCORTISONE TOPICAL d03205A B= R21 Rash and other nonspecific skin eruption Ap E@ A INSULIN GLARGINE d04538A C- E11 Type 2 diabetes mellitus Ap E@ A LISINOPRIL d00732A C E11.2 Type 2 diabetes mellitus with kidney complications Ap E@ A METFORMIN d03807A C E11 Type 2 diabetes mellitus Ap E@ A NYSTATIN TOPICAL d04399A A R21 Rash and other nonspecific skin eruption Ap E@ A SITAGLIPTIN d05896A C- E11 Type 2 diabetes mellitus Ap EP A . . . E` A ALLOPURINOL d00023A C[@ M1A Chronic gout A E` A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A E` A EZETIMIBE d04824A C E78.0 Pure hypercholesterolemia A E` A INSULIN DETEMIR d05436A C E11 Type 2 diabetes mellitus A E` A INSULIN LISPRO d04373A C E11 Type 2 diabetes mellitus A E` A OLMESARTAN d04801A C I10 Essential (primary) hypertension A E` A PANTOPRAZOLE d04514A C- K21 Gastro-esophageal reflux disease A E` A PAROXETINE d03157A B= F32.9 Major depressive disorder, single episode, unspecified A E` A SPIRONOLACTONE d00373A C R60.9 Edema, unspecified A E` A TORSEMIDE d03189A Cr E11 Type 2 diabetes mellitus A E` A WARFARIN d00022A C- D75.9P Prevent blood clots A Ep A . . . E A ANTIDEPRESSANTS - UNSPECIFIED c00249A C- F41.9 Anxiety disorder, unspecified A@ E A ARIPIPRAZOLE d04825A Ei F32.9 Major depressive disorder, single episode, unspecified A@ E A IRON SUCROSE d04725A C D64.9 Anemia, unspecified A@ E A PANTOPRAZOLE d04514A B[ K22 Other diseases of esophagus A@ E A . . . E A . . . E A . . . E A ALBUTEROL d00749A C J44.9 Chronic obstructive pulmonary disease, unspecified A E A AMLODIPINE d00689A C I21.P Prevent heart attack/myocardial infarction A E A CLOPIDOGREL d04258A D I21.P Prevent heart attack/myocardial infarction A E A FUROSEMIDE d00070A C- R60.9 Edema, unspecified A E A LISINOPRIL d00732A C I50.9 Heart failure, unspecified A E A MELOXICAM d04532A Cr M19.9 Osteoarthritis, unspecified site A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A METOPROLOL d00134A C I21.P Prevent heart attack/myocardial infarction A E A PANTOPRAZOLE d04514A C K21 K30 Gastro-esophageal reflux disease Functional dyspepsia A E A ROPINIROLE d04215A C- G25.81 Restless legs syndrome A E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E A . . . E A CLINDAMYCIN d00043A Ap K04.7 Periapical abscess without sinus A E A AMLODIPINE; BENAZEPRIL d03829A D I10 Essential (primary) hypertension A` E A APIXABAN d07804A B= Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A` E A ATENOLOL d00004A B- I10 Essential (primary) hypertension A` E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A` E A FLECAINIDE d00234A CDp I49.9 Cardiac arrhythmia, unspecified A` E A METFORMIN d03807A Cr R73 Elevated blood glucose level A` E A AMOXICILLIN d00088A AP H66.9 Otitis media, unspecified A E A . . . E0 A 99999 . . A E@ A . . . EP A COLCHICINE d00150A CDp M1A Chronic gout A EP A TAMSULOSIN d04121A C- N40 Enlarged prostate A E` A ALPRAZOLAM d00168A C F41.0 F41.9 Panic disorder [episodic paroxysmal anxiety] without agoraphobia Anxiety disorder, unspecified A@ E` A ATENOLOL d00004A C R00 Abnormalities of heart beat A@ E` A ATORVASTATIN d04105A B[ E78.0 Pure hypercholesterolemia A@ E` A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified A@ Ep A AMOXICILLIN d00088A A H66.9 J01.9 Otitis media, unspecified Acute sinusitis, unspecified A E A LOSARTAN d03821A C I10 Essential (primary) hypertension A0 E A MONTELUKAST d04289A Cr J45 Asthma A0 E A VENLAFAXINE d03181A D N95 Menopausal and other perimenopausal disorders A0 E A . . . E A ATENOLOL d00004A D I10 Essential (primary) hypertension A E A . . . E A . . . E A DICYCLOMINE d00999A C K58 Irritable bowel syndrome A E A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A E A BUPROPION d00181A CDp F31.9 Bipolar disorder, unspecified A E A FLUTICASONE NASAL d04283A C J30.2 Other seasonal allergic rhinitis A E A HYDROCODONE d03075A C[@ M54 Dorsalgia A E A HYDROXYZINE d00907A B F41.9 Anxiety disorder, unspecified A E A INSULIN ISOPHANE (NPH) d04370A Dc E11 Type 2 diabetes mellitus A E A INSULIN REGULAR d04369A Dc E11 Type 2 diabetes mellitus A E A LAMOTRIGINE d03809A CDp F31.9 Bipolar disorder, unspecified A E A LISINOPRIL d00732A C E11.2P Prevent diabetic kidney disease A E A NAPROXEN d00019A C M54 Dorsalgia A E A PROPRANOLOL d00032A C R25.1 Tremor, unspecified A E A ROPINIROLE d04215A Ap G25.81 Restless legs syndrome A E A TEMAZEPAM d00384A C- G47.0 Insomnia A E A TOPIRAMATE d04115A CDp F31.9 Bipolar disorder, unspecified A E A OMEPRAZOLE d00325A A R05 Cough A E A TRAMADOL d03826A B M25.5 Pain in joint A E A BUPROPION d00181A A F32.9 Major depressive disorder, single episode, unspecified A0 E A METFORMIN d03807A Cr 55555 A0 E A ROPINIROLE d04215A C G25.81 Restless legs syndrome A0 E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E0 A . . . E@ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E@ A ICOSAPENT d07891A C E78.1 Pure hyperglyceridemia A0 E@ A METFORMIN d03807A C E11 Type 2 diabetes mellitus A0 EP A . . . E` A ALBUTEROL d00749A B[ R06.02 R06.2 Shortness of breath Wheezing A Ep A ATORVASTATIN d04105A C 99999 A Ep A DIGOXIN d00210A C 99999 A Ep A DOXAZOSIN d00726A C 99999 A Ep A FINASTERIDE d00563A C 99999 A Ep A FUROSEMIDE d00070A C 99999 A Ep A GLIPIZIDE d00246A C 99999 A Ep A METOPROLOL d00134A C 99999 A Ep A WARFARIN d00022A C 99999 A E A . . . E A METHIMAZOLE d00290A Cr E05 Thyrotoxicosis [hyperthyroidism] A E A . . . E A . . . E A ARIPIPRAZOLE d04825A C- F39 F99 Unspecified mood [affective] disorder Mental disorder, not otherwise specified A E A ESCITALOPRAM d04812A C F32.9 Major depressive disorder, single episode, unspecified A E A . . . E A . . . E A 99999 A B[ Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A . . . E A . . . E0 A . . . E@ A . . . EP A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia A` EP A DIPYRIDAMOLE d00213A C D75.9P Prevent blood clots A` EP A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A D# I10 Essential (primary) hypertension A` EP A OMEGA-3 POLYUNSATURATED FATTY ACIDS d00497A C E78.1 Pure hyperglyceridemia A` EP A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease A` EP A TRAMADOL d03826A D M19.9 Osteoarthritis, unspecified site A` E` A . . . Ep A . . . E A . . . E A DORZOLAMIDE OPHTHALMIC d03805A D H40 Glaucoma A@ E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A D I10 Essential (primary) hypertension A@ E A NAPROXEN d00019A Dc M13 Other arthritis A@ E A TIMOLOL OPHTHALMIC d04037A D H40 Glaucoma A@ E A . . . E A BUPROPION d00181A B F32.9 Major depressive disorder, single episode, unspecified A@ E A DESMOPRESSIN d00583A B R32 Unspecified urinary incontinence A@ E A ESCITALOPRAM d04812A B F39 Unspecified mood [affective] disorder A@ E A TRAZODONE d00395A B G47.0 Insomnia A@ E A . . . E A . . . E A . . . E A . . . E A FLUTICASONE; SALMETEROL d04611A D J45 Asthma A E A MONTELUKAST d04289A D J45 Asthma A E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A FUROSEMIDE d00070A C[@ I10 R60.9 Essential (primary) hypertension Edema, unspecified AP E` A GABAPENTIN d03182A Dc M79.2 Neuralgia and neuritis, unspecified AP E` A LOVASTATIN d00280A Dc E78.0 Pure hypercholesterolemia AP E` A METOPROLOL d00134A Dc I10 Essential (primary) hypertension AP E` A MILNACIPRAN d06635A Dc M79.7 Fibromyalgia AP Ep A . . . E A AMOXICILLIN d00088A B J01.9 N30 Acute sinusitis, unspecified Cystitis Ap E A AMPHETAMINE d00803A Dc F90 Attention-deficit hyperactivity disorders Ap E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C Z79.3 Long term (current) use of hormonal contraceptives Ap E A LOSARTAN d03821A C- I10 Essential (primary) hypertension Ap E A MONTELUKAST d04289A C- J30.9 R05 Allergic rhinitis, unspecified Cough Ap E A VENLAFAXINE d03181A C F41.9 Anxiety disorder, unspecified Ap E A ZALEPLON d04452A B G47.9 Sleep disorder, unspecified Ap E A ATORVASTATIN d04105A0 CDp E78.0 Pure hypercholesterolemia A E A CARVEDILOL d03847A0 CDp I10 Essential (primary) hypertension A E A CIPROFLOXACIN d00011A0 CDp A49.9P N39.0 Prevent bacterial infection Urinary tract infection, site not specified A E A CITALOPRAM d04332A0 CDp F32.9 Major depressive disorder, single episode, unspecified A E A CLONAZEPAM d00197A0 CDp F32.9 Major depressive disorder, single episode, unspecified A E A DONEPEZIL d04099A0 CDp G31.9 Degenerative disease of nervous system, unspecified A E A GLIPIZIDE d00246A0 CDp E11 Type 2 diabetes mellitus A E A INSULIN DETEMIR d05436A0 CDp E11 Type 2 diabetes mellitus A E A LISINOPRIL d00732A0 CDp I10 Essential (primary) hypertension A E A NAPROXEN d00019A0 B M13 M79.1 Other arthritis Myalgia A E A OMEPRAZOLE d00325A0 CDp K21 Gastro-esophageal reflux disease A E A POLYETHYLENE GLYCOL 3350 d05350A0 CDp K59.0 Constipation A E A QUETIAPINE d04220A0 CDp F31.9 Bipolar disorder, unspecified A E A RISPERIDONE d03180A0 CDp F31.9 Bipolar disorder, unspecified A E A SUCRALFATE d00377A0 CDp K25 Gastric ulcer A E A . . . E A . . . E A . . . E A AMLODIPINE d00689A B[ I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A E A BACLOFEN d00967A B M54 Dorsalgia A E A BECLOMETHASONE d00760A CDp R06.2 Wheezing A E A CYCLOBENZAPRINE d00963A B M54 Dorsalgia A E A FLUOXETINE d00236A C- F41.9 Anxiety disorder, unspecified A E A LATANOPROST OPHTHALMIC d04017A Cr H40 Glaucoma A E A METOPROLOL d00134A B[ I10 Essential (primary) hypertension A E A MORPHINE d00308A B= M54 Dorsalgia A E A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A E A TRAMADOL d03826A C M79.1 Myalgia A E A . . . E A . . . E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C F90 Attention-deficit hyperactivity disorders A@ E A LURASIDONE d07705A C F31.9 Bipolar disorder, unspecified A@ E A QUETIAPINE d04220A CDp G47.0 Insomnia A@ E A TRAMADOL d03826A D= M79.7 Fibromyalgia A@ E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A GLIPIZIDE d00246A C- E11 Type 2 diabetes mellitus AP E` A LEVOTHYROXINE d00278A D E07.9 Disorder of thyroid, unspecified AP E` A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension AP E` A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus AP E` A PRAVASTATIN d00348A Dc E78.0 Pure hypercholesterolemia AP Ep A . . . E A . . . E A . . . E A AMLODIPINE d00689A Dc I10 Essential (primary) hypertension A E A CARVEDILOL d03847A C I10 Essential (primary) hypertension A E A DORZOLAMIDE; TIMOLOL OPHTHALMIC d04303A C H26.9 Unspecified cataract A E A FUROSEMIDE d00070A Dc I10 Essential (primary) hypertension A E A HYDRALAZINE d00132A Cr I10 Essential (primary) hypertension A E A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A E A LOVASTATIN d00280A Dc E78.0 Pure hypercholesterolemia A E A TERAZOSIN d00386A C N42.9 Disorder of prostate, unspecified A E A TRAVOPROST OPHTHALMIC d04753A C H26.9 Unspecified cataract A E A VALSARTAN d04113A Cr I10 Essential (primary) hypertension A E A . . . E A . . . E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A` E A BETHANECHOL d01427A Cr R39.9 Unspecified symptoms and signs involving the genitourinary system A` E A DOXAZOSIN d00726A DO R39.1 Other difficulties with micturition A` E A FINASTERIDE d00563A Cr R39.9 Unspecified symptoms and signs involving the genitourinary system A` E A METOPROLOL d00134A Cr 99999 A` E A PANTOPRAZOLE d04514A C R12 Heartburn A` E A CETIRIZINE d03827A A T78.40 Allergy, unspecified A0 E A FLUTICASONE d01296A C- J45 Asthma A0 E A MOMETASONE d05262A B J45 Asthma A0 E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ E A EMPAGLIFLOZIN d08275A B[ E11 Type 2 diabetes mellitus A@ E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E A ESCITALOPRAM d04812A C F41.9 Anxiety disorder, unspecified A E A . . . E A ONDANSETRON d00867A B R11 Nausea and vomiting A E A RANITIDINE d00021A C- K21 R11 Gastro-esophageal reflux disease Nausea and vomiting A E0 A ALBUTEROL d00749A C[@ J45 Asthma A@ E0 A ALBUTEROL d00749A C[@ J45 Asthma A@ E0 A BECLOMETHASONE d00760A C[@ J45 Asthma A@ E0 A MONTELUKAST d04289A Cr J45 Asthma A@ E@ A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A E@ A CLOPIDOGREL d04258A D D75.9P Prevent blood clots A E@ A FINASTERIDE d00563A D N40 Enlarged prostate A E@ A GLIPIZIDE d00246A B E11 Type 2 diabetes mellitus A E@ A HYDROCHLOROTHIAZIDE d00253A Cr R60.9 Edema, unspecified A E@ A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E@ A LOSARTAN d03821A D I21.P Prevent heart attack/myocardial infarction A E@ A METFORMIN d03807A D E11 Type 2 diabetes mellitus A E@ A METOPROLOL d00134A D I21.P Prevent heart attack/myocardial infarction A E@ A RANITIDINE d00021A C- K21 Gastro-esophageal reflux disease A E@ A TAMSULOSIN d04121A D N40 Enlarged prostate A EP A . . . E` A . . . Ep A CLOPIDOGREL d04258A C I63 Cerebral infarction Ap Ep A HYDROCHLOROTHIAZIDE d00253A C"0 I10 Essential (primary) hypertension Ap Ep A LISINOPRIL d00732A D I10 Essential (primary) hypertension Ap Ep A METFORMIN d03807A D E11 Type 2 diabetes mellitus Ap Ep A METOPROLOL d00134A D I10 Essential (primary) hypertension Ap Ep A OMEPRAZOLE d00325A D K30 R12 Functional dyspepsia Heartburn Ap Ep A SIMVASTATIN d00746A D E78.0 I63.P Pure hypercholesterolemia Prevent stroke Ap E A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia AP E A CARVEDILOL d03847A C I50.9 Heart failure, unspecified AP E A FUROSEMIDE d00070A C I10 Essential (primary) hypertension AP E A HYDRALAZINE d00132A Cr I50.9 Heart failure, unspecified AP E A LOSARTAN d03821A C I10 Essential (primary) hypertension AP E A AMLODIPINE d00689A D' I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A . . . E A DULOXETINE d05355A Dc F33.9 Major depressive disorder, recurrent, unspecified A0 E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A0 E A . . . E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A BENAZEPRIL d00730A D I10 Essential (primary) hypertension A E A FUROSEMIDE d00070A CDp R60.9 Edema, unspecified A E A INSULIN ISOPHANE (NPH) d04370A D* E11 Type 2 diabetes mellitus A E A INSULIN REGULAR d04369A D* E11 Type 2 diabetes mellitus A E A METFORMIN d03807A D E11 Type 2 diabetes mellitus A E A OMEGA-3 POLYUNSATURATED FATTY ACIDS d00497A CDp E78.1 Pure hyperglyceridemia A E A OMEPRAZOLE d00325A C- K31.9 Disease of stomach and duodenum, unspecified A E A POTASSIUM CHLORIDE d00345A CDp Z79 Long term (current) drug therapy A E A ALBUTEROL d00749A C J45 Asthma A E A ALPRAZOLAM d00168A D& F41.9 Anxiety disorder, unspecified A E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A GABAPENTIN d03182A CDp M79.7 Fibromyalgia A E A GEMFIBROZIL d00245A C E78.0 Pure hypercholesterolemia A E A HYDROCHLOROTHIAZIDE d00253A Cr I10 R60.9 Essential (primary) hypertension Edema, unspecified A E A HYDROCODONE d03075A D& T14.9 Unspecified injury A E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E A PRAZOSIN d00138A Cr I10 Essential (primary) hypertension A E A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease A E A SERTRALINE d00880A D# F41.9 Anxiety disorder, unspecified A E A TIOTROPIUM d04829A C J45 Asthma A E A TIZANIDINE d04102A C[@ M79.7 Fibromyalgia A E A ZOLPIDEM d00910A C F41.9 Anxiety disorder, unspecified A E0 A LOSARTAN d03821A C[@ I10 Essential (primary) hypertension A E0 A OMEPRAZOLE d00325A B= K27 Peptic ulcer, site unspecified A E@ A . . . EP A PHENYTOIN d00143A B= G40 Epilepsy and recurrent seizures A E` A . . . Ep A . . . E A LEVOTHYROXINE d00278A C 99999 A E A . . . E A . . . E A . . . E A . . . E A . . . E A AMLODIPINE d00689A Bz I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia AP E@ A DULOXETINE d05355A B M79.7 Fibromyalgia AP E@ A PANTOPRAZOLE d04514A CDp K21 Gastro-esophageal reflux disease AP E@ A PREGABALIN d05508A C M79.7 Fibromyalgia AP E@ A RANITIDINE d00021A CDp K21 Gastro-esophageal reflux disease AP EP A . . . E` A BACLOFEN d00967A Cr M54 Dorsalgia Ap E` A DICLOFENAC d00848A C M25.5 Pain in joint Ap E` A GABAPENTIN d03182A C"0 G99.8 Other specified disorders of nervous system in diseases classified elsewhere Ap E` A MOMETASONE TOPICAL d01300A B[ L40 Psoriasis Ap E` A NAPROXEN d00019A Cr M25.5 Pain in joint Ap E` A OMEPRAZOLE d00325A C K30 Functional dyspepsia Ap E` A TRAMADOL d03826A Cr M54 Dorsalgia Ap Ep A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A E A . . . E A ACETAMINOPHEN; BUTALBITAL; CAFFEINE d03455A D9 R51 Headache A E A OMEPRAZOLE d00325A C[@ K21 Gastro-esophageal reflux disease A E A . . . E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A E A PAROXETINE d03157A C- F32.9 Major depressive disorder, single episode, unspecified A E A LISDEXAMFETAMINE d06663A A@ F90 Attention-deficit hyperactivity disorders A E A TAMSULOSIN d04121A C- R32 Unspecified urinary incontinence A E A . . . E A EZETIMIBE d04824A Cr E78.0 Pure hypercholesterolemia A0 E A FENOFIBRIC ACID d07371A Cr E78.0 Pure hypercholesterolemia A0 E A NEBIVOLOL d05265A Cr I10 Essential (primary) hypertension A0 E A . . . E A . . . E A . . . E0 A HYDROCHLOROTHIAZIDE d00253A C- I10 Essential (primary) hypertension A E@ A . . . EP A . . . E` A . . . Ep A METHYLPHENIDATE d00900A B[ F90 Attention-deficit hyperactivity disorders A E A . . . E A ALBUTEROL d00749A Dc J45 Asthma A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A GABAPENTIN d03182A C[@ M79.7 Fibromyalgia A E A IBUPROFEN d00015A D* M13 Other arthritis A E A LISINOPRIL d00732A B I10 Essential (primary) hypertension A E A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A E A METOPROLOL d00134A C R60.9 Edema, unspecified A E A MONTELUKAST d04289A C J45 Asthma A E A NAPROXEN d00019A C[@ M06.9 Rheumatoid arthritis, unspecified A E A CLINDAMYCIN d00043A B= A49.9P Prevent bacterial infection A0 E A IBUPROFEN d00015A B* R52 Pain, unspecified A0 E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A0 E A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension Ap E A CHLORTHALIDONE d00192A C 99999 Ap E A ENALAPRIL d00013A C I10 Essential (primary) hypertension Ap E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified Ap E A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus Ap E A OMEPRAZOLE d00325A C[@ K21 Gastro-esophageal reflux disease Ap E A PRAVASTATIN d00348A C[@ E78.0 Pure hypercholesterolemia Ap E A . . . E A ALBUTEROL d00749A Cr J45 Asthma A E A ALBUTEROL d00749A C[@ J42 J45 Unspecified chronic bronchitis Asthma A E A . . . E A . . . E A METFORMIN d03807A B E28 Ovarian dysfunction A E A . . . E0 A . . . E@ A . . . EP A 99999 . . A@ EP A LISINOPRIL d00732A D E11.2 Type 2 diabetes mellitus with kidney complications A@ EP A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ EP A RANITIDINE d00021A D R12 Heartburn A@ E` A NAPROXEN d00019A B M25.5 Pain in joint A Ep A DONEPEZIL d04099A C- R41 Other symptoms and signs involving cognitive functions and awareness A Ep A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C F90 Attention-deficit hyperactivity disorders A E A ESCITALOPRAM d04812A B= F32.9 Major depressive disorder, single episode, unspecified A E A . . . E A IRBESARTAN d04222A C I10 Essential (primary) hypertension A E A OMEPRAZOLE d00325A B K25 Gastric ulcer A E A . . . E A . . . E A . . . E A . . . E A . . . E A ATENOLOL d00004A D I10 Essential (primary) hypertension A0 E A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A0 E A HYDROCHLOROTHIAZIDE d00253A D R60.9 Edema, unspecified A0 E A DICYCLOMINE d00999A C K51 Ulcerative colitis A0 E A MIRTAZAPINE d04025A B F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A0 E A ONDANSETRON d00867A C K51 Ulcerative colitis A0 E A BUPROPION d00181A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A@ E A CHLORHEXIDINE TOPICAL d01231A D A49.9P Prevent bacterial infection A@ E A FLUOCINOLONE OTIC d06032A DGJ H93.9 Unspecified disorder of ear A@ E A FLUTICASONE NASAL d04283A D9 J30.9 Allergic rhinitis, unspecified A@ E0 A . . . E@ A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C N92 Excessive, frequent and irregular menstruation A EP A ATENOLOL d00004A C R00 Abnormalities of heart beat A@ EP A METHADONE d00050A Cr M54 Dorsalgia A@ EP A OMEPRAZOLE d00325A C[@ K21 Gastro-esophageal reflux disease A@ EP A PROMETHAZINE d00787A C K46 R11 Unspecified abdominal hernia Nausea and vomiting A@ E` A FLUTICASONE d01296A Cr J45 Asthma A Ep A TOPIRAMATE d04115A Ei G40 Epilepsy and recurrent seizures A E A . . . E A ACETAMINOPHEN; CODEINE d03423A D T14.9 Unspecified injury Ap E A LEVOCETIRIZINE d05851A B= R09.81 Nasal congestion Ap E A LOSARTAN d03821A Cr I10 Essential (primary) hypertension Ap E A MELOXICAM d04532A B M06.9 Rheumatoid arthritis, unspecified Ap E A METHSCOPOLAMINE d00989A B= R09.3 Abnormal sputum Ap E A PANTOPRAZOLE d04514A Cr K21 Gastro-esophageal reflux disease Ap E A UMECLIDINIUM; VILANTEROL d08188A B R05 Cough Ap E A CIPROFLOXACIN d00011A Ap K51 Ulcerative colitis A0 E A METRONIDAZOLE d00108A Ap K51 Ulcerative colitis A0 E A ONDANSETRON d00867A Ap R11 Nausea and vomiting A0 E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C- Z79.3 Long term (current) use of hormonal contraceptives A E A METHYLPHENIDATE d00900A B F90 Attention-deficit hyperactivity disorders A E A CLOPIDOGREL d04258A D/ D75.9P Prevent blood clots A0 E A PANTOPRAZOLE d04514A Cr K21 K25 K30 Gastro-esophageal reflux disease Gastric ulcer Functional dyspepsia A0 E A VERAPAMIL d00048A C- I10 Essential (primary) hypertension A0 E A . . . E A . . . E A . . . E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A E A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A E A ALBUTEROL d00749A Cr J45 Asthma A E0 A . . . E@ A CARVEDILOL d03847A C I10 Essential (primary) hypertension A0 E@ A HYDROCHLOROTHIAZIDE d00253A B= R60.9 Edema, unspecified A0 E@ A LOSARTAN d03821A C I10 Essential (primary) hypertension A0 EP A CLINDAMYCIN TOPICAL d01241A C- L70 Acne A EP A TRETINOIN TOPICAL d01244A C- L70 Acne A E` A . . . Ep A . . . E A . . . E A HYDROCHLOROTHIAZIDE d00253A D I10 Essential (primary) hypertension A E A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia A E A PANTOPRAZOLE d04514A Ap K30 Functional dyspepsia A E A . . . E A . . . E A . . . E A . . . E A LOSARTAN d03821A C I10 Essential (primary) hypertension A E A NORETHINDRONE d00555A C Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A . . . E A DILTIAZEM d00045A CP I48.9 Unspecified atrial fibrillation and atrial flutter A0 E A FLUOXETINE d00236A CDp F41.9 Anxiety disorder, unspecified A0 E A TRAZODONE d00395A C- F41.9 Anxiety disorder, unspecified A0 E0 A ESCITALOPRAM d04812A Cr F41.9 Anxiety disorder, unspecified A E0 A THYROID DESICCATED d00655A Cr E03.9 E06 Hypothyroidism, unspecified Thyroiditis A E@ A . . . EP A . . . E` A . . . Ep A ACETAMINOPHEN; HYDROCODONE d03428A C- M54 Dorsalgia A Ep A CYCLOBENZAPRINE d00963A C- M54 Dorsalgia A E A FAMOTIDINE d00141A A@ K21 Gastro-esophageal reflux disease A E A NAPROXEN d00019A A@ M25.5 R07.9 Pain in joint Chest pain, unspecified A E A AMLODIPINE d00689A Dc I10 Essential (primary) hypertension A@ E A FLUTICASONE NASAL d04283A Dc J30.2 Other seasonal allergic rhinitis A@ E A LEVOCETIRIZINE d05851A C T78.40 Allergy, unspecified A@ E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A@ E A . . . E A . . . E A . . . E A . . . E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified AP E A QUETIAPINE d04220A D F39 G47.0 Unspecified mood [affective] disorder Insomnia AP E A RISPERIDONE d03180A D F39 F90 F91 Unspecified mood [affective] disorder Attention-deficit hyperactivity disorders Conduct disorders AP E A TRAZODONE d00395A D F31.9 F32.9 F39 Bipolar disorder, unspecified Major depressive disorder, single episode, unspecified Unspecified mood [affective] disorder AP E A ZIPRASIDONE d04747A D F31.9 F90 G47.0 Bipolar disorder, unspecified Attention-deficit hyperactivity disorders Insomnia AP E A . . . E A ALLOPURINOL d00023A C- F32.9 Major depressive disorder, single episode, unspecified A` E A BUPROPION d00181A B M10.9 Gout, unspecified A` E A COLCHICINE d00150A B 55555 A` E A ESCITALOPRAM d04812A CDp F32.9 Major depressive disorder, single episode, unspecified A` E A ROFLUMILAST d07684A B J43 Emphysema A` E A TAMSULOSIN d04121A C R39.1 Other difficulties with micturition A` E A 99999 . . A@ E A INSULIN LISPRO d04373A Cr E11 Type 2 diabetes mellitus A@ E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E A FINASTERIDE d00563A C N40 Enlarged prostate A0 E A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A0 E A TELMISARTAN d04364A C I10 I21.P Essential (primary) hypertension Prevent heart attack/myocardial infarction A0 E A HYDROCHLOROTHIAZIDE d00253A CP I10 Essential (primary) hypertension A E A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A ATROPINE; DIPHENOXYLATE d03506A C- R19.7 Diarrhea, unspecified AP E A CETIRIZINE d03827A C[@ J30.1 L50 T78.40 Allergic rhinitis due to pollen Urticaria Allergy, unspecified AP E A NAPROXEN d00019A C- T14.9 Unspecified injury AP E A PREDNISONE d00350A C[@ M65.9 Synovitis and tenosynovitis, unspecified AP E A RANITIDINE d00021A C- K21 Gastro-esophageal reflux disease AP E A . . . E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A E A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A E0 A CYPROHEPTADINE d00790A Ap G43 Migraine A E@ A . . . EP A . . . E` A . . . Ep A ALLOPURINOL d00023A DGJ M1A Chronic gout A E A . . . E A . . . E A . . . E A GLUCAGON d00593A Ap 55555 A E A METFORMIN d03807A Ap E11 Type 2 diabetes mellitus A E A . . . E A . . . E A . . . E A AMOXICILLIN d00088A A B34.9 Viral infection, unspecified A E A DILTIAZEM d00045A DK I10 Essential (primary) hypertension A E A GLIPIZIDE d00246A D E11 Type 2 diabetes mellitus A E A HYDROCHLOROTHIAZIDE d00253A D# I10 Essential (primary) hypertension A E A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A E A LOSARTAN d03821A D# I10 Essential (primary) hypertension A E A METFORMIN d03807A DNk E11 Type 2 diabetes mellitus A E A METOPROLOL d00134A C[@ I48.9 Unspecified atrial fibrillation and atrial flutter A E A OMEPRAZOLE d00325A D K30 Functional dyspepsia A E A PRAVASTATIN d00348A D E78.0 Pure hypercholesterolemia A E A RIVAROXABAN d07356A C[@ I48.9 Unspecified atrial fibrillation and atrial flutter A E A BUPROPION d00181A C- F39 Unspecified mood [affective] disorder A E A PAROXETINE d03157A B[ F32.9 Major depressive disorder, single episode, unspecified A E A . . . E0 A ALBUTEROL d00749A D J45 Asthma A E0 A ATENOLOL d00004A C 99999 A E0 A FLUTICASONE; SALMETEROL d04611A B= J45 Asthma A E0 A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E0 A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E0 A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia A E0 A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A E0 A MONTELUKAST d04289A CDp 99999 A E0 A OMEPRAZOLE d00325A B K31.9 Disease of stomach and duodenum, unspecified A E@ A . . . EP A . . . E` A AMLODIPINE d00689A D I10 Essential (primary) hypertension AP E` A EZETIMIBE d04824A B E78.0 Pure hypercholesterolemia AP E` A LISINOPRIL d00732A D% I10 Essential (primary) hypertension AP E` A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP E` A OXYBUTYNIN d00328A B= R32 Unspecified urinary incontinence AP Ep A AMLODIPINE d00689A C I10 Essential (primary) hypertension A Ep A METOPROLOL d00134A C I10 Essential (primary) hypertension A E A . . . E A AMOXICILLIN d00088A Ap J02.0 Streptococcal pharyngitis A E A BROMPHENIRAMINE; DEXTROMETHORPHAN; PSEUDOEPHEDRINE d03368A A J02.0 Streptococcal pharyngitis A E A CARVEDILOL d03847A CP I49.9 I50.9 Cardiac arrhythmia, unspecified Heart failure, unspecified A0 E A LISINOPRIL d00732A CP I50.9 Heart failure, unspecified A0 E A SIMVASTATIN d00746A CP E78.0 Pure hypercholesterolemia A0 E A CARVEDILOL d03847A C I51.9 Heart disease, unspecified A@ E A GLIMEPIRIDE d03864A C E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A@ E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A@ E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A D L70 N94 Z79.3 Acne Pain and other conditions associated with female genital organs and menstrual cycle Long term (current) use of hormonal contraceptives A E A . . . E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A ATENOLOL d00004A CP I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A E A AZELASTINE NASAL d04068A C- T78.40 Allergy, unspecified A E A FLUTICASONE NASAL d04283A Dc J30.1 Allergic rhinitis due to pollen A E A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus A E A HYDROCHLOROTHIAZIDE d00253A D R60.9 Edema, unspecified A E A LISINOPRIL d00732A D I10 Essential (primary) hypertension A E A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease A E A WARFARIN d00022A D D75.9P Prevent blood clots A E A . . . E A . . . E A . . . E0 A . . . E@ A ALBUTEROL d00749A CDp J45 Asthma A E@ A FLUTICASONE NASAL d04283A C J30.2 Other seasonal allergic rhinitis A EP A AMOXICILLIN d00088A A0 J40 Bronchitis, not specified as acute or chronic A EP A PREDNISONE d00350A A0 J42 Unspecified chronic bronchitis A E` A ALBUTEROL d00749A CDp J44.9 Chronic obstructive pulmonary disease, unspecified A E` A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E` A DORZOLAMIDE OPHTHALMIC d03805A Dc H40 Glaucoma A E` A DRONABINOL d00866A C- R63 Symptoms and signs concerning food and fluid intake A E` A FORMOTEROL; MOMETASONE d07660A CDp J44.9 Chronic obstructive pulmonary disease, unspecified A E` A IPRATROPIUM d00265A CDp R06.02 R06.2 Shortness of breath Wheezing A E` A LATANOPROST OPHTHALMIC d04017A Dc H40 Glaucoma A E` A OLODATEROL; TIOTROPIUM d08362A C R06.2 R06.9 Wheezing Unspecified abnormalities of breathing A E` A PREDNISONE d00350A C R06.02 R06.2 Shortness of breath Wheezing A E` A TERAZOSIN d00386A C R35 Polyuria A Ep A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A Ep A HYDROCHLOROTHIAZIDE d00253A B I10 Essential (primary) hypertension A E A . . . E A . . . E A BUPRENORPHINE; NALOXONE d04819A C F11.23 Opioid dependence with withdrawal A E A . . . E A POLYETHYLENE GLYCOL 3350 d05350A C- K59.0 Constipation A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A ENALAPRIL d00013A CDp I10 Essential (primary) hypertension A@ E` A GLIPIZIDE d00246A CDp E11 Type 2 diabetes mellitus A@ E` A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A@ E` A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A@ Ep A . . . E A AMLODIPINE d00689A C D64.9 M81 N28.9 Anemia, unspecified Osteoporosis without current pathological fracture Disorder of kidney and ureter, unspecified A` E A CHLORTHALIDONE d00192A D I10 Essential (primary) hypertension A` E A LEVOTHYROXINE d00278A D* Z90 Acquired absence of organs, not elsewhere classified A` E A METOPROLOL d00134A C 99999 A` E A POTASSIUM CHLORIDE d00345A B[ E87.6 Hypokalemia A` E A URSODIOL d01005A D K87 Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere A` E A . . . E A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A@ E A ENALAPRIL d00013A C[@ N19 Unspecified kidney failure A@ E A MEMANTINE d04899A B= R41 Other symptoms and signs involving cognitive functions and awareness A@ E A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A@ E A . . . E A AMITRIPTYLINE d00146A C- G43 Migraine A@ E A NADOLOL d00018A B[ G43.P Prevent migraine A@ E A NAPROXEN d00019A C- G43 Migraine A@ E A RANITIDINE d00021A C- K21 Gastro-esophageal reflux disease A@ E A . . . E A . . . E A ISOSORBIDE MONONITRATE d00269A C"0 I21.P Prevent heart attack/myocardial infarction A@ E A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A@ E A METOPROLOL d00134A C"0 I21.P Prevent heart attack/myocardial infarction A@ E A OMEPRAZOLE d00325A C[@ K30 Functional dyspepsia A@ E A . . . E A . . . E A . . . E0 A CETIRIZINE d03827A B T78.40 Allergy, unspecified A E0 A MUPIROCIN TOPICAL d01267A B R21 Rash and other nonspecific skin eruption A E@ A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia A0 E@ A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Dc I10 Essential (primary) hypertension A0 E@ A OMEPRAZOLE d00325A C[@ K21 K30 Gastro-esophageal reflux disease Functional dyspepsia A0 EP A . . . E` A DICLOFENAC d00848A B[ M19.9 Osteoarthritis, unspecified site A Ep A . . . E A 77777 . . A E A AMLODIPINE d00689A C- I20.9 Angina pectoris, unspecified A@ E A FUROSEMIDE d00070A C- R60.9 Edema, unspecified A@ E A LOSARTAN d03821A C- E87.6 Hypokalemia A@ E A METOPROLOL d00134A C- I10 Essential (primary) hypertension A@ E A . . . E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A E A . . . E A . . . E A 99999 . . A E A . . . E A . . . E A . . . E A . . . E0 A IRBESARTAN d04222A0 C[@ I10 Essential (primary) hypertension A E@ A . . . EP A ACETAMINOPHEN; OXYCODONE d03431A B= G89 T14.9 Pain, not elsewhere classified Unspecified injury A E` A . . . Ep A MINOCYCLINE d00110A B= L70 Acne A E A . . . E A . . . E A LISINOPRIL d00732A CP I10 Essential (primary) hypertension A0 E A RANITIDINE d00021A CP K25 Gastric ulcer A0 E A WARFARIN d00022A CP I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified A0 E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A AMOXICILLIN d00088A Bm H66.9 Otitis media, unspecified A E A . . . E0 A ETHINYL ESTRADIOL; NORGESTIMATE d03781A B 55555 A0 E0 A FLUOXETINE d00236A B F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A0 E0 A MONTELUKAST d04289A C J30.9 Allergic rhinitis, unspecified A0 E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A MONTELUKAST d04289A Bz J30.9 J45 R06.2 Allergic rhinitis, unspecified Asthma Wheezing A E A SERTRALINE d00880A C F32.9 F39 F41.9 Major depressive disorder, single episode, unspecified Unspecified mood [affective] disorder Anxiety disorder, unspecified A E A . . . E A AMLODIPINE d00689A C I10 I20.9 Essential (primary) hypertension Angina pectoris, unspecified A E A ATORVASTATIN d04105A C I21.P I63.P Prevent heart attack/myocardial infarction Prevent stroke A E A CARVEDILOL d03847A C I63 Cerebral infarction A E A HYDRALAZINE d00132A C[@ I10 Essential (primary) hypertension A E A INDAPAMIDE d00260A C 99999 A E A INSULIN ISOPHANE (NPH) d04370A C E11 Type 2 diabetes mellitus A E A INSULIN REGULAR d04369A C E11 Type 2 diabetes mellitus A E A LOSARTAN d03821A C E78.0 Pure hypercholesterolemia A E A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A E A NAPROXEN d00019A B= M25.9 Joint disorder, unspecified A E A . . . E A . . . E A AMPHETAMINE d00803A B[ F90 Attention-deficit hyperactivity disorders A E A MONTELUKAST d04289A B J30.9 R06.9 Allergic rhinitis, unspecified Unspecified abnormalities of breathing A E A DONEPEZIL d04099A Ei G31.9 R41 Degenerative disease of nervous system, unspecified Other symptoms and signs involving cognitive functions and awareness AP E A DULOXETINE d05355A Ei N39.4 Other specified urinary incontinence AP E A LEVOTHYROXINE d00278A Ei E03.9 Hypothyroidism, unspecified AP E A METFORMIN d03807A Ei E11 Type 2 diabetes mellitus AP E A PIOGLITAZONE d04442A Ei E11 Type 2 diabetes mellitus AP E A ALLOPURINOL d00023A D M1A Chronic gout A E A AMLODIPINE d00689A C I10 I21.P Essential (primary) hypertension Prevent heart attack/myocardial infarction A E A AMMONIUM LACTATE TOPICAL d04049A C[@ L98.9 Disorder of the skin and subcutaneous tissue, unspecified A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A CARVEDILOL d03847A C I10 I21.P Essential (primary) hypertension Prevent heart attack/myocardial infarction A E A CLINDAMYCIN TOPICAL d01241A C[@ L08.9 Local infection of the skin and subcutaneous tissue, unspecified A E A CLONIDINE d00044A CDp I10 I21.P Essential (primary) hypertension Prevent heart attack/myocardial infarction A E A FLUOXETINE d00236A B F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A GLIPIZIDE d00246A D E11 Type 2 diabetes mellitus A E A INSULIN ASPART; INSULIN ASPART PROTAMINE d04839A C- E11 Type 2 diabetes mellitus A E A LISINOPRIL d00732A D I10 Essential (primary) hypertension A E A METFORMIN d03807A D E11 Type 2 diabetes mellitus A E A OMEPRAZOLE d00325A Cr K21 K30 Gastro-esophageal reflux disease Functional dyspepsia A E A SILDENAFIL d04299A Cr N52.9 Male erectile dysfunction, unspecified A E A TRIAMCINOLONE TOPICAL d03206A C L08.9 Local infection of the skin and subcutaneous tissue, unspecified A E A . . . E A LEVETIRACETAM d04499A Cr G40 Epilepsy and recurrent seizures A E0 A . . . E@ A . . . EP A MESALAMINE d01031A A K50 K51 Crohn's disease [regional enteritis] Ulcerative colitis A0 EP A ONDANSETRON d00867A Cr R11 Nausea and vomiting A0 EP A SULFASALAZINE d00379A Cf K50 K51 Crohn's disease [regional enteritis] Ulcerative colitis A0 E` A . . . Ep A . . . E A . . . E A . . . E A PANTOPRAZOLE d04514A Cr K30 Functional dyspepsia A E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia AP E A BUSPIRONE d00182A CDp F41.9 Anxiety disorder, unspecified AP E A ESCITALOPRAM d04812A CDp F32.9 F43.1 Major depressive disorder, single episode, unspecified Post-traumatic stress disorder (PTSD) AP E A SULFASALAZINE d00379A D% K51 Ulcerative colitis AP E A TRAMADOL d03826A C- M25.5 M54 T14.9 Pain in joint Dorsalgia Unspecified injury AP E A . . . E A DESVENLAFAXINE d07113A C F32.9 Major depressive disorder, single episode, unspecified A E A . . . E A BISOPROLOL d00709A C I51.9 Heart disease, unspecified A` E A CLONIDINE d00044A C I10 Essential (primary) hypertension A` E A FAMOTIDINE d00141A C K57 Diverticular disease of intestine A` E A HYDRALAZINE d00132A C I10 Essential (primary) hypertension A` E A LOSARTAN d03821A C I10 Essential (primary) hypertension A` E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A` E A ACETAMINOPHEN; OXYCODONE d03431A A M79.1 Myalgia A E A DICLOFENAC d00848A C M79.1 Myalgia A E A ALPRAZOLAM d00168A C[@ F41.9 Anxiety disorder, unspecified A E0 A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A E0 A PRAVASTATIN d00348A CDp E78.0 Pure hypercholesterolemia A E@ A . . . EP A . . . E` A ETHINYL ESTRADIOL; NORGESTIMATE d03781A B N94 Pain and other conditions associated with female genital organs and menstrual cycle A Ep A . . . E A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A C I10 Essential (primary) hypertension A` E A IPRATROPIUM d00265A B T78.40 Allergy, unspecified A` E A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A` E A NORTRIPTYLINE d00144A CDp M54 Dorsalgia A` E A OMEPRAZOLE d00325A B[ R12 Heartburn A` E A ROSUVASTATIN d04851A Cr E78.0 Pure hypercholesterolemia A` E A ATORVASTATIN d04105A D ^ E78.0 Pure hypercholesterolemia A` E A CLOPIDOGREL d04258A D D75.9P Prevent blood clots A` E A FINASTERIDE d00563A D N40 Enlarged prostate A` E A METOPROLOL d00134A D ^ I10 R00 Essential (primary) hypertension Abnormalities of heart beat A` E A RAMIPRIL d00728A D ^ I10 Essential (primary) hypertension A` E A SILODOSIN d07354A D N40 Enlarged prostate A` E A . . . E A . . . E A . . . E A OSELTAMIVIR d04462A Bz E63.9 Nutritional deficiency, unspecified A E A . . . E A . . . E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A@ E A AZITHROMYCIN d00091A A0 J42 Unspecified chronic bronchitis A@ E A RAMIPRIL d00728A C I99.9 Unspecified disorder of circulatory system A@ E A WARFARIN d00022A CP D75.9P Prevent blood clots A@ E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A CDp I10 Essential (primary) hypertension A0 E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A0 E A METFORMIN d03807A CDp R73 Elevated blood glucose level A0 E A ATENOLOL d00004A C I10 Essential (primary) hypertension A@ E A ATROPINE; DIPHENOXYLATE d03506A Cr R19.7 Diarrhea, unspecified A@ E A ESOMEPRAZOLE d04749A Cr K21 Gastro-esophageal reflux disease A@ E A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A C I10 Essential (primary) hypertension A@ E0 A . . . E@ A . . . EP A . . . E` A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified A E` A NAPROXEN d00019A C M79.1 Myalgia A Ep A ALLOPURINOL d00023A0 B E79.9 Disorder of purine and pyrimidine metabolism, unspecified B Ep A ALPRAZOLAM d00168A0 Cr F41.9 G47.9 Anxiety disorder, unspecified Sleep disorder, unspecified B Ep A ATENOLOL d00004A0 Ei I10 Essential (primary) hypertension B Ep A ATORVASTATIN d04105A0 CDp E78.0 Pure hypercholesterolemia B Ep A CARVEDILOL d03847A0 C 99999 B Ep A CLOPIDOGREL d04258A0 C- I63.P Prevent stroke B Ep A DOCUSATE d01021A0 Bz K59.0 Constipation B Ep A FUROSEMIDE d00070A0 B= R60.9 Edema, unspecified B Ep A GABAPENTIN d03182A0 C M79.2 Neuralgia and neuritis, unspecified B Ep A GLIPIZIDE d00246A0 Cr E11 Type 2 diabetes mellitus B Ep A INSULIN ASPART d04697A0 B E11 Type 2 diabetes mellitus B Ep A LOSARTAN d03821A0 Ei 99999 B Ep A MECLIZINE d00859A0 Cr R42 Dizziness and giddiness B Ep A MONTELUKAST d04289A0 B R09.81 Nasal congestion B Ep A OMEPRAZOLE d00325A0 C K21 Gastro-esophageal reflux disease B Ep A SERTRALINE d00880A0 C- F32.9 Major depressive disorder, single episode, unspecified B E A . . . E A . . . E A BENZONATATE d00796A A R05 Cough A0 E A MONTELUKAST d04289A A R05 Cough A0 E A RANITIDINE d00021A A T78.40 Allergy, unspecified A0 E A BROMPHENIRAMINE; DEXTROMETHORPHAN; PSEUDOEPHEDRINE d03368A B R05 Cough A E A PREDNISONE d00350A B J42 Unspecified chronic bronchitis A E A ALBUTEROL d00749A C- J45 Asthma A E A ALPRAZOLAM d00168A C- F41.9 Anxiety disorder, unspecified A E A CLOPIDOGREL d04258A CDp D75.9P Prevent blood clots A E A EMPAGLIFLOZIN d08275A B= I51.9P R73 Prevent heart disease Elevated blood glucose level A E A GLYBURIDE d00248A Cr R73 Elevated blood glucose level A E A LEVOTHYROXINE d00278A Cr E07.9 Disorder of thyroid, unspecified A E A QUINAPRIL d00365A Cr I10 Essential (primary) hypertension A E A TESTOSTERONE d00558A B R53 Malaise and fatigue A E A . . . E A . . . E A . . . E A LOSARTAN d03821A C I10 Essential (primary) hypertension AP E A METFORMIN; SITAGLIPTIN d06720A CDp E11 Type 2 diabetes mellitus AP E A METOPROLOL d00134A C I10 Essential (primary) hypertension AP E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia AP E A VALACYCLOVIR d03838A C A60.9 Anogenital herpesviral infection, unspecified AP E A . . . E A . . . E0 A . . . E@ A METFORMIN d03807A B[ E11 Type 2 diabetes mellitus A EP A . . . E` A . . . Ep A . . . E A . . . E A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension Ap E A CARVEDILOL d03847A Cr I10 Essential (primary) hypertension Ap E A FUROSEMIDE d00070A Cr I10 Essential (primary) hypertension Ap E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension Ap E A METHOTREXATE d00060A B L29.9 N95 Pruritus, unspecified Menopausal and other perimenopausal disorders Ap E A PAROXETINE d03157A B N95 Menopausal and other perimenopausal disorders Ap E A POTASSIUM CHLORIDE d00345A Cr E87.6 Hypokalemia Ap E A . . . E A . . . E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E A METFORMIN d03807A B[ R73 Elevated blood glucose level A E A METHYLPHENIDATE d00900A B F90 Attention-deficit hyperactivity disorders A E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A SERTRALINE d00880A Cr F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A . . . E A . . . E A AMIODARONE d00002A C- R00 Abnormalities of heart beat A` E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A` E A MEGESTROL d01348A B R63 Symptoms and signs concerning food and fluid intake A` E A METOPROLOL d00134A C- I10 Essential (primary) hypertension A` E A PANTOPRAZOLE d04514A C- B96.81 Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere A` E A SIMVASTATIN d00746A C50 E78.0 Pure hypercholesterolemia A` E A ATORVASTATIN d04105A C I21.P Prevent heart attack/myocardial infarction A@ E A CARVEDILOL d03847A C I10 Essential (primary) hypertension A@ E A ISOSORBIDE MONONITRATE d00269A A R07.9 Chest pain, unspecified A@ E A VALSARTAN d04113A C I10 Essential (primary) hypertension A@ E0 A ALLOPURINOL d00023A D9 M1A Chronic gout A` E0 A ALPRAZOLAM d00168A Cr G47.9 Sleep disorder, unspecified A` E0 A FUROSEMIDE d00070A Dc R60.9 Edema, unspecified A` E0 A MELOXICAM d04532A Cr M19.9 Osteoarthritis, unspecified site A` E0 A POTASSIUM CHLORIDE d00345A Dc E87.6P Prevent hypokalemia A` E0 A PREDNISONE d00350A D* M35 Other systemic involvement of connective tissue A` E@ A ETHINYL ESTRADIOL; NORGESTIMATE d03781A B Z79.3 Long term (current) use of hormonal contraceptives A EP A . . . E` A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A@ E` A GLIMEPIRIDE d03864A B 99999 A@ E` A LOSARTAN d03821A C 99999 A@ E` A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A@ Ep A . . . E A CETIRIZINE d03827A C- J30.1 Allergic rhinitis due to pollen AP E A FLUTICASONE d01296A CDp R06.2 Wheezing AP E A HYDROCODONE d03075A C M54 Dorsalgia AP E A MONTELUKAST d04289A C- J30.9 Allergic rhinitis, unspecified AP E A PREGABALIN d05508A CDp M79.2 Neuralgia and neuritis, unspecified AP E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A ATENOLOL d00004A D I10 Essential (primary) hypertension A@ E A HYDROCHLOROTHIAZIDE d00253A DO I10 Essential (primary) hypertension A@ E A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A@ E A PRAVASTATIN d00348A DO E78.0 Pure hypercholesterolemia A@ E0 A NABUMETONE d00310A C M19.9 M54 Osteoarthritis, unspecified site Dorsalgia A0 E0 A NITROFURANTOIN d00112A A@ N39.0 Urinary tract infection, site not specified A0 E0 A SIMVASTATIN d00746A Dc E78.0 Pure hypercholesterolemia A0 E@ A . . . EP A CETIRIZINE d03827A B R09.81 T78.40 Nasal congestion Allergy, unspecified A EP A FLUTICASONE NASAL d04283A B J30.2 J30.9 Other seasonal allergic rhinitis Allergic rhinitis, unspecified A E` A . . . Ep A APIXABAN d07804A B I48.9 Unspecified atrial fibrillation and atrial flutter A Ep A CHOLESTYRAMINE d00193A C- 55555 A Ep A CITALOPRAM d04332A Cr F32.9 Major depressive disorder, single episode, unspecified A Ep A FUROSEMIDE d00070A Cr I51.9 Heart disease, unspecified A Ep A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A Ep A METOCLOPRAMIDE d00298A C K92.9 Disease of digestive system, unspecified A Ep A MYCOPHENOLATE MOFETIL d03839A CDp M06.9 Rheumatoid arthritis, unspecified A Ep A OMEPRAZOLE d00325A C R12 Heartburn A Ep A PREDNISONE d00350A CJ J98.9 Respiratory disorder, unspecified A Ep A SPIRONOLACTONE d00373A C I51.9 Heart disease, unspecified A E A . . . E A . . . E A DESOGESTREL; ETHINYL ESTRADIOL d03782A C- Z79.3 Long term (current) use of hormonal contraceptives A E A SERTRALINE d00880A Cr F32.9 Major depressive disorder, single episode, unspecified A E A . . . E A ATENOLOL d00004A D9 I10 Essential (primary) hypertension A E A CLOPIDOGREL d04258A Cr D75.9P Prevent blood clots A E A DOXAZOSIN d00726A Dc I10 Essential (primary) hypertension A E A HYDRALAZINE d00132A Cr I10 Essential (primary) hypertension A E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A RANITIDINE d00021A C[@ K21 Gastro-esophageal reflux disease A E A RIVAROXABAN d07356A Dc D75.9P Prevent blood clots A E A ROSUVASTATIN d04851A C- E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A HYDROCHLOROTHIAZIDE; IRBESARTAN d04245A Bz I10 Essential (primary) hypertension A E A INSULIN ISOPHANE (NPH) d04370A B R73 Elevated blood glucose level A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A AMLODIPINE d00689A C I10 Essential (primary) hypertension Ap E A FAMOTIDINE d00141A C K21 Gastro-esophageal reflux disease Ap E A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified Ap E A POTASSIUM CHLORIDE d00345A B E87.6 Hypokalemia Ap E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia Ap E A SPIRONOLACTONE d00373A C I10 Essential (primary) hypertension Ap E A TORSEMIDE d03189A B R60.9 Edema, unspecified Ap E A . . . E0 A ANASTROZOLE d03873A C- C50.P prevent breast cancer A E0 A PAROXETINE d03157A C F32.9 Major depressive disorder, single episode, unspecified A E@ A . . . EP A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A0 EP A LEVOTHYROXINE d00278A C 99999 A0 EP A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A0 E` A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A E` A GABAPENTIN d03182A CDp M79.2 Neuralgia and neuritis, unspecified A E` A HYDROXYZINE d00907A C F41.9 Anxiety disorder, unspecified A E` A INSULIN ISOPHANE (NPH) d04370A C- E11 Type 2 diabetes mellitus A E` A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A E` A MORPHINE d00308A C- R52 Pain, unspecified A E` A OXYCODONE d00329A C[@ R52 Pain, unspecified A E` A PROMETHAZINE d00787A C R11 Nausea and vomiting A E` A TIZANIDINE d04102A B M62.83 Muscle spasm A Ep A . . . E A . . . E A . . . E A DEXMETHYLPHENIDATE d04777A CDp F90 Attention-deficit hyperactivity disorders A E A RISPERIDONE d03180A C- G47.0 Insomnia A E A . . . E A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A` E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A` E A LISINOPRIL d00732A Cr E11.2 Type 2 diabetes mellitus with kidney complications A` E A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A` E A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A` E A RANITIDINE d00021A Cr K30 Functional dyspepsia A` E A . . . E A APIXABAN d07804A B Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A` E A FUROSEMIDE d00070A B R60.9 Edema, unspecified A` E A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus A` E A HYDRALAZINE d00132A B I10 Essential (primary) hypertension A` E A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A` E A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A` E A INSULIN DETEMIR d05436A C E11 Type 2 diabetes mellitus A0 E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A0 E A METFORMIN d03807A C R73 Elevated blood glucose level A0 E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A E A . . . E A . . . E0 A . . . E@ A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E@ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E@ A CETIRIZINE d03827A C T78.40 Allergy, unspecified A E@ A GABAPENTIN d03182A CDp M79.2 Neuralgia and neuritis, unspecified A E@ A HYDROCODONE d03075A CP M54 Dorsalgia A E@ A LEVOTHYROXINE d00278A C- E07.9 Disorder of thyroid, unspecified A E@ A TAMSULOSIN d04121A C- N40 Enlarged prostate A E@ A TRIAMTERENE d00396A CP I10 Essential (primary) hypertension A EP A CETIRIZINE d03827A C J30.9 R09.81 Allergic rhinitis, unspecified Nasal congestion A` EP A FLUTICASONE NASAL d04283A C J30.9 Allergic rhinitis, unspecified A` EP A LOSARTAN d03821A C I10 Essential (primary) hypertension A` EP A MELOXICAM d04532A C M25.5 Pain in joint A` EP A OMEPRAZOLE d00325A B K21 Gastro-esophageal reflux disease A` EP A SERTRALINE d00880A B F32.9 Major depressive disorder, single episode, unspecified A` E` A . . . Ep A . . . E A . . . E A BENAZEPRIL d00730A C- 99999 A@ E A DONEPEZIL d04099A CDp 99999 A@ E A LOVASTATIN d00280A CDp I10 Essential (primary) hypertension A@ E A TERAZOSIN d00386A C- 99999 A@ E A . . . E A . . . E A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A` E A ATENOLOL d00004A CDp I10 Essential (primary) hypertension A` E A FENOFIBRATE d04286A C E78.0 Pure hypercholesterolemia A` E A HYDROCHLOROTHIAZIDE d00253A CDp I10 Essential (primary) hypertension A` E A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A` E A LOSARTAN d03821A C I10 Essential (primary) hypertension A` E A . . . E A . . . E A ALBUTEROL d00749A D J45 Asthma A E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E0 A . . . E@ A ALBUTEROL; IPRATROPIUM d04066A CDp J44.9 Chronic obstructive pulmonary disease, unspecified A E@ A ASPIRIN d00170A C- D75.9P Prevent blood clots A E@ A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A E@ A BUPROPION d00181A Cr F32.9 Major depressive disorder, single episode, unspecified A E@ A BUSPIRONE d00182A D ^ F41.9 Anxiety disorder, unspecified A E@ A CALCIPOTRIENE TOPICAL d03788A C L40 Psoriasis A E@ A FLUOXETINE d00236A D ^ F32.9 Major depressive disorder, single episode, unspecified A E@ A LORAZEPAM d00149A C F41.9 Anxiety disorder, unspecified A EP A . . . E` A . . . Ep A . . . E A . . . E A ATOVAQUONE d01120A B# B99.9 Unspecified infectious disease A0 E A CIPROFLOXACIN d00011A BF R19.7 Diarrhea, unspecified A0 E A MUPIROCIN TOPICAL d01267A B# L08.9 Local infection of the skin and subcutaneous tissue, unspecified A0 E A . . . E A ESCITALOPRAM d04812A C[@ F32.9 Major depressive disorder, single episode, unspecified A0 E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Dc I10 Essential (primary) hypertension A0 E A LOVASTATIN d00280A Dc E78.0 Pure hypercholesterolemia A0 E A AMOXICILLIN d00088A A@ J02 Acute pharyngitis A E A MONTELUKAST d04289A CDp J30.9 Allergic rhinitis, unspecified A E A METOPROLOL d00134A C I10 Essential (primary) hypertension A E A . . . E A 99999 . . A E A . . . E A LISINOPRIL d00732A D I10 Essential (primary) hypertension A0 E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A0 E A NAPROXEN d00019A Bz T14.9 Unspecified injury A0 E A AMIODARONE d00002A0 Ei 99999 A E A ASPIRIN d00170A0 Ei Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A E A INSULIN ISOPHANE (NPH) d04370A0 Ei R73 Elevated blood glucose level A E A INSULIN REGULAR d04369A0 Ei E11 Type 2 diabetes mellitus A E A LEVOTHYROXINE d00278A0 Ei 99999 A E A POTASSIUM CHLORIDE d00345A0 Ei 99999 A E A SACUBITRIL; VALSARTAN d08369A0 B I50.9 Heart failure, unspecified A E A SIMVASTATIN d00746A0 Ei 99999 A E A TAMSULOSIN d04121A0 Ei 99999 A E A TORSEMIDE d03189A0 Ei 99999 A E A WARFARIN d00022A0 Ei Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A E0 A . . . E@ A ALBIGLUTIDE d08251A B E11 Type 2 diabetes mellitus AP E@ A AMLODIPINE d00689A D I10 Essential (primary) hypertension AP E@ A DAPAGLIFLOZIN; METFORMIN d08245A B E11 Type 2 diabetes mellitus AP E@ A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A D I10 Essential (primary) hypertension AP E@ A SIMVASTATIN d00746A C E78.0P Prevent high cholesterol AP EP A . . . E` A . . . Ep A TRAMADOL d03826A B M54 Dorsalgia A E A ROSUVASTATIN d04851A Cr E78.0 Pure hypercholesterolemia A E A ALPRAZOLAM d00168A C[@ R45 Symptoms and signs involving emotional state A E A FLUTICASONE NASAL d04283A Cr J30.1 Allergic rhinitis due to pollen A@ E A LOSARTAN d03821A C I10 Essential (primary) hypertension A@ E A TRAMADOL d03826A B M54 Dorsalgia A@ E A TRAZODONE d00395A C G47.0 Insomnia A@ E A . . . E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A0 E A METFORMIN d03807A C"0 E11.P Prevent diabetes A0 E A PRAVASTATIN d00348A B= E78.0 Pure hypercholesterolemia A0 E A . . . E A . . . E A . . . E A ACETAMINOPHEN; OXYCODONE d03431A B= M54 M79.2 Dorsalgia Neuralgia and neuritis, unspecified A E A . . . E A TRETINOIN TOPICAL d01244A A L70 Acne A E0 A ATENOLOL d00004A Dc I10 Essential (primary) hypertension AP E0 A HYDROCHLOROTHIAZIDE d00253A Dc I10 Essential (primary) hypertension AP E0 A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified AP E0 A METFORMIN d03807A C- E11 Type 2 diabetes mellitus AP E0 A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia AP E@ A . . . EP A . . . E` A ALPRAZOLAM d00168A Bz F41.9 Anxiety disorder, unspecified A Ep A ATENOLOL d00004A Cr I10 Essential (primary) hypertension Ap Ep A HYDRALAZINE d00132A C I10 Essential (primary) hypertension Ap Ep A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension Ap Ep A LEVOTHYROXINE d00278A C[@ E03.9 Hypothyroidism, unspecified Ap Ep A LOSARTAN d03821A C[@ I10 Essential (primary) hypertension Ap Ep A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus Ap Ep A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia Ap E A MONTELUKAST d04289A Cr J45 Asthma A E A . . . E A . . . E A . . . E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C"0 Z79.3 Long term (current) use of hormonal contraceptives A E A FLUORIDE TOPICAL d04397A B= K05.6 Periodontal disease, unspecified A E A ALBUTEROL d00749A C R06.02 Shortness of breath A E A FLUTICASONE d01296A C J45 R05 R06.2 Asthma Cough Wheezing A E A AZITHROMYCIN d00091A AP J40 Bronchitis, not specified as acute or chronic A0 E A DOXYCYCLINE d00037A A J18.9 Pneumonia, unspecified organism A0 E A OLMESARTAN d04801A CDp I10 Essential (primary) hypertension A0 E A LEVOTHYROXINE d00278A D)Y E03.9 Hypothyroidism, unspecified A E A . . . E A . . . E A ALLOPURINOL d00023A D M1A Chronic gout AP E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E A CARVEDILOL d03847A C I21.P Prevent heart attack/myocardial infarction AP E A CLOPIDOGREL d04258A C I21.P Prevent heart attack/myocardial infarction AP E A RAMIPRIL d00728A C I10 Essential (primary) hypertension AP E0 A . . . E@ A . . . EP A ALLOPURINOL d00023A C M1A Chronic gout A EP A CARVEDILOL d03847A C I50.9 Heart failure, unspecified A EP A DULOXETINE d05355A Cr F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A EP A FENOFIBRATE d04286A C E78.0 Pure hypercholesterolemia A EP A FUROSEMIDE d00070A C I51.9 Heart disease, unspecified A EP A HYDRALAZINE; ISOSORBIDE DINITRATE d05540A Cr I10 I51.9P Essential (primary) hypertension Prevent heart disease A EP A INSULIN LISPRO; INSULIN LISPRO PROTAMINE d04510A C R73 Elevated blood glucose level A EP A LOSARTAN d03821A C I10 Essential (primary) hypertension A EP A OMEGA-3 POLYUNSATURATED FATTY ACIDS d00497A C E78.0 I51.9P Pure hypercholesterolemia Prevent heart disease A EP A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A E` A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A Ep A ESOMEPRAZOLE d04749A C- K30 Functional dyspepsia AP Ep A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified AP Ep A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension AP Ep A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia AP Ep A ZOLPIDEM d00910A Cr G47.9 Sleep disorder, unspecified AP E A . . . E A CILOSTAZOL d04382A C I70 Atherosclerosis A E A GABAPENTIN d03182A Cr B02 Zoster [herpes zoster] A E A INSULIN ISOPHANE; INSULIN REGULAR d04374A Dc E11 Type 2 diabetes mellitus A E A LATANOPROST OPHTHALMIC d04017A C H57.9 Unspecified disorder of eye and adnexa A E A METOPROLOL d00134A C- I10 Essential (primary) hypertension A E A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A E A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A E A TIMOLOL OPHTHALMIC d04037A C H40 Glaucoma A E A ESCITALOPRAM d04812A Cr F33.9 Major depressive disorder, recurrent, unspecified A E A ERYTHROMYCIN OPHTHALMIC d03973A A@ H10 Conjunctivitis A@ E A IBUPROFEN d00015A D N94 Pain and other conditions associated with female genital organs and menstrual cycle A@ E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A@ E A RANITIDINE d00021A CDp K21 Gastro-esophageal reflux disease A@ E A ALLOPURINOL d00023A C M1A Chronic gout A@ E A CHLORTHALIDONE d00192A C- I10 Essential (primary) hypertension A@ E A INSULIN GLARGINE d04538A C[@ E11 Type 2 diabetes mellitus A@ E A LOSARTAN d03821A C- I10 Essential (primary) hypertension A@ E A . . . E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A Cr I10 Essential (primary) hypertension Ap E A MELOXICAM d04532A CDp M79.1 Myalgia Ap E A METOPROLOL d00134A CP I10 Essential (primary) hypertension Ap E A OXCARBAZEPINE d04513A C- M79.2 Neuralgia and neuritis, unspecified Ap E A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia Ap E A TAMSULOSIN d04121A C N40 Enlarged prostate Ap E A TIZANIDINE d04102A B G47.9 M62.83 M79.1 Sleep disorder, unspecified Muscle spasm Myalgia Ap E A ONDANSETRON d00867A B= R11.P Prevent nausea or vomiting A E A . . . E A . . . E A . . . E0 A CEPHALEXIN d00096A A N39.0 Urinary tract infection, site not specified A E0 A CIPROFLOXACIN d00011A A N39.0 Urinary tract infection, site not specified A E0 A LANSOPRAZOLE d03828A D ^ K21 Gastro-esophageal reflux disease A E0 A LEVOTHYROXINE d00278A D% E03.9 Hypothyroidism, unspecified A E0 A LORAZEPAM d00149A B F41.9 Anxiety disorder, unspecified A E0 A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension A E0 A MIRTAZAPINE d04025A C F32.9 G47.9 Major depressive disorder, single episode, unspecified Sleep disorder, unspecified A E0 A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A E@ A HYDROXYCHLOROQUINE d00817A C M06.9 Rheumatoid arthritis, unspecified A0 E@ A LEFLUNOMIDE d04349A C M06.9 Rheumatoid arthritis, unspecified A0 E@ A LEVOTHYROXINE d00278A D' E03.9 Hypothyroidism, unspecified A0 EP A . . . E` A AMOXICILLIN d00088A AP H66.9 Otitis media, unspecified A Ep A ATENOLOL d00004A D1 I10 Essential (primary) hypertension A Ep A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E A . . . E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension AP E A LOSARTAN d03821A C I10 Essential (primary) hypertension AP E A PANTOPRAZOLE d04514A C[@ K21 Gastro-esophageal reflux disease AP E A POTASSIUM CHLORIDE d00345A B E87.6 Hypokalemia AP E A . . . E A BUPROPION d00181A B F32.9 Major depressive disorder, single episode, unspecified A@ E A GABAPENTIN d03182A0 Bz M54 M81 Dorsalgia Osteoporosis without current pathological fracture A@ E A LIDOCAINE; PRILOCAINE TOPICAL d03655A0 B= T14.9 Unspecified injury A@ E A OXYCODONE d00329A0 C[@ M54 Dorsalgia A@ E A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A E A ROSUVASTATIN d04851A D E78.0 Pure hypercholesterolemia A E A AMLODIPINE d00689A B I10 Essential (primary) hypertension A` E A CELECOXIB d04380A Bz M06.9 Rheumatoid arthritis, unspecified A` E A GLIPIZIDE d00246A Cr E11 Type 2 diabetes mellitus A` E A HYDROCHLOROTHIAZIDE d00253A CDp I10 Essential (primary) hypertension A` E A PANTOPRAZOLE d04514A C K30 Functional dyspepsia A` E A VALSARTAN d04113A C I10 Essential (primary) hypertension A` E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A 77777 . . Ap E` A 99999 . . Ap E` A AMLODIPINE d00689A D ^ I10 Essential (primary) hypertension Ap E` A METOPROLOL d00134A D ^ I10 Essential (primary) hypertension Ap E` A MONTELUKAST d04289A C J44.9 Chronic obstructive pulmonary disease, unspecified Ap E` A OMEPRAZOLE d00325A D ^ K21 Gastro-esophageal reflux disease Ap E` A ROSUVASTATIN d04851A D ^ E78.0 Pure hypercholesterolemia Ap Ep A ATORVASTATIN d04105A B= I25.9 Chronic ischemic heart disease, unspecified Ap Ep A CLOPIDOGREL d04258A B= I25.9 Chronic ischemic heart disease, unspecified Ap Ep A GEMFIBROZIL d00245A CDp E78.0 Pure hypercholesterolemia Ap Ep A LISINOPRIL d00732A CDp R73 Elevated blood glucose level Ap Ep A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus Ap Ep A METOPROLOL d00134A B= I50.9 I51.9 Heart failure, unspecified Heart disease, unspecified Ap Ep A NITROGLYCERIN d00321A B= I20.9 Angina pectoris, unspecified Ap E A . . . E A . . . E A ALPRAZOLAM d00168A C 99999 Ap E A CITALOPRAM d04332A C 99999 Ap E A FINASTERIDE d00563A C- N40 Enlarged prostate Ap E A GABAPENTIN d03182A C- M79.2 M79.6 Neuralgia and neuritis, unspecified Pain in limb, hand, foot, fingers and toes Ap E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C- 99999 Ap E A METOPROLOL d00134A C- I10 Essential (primary) hypertension Ap E A TAMSULOSIN d04121A C- N40 R32 Enlarged prostate Unspecified urinary incontinence Ap E A . . . E A PANTOPRAZOLE d04514A B K21 Gastro-esophageal reflux disease A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A CLOPIDOGREL d04258A C D75.9P Prevent blood clots A E A CYCLOBENZAPRINE d00963A Dc M62.83 Muscle spasm A E A LISINOPRIL d00732A C R00 Abnormalities of heart beat A E A METOPROLOL d00134A C I10 Essential (primary) hypertension A E A MINOCYCLINE d00110A CDp L70 Acne A E A OXYCODONE d00329A Dc M54 M79.1 Dorsalgia Myalgia A E A RANITIDINE d00021A C K30 Functional dyspepsia A E A . . . E A . . . E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A CDp Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E0 A INSULIN ASPART d04697A D E10 Type 1 diabetes mellitus A0 E0 A INSULIN DETEMIR d05436A D E10 Type 1 diabetes mellitus A0 E0 A LOVASTATIN d00280A B= E78.0 Pure hypercholesterolemia A0 E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A CDp M54 Dorsalgia A` E A CYCLOBENZAPRINE d00963A B M54 Dorsalgia A` E A FUROSEMIDE d00070A C R60.9 Edema, unspecified A` E A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A D I10 Essential (primary) hypertension A` E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A` E A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A` E A METOPROLOL d00134A C I10 Essential (primary) hypertension A0 E A MIRABEGRON d07876A Cr N39.4 R35 Other specified urinary incontinence Polyuria A0 E A TAMSULOSIN d04121A C N40 Enlarged prostate A0 E A CEPHALEXIN d00096A A J00 Acute nasopharyngitis [common cold] A E A INSULIN ASPART d04697A C E10 Type 1 diabetes mellitus A E A INSULIN DETEMIR d05436A B E10 Type 1 diabetes mellitus A E A . . . E A . . . E A METOPROLOL d00134A Dc I10 Essential (primary) hypertension A0 E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A0 E A SERTRALINE d00880A C F41.9 Anxiety disorder, unspecified A0 E A AMLODIPINE d00689A D I10 Essential (primary) hypertension Ap E A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus Ap E A METFORMIN d03807A D E11 Type 2 diabetes mellitus Ap E A PAROXETINE d03157A B F32.9 F39 M79.2 Major depressive disorder, single episode, unspecified Unspecified mood [affective] disorder Neuralgia and neuritis, unspecified Ap E A RAMIPRIL d00728A D I10 Essential (primary) hypertension Ap E A ROSUVASTATIN d04851A D E78.0 Pure hypercholesterolemia Ap E A TAMSULOSIN d04121A C"0 R35 Polyuria Ap E A . . . E A . . . E0 A . . . E@ A . . . EP A ALPRAZOLAM d00168A C- F41.9 Anxiety disorder, unspecified A` EP A ARIPIPRAZOLE d04825A CDp F39 Unspecified mood [affective] disorder A` EP A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A` EP A MIRTAZAPINE d04025A B G47.0 Insomnia A` EP A OXYCODONE d00329A Dc M25.5 Pain in joint A` EP A SERTRALINE d00880A B F31.9 Bipolar disorder, unspecified A` E` A ANASTROZOLE d03873A B K92.9 Disease of digestive system, unspecified A E` A MEGESTROL d01348A C K30 Functional dyspepsia A Ep A DULOXETINE d05355A C- F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A@ Ep A ESOMEPRAZOLE d04749A Dc K21 Gastro-esophageal reflux disease A@ Ep A QUETIAPINE d04220A B[ F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A@ Ep A TOFACITINIB d07925A B M06.9 Rheumatoid arthritis, unspecified A@ E A . . . E A . . . E A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A E A . . . E A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E A FLUCONAZOLE d00071A A B37 Candidiasis A E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A Dc Z79.3 Long term (current) use of hormonal contraceptives A E A ATOMOXETINE d04827A C- F90 Attention-deficit hyperactivity disorders A E A KETOCONAZOLE TOPICAL d03202A C 55555 A E A . . . E A DIGOXIN d00210A C I50.9 Heart failure, unspecified Ap E A LAMOTRIGINE d03809A C G40 Epilepsy and recurrent seizures Ap E A LEVOTHYROXINE d00278A B[ E03.9 Hypothyroidism, unspecified Ap E A RIVAROXABAN d07356A CDp D75.9P Z95 Prevent blood clots Presence of cardiac and vascular implants and grafts Ap E A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A B= N39.0 Urinary tract infection, site not specified Ap E A VENLAFAXINE d03181A BZ F41.9 Anxiety disorder, unspecified Ap E A VENLAFAXINE d03181A C F41.9 Anxiety disorder, unspecified Ap E A . . . E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension Ap E A CETIRIZINE d03827A C- T78.40 Allergy, unspecified Ap E A ISOSORBIDE MONONITRATE d00269A C I20.9 Angina pectoris, unspecified Ap E A LOSARTAN d03821A B= I10 Essential (primary) hypertension Ap E A METOPROLOL d00134A C I10 Essential (primary) hypertension Ap E A TAMSULOSIN d04121A Cr N40 Enlarged prostate Ap E A TERAZOSIN d00386A B= I10 Essential (primary) hypertension Ap E0 A . . . E@ A 99999 . . A EP A . . . E` A . . . Ep A AMPHETAMINE; DEXTROAMPHETAMINE d04035A D F90 Attention-deficit hyperactivity disorders A@ Ep A ESTRADIOL d00537A C[@ Z79.890 Hormone replacement therapy A@ Ep A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease A@ Ep A PROMETHAZINE d00787A C R11 R51 Nausea and vomiting Headache A@ E A ACETAMINOPHEN; OXYCODONE d03431A C M54 Dorsalgia Ap E A CLONAZEPAM d00197A Cr F41.9 Anxiety disorder, unspecified Ap E A DIAZEPAM d00148A C G47.9 M62.83 Sleep disorder, unspecified Muscle spasm Ap E A DICLOFENAC d00848A C- M19.9 Osteoarthritis, unspecified site Ap E A GABAPENTIN d03182A C- M79.2 Neuralgia and neuritis, unspecified Ap E A OXYCODONE d00329A C M54 Dorsalgia Ap E A SERTRALINE d00880A Cr F32.9 Major depressive disorder, single episode, unspecified Ap E A . . . E A METFORMIN d03807A CP R73 Elevated blood glucose level A E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A CDp I10 Essential (primary) hypertension AP E A MELOXICAM d04532A CDp 99999 AP E A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus AP E A PRAVASTATIN d00348A CDp E78.0 Pure hypercholesterolemia AP E A SERTRALINE d00880A CDp F32.9 Major depressive disorder, single episode, unspecified AP E A 99999 . . A E A . . . E A . . . E A . . . E A 77777 . . A E A ALBUTEROL d00749A C J45 Asthma A E A MONTELUKAST d04289A Cr J45 Asthma A E A ALENDRONATE d03849A C M81 Osteoporosis without current pathological fracture A E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E0 A . . . E@ A . . . EP A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A0 EP A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A0 EP A POTASSIUM CHLORIDE d00345A CDp E87.6 Hypokalemia A0 E` A . . . Ep A . . . E A . . . E A . . . E A CANAGLIFLOZIN d08080A C E11 Type 2 diabetes mellitus A0 E A LOSARTAN d03821A C E11.2 Type 2 diabetes mellitus with kidney complications A0 E A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A0 E A . . . E A AMLODIPINE d00689A A I10 Essential (primary) hypertension A E A AMLODIPINE d00689A D I10 Essential (primary) hypertension A0 E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A D I50.9 Heart failure, unspecified A0 E A PRAVASTATIN d00348A D E78.0 Pure hypercholesterolemia A0 E A NYSTATIN TOPICAL d04399A A0 B35 B37 Dermatophytosis Candidiasis A E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A METOPROLOL d00134A C I10 Essential (primary) hypertension A E A . . . E A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A E0 A CITALOPRAM d04332A A G47.0 Insomnia A E0 A LISINOPRIL d00732A A I10 Essential (primary) hypertension A E@ A . . . EP A AZITHROMYCIN d00091A AP J06.9 Acute upper respiratory infection, unspecified A E` A ACETAMINOPHEN; OXYCODONE d03431A C M19.9 M79.1 Osteoarthritis, unspecified site Myalgia A E` A APIXABAN d07804A C D75.9P Prevent blood clots A E` A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A E` A CITALOPRAM d04332A C[@ F39 Unspecified mood [affective] disorder A E` A DONEPEZIL d04099A C[@ R41 Other symptoms and signs involving cognitive functions and awareness A E` A HYDRALAZINE d00132A C I10 Essential (primary) hypertension A E` A ISOSORBIDE MONONITRATE d00269A C I21.P Prevent heart attack/myocardial infarction A E` A METOPROLOL d00134A C I50.9 Heart failure, unspecified A E` A PANTOPRAZOLE d04514A C K21 K30 Gastro-esophageal reflux disease Functional dyspepsia A E` A PREDNISONE d00350A AP M06.9 N18.9 Rheumatoid arthritis, unspecified Chronic kidney disease, unspecified A E` A SITAGLIPTIN d05896A C E11 Type 2 diabetes mellitus A E` A TAMSULOSIN d04121A Cr N40 R35 Enlarged prostate Polyuria A E` A TORSEMIDE d03189A B= I50.9 R60.9 Heart failure, unspecified Edema, unspecified A Ep A FINASTERIDE d00563A CDp N40 Enlarged prostate A` Ep A HYDROCHLOROTHIAZIDE d00253A CDp I10 Essential (primary) hypertension A` Ep A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A` Ep A METOPROLOL d00134A Ei I10 Essential (primary) hypertension A` Ep A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified A` Ep A SIMVASTATIN d00746A Ei E78.0 Pure hypercholesterolemia A` E A . . . E A 77777 . . A E A . . . E A . . . E A . . . E A NIFEDIPINE d00051A Cr I99.9 Unspecified disorder of circulatory system A E A SILDENAFIL d04299A C- I99.9 Unspecified disorder of circulatory system A E A BETAMETHASONE TOPICAL d03197A B R21 Rash and other nonspecific skin eruption A E A . . . E A ESCITALOPRAM d04812A B F32.9 Major depressive disorder, single episode, unspecified A E A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified A@ E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ E A HYDROCHLOROTHIAZIDE d00253A Dc I10 Essential (primary) hypertension A@ E A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension A@ E A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A E A ZALEPLON d04452A C G47.0 G47.9 Insomnia Sleep disorder, unspecified A E0 A . . . E@ A . . . EP A ALBUTEROL d00749A C R05 R06.2 R06.9P Cough Wheezing Prevent breathing difficulty A0 EP A BECLOMETHASONE d00760A C- J45 Asthma A0 EP A PREDNISOLONE d00084A AP R06.2 Wheezing A0 E` A AMLODIPINE d00689A C I10 Essential (primary) hypertension Ap E` A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia Ap E` A GABAPENTIN d03182A B M79.2 Neuralgia and neuritis, unspecified Ap E` A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension Ap E` A INSULIN DETEMIR d05436A B E11 Type 2 diabetes mellitus Ap E` A METFORMIN d03807A D* R73 Elevated blood glucose level Ap E` A PANTOPRAZOLE d04514A B K21 Gastro-esophageal reflux disease Ap Ep A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A AMOXICILLIN d00088A A J01.9 Acute sinusitis, unspecified A E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A . . . EP A AMLODIPINE d00689A C[@ I10 I21.P Essential (primary) hypertension Prevent heart attack/myocardial infarction A@ EP A FUROSEMIDE d00070A C[@ K76.9 Liver disease, unspecified A@ EP A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension A@ EP A PAROXETINE d03157A C[@ F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A@ E` A . . . Ep A ALLOPURINOL d00023A Cr M1A Chronic gout AP Ep A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia AP Ep A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A Cr I10 Essential (primary) hypertension AP Ep A INSULIN ISOPHANE; INSULIN REGULAR d04374A CDp E11 Type 2 diabetes mellitus AP Ep A METOPROLOL d00134A Cr I10 Essential (primary) hypertension AP E A . . . E A CITALOPRAM d04332A D F32.9 Major depressive disorder, single episode, unspecified A E A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia Ap E A CLINDAMYCIN d00043A A@ K05.6 Periodontal disease, unspecified Ap E A CLOPIDOGREL d04258A C I21 ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction Ap E A EMPAGLIFLOZIN d08275A C E11 R73 Type 2 diabetes mellitus Elevated blood glucose level Ap E A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus Ap E A LISINOPRIL d00732A C I10 I50.9 Essential (primary) hypertension Heart failure, unspecified Ap E A OMEPRAZOLE d00325A B[ K21 Gastro-esophageal reflux disease Ap E A BACLOFEN d00967A D M62.83 Muscle spasm A E A . . . E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A ATENOLOL d00004A C I10 Essential (primary) hypertension A E A BACLOFEN d00967A C[@ M62.83 M79.2 Muscle spasm Neuralgia and neuritis, unspecified A E A BALSALAZIDE d04700A C K58 Irritable bowel syndrome A E A DULOXETINE d05355A C F32.9 Major depressive disorder, single episode, unspecified A E A FENOFIBRATE d04286A C E78.0 Pure hypercholesterolemia A E A GABAPENTIN d03182A C G40 M79.7 Epilepsy and recurrent seizures Fibromyalgia A E A HYDROCODONE d03075A C M79.2 R51 Neuralgia and neuritis, unspecified Headache A E A LEVETIRACETAM d04499A C[@ G40 Epilepsy and recurrent seizures A E A LEVOTHYROXINE d00278A CDp E04 Other nontoxic goiter A E A LOSARTAN d03821A C I10 Essential (primary) hypertension A E A ROPINIROLE d04215A Cr G25.81 Restless legs syndrome A E A TOPIRAMATE d04115A CDp G40 Epilepsy and recurrent seizures A E A OXCARBAZEPINE d04513A C F39 Unspecified mood [affective] disorder A@ E A PAROXETINE d03157A C F32.9 Major depressive disorder, single episode, unspecified A@ E A QUETIAPINE d04220A C F31.9 Bipolar disorder, unspecified A@ E A TRAZODONE d00395A C F31.9 Bipolar disorder, unspecified A@ E A INSULIN LISPRO d04373A C E11 Type 2 diabetes mellitus A E A BENAZEPRIL d00730A C I10 Essential (primary) hypertension A E A HYDRALAZINE d00132A C I10 Essential (primary) hypertension A E A INSULIN GLARGINE d04538A Cr E11 Type 2 diabetes mellitus A E A INSULIN LISPRO d04373A Cr E11 Type 2 diabetes mellitus A E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A LORAZEPAM d00149A C F41.9 Anxiety disorder, unspecified A E A OXYBUTYNIN d00328A C R32 Unspecified urinary incontinence A E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E A TRAMADOL d03826A B M54 Dorsalgia A E0 A . . . E@ A LACOSAMIDE d07349A Bz G40 Epilepsy and recurrent seizures A E@ A LEVETIRACETAM d04499A C- G40 Epilepsy and recurrent seizures A EP A . . . E` A 99999 . . A Ep A . . . E A . . . E A . . . E A . . . E A . . . E A ACETAMINOPHEN; CODEINE d03423A A R52 Pain, unspecified A0 E A ACYCLOVIR d00001A CP A60.9 Anogenital herpesviral infection, unspecified A0 E A AMOXICILLIN d00088A A K04.7 Periapical abscess without sinus A0 E A . . . E A OXYCODONE d00329A B M54 Dorsalgia A E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A` E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A` E A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A` E A INSULIN ISOPHANE (NPH) d04370A C- E11 Type 2 diabetes mellitus A` E A LOSARTAN d03821A C I10 Essential (primary) hypertension A` E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` E A ATORVASTATIN d04105A0 C E78.0 Pure hypercholesterolemia A E A AZELASTINE NASAL d04068A0 B T78.40 Allergy, unspecified A E A BRIMONIDINE OPHTHALMIC d04048A C[@ H40 Glaucoma A E A BROMFENAC OPHTHALMIC d05518A0 C- H57.9 Unspecified disorder of eye and adnexa A E A FLUTICASONE NASAL d04283A0 C- H57.9 Unspecified disorder of eye and adnexa A E A HYDROXYCHLOROQUINE d00817A0 C[@ L93 Lupus erythematosus A E A MYCOPHENOLATE MOFETIL d03839A Ei L93 Lupus erythematosus A E A PREDNISONE d00350A C[@ T86.9P Prevent transplanted organ and tissue rejection A E A SIROLIMUS d04453A Ei T86.9P Prevent transplanted organ and tissue rejection A E A TIMOLOL OPHTHALMIC d04037A C- H57.9 Unspecified disorder of eye and adnexa A E A TRAMADOL d03826A0 C[@ M25.5 Pain in joint A E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 E` A VERAPAMIL d00048A C I10 Essential (primary) hypertension A0 E` A ZOLPIDEM d00910A B G47.0 Insomnia A0 Ep A CLONIDINE d00044A C"@ G47.0 Insomnia A0 Ep A METHYLPHENIDATE d00900A B F90 Attention-deficit hyperactivity disorders A0 Ep A OXCARBAZEPINE d04513A B= F31.9 Bipolar disorder, unspecified A0 E A . . . E A AMLODIPINE d00689A C"@ I10 Essential (primary) hypertension A E A . . . E A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A0 E A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A0 E A FENOFIBRATE d04286A C E78.1 Pure hyperglyceridemia A0 E A . . . E A . . . E A . . . E A BUPROPION d00181A C 77777 AP E A BUSPIRONE d00182A C F32.9 Major depressive disorder, single episode, unspecified AP E A CITALOPRAM d04332A C F41.9 Anxiety disorder, unspecified AP E A HYDROXYZINE d00907A C G47.0 Insomnia AP E A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP E A AMLODIPINE d00689A Ei I10 Essential (primary) hypertension A` E A CARVEDILOL d03847A C- I10 Essential (primary) hypertension A` E A CINACALCET d05218A C9 N19 Unspecified kidney failure A` E A CLOTRIMAZOLE TOPICAL d04395A B[ H66.9 Otitis media, unspecified A` E A LINAGLIPTIN d07767A Cr E11 Type 2 diabetes mellitus A` E A SEVELAMER d04363A CDp N19 Unspecified kidney failure A` E A . . . E A ASPIRIN d00170A Dc D75.9P I21.P Prevent blood clots Prevent heart attack/myocardial infarction A E A BIMATOPROST OPHTHALMIC d04754A D# H40 Glaucoma A E A BRINZOLAMIDE OPHTHALMIC d04301A D# H40 Glaucoma A E A LISINOPRIL d00732A C 99999 A E A METFORMIN d03807A D E11 Type 2 diabetes mellitus A E A OXYBUTYNIN d00328A C R32 Unspecified urinary incontinence A E A PIOGLITAZONE d04442A D E11 Type 2 diabetes mellitus A E A PIOGLITAZONE d04442A D E11 Type 2 diabetes mellitus A E A SIMVASTATIN d00746A C 99999 A E A SITAGLIPTIN d05896A D E11 Type 2 diabetes mellitus A E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A DORZOLAMIDE; TIMOLOL OPHTHALMIC d04303A B H40 Glaucoma A Ep A PREDNISONE d00350A D' D89.9 Disorder involving the immune mechanism, unspecified A E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A ALBUTEROL d00749A C- J45 Asthma A@ E A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A@ E A CETIRIZINE d03827A Ap R05 Cough A@ E A FLUTICASONE NASAL d04283A C J30.9 Allergic rhinitis, unspecified A@ E A . . . E A . . . E A . . . E A . . . E A HYDROCODONE d03075A C M25.5 Pain in joint A E A IBUPROFEN d00015A C M25.5 Pain in joint A E A . . . E0 A . . . E@ A ACETAMINOPHEN; HYDROCODONE d03428A A K08.8 Other specified disorders of teeth and supporting structures A E@ A PENICILLIN V POTASSIUM d07730A A A49.9P Prevent bacterial infection A EP A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A0 EP A TIZANIDINE d04102A B= M62.83 Muscle spasm A0 EP A TRAMADOL d03826A B= M25.5 Pain in joint A0 E` A . . . Ep A . . . E A AMLODIPINE d00689A Ei I10 Essential (primary) hypertension A E A CARBIDOPA; LEVODOPA d03473A C G20 Parkinson's disease A E A HYDROCHLOROTHIAZIDE d00253A Ei R60.9 Edema, unspecified A E A LEVOTHYROXINE d00278A Ei E03.9 Hypothyroidism, unspecified A E A NADOLOL d00018A Ei I10 Essential (primary) hypertension A E A OLMESARTAN d04801A C I10 Essential (primary) hypertension A E A PANTOPRAZOLE d04514A Ei K21 Gastro-esophageal reflux disease A E A SIMVASTATIN d00746A Ei I63.P Prevent stroke A E A TOLTERODINE d04294A C R32 Unspecified urinary incontinence A E A . . . E A ALBUTEROL d00749A B* B34.9 Viral infection, unspecified A E A AMOXICILLIN; CLAVULANATE d00089A A H66.9 Otitis media, unspecified A E A RANITIDINE d00021A B K21 Gastro-esophageal reflux disease A E A . . . E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A0 E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C- I10 Essential (primary) hypertension A0 E A NAPROXEN d00019A C- M54 Dorsalgia A0 E A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A E A . . . E0 A MONTELUKAST d04289A CDp J30.9 Allergic rhinitis, unspecified A E@ A PHENTERMINE d00806A B* E66 Overweight and obesity A EP A VALACYCLOVIR d03838A Cr B00.9 Herpesviral infection, unspecified A E` A . . . Ep A ALPRAZOLAM d00168A C[@ F41.9 Anxiety disorder, unspecified AP Ep A ATENOLOL d00004A Cr I10 I49.9 Essential (primary) hypertension Cardiac arrhythmia, unspecified AP Ep A CARIPRAZINE d08379A CDp F43.1 Post-traumatic stress disorder (PTSD) AP Ep A FLUOXETINE d00236A C[@ F32.9 Major depressive disorder, single episode, unspecified AP Ep A METFORMIN d03807A A E66 Overweight and obesity AP E A METOPROLOL d00134A C I10 Essential (primary) hypertension AP E A OMEPRAZOLE d00325A Dc K21 K27 Gastro-esophageal reflux disease Peptic ulcer, site unspecified AP E A OXYBUTYNIN d00328A Cr R32 Unspecified urinary incontinence AP E A PAROXETINE d03157A D F41.9 Anxiety disorder, unspecified AP E A ROSUVASTATIN d04851A C- E78.0 Pure hypercholesterolemia AP E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A E A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A E A . . . E A BUPROPION d00181A C F32.9 Major depressive disorder, single episode, unspecified A` E A FENOFIBRIC ACID d07371A C E78.0 Pure hypercholesterolemia A` E A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension A` E A METFORMIN d03807A C R73 Elevated blood glucose level A` E A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A` E A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified A` E A . . . E A . . . E A AZATHIOPRINE d00024A B[ K76.9 Liver disease, unspecified Ap E A LEVETIRACETAM d04499A D M79.7 Fibromyalgia Ap E A NALTREXONE d01406A D M79.7 Fibromyalgia Ap E A NITROFURANTOIN d00112A C N39.0 Urinary tract infection, site not specified Ap E A PREDNISONE d00350A B K76.9 Liver disease, unspecified Ap E A VALACYCLOVIR d03838A D B02 Zoster [herpes zoster] Ap E A WARFARIN d00022A D Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets Ap E A FAMOTIDINE; IBUPROFEN d07764A B[ T14.9 Unspecified injury A E A . . . E A ENALAPRIL; HYDROCHLOROTHIAZIDE d03740A D I10 Essential (primary) hypertension A E A MELOXICAM d04532A C M19.9 Osteoarthritis, unspecified site A E A DOXYCYCLINE d00037A C- L70 Acne A E A DROSPIRENONE; ETHINYL ESTRADIOL d04760A B[ L70 Acne A E0 A DEXAMETHASONE; TOBRAMYCIN OPHTHALMIC d03536A B H10.1 Acute atopic conjunctivitis A@ E0 A GENTAMICIN OPHTHALMIC d03974A B H57.9 Unspecified disorder of eye and adnexa A@ E0 A OPHTHALMIC PREPARATIONS - UNSPECIFIED c00147A Ap H10.1 Acute atopic conjunctivitis A@ E0 A TRAMADOL d03826A B R10 Abdominal and pelvic pain A@ E@ A NEBIVOLOL d05265A C[@ I10 Essential (primary) hypertension A E@ A PRAVASTATIN d00348A C[@ E78.0 Pure hypercholesterolemia A EP A AMLODIPINE d00689A C I10 Essential (primary) hypertension A EP A CONJUGATED ESTROGENS d00541A D Z79.890 Hormone replacement therapy A EP A DONEPEZIL d04099A C- G31.9 Degenerative disease of nervous system, unspecified A EP A ESCITALOPRAM d04812A CDp F32.9 Major depressive disorder, single episode, unspecified A EP A FUROSEMIDE d00070A B[ R60.9 Edema, unspecified A EP A GLIMEPIRIDE d03864A B E11 Type 2 diabetes mellitus A EP A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Dc I10 Essential (primary) hypertension A EP A INSULIN GLARGINE d04538A Bz E11 Type 2 diabetes mellitus A EP A MEMANTINE d04899A C- G31.9 Degenerative disease of nervous system, unspecified A EP A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A E` A . . . Ep A . . . E A INSULIN LISPRO d04373A D E10 Type 1 diabetes mellitus A E A . . . E A . . . E A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia Ap E A DULOXETINE d05355A A M54 Dorsalgia Ap E A FINASTERIDE d00563A C- N40 Enlarged prostate Ap E A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified Ap E A LISINOPRIL d00732A B I10 Essential (primary) hypertension Ap E A METFORMIN d03807A C- E11 Type 2 diabetes mellitus Ap E A TAMSULOSIN d04121A C- N40 Enlarged prostate Ap E A . . . E A CANAGLIFLOZIN d08080A C E11 Type 2 diabetes mellitus A0 E A LOSARTAN d03821A C- I10 Essential (primary) hypertension A0 E A SITAGLIPTIN d05896A C E11 Type 2 diabetes mellitus A0 E A AMLODIPINE d00689A B= I10 Essential (primary) hypertension A@ E A GABAPENTIN d03182A B M79.6 Pain in limb, hand, foot, fingers and toes A@ E A INDOMETHACIN d00039A D ^ M10.9 Gout, unspecified A@ E A OLMESARTAN d04801A B= I10 Essential (primary) hypertension A@ E A . . . E A ALENDRONATE d03849A B= M81 Osteoporosis without current pathological fracture A E A BIMATOPROST OPHTHALMIC d04754A C"0 H40 Glaucoma A E A CYCLOSPORINE OPHTHALMIC d04836A B[ H04 Disorders of lacrimal system A E A ESCITALOPRAM d04812A C F41.9 Anxiety disorder, unspecified A E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A MECLIZINE d00859A C R42 Dizziness and giddiness A E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E A ROSUVASTATIN d04851A D= E78.0 Pure hypercholesterolemia A E A TIZANIDINE d04102A C M62.83 Muscle spasm A E A BACLOFEN d00967A C[@ M54 M62.83 Dorsalgia Muscle spasm A0 E A BUPROPION d00181A B[ F32.9 Major depressive disorder, single episode, unspecified A0 E A NAPROXEN d00019A C[@ M25.5 M54 R51 Pain in joint Dorsalgia Headache A0 E A AMLODIPINE d00689A CP I10 Essential (primary) hypertension A E0 A . . . E@ A ANASTROZOLE d03873A C- C50.P prevent breast cancer Ap E@ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia Ap E@ A CHLORPROMAZINE d00064A B F20 Schizophrenia Ap E@ A METOPROLOL d00134A CDp I10 Essential (primary) hypertension Ap E@ A OMEPRAZOLE d00325A C- R12 Heartburn Ap E@ A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified Ap E@ A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia Ap EP A . . . E` A . . . Ep A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A GLIMEPIRIDE d03864A Cr E11 Type 2 diabetes mellitus A@ E A INSULIN GLARGINE d04538A C[@ R73 Elevated blood glucose level A@ E A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A@ E A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A@ E A . . . E A . . . E A . . . E A . . . E A . . . E0 A ACETAMINOPHEN; HYDROCODONE d03428A C M54 Dorsalgia A E0 A IBUPROFEN d00015A C M54 Dorsalgia A E@ A . . . EP A . . . E` A . . . Ep A 99999 . . A Ep A METFORMIN d03807A D E11 Type 2 diabetes mellitus A E A . . . E A ESCITALOPRAM d04812A B F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified AP E A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A C I10 Essential (primary) hypertension AP E A ONDANSETRON d00867A B R11 Nausea and vomiting AP E A RIVAROXABAN d07356A C D75.9P Prevent blood clots AP E A SUMATRIPTAN d03160A Cr G43 Migraine AP E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A Bz N92 Excessive, frequent and irregular menstruation A E A . . . E A . . . E A AZATHIOPRINE d00024A D,3 K76.9 Liver disease, unspecified A E A LEVOTHYROXINE d00278A D& E03.9 Hypothyroidism, unspecified A E A . . . E A . . . E A . . . E A BUPROPION d00181A C"0 F90 Attention-deficit hyperactivity disorders A E A . . . E0 A LOSARTAN d03821A C I10 Essential (primary) hypertension A E@ A ALBUTEROL d00749A D J45 Asthma A@ E@ A IRBESARTAN d04222A Ap I10 Essential (primary) hypertension A@ E@ A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A@ E@ A METFORMIN d03807A C- R73 Elevated blood glucose level A@ EP A 99999 . . A E` A BUDESONIDE d04276A A G47.9 Sleep disorder, unspecified A Ep A . . . E A AMOXICILLIN d00088A Ap J02 Acute pharyngitis A E A METHYLPHENIDATE d00900A CDp F90 Attention-deficit hyperactivity disorders A E A ESOMEPRAZOLE d04749A C- K21 R12 Gastro-esophageal reflux disease Heartburn A E A HYDROCHLOROTHIAZIDE d00253A C[@ I10 Essential (primary) hypertension A E A AMITRIPTYLINE d00146A D F32.9 G47.0 K58 Major depressive disorder, single episode, unspecified Insomnia Irritable bowel syndrome A` E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A` E A DULOXETINE d05355A C F32.9 Major depressive disorder, single episode, unspecified A` E A FENOFIBRATE d04286A B E78.0 Pure hypercholesterolemia A` E A GABAPENTIN d03182A Dc G99.8 M54 Other specified disorders of nervous system in diseases classified elsewhere Dorsalgia A` E A TRAMADOL d03826A C[@ M54 Dorsalgia A` E A . . . E A . . . E A BUPROPION d00181A B= F17.2 F32.9 Nicotine dependence Major depressive disorder, single episode, unspecified A E A . . . E A . . . E A BUPROPION d00181A C F17.2 Nicotine dependence A` E A ELUXADOLINE d08401A Cr K58 Irritable bowel syndrome A` E A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A` E A LOPERAMIDE d01025A C R19.7 Diarrhea, unspecified A` E A MELOXICAM d04532A Cr M79.1 Myalgia A` E A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease A` E A HYDROCHLOROTHIAZIDE d00253A0 D* R60.9 Edema, unspecified A@ E A LOSARTAN d03821A0 C I10 Essential (primary) hypertension A@ E A METOPROLOL d00134A0 C- I10 Essential (primary) hypertension A@ E A SIMVASTATIN d00746A0 C E78.0 Pure hypercholesterolemia A@ E A . . . E0 A AMLODIPINE d00689A D I10 Essential (primary) hypertension A@ E0 A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A@ E0 A GLIMEPIRIDE d03864A D E11 Type 2 diabetes mellitus A@ E0 A METFORMIN d03807A D E11 Type 2 diabetes mellitus A@ E@ A ALBUTEROL d00749A C- R06.9 Unspecified abnormalities of breathing AP E@ A ALBUTEROL d00749A C J45 Asthma AP E@ A BUDESONIDE d04276A C J45 Asthma AP E@ A CETIRIZINE d03827A B T78.40 Allergy, unspecified AP E@ A FLUTICASONE NASAL d04283A B R09.8 Other specified symptoms and signs involving the circulatory and respiratory systems AP EP A . . . E` A ACETAMINOPHEN; BUTALBITAL d03456A C G43 Migraine A Ep A ACETAMINOPHEN; CODEINE d03423A A K02 R52 Dental caries Pain, unspecified A E A POLYETHYLENE GLYCOL 3350 d05350A A K92.9 Disease of digestive system, unspecified A E A . . . E A ALBUTEROL d00749A CDp R06.02 Shortness of breath A E A . . . E A LEVOTHYROXINE d00278A DU E03.9 Hypothyroidism, unspecified A@ E A MEMANTINE d04899A C G30.9 G31.9 Alzheimer's disease, unspecified Degenerative disease of nervous system, unspecified A@ E A PAROXETINE d03157A Dc F32.9 Major depressive disorder, single episode, unspecified A@ E A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A@ E A CLOPIDOGREL d04258A B[ Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A@ E A METFORMIN d03807A C I51.9 Heart disease, unspecified A@ E A METOPROLOL d00134A C I50.9 Heart failure, unspecified A@ E A SIMVASTATIN d00746A C I51.9 Heart disease, unspecified A@ E A . . . E A . . . E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A A M79.6 Pain in limb, hand, foot, fingers and toes Ap E A CETIRIZINE d03827A C R09.81 Nasal congestion Ap E A FENOFIBRATE d04286A C- E78.0P Prevent high cholesterol Ap E A LANSOPRAZOLE d03828A C K21 Gastro-esophageal reflux disease Ap E A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus Ap E A METOPROLOL d00134A C I10.P Prevent hypertension Ap E A WARFARIN d00022A C Z95 Presence of cardiac and vascular implants and grafts Ap E0 A ARIPIPRAZOLE d04825A C"0 F39 Unspecified mood [affective] disorder A0 E0 A FLUOXETINE d00236A CDp F32.9 Major depressive disorder, single episode, unspecified A0 E0 A LAMOTRIGINE d03809A B[ F39 Unspecified mood [affective] disorder A0 E@ A ATENOLOL d00004A0 B[ I21.P Prevent heart attack/myocardial infarction A E@ A ATORVASTATIN d04105A0 B[ E78.0P Prevent high cholesterol A E@ A CLONAZEPAM d00197A0 D F41.9 Anxiety disorder, unspecified A E@ A CLOPIDOGREL d04258A0 B[ D75.9P Prevent blood clots A E@ A LEVOTHYROXINE d00278A0 Dc E03.9 Hypothyroidism, unspecified A E@ A LOSARTAN d03821A0 Bz I21.P Prevent heart attack/myocardial infarction A E@ A MEMANTINE d04899A0 CDp G30.9 Alzheimer's disease, unspecified A E@ A TRAMADOL d03826A Bz M19.9 Osteoarthritis, unspecified site A E@ A TRAZODONE d00395A0 B G47.9 Sleep disorder, unspecified A EP A CEFDINIR d04256A A J40 Bronchitis, not specified as acute or chronic Ap EP A DOXAZOSIN d00726A CP 99999 Ap EP A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A CP R60.9 Edema, unspecified Ap EP A METFORMIN d03807A D R73 Elevated blood glucose level Ap EP A METHYLPREDNISOLONE d00293A A J20.9 Acute bronchitis, unspecified Ap EP A POTASSIUM CHLORIDE d00345A CP E87.6 Hypokalemia Ap EP A PRAVASTATIN d00348A CP E78.0 Pure hypercholesterolemia Ap E` A . . . Ep A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP E A HYDROXYCHLOROQUINE d00817A C L93 Lupus erythematosus AP E A LOSARTAN d03821A C I10 Essential (primary) hypertension AP E A MELOXICAM d04532A C M13 Other arthritis AP E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease AP E A BUSPIRONE d00182A C[@ F41.9 Anxiety disorder, unspecified A0 E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C[@ I10 Essential (primary) hypertension A0 E A OMEPRAZOLE d00325A B K21 Gastro-esophageal reflux disease A0 E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ E A GLIMEPIRIDE d03864A B E11 Type 2 diabetes mellitus A@ E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A@ E A . . . E A . . . E A . . . E A GEMFIBROZIL d00245A Cr E78.0 Pure hypercholesterolemia A` E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Cr I10 Essential (primary) hypertension A` E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A` E A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A` E A POTASSIUM CHLORIDE d00345A Cr E87.6 Hypokalemia A` E A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia A` E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A TAMSULOSIN d04121A C N40 Enlarged prostate A0 E` A TESTOSTERONE d00558A C[@ E29.1 Testicular hypofunction A0 E` A THYROID DESICCATED d00655A C E03.9 Hypothyroidism, unspecified A0 Ep A . . . E A . . . E A ATENOLOL d00004A Cr I63.P Prevent stroke A E A HYDROCODONE d03075A Cr M54 Dorsalgia A E A GEMFIBROZIL d00245A CDp E78.0 E78.1 Pure hypercholesterolemia Pure hyperglyceridemia A@ E A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus A@ E A LISINOPRIL d00732A B I21.P Prevent heart attack/myocardial infarction A@ E A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A@ E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A . . . E A . . . E A ALBUTEROL d00749A A R06.9P Prevent breathing difficulty A E A PREDNISOLONE d00084A A J42 Unspecified chronic bronchitis A E A ENALAPRIL d00013A B[ I10 Essential (primary) hypertension A@ E A INSULIN GLARGINE d04538A D E11 Type 2 diabetes mellitus A@ E A LISINOPRIL d00732A C- K76.9P Prevent liver disease A@ E A METFORMIN d03807A Cr R73 Elevated blood glucose level A@ E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A` E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A` E A LOSARTAN d03821A C I10 Essential (primary) hypertension A` E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` E A METOPROLOL d00134A C I10 Essential (primary) hypertension A` E A OXYBUTYNIN d00328A C N32.81 N39.4 R39.1 Overactive bladder Other specified urinary incontinence Other difficulties with micturition A` E A . . . E A . . . E0 A . . . E@ A . . . EP A AMLODIPINE d00689A D I10 Essential (primary) hypertension A@ EP A FEBUXOSTAT d07397A C M1A Chronic gout A@ EP A HYDROCHLOROTHIAZIDE d00253A CDp R52 Pain, unspecified A@ EP A OMEPRAZOLE d00325A C R12 Heartburn A@ E` A LIRAGLUTIDE d07466A C- E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A` E` A METFORMIN d03807A C- E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A` E` A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A` E` A OLANZAPINE d04050A Cr F32.9 Major depressive disorder, single episode, unspecified A` E` A VENLAFAXINE d03181A Cr F32.9 Major depressive disorder, single episode, unspecified A` E` A ZOLPIDEM d00910A Cr G47.0 Insomnia A` Ep A BUSPIRONE d00182A C- G40 Epilepsy and recurrent seizures A Ep A CARBAMAZEPINE d00058A C- F41.9 Anxiety disorder, unspecified A E A ALLOPURINOL d00023A D M1A Chronic gout A0 E A HYDROCHLOROTHIAZIDE d00253A D I10 Essential (primary) hypertension A0 E A LISINOPRIL d00732A D I10 Essential (primary) hypertension A0 E A BUDESONIDE; FORMOTEROL d04795A CDp J44.9 Chronic obstructive pulmonary disease, unspecified A` E A DABIGATRAN d07137A C D75.9P Prevent blood clots A` E A GABAPENTIN d03182A C- M79.2 Neuralgia and neuritis, unspecified A` E A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension A` E A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A` E A POTASSIUM CHLORIDE d00345A B E87.6 Hypokalemia A` E A . . . E A . . . E A ADALIMUMAB d04835A C L40 Psoriasis A0 E A LEVETIRACETAM d04499A B G40 Epilepsy and recurrent seizures A0 E A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A0 E A AMLODIPINE; BENAZEPRIL d03829A C I10 Essential (primary) hypertension A0 E A FLUTICASONE NASAL d04283A C J30.1 J30.2 J30.9 Allergic rhinitis due to pollen Other seasonal allergic rhinitis Allergic rhinitis, unspecified A0 E A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease A0 E A . . . E A . . . E A . . . E A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A E A HYDROCHLOROTHIAZIDE d00253A C- 99999 A E A IBUPROFEN d00015A B M25.5 M54 M79.1 Pain in joint Dorsalgia Myalgia A E A LOSARTAN d03821A C- 99999 A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A POTASSIUM CHLORIDE d00345A B E87.6 Hypokalemia A E A SILDENAFIL d04299A C N52.9 Male erectile dysfunction, unspecified A E A TAMSULOSIN d04121A C[@ N40 Enlarged prostate A E A . . . E0 A . . . E@ A IRBESARTAN d04222A C I10 Essential (primary) hypertension A EP A DONEPEZIL d04099A C F32.9 Major depressive disorder, single episode, unspecified A EP A GABAPENTIN d03182A CDp E11.4 Type 2 diabetes mellitus with neurological complications A EP A GLIMEPIRIDE d03864A CDp E11 Type 2 diabetes mellitus A EP A LISINOPRIL d00732A B I10 Essential (primary) hypertension A EP A LORAZEPAM d00149A C G47.0 Insomnia A EP A METFORMIN d03807A D E11 Type 2 diabetes mellitus A EP A METOPROLOL d00134A C I10 Essential (primary) hypertension A EP A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A EP A VENLAFAXINE d03181A Dc F32.9 Major depressive disorder, single episode, unspecified A E` A . . . Ep A . . . E A . . . E A . . . E A ATENOLOL d00004A Dc I10 Essential (primary) hypertension A E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A E A . . . E A . . . E A LISINOPRIL d00732A CP I10 Essential (primary) hypertension A E A . . . E A TAMSULOSIN d04121A A N20.0 Calculus of kidney A E A CETIRIZINE d03827A B= J30.9 R09.81 T78.40 Allergic rhinitis, unspecified Nasal congestion Allergy, unspecified A@ E A CITALOPRAM d04332A Dc F32.9 Major depressive disorder, single episode, unspecified A@ E A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A@ E A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A@ E A . . . E A . . . E0 A . . . E@ A DILTIAZEM d00045A CDp I10 I48.9 Essential (primary) hypertension Unspecified atrial fibrillation and atrial flutter A@ E@ A DIVALPROEX SODIUM d03833A D* 99999 A@ E@ A MYCOPHENOLATE MOFETIL d03839A D T86.9P Prevent transplanted organ and tissue rejection A@ E@ A TACROLIMUS d03752A D T86.9P Prevent transplanted organ and tissue rejection A@ EP A CYCLOBENZAPRINE d00963A C M54 Dorsalgia A@ EP A GABAPENTIN d03182A B M79.2 Neuralgia and neuritis, unspecified A@ EP A IBUPROFEN d00015A C M54 Dorsalgia A@ EP A LOSARTAN d03821A C I10 Essential (primary) hypertension A@ E` A 99999 . . A Ep A . . . E A ALBUTEROL d00749A D* J44.9 Chronic obstructive pulmonary disease, unspecified A0 E A ALBUTEROL; IPRATROPIUM d04066A C J44.9 Chronic obstructive pulmonary disease, unspecified A0 E A FLUTICASONE; VILANTEROL d08100A Cr J44.9 Chronic obstructive pulmonary disease, unspecified A0 E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A0 A T14.9 Unspecified injury A@ E A DEXAMETHASONE d00206A Ap R60.9 Edema, unspecified A@ E A METHOCARBAMOL d00965A B T14.9 Unspecified injury A@ E A PANTOPRAZOLE d04514A A K25.P Prevent gastric ulcer A@ E A INSULIN ISOPHANE; INSULIN REGULAR d04374A D E11 Type 2 diabetes mellitus AP E A LISINOPRIL d00732A CDp E11.2P Prevent diabetic kidney disease AP E A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP E A METFORMIN; SITAGLIPTIN d06720A CDp E11 Type 2 diabetes mellitus AP E A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia AP E A . . . E A . . . E0 A CETIRIZINE d03827A A R05 Cough A E@ A ALBUTEROL d00749A C J44.9 Chronic obstructive pulmonary disease, unspecified A E@ A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified A E@ A BUDESONIDE d04276A C J44.9 Chronic obstructive pulmonary disease, unspecified A E@ A CLOPIDOGREL d04258A C[@ I21.P Prevent heart attack/myocardial infarction A E@ A DIGOXIN d00210A Cr I49.9 Cardiac arrhythmia, unspecified A E@ A FORMOTEROL d04572A C J44.9 Chronic obstructive pulmonary disease, unspecified A E@ A FUROSEMIDE d00070A Cr R39.9 Unspecified symptoms and signs involving the genitourinary system A E@ A GEMFIBROZIL d00245A C[@ E78.0 Pure hypercholesterolemia A E@ A METFORMIN d03807A C R73 Elevated blood glucose level A E@ A METOPROLOL d00134A C I10 Essential (primary) hypertension A E@ A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A E@ A PROMETHAZINE d00787A Cr R11 Nausea and vomiting A E@ A RANITIDINE d00021A CDp K30 Functional dyspepsia A E@ A WARFARIN d00022A C[@ D75.9P Prevent blood clots A EP A AZITHROMYCIN d00091A AP J01.9 Acute sinusitis, unspecified A E` A ALBUTEROL d00749A D* J45 Asthma A Ep A . . . E A ALBUTEROL d00749A Ei R06.9 Unspecified abnormalities of breathing A E A AMLODIPINE d00689A0 Ei I10 Essential (primary) hypertension A E A ATENOLOL d00004A0 Ei I10 Essential (primary) hypertension A E A CLONIDINE d00044A0 Ei I10 Essential (primary) hypertension A E A FUROSEMIDE d00070A0 Ei I10 Essential (primary) hypertension A E A HYDRALAZINE d00132A0 Ei I10 Essential (primary) hypertension A E A IPRATROPIUM d00265A0 DGJ R06.9 Unspecified abnormalities of breathing A E A ISOSORBIDE MONONITRATE d00269A0 Ei I10 Essential (primary) hypertension A E A LOVASTATIN d00280A Ei E78.0 Pure hypercholesterolemia A E A VALSARTAN d04113A0 Ei I10 Essential (primary) hypertension A E A . . . E A LISINOPRIL d00732A D9 I10 Essential (primary) hypertension A E A TERAZOSIN d00386A CP N42.9 Disorder of prostate, unspecified A E A . . . E A . . . E A . . . E A ALPRAZOLAM d00168A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A B F90 Attention-deficit hyperactivity disorders A E A ATORVASTATIN d04105A C- 99999 A` E A GEMFIBROZIL d00245A C- 99999 A` E A GLIPIZIDE d00246A C- 99999 A` E A LISINOPRIL d00732A C- 99999 A` E A METFORMIN d03807A C- 99999 A` E A OMEPRAZOLE d00325A C K31.9 Disease of stomach and duodenum, unspecified A` E A ALBUTEROL d00749A C J45 R06.02 Asthma Shortness of breath A E A ALBUTEROL d00749A C J45 R05 R06.2 Asthma Cough Wheezing A E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A E0 A CEPHALEXIN d00096A A L08.9 Local infection of the skin and subcutaneous tissue, unspecified A E@ A ATENOLOL d00004A D* I10 Essential (primary) hypertension A0 E@ A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A0 E@ A NAPROXEN d00019A D# M25.5 Pain in joint A0 EP A . . . E` A . . . Ep A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A 99999 . . A@ E A AMOXICILLIN; CLAVULANATE d00089A Ap H66.9 Otitis media, unspecified A@ E A CEFDINIR d04256A A@ H66.9 Otitis media, unspecified A@ E A CIPROFLOXACIN; DEXAMETHASONE OTIC d04890A A` H66.9P Prevent ear infection A@ E A . . . E A . . . E A ENALAPRIL d00013A C- I10 Essential (primary) hypertension A E A . . . E0 A . . . E@ A . . . EP A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A EP A NEBIVOLOL d05265A C- I10 Essential (primary) hypertension A E` A ALBUTEROL d00749A Bz J45 Asthma A@ E` A CLONIDINE d00044A C"0 G47.0 Insomnia A@ E` A FLUTICASONE NASAL d04283A Bz J30.2 Other seasonal allergic rhinitis A@ E` A METHYLPHENIDATE d00900A Bz F90 Attention-deficit hyperactivity disorders A@ Ep A . . . E A . . . E A FAMCICLOVIR d03775A C A60.9 Anogenital herpesviral infection, unspecified A0 E A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease A0 E A TAMSULOSIN d04121A C N40 Enlarged prostate A0 E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E A FUROSEMIDE d00070A C- R60.9 Edema, unspecified AP E A GABAPENTIN d03182A Dc M79.2 Neuralgia and neuritis, unspecified AP E A METFORMIN d03807A B E11 Type 2 diabetes mellitus AP E A POTASSIUM CHLORIDE d00345A B= E87.6 Hypokalemia AP E A CARVEDILOL d03847A C I50.9 Heart failure, unspecified A@ E A HYDRALAZINE d00132A Cr I10 Essential (primary) hypertension A@ E A LOSARTAN d03821A Cr I50.9 Heart failure, unspecified A@ E A PRAVASTATIN d00348A C I21.P Prevent heart attack/myocardial infarction A@ E A . . . E A . . . E A . . . E A . . . E A ESOMEPRAZOLE d04749A B= K30 Functional dyspepsia A E A . . . E0 A . . . E@ A . . . EP A . . . E` A OFLOXACIN OPHTHALMIC d03977A Ap H10 Conjunctivitis A E` A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A Ap A49.9 Bacterial infection, unspecified A Ep A . . . E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A0 E A ATORVASTATIN d04105A B I99.9 Unspecified disorder of circulatory system A0 E A AZITHROMYCIN d00091A A0 J40 Bronchitis, not specified as acute or chronic A0 E A . . . E A . . . E° A LETROZOLE d04156A C[@ C50 Malignant neoplasm of breast A0 E° A LEVOTHYROXINE d00278A C E04 Other nontoxic goiter A0 E° A LOSARTAN d03821A C I10 Essential (primary) hypertension A0 E A ALBUTEROL d00749A D 55555 A E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A Cr M54 Dorsalgia A E A AMLODIPINE d00689A C 99999 A E A ATORVASTATIN d04105A C 99999 A E A FINASTERIDE d00563A C 99999 A E A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A METHOCARBAMOL d00965A C M62.83 Muscle spasm A E A NAPROXEN d00019A C M54 Dorsalgia A E A TERAZOSIN d00386A C 99999 A E A . . . E A . . . E A CLINDAMYCIN d00043A C- K04.7P Prevent tooth infection A E A FINASTERIDE d00563A C[@ R39.9 Unspecified symptoms and signs involving the genitourinary system A E A GLIMEPIRIDE d03864A CDp E11 Type 2 diabetes mellitus A E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A PANTOPRAZOLE d04514A Cr K21 Gastro-esophageal reflux disease A E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E A SITAGLIPTIN d05896A A E11 Type 2 diabetes mellitus A E A TRAMADOL d03826A C- M25.5 Pain in joint A E0 A . . . E@ A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A E@ A BUSPIRONE d00182A C 99999 A E@ A CITALOPRAM d04332A C- F39 Unspecified mood [affective] disorder A E@ A ISOSORBIDE MONONITRATE d00269A B I20.9 Angina pectoris, unspecified A E@ A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E@ A LOSARTAN d03821A C G25.81 Restless legs syndrome A E@ A METOPROLOL d00134A C- I10 Essential (primary) hypertension A E@ A PANTOPRAZOLE d04514A B K30 Functional dyspepsia A EP A . . . E` A ATORVASTATIN d04105A B M85.9 Disorder of bone density and structure, unspecified Ap E` A CYCLOBENZAPRINE d00963A C M54 Dorsalgia Ap E` A FLUOXETINE d00236A B F33.9 Major depressive disorder, recurrent, unspecified Ap E` A FUROSEMIDE d00070A C I50.9 Heart failure, unspecified Ap E` A MELOXICAM d04532A C M25.5 M54 Pain in joint Dorsalgia Ap E` A METOPROLOL d00134A C I10 I50.9 Essential (primary) hypertension Heart failure, unspecified Ap E` A TRAZODONE d00395A C G47.0 Insomnia Ap Ep A . . . EÀ A . . . EÐ A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A EÐ A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A Eà A DIVALPROEX SODIUM d03833A B G47.9 Sleep disorder, unspecified A Eð A GABAPENTIN d03182A C- M79.2 Neuralgia and neuritis, unspecified A E A . . . E A . . . E A ZOLPIDEM d00910A C G47.0 Insomnia A E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A ESOMEPRAZOLE d04749A C K21 Gastro-esophageal reflux disease AP E@ A FORMOTEROL; GLYCOPYRROLATE d08435A B[ J45 Asthma AP E@ A ICOSAPENT d07891A C E78.1 Pure hyperglyceridemia AP E@ A METOPROLOL d00134A C I10 Essential (primary) hypertension AP E@ A TENOFOVIR d04774A C K76.9 Liver disease, unspecified AP EP A . . . E` A . . . Ep A DESMOPRESSIN d00583A B R32 Unspecified urinary incontinence A EĀ A CLOTRIMAZOLE TOPICAL d04395A Ap B35 Dermatophytosis A EĐ A CARVEDILOL d03847A D I51.9 Heart disease, unspecified A EĠ A . . . Eİ A . . . E A . . . E A ALBUTEROL d00749A C J45 Asthma A` E A ALLOPURINOL d00023A C M1A Chronic gout A` E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A` E A ATENOLOL; CHLORTHALIDONE d03258A C I10 Essential (primary) hypertension A` E A CETIRIZINE d03827A C- 99999 A` E A MELOXICAM d04532A C M54 M79.1 Dorsalgia Myalgia A` E A IBUPROFEN d00015A CDp M54 R51 Dorsalgia Headache A E A MINOCYCLINE d00110A C- L70 Acne A E A AMLODIPINE d00689A Dc I10 Essential (primary) hypertension AP E A BIMATOPROST OPHTHALMIC d04754A Dc H40 Glaucoma AP E A BRIMONIDINE OPHTHALMIC d04048A Dc H40 Glaucoma AP E A DORZOLAMIDE; TIMOLOL OPHTHALMIC d04303A Dc H40 Glaucoma AP E A LOSARTAN d03821A Dc I10 Essential (primary) hypertension AP E A ACETAMINOPHEN; HYDROCODONE d03428A D M54 Dorsalgia A E A ESOMEPRAZOLE d04749A C K30 Functional dyspepsia A E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A ALBUTEROL d00749A CDp J44.9 Chronic obstructive pulmonary disease, unspecified A Ep A CITALOPRAM d04332A Cr F32.9 Major depressive disorder, single episode, unspecified A Ep A CLONIDINE d00044A Cr I10 Essential (primary) hypertension A Ep A FLUTICASONE; VILANTEROL d08100A CDp J44.9 Chronic obstructive pulmonary disease, unspecified A Ep A FUROSEMIDE d00070A Cr R60.9 Edema, unspecified A Ep A GABAPENTIN d03182A Cr M79.2 Neuralgia and neuritis, unspecified A Ep A HYDROCHLOROTHIAZIDE d00253A Cr R60.9 Edema, unspecified A Ep A QUETIAPINE d04220A Cr F32.9 G47.9 Major depressive disorder, single episode, unspecified Sleep disorder, unspecified A Ep A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A Eŀ A . . . EŐ A . . . EŠ A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified A EŠ A CYCLOBENZAPRINE d00963A C Z79 Long term (current) drug therapy A EŠ A DICYCLOMINE d00999A Cr K58 Irritable bowel syndrome A EŠ A GABAPENTIN d03182A C- M79.2 Neuralgia and neuritis, unspecified A EŠ A LOVASTATIN d00280A CDp E78.0 Pure hypercholesterolemia A EŠ A MONTELUKAST d04289A C T78.40 Allergy, unspecified A EŠ A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease A EŠ A PREGABALIN d05508A B M79.2 Neuralgia and neuritis, unspecified A EŠ A SERTRALINE d00880A C[@ F32.9 Major depressive disorder, single episode, unspecified A EŠ A ZOLPIDEM d00910A C- G47.0 Insomnia A EŰ A . . . E A . . . E A HYDROXYZINE d00907A C F41.9 Anxiety disorder, unspecified A E A RANITIDINE d00021A C K30 R12 Functional dyspepsia Heartburn A E A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A` E A BUPROPION d00181A CDp F32.9 Major depressive disorder, single episode, unspecified A` E A LISINOPRIL d00732A D# I10 Essential (primary) hypertension A` E A METOPROLOL d00134A Cr R00 Abnormalities of heart beat A` E A SPIRONOLACTONE d00373A Cr I10 Essential (primary) hypertension A` E A TRAZODONE d00395A CDp G47.0 G47.9 Insomnia Sleep disorder, unspecified A` E A ATORVASTATIN d04105A C 99999 A E A CLOPIDOGREL d04258A C N28.9 Disorder of kidney and ureter, unspecified A E A DAPAGLIFLOZIN d07928A Ap E11 Type 2 diabetes mellitus A E A DOXAZOSIN d00726A C 99999 A E A FINASTERIDE d00563A C 99999 A E A FUROSEMIDE d00070A C 99999 A E A GABAPENTIN d03182A CP M79.2 Neuralgia and neuritis, unspecified A E A GLIPIZIDE d00246A D E11 Type 2 diabetes mellitus A E A LISINOPRIL d00732A C E78.0 Pure hypercholesterolemia A E A METOPROLOL d00134A CP 99999 A E A OMEGA-3 POLYUNSATURATED FATTY ACIDS d00497A C"0 M19.9 Osteoarthritis, unspecified site A E A . . . E A . . . E A . . . E0 A . . . E@ A . . . EP A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A` EP A HYDRALAZINE d00132A Cr I10 Essential (primary) hypertension A` EP A LATANOPROST OPHTHALMIC d04017A D H40 Glaucoma A` EP A LEVOTHYROXINE d00278A D9 E03.9 Hypothyroidism, unspecified A` EP A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A` EP A OXYBUTYNIN d00328A C- N32.81 Overactive bladder A` E` A . . . Ep A FINASTERIDE d00563A B< N40 Enlarged prostate A0 Ep A METHYLPREDNISOLONE d00293A Ap R21 Rash and other nonspecific skin eruption A0 Ep A TAMSULOSIN d04121A B< N40 Enlarged prostate A0 Eƀ A . . . EƐ A . . . EƠ A AMLODIPINE d00689A C I10 Essential (primary) hypertension A EƠ A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia A EƠ A BRIMONIDINE; BRINZOLAMIDE OPHTHALMIC d08086A CDp H40 Glaucoma A EƠ A CARVEDILOL d03847A Dc R00 Abnormalities of heart beat A EƠ A FINASTERIDE d00563A C- N40 Enlarged prostate A EƠ A INSULIN ASPART d04697A Dc E11 Type 2 diabetes mellitus A EƠ A INSULIN GLARGINE d04538A Dc E11 Type 2 diabetes mellitus A EƠ A ISOSORBIDE MONONITRATE d00269A C I10 Essential (primary) hypertension A EƠ A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension A EƠ A PREGABALIN d05508A Dc M79.2 Neuralgia and neuritis, unspecified A Eư A ARIPIPRAZOLE d04825A C- F39 Unspecified mood [affective] disorder A Eư A ATOMOXETINE d04827A C F90 Attention-deficit hyperactivity disorders A Eư A CLONAZEPAM d00197A CP G47.9 Sleep disorder, unspecified A Eư A GUANFACINE d00717A C[@ F39 F41.9 F90 Unspecified mood [affective] disorder Anxiety disorder, unspecified Attention-deficit hyperactivity disorders A Eư A LITHIUM d00061A C F31.9 Bipolar disorder, unspecified A Eư A METHYLPHENIDATE d00900A C F90 Attention-deficit hyperactivity disorders A Eư A MIRTAZAPINE d04025A A G47.9 Sleep disorder, unspecified A Eư A PAROXETINE d03157A C F39 Unspecified mood [affective] disorder A E A ALLOPURINOL d00023A C- M1A Chronic gout B E A AMBRISENTAN d06841A CDp I27.9 Pulmonary heart disease, unspecified B E A BRIMONIDINE OPHTHALMIC d04048A C H40 Glaucoma B E A CARVEDILOL d03847A CDp J98.9 Respiratory disorder, unspecified B E A DEXLANSOPRAZOLE d07395A C9 K21 Gastro-esophageal reflux disease B E A DULOXETINE d05355A CDp K31.9 Disease of stomach and duodenum, unspecified B E A FLUTICASONE; VILANTEROL d08100A B R06.02 Shortness of breath B E A INSULIN LISPRO d04373A B E11 Type 2 diabetes mellitus B E A LATANOPROST OPHTHALMIC d04017A C- H40 Glaucoma B E A LINACLOTIDE d07902A C K59.0 Constipation B E A POTASSIUM CHLORIDE d00345A CDp 99999 B E A PRAVASTATIN d00348A CDp E78.0 Pure hypercholesterolemia B E A PREDNISONE d00350A C[@ J44.9 Chronic obstructive pulmonary disease, unspecified B E A RANITIDINE d00021A CDp 99999 B E A RIOCIGUAT d08140A CDp I27.9 Pulmonary heart disease, unspecified B E A SPIRONOLACTONE d00373A CDp I27.9 Pulmonary heart disease, unspecified B E A TIOTROPIUM d04829A CDp J45 Asthma B E A TORSEMIDE d03189A C- J98.9 Respiratory disorder, unspecified B E A ALLOPURINOL d00023A C M10.9 Gout, unspecified A` E A AMMONIUM LACTATE TOPICAL d04049A CP L40 Psoriasis A` E A CARVEDILOL d03847A C I10 Essential (primary) hypertension A` E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A` E A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension A` E A TAMSULOSIN d04121A C N40 R35 Enlarged prostate Polyuria A` E A DILTIAZEM d00045A C R00 Abnormalities of heart beat A E A ESOMEPRAZOLE d04749A C K30 Functional dyspepsia A E A FINASTERIDE d00563A C N40 Enlarged prostate A E A FUROSEMIDE d00070A C R60.9 Edema, unspecified A E A LOSARTAN d03821A C I10 Essential (primary) hypertension A E A METOPROLOL d00134A Dc I10 Essential (primary) hypertension A E A POTASSIUM CHLORIDE d00345A D E87.6 Hypokalemia A E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A E A WARFARIN d00022A Dc D75.9P Prevent blood clots A E A ALPRAZOLAM d00168A C- F41.9 Anxiety disorder, unspecified A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A CARBAMAZEPINE d00058A C- G40 Epilepsy and recurrent seizures A E A GABAPENTIN d03182A D M54 Dorsalgia A E A IPRATROPIUM d00265A C J45 Asthma A E A LEVETIRACETAM d04499A C G40 Epilepsy and recurrent seizures A E A LEVOTHYROXINE d00278A C[@ E03.9 Hypothyroidism, unspecified A E A MECLIZINE d00859A C- R42 Dizziness and giddiness A E A NITROGLYCERIN d00321A C R07.9 Chest pain, unspecified A E A OMEGA-3 POLYUNSATURATED FATTY ACIDS d00497A C[@ E78.0 Pure hypercholesterolemia A E A PENTOXIFYLLINE d00336A B[ I70 Atherosclerosis A E A . . . E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A B[ F90 F99 Attention-deficit hyperactivity disorders Mental disorder, not otherwise specified A E A CLONIDINE d00044A A@ G47.0 Insomnia A E A DOXYCYCLINE d00037A Ap L70 Acne A E0 A . . . E@ A . . . EP A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A D I10 Essential (primary) hypertension A E` A ALLOPURINOL d00023A C M1A Chronic gout AP E` A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension AP E` A ATENOLOL d00004A Dc I10 Essential (primary) hypertension AP E` A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia AP E` A IRBESARTAN d04222A C I10 Essential (primary) hypertension AP Ep A ALBUTEROL d00749A A@ J45 Asthma A Ep A FLUTICASONE d01296A Ap J45 Asthma A Eǀ A . . . Eǐ A . . . EǠ A DROSPIRENONE; ETHINYL ESTRADIOL d04760A B N92 Excessive, frequent and irregular menstruation A Eǰ A ALLOPURINOL d00023A C M25.5 Pain in joint A Eǰ A ATENOLOL d00004A C I10 Essential (primary) hypertension A Eǰ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A Eǰ A DONEPEZIL; MEMANTINE d08337A C R41 Other symptoms and signs involving cognitive functions and awareness A Eǰ A GLIMEPIRIDE d03864A C E11.P Prevent diabetes A Eǰ A LEVOCETIRIZINE d05851A CDp L29.9 Pruritus, unspecified A Eǰ A LISINOPRIL d00732A C I10 Essential (primary) hypertension A Eǰ A MELOXICAM d04532A Cr M79.1 Myalgia A Eǰ A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A . . . E A . . . E A . . . E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A CDp I10 Essential (primary) hypertension A E A ACETAMINOPHEN; HYDROCODONE d03428A Dc M54 R52 Dorsalgia Pain, unspecified A E A ALBUTEROL d00749A B J44.9 Chronic obstructive pulmonary disease, unspecified A E A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A E A BUPROPION d00181A C F32.9 Major depressive disorder, single episode, unspecified A E A GABAPENTIN d03182A D M79.2 Neuralgia and neuritis, unspecified A E A OMEPRAZOLE d00325A CDp K30 R12 Functional dyspepsia Heartburn A E A RANITIDINE d00021A C- K30 R12 Functional dyspepsia Heartburn A E A UMECLIDINIUM; VILANTEROL d08188A B J44.9 Chronic obstructive pulmonary disease, unspecified A E A VERAPAMIL d00048A B I10 Essential (primary) hypertension A E A . . . E A . . . E0 A NAPROXEN d00019A C N94 Pain and other conditions associated with female genital organs and menstrual cycle A E@ A ALBUTEROL; IPRATROPIUM d04066A C R06.2 R06.9P Wheezing Prevent breathing difficulty A E@ A FLUTICASONE; SALMETEROL d04611A C R06.9 Unspecified abnormalities of breathing A EP A . . . E` A . . . Ep A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ Ep A LOSARTAN d03821A C I10 Essential (primary) hypertension A@ Ep A METFORMIN d03807A C E11.P Prevent diabetes A@ Ep A TAMSULOSIN d04121A C R35 Polyuria A@ EȀ A . . . EȐ A ALLOPURINOL d00023A B M1A Chronic gout A@ EȐ A GLIMEPIRIDE d03864A Dc E11 Type 2 diabetes mellitus A@ EȐ A LISINOPRIL d00732A Dc E11 Type 2 diabetes mellitus A@ EȐ A METFORMIN d03807A Dc E11.P Prevent diabetes A@ EȠ A . . . EȰ A . . . E A . . . E A . . . E A CARVEDILOL d03847A C- I10 Essential (primary) hypertension A E A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A E A . . . E A ALBUTEROL d00749A C J45 Asthma A E A BACLOFEN d00967A Cr M79.1 Myalgia A E A BUPROPION d00181A CDp R53 Malaise and fatigue A E A FAMOTIDINE d00141A CDp R07.9 Chest pain, unspecified A E A FLUTICASONE d01296A C J45 Asthma A E A FLUTICASONE NASAL d04283A C T78.40 Allergy, unspecified A E A LORAZEPAM d00149A B F41.9 Anxiety disorder, unspecified A E A MONTELUKAST d04289A CDp R06.2 Wheezing A E A PANTOPRAZOLE d04514A C- R07.9 Chest pain, unspecified A E A TRAMADOL d03826A C M54 Dorsalgia A E A . . . E A . . . E0 A . . . E@ A ALBUTEROL d00749A C J44.9 Chronic obstructive pulmonary disease, unspecified A` E@ A ATENOLOL d00004A C I10 I51.9 Essential (primary) hypertension Heart disease, unspecified A` E@ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A` E@ A CLOPIDOGREL d04258A C D75.9P Prevent blood clots A` E@ A LISINOPRIL d00732A C I10 Essential (primary) hypertension A` E@ A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified A` EP A LISINOPRIL d00732A B I10 Essential (primary) hypertension A E` A . . . Ep A . . . Eɀ A . . . Eɐ A CEPHALEXIN d00096A A J01.9 Acute sinusitis, unspecified A Eɠ A . . . Eɰ A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A ACETAMINOPHEN; OXYCODONE d03431A B[ M54 Dorsalgia A E A ALBUTEROL; IPRATROPIUM d04066A CDp R06.9 Unspecified abnormalities of breathing A E A BENZONATATE d00796A C R05 Cough A E A CYCLOBENZAPRINE d00963A Bz M54 Dorsalgia A E A DILTIAZEM d00045A B[ I10 Essential (primary) hypertension A E A FLUTICASONE; VILANTEROL d08100A B J44.9 Chronic obstructive pulmonary disease, unspecified A E A FUROSEMIDE d00070A C[@ R60.9 Edema, unspecified A E A HOMATROPINE; HYDROCODONE d03340A B R05 Cough A E A MELOXICAM d04532A Bz M79.6 Pain in limb, hand, foot, fingers and toes A E A POLYETHYLENE GLYCOL 3350 d05350A B K59.0 Constipation A E A PREDNISONE d00350A CDp J44.9 Chronic obstructive pulmonary disease, unspecified A E A THEOPHYLLINE d00142A Bz R07.9 Chest pain, unspecified A E A . . . E0 A . . . E@ A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia AP E@ A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A B I10 Essential (primary) hypertension AP E@ A LORAZEPAM d00149A Cr F41.9 Anxiety disorder, unspecified AP E@ A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP E@ A NAPROXEN d00019A Cr M54 M79.1 Dorsalgia Myalgia AP EP A . . . E` A AMOXICILLIN d00088A Ap K04.7P Prevent tooth infection A E` A IBUPROFEN d00015A C K08.8 N28.9 Other specified disorders of teeth and supporting structures Disorder of kidney and ureter, unspecified A Ep A ALBUTEROL d00749A Ei J44.9 Chronic obstructive pulmonary disease, unspecified A` Ep A CYCLOBENZAPRINE d00963A C- 99999 A` Ep A FLUTICASONE; VILANTEROL d08100A Ei J42 Unspecified chronic bronchitis A` Ep A HYDROXYZINE d00907A C 99999 A` Ep A LATANOPROST OPHTHALMIC d04017A C- H40 Glaucoma A` Ep A NAPROXEN d00019A Ei M79.7 Fibromyalgia A` Eʀ A CYPROHEPTADINE d00790A A R63 Symptoms and signs concerning food and fluid intake A Eʐ A . . . Eʠ A PHENTERMINE d00806A A E66 Overweight and obesity A Eʰ A . . . E A 99999 . . A E A LINAGLIPTIN; METFORMIN d07825A C- E11 Type 2 diabetes mellitus A E A FLUTICASONE d01296A C- J45 R05 Asthma Cough A E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A METFORMIN d03807A C R73 Elevated blood glucose level A E A . . . E A . . . E A . . . E0 A . . . E@ A ESOMEPRAZOLE d04749A C K30 K92.9 Functional dyspepsia Disease of digestive system, unspecified A0 E@ A FUROSEMIDE d00070A C R60.9 Edema, unspecified A0 E@ A METHOTREXATE d00060A Cr M06.9 Rheumatoid arthritis, unspecified A0 EP A . . . E` A EVOLOCUMAB d08383A B E78.0 Pure hypercholesterolemia A E` A LOSARTAN d03821A C- I10 Essential (primary) hypertension A Ep A . . . Eˀ A ACETAMINOPHEN; HYDROCODONE d03428A D% M54 Dorsalgia A Eˀ A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified A Eˀ A CELECOXIB d04380A B[ Z79.1 Long term (current) use of non-steroidal anti-inflammatories (NSAID) A Eˀ A HYDROCHLOROTHIAZIDE d00253A B= I10 Essential (primary) hypertension A Eˀ A INSULIN ASPART d04697A CDp E11 Type 2 diabetes mellitus A Eˀ A INSULIN GLARGINE d04538A B E11 Type 2 diabetes mellitus A Eˀ A MONTELUKAST d04289A C J44.9 J45 R06.9 Chronic obstructive pulmonary disease, unspecified Asthma Unspecified abnormalities of breathing A Eˀ A OMEPRAZOLE d00325A Bz K21 Gastro-esophageal reflux disease A Eˀ A PYRIDOSTIGMINE d00363A A` 99999 A Eˀ A RAMIPRIL d00728A C I10 Essential (primary) hypertension A Eˀ A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A Eː A . . . Eˠ A . . . E˰ A . . . E A AMOXICILLIN d00088A A J01.9 Acute sinusitis, unspecified A E A PREDNISONE d00350A A J30.1 Allergic rhinitis due to pollen A E A . . . E A . . . E A AMLODIPINE d00689A C9 I51.9P Prevent heart disease A E A ASPIRIN; DIPYRIDAMOLE d04497A C9 D75.9P I63.P Prevent blood clots Prevent stroke A E A ATORVASTATIN d04105A C9 E78.0 Pure hypercholesterolemia A E A LAMOTRIGINE d03809A C9 G99.8 Other specified disorders of nervous system in diseases classified elsewhere A E A MELOXICAM d04532A C M19.9 Osteoarthritis, unspecified site A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A METOPROLOL d00134A C9 I51.9P Prevent heart disease A E A OMEPRAZOLE d00325A C[@ K30 Functional dyspepsia A E A ONDANSETRON d00867A B K30 R11 Functional dyspepsia Nausea and vomiting A E A TOLTERODINE d04294A C9 R32 Unspecified urinary incontinence A E A . . . E A . . . E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C"0 F90 Attention-deficit hyperactivity disorders A E A LISDEXAMFETAMINE d06663A Ap F90 Attention-deficit hyperactivity disorders A E0 A DEXMETHYLPHENIDATE d04777A Cr F90 Attention-deficit hyperactivity disorders A E@ A CETIRIZINE d03827A B= T78.40 Allergy, unspecified A EP A . . . E` A ALBUTEROL d00749A C J45 Asthma A0 E` A METFORMIN d03807A B[ E11 Type 2 diabetes mellitus A0 E` A SIMVASTATIN d00746A B[ E78.0 Pure hypercholesterolemia A0 Ep A CEFDINIR d04256A A H66.9 Otitis media, unspecified A È A RANITIDINE d00021A B= K21 Gastro-esophageal reflux disease A E̐ A AMITRIPTYLINE d00146A Cr K21 Gastro-esophageal reflux disease A` E̐ A ENALAPRIL d00013A C I10 Essential (primary) hypertension A` E̐ A LATANOPROST OPHTHALMIC d04017A C H40 Glaucoma A` E̐ A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A` E̐ A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease A` E̐ A PREDNISONE d00350A C E27.9 Disorder of adrenal gland, unspecified A` E̠ A FUROSEMIDE d00070A C R60.9 Edema, unspecified A@ E̠ A LISINOPRIL d00732A D* I10 Essential (primary) hypertension A@ E̠ A METOPROLOL d00134A D* I10 Essential (primary) hypertension A@ E̠ A TRAMADOL d03826A Cr M19.9 Osteoarthritis, unspecified site A@ Ḛ A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A B= L70 Acne A E A . . . E A . . . E A AMLODIPINE d00689A Dc I10 Essential (primary) hypertension A0 E A ATORVASTATIN d04105A B[ E78.0 Pure hypercholesterolemia A0 E A CLOPIDOGREL d04258A D I63.P Prevent stroke A0 E A . . . E A DILTIAZEM d00045A C R00 Abnormalities of heart beat A@ E A METOPROLOL d00134A C R00 Abnormalities of heart beat A@ E A MIRABEGRON d07876A B[ R32 Unspecified urinary incontinence A@ E A WARFARIN d00022A C"0 I48.9 Unspecified atrial fibrillation and atrial flutter A@ E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A METHYLPHENIDATE d00900A B F90 Attention-deficit hyperactivity disorders A Ep A . . . È A . . . E͐ A . . . E͠ A . . . EͰ A . . . E A LISINOPRIL d00732A D# I10 Essential (primary) hypertension A E A PAROXETINE d03157A D# F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A CIPROFLOXACIN d00011A A N30 Cystitis A E A ALFUZOSIN d04797A Cr N40 Enlarged prostate A0 E A FINASTERIDE d00563A C- N40 Enlarged prostate A0 E A MELOXICAM d04532A C M13 Other arthritis A0 E A . . . E A . . . E A AMLODIPINE d00689A C I21.P Prevent heart attack/myocardial infarction AP E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E A LEVOTHYROXINE d00278A Bz E07.9 Disorder of thyroid, unspecified AP E A TRAMADOL d03826A Ei M19.9 Osteoarthritis, unspecified site AP E A TRAZODONE d00395A CDp G47.9 Sleep disorder, unspecified AP E A AMLODIPINE d00689A D I10 Essential (primary) hypertension A` E A GLIPIZIDE d00246A C R73 Elevated blood glucose level A` E A METFORMIN d03807A D E11 Type 2 diabetes mellitus A` E A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension A` E A PANTOPRAZOLE d04514A A K30 Functional dyspepsia A` E A RAMIPRIL d00728A D R73 Elevated blood glucose level A` E0 A . . . E@ A . . . EP A . . . E` A AMLODIPINE d00689A Dc I10 Essential (primary) hypertension A0 E` A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A0 E` A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A0 Ep A . . . E A INSULIN GLARGINE d04538A D E11 Type 2 diabetes mellitus A E A TAMSULOSIN d04121A C N40 Enlarged prostate A Eΐ A ACETAMINOPHEN; HYDROCODONE d03428A CDp M25.5 M54 Pain in joint Dorsalgia A Eΐ A CARISOPRODOL d00960A CDp M25.5 M54 Pain in joint Dorsalgia A EΠ A . . . Eΰ A . . . E A . . . E A DEXMETHYLPHENIDATE d04777A CDp F90 Attention-deficit hyperactivity disorders A E A ALBUTEROL d00749A C- R06.02 Shortness of breath A` E A BUDESONIDE; FORMOTEROL d04795A C- R06.9 Unspecified abnormalities of breathing A` E A LEVOTHYROXINE d00278A C 99999 A` E A LOVASTATIN d00280A Dc E78.0 Pure hypercholesterolemia A` E A OXYBUTYNIN d00328A B R35 Polyuria A` E A PREDNISONE d00350A B 99999 A` E A . . . E A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A C[@ I10 Essential (primary) hypertension A E A PRAVASTATIN d00348A C[@ E78.0 Pure hypercholesterolemia A E A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A0 E A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A0 E A WARFARIN d00022A Cr D75.9P Prevent blood clots A0 E A . . . E0 A APIXABAN d07804A C"0 Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets AP E0 A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia AP E0 A LISINOPRIL d00732A C- I21.P Prevent heart attack/myocardial infarction AP E0 A METOPROLOL d00134A CDp I49.9 Cardiac arrhythmia, unspecified AP E0 A TAMSULOSIN d04121A C N40 Enlarged prostate AP E@ A DICLOFENAC d00848A C M19.9 Osteoarthritis, unspecified site A EP A . . . E` A . . . Ep A . . . Eπ A . . . Eϐ A . . . EϠ A . . . Eϰ A . . . E A . . . E A OMEPRAZOLE d00325A A K21 R12 Gastro-esophageal reflux disease Heartburn A E A . . . E A ATORVASTATIN d04105A D I21.P Prevent heart attack/myocardial infarction AP E A FAMOTIDINE d00141A C K30 Functional dyspepsia AP E A METFORMIN d03807A CDp R73 Elevated blood glucose level AP E A OMEPRAZOLE d00325A A K30 Functional dyspepsia AP E A VENLAFAXINE d03181A C F39 Unspecified mood [affective] disorder AP E A LISINOPRIL d00732A C 99999 A0 E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A0 E A TAMSULOSIN d04121A C 99999 A0 E A . . . E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A E A PRAVASTATIN d00348A B[ E78.0 Pure hypercholesterolemia A E0 A ALOGLIPTIN; PIOGLITAZONE d07965A C ` E11 Type 2 diabetes mellitus AP E0 A ATORVASTATIN d04105A C ` E78.0 Pure hypercholesterolemia AP E0 A FLUTICASONE NASAL d04283A C[@ J30.9 Allergic rhinitis, unspecified AP E0 A LISINOPRIL d00732A C ` E11.2 Type 2 diabetes mellitus with kidney complications AP E0 A METFORMIN d03807A C ` E11 Type 2 diabetes mellitus AP E@ A . . . EP A GABAPENTIN d03182A CDp F41.9 M79.2 Anxiety disorder, unspecified Neuralgia and neuritis, unspecified A0 EP A OXYBUTYNIN d00328A D* N32.81 Overactive bladder A0 EP A PROPRANOLOL d00032A C- I10 Essential (primary) hypertension A0 E` A . . . Ep A . . . EЀ A . . . EА A . . . EР A . . . Eа A . . . E A . . . E A . . . E A PAROXETINE d03157A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A . . . EP A BENAZEPRIL d00730A C I10 Essential (primary) hypertension Ap EP A FLUOXETINE d00236A B F32.9 Major depressive disorder, single episode, unspecified Ap EP A GLIPIZIDE d00246A Dc E11 Type 2 diabetes mellitus Ap EP A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus Ap EP A METOPROLOL d00134A C"0 I10 Essential (primary) hypertension Ap EP A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia Ap EP A TRAZODONE d00395A B F41.9 G47.0 Anxiety disorder, unspecified Insomnia Ap E` A LEVOTHYROXINE d00278A D# E04 Other nontoxic goiter A Ep A ALBUTEROL d00749A B= J45.P R05 Prevent asthma Cough A Eр A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A Eр A METOPROLOL d00134A CDp I21.P Prevent heart attack/myocardial infarction A Eѐ A . . . EѠ A METHYLPHENIDATE d00900A C- 55555 A EѰ A . . . E A . . . E A . . . E A . . . E A . . . E A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A E A TELMISARTAN d04364A Cr I10 Essential (primary) hypertension A E A CEPHALEXIN d00096A Ap 55555 A E A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A Ap 55555 A E A METOPROLOL d00134A C I10 Essential (primary) hypertension A E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A ETHINYL ESTRADIOL; NORELGESTROMIN d04779A C Z79.3 Long term (current) use of hormonal contraceptives A EҀ A . . . EҐ A ACETAMINOPHEN; CODEINE d03423A B M54 Dorsalgia Ap EҐ A ALBUTEROL d00749A B J44.9 R06.02 Chronic obstructive pulmonary disease, unspecified Shortness of breath Ap EҐ A ALBUTEROL d00749A CDp D89.9 J44.9 Disorder involving the immune mechanism, unspecified Chronic obstructive pulmonary disease, unspecified Ap EҐ A BUDESONIDE; FORMOTEROL d04795A CDp J44.9 R06.02 Chronic obstructive pulmonary disease, unspecified Shortness of breath Ap EҐ A IPRATROPIUM d00265A CDp J44.9 R06.02 Chronic obstructive pulmonary disease, unspecified Shortness of breath Ap EҐ A OMEPRAZOLE d00325A Dc K21 Gastro-esophageal reflux disease Ap EҐ A POTASSIUM CITRATE d01423A C- E87.6 N20.0 Hypokalemia Calculus of kidney Ap EҠ A . . . EҰ A AMOXICILLIN d00088A A@ J42 Unspecified chronic bronchitis A E A . . . E A . . . E A . . . E A . . . E A . . . E A ALPRAZOLAM d00168A C F41.0 Panic disorder [episodic paroxysmal anxiety] without agoraphobia A E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A B F90 Attention-deficit hyperactivity disorders A E A . . . E0 A . . . E@ A . . . EP A . . . E` A AMIODARONE d00002A C[@ I49.9 Cardiac arrhythmia, unspecified A` E` A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A` E` A CLOPIDOGREL d04258A D I21.P Prevent heart attack/myocardial infarction A` E` A FERRIC CITRATE d08336A D 55555 A` E` A ISOSORBIDE MONONITRATE d00269A C[@ I20.9 Angina pectoris, unspecified A` E` A SEVELAMER d04363A D N19 Unspecified kidney failure A` Ep A . . . EӀ A ATORVASTATIN d04105A CDp E78.1 Pure hyperglyceridemia A EӐ A . . . EӠ A . . . EӰ A . . . E A . . . E A CYCLOSPORINE OPHTHALMIC d04836A C H04 Disorders of lacrimal system A E A ROSUVASTATIN d04851A Cr E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C"0 N92 Z79.3 Excessive, frequent and irregular menstruation Long term (current) use of hormonal contraceptives A E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A CHLORTHALIDONE d00192A C I99.9 Unspecified disorder of circulatory system A0 E` A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A0 E` A METOPROLOL d00134A C N28.9P Prevent kidney disease A0 Ep A . . . EԀ A AMLODIPINE d00689A C- I10 Essential (primary) hypertension AP EԀ A GLIPIZIDE d00246A C- E11 Type 2 diabetes mellitus AP EԀ A LOSARTAN d03821A C- I10 Essential (primary) hypertension AP EԀ A METOPROLOL d00134A C- I10 R07.9 Essential (primary) hypertension Chest pain, unspecified AP EԀ A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia AP EԐ A . . . EԠ A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A C"0 E78.0 Pure hypercholesterolemia A E A CYCLOBENZAPRINE d00963A D9 M62.83 Muscle spasm A E A GLIPIZIDE d00246A D E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A E A GUAIFENESIN d00797A B J00 Acute nasopharyngitis [common cold] A E A METFORMIN d03807A D R73 Elevated blood glucose level A E A OMEPRAZOLE d00325A D K27 Peptic ulcer, site unspecified A E A SILDENAFIL d04299A C[@ I99.9 Unspecified disorder of circulatory system A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E0 A CARVEDILOL d03847A C I10 Essential (primary) hypertension A` E0 A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A` E0 A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A` E0 A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A` E0 A METFORMIN d03807A C R73 Elevated blood glucose level A` E0 A NIFEDIPINE d00051A B I10 Essential (primary) hypertension A` E@ A . . . EP A . . . E` A . . . Ep A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A0 Ep A ATORVASTATIN d04105A Cr E78.0P Prevent high cholesterol A0 Ep A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A0 EՀ A . . . EՐ A . . . Eՠ A . . . Eհ A . . . E A AMOXICILLIN d00088A AP J20.9 Acute bronchitis, unspecified A E A . . . E A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A E A DILTIAZEM d00045A Cr I10 Essential (primary) hypertension A E A GABAPENTIN d03182A CDp M79.2 Neuralgia and neuritis, unspecified A E A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A C I10 R60.9 Essential (primary) hypertension Edema, unspecified A E A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A E A LOVASTATIN d00280A Cr I21.P Prevent heart attack/myocardial infarction A E A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A E A MIRABEGRON d07876A CDp R32 Unspecified urinary incontinence A E A . . . E A METHYLPHENIDATE d00900A C F90 Attention-deficit hyperactivity disorders A E A . . . E A RANITIDINE d00021A Ap K21 Gastro-esophageal reflux disease A E0 A DICYCLOMINE d00999A A K58 Irritable bowel syndrome A E0 A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E@ A . . . EP A . . . E` A BUSPIRONE d00182A0 B F33.9 Major depressive disorder, recurrent, unspecified A` E` A COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR d07899A0 Cr B20 Human immunodeficiency virus [HIV] disease A` E` A ESCITALOPRAM d04812A0 Cr F31.9 Bipolar disorder, unspecified A` E` A LAMOTRIGINE d03809A0 Cr F31.9 Bipolar disorder, unspecified A` E` A ROSUVASTATIN d04851A0 CDp E78.0 Pure hypercholesterolemia A` E` A TERAZOSIN d00386A0 CDp N40 Enlarged prostate A` Ep A ACETAMINOPHEN; HYDROCODONE d03428A C- M54 Dorsalgia A Ep A ALPRAZOLAM d00168A B= F41.9 Anxiety disorder, unspecified A Ep A AMIODARONE d00002A B= I49.9 Cardiac arrhythmia, unspecified A Ep A AMLODIPINE d00689A Cr 99999 A Ep A APIXABAN d07804A B D75.9P Prevent blood clots A Ep A ASPIRIN d00170A D D75.9P Prevent blood clots A Ep A ATORVASTATIN d04105A D 99999 A Ep A ISOSORBIDE d00653A D 99999 A Ep A METOPROLOL d00134A B I49.9 Cardiac arrhythmia, unspecified A Ep A ONDANSETRON d00867A B R11 Nausea and vomiting A Ep A ROPINIROLE d04215A D 99999 A Eր A . . . E A ETHINYL ESTRADIOL; ETHYNODIOL d03388A D Z79.3 Long term (current) use of hormonal contraceptives A E֠ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ E֠ A LEVOTHYROXINE d00278A C[@ E03.9 Hypothyroidism, unspecified A@ E֠ A TRAZODONE d00395A C- G47.0 Insomnia A@ E֠ A VENLAFAXINE d03181A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A@ Eְ A BUPROPION d00181A B= F32.9 Major depressive disorder, single episode, unspecified A@ Eְ A ETHINYL ESTRADIOL; NORETHINDRONE d03238A Bz N92 Excessive, frequent and irregular menstruation A@ Eְ A FLUOXETINE d00236A C- F32.9 Major depressive disorder, single episode, unspecified A@ Eְ A LEVOCETIRIZINE d05851A C T78.40 Allergy, unspecified A@ E A . . . E A . . . E A . . . E A . . . E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A0 E A MELOXICAM d04532A B[ M54 Dorsalgia A0 E A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease A0 E A AMLODIPINE d00689A C I10 Essential (primary) hypertension Ap E A CARVEDILOL d03847A C I49.9 Cardiac arrhythmia, unspecified Ap E A FUROSEMIDE d00070A C R60.9 Edema, unspecified Ap E A NAPROXEN d00019A C Z79 Long term (current) drug therapy Ap E A OMEPRAZOLE d00325A C K30 R12 Functional dyspepsia Heartburn Ap E A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia Ap E A SPIRONOLACTONE d00373A CDp R60.9 Edema, unspecified Ap E0 A . . . E@ A CHLORHEXIDINE TOPICAL d01231A B K04.7P Prevent tooth infection A E@ A FLUORIDE TOPICAL d04397A B[ K02 Dental caries A EP A . . . E` A . . . Ep A RANITIDINE d00021A Bz K21 Gastro-esophageal reflux disease A E׀ A CLONAZEPAM d00197A C G47.0 Insomnia A@ E׀ A IRBESARTAN d04222A C I10 Essential (primary) hypertension A@ E׀ A METFORMIN d03807A C R73 Elevated blood glucose level A@ E׀ A METOPROLOL d00134A C I10 Essential (primary) hypertension A@ Eא A . . . Eנ A . . . Eװ A . . . E A . . . E A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A E A BACLOFEN d00967A CDp M25.5 M54 Pain in joint Dorsalgia A E A DUTASTERIDE d04788A Cr N40 Enlarged prostate A E A NEBIVOLOL d05265A C[@ I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A ATENOLOL d00004A C I10 Essential (primary) hypertension A0 E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E A CLOPIDOGREL d04258A C I21.P Prevent heart attack/myocardial infarction A0 E0 A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A E0 A MELOXICAM d04532A A M13 Other arthritis A E@ A BENAZEPRIL d00730A Cr I10 Essential (primary) hypertension Ap E@ A DOXYCYCLINE d00037A AP L08.9 Local infection of the skin and subcutaneous tissue, unspecified Ap E@ A FUROSEMIDE d00070A Cr R60.9 Edema, unspecified Ap E@ A GLIMEPIRIDE d03864A B E11 Type 2 diabetes mellitus Ap E@ A POTASSIUM CHLORIDE d00345A C I51.9 Heart disease, unspecified Ap E@ A TIOTROPIUM d04829A C J45 Asthma Ap E@ A WARFARIN d00022A Cr D75.9P Prevent blood clots Ap EP A . . . E` A . . . Ep A . . . E A . . . Eؐ A . . . Eؠ A . . . Eذ A . . . E A ATORVASTATIN d04105A C- E78.0P Prevent high cholesterol A E A LOSARTAN d03821A C I10 Essential (primary) hypertension A E A . . . E A . . . E A ALBUTEROL d00749A0 A R05 Cough A E A CEFDINIR d04256A0 A J42 Unspecified chronic bronchitis A E A RANITIDINE d00021A B K21 Gastro-esophageal reflux disease A E A METHYLPHENIDATE d00900A Bz F90 Attention-deficit hyperactivity disorders A E A . . . E0 A . . . E@ A NEBIVOLOL d05265A C[@ I10 Essential (primary) hypertension A E@ A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified A EP A . . . E` A . . . Ep A . . . Eـ A . . . Eِ A . . . E٠ A . . . Eٰ A 99999 . . A E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia Ap E A CHLORTHALIDONE d00192A CDp I10 Essential (primary) hypertension Ap E A HYDRALAZINE d00132A C- I10 Essential (primary) hypertension Ap E A INSULIN GLARGINE d04538A Cr E11 Type 2 diabetes mellitus Ap E A LOSARTAN d03821A C I10 Essential (primary) hypertension Ap E A METFORMIN d03807A C E11 Type 2 diabetes mellitus Ap E A NIFEDIPINE d00051A B I10 Essential (primary) hypertension Ap E A . . . E A AMIODARONE d00002A C I51.9 Heart disease, unspecified B E A AMLODIPINE d00689A C I10 Essential (primary) hypertension B E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia B E A BUDESONIDE; FORMOTEROL d04795A CDp J44.9 Chronic obstructive pulmonary disease, unspecified B E A FINASTERIDE d00563A C[@ 99999 B E A FLUTICASONE; SALMETEROL d04611A C J44.9 Chronic obstructive pulmonary disease, unspecified B E A FUROSEMIDE d00070A C I10 Essential (primary) hypertension B E A GABAPENTIN d03182A C M79.6 Pain in limb, hand, foot, fingers and toes B E A LISINOPRIL d00732A C I10 Essential (primary) hypertension B E A LORAZEPAM d00149A C F41.9 Anxiety disorder, unspecified B E A MECLIZINE d00859A C R42 Dizziness and giddiness B E A METOPROLOL d00134A C[@ I49.9 Cardiac arrhythmia, unspecified B E A MOUTH AND THROAT PRODUCTS - UNSPECIFIED c00146A B J02 Acute pharyngitis B E A NITROGLYCERIN d00321A C I51.9 Heart disease, unspecified B E A SUCRALFATE d00377A B J02 Acute pharyngitis B E A WARFARIN d00022A C D75.9P Prevent blood clots B E A SERTRALINE d00880A C- F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E0 A METHIMAZOLE d00290A B[ E07.9 Disorder of thyroid, unspecified A@ E0 A METOPROLOL d00134A CDp R00 Abnormalities of heart beat A@ E0 A ROSUVASTATIN d04851A B[ E78.0 Pure hypercholesterolemia A@ E0 A VENLAFAXINE d03181A C- F41.9 Anxiety disorder, unspecified A@ E@ A . . . EP A ESOMEPRAZOLE d04749A A K30 Functional dyspepsia A` EP A LAMOTRIGINE d03809A CP F31.9 Bipolar disorder, unspecified A` EP A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A` EP A METFORMIN d03807A CDp R73 Elevated blood glucose level A` EP A MODAFINIL d04378A0 C- R53 Malaise and fatigue A` EP A TOPIRAMATE d04115A B E66 Overweight and obesity A` E` A . . . Ep A . . . Eڀ A . . . Eڐ A . . . Eڠ A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A Eڠ A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A Eڰ A . . . E A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A E A LISINOPRIL d00732A D I51.9P Prevent heart disease A E A . . . E A . . . E A ATORVASTATIN d04105A0 D E78.0 Pure hypercholesterolemia A E A CYCLOSPORINE OPHTHALMIC d04836A0 C H04 Disorders of lacrimal system A E A FLUTICASONE; SALMETEROL d04611A0 C J45 Asthma A E A HYDROCODONE d03075A0 Cr M54 Dorsalgia A E A IPRATROPIUM NASAL d04235A0 Cr J30.1 Allergic rhinitis due to pollen A E A LATANOPROST OPHTHALMIC d04017A0 C H40 Glaucoma A E A LEVOTHYROXINE d00278A0 D E03.9 Hypothyroidism, unspecified A E A LISINOPRIL d00732A0 C I10 Essential (primary) hypertension A E A NIFEDIPINE d00051A0 B I10 Essential (primary) hypertension A E A PANTOPRAZOLE d04514A0 C K21 Gastro-esophageal reflux disease A E A SERTRALINE d00880A0 D= F41.9 Anxiety disorder, unspecified A E A SEVELAMER d04363A0 B[ N19 Unspecified kidney failure A E A ATENOLOL d00004A C I10 Essential (primary) hypertension A E A BUPROPION d00181A B F32.9 Major depressive disorder, single episode, unspecified A E A ESCITALOPRAM d04812A B F32.9 Major depressive disorder, single episode, unspecified A E A GABAPENTIN d03182A B M19.9 Osteoarthritis, unspecified site A E A HYDROCHLOROTHIAZIDE d00253A B I10 Essential (primary) hypertension A E A INSULIN ASPART d04697A C- E11 Type 2 diabetes mellitus A E A INSULIN GLARGINE d04538A C- E11 Type 2 diabetes mellitus A E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A E A SIMVASTATIN d00746A B E78.0 Pure hypercholesterolemia A E A CITALOPRAM d04332A Ei 99999 A E A PRIMIDONE d00352A C- 99999 A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E0 A AMPHETAMINE; DEXTROAMPHETAMINE d04035A CDp F90 Attention-deficit hyperactivity disorders A E0 A GUANFACINE d00717A C F90 Attention-deficit hyperactivity disorders A E@ A METHADONE d00050A B F11.23 Opioid dependence with withdrawal A EP A . . . E` A . . . Ep A ALLOPURINOL d00023A C9 M1A Chronic gout A Ep A METOPROLOL d00134A B I10 Essential (primary) hypertension A Eۀ A . . . Eې A . . . E۠ A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C[@ Z79.3 Long term (current) use of hormonal contraceptives A E۰ A . . . E A ALLOPURINOL d00023A Dc M1A Chronic gout Ap E A DULOXETINE d05355A CDp M79.2 Neuralgia and neuritis, unspecified Ap E A FINASTERIDE d00563A CDp R35 Polyuria Ap E A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus Ap E A MONTELUKAST d04289A CDp R06.9 Unspecified abnormalities of breathing Ap E A RIVAROXABAN d07356A CDp D75.9P Prevent blood clots Ap E A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia Ap E A . . . E A 99999 . . A E A . . . E A . . . E A . . . E A IBUPROFEN d00015A B G43 Migraine A E A PREDNISONE d00350A Cr 55555 A E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E܀ A . . . Eܐ A . . . Eܠ A . . . Eܰ A CELECOXIB d04380A B= N94 Pain and other conditions associated with female genital organs and menstrual cycle A0 Eܰ A MEDROXYPROGESTERONE d00284A B N94 Pain and other conditions associated with female genital organs and menstrual cycle A0 Eܰ A OXYCODONE d00329A A G89 Pain, not elsewhere classified A0 E Ap . . . E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A B F90 Attention-deficit hyperactivity disorders A0 E A FLUOXETINE d00236A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A0 E A LORAZEPAM d00149A C F41.9 Anxiety disorder, unspecified A0 E A . . . E A . . . E A GEMFIBROZIL d00245A Bz E78.1 Pure hyperglyceridemia A E A TAMSULOSIN d04121A Bz N40 Enlarged prostate A E A ALPRAZOLAM d00168A B F32.9 Major depressive disorder, single episode, unspecified A0 E A CEFUROXIME d00056A Ap J01.9 Acute sinusitis, unspecified A0 E A TESTOSTERONE d00558A Dc E29.1 Testicular hypofunction A0 E A ATORVASTATIN d04105A D9 E78.0 Pure hypercholesterolemia A@ E A EZETIMIBE d04824A C E78.0 Pure hypercholesterolemia A@ E A METOPROLOL d00134A C I10 Essential (primary) hypertension A@ E A NITROGLYCERIN d00321A C R07.9 Chest pain, unspecified A@ E0 A BRIMONIDINE OPHTHALMIC d04048A Cr H40 Glaucoma A E@ A FLUTICASONE; SALMETEROL d04611A C[@ J45 Asthma A EP A CETIRIZINE d03827A B T78.40 Allergy, unspecified A E` A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ E` A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A@ E` A FLUTICASONE NASAL d04283A Bz R09.81 Nasal congestion A@ E` A IBUPROFEN d00015A D M54 Dorsalgia A@ Ep A . . . E݀ A ALBUTEROL d00749A C[@ J44.9 Chronic obstructive pulmonary disease, unspecified A E݀ A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A E݀ A BIMATOPROST OPHTHALMIC d04754A D ^ H40 Glaucoma A E݀ A CARVEDILOL d03847A D I10 Essential (primary) hypertension A E݀ A CHOLESTYRAMINE d00193A B R19.7 Diarrhea, unspecified A E݀ A CILOSTAZOL d04382A D I70 Atherosclerosis A E݀ A EPLERENONE d04815A C I50.9 Heart failure, unspecified A E݀ A FUROSEMIDE d00070A D N28.9 Disorder of kidney and ureter, unspecified A E݀ A INSULIN ASPART d04697A Dc R73 Elevated blood glucose level A E݀ A INSULIN GLARGINE d04538A D R73 Elevated blood glucose level A E݀ A ISOSORBIDE DINITRATE d00268A D I10 Essential (primary) hypertension A E݀ A MACITENTAN d08126A CDp I27.9 Pulmonary heart disease, unspecified A E݀ A OLMESARTAN d04801A B[ I50.9 Heart failure, unspecified A E݀ A PENICILLIN V POTASSIUM d07730A A@ K05.6 Periodontal disease, unspecified A E݀ A RANOLAZINE d05719A D R07.9 Chest pain, unspecified A Eݐ A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A Eݠ A 99999 . . A Eݰ A . . . E A . . . E A . . . E A BUDESONIDE; FORMOTEROL d04795A CDp J45 Asthma A E A CLONAZEPAM d00197A C F41.9 Anxiety disorder, unspecified A E A FLUOXETINE d00236A C F32.9 Major depressive disorder, single episode, unspecified A E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I50.9 Heart failure, unspecified A E A LEVOTHYROXINE d00278A B[ E03.9 Hypothyroidism, unspecified A E A METOPROLOL d00134A C I10 Essential (primary) hypertension A E A MOMETASONE NASAL d04223A C- J30.9 Allergic rhinitis, unspecified A E A MONTELUKAST d04289A C J45 Asthma A E A POLYETHYLENE GLYCOL 3350 d05350A B K59.0 Constipation A E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E A HYDROCHLOROTHIAZIDE d00253A C[@ R60.9 Edema, unspecified A0 E A LEVOTHYROXINE d00278A D"8 E03.9 Hypothyroidism, unspecified A0 E A . . . E0 A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C Z79.3 Long term (current) use of hormonal contraceptives A0 E0 A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A0 E0 A MINOCYCLINE d00110A Cr L08.9 L70 Local infection of the skin and subcutaneous tissue, unspecified Acne A0 E@ A . . . EP A . . . E` A BUPROPION d00181A C F32.9 Major depressive disorder, single episode, unspecified A E` A CETIRIZINE d03827A C- J30.1 R09.81 Allergic rhinitis due to pollen Nasal congestion A E` A CYCLOBENZAPRINE d00963A D# M62.83 Muscle spasm A E` A DOCUSATE d01021A D K59.0 Constipation A E` A FENOFIBRATE d04286A Cr E78.0 Pure hypercholesterolemia A E` A GABAPENTIN d03182A Cr M54 Dorsalgia A E` A LISINOPRIL d00732A D# I10 Essential (primary) hypertension A E` A MORPHINE d00308A D# M54 Dorsalgia A E` A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A Ep A . . . Eހ A . . . Eސ A ENALAPRIL d00013A Cr I10 Essential (primary) hypertension A0 Eސ A PRAVASTATIN d00348A B[ E78.0 Pure hypercholesterolemia A0 Eސ A RANITIDINE d00021A C- K21 Gastro-esophageal reflux disease A0 Eޠ A 77777 . . A Eް A . . . E A . . . E A . . . E A . . . E A 99999 . . A E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A E A ACETAMINOPHEN; BUTALBITAL; CAFFEINE d03455A C[@ R51 Headache Ap E A CIPROFLOXACIN d00011A Ap N30 N39.0 Cystitis Urinary tract infection, site not specified Ap E A CYCLOBENZAPRINE d00963A C[@ M62.83 Muscle spasm Ap E A ESCITALOPRAM d04812A C[@ F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Ap E A ESTRADIOL d00537A B= Z79.890 Hormone replacement therapy Ap E A MECLIZINE d00859A C- R42 Dizziness and giddiness Ap E A OXYBUTYNIN d00328A Ap N39.4 R32 Other specified urinary incontinence Unspecified urinary incontinence Ap E A AMLODIPINE; BENAZEPRIL d03829A C I10 Essential (primary) hypertension A@ E A CIMETIDINE d00140A C K21 Gastro-esophageal reflux disease A@ E A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A@ E A VALACYCLOVIR d03838A C A60.9 Anogenital herpesviral infection, unspecified A@ E A HYDROXYZINE d00907A C G47.0 Insomnia A E A OXCARBAZEPINE d04513A C F39 Unspecified mood [affective] disorder A E0 A . . . E@ A ALBUTEROL d00749A Bz J20.9 J42 J45 Acute bronchitis, unspecified Unspecified chronic bronchitis Asthma A EP A . . . E` A CLOPIDOGREL d04258A Cr D75.9P Prevent blood clots A0 E` A IRBESARTAN d04222A Cr I10 Essential (primary) hypertension A0 E` A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A0 Ep A . . . E߀ A . . . Eߐ A METHYLPHENIDATE d00900A Cr F90 Attention-deficit hyperactivity disorders A Eߠ A . . . E߰ A . . . E A ALLOPURINOL d00023A Cr M1A Chronic gout A@ E A ASPIRIN d00170A C I21.P Prevent heart attack/myocardial infarction A@ E A FENOFIBRATE d04286A Cr E78.0 Pure hypercholesterolemia A@ E A FINASTERIDE d00563A C N40 Enlarged prostate A@ E A . . . E A . . . E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A0 CDp F90 Attention-deficit hyperactivity disorders A0 E A CYPROHEPTADINE d00790A C- R63 Symptoms and signs concerning food and fluid intake A0 E A FLUOXETINE d00236A B F32.9 F39 Major depressive disorder, single episode, unspecified Unspecified mood [affective] disorder A0 E A . . . E A . . . E A BECLOMETHASONE d00760A CDp J45 Asthma A E A MONTELUKAST d04289A Cr J30.9 Allergic rhinitis, unspecified A E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A FLUTICASONE NASAL d04283A C J30.9 Allergic rhinitis, unspecified A E A PROMETHAZINE d00787A Ap R05 Cough A E A OXYBUTYNIN d00328A Dc N32.81 Overactive bladder A E A TAMSULOSIN d04121A Cr N40 Enlarged prostate A E A ASPIRIN d00170A D I51.9P Z79.0 Prevent heart disease Long term (current) use of anticoagulants and antithrombotics/antiplatelets A E A ATENOLOL d00004A D I10 Essential (primary) hypertension A E A DILTIAZEM d00045A D I10 Essential (primary) hypertension A E A EPLERENONE d04815A Cr I10 Essential (primary) hypertension A E A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A E A GLIPIZIDE d00246A Cr E11 Type 2 diabetes mellitus A E A LISINOPRIL d00732A D I10 Essential (primary) hypertension A E A METFORMIN d03807A D E11 Type 2 diabetes mellitus A E A PRAVASTATIN d00348A D E78.0 Pure hypercholesterolemia A E A SAXAGLIPTIN d07467A C- E11 Type 2 diabetes mellitus A E A TERAZOSIN d00386A D R35 Polyuria A E A . . . E A . . . E A FLUCONAZOLE d00071A C- B35 Dermatophytosis A E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A@ E A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A@ E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E A AMOXICILLIN d00088A C A49.9P Prevent bacterial infection A E0 A ALBUTEROL d00749A D# J45 Asthma A E@ A . . . EP A PHENTERMINE d00806A B E66 Overweight and obesity A E` A . . . Ep A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A Ep A CETIRIZINE d03827A A T78.40 Allergy, unspecified A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A RISPERIDONE d03180A C F20 Schizophrenia A E A . . . E A . . . E A . . . E0 A . . . E@ A . . . EP A DIVALPROEX SODIUM d03833A C F84 Pervasive developmental disorders A EP A RISPERIDONE d03180A Dc F84 Pervasive developmental disorders A E` A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A0 E` A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus A0 E` A METOPROLOL d00134A B I10 Essential (primary) hypertension A0 Ep A COLESTIPOL d00744A C- N20.0 Calculus of kidney A` Ep A DIGOXIN d00210A CDp I49.9 Cardiac arrhythmia, unspecified A` Ep A DILTIAZEM d00045A CDp I10 Essential (primary) hypertension A` Ep A GABAPENTIN d03182A CDp M54 Dorsalgia A` Ep A TAMSULOSIN d04121A C- N20.0 Calculus of kidney A` Ep A WARFARIN d00022A D& D75.9P Prevent blood clots A` E A ATENOLOL d00004A D I10 Essential (primary) hypertension AP E A ATORVASTATIN d04105A D 99999 AP E A ENALAPRIL d00013A D I10 Essential (primary) hypertension AP E A FINASTERIDE d00563A C N40 Enlarged prostate AP E A TERAZOSIN d00386A C N40 Enlarged prostate AP E A FLUTICASONE NASAL d04283A C"0 J30.9 Allergic rhinitis, unspecified A@ E A HYDROCORTISONE TOPICAL d03205A CDp L20.9 Atopic dermatitis, unspecified A@ E A LEVOCETIRIZINE d05851A C- L20.9 T78.40 Atopic dermatitis, unspecified Allergy, unspecified A@ E A TRIAMCINOLONE TOPICAL d03206A CDp L20.9 Atopic dermatitis, unspecified A@ E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A E A . . . E A . . . E0 A CETIRIZINE d03827A B T78.40 Allergy, unspecified A0 E0 A DEXMETHYLPHENIDATE d04777A B F90 Attention-deficit hyperactivity disorders A0 E0 A FLUTICASONE NASAL d04283A C J30.2 Other seasonal allergic rhinitis A0 E@ A . . . EP A CITALOPRAM d04332A C- F32.9 Major depressive disorder, single episode, unspecified A EP A CYCLOBENZAPRINE d00963A C- M62.83 Muscle spasm A EP A FAMOTIDINE d00141A C- K30 Functional dyspepsia A EP A LORAZEPAM d00149A C- F41.9 Anxiety disorder, unspecified A EP A MORPHINE d00308A C G89 M25.5 M54 Pain, not elsewhere classified Pain in joint Dorsalgia A EP A PREGABALIN d05508A C- E11.4 M79.2 Type 2 diabetes mellitus with neurological complications Neuralgia and neuritis, unspecified A EP A PROCHLORPERAZINE d00355A C- R11 Nausea and vomiting A EP A TEMAZEPAM d00384A C- G47.9 Sleep disorder, unspecified A EP A TRAZODONE d00395A C- F32.9 Major depressive disorder, single episode, unspecified A E` A . . . Ep A ESTRADIOL d00537A C N95 Menopausal and other perimenopausal disorders A0 Ep A OXYBUTYNIN d00328A C N32.81 Overactive bladder A0 Ep A VENLAFAXINE d03181A Dc F32.9 Major depressive disorder, single episode, unspecified A0 E A . . . E A . . . E A CLONIDINE d00044A B I10 Essential (primary) hypertension A E A DILTIAZEM d00045A B I10 Essential (primary) hypertension A E A DOXAZOSIN d00726A C I99.9 Unspecified disorder of circulatory system A E A ENALAPRIL d00013A C I10 Essential (primary) hypertension A E A ESOMEPRAZOLE d04749A C K31.9 Disease of stomach and duodenum, unspecified A E A FAMOTIDINE d00141A C K30 Functional dyspepsia A E A FUROSEMIDE d00070A C R60.9 Edema, unspecified A E A GABAPENTIN d03182A CDp M19.9 Osteoarthritis, unspecified site A E A MECLIZINE d00859A CDp R42 Dizziness and giddiness A E A PREDNISONE d00350A Cr M06.9 Rheumatoid arthritis, unspecified A E A . . . E A . . . E A . . . E A . . . E A . . . E A INSULIN ASPART d04697A C- E10 Type 1 diabetes mellitus A E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A . . . E A . . . E0 A FENOFIBRATE d04286A C- E78.0 Pure hypercholesterolemia A E0 A METFORMIN d03807A C E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A E@ A . . . EP A BUSPIRONE d00182A B[ F41.9 Anxiety disorder, unspecified A@ EP A FLUOXETINE d00236A C F32.9 Major depressive disorder, single episode, unspecified A@ EP A OXCARBAZEPINE d04513A C F31.9 F32.9 Bipolar disorder, unspecified Major depressive disorder, single episode, unspecified A@ EP A RANITIDINE d00021A C K30 Functional dyspepsia A@ E` A . . . Ep A HYDROXYZINE d00907A C G47.9 Sleep disorder, unspecified A Ep A RISPERIDONE d03180A C 55555 A E A . . . E A ALBUTEROL d00749A CDp J45 Asthma A E A . . . E A . . . E A . . . E A ATENOLOL d00004A C I10 Essential (primary) hypertension A E A DICYCLOMINE d00999A C R10 Abdominal and pelvic pain A E A FLUTICASONE NASAL d04283A Cr J30.2 Other seasonal allergic rhinitis A E A FUROSEMIDE d00070A C- J98.9 Respiratory disorder, unspecified A E A LEVOTHYROXINE d00278A D% E03.9 Hypothyroidism, unspecified A E A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A E A MECLIZINE d00859A D9 R42 Dizziness and giddiness A E A OMEPRAZOLE d00325A D B96.81 Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere A E A PITAVASTATIN d07637A CDp E78.0 Pure hypercholesterolemia A E A SPIRONOLACTONE d00373A CDp I10 Essential (primary) hypertension A E A . . . E A ATORVASTATIN d04105A C[@ E78.0P Prevent high cholesterol A0 E A ATORVASTATIN d04105A C[@ E78.0P Prevent high cholesterol A0 E A METFORMIN d03807A C[@ R73 Elevated blood glucose level A0 E A . . . E A . . . E A . . . E0 A . . . E@ A PREDNISONE d00350A Ap L40 Psoriasis A EP A RANITIDINE d00021A Ap J00 J02 Acute nasopharyngitis [common cold] Acute pharyngitis A E` A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension AP E` A ASPIRIN d00170A CDp I21.P Prevent heart attack/myocardial infarction AP E` A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia AP E` A CANAGLIFLOZIN d08080A C E11 Type 2 diabetes mellitus AP E` A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C"0 I10 Essential (primary) hypertension AP Ep A . . . E A AMOXICILLIN d00088A B H66.9 Otitis media, unspecified A E A BECLOMETHASONE d00760A C[@ J45 Asthma A E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C Z79.3 Long term (current) use of hormonal contraceptives A E A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A` E A DOXYCYCLINE d00037A C[@ L71 Rosacea A` E A FAMOTIDINE d00141A CDp K30 Functional dyspepsia A` E A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A` E A ROSUVASTATIN d04851A B E78.0 Pure hypercholesterolemia A` E A SPIRONOLACTONE d00373A Cr I10 Essential (primary) hypertension A` E A . . . E A . . . E A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A E A . . . E A BETHANECHOL d01427A B[ 99999 A E A LANSOPRAZOLE d03828A B[ K21 Gastro-esophageal reflux disease A E A . . . E A . . . E0 A ALBUTEROL d00749A C R06.2 Wheezing A E0 A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E0 A CARVEDILOL d03847A C I25.9 Chronic ischemic heart disease, unspecified A E0 A CLOPIDOGREL d04258A C D75.9P Prevent blood clots A E0 A FLUTICASONE; SALMETEROL d04611A C J45 R06.9 Asthma Unspecified abnormalities of breathing A E0 A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A E0 A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A E0 A METFORMIN d03807A C R73 Elevated blood glucose level A E@ A . . . EP A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 EP A CYCLOSPORINE OPHTHALMIC d04836A C"0 H04 Disorders of lacrimal system A0 EP A LOSARTAN d03821A BZ I10 Essential (primary) hypertension A0 E` A ALPRAZOLAM d00168A C- F41.9 Anxiety disorder, unspecified A@ E` A BUPROPION d00181A B F32.9 Major depressive disorder, single episode, unspecified A@ E` A PANTOPRAZOLE d04514A C- K21 Gastro-esophageal reflux disease A@ E` A ZOLPIDEM d00910A B= G47.0 Insomnia A@ Ep A MESALAMINE d01031A CDp K50 Crohn's disease [regional enteritis] A` Ep A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A` Ep A PANTOPRAZOLE d04514A C 99999 A` Ep A PRAVASTATIN d00348A C 99999 A` Ep A PREDNISONE d00350A B D89.9 Disorder involving the immune mechanism, unspecified A` Ep A PROPRANOLOL d00032A Cr 99999 A` E A . . . E A FENOFIBRIC ACID d07371A C- E78.0 Pure hypercholesterolemia A0 E A LOSARTAN d03821A C- I10 Essential (primary) hypertension A0 E A PRAVASTATIN d00348A C- E78.0 Pure hypercholesterolemia A0 E A . . . E A ACETAMINOPHEN; CODEINE d03423A Ap R52 Pain, unspecified A E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C- F41.9 F90 R41 Anxiety disorder, unspecified Attention-deficit hyperactivity disorders Other symptoms and signs involving cognitive functions and awareness A E A ALBUTEROL d00749A B= H66.9 Otitis media, unspecified A` E A AMOXICILLIN; CLAVULANATE d00089A A H66.9 Otitis media, unspecified A` E A AZITHROMYCIN d00091A A0 H66.9 Otitis media, unspecified A` E A CIPROFLOXACIN OTIC d04287A A H66.9 Otitis media, unspecified A` E A IBUPROFEN d00015A A H93.9 Unspecified disorder of ear A` E A PREDNISOLONE d00084A A0 R07.9 Chest pain, unspecified A` E A . . . E A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus AP E A LEVOTHYROXINE d00278A B E07.9 Disorder of thyroid, unspecified AP E A LISINOPRIL d00732A C 99999 AP E A METFORMIN d03807A C R73 Elevated blood glucose level AP E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia AP E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia Ap E A DILTIAZEM d00045A B= I10.P Prevent hypertension Ap E A FUROSEMIDE d00070A C I51.9 Heart disease, unspecified Ap E A GABAPENTIN d03182A D M79.2 T14.9 Neuralgia and neuritis, unspecified Unspecified injury Ap E A HYDROCHLOROTHIAZIDE d00253A C I51.9P Prevent heart disease Ap E A PANTOPRAZOLE d04514A D3T K21 Gastro-esophageal reflux disease Ap E A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia Ap E A . . . E A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A B= R60.9 Edema, unspecified AP E A INSULIN DETEMIR d05436A B[ E11 Type 2 diabetes mellitus AP E A RAMIPRIL d00728A C[@ I10 Essential (primary) hypertension AP E A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified AP E A SITAGLIPTIN d05896A CDp E11 Type 2 diabetes mellitus AP E A . . . E0 A ERYTHROMYCIN OPHTHALMIC d03973A A0 H04 Disorders of lacrimal system A E@ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E@ A FLUOXETINE d00236A C F32.9 Major depressive disorder, single episode, unspecified A EP A . . . E` A . . . Ep A . . . E A . . . E A . . . E A . . . E A . . . E A ALLOPURINOL d00023A B M1A Chronic gout A E A FLUOXETINE d00236A B F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A CARBAMAZEPINE d00058A C F39 Unspecified mood [affective] disorder A E@ A LORATADINE; PSEUDOEPHEDRINE d03818A CP H10 T78.40 Conjunctivitis Allergy, unspecified A EP A ALBUTEROL d00749A . J45 Asthma A EP A MONTELUKAST d04289A A J30.9 Allergic rhinitis, unspecified A E` A MEMANTINE d04899A B 99999 A0 E` A RIVASTIGMINE d04537A B 99999 A0 E` A WARFARIN d00022A B 99999 A0 Ep A . . . E A . . . E A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A E A . . . E A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A0 E A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A0 E A TRAMADOL d03826A CDp M13 Other arthritis A0 E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A ACETAMINOPHEN; CODEINE d03423A B[ R51 Headache A Ep A SPIRONOLACTONE d00373A B[ L65.9 Nonscarring hair loss, unspecified A E A . . . E A LEVOTHYROXINE d00278A B E05 Thyrotoxicosis [hyperthyroidism] A E A ALBUTEROL d00749A A J45 Asthma A E A BUDESONIDE; FORMOTEROL d04795A B J45 Asthma A E A ESCITALOPRAM d04812A C[@ F41.9 Anxiety disorder, unspecified AP E A GABAPENTIN d03182A C[@ G25.81 Restless legs syndrome AP E A MELOXICAM d04532A B M25.5 Pain in joint AP E A OMEPRAZOLE d00325A CDp K21 K92.9 Gastro-esophageal reflux disease Disease of digestive system, unspecified AP E A TRIAMTERENE d00396A C R60.9 Edema, unspecified AP E A DOXYCYCLINE d00037A Ap A49.9 Bacterial infection, unspecified A E A METRONIDAZOLE d00108A Ap A49.9 N39.0 Bacterial infection, unspecified Urinary tract infection, site not specified A E A . . . E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C- I10 Essential (primary) hypertension A0 E A OXYBUTYNIN d00328A C N32.81 Overactive bladder A0 E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A0 E A . . . E A . . . E A ALBUTEROL d00749A Ap R06.02 Shortness of breath A E A CEFDINIR d04256A A J02 Acute pharyngitis A E A ESCITALOPRAM d04812A C[@ F41.9 Anxiety disorder, unspecified A0 E A FENOFIBRATE d04286A CDp E78.0 E78.1 Pure hypercholesterolemia Pure hyperglyceridemia A0 E A METOPROLOL d00134A C I10 Essential (primary) hypertension A0 E0 A PROPRANOLOL d00032A B[ I10 Essential (primary) hypertension A E0 A TRIAMCINOLONE TOPICAL d03206A Cr L20.9 Atopic dermatitis, unspecified A E@ A AMLODIPINE d00689A C I10 Essential (primary) hypertension A0 E@ A METOPROLOL d00134A C I10 Essential (primary) hypertension A0 E@ A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A0 EP A . . . E` A . . . Ep A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A0 Ep A METOPROLOL d00134A Dc I49.9 Cardiac arrhythmia, unspecified A0 Ep A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A0 E A . . . E A . . . E A . . . E A CITALOPRAM d04332A C F41.9 Anxiety disorder, unspecified A E A QUETIAPINE d04220A C F29 F32.9 G47.0 Unspecified psychosis not due to a substance or known physiological condition Major depressive disorder, single episode, unspecified Insomnia A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia Ap E A BACLOFEN d00967A C 99999 Ap E A CHLORTHALIDONE d00192A C I10 Essential (primary) hypertension Ap E A DONEPEZIL d04099A C[@ R41 Other symptoms and signs involving cognitive functions and awareness Ap E A GABAPENTIN d03182A Cr 99999 Ap E A LISINOPRIL d00732A C I10 Essential (primary) hypertension Ap E A PHENYTOIN d00143A D* G40 Epilepsy and recurrent seizures Ap E A . . . E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A E A ESTERIFIED ESTROGENS d00542A Cr N95 Menopausal and other perimenopausal disorders A E A FLUTICASONE NASAL d04283A C- J30.1 Allergic rhinitis due to pollen A E A MEDROXYPROGESTERONE d00284A Cr N95 Menopausal and other perimenopausal disorders A E A PROPRANOLOL d00032A D F41.9 Anxiety disorder, unspecified A E A QUETIAPINE d04220A D F29 Unspecified psychosis not due to a substance or known physiological condition A E A RISPERIDONE d03180A D F41.9 Anxiety disorder, unspecified A E A SERTRALINE d00880A D F32.9 Major depressive disorder, single episode, unspecified A E A . . . E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A@ E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A@ E A DIMETHYL FUMARATE d08079A Cr G99.8 Other specified disorders of nervous system in diseases classified elsewhere A@ E A FUROSEMIDE d00070A Cr R60.9 Edema, unspecified A@ E A NORTRIPTYLINE d00144A Cr R51 Headache A@ E A PROPRANOLOL d00032A CDp G43 Migraine A@ E0 A ATORVASTATIN d04105A B[ E78.0 Pure hypercholesterolemia A E@ A . . . EP A ALBUTEROL d00749A C- J45 Asthma A EP A ALENDRONATE d03849A C- M81.P Prevent bone loss/osteoporosis A EP A AZITHROMYCIN d00091A C- T86.9P Prevent transplanted organ and tissue rejection A EP A CLOTRIMAZOLE d01236A C- B35 B37 Dermatophytosis Candidiasis A EP A DULOXETINE d05355A B= F32.9 Major depressive disorder, single episode, unspecified A EP A FUROSEMIDE d00070A C- J98.9 Respiratory disorder, unspecified A EP A GABAPENTIN d03182A C- E11.4 M79.2 Type 2 diabetes mellitus with neurological complications Neuralgia and neuritis, unspecified A EP A GLIPIZIDE d00246A C- E11 Type 2 diabetes mellitus A EP A INSULIN LISPRO d04373A C- E11 Type 2 diabetes mellitus A EP A PANTOPRAZOLE d04514A C- K30 Functional dyspepsia A EP A PRAVASTATIN d00348A C- E78.1 Pure hyperglyceridemia A EP A PREDNISONE d00350A C- J44.9 Chronic obstructive pulmonary disease, unspecified A EP A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A C- A49.9P Prevent bacterial infection A EP A TACROLIMUS d03752A C- T86.9P Prevent transplanted organ and tissue rejection A E` A . . . Ep A . . . E A . . . E A . . . E A BENZTROPINE d00175A Dc T88.7P Prevent drug side effect Ap E A DIVALPROEX SODIUM d03833A Dc F31.9 Bipolar disorder, unspecified Ap E A INSULIN DETEMIR d05436A C E11 Type 2 diabetes mellitus Ap E A METFORMIN d03807A C- E11 Type 2 diabetes mellitus Ap E A PALIPERIDONE d06297A C[@ F32.9 Major depressive disorder, single episode, unspecified Ap E A QUETIAPINE d04220A CDp G47.9 Sleep disorder, unspecified Ap E A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia Ap E A . . . E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A E A CLOPIDOGREL d04258A Cr Z95 Presence of cardiac and vascular implants and grafts A E A INSULIN GLARGINE d04538A Cr R73 Elevated blood glucose level A E A ISOSORBIDE DINITRATE d00268A Cr R07.9 Chest pain, unspecified A E A METFORMIN d03807A Cr R73 Elevated blood glucose level A E A METOPROLOL d00134A Cr I50.9 Heart failure, unspecified A E A RANOLAZINE d05719A Cr I20.9 Angina pectoris, unspecified A E A TAMSULOSIN d04121A Cr R35 Polyuria A E A . . . E A . . . E A LISINOPRIL d00732A0 B E11.2 Type 2 diabetes mellitus with kidney complications A E A METFORMIN d03807A0 B E11 Type 2 diabetes mellitus A E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension Ap E A CLOPIDOGREL d04258A C I63.P Prevent stroke Ap E A DONEPEZIL d04099A C R41 Other symptoms and signs involving cognitive functions and awareness Ap E A FLUOXETINE d00236A CDp F41.9 Anxiety disorder, unspecified Ap E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified Ap E A LISINOPRIL d00732A C I10 Essential (primary) hypertension Ap E A SPIRONOLACTONE d00373A C- R60.9 Edema, unspecified Ap E A . . . E0 A ALENDRONATE d03849A C M81 Osteoporosis without current pathological fracture AP E0 A LOSARTAN d03821A C I10 Essential (primary) hypertension AP E0 A MYCOPHENOLIC ACID d05217A C- T86.9P Prevent transplanted organ and tissue rejection AP E0 A PREDNISONE d00350A C- T86.9P Prevent transplanted organ and tissue rejection AP E0 A TACROLIMUS d03752A C- T86.9P Prevent transplanted organ and tissue rejection AP E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A . . . E A . . . E A . . . E A CARVEDILOL d03847A C R07.9 Chest pain, unspecified A@ E A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A@ E A MELOXICAM d04532A C M25.5 Pain in joint A@ E A ROSUVASTATIN d04851A C- E78.0 Pure hypercholesterolemia A@ E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A LISINOPRIL d00732A D I10 Essential (primary) hypertension A E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A0 E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A0 E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A0 E A ARIPIPRAZOLE d04825A B= F31.9 F42 F90 Bipolar disorder, unspecified Obsessive-compulsive disorder Attention-deficit hyperactivity disorders A E A . . . E A . . . E0 A . . . E@ A . . . EP A ALLOPURINOL d00023A C M1A Chronic gout AP EP A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia AP EP A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A D I10 Essential (primary) hypertension AP EP A INSULIN ASPART d04697A C E11 Type 2 diabetes mellitus AP EP A INSULIN DETEMIR d05436A C E11 Type 2 diabetes mellitus AP E` A . . . Ep A . . . E A . . . E A . . . E A IBUPROFEN d00015A A` K08.8 Other specified disorders of teeth and supporting structures A E A . . . E A . . . E A . . . E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A C M54 Dorsalgia A E A AMLODIPINE d00689A B I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A CAPECITABINE d04311A B C80.1 Malignant (primary) neoplasm, unspecified A E A DULOXETINE d05355A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A HYDROCHLOROTHIAZIDE d00253A Dc I10 Essential (primary) hypertension A E A IBUPROFEN d00015A C M54 Dorsalgia A E A INSULIN ISOPHANE (NPH) d04370A Dc E11 Type 2 diabetes mellitus A E A INSULIN REGULAR d04369A Dc E11 Type 2 diabetes mellitus A E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A METOPROLOL d00134A B I10 Essential (primary) hypertension A E A ONDANSETRON d00867A B R11.P Prevent nausea or vomiting A E A PROCHLORPERAZINE d00355A B R11 Nausea and vomiting A E A TEMOZOLOMIDE d04451A B C80.1 Malignant (primary) neoplasm, unspecified A E A . . . E A . . . E0 A AMLODIPINE d00689A B[ I21.P Prevent heart attack/myocardial infarction A E0 A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A E0 A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C R60.9 Edema, unspecified A E0 A INSULIN DETEMIR d05436A C E11 Type 2 diabetes mellitus A E0 A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E0 A METOPROLOL d00134A B[ I21.P Prevent heart attack/myocardial infarction A E0 A RANITIDINE d00021A B K30 Functional dyspepsia A E0 A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A E@ A . . . EP A . . . E` A ALBUTEROL d00749A C- J45 Asthma A Ep A . . . E A FLUTICASONE NASAL d04283A CDp J30.9 Allergic rhinitis, unspecified A0 E A LOSARTAN d03821A C[@ 99999 A0 E A METOPROLOL d00134A C[@ 99999 A0 E A . . . E A . . . E A CETIRIZINE d03827A Bz T78.40 Allergy, unspecified A E A FORMOTEROL; MOMETASONE d07660A B R06.2 Wheezing A E A CLONAZEPAM d00197A A F41.9 Anxiety disorder, unspecified A0 E A CYCLOBENZAPRINE d00963A A0 M79.1 Myalgia A0 E A IBUPROFEN d00015A C M54 Dorsalgia A0 E A . . . E A . . . E A . . . E A AMLODIPINE d00689A C I25.9 Chronic ischemic heart disease, unspecified A` E A ATORVASTATIN d04105A D* E78.0 Pure hypercholesterolemia A` E A CHLORTHALIDONE d00192A Cr I10 Essential (primary) hypertension A` E A METFORMIN d03807A C R73 Elevated blood glucose level A` E A METOPROLOL d00134A Dc I10 Essential (primary) hypertension A` E A RAMIPRIL d00728A C I10 Essential (primary) hypertension A` E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A@ E A GLIMEPIRIDE d03864A B E11 Type 2 diabetes mellitus A@ E A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A@ E A METFORMIN d03807A B E11 Type 2 diabetes mellitus A@ E A . . . E A . . . E A ROSUVASTATIN d04851A B E78.0 Pure hypercholesterolemia A E A ALBUTEROL d00749A C J45 Asthma A E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A A R07.9 Chest pain, unspecified AP E A ATORVASTATIN d04105A A E78.0 Pure hypercholesterolemia AP E A CLOPIDOGREL d04258A A D75.9P Prevent blood clots AP E A METOPROLOL d00134A A I10 Essential (primary) hypertension AP E A TRAMADOL d03826A Ap R07.9 Chest pain, unspecified AP E A . . . E A ALLOPURINOL d00023A C M10.9P Prevent gout AP E A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia AP E A SOLIFENACIN d05413A C- R60.9 Edema, unspecified AP E A TAMSULOSIN d04121A C- R39.9 Unspecified symptoms and signs involving the genitourinary system AP E A . . . E0 A . . . E@ A . . . EP A METFORMIN d03807A CDp E11.P R73 Prevent diabetes Elevated blood glucose level A0 EP A RAMIPRIL d00728A CDp I10 Essential (primary) hypertension A0 EP A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A0 E` A GEMFIBROZIL d00245A C- E78.0 E78.1 Pure hypercholesterolemia Pure hyperglyceridemia A@ E` A GLIPIZIDE d00246A C- R73 Elevated blood glucose level A@ E` A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A@ E` A METFORMIN d03807A C- E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A@ Ep A . . . E A . . . E A . . . E A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension AP E A GABAPENTIN d03182A CDp R20 Disturbances of skin sensation AP E A HYDRALAZINE d00132A Cr I10 Essential (primary) hypertension AP E A LEVOTHYROXINE d00278A Cr K31.9 Disease of stomach and duodenum, unspecified AP E A MECLIZINE d00859A Cr R42 Dizziness and giddiness AP E A . . . E A FLUTICASONE; VILANTEROL d08100A B R06.9 Unspecified abnormalities of breathing A E A . . . E A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A@ E A HYDROCHLOROTHIAZIDE d00253A Cr R60.9 Edema, unspecified A@ E A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A@ E A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A@ E A BROMPHENIRAMINE; DEXTROMETHORPHAN; PSEUDOEPHEDRINE d03368A A0 T78.40 Allergy, unspecified A E A . . . E A FLUOXETINE d00236A B F41.9 Anxiety disorder, unspecified A E A . . . E0 A . . . E@ A ALBUTEROL d00749A D J45 Asthma A EP A . . . E` A . . . Ep A CYCLOSPORINE OPHTHALMIC d04836A C- H04 Disorders of lacrimal system A0 Ep A PROGESTERONE d00550A C- 55555 A0 Ep A THYROID DESICCATED d00655A C- E03.9 Hypothyroidism, unspecified A0 E A . . . E A . . . E A . . . E A DORZOLAMIDE; TIMOLOL OPHTHALMIC d04303A B H40 Glaucoma A E A EXEMESTANE d04461A C9 C50 Malignant neoplasm of breast A E A SODIUM CHLORIDE d00438A B J30.2 R05 Other seasonal allergic rhinitis Cough A E A . . . E A . . . E A . . . E A . . . E A ABACAVIR; LAMIVUDINE d05354A0 D B20 Human immunodeficiency virus [HIV] disease A@ E A AZITHROMYCIN d00091A0 D 99999 A@ E A DARUNAVIR d05825A0 D B20 Human immunodeficiency virus [HIV] disease A@ E A MONTELUKAST d04289A0 D 99999 A@ E A ACETAMINOPHEN; HYDROCODONE d03428A C R52 Pain, unspecified A E A ATORVASTATIN d04105A CDp I10 Essential (primary) hypertension A E A FLUTICASONE NASAL d04283A C J30.2 Other seasonal allergic rhinitis A E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A CDp 99999 A E A INSULIN DETEMIR d05436A C[@ E11 Type 2 diabetes mellitus A E A LIRAGLUTIDE d07466A C- E11 Type 2 diabetes mellitus A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A OMEPRAZOLE d00325A CDp R12 Heartburn A E0 A IBANDRONATE d05357A Cr M81 Osteoporosis without current pathological fracture A E0 A LOSARTAN d03821A C I10 Essential (primary) hypertension A E0 A MELOXICAM d04532A C F41.9 M54 M62.83 Anxiety disorder, unspecified Dorsalgia Muscle spasm A E0 A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease A E0 A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A E0 A PREDNISONE d00350A AP J42 Unspecified chronic bronchitis A E0 A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease A E0 A TRAZODONE d00395A C G47.0 Insomnia A E@ A ALENDRONATE d03849A C M81 Osteoporosis without current pathological fracture A E@ A CITALOPRAM d04332A C F32.9 Major depressive disorder, single episode, unspecified A E@ A FUROSEMIDE d00070A D I50.9 Heart failure, unspecified A E@ A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E@ A LISINOPRIL d00732A D I10 Essential (primary) hypertension A E@ A LOVASTATIN d00280A D E78.0 Pure hypercholesterolemia A E@ A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A E@ A POTASSIUM CHLORIDE d00345A CDp E87.6 Hypokalemia A EP A ANTIHYPERTENSIVE AGENTS - UNSPECIFIED h00024A C I10 Essential (primary) hypertension A0 EP A CARBAMAZEPINE d00058A D G40 Epilepsy and recurrent seizures A0 EP A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia A0 E` A LOSARTAN d03821A Bz I10 Essential (primary) hypertension A Ep A BUPROPION d00181A Dc F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A@ Ep A MIRTAZAPINE d04025A Dc G47.9 Sleep disorder, unspecified A@ Ep A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A@ Ep A RAMIPRIL d00728A D* I10 Essential (primary) hypertension A@ E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E A AZITHROMYCIN d00091A AP H66.9 R50.9 Otitis media, unspecified Fever, unspecified A E A . . . E A AMOXICILLIN d00088A A J02 Acute pharyngitis A E A . . . E A . . . E A . . . E A AMLODIPINE d00689A D I10 Essential (primary) hypertension A` E A CARVEDILOL d03847A DGJ I10 Essential (primary) hypertension A` E A CLONIDINE d00044A D# I10 Essential (primary) hypertension A` E A KETOCONAZOLE TOPICAL d03202A B L71 Rosacea A` E A LEVOTHYROXINE d00278A DGJ E03.9 Hypothyroidism, unspecified A` E A SIMVASTATIN d00746A DGJ E78.0 Pure hypercholesterolemia A` E A . . . E A . . . E A . . . E0 A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia AP E0 A CLOPIDOGREL d04258A B I51.9 Heart disease, unspecified AP E0 A EZETIMIBE d04824A B I51.9 Heart disease, unspecified AP E0 A LOSARTAN d03821A B I51.9 Heart disease, unspecified AP E0 A METOPROLOL d00134A B I51.9 Heart disease, unspecified AP E@ A CITALOPRAM d04332A C F41.9 Anxiety disorder, unspecified A E@ A LISINOPRIL d00732A C I10 Essential (primary) hypertension A EP A METFORMIN d03807A C"0 E11 Type 2 diabetes mellitus A E` A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A Ep A BUPROPION d00181A CDp F33.9 Major depressive disorder, recurrent, unspecified A Ep A ESCITALOPRAM d04812A C- F41.9 Anxiety disorder, unspecified A E A . . . E A . . . E A ALBUTEROL d00749A C[@ J45 Asthma AP E A ALPRAZOLAM d00168A D R45 Symptoms and signs involving emotional state AP E A FUROSEMIDE d00070A A@ R60.9 Edema, unspecified AP E A LEVOTHYROXINE d00278A D E04 Other nontoxic goiter AP E A PANTOPRAZOLE d04514A Bz K21 Gastro-esophageal reflux disease AP E A CYCLOBENZAPRINE d00963A B M79.1 Myalgia A E A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E A AMOXICILLIN; CLAVULANATE d00089A A@ H66.9 Otitis media, unspecified A E A ATENOLOL d00004A Ei 99999 AP E A ATORVASTATIN d04105A Ei E78.0 Pure hypercholesterolemia AP E A COLCHICINE d00150A B M19.9 Osteoarthritis, unspecified site AP E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Ei I10 Essential (primary) hypertension AP E A SITAGLIPTIN d05896A Ei E11 Type 2 diabetes mellitus AP E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A0 E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E A CARVEDILOL d03847A Cr I10 Essential (primary) hypertension A0 E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A B T14.9 Unspecified injury A@ E A AZITHROMYCIN d00091A A B99.9 Unspecified infectious disease A@ E A IBUPROFEN d00015A B G89 T14.9 Pain, not elsewhere classified Unspecified injury A@ E A METRONIDAZOLE TOPICAL d03208A A A49.9 Bacterial infection, unspecified A@ E A . . . E0 A CETIRIZINE d03827A C- T78.40 Allergy, unspecified A E@ A . . . EP A TRIAMCINOLONE TOPICAL d03206A0 Cr L20.9 Atopic dermatitis, unspecified A E` A FLUTICASONE; SALMETEROL d04611A B J45 Asthma A E` A LEVOCETIRIZINE d05851A B T78.40 Allergy, unspecified A Ep A LEVOTHYROXINE d00278A B E03.9 Hypothyroidism, unspecified A E A BENZONATATE d00796A A J40 Bronchitis, not specified as acute or chronic A E A LEVOTHYROXINE d00278A D ^ E03.9 Hypothyroidism, unspecified A E A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia A E A BUPROPION d00181A C- F32.9 Major depressive disorder, single episode, unspecified A E A CARBIDOPA; LEVODOPA d03473A C- G20 Parkinson's disease A E A ESCITALOPRAM d04812A C- F32.9 Major depressive disorder, single episode, unspecified A E A GLIMEPIRIDE d03864A Dc E11 Type 2 diabetes mellitus A E A LOSARTAN d03821A Dc I10 Essential (primary) hypertension A E A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus A E A METOPROLOL d00134A Dc I10 Essential (primary) hypertension A E A RASAGILINE d05612A C- G20 Parkinson's disease A E A ROTIGOTINE d05848A C- G20 Parkinson's disease A E A TOPIRAMATE d04115A C- R25.1 Tremor, unspecified A E A . . . E A . . . E A . . . E A CONJUGATED ESTROGENS TOPICAL d04396A C N39.0P Prevent urinary tract infection A E A LEVOTHYROXINE d00278A D# E03.9 Hypothyroidism, unspecified A E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ E A CARVEDILOL d03847A C I21.P Prevent heart attack/myocardial infarction A@ E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A@ E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E A . . . E A . . . E A ATENOLOL d00004A D* I10 Essential (primary) hypertension A E0 A ACETAMINOPHEN; HYDROCODONE d03428A C M54 Dorsalgia A@ E0 A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ E0 A DULOXETINE d05355A C[@ F32.9 Major depressive disorder, single episode, unspecified A@ E0 A LURASIDONE d07705A C[@ F32.9 Major depressive disorder, single episode, unspecified A@ E@ A . . . EP A AMOXICILLIN d00088A C- A49.9P Z96 Prevent bacterial infection Presence of other functional implants A EP A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A E` A LISINOPRIL d00732A C- I10 N28.9P Essential (primary) hypertension Prevent kidney disease A0 E` A OMEPRAZOLE d00325A C- K27 R12 Peptic ulcer, site unspecified Heartburn A0 E` A PREGABALIN d05508A C"0 55555 A0 Ep A . . . E A . . . E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A . . . E A GLIPIZIDE d00246A Cr E11 Type 2 diabetes mellitus A@ E A LISINOPRIL d00732A CDp E11.2 Type 2 diabetes mellitus with kidney complications A@ E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A@ E A . . . E A BENAZEPRIL d00730A C[@ I10 Essential (primary) hypertension A@ E A LEVOTHYROXINE d00278A C E66 Overweight and obesity A@ E A RANITIDINE d00021A C- K21 Gastro-esophageal reflux disease A@ E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A@ E A AMLODIPINE d00689A B I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia Ap E A DIGOXIN d00210A Cr I48.9 I49.9 Unspecified atrial fibrillation and atrial flutter Cardiac arrhythmia, unspecified Ap E A DILTIAZEM d00045A Cr I48.9 Unspecified atrial fibrillation and atrial flutter Ap E A FLUTICASONE NASAL d04283A C[@ R09.81 Nasal congestion Ap E A HYDROCODONE d03075A C[@ M25.5 Z96 Pain in joint Presence of other functional implants Ap E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension Ap E A WARFARIN d00022A CDp D75.9P Prevent blood clots Ap E A RIZATRIPTAN d04328A B G43 Migraine A E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A CLOPIDOGREL d04258A C I63.P Prevent stroke A E A DORZOLAMIDE OPHTHALMIC d03805A C- H40 Glaucoma A E A FENOFIBRATE d04286A C E78.0 Pure hypercholesterolemia A E A GLIPIZIDE d00246A C R73 Elevated blood glucose level A E A LATANOPROST OPHTHALMIC d04017A C- H40 Glaucoma A E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia A E A METFORMIN d03807A C R73 Elevated blood glucose level A E A METOPROLOL d00134A C I10 Essential (primary) hypertension A E A TIMOLOL OPHTHALMIC d04037A C- H40 Glaucoma A E A . . . E A . . . E A . . . E A VENLAFAXINE d03181A C F32.9 Major depressive disorder, single episode, unspecified A E A . . . E A . . . E A . . . E A . . . E A CYCLOBENZAPRINE d00963A CDp M54 Dorsalgia AP E A FLUOXETINE d00236A C F32.9 F42 Major depressive disorder, single episode, unspecified Obsessive-compulsive disorder AP E A GABAPENTIN d03182A CDp F39 Unspecified mood [affective] disorder AP E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified AP E A OXCARBAZEPINE d04513A CDp F39 Unspecified mood [affective] disorder AP E A . . . E0 A . . . E@ A . . . EP A ASPIRIN d00170A D I63.P Prevent stroke A@ EP A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A@ EP A DICLOFENAC d00848A B Z79 Long term (current) drug therapy A@ EP A SILDENAFIL d04299A C N52.9 Male erectile dysfunction, unspecified A@ E` A . . . Ep A . . . E A SUMATRIPTAN d03160A C- G43 Migraine A E A . . . E A DESOGESTREL; ETHINYL ESTRADIOL d03782A B Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A . . . E A ALENDRONATE d03849A Ei M81 Osteoporosis without current pathological fracture AP E A GABAPENTIN d03182A C- 99999 AP E A HYDROXYCHLOROQUINE d00817A C- M19.9 Osteoarthritis, unspecified site AP E A LEFLUNOMIDE d04349A C- 99999 AP E A METHOTREXATE d00060A Dc M06.9 Rheumatoid arthritis, unspecified AP E A 77777 . . A E A ALENDRONATE d03849A C M81 Osteoporosis without current pathological fracture A@ E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Cr I10 Essential (primary) hypertension A@ E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A@ E A . . . E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A Ep A . . . E A . . . E A . . . E A ESCITALOPRAM d04812A B[ F41.9 Anxiety disorder, unspecified A E A . . . E A . . . E A CANNABIS d03879A C F41.9 R52 Anxiety disorder, unspecified Pain, unspecified A0 E A EFAVIRENZ; EMTRICITABINE; TENOFOVIR d05847A Cr B20 Human immunodeficiency virus [HIV] disease A0 E A IBUPROFEN d00015A C M25.5 Pain in joint A0 E A . . . E A . . . E A . . . E A . . . E A ALENDRONATE d03849A CDp M19.9 Osteoarthritis, unspecified site A0 E A IBUPROFEN d00015A CDp M54 Dorsalgia A0 E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A0 E0 A . . . E@ A . . . EP A ATENOLOL d00004A D"8 I10 Essential (primary) hypertension A0 EP A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A B I10 Essential (primary) hypertension A0 EP A PRIMIDONE d00352A C R25.1 Tremor, unspecified A0 E` A CARVEDILOL d03847A C I10 Essential (primary) hypertension A E` A SIMVASTATIN d00746A C E78.0P Prevent high cholesterol A Ep A ETHINYL ESTRADIOL; NORETHINDRONE d03238A B Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A ATORVASTATIN d04105A C 99999 A@ E A BENZTROPINE d00175A C 99999 A@ E A BUDESONIDE; FORMOTEROL d04795A C J45 R05 Asthma Cough A@ E A OLANZAPINE d04050A C F20 Schizophrenia A@ E A ALLOPURINOL d00023A C- M10.9P Prevent gout A@ E A ATORVASTATIN d04105A B[ E78.0 Pure hypercholesterolemia A@ E A HYDROXYCHLOROQUINE d00817A C- M06.9 Rheumatoid arthritis, unspecified A@ E A PREDNISONE d00350A C- M06.9 Rheumatoid arthritis, unspecified A@ E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A MONTELUKAST d04289A C R06.2 Wheezing A E A . . . E A AMITRIPTYLINE d00146A D G47.0 Insomnia AP E A ATORVASTATIN d04105A D E78.0P Prevent high cholesterol AP E A DILTIAZEM d00045A D I10 Essential (primary) hypertension AP E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A D I50.9 Heart failure, unspecified AP E A METOPROLOL d00134A D I10 Essential (primary) hypertension AP E A AMOXICILLIN; CLAVULANATE d00089A A H66.9 Otitis media, unspecified A E A LISINOPRIL d00732A B= I10 Essential (primary) hypertension A E A DIAZEPAM d00148A B[ M62.83 Muscle spasm AP E A DICLOFENAC d00848A A0 T14.9 Unspecified injury AP E A FENTANYL d00233A B[ M54 Dorsalgia AP E A LISINOPRIL d00732A Bz I10 Essential (primary) hypertension AP E A METAXALONE d00964A B[ M54 Dorsalgia AP E A SILDENAFIL d04299A B N52.9 Male erectile dysfunction, unspecified A E A . . . E0 A TERAZOSIN d00386A Cr N40 Enlarged prostate A E0 A WARFARIN d00022A C- I21 ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction A E@ A ETHINYL ESTRADIOL; NORGESTIMATE d03781A B L70 Z79.3 Acne Long term (current) use of hormonal contraceptives A EP A . . . E` A . . . Ep A VENLAFAXINE d03181A D= F32.9 Major depressive disorder, single episode, unspecified A E A SIMVASTATIN d00746A B E78.0 Pure hypercholesterolemia A E A . . . E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C- Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A E A . . . E A ETONOGESTREL d04772A B[ Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A . . . E A LISINOPRIL d00732A B I10 I21.P Essential (primary) hypertension Prevent heart attack/myocardial infarction A E A . . . E0 A LOSARTAN d03821A C I10 Essential (primary) hypertension A E@ A 77777 . . A EP A . . . E` A AMLODIPINE d00689A C I10 Essential (primary) hypertension A` E` A DIAZEPAM d00148A C F41.9 Anxiety disorder, unspecified A` E` A PANTOPRAZOLE d04514A C K30 Functional dyspepsia A` E` A SUCRALFATE d00377A C R10 Abdominal and pelvic pain A` E` A TRAMADOL d03826A CDp M54 R10 Dorsalgia Abdominal and pelvic pain A` E` A TRIMETHOBENZAMIDE d00862A C R10 Abdominal and pelvic pain A` Ep A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A D Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A B E78.0P Prevent high cholesterol A0 E A LISINOPRIL d00732A B N28.9P Prevent kidney disease A0 E A METFORMIN d03807A B E11 Type 2 diabetes mellitus A0 E0 A . . . E@ A ALBUTEROL d00749A CDp R06.02 R06.2 R07.9 Shortness of breath Wheezing Chest pain, unspecified AP E@ A BUDESONIDE; FORMOTEROL d04795A CDp J43 R07.9 Emphysema Chest pain, unspecified AP E@ A IPRATROPIUM d00265A CDp R06.9 Unspecified abnormalities of breathing AP E@ A SOTALOL d00371A CDp I50.9 Heart failure, unspecified AP E@ A TAMSULOSIN d04121A CDp R39.9 Unspecified symptoms and signs involving the genitourinary system AP EP A . . . E` A ALBUTEROL d00749A C R06.02 Shortness of breath A Ep A . . . E A . . . E A . . . E A AMLODIPINE d00689A D I10 Essential (primary) hypertension AP E A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia AP E A BENAZEPRIL d00730A D I10 Essential (primary) hypertension AP E A GLIPIZIDE d00246A D E11 R73 Type 2 diabetes mellitus Elevated blood glucose level AP E A METFORMIN d03807A D% E11 R73 Type 2 diabetes mellitus Elevated blood glucose level AP E A . . . E A FLUTICASONE NASAL d04283A Cr R09.81 Nasal congestion A E A FLUTICASONE; SALMETEROL d04611A C J45 Asthma A E A . . . E A . . . E A . . . E A . . . E A . . . E A ATENOLOL d00004A Dc I10 Essential (primary) hypertension AP E A EZETIMIBE d04824A D E78.0 E78.1 Pure hypercholesterolemia Pure hyperglyceridemia AP E A LOSARTAN d03821A Dc I10 Essential (primary) hypertension AP E A PANTOPRAZOLE d04514A C[@ K30 Functional dyspepsia AP E A SIMVASTATIN d00746A D= E78.0 E78.1 Pure hypercholesterolemia Pure hyperglyceridemia AP E0 A ACETAMINOPHEN; HYDROCODONE d03428A C- M79.1 N94 Myalgia Pain and other conditions associated with female genital organs and menstrual cycle A E0 A ALBUTEROL d00749A C- J44.9 J45 Chronic obstructive pulmonary disease, unspecified Asthma A E0 A ALBUTEROL d00749A Cr J42 J45 Unspecified chronic bronchitis Asthma A E0 A CLONIDINE d00044A C I10 Essential (primary) hypertension A E0 A CYCLOBENZAPRINE d00963A Cr M62.83 M79.1 Muscle spasm Myalgia A E0 A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified A E0 A LIDOCAINE TOPICAL d00683A Ap M25.5 Pain in joint A E0 A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A E0 A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A E@ A . . . EP A . . . E` A APIXABAN d07804A Bz D75.9P Prevent blood clots A E` A ATORVASTATIN d04105A C E78.0P Prevent high cholesterol A Ep A . . . E A . . . E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A C P R52 Pain, unspecified A E A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A E A . . . E A LOVASTATIN d00280A C- E78.0 Pure hypercholesterolemia A E A ALBUTEROL d00749A D J45 Asthma B E A AMLODIPINE d00689A C I10 Essential (primary) hypertension B E A BRIMONIDINE OPHTHALMIC d04048A B[ 99999 B E A BRIMONIDINE OPHTHALMIC d04048A C H40 Glaucoma B E A DICYCLOMINE d00999A CDp R10 Abdominal and pelvic pain B E A DULOXETINE d05355A B[ F32.9 R52 Major depressive disorder, single episode, unspecified Pain, unspecified B E A FLUTICASONE d01296A D' R06.9 Unspecified abnormalities of breathing B E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension B E A LIDOCAINE TOPICAL d00683A D R52 Pain, unspecified B E A MELOXICAM d04532A B M25.9 Joint disorder, unspecified B E A METFORMIN d03807A C E11 Type 2 diabetes mellitus B E A NORTRIPTYLINE d00144A CDp M79.2 Neuralgia and neuritis, unspecified B E A PANTOPRAZOLE d04514A D K21 K30 Gastro-esophageal reflux disease Functional dyspepsia B E A POTASSIUM CHLORIDE d00345A C"0 E87.6 Hypokalemia B E A SALMETEROL d03759A D R06.9 Unspecified abnormalities of breathing B E A TIMOLOL OPHTHALMIC d04037A C H26.9 Unspecified cataract B E A . . . E A . . . E A MONTELUKAST d04289A Cr J30.9 Allergic rhinitis, unspecified A E A . . . E0 A OSELTAMIVIR d04462A A0 J09 Influenza due to certain identified influenza viruses A E@ A . . . EP A ETHINYL ESTRADIOL; NORETHINDRONE d03238A Bz Z79.3 Long term (current) use of hormonal contraceptives A E` A ATENOLOL d00004A D# I10 Essential (primary) hypertension A` E` A CLONIDINE d00044A B I10 Essential (primary) hypertension A` E` A FUROSEMIDE d00070A A R60.9 Edema, unspecified A` E` A LEVOTHYROXINE d00278A Cr E07.9 Disorder of thyroid, unspecified A` E` A POLYETHYLENE GLYCOL 3350 d05350A B K59.0 Constipation A` E` A VALSARTAN d04113A Dc I10 Essential (primary) hypertension A` Ep A FLUTICASONE d01296A CDp J45 Asthma A E A . . . E A ALBUTEROL d00749A CDp J45 R06.2 Asthma Wheezing A E A MONTELUKAST d04289A B J30.9 J45 R06.2 Allergic rhinitis, unspecified Asthma Wheezing A E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A AP K08.8 Other specified disorders of teeth and supporting structures A0 E A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A0 E A CLINDAMYCIN d00043A AP A49.9 Bacterial infection, unspecified A0 E A . . . E A . . . E A AMLODIPINE; BENAZEPRIL d03829A C I10 Essential (primary) hypertension A` E A ATORVASTATIN d04105A C 99999 A` E A HYDRALAZINE d00132A C I10 Essential (primary) hypertension A` E A HYDROCHLOROTHIAZIDE d00253A0 C R60.9 Edema, unspecified A` E A PHENOBARBITAL d00340A D G40 Epilepsy and recurrent seizures A` E A PIOGLITAZONE d04442A0 C E11 Type 2 diabetes mellitus A` E A . . . E A AMLODIPINE; BENAZEPRIL d03829A Cr I10 Essential (primary) hypertension A E A . . . E0 A ALBUTEROL d00749A C[@ J45 Asthma A E@ A AMITRIPTYLINE d00146A C M79.2 M79.7 R51 Neuralgia and neuritis, unspecified Fibromyalgia Headache A` E@ A DULOXETINE d05355A C M79.7 Fibromyalgia A` E@ A HYDROCHLOROTHIAZIDE d00253A CDp I10 Essential (primary) hypertension A` E@ A NAPROXEN d00019A C M54 M79.1 Dorsalgia Myalgia A` E@ A NIFEDIPINE d00051A C I10 Essential (primary) hypertension A` E@ A RANITIDINE d00021A Cr K21 Gastro-esophageal reflux disease A` EP A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A` EP A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` EP A METHOTREXATE d00060A C M06.9 Rheumatoid arthritis, unspecified A` EP A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia A` EP A PREDNISONE d00350A Dc M06.9 Rheumatoid arthritis, unspecified A` EP A PROPRANOLOL d00032A C I10 Essential (primary) hypertension A` E` A . . . Ep A LORAZEPAM d00149A CDp F41.9 Anxiety disorder, unspecified A E A . . . E A . . . E A . . . E A . . . E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E A TOPIRAMATE d04115A C G43 Migraine A E A CIPROFLOXACIN; HYDROCORTISONE OTIC d04288A AP H60 Otitis externa A E A FLUTICASONE NASAL d04283A C J30.9 Allergic rhinitis, unspecified A E A LEVOCETIRIZINE d05851A C T78.40 Allergy, unspecified A E A LISINOPRIL d00732A D I10 Essential (primary) hypertension A E A METFORMIN d03807A C R73 Elevated blood glucose level A E A MONTELUKAST d04289A Dc T78.40 Allergy, unspecified A E A NIFEDIPINE d00051A D I10 Essential (primary) hypertension A E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E A SPIRONOLACTONE d00373A B L70 Acne A E A . . . E A . . . E A METOPROLOL d00134A CDp I49.9 Cardiac arrhythmia, unspecified A0 E A OMEPRAZOLE d00325A B= K25 Gastric ulcer A0 E A ROSUVASTATIN d04851A Ap E78.0 Pure hypercholesterolemia A0 E A ALBUTEROL d00749A D J45 Asthma A E A CETIRIZINE d03827A C T78.40 Allergy, unspecified A E A . . . E 0 A . . . E @ A . . . E P A CLOPIDOGREL d04258A C[@ D75.9P I63 Prevent blood clots Cerebral infarction A E P A FUROSEMIDE d00070A CDp R60.9 Edema, unspecified A E P A GLIPIZIDE d00246A B R73 Elevated blood glucose level A E P A LEVOCETIRIZINE d05851A B[ T78.40 Allergy, unspecified A E P A LOSARTAN d03821A C I10 Essential (primary) hypertension A E P A METFORMIN d03807A D E11 Type 2 diabetes mellitus A E P A PANTOPRAZOLE d04514A B K21 R12 Gastro-esophageal reflux disease Heartburn A E P A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A E ` A . . . E p A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A INSULIN ASPART d04697A C E11 Type 2 diabetes mellitus A E A ATENOLOL d00004A C I10 Essential (primary) hypertension A@ E A CLONAZEPAM d00197A C F41.9 Anxiety disorder, unspecified A@ E A CLONIDINE d00044A B F41.9 Anxiety disorder, unspecified A@ E A MIRTAZAPINE d04025A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A@ E A . . . E A LOSARTAN d03821A C I10 Essential (primary) hypertension A E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A . . . E A . . . E A AMLODIPINE d00689A0 Dc I10 Essential (primary) hypertension A@ E A CARVEDILOL d03847A0 Dc R00 Abnormalities of heart beat A@ E A CLOBAZAM d04557A0 Dc R45 Symptoms and signs involving emotional state A@ E A IMIPRAMINE d00259A0 Dc F41.9 Anxiety disorder, unspecified A@ E A . . . E A . . . E A LOSARTAN d03821A C"0 I10 Essential (primary) hypertension A E A . . . E A ALPRAZOLAM d00168A Bz F41.9 Anxiety disorder, unspecified AP E A BUPROPION d00181A A@ E66 F41.9 Overweight and obesity Anxiety disorder, unspecified AP E A HYDROCHLOROTHIAZIDE d00253A Cr I10 Essential (primary) hypertension AP E A METOCLOPRAMIDE d00298A C- G43 Migraine AP E A TOPIRAMATE d04115A CDp E66 G43 Overweight and obesity Migraine AP E A . . . E A ATORVASTATIN d04105A0 C E78.0 Pure hypercholesterolemia A E A AZITHROMYCIN d00091A0 C T86.9P Prevent transplanted organ and tissue rejection A E A GLIPIZIDE d00246A0 C- E11 Type 2 diabetes mellitus A E A ITRACONAZOLE d00102A0 C B37 Candidiasis A E A METOCLOPRAMIDE d00298A0 C K21 Gastro-esophageal reflux disease A E A MYCOPHENOLATE MOFETIL d03839A0 C T86.9P Prevent transplanted organ and tissue rejection A E A OMEPRAZOLE d00325A0 C R12 Heartburn A E A PREDNISONE d00350A0 C T86.9P Prevent transplanted organ and tissue rejection A E A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A0 C T86.9P Prevent transplanted organ and tissue rejection A E A TACROLIMUS d03752A0 C T86.9P Prevent transplanted organ and tissue rejection A E0 A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A@ E0 A CLOPIDOGREL d04258A D 99999 A@ E0 A LEVOTHYROXINE d00278A B# E03.9 Hypothyroidism, unspecified A@ E0 A METOPROLOL d00134A B I10 Essential (primary) hypertension A@ E@ A . . . EP A ALBUTEROL d00749A Cr J44.9 Chronic obstructive pulmonary disease, unspecified AP EP A FORMOTEROL; MOMETASONE d07660A Cr J44.9 Chronic obstructive pulmonary disease, unspecified AP EP A ROFLUMILAST d07684A Cr J44.9 Chronic obstructive pulmonary disease, unspecified AP EP A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia AP EP A TIOTROPIUM d04829A Cr J44.9 Chronic obstructive pulmonary disease, unspecified AP E` A . . . Ep A . . . E A CARBIDOPA; LEVODOPA d03473A D G20 Parkinson's disease AP E A GABAPENTIN d03182A D M79.2 Neuralgia and neuritis, unspecified AP E A LEVOTHYROXINE d00278A D# E03.9 Hypothyroidism, unspecified AP E A METOPROLOL d00134A Cr 99999 AP E A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease AP E A . . . E A . . . E A AMLODIPINE d00689A D* I10 Essential (primary) hypertension A0 E A BICALUTAMIDE d03850A C C61 Malignant neoplasm of prostate A0 E A MIRABEGRON d07876A C- R32 Unspecified urinary incontinence A0 E A . . . E A . . . E A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A E A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A E A . . . E A . . . E A ALENDRONATE d03849A B M81.P Prevent bone loss/osteoporosis A E A BENAZEPRIL d00730A D I10 Essential (primary) hypertension A E A POTASSIUM CHLORIDE d00345A D E87.6 Hypokalemia A E0 A ANASTROZOLE d03873A C C50 Malignant neoplasm of breast A E@ A . . . EP A . . . E` A . . . Ep A ARIPIPRAZOLE d04825A B F39 Unspecified mood [affective] disorder A Ep A SERTRALINE d00880A C- F41.9 Anxiety disorder, unspecified A E A ACETAMINOPHEN; HYDROCODONE d03428A C M13 M79.1 Other arthritis Myalgia A E A DIVALPROEX SODIUM d03833A C F39 Unspecified mood [affective] disorder A E A DULOXETINE d05355A C F32.9 M79.1 Major depressive disorder, single episode, unspecified Myalgia A E A FUROSEMIDE d00070A C R60.9 Edema, unspecified A E A GABAPENTIN d03182A B M54 Dorsalgia A E A GABAPENTIN d03182A B= G30.9 Alzheimer's disease, unspecified A E A LIOTHYRONINE d00658A C- E03.9 Hypothyroidism, unspecified A E A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A E A POTASSIUM CHLORIDE d00345A Cr E87.6P Prevent hypokalemia A E A RIVAROXABAN d07356A CDp D75.9P Prevent blood clots A E A ROPINIROLE d04215A C[@ G25.81 Restless legs syndrome A E A TRAZODONE d00395A C G47.0 Insomnia A E A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A A H66.9 Otitis media, unspecified A E A . . . E A . . . E A . . . E A CETIRIZINE d03827A C T78.40 Allergy, unspecified A E A ESCITALOPRAM d04812A B I10 Essential (primary) hypertension A0 E A GABAPENTIN d03182A B M79.2 Neuralgia and neuritis, unspecified A0 E A PANTOPRAZOLE d04514A B 99999 A0 E A . . . E A ATENOLOL d00004A D 99999 AP E A CAPTOPRIL d00006A Dc 99999 AP E A FENOFIBRATE d04286A Dc E78.0 Pure hypercholesterolemia AP E A HYDROCHLOROTHIAZIDE d00253A Dc 99999 AP E A METFORMIN d03807A Dc R73 Elevated blood glucose level AP E A GLIPIZIDE d00246A C R73 Elevated blood glucose level Ap E A INSULIN GLARGINE d04538A B E11 Type 2 diabetes mellitus Ap E A METFORMIN; SITAGLIPTIN d06720A C"0 R73 Elevated blood glucose level Ap E A METOPROLOL d00134A CDp I10 Essential (primary) hypertension Ap E A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia Ap E A SPIRONOLACTONE d00373A B N28.9P Prevent kidney disease Ap E A VALSARTAN d04113A C- I10 Essential (primary) hypertension Ap E A . . . E0 A CLOPIDOGREL d04258A C D75.9P Prevent blood clots A E0 A DAPAGLIFLOZIN d07928A A E11 Type 2 diabetes mellitus A E0 A DULOXETINE d05355A C E11.4 Type 2 diabetes mellitus with neurological complications A E0 A ESTRADIOL d00537A D9 Z79.890 Hormone replacement therapy A E0 A GABAPENTIN d03182A CDp B02 Zoster [herpes zoster] A E0 A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A CDp R60.9 Edema, unspecified A E0 A LEVOTHYROXINE d00278A B E03.9 Hypothyroidism, unspecified A E0 A LOSARTAN d03821A C- I10 Essential (primary) hypertension A E@ A ACETAMINOPHEN; OXYCODONE d03431A CDp R52 Pain, unspecified AP E@ A ALPRAZOLAM d00168A C- F32.9 Major depressive disorder, single episode, unspecified AP E@ A ATENOLOL d00004A D I10 Essential (primary) hypertension AP E@ A FUROSEMIDE d00070A C"0 I51.9 R60.9 Heart disease, unspecified Edema, unspecified AP E@ A PREDNISONE d00350A B J44.9 Chronic obstructive pulmonary disease, unspecified AP EP A . . . E` A . . . Ep A . . . E A . . . E A . . . E A . . . E A DICYCLOMINE d00999A C M62.83 Muscle spasm AP E A INSULIN ASPART; INSULIN ASPART PROTAMINE d04839A C E11 Type 2 diabetes mellitus AP E A INSULIN GLARGINE d04538A CDp E11 Type 2 diabetes mellitus AP E A LISINOPRIL d00732A C[@ E11.2 Type 2 diabetes mellitus with kidney complications AP E A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia AP E A . . . E A . . . E A . . . E A . . . E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C N94 Pain and other conditions associated with female genital organs and menstrual cycle A E A ZOLPIDEM d00910A C G47.9 Sleep disorder, unspecified A E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A E A ALBUTEROL d00749A D J45 Asthma A@ E A ALBUTEROL d00749A Dc J45 Asthma A@ E A CETIRIZINE d03827A C J45 T78.40 Asthma Allergy, unspecified A@ E A FLUTICASONE; SALMETEROL d04611A C J45 Asthma A@ E0 A . . . E@ A AZITHROMYCIN d00091A A J01.9 Acute sinusitis, unspecified A EP A ALBUTEROL d00749A CDp J45.P R06.2 Prevent asthma Wheezing A EP A FLUTICASONE NASAL d04283A B= J30.9 R09.8 R09.81 Allergic rhinitis, unspecified Other specified symptoms and signs involving the circulatory and respiratory systems Nasal congestion A E` A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E` A BUSPIRONE d00182A B F41.9 Anxiety disorder, unspecified A E` A DEXLANSOPRAZOLE d07395A Cr K21 K30 Gastro-esophageal reflux disease Functional dyspepsia A E` A EZETIMIBE d04824A B[ E78.0 Pure hypercholesterolemia A E` A GABAPENTIN d03182A Cr M79.2 Neuralgia and neuritis, unspecified A E` A ISOSORBIDE MONONITRATE d00269A Cr I20.9 I21.P Angina pectoris, unspecified Prevent heart attack/myocardial infarction A E` A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A E` A METOCLOPRAMIDE d00298A C K21 Gastro-esophageal reflux disease A E` A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A E` A SITAGLIPTIN d05896A C- E11 Type 2 diabetes mellitus A E` A VALSARTAN d04113A CDp I50.9 Heart failure, unspecified A E` A ZOLPIDEM d00910A C[@ G47.0 Insomnia A E` A ZONISAMIDE d04527A Cr M79.2 Neuralgia and neuritis, unspecified A Ep A CYANOCOBALAMIN d00413A Dc D64.9 E63.9 Anemia, unspecified Nutritional deficiency, unspecified A E A . . . E A AMLODIPINE d00689A D* I10 Essential (primary) hypertension A` E A FLUTICASONE NASAL d04283A Dc R09.81 Nasal congestion A` E A HYDROCHLOROTHIAZIDE d00253A D* I10 Essential (primary) hypertension A` E A LISINOPRIL d00732A D* I10 Essential (primary) hypertension A` E A OMEPRAZOLE d00325A C R12 Heartburn A` E A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A` E A . . . E A . . . E A . . . E A ERYTHROMYCIN TOPICAL d03200A B L70 Acne A E A . . . E A MOMETASONE NASAL d04223A CDp J30.9 Allergic rhinitis, unspecified A E A FLUTICASONE NASAL d04283A B J30.2 Other seasonal allergic rhinitis A E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A CLOBAZAM d04557A CDp G40 Epilepsy and recurrent seizures A` E` A ETHOSUXIMIDE d00227A C[@ G40 Epilepsy and recurrent seizures A` E` A HYDROCODONE d03075A Ap T14.9 Unspecified injury A` E` A LEUCOVORIN d00275A C- G40 Epilepsy and recurrent seizures A` E` A LEVETIRACETAM d04499A Cr G40 Epilepsy and recurrent seizures A` E` A LORAZEPAM d00149A C G40 Epilepsy and recurrent seizures A` Ep A . . . E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C[@ Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A . . . E A . . . E A HYDROCHLOROTHIAZIDE d00253A D= I10 Essential (primary) hypertension A@ E A LEVOTHYROXINE d00278A D# E05 Thyrotoxicosis [hyperthyroidism] A@ E A METFORMIN; SITAGLIPTIN d06720A C E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A@ E A RAMIPRIL d00728A D& I10 Essential (primary) hypertension A@ E A ALLOPURINOL d00023A C E79.9 Disorder of purine and pyrimidine metabolism, unspecified A E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A E A CARVEDILOL d03847A C I10 Essential (primary) hypertension A E A CETIRIZINE d03827A C T78.40 Allergy, unspecified A E A CLOPIDOGREL d04258A C I63.P Prevent stroke A E A FUROSEMIDE d00070A C R60.9 Edema, unspecified A E A GABAPENTIN d03182A C- M79.2 Neuralgia and neuritis, unspecified A E A INSULIN ASPART d04697A C- E11 Type 2 diabetes mellitus A E A INSULIN GLARGINE d04538A C- E11 Type 2 diabetes mellitus A E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A E A ESTRADIOL d00537A D Z79.890 Hormone replacement therapy A0 E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A0 E A VALSARTAN d04113A D R60.9 Edema, unspecified A0 E A . . . E A . . . E A ATENOLOL d00004A D I10 Essential (primary) hypertension A E A FLUTICASONE; SALMETEROL d04611A CDp J45 Asthma A E A MONTELUKAST d04289A CDp J45 Asthma A E0 A ALBUTEROL d00749A D T78.40 Allergy, unspecified A E@ A . . . EP A AMLODIPINE d00689A C I10 Essential (primary) hypertension A EP A VALSARTAN d04113A C I10 Essential (primary) hypertension A E` A ALBUTEROL d00749A C- J45 Asthma Ap E` A BUPROPION d00181A C[@ F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Ap E` A CLONAZEPAM d00197A C F41.9 Anxiety disorder, unspecified Ap E` A FLUOXETINE d00236A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Ap E` A FLUTICASONE d01296A CDp R06.9 Unspecified abnormalities of breathing Ap E` A FLUTICASONE; SALMETEROL d04611A CDp J44.9 Chronic obstructive pulmonary disease, unspecified Ap E` A TIOTROPIUM d04829A CDp J44.9 Chronic obstructive pulmonary disease, unspecified Ap Ep A AMLODIPINE d00689A Cr I51.9 Heart disease, unspecified AP Ep A ATENOLOL d00004A Dc I51.9 Heart disease, unspecified AP Ep A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia AP Ep A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified AP Ep A OXYBUTYNIN d00328A D N39.4 Other specified urinary incontinence AP E A AMIODARONE d00002A A I48.9 Unspecified atrial fibrillation and atrial flutter A` E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A` E A APIXABAN d07804A C I48.9 Unspecified atrial fibrillation and atrial flutter A` E A CITALOPRAM d04332A C[@ F32.9 Major depressive disorder, single episode, unspecified A` E A FUROSEMIDE d00070A C R60.9 Edema, unspecified A` E A METOPROLOL d00134A C I10 Essential (primary) hypertension A` E A . . . E A . . . E A . . . E A ALBUTEROL d00749A C J45 Asthma AP E A BUPROPION d00181A C"0 F41.9 Anxiety disorder, unspecified AP E A CYCLOBENZAPRINE d00963A C"0 M79.1 Myalgia AP E A GABAPENTIN d03182A C- M79.2 Neuralgia and neuritis, unspecified AP E A METOPROLOL d00134A C R00 Abnormalities of heart beat AP E A APIXABAN d07804A0 B D75.9P Prevent blood clots A E A ESCITALOPRAM d04812A0 B F32.9 Major depressive disorder, single episode, unspecified A E A GABAPENTIN d03182A0 B M79.2 Neuralgia and neuritis, unspecified A E A LEVOTHYROXINE d00278A0 B E03.9 Hypothyroidism, unspecified A E A MIRABEGRON d07876A0 B= N32.81 Overactive bladder A E A PRAMIPEXOLE d04145A0 B= G25.81 Restless legs syndrome A E A TRAMADOL d03826A0 B M79.2 Neuralgia and neuritis, unspecified A E A TRIMETHOPRIM d00123A0 B= N39.0 Urinary tract infection, site not specified A E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A GLYBURIDE d00248A C- E11 Type 2 diabetes mellitus A E A . . . E A ALLOPURINOL d00023A D* M10.9P Prevent gout A` E A LISINOPRIL d00732A D)Y I10 Essential (primary) hypertension A` E A MELOXICAM d04532A C M13 Other arthritis A` E A SERTRALINE d00880A C F41.9 Anxiety disorder, unspecified A` E A SILDENAFIL d04299A D N52.9 Male erectile dysfunction, unspecified A` E A ZOLPIDEM d00910A C- G47.9 Sleep disorder, unspecified A` E A . . . E0 A IBUPROFEN d00015A C N94 Pain and other conditions associated with female genital organs and menstrual cycle A E@ A . . . EP A . . . E` A ALBUTEROL d00749A C- J45 Asthma A E` A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A E` A BENZONATATE d00796A B R05 Cough A E` A ETANERCEPT d04365A CDp M06.9 Rheumatoid arthritis, unspecified A E` A FLUOXETINE d00236A C F41.9 Anxiety disorder, unspecified A E` A HYDROXYCHLOROQUINE d00817A C M06.9 Rheumatoid arthritis, unspecified A E` A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A E` A PREDNISONE d00350A CDp M06.9 Rheumatoid arthritis, unspecified A Ep A . . . E A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A B Z79.3 Long term (current) use of hormonal contraceptives A E A ARIPIPRAZOLE d04825A C- F20 F32.9 Schizophrenia Major depressive disorder, single episode, unspecified Ap E A BUDESONIDE; FORMOTEROL d04795A C[@ J44.9 J45 Chronic obstructive pulmonary disease, unspecified Asthma Ap E A FLUOXETINE d00236A C F32.9 Major depressive disorder, single episode, unspecified Ap E A IBUPROFEN d00015A CDp M19.9 Osteoarthritis, unspecified site Ap E A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension Ap E A LORAZEPAM d00149A B F41.9 Anxiety disorder, unspecified Ap E A QUETIAPINE d04220A C F20 Schizophrenia Ap E A . . . E A . . . E A FAMOTIDINE; IBUPROFEN d07764A A M54 Dorsalgia A@ E A HYDROCODONE d03075A C M54 Dorsalgia A@ E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A@ E A OMEPRAZOLE d00325A C K25.P Prevent gastric ulcer A@ E A . . . E A GUANFACINE d00717A C F90 Attention-deficit hyperactivity disorders A E A METHYLPHENIDATE d00900A Cr F90 Attention-deficit hyperactivity disorders A E A . . . E A ACETAMINOPHEN; CODEINE d03423A A K08.8 Other specified disorders of teeth and supporting structures A E A AZITHROMYCIN d00091A A K04.7P Prevent tooth infection A E A . . . E A . . . E 0 A . . . E @ A HYDROXYZINE d00907A C F41.9 L23 Anxiety disorder, unspecified Allergic contact dermatitis A E @ A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A E P A . . . E ` A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A0 E ` A NABUMETONE d00310A C R52 Pain, unspecified A0 E ` A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A0 E p A . . . E A . . . E A ATENOLOL d00004A D* I10 Essential (primary) hypertension A@ E A HYDROCHLOROTHIAZIDE d00253A D I10 Essential (primary) hypertension A@ E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A@ E A SIMVASTATIN d00746A D* E78.0 Pure hypercholesterolemia A@ E A . . . E A . . . E A NAPROXEN d00019A C R51 Headache A E A HYDRALAZINE d00132A D I10 Essential (primary) hypertension A` E A ISOSORBIDE MONONITRATE d00269A D I20.9 Angina pectoris, unspecified A` E A PREDNISONE d00350A C N18.9 Chronic kidney disease, unspecified A` E A ROSUVASTATIN d04851A D E78.0 Pure hypercholesterolemia A` E A SEVELAMER d04363A D N19 Unspecified kidney failure A` E A TACROLIMUS d03752A D N19 Unspecified kidney failure A` E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A0 E A HYDROCHLOROTHIAZIDE d00253A Dc I10 Essential (primary) hypertension A0 E A TERAZOSIN d00386A Dc I10 N40 Essential (primary) hypertension Enlarged prostate A0 E A GABAPENTIN d03182A C M25.5 Pain in joint A E A . . . E A . . . E A . . . E 0 A . . . E @ A FEXOFENADINE d04040A C J30.1 J30.9 T78.40 Allergic rhinitis due to pollen Allergic rhinitis, unspecified Allergy, unspecified A E P A . . . E ` A . . . E p A DILTIAZEM d00045A B I10 Essential (primary) hypertension A0 E p A HYDROCHLOROTHIAZIDE d00253A C- R60.9 Edema, unspecified A0 E p A OMEPRAZOLE d00325A C- R12 Heartburn A0 E A . . . E A HYDROCHLOROTHIAZIDE d00253A B[ I10 Essential (primary) hypertension A E A METOPROLOL d00134A Bz I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A . . . E A . . . E A AMLODIPINE d00689A D/ I10 Essential (primary) hypertension A` E A CLOPIDOGREL d04258A CDp I63.P Z79.0 Prevent stroke Long term (current) use of anticoagulants and antithrombotics/antiplatelets A` E A HYDROCHLOROTHIAZIDE d00253A D/ I10 R60.9 Essential (primary) hypertension Edema, unspecified A` E A LOSARTAN d03821A D/ I10 Essential (primary) hypertension A` E A METFORMIN d03807A D E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A` E A PANTOPRAZOLE d04514A D K30 Functional dyspepsia A` E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A . . . E 0 A . . . E @ A . . . E P A . . . E ` A OXYBUTYNIN d00328A Cr N32.81 Overactive bladder A E p A . . . E A . . . E A GLYBURIDE d00248A Cr E11 Type 2 diabetes mellitus A@ E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Cr I10 Essential (primary) hypertension A@ E A IBUPROFEN d00015A C[@ N94 Pain and other conditions associated with female genital organs and menstrual cycle A@ E A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A@ E A CLOBAZAM d04557A C G40 Epilepsy and recurrent seizures A0 E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A0 E A TOPIRAMATE d04115A Cr G40 Epilepsy and recurrent seizures A0 E A ALBUTEROL d00749A D J44.9 J45 R06.02 Chronic obstructive pulmonary disease, unspecified Asthma Shortness of breath A@ E A FORMOTEROL; MOMETASONE d07660A C- J44.9 J45 Chronic obstructive pulmonary disease, unspecified Asthma A@ E A MONTELUKAST d04289A C J44.9 J45 Chronic obstructive pulmonary disease, unspecified Asthma A@ E A TIOTROPIUM d04829A C J44.9 J45 Chronic obstructive pulmonary disease, unspecified Asthma A@ E A AMOXICILLIN; CLAVULANATE d00089A A A49.9 Bacterial infection, unspecified A E A MUPIROCIN TOPICAL d01267A A R21 Rash and other nonspecific skin eruption A E A . . . E A . . . E A . . . E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A B M79.7 Fibromyalgia A@ E A GABAPENTIN d03182A C E11.4 Type 2 diabetes mellitus with neurological complications A@ E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A@ E A TIZANIDINE d04102A C- M79.7 Fibromyalgia A@ E 0 A . . . E @ A . . . E P A CARVEDILOL d03847A Cr I49.9 Cardiac arrhythmia, unspecified A@ E P A INSULIN LISPRO d04373A D E11 Type 2 diabetes mellitus A@ E P A PANTOPRAZOLE d04514A Cr K21 Gastro-esophageal reflux disease A@ E P A ROSUVASTATIN d04851A Cr E78.0 Pure hypercholesterolemia A@ E ` A AMLODIPINE d00689A C I10 Essential (primary) hypertension A` E ` A METFORMIN d03807A CDp R73 Elevated blood glucose level A` E ` A METOPROLOL d00134A C I10 Essential (primary) hypertension A` E ` A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A` E ` A ROSUVASTATIN d04851A Cr E78.0 Pure hypercholesterolemia A` E ` A SERTRALINE d00880A C- F41.9 Anxiety disorder, unspecified A` E p A . . . E A . . . E A . . . E A ANASTROZOLE d03873A C- C50 Malignant neoplasm of breast A E A ESOMEPRAZOLE d04749A D* K21 Gastro-esophageal reflux disease A E A . . . E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A . . . E A ALBUTEROL d00749A Cr J45 Asthma A` E A CIPROFLOXACIN; DEXAMETHASONE OTIC d04890A A H60 Otitis externa A` E A FLUTICASONE d01296A CDp J45 Asthma A` E A FLUTICASONE NASAL d04283A CDp R09.81 Nasal congestion A` E A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A` E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` E A . . . E A . . . E 0 A . . . E @ A . . . E P A ALLOPURINOL d00023A CDp M1A Chronic gout A E P A AMLODIPINE d00689A A I10 Essential (primary) hypertension A E P A FUROSEMIDE d00070A D9 R60.9 Edema, unspecified A E P A HYDROXYCHLOROQUINE d00817A C"0 M06.9 Rheumatoid arthritis, unspecified A E P A LEVOTHYROXINE d00278A C"0 E03.9 Hypothyroidism, unspecified A E P A METHOCARBAMOL d00965A B M62.83 Muscle spasm A E P A PANTOPRAZOLE d04514A CDp K22 Other diseases of esophagus A E P A RANITIDINE d00021A B K25 Gastric ulcer A E ` A . . . E p A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E A . . . E A OMEPRAZOLE d00325A B K21 Gastro-esophageal reflux disease A E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A A K08.8 Other specified disorders of teeth and supporting structures A E A AMOXICILLIN d00088A A K04.7 Periapical abscess without sinus A E A AMLODIPINE d00689A B[ I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A . . . E A CYCLOBENZAPRINE d00963A D0z T14.9 Unspecified injury A0 E A ESZOPICLONE d05421A C G47.0 Insomnia A0 E A LORAZEPAM d00149A C F41.9 Anxiety disorder, unspecified A0 E A 99999 . . AP E A ESCITALOPRAM d04812A C F32.9 Major depressive disorder, single episode, unspecified AP E A FINASTERIDE d00563A C N40 Enlarged prostate AP E A INSULIN DEGLUDEC d08054A C E11 Type 2 diabetes mellitus AP E A LOSARTAN d03821A CDp I10 Essential (primary) hypertension AP E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A AMLODIPINE d00689A D I10 I21.P Essential (primary) hypertension Prevent heart attack/myocardial infarction A Ep A FAMOTIDINE d00141A D I21.P Prevent heart attack/myocardial infarction A Ep A HYDROCHLOROTHIAZIDE d00253A D R60.9 Edema, unspecified A Ep A LOSARTAN d03821A D I21.P Prevent heart attack/myocardial infarction A Ep A POTASSIUM CHLORIDE d00345A D I51.9 Heart disease, unspecified A Ep A PRAVASTATIN d00348A D E78.0 Pure hypercholesterolemia A Ep A SOTALOL d00371A D I49.9 Cardiac arrhythmia, unspecified A Ep A WARFARIN d00022A B D75.9P Prevent blood clots A E A CELECOXIB d04380A Cr M13 Other arthritis A0 E A METOPROLOL d00134A D I10 Essential (primary) hypertension A0 E A PANTOPRAZOLE d04514A B[ K30 R12 Functional dyspepsia Heartburn A0 E A . . . E A ALBUTEROL d00749A CDp J45 Asthma A@ E A ALBUTEROL d00749A C[@ J45 Asthma A@ E A BUDESONIDE; FORMOTEROL d04795A C[@ J45 Asthma A@ E A TIOTROPIUM d04829A C J44.9 Chronic obstructive pulmonary disease, unspecified A@ E A . . . E A . . . E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A E A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A@ E A CHLORTHALIDONE d00192A Cr I10 Essential (primary) hypertension A@ E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A@ E A METFORMIN d03807A C E11.P Prevent diabetes A@ E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A EP A . . . E` A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A E` A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A D I10 Essential (primary) hypertension A Ep A . . . E A POLYMYXIN B; TRIMETHOPRIM OPHTHALMIC d03529A A0 H10 Conjunctivitis A E A . . . E A CYCLOBENZAPRINE d00963A A T14.9 Unspecified injury A0 E A INSULIN GLARGINE d04538A B E11 Type 2 diabetes mellitus A0 E A LOVASTATIN d00280A C- E78.0 Pure hypercholesterolemia A0 E A . . . E A . . . E A CARVEDILOL d03847A D I10 Z79.0 Essential (primary) hypertension Long term (current) use of anticoagulants and antithrombotics/antiplatelets A@ E A LISINOPRIL d00732A D I10 Z79.0 Essential (primary) hypertension Long term (current) use of anticoagulants and antithrombotics/antiplatelets A@ E A PRAVASTATIN d00348A D D75.9P E78.0 Prevent blood clots Pure hypercholesterolemia A@ E A TRAMADOL d03826A D M25.5 Pain in joint A@ E A . . . E A . . . E A . . . E A 99999 . . A E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A LOSARTAN d03821A C I10 Essential (primary) hypertension A E0 A . . . E@ A TAMOXIFEN d00381A C C50.P prevent breast cancer A EP A CLONIDINE d00044A C N95 Menopausal and other perimenopausal disorders A@ EP A IBUPROFEN d00015A C- M54 Dorsalgia A@ EP A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease A@ EP A OXYCODONE d00329A C M54 Dorsalgia A@ E` A . . . Ep A . . . E A AMLODIPINE d00689A Cr 99999 A` E A ATORVASTATIN d04105A Cr 99999 A` E A BRINZOLAMIDE OPHTHALMIC d04301A Cr H40 Glaucoma A` E A LISINOPRIL d00732A C 99999 A` E A METOPROLOL d00134A Cr 99999 A` E A TIMOLOL OPHTHALMIC d04037A Cr H40 Glaucoma A` E A . . . E A AMOXICILLIN; CLAVULANATE d00089A A J01.9 Acute sinusitis, unspecified A E A FLUOXETINE d00236A C F32.9 Major depressive disorder, single episode, unspecified A E A . . . E A . . . E A BRIMONIDINE; TIMOLOL OPHTHALMIC d05283A C H40 Glaucoma AP E A BUSPIRONE d00182A Cr F41.9 Anxiety disorder, unspecified AP E A LATANOPROST OPHTHALMIC d04017A C H40 Glaucoma AP E A LOSARTAN d03821A C[@ I10 Essential (primary) hypertension AP E A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension AP E A . . . E A ATOMOXETINE d04827A B= F90 Attention-deficit hyperactivity disorders A E A DIVALPROEX SODIUM d03833A C[@ G40 Epilepsy and recurrent seizures A E A . . . E A . . . E0 A . . . E@ A . . . EP A INDOMETHACIN d00039A Ap R60.9 Edema, unspecified A0 EP A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A0 EP A METFORMIN d03807A CP E11.P Prevent diabetes A0 E` A . . . Ep A AMOXICILLIN d00088A A0 J02 Acute pharyngitis A E A . . . E A ACETAMINOPHEN; OXYCODONE d03431A B L93 R52 Lupus erythematosus Pain, unspecified B E A CLONAZEPAM d00197A D F32.9 Major depressive disorder, single episode, unspecified B E A ESCITALOPRAM d04812A C F32.9 Major depressive disorder, single episode, unspecified B E A ESOMEPRAZOLE d04749A D K21 K22 Gastro-esophageal reflux disease Other diseases of esophagus B E A FLUTICASONE; VILANTEROL d08100A C- J44.9 Chronic obstructive pulmonary disease, unspecified B E A GABAPENTIN d03182A D M79.2 M79.7 Neuralgia and neuritis, unspecified Fibromyalgia B E A HYDROXYCHLOROQUINE d00817A D L93 Lupus erythematosus B E A LEVOFLOXACIN d04109A C J18.9 J40 Pneumonia, unspecified organism Bronchitis, not specified as acute or chronic B E A LUBIPROSTONE d05736A Cr K58 Irritable bowel syndrome B E A METHYLPHENIDATE d00900A Dc F90 Attention-deficit hyperactivity disorders B E A METOPROLOL d00134A C- R00 Abnormalities of heart beat B E A MISOPROSTOL d00303A C K58 Irritable bowel syndrome B E A MONTELUKAST d04289A D R06.9 Unspecified abnormalities of breathing B E A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia B E A PREDNISONE d00350A C- J44.9 Chronic obstructive pulmonary disease, unspecified B E A RIZATRIPTAN d04328A D G43 Migraine B E A TAMOXIFEN d00381A C C50 Malignant neoplasm of breast B E A TOPIRAMATE d04115A Dc M79.2 Neuralgia and neuritis, unspecified B E A VALACYCLOVIR d03838A D B02 Zoster [herpes zoster] B E A VERAPAMIL d00048A C I63 Cerebral infarction B E A ACETAMINOPHEN; HYDROCODONE d03428A D* R52 Pain, unspecified AP E A CLOPIDOGREL d04258A D Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets AP E A GLIMEPIRIDE d03864A B E11 Type 2 diabetes mellitus AP E A METFORMIN d03807A D- E11 Type 2 diabetes mellitus AP E A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia AP E A CETIRIZINE d03827A A J45 Asthma A E A FLUTICASONE d01296A CP J45 Asthma A E A METHYLPHENIDATE d00900A C- F90 Attention-deficit hyperactivity disorders A E A BUSPIRONE d00182A B F41.9 Anxiety disorder, unspecified A@ E A ESOMEPRAZOLE d04749A A K30 Functional dyspepsia A@ E A FLUOXETINE d00236A B F32.9 Major depressive disorder, single episode, unspecified A@ E A PROPRANOLOL d00032A B F41.9 Anxiety disorder, unspecified A@ E A . . . E A . . . E A ALLOPURINOL d00023A C[@ M10.9P Prevent gout A0 E A AMLODIPINE d00689A Dc I10 Essential (primary) hypertension A0 E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A0 E A LEVOTHYROXINE d00278A CP E03.9 Hypothyroidism, unspecified A E A . . . E0 A DULOXETINE d05355A A F32.9 Major depressive disorder, single episode, unspecified A0 E0 A IBUPROFEN d00015A C G99.8 Other specified disorders of nervous system in diseases classified elsewhere A0 E0 A TERBINAFINE d04012A A B35 Dermatophytosis A0 E@ A . . . EP A ATENOLOL d00004A CDp E11 Type 2 diabetes mellitus A` EP A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A` EP A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A` EP A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` EP A RAMIPRIL d00728A Cr I10 Essential (primary) hypertension A` EP A RANITIDINE d00021A Bz K31.9 R14 Disease of stomach and duodenum, unspecified Flatulence and related conditions A` E` A . . . Ep A ATENOLOL d00004A CDp I21.P Prevent heart attack/myocardial infarction AP Ep A GLIPIZIDE d00246A Cr E11 Type 2 diabetes mellitus AP Ep A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension AP Ep A METFORMIN d03807A C- 99999 AP Ep A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia AP E A 99999 . . A E A CHLORTHALIDONE d00192A A I10 Essential (primary) hypertension Ap E A IBUPROFEN d00015A B R10 Abdominal and pelvic pain Ap E A LORAZEPAM d00149A C- F41.0 F41.9 Panic disorder [episodic paroxysmal anxiety] without agoraphobia Anxiety disorder, unspecified Ap E A METOPROLOL d00134A Bz I10 Essential (primary) hypertension Ap E A MIRTAZAPINE d04025A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Ap E A PANTOPRAZOLE d04514A Cr K21 Gastro-esophageal reflux disease Ap E A TIZANIDINE d04102A C M54 Dorsalgia Ap E A CIPROFLOXACIN d00011A C"0 B99.9 Unspecified infectious disease A E A CLOPIDOGREL d04258A CDp Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A E A ESTRADIOL TOPICAL d04210A A N95 Menopausal and other perimenopausal disorders A E A FENOFIBRATE d04286A C E78.1 Pure hyperglyceridemia A E A INSULIN GLARGINE d04538A C- R73 Elevated blood glucose level A E A INSULIN REGULAR d04369A C- E11 Type 2 diabetes mellitus A E A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A E A PRAVASTATIN d00348A C"0 I21.P Prevent heart attack/myocardial infarction A E A . . . E A . . . E A ASPIRIN d00170A C M54 Dorsalgia A@ E A BENZONATATE d00796A B R05 Cough A@ E A DILTIAZEM d00045A C I51.9 Heart disease, unspecified A@ E A FUROSEMIDE d00070A C R60.9 Edema, unspecified A@ E A . . . E A . . . E A . . . E A ALBUTEROL d00749A C J45 Asthma A E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension AP E A METFORMIN d03807A C- E11.P Prevent diabetes AP E A METOPROLOL d00134A C I10 Essential (primary) hypertension AP E A SERTRALINE d00880A C"0 F32.9 Major depressive disorder, single episode, unspecified AP E A TAMSULOSIN d04121A Cr N40 Enlarged prostate AP E0 A ENALAPRIL d00013A C I10 Essential (primary) hypertension A E0 A SERTRALINE d00880A Dc F41.9 Anxiety disorder, unspecified A E@ A . . . EP A IBUPROFEN d00015A A R51 Headache A E` A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A0 E` A HYDROCHLOROTHIAZIDE d00253A C[@ I10 Essential (primary) hypertension A0 E` A OMEGA-3 POLYUNSATURATED FATTY ACIDS d00497A C- A0 Ep A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A` Ep A GLIPIZIDE d00246A Cr R73 Elevated blood glucose level A` Ep A INSULIN ISOPHANE (NPH) d04370A C- E11 Type 2 diabetes mellitus A` Ep A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A` Ep A METFORMIN d03807A Cr R73 Elevated blood glucose level A` Ep A NAPROXEN d00019A B M25.5 Pain in joint A` E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A AMLODIPINE d00689A D# I10 Essential (primary) hypertension A0 E A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A Dc I10 Essential (primary) hypertension A0 E A METOPROLOL d00134A D I10 Essential (primary) hypertension A0 E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C N92 Excessive, frequent and irregular menstruation A E A . . . E A . . . E A . . . E0 A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A E0 A TERAZOSIN d00386A C- I10 Essential (primary) hypertension A E@ A . . . EP A OMEPRAZOLE d00325A C- K30 Functional dyspepsia A EP A VENLAFAXINE d03181A C F32.9 Major depressive disorder, single episode, unspecified A E` A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C"0 I10 Essential (primary) hypertension A Ep A . . . E A . . . E A . . . E A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A0 E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A0 E A TIMOLOL OPHTHALMIC d04037A C H40 Glaucoma A0 E A . . . E A . . . E A . . . E A BACLOFEN d00967A C- M62.83 Muscle spasm A E A FUROSEMIDE d00070A B R60.9 Edema, unspecified A E A LATANOPROST OPHTHALMIC d04017A C- H40 Glaucoma A E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A E A METOPROLOL d00134A C I10 I50.9 Essential (primary) hypertension Heart failure, unspecified A E A POTASSIUM CHLORIDE d00345A B E87.6 Hypokalemia A E A WARFARIN d00022A B D75.9P Prevent blood clots A E A . . . E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ E A GLIPIZIDE d00246A D R73 Elevated blood glucose level A@ E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A D I10 Essential (primary) hypertension A@ E A METFORMIN d03807A D R73 Elevated blood glucose level A@ E A . . . E0 A . . . E@ A . . . EP A AMLODIPINE d00689A D# I10 Essential (primary) hypertension A0 EP A FLUTICASONE NASAL d04283A C J30.2 Other seasonal allergic rhinitis A0 EP A HYDROCHLOROTHIAZIDE d00253A D# I10 Essential (primary) hypertension A0 E` A . . . Ep A . . . E A . . . E A TESTOSTERONE d00558A Cr M81 Osteoporosis without current pathological fracture A E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A D I10 Essential (primary) hypertension A0 E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A0 E A TAMSULOSIN d04121A C N42.9 Disorder of prostate, unspecified A0 E A CLOPIDOGREL d04258A CDp I21.P Prevent heart attack/myocardial infarction AP E A FUROSEMIDE d00070A CDp R60.9 Edema, unspecified AP E A METOPROLOL d00134A CDp I10 Essential (primary) hypertension AP E A OXYBUTYNIN d00328A CDp N39.4 Other specified urinary incontinence AP E A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia AP E A . . . E A ALLOPURINOL d00023A C M10.9P Prevent gout A E A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A E A DAPAGLIFLOZIN; METFORMIN d08245A B= E11 Type 2 diabetes mellitus A E A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A E A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A E A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A E A SEMAGLUTIDE d08688A B R73 Elevated blood glucose level A E A . . . E A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A Ap R21 Z79 Rash and other nonspecific skin eruption Long term (current) drug therapy A E A ATORVASTATIN d04105A B[ E78.0 Pure hypercholesterolemia Ap E A GLIMEPIRIDE d03864A C[@ E11 Type 2 diabetes mellitus Ap E A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A C- I10 Essential (primary) hypertension Ap E A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus Ap E A METOPROLOL d00134A C I49.9 R00 Cardiac arrhythmia, unspecified Abnormalities of heart beat Ap E A PRAMIPEXOLE d04145A C G25.81 Restless legs syndrome Ap E A SITAGLIPTIN d05896A C- E11 Type 2 diabetes mellitus Ap E A ATORVASTATIN d04105A A E78.0 Pure hypercholesterolemia A E A . . . E0 A . . . E@ A . . . EP A . . . E` A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A Ep A . . . E A . . . E A 99999 . . A E A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A B I10 Essential (primary) hypertension A@ E A LEVOCETIRIZINE d05851A B[ T78.40 Allergy, unspecified A@ E A PHENYTOIN d00143A D G40 Epilepsy and recurrent seizures A@ E A PRAVASTATIN d00348A B[ E78.0 Pure hypercholesterolemia A@ E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A0 E A RALOXIFENE d04261A Cr M85.9 Disorder of bone density and structure, unspecified A0 E A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E A CANAGLIFLOZIN; METFORMIN d08280A C- E11 Type 2 diabetes mellitus A E A CARVEDILOL d03847A D I10 Essential (primary) hypertension A E A DILTIAZEM d00045A CDp R00 Abnormalities of heart beat A E A FUROSEMIDE d00070A B I51.9 Heart disease, unspecified A E A POTASSIUM CHLORIDE d00345A B[ E87.6 Hypokalemia A E A RAMIPRIL d00728A Cr I50.9 Heart failure, unspecified A E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E A WARFARIN d00022A D D75.9P Prevent blood clots A E A . . . E A AMOXICILLIN d00088A A J06.9 Acute upper respiratory infection, unspecified A E A . . . E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A E A RANITIDINE d00021A A K30 Functional dyspepsia A E A . . . E0 A LOSARTAN d03821A B= E11.8 Type 2 diabetes mellitus with unspecified complications A0 E0 A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A0 E0 A MIRABEGRON d07876A B R35 Polyuria A0 E@ A . . . EP A CLONAZEPAM d00197A A@ F32.9 G47.0 Major depressive disorder, single episode, unspecified Insomnia A0 EP A LORAZEPAM d00149A BK F41.9 Anxiety disorder, unspecified A0 EP A VENLAFAXINE d03181A B[ F32.9 Major depressive disorder, single episode, unspecified A0 E` A . . . Ep A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A0 Ep A ENALAPRIL d00013A C I10 Essential (primary) hypertension A0 Ep A METFORMIN d03807A C E11 Type 2 diabetes mellitus A0 E A IBUPROFEN d00015A C N94 Pain and other conditions associated with female genital organs and menstrual cycle A E A SUMATRIPTAN d03160A CDp G43 Migraine A E A AMLODIPINE d00689A B* I10 I21.P Essential (primary) hypertension Prevent heart attack/myocardial infarction AP E A ATORVASTATIN d04105A B[ I10 I63.P Essential (primary) hypertension Prevent stroke AP E A CARVEDILOL d03847A Cr I10 I50.9 Essential (primary) hypertension Heart failure, unspecified AP E A DULOXETINE d05355A C M19.9 Osteoarthritis, unspecified site AP E A HYDROCHLOROTHIAZIDE; OLMESARTAN d04878A Cr I10 Essential (primary) hypertension AP E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A` E A CETIRIZINE d03827A C- H10.1 J30.9 T78.40 Acute atopic conjunctivitis Allergic rhinitis, unspecified Allergy, unspecified A` E A HYOSCYAMINE; METHENAM; M-BLUE; SODIUM BIPHOSPHATE d07726A A N39.0 Urinary tract infection, site not specified A` E A LOSARTAN d03821A C- I10 Essential (primary) hypertension A` E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` E A TAMSULOSIN d04121A B= N42.9 Disorder of prostate, unspecified A` E A 77777 . . A E A ATORVASTATIN d04105A C9 E78.0 Pure hypercholesterolemia A@ E A CLOPIDOGREL d04258A C9 Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A@ E A LISINOPRIL d00732A C9 I10 Essential (primary) hypertension A@ E A METOPROLOL d00134A C9 I10 R07.9 Essential (primary) hypertension Chest pain, unspecified A@ E A FLUTICASONE; SALMETEROL d04611A A R05 Cough A E A METOPROLOL d00134A C I10 Essential (primary) hypertension A E A . . . E A SERTRALINE d00880A B= F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A . . . E A . . . E A ESCITALOPRAM d04812A C9 99999 A E A FUROSEMIDE d00070A Cr 99999 A E A LAMOTRIGINE d03809A Ei 99999 A E A MEMANTINE d04899A Ei G31.9 Degenerative disease of nervous system, unspecified A E A OMEPRAZOLE d00325A Ei 99999 A E A PROPAFENONE d00358A Ei 99999 A E A TRAZODONE d00395A Cr 99999 A E A VALSARTAN d04113A Cr K92.9 Disease of digestive system, unspecified A E0 A NAPROXEN d00019A A0 T14.9 Unspecified injury A E@ A . . . EP A . . . E` A CONJUGATED ESTROGENS d00541A Cr N95 Menopausal and other perimenopausal disorders A E` A METFORMIN d03807A C- R73 Elevated blood glucose level A Ep A . . . E A ALBUTEROL d00749A Cr J45 Asthma AP E A ALBUTEROL d00749A Cr J45 Asthma AP E A FLUTICASONE NASAL d04283A C[@ T78.40 Allergy, unspecified AP E A FLUTICASONE; SALMETEROL d04611A B= J45 Asthma AP E A PREDNISOLONE d00084A Cr J45 Asthma AP E A . . . E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A Cr Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A0 C M54 Dorsalgia Ap E A DESIPRAMINE d00145A0 C- G47.9 Sleep disorder, unspecified Ap E A LOSARTAN d03821A0 Cr I10 Essential (primary) hypertension Ap E A METFORMIN d03807A0 CDp R73 Elevated blood glucose level Ap E A METOPROLOL d00134A0 C[@ I10 Essential (primary) hypertension Ap E A OMEPRAZOLE d00325A0 D,3 K21 K30 R12 Gastro-esophageal reflux disease Functional dyspepsia Heartburn Ap E A SIMVASTATIN d00746A0 CDp E78.0 Pure hypercholesterolemia Ap E A AMOXICILLIN d00088A Ap K04.7 Periapical abscess without sinus A E A AMLODIPINE d00689A D I10 Essential (primary) hypertension A@ E A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A@ E A GLIMEPIRIDE d03864A D E11 Type 2 diabetes mellitus A@ E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A D I10 Essential (primary) hypertension A@ E A 99999 . . A E A ALBUTEROL d00749A C- J45 R06.02 R06.9P Asthma Shortness of breath Prevent breathing difficulty A E A ACETAMINOPHEN; HYDROCODONE d03428A B= M79.1 Myalgia A@ E A CIPROFLOXACIN d00011A B N30 Cystitis A@ E A FUROSEMIDE d00070A B= N28.9 Disorder of kidney and ureter, unspecified A@ E A POTASSIUM CHLORIDE d00345A B= E87.6 Hypokalemia A@ E A . . . E0 A ATORVASTATIN d04105A C E78.0P Prevent high cholesterol A E0 A LEVOTHYROXINE d00278A D=O E05 Thyrotoxicosis [hyperthyroidism] A E@ A . . . EP A . . . E` A . . . Ep A . . . E A FLUTICASONE NASAL d04283A B J30.2 Other seasonal allergic rhinitis A E A ALBUTEROL d00749A C[@ J45 Asthma A@ E A AZELASTINE NASAL d04068A CDp T78.40 Allergy, unspecified A@ E A BUDESONIDE; FORMOTEROL d04795A CDp R05 Cough A@ E A FLUTICASONE NASAL d04283A CDp J30.2 Other seasonal allergic rhinitis A@ E A ACETAMINOPHEN; HYDROCODONE d03428A C- M79.6 Pain in limb, hand, foot, fingers and toes A@ E A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified A@ E A IBUPROFEN d00015A C M79.6 R51 Pain in limb, hand, foot, fingers and toes Headache A@ E A PHENTERMINE d00806A C E66 Overweight and obesity A@ E A . . . E A . . . E A LOSARTAN d03821A C R51 Headache A E A . . . E A . . . E A AMOXICILLIN d00088A Ap H66.9 Otitis media, unspecified A0 E A ARIPIPRAZOLE d04825A C- F39 F90 Unspecified mood [affective] disorder Attention-deficit hyperactivity disorders A0 E A METHYLPHENIDATE d00900A C- F39 F90 Unspecified mood [affective] disorder Attention-deficit hyperactivity disorders A0 E A ASPIRIN d00170A C- D75.9P Prevent blood clots A E A DICLOFENAC d00848A C- M19.9 Osteoarthritis, unspecified site A E A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus AP E A HYDROCHLOROTHIAZIDE d00253A C P I10 Essential (primary) hypertension AP E A LOSARTAN d03821A C I10 Essential (primary) hypertension AP E A METFORMIN d03807A C P E11 Type 2 diabetes mellitus AP E A PRAVASTATIN d00348A B E78.0 Pure hypercholesterolemia AP E0 A . . . E@ A . . . EP A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A@ EP A AZELASTINE OPHTHALMIC d04541A C H57.9 Unspecified disorder of eye and adnexa A@ EP A LOSARTAN d03821A C- I10 Essential (primary) hypertension A@ EP A OMEPRAZOLE d00325A C- K30 R10 Functional dyspepsia Abdominal and pelvic pain A@ E` A ESCITALOPRAM d04812A C- F41.9 Anxiety disorder, unspecified A E` A ROSUVASTATIN d04851A B= E78.0 Pure hypercholesterolemia A Ep A . . . E A . . . E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A D Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A . . . E A CALCIUM ACETATE d03689A C N19 Unspecified kidney failure A0 E A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A0 E A LABETALOL d00016A C I10 Essential (primary) hypertension A0 E A . . . E A . . . E A . . . E A BECLOMETHASONE d00760A C J45 Asthma A E A SOMATROPIN d00577A Bz Z79.890 Hormone replacement therapy A E A CETIRIZINE d03827A C"0 T78.40 Allergy, unspecified A E A . . . E0 A . . . E@ A . . . EP A ACETAMINOPHEN; HYDROCODONE d03428A C M54 Dorsalgia A EP A CYCLOBENZAPRINE d00963A CDp M79.1 Myalgia A EP A DICLOFENAC d00848A C- M19.9 Osteoarthritis, unspecified site A EP A DULOXETINE d05355A C M54 Dorsalgia A EP A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A EP A LORAZEPAM d00149A CDp G47.0 Insomnia A EP A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia A EP A ROPINIROLE d04215A CDp G25.81 Restless legs syndrome A EP A SUCRALFATE d00377A B K27 Peptic ulcer, site unspecified A E` A ATORVASTATIN d04105A Bz E78.0 Pure hypercholesterolemia A E` A CLOPIDOGREL d04258A Ap I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified A E` A INSULIN GLARGINE d04538A C[@ E11 Type 2 diabetes mellitus A E` A ISOSORBIDE DINITRATE d00268A B R07.9 Chest pain, unspecified A E` A LOSARTAN d03821A C I10 Essential (primary) hypertension A E` A METOPROLOL d00134A A I10 I51.9 Essential (primary) hypertension Heart disease, unspecified A E` A MONTELUKAST d04289A C J30.9 J45 Allergic rhinitis, unspecified Asthma A E` A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease A E` A PREGABALIN d05508A B M79.2 Neuralgia and neuritis, unspecified A E` A SUCRALFATE d00377A B[ K21 Gastro-esophageal reflux disease A E` A TORSEMIDE d03189A A R60.9 Edema, unspecified A E` A VENLAFAXINE d03181A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A Ep A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A@ Ep A HYDROCHLOROTHIAZIDE; OLMESARTAN d04878A C- I10 Essential (primary) hypertension A@ Ep A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ Ep A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A@ E A . . . E A 99999 . . A E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A E A ACETAMINOPHEN; OXYCODONE d03431A C T14.9 Unspecified injury B E A ALBUTEROL d00749A A F41.9 R06.9 Anxiety disorder, unspecified Unspecified abnormalities of breathing B E A ALBUTEROL d00749A D R06.02 Shortness of breath B E A AMLODIPINE d00689A D# I10 Essential (primary) hypertension B E A CLONAZEPAM d00197A D F41.9 Anxiety disorder, unspecified B E A DOCUSATE d01021A C- K59.0 Constipation B E A EZETIMIBE; SIMVASTATIN d05348A D ^ E78.0 Pure hypercholesterolemia B E A FENOFIBRIC ACID d07371A D ^ E78.0 Pure hypercholesterolemia B E A FLUTICASONE; SALMETEROL d04611A Cr J44.9 Chronic obstructive pulmonary disease, unspecified B E A FUROSEMIDE d00070A A R60.9 Edema, unspecified B E A LISINOPRIL d00732A D,3 I10 Essential (primary) hypertension B E A METFORMIN d03807A C E11 Type 2 diabetes mellitus B E A METOPROLOL d00134A Cr I10 Essential (primary) hypertension B E A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease B E A QUETIAPINE d04220A A G47.0 Insomnia B E A TOPIRAMATE d04115A D F31.9 Bipolar disorder, unspecified B E A . . . E A . . . E A BUPRENORPHINE; NALOXONE d04819A C F11.23 Opioid dependence with withdrawal A0 E A HYDROCHLOROTHIAZIDE d00253A Cr R60.9 Edema, unspecified A0 E A LISINOPRIL d00732A B I10 Essential (primary) hypertension A0 E A . . . E A . . . E A AMLODIPINE d00689A D I10 Essential (primary) hypertension AP E A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia AP E A GLIPIZIDE d00246A Dc E11 Type 2 diabetes mellitus AP E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A D I10 Essential (primary) hypertension AP E A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus AP E A FLUOXETINE d00236A C F33.9 F41.9 F43.1 Major depressive disorder, recurrent, unspecified Anxiety disorder, unspecified Post-traumatic stress disorder (PTSD) A E A NAPROXEN d00019A A M25.5 Pain in joint A E A . . . E 0 A THYROID DESICCATED d00655A C E03.9 Hypothyroidism, unspecified A E @ A SIMVASTATIN d00746A D> E78.0 Pure hypercholesterolemia A E @ A TERAZOSIN d00386A D> N40 Enlarged prostate A E P A ACETAMINOPHEN; OXYCODONE d03431A C[@ M54 Dorsalgia A E P A IBUPROFEN d00015A C[@ Z79.1 Long term (current) use of non-steroidal anti-inflammatories (NSAID) A E ` A . . . E p A DONEPEZIL d04099A Cr G31.9 R41 Degenerative disease of nervous system, unspecified Other symptoms and signs involving cognitive functions and awareness A E A . . . E A . . . E A AMOXICILLIN d00088A A J42 Unspecified chronic bronchitis A E A PREDNISONE d00350A Ap J42 Unspecified chronic bronchitis A E A . . . E A . . . E A FORMOTEROL; MOMETASONE d07660A C J45 Asthma A E A . . . E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E A CARVEDILOL d03847A Ei 99999 A E A DIVALPROEX SODIUM d03833A C- G40 Epilepsy and recurrent seizures A E A FUROSEMIDE d00070A B 99999 A E A NITROGLYCERIN d00321A D4 R00 Abnormalities of heart beat A E A PANTOPRAZOLE d04514A Ei 99999 A E A RIVAROXABAN d07356A CDp I10 Essential (primary) hypertension A E A ROSUVASTATIN d04851A Cr E78.0 Pure hypercholesterolemia A E A SACUBITRIL; VALSARTAN d08369A C- I51.9 Heart disease, unspecified A E A SPIRONOLACTONE d00373A B 99999 A E A . . . E A . . . E 0 A . . . E @ A AMITRIPTYLINE d00146A D1 F41.9 Anxiety disorder, unspecified A@ E @ A CYCLOBENZAPRINE d00963A B M54 M79.1 T14.9 Dorsalgia Myalgia Unspecified injury A@ E @ A PERPHENAZINE d00855A D1 F41.9 Anxiety disorder, unspecified A@ E @ A ZOLPIDEM d00910A B G47.9 Sleep disorder, unspecified A@ E P A . . . E ` A . . . E p A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A0 E p A LOSARTAN d03821A C I10 Essential (primary) hypertension A0 E p A SERTRALINE d00880A C- F32.9 Major depressive disorder, single episode, unspecified A0 E A PHENTERMINE d00806A B E66 Overweight and obesity A E A . . . E A . . . E A . . . E A ALBUTEROL d00749A C J45 Asthma A E A ALBUTEROL d00749A C J44.9 Chronic obstructive pulmonary disease, unspecified Ap E A ALPRAZOLAM d00168A D M79.2 Neuralgia and neuritis, unspecified Ap E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia Ap E A CYCLOBENZAPRINE d00963A D ^ M79.2 Neuralgia and neuritis, unspecified Ap E A GABAPENTIN d03182A D ^ M79.2 Neuralgia and neuritis, unspecified Ap E A SERTRALINE d00880A D ^ F32.9 Major depressive disorder, single episode, unspecified Ap E A TIOTROPIUM d04829A C J44.9 Chronic obstructive pulmonary disease, unspecified Ap E A . . . E A ESOMEPRAZOLE d04749A C K21 Gastro-esophageal reflux disease AP E A HYDROCODONE d03075A C M25.5 Pain in joint AP E A METFORMIN d03807A C E28 Ovarian dysfunction AP E A NORETHINDRONE d00555A Bz E28 Ovarian dysfunction AP E A ROPINIROLE d04215A C[@ G25.81 Restless legs syndrome AP E A . . . E A . . . E A . . . E 0 A ALBUTEROL d00749A B J45 Asthma Ap E 0 A ALBUTEROL d00749A B J45 Asthma Ap E 0 A BECLOMETHASONE d00760A B J45 Asthma Ap E 0 A DEXMETHYLPHENIDATE d04777A C F90 Attention-deficit hyperactivity disorders Ap E 0 A FLUTICASONE NASAL d04283A C J30.9 Allergic rhinitis, unspecified Ap E 0 A MONTELUKAST d04289A C J30.9 Allergic rhinitis, unspecified Ap E 0 A SERTRALINE d00880A C F90 Attention-deficit hyperactivity disorders Ap E @ A . . . E P A ESOMEPRAZOLE; NAPROXEN d07631A B= M19.9 Osteoarthritis, unspecified site A E ` A . . . E p A TESTOSTERONE d00558A C E29.1 Testicular hypofunction A E A . . . E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A D Z79.3 Long term (current) use of hormonal contraceptives A E A BUSPIRONE d00182A Cr F41.9 Anxiety disorder, unspecified A` E A CETIRIZINE d03827A Cr T78.40 Allergy, unspecified A` E A FLUTICASONE NASAL d04283A B= J30.2 Other seasonal allergic rhinitis A` E A GUANFACINE d00717A Cr F90 Attention-deficit hyperactivity disorders A` E A LAMOTRIGINE d03809A Cr F90 Attention-deficit hyperactivity disorders A` E A QUETIAPINE d04220A Cr F90 Attention-deficit hyperactivity disorders A` E A . . . E A . . . E A ESOMEPRAZOLE d04749A C- K30 Functional dyspepsia A E A . . . E A DAPSONE TOPICAL d05543A C L70 Acne AP E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A D= E28 L70 Ovarian dysfunction Acne AP E A FLUORIDE TOPICAL d04397A C K02 Dental caries AP E A SPIRONOLACTONE d00373A Cr L70 Acne AP E A TRETINOIN d03863A Cr L70 Acne AP E A IBUPROFEN d00015A C R50.9 Fever, unspecified A E A . . . E A . . . E 0 A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A CDp I10 Essential (primary) hypertension A E 0 A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A E @ A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A E P A . . . E ` A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A E ` A VALSARTAN d04113A CDp I10 Essential (primary) hypertension A E p A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A CDp N92 N94 Excessive, frequent and irregular menstruation Pain and other conditions associated with female genital organs and menstrual cycle A E p A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A . . . E A . . . E A . . . E A . . . E A . . . E A LOSARTAN d03821A C- I10 Essential (primary) hypertension A E A AMLODIPINE d00689A Cr 99999 A E A ASPIRIN d00170A C I21.P Prevent heart attack/myocardial infarction A E A FUROSEMIDE d00070A C- R60.9 Edema, unspecified A E A GLIPIZIDE d00246A Cr R73 Elevated blood glucose level A E A LOSARTAN d03821A C I10 Essential (primary) hypertension A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A RANITIDINE d00021A C R12 Heartburn A E A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A E A COLESTIPOL d00744A0 C- R19.7 Diarrhea, unspecified A E A MELOXICAM d04532A0 C M19.9 M25.5 Osteoarthritis, unspecified site Pain in joint A E A MONTELUKAST d04289A0 C J45 Asthma A E A OMEPRAZOLE d00325A0 C K21 K58 Gastro-esophageal reflux disease Irritable bowel syndrome A E A OXYBUTYNIN d00328A0 CDp N32.81 R39.1 Overactive bladder Other difficulties with micturition A E A PHENYTOIN d00143A0 D% 55555 A E A PROPRANOLOL d00032A0 DE I49.9 Cardiac arrhythmia, unspecified A E A TEMAZEPAM d00384A0 C G47.0 Insomnia A E A . . . E A DEXTROAMPHETAMINE d00804A C- F99 Mental disorder, not otherwise specified A E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A Cr N92 Z79.3 Excessive, frequent and irregular menstruation Long term (current) use of hormonal contraceptives A E A . . . E 0 A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A0 E 0 A LOSARTAN d03821A C I10 Essential (primary) hypertension A0 E 0 A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A0 E @ A ATENOLOL d00004A C I51.9P Prevent heart disease A E P A NITROFURANTOIN d00112A AP N30 Cystitis A E ` A . . . E p A . . . E A . . . E A . . . E A . . . E A 55555 A0 C- J44.9 Chronic obstructive pulmonary disease, unspecified A` E A ATORVASTATIN d04105A0 D E78.0 Pure hypercholesterolemia A` E A BUDESONIDE; FORMOTEROL d04795A0 C J44.9 Chronic obstructive pulmonary disease, unspecified A` E A LEVOTHYROXINE d00278A0 DGJ E03.9 Hypothyroidism, unspecified A` E A OMEPRAZOLE d00325A0 C K30 Functional dyspepsia A` E A PAROXETINE d03157A0 DGJ F32.9 Major depressive disorder, single episode, unspecified A` E A . . . E A . . . E A ALBUTEROL d00749A D J43 J45 Emphysema Asthma A E A ATORVASTATIN d04105A B[ E78.0 Pure hypercholesterolemia A E A INSULIN DETEMIR d05436A D E11 Type 2 diabetes mellitus A E A LAMOTRIGINE d03809A C F39 Unspecified mood [affective] disorder A E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A MIRTAZAPINE d04025A B= G47.9 Sleep disorder, unspecified A E A QUETIAPINE d04220A C G47.0 Insomnia A E A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified A E A . . . E! A . . . E! A ATENOLOL d00004A D* R00 Abnormalities of heart beat AP E! A CILOSTAZOL d04382A C- I70 Atherosclerosis AP E! A CLOPIDOGREL d04258A C- I63 Cerebral infarction AP E! A FUROSEMIDE d00070A C- R60.9 Edema, unspecified AP E! A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia AP E! A ALBUTEROL d00749A B J44.9 Chronic obstructive pulmonary disease, unspecified A E! A BUDESONIDE; FORMOTEROL d04795A B J44.9 Chronic obstructive pulmonary disease, unspecified A E! A HYDROXYZINE d00907A B F41.9 Anxiety disorder, unspecified A E! A METOPROLOL d00134A B[ R00 Abnormalities of heart beat A E! A OMEPRAZOLE d00325A CDp R12 Heartburn A E! A QUETIAPINE d04220A B= G47.9 Sleep disorder, unspecified A E! A SERTRALINE d00880A B F31.9 Bipolar disorder, unspecified A E! A TIZANIDINE d04102A B F31.9 Bipolar disorder, unspecified A E! A TRAZODONE d00395A D G47.9 Sleep disorder, unspecified A E!0 A . . . E!@ A . . . E!P A AMIODARONE d00002A C 99999 Ap E!P A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia Ap E!P A LISINOPRIL d00732A C I10 Essential (primary) hypertension Ap E!P A METOPROLOL d00134A B 99999 Ap E!P A TORSEMIDE d03189A B I10 Essential (primary) hypertension Ap E!P A VERAPAMIL d00048A D I10 Essential (primary) hypertension Ap E!P A ZOLPIDEM d00910A A G47.0 Insomnia Ap E!` A ASPIRIN d00170A C- Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A` E!` A CLOPIDOGREL d04258A C- Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A` E!` A DULOXETINE d05355A C F32.9 M19.9 Major depressive disorder, single episode, unspecified Osteoarthritis, unspecified site A` E!` A LORAZEPAM d00149A Cr F41.9 Anxiety disorder, unspecified A` E!` A LOVASTATIN d00280A C[@ E78.0 Pure hypercholesterolemia A` E!` A MIRTAZAPINE d04025A Cr G47.0 Insomnia A` E!p A . . . E! A DULOXETINE d05355A B M79.7 Fibromyalgia A E! A IBUPROFEN d00015A C M06.9 R51 Rheumatoid arthritis, unspecified Headache A E! A . . . E! A FLUTICASONE; SALMETEROL d04611A C J44.9 Chronic obstructive pulmonary disease, unspecified AP E! A MONTELUKAST d04289A Cr J30.9 Allergic rhinitis, unspecified AP E! A NIFEDIPINE d00051A Dc I10 Essential (primary) hypertension AP E! A PRAVASTATIN d00348A Dc E78.0 Pure hypercholesterolemia AP E! A TIOTROPIUM d04829A C J44.9 Chronic obstructive pulmonary disease, unspecified AP E! A . . . E! A ALLOPURINOL d00023A Ei 99999 A E! A ATORVASTATIN d04105A Ei 99999 A E! A CARBIDOPA d00184A Ei 99999 A E! A COLCHICINE d00150A Ei 99999 A E! A DONEPEZIL d04099A Ei 99999 A E! A DULOXETINE d05355A Ei 99999 A E! A INSULIN ASPART d04697A C[@ 99999 A E! A INSULIN GLARGINE d04538A C[@ 99999 A E! A OXYBUTYNIN d00328A Ei 99999 A E! A PANTOPRAZOLE d04514A Ei 99999 A E! A PRAZOSIN d00138A Ei 99999 A E! A QUETIAPINE d04220A Ei 99999 A E! A ACETAMINOPHEN; CODEINE d03423A Ap K08.8 Other specified disorders of teeth and supporting structures A` E! A AMOXICILLIN d00088A A K08.4 Partial loss of teeth A` E! A DICLOFENAC d00848A C M79.6 Pain in limb, hand, foot, fingers and toes A` E! A GLIPIZIDE d00246A C 99999 A` E! A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` E! A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A` E! A . . . E! A TAMSULOSIN d04121A Dc R39.9 Unspecified symptoms and signs involving the genitourinary system A E" A COLESTIPOL d00744A Cr E78.0 Pure hypercholesterolemia A0 E" A LEVOTHYROXINE d00278A D; E03.9 Hypothyroidism, unspecified A0 E" A LOSARTAN d03821A C[@ I10 Essential (primary) hypertension A0 E" A . . . E" A . . . E"0 A ETHINYL ESTRADIOL; NORETHINDRONE d03238A B[ Z79.3 Long term (current) use of hormonal contraceptives A E"@ A . . . E"P A ACETAMINOPHEN; HYDROCODONE d03428A A0 G89 Pain, not elsewhere classified A E"` A . . . E"p A . . . E" A . . . E" A . . . E" A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A D* I10 Essential (primary) hypertension A E" A MELOXICAM d04532A C M25.5 Pain in joint A E" A . . . E" A . . . E" A . . . E" A . . . E" A CLONIDINE d00044A C- G47.0 Insomnia A E# A GLIPIZIDE d00246A B R73 Elevated blood glucose level A@ E# A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E# A METFORMIN d03807A C- R73 Elevated blood glucose level A@ E# A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A@ E# A . . . E# A . . . E#0 A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A E#@ A . . . E#P A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A0 E#P A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A0 E#P A VALSARTAN d04113A C[@ I21.P Prevent heart attack/myocardial infarction A0 E#` A 99999 . . A E#p A . . . E# A BUPROPION d00181A CDp F41.9 Anxiety disorder, unspecified A` E# A DILTIAZEM d00045A CDp I10 Essential (primary) hypertension A` E# A GABAPENTIN d03182A A M79.2 Neuralgia and neuritis, unspecified A` E# A HYDRALAZINE d00132A B I10 Essential (primary) hypertension A` E# A OXCARBAZEPINE d04513A B G40 Epilepsy and recurrent seizures A` E# A TRAZODONE d00395A CDp F32.9 Major depressive disorder, single episode, unspecified A` E# A . . . E# A . . . E# A . . . E# A ESOMEPRAZOLE d04749A A K30 Functional dyspepsia A E# A . . . E# A . . . E# A FLUTICASONE TOPICAL d04284A C- L20.9 Atopic dermatitis, unspecified A E$ A . . . E$ A . . . E$ A . . . E$0 A MINOCYCLINE d00110A B[ L70 Acne A E$@ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E$@ A LOSARTAN d03821A C I10 Essential (primary) hypertension A0 E$@ A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A0 E$P A RANITIDINE d00021A Cr K21 Gastro-esophageal reflux disease A E$` A . . . E$p A . . . E$ A . . . E$ A . . . E$ A . . . E$ A . . . E$ A . . . E$ A CLOPIDOGREL d04258A B D75.9P Prevent blood clots A E$ A HYDROCHLOROTHIAZIDE; OLMESARTAN d04878A B I10 Essential (primary) hypertension A E$ A . . . E$ A AMOXICILLIN d00088A A` K04.7P Prevent tooth infection A E$ A KETOROLAC d00273A A` K08.8 Other specified disorders of teeth and supporting structures A E% A . . . E% A 99999 . . A E% A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension A E% A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A E%0 A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A E%0 A LOSARTAN d03821A C I10 Essential (primary) hypertension A E%@ A . . . E%P A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A D I10 Essential (primary) hypertension A E%P A INSULIN GLARGINE d04538A D E11 Type 2 diabetes mellitus A E%P A ISOSORBIDE MONONITRATE d00269A D I21.P Prevent heart attack/myocardial infarction A E%P A LIRAGLUTIDE d07466A Cr R73 Elevated blood glucose level A E%P A METFORMIN d03807A D E11 Type 2 diabetes mellitus A E%P A METOPROLOL d00134A D I49.9 Cardiac arrhythmia, unspecified A E%P A PANTOPRAZOLE d04514A D K21 Gastro-esophageal reflux disease A E%P A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A E%` A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E%` A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E%p A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension AP E%p A CARVEDILOL d03847A Cr I10 Essential (primary) hypertension AP E%p A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Cr I10 Essential (primary) hypertension AP E%p A RANITIDINE d00021A B. K21 Gastro-esophageal reflux disease AP E%p A SIMVASTATIN d00746A CP E78.0 Pure hypercholesterolemia AP E% A ESTRADIOL d00537A CP Z79.890 Hormone replacement therapy A E% A GABAPENTIN d03182A B* G40 M79.2 Epilepsy and recurrent seizures Neuralgia and neuritis, unspecified A E% A . . . E% A . . . E% A . . . E% A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A E% A LOVASTATIN d00280A C- E78.0 Pure hypercholesterolemia A E% A . . . E% A . . . E& A . . . E& A . . . E& A FUROSEMIDE d00070A Cr I10 Essential (primary) hypertension A0 E& A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A0 E& A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A0 E&0 A . . . E&@ A AMLODIPINE d00689A B I10 Essential (primary) hypertension A@ E&@ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ E&@ A CLOPIDOGREL d04258A B I63 Cerebral infarction A@ E&@ A LOSARTAN d03821A B I10 Essential (primary) hypertension A@ E&P A ADALIMUMAB d04835A Cr M06.9 Rheumatoid arthritis, unspecified AP E&P A IBANDRONATE d05357A B[ M81 Osteoporosis without current pathological fracture AP E&P A LATANOPROST OPHTHALMIC d04017A AP H40 Glaucoma AP E&P A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified AP E&P A METHOTREXATE d00060A C M06.9 Rheumatoid arthritis, unspecified AP E&` A . . . E&p A . . . E& A . . . E& A . . . E& A ACETAMINOPHEN; HYDROCODONE d03428A C M54 Dorsalgia Ap E& A DOXYCYCLINE d00037A Ap L08.9 Local infection of the skin and subcutaneous tissue, unspecified Ap E& A DRONEDARONE d07458A Cr I49.9 Cardiac arrhythmia, unspecified Ap E& A ISOSORBIDE d00653A Cr H40 Glaucoma Ap E& A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified Ap E& A PREDNISONE d00350A Cr 55555 Ap E& A SIMVASTATIN d00746A Cr I21.P Prevent heart attack/myocardial infarction Ap E& A ALBUTEROL d00749A CDp J45 Asthma A E& A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E& A CHLORTHALIDONE d00192A C I10 Essential (primary) hypertension A E& A CITALOPRAM d04332A C F32.9 Major depressive disorder, single episode, unspecified A E& A CYCLOBENZAPRINE d00963A C M62.83 Muscle spasm A E& A FLUTICASONE NASAL d04283A B J30.9 Allergic rhinitis, unspecified A E& A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A E& A MONTELUKAST d04289A Cr J30.9 Allergic rhinitis, unspecified A E& A TOPIRAMATE d04115A C M79.2 Neuralgia and neuritis, unspecified A E& A TRAMADOL d03826A C M54 M79.6 Dorsalgia Pain in limb, hand, foot, fingers and toes A E& A VALSARTAN d04113A C I10 Essential (primary) hypertension A E& A BIMATOPROST OPHTHALMIC d04754A CDp H40 Glaucoma A E& A . . . E& Ap . . . E& A CEPHALEXIN d00096A B L08.9 Local infection of the skin and subcutaneous tissue, unspecified A E' A . . . E' A AMLODIPINE d00689A C I10 Essential (primary) hypertension A` E' A GLIPIZIDE d00246A C[@ R73 Elevated blood glucose level A` E' A HYDROCHLOROTHIAZIDE d00253A C 99999 A` E' A LISINOPRIL d00732A C I10 Essential (primary) hypertension A` E' A METFORMIN d03807A C[@ R73 Elevated blood glucose level A` E' A TAMSULOSIN d04121A C R35 Polyuria A` E' A . . . E'0 A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E'0 A VALSARTAN d04113A C I10 Essential (primary) hypertension A E'@ A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A E'P A . . . E'` A CITALOPRAM d04332A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E'` A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A E'` A INSULIN LISPRO d04373A C E11 Type 2 diabetes mellitus A E'` A ISOSORBIDE MONONITRATE d00269A C Z95 Presence of cardiac and vascular implants and grafts A E'` A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E'` A LOSARTAN d03821A C I51.9 Heart disease, unspecified A E'` A MIRABEGRON d07876A C- N32.81 Overactive bladder A E'` A PANTOPRAZOLE d04514A C 99999 A E'` A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A E'p A . . . E' A . . . E' A . . . E' A . . . E' A AMLODIPINE d00689A Ei I10 Essential (primary) hypertension A E' A DIVALPROEX SODIUM d03833A Ei F32.9 F33.9 Major depressive disorder, single episode, unspecified Major depressive disorder, recurrent, unspecified A E' A FAMOTIDINE d00141A B[ K21 Gastro-esophageal reflux disease A E' A FENOFIBRATE d04286A Ei E78.0 Pure hypercholesterolemia A E' A FLUOXETINE d00236A Ei F32.9 F33.9 F41.9 Major depressive disorder, single episode, unspecified Major depressive disorder, recurrent, unspecified Anxiety disorder, unspecified A E' A INSULIN ISOPHANE; INSULIN REGULAR d04374A C- E11 Type 2 diabetes mellitus A E' A LAMOTRIGINE d03809A Ei F32.9 F33.9 Major depressive disorder, single episode, unspecified Major depressive disorder, recurrent, unspecified A E' A LOSARTAN d03821A Ei I10 Essential (primary) hypertension A E' A METFORMIN d03807A B E11 Type 2 diabetes mellitus A E' A QUETIAPINE d04220A B[ F41.9 Anxiety disorder, unspecified A E' A QUETIAPINE d04220A D G47.0 Insomnia A E' A ROPINIROLE d04215A Ei R25 Abnormal involuntary movements A E' A ROSUVASTATIN d04851A Ei E78.0 Pure hypercholesterolemia A E' A . . . E' A ATENOLOL d00004A Cr I10 Essential (primary) hypertension A0 E' A HYDROCHLOROTHIAZIDE d00253A C- I10 Essential (primary) hypertension A0 E' A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia A0 E' A . . . E' A . . . E( A . . . E( A . . . E( A ARIPIPRAZOLE d04825A B F32.9 Major depressive disorder, single episode, unspecified Ap E( A DICLOFENAC d00848A Ei M19.9 Osteoarthritis, unspecified site Ap E( A FUROSEMIDE d00070A C I51.9 Heart disease, unspecified Ap E( A INSULIN ASPART d04697A D# E11 Type 2 diabetes mellitus Ap E( A INSULIN GLARGINE d04538A D# E11 Type 2 diabetes mellitus Ap E( A MIRTAZAPINE d04025A B 99999 Ap E( A QUETIAPINE d04220A B R52 Pain, unspecified Ap E(0 A . . . E(@ A . . . E(P A 99999 . . A E(` A . . . E(p A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia AP E(p A DULOXETINE d05355A C F33.9 Major depressive disorder, recurrent, unspecified AP E(p A GABAPENTIN d03182A CDp M79.2 M79.7 Neuralgia and neuritis, unspecified Fibromyalgia AP E(p A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A B= I10 R60.9 Essential (primary) hypertension Edema, unspecified AP E(p A INSULIN DETEMIR d05436A CDp E11 R73 Type 2 diabetes mellitus Elevated blood glucose level AP E( A . . . E( A ALPRAZOLAM d00168A B= F41.9 Anxiety disorder, unspecified A0 E( A ETHINYL ESTRADIOL; NORELGESTROMIN d04779A CDp Z79.3 Long term (current) use of hormonal contraceptives A0 E( A LISDEXAMFETAMINE d06663A C"0 F90 Attention-deficit hyperactivity disorders A0 E( A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E( A CETIRIZINE d03827A A R09.81 Nasal congestion A E( A . . . E( A ALBUTEROL d00749A B B34.9 R06.9P Viral infection, unspecified Prevent breathing difficulty A@ E( A AZITHROMYCIN d00091A0 AP R06.9 Unspecified abnormalities of breathing A@ E( A OSELTAMIVIR d04462A AP J09 Influenza due to certain identified influenza viruses A@ E( A PREDNISOLONE d00084A Ap R06.9 Unspecified abnormalities of breathing A@ E( A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A` E( A APIXABAN d07804A0 CDp D75.9P Prevent blood clots A` E( A DONEPEZIL d04099A0 CDp R41 Other symptoms and signs involving cognitive functions and awareness A` E( A DULOXETINE d05355A0 C- F32.9 F41.9 G47.0 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Insomnia A` E( A GABAPENTIN d03182A0 CDp F31.9 Bipolar disorder, unspecified A` E( A METHADONE d00050A C M25.5 M54 M79.1 Pain in joint Dorsalgia Myalgia A` E( A IBUPROFEN d00015A B G89 Pain, not elsewhere classified A E( A AMITRIPTYLINE d00146A C- G47.0 Insomnia AP E( A DONEPEZIL d04099A C- R41 Other symptoms and signs involving cognitive functions and awareness AP E( A HYDROCHLOROTHIAZIDE d00253A C- I10 Essential (primary) hypertension AP E( A METFORMIN d03807A C- E11 R73 Type 2 diabetes mellitus Elevated blood glucose level AP E( A RAMIPRIL d00728A C- I10 Essential (primary) hypertension AP E) A ISOSORBIDE MONONITRATE d00269A C I20.9 Angina pectoris, unspecified A E) A ALENDRONATE d03849A C M81 Osteoporosis without current pathological fracture AP E) A PREDNISONE d00350A D E78.0 Pure hypercholesterolemia AP E) A PROCHLORPERAZINE d00355A Cr R11 Nausea and vomiting AP E) A TACROLIMUS d03752A D L40 Psoriasis AP E) A TRAMADOL d03826A C M54 Dorsalgia AP E) A . . . E)0 A . . . E)@ A CETIRIZINE d03827A D J30.1 T78.40 Allergic rhinitis due to pollen Allergy, unspecified A@ E)@ A LISINOPRIL d00732A Cr E78.0 Pure hypercholesterolemia A@ E)@ A OMEPRAZOLE d00325A D K30 Functional dyspepsia A@ E)@ A WARFARIN d00022A Cr Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A@ E)P A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A E)P A GABAPENTIN d03182A Ei R52 Pain, unspecified A E)P A GLIPIZIDE d00246A Ei E11 Type 2 diabetes mellitus A E)P A HYDROCHLOROTHIAZIDE d00253A D I99.9 Unspecified disorder of circulatory system A E)P A INSULIN LISPRO; INSULIN LISPRO PROTAMINE d04510A Ei E11 Type 2 diabetes mellitus A E)P A ISOSORBIDE DINITRATE d00268A D I51.9P Prevent heart disease A E)P A LOSARTAN d03821A Ei I10 Essential (primary) hypertension A E)P A METFORMIN d03807A D E11 Type 2 diabetes mellitus A E)P A SITAGLIPTIN d05896A Ei E11 Type 2 diabetes mellitus A E)` A ALENDRONATE d03849A D M85.9 Disorder of bone density and structure, unspecified A0 E)` A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A0 E)` A PRAVASTATIN d00348A B E78.0 Pure hypercholesterolemia A0 E)p A ACETAMINOPHEN; BUTALBITAL; CAFFEINE d03455A C- G43 Migraine A@ E)p A OXCARBAZEPINE d04513A B F39 Unspecified mood [affective] disorder A@ E)p A PAROXETINE d03157A C- F39 F41.9 Unspecified mood [affective] disorder Anxiety disorder, unspecified A@ E)p A TOPIRAMATE d04115A C- G43 Migraine A@ E) A IBUPROFEN d00015A Ap R07.9 Chest pain, unspecified A E) A . . . E) A . . . E) A . . . E) A ATENOLOL d00004A D I49.9 Cardiac arrhythmia, unspecified A@ E) A ESOMEPRAZOLE d04749A Ap K21 Gastro-esophageal reflux disease A@ E) A LAMOTRIGINE d03809A Bz G40 Epilepsy and recurrent seizures A@ E) A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A@ E) A . . . E) A . . . E) A . . . E* A TRIAMTERENE d00396A C- I10 Essential (primary) hypertension A E* A 99999 . . A E* A . . . E*0 A . . . E*@ A . . . E*P A . . . E*` A . . . E*p A . . . E* A . . . E* A . . . E* A ALBUTEROL d00749A C- J45 Asthma A E* A . . . E* A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C[@ I10 Essential (primary) hypertension A E* A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A E* A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ E* A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus A@ E* A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A@ E* A METOPROLOL d00134A B I49.9 Cardiac arrhythmia, unspecified A@ E* A ACETAMINOPHEN; HYDROCODONE d03428A C M25.5 M54 Pain in joint Dorsalgia B E* A ALBUTEROL d00749A A J44.9 Chronic obstructive pulmonary disease, unspecified B E* A ALBUTEROL; IPRATROPIUM d04066A C[@ J44.9 Chronic obstructive pulmonary disease, unspecified B E* A ALPRAZOLAM d00168A Bz F41.9 Anxiety disorder, unspecified B E* A ATORVASTATIN d04105A C[@ I21.P Prevent heart attack/myocardial infarction B E* A CARVEDILOL d03847A C- I10 I50.9 Essential (primary) hypertension Heart failure, unspecified B E* A CLOPIDOGREL d04258A C[@ I21 ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction B E* A ESOMEPRAZOLE d04749A C- K21 Gastro-esophageal reflux disease B E* A FLUTICASONE NASAL d04283A A J30.9 Allergic rhinitis, unspecified B E* A FUROSEMIDE d00070A C[@ I50.9 I51.9 Heart failure, unspecified Heart disease, unspecified B E* A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified B E* A LIRAGLUTIDE d07466A C E11 Type 2 diabetes mellitus B E* A LISINOPRIL d00732A C I10 I50.9 Essential (primary) hypertension Heart failure, unspecified B E* A LISINOPRIL d00732A C I10 Essential (primary) hypertension B E* A METFORMIN d03807A C E11 Type 2 diabetes mellitus B E* A NITROGLYCERIN d00321A B= I20.9 Angina pectoris, unspecified B E* A POTASSIUM CHLORIDE d00345A C[@ E87.6 Hypokalemia B E* A PREGABALIN d05508A C E11.4 Type 2 diabetes mellitus with neurological complications B E* A ROPINIROLE d04215A Cr G25.81 Restless legs syndrome B E* A . . . E+ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E+ A LISDEXAMFETAMINE d06663A C[@ F90 Attention-deficit hyperactivity disorders A E+ A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E+ A . . . E+0 A . . . E+@ A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E+@ A CLONIDINE d00044A C I10 Essential (primary) hypertension A E+@ A ESOMEPRAZOLE d04749A C K21 Gastro-esophageal reflux disease A E+@ A FUROSEMIDE d00070A C R60.9 Edema, unspecified A E+@ A METFORMIN d03807A D E11 Type 2 diabetes mellitus A E+@ A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A E+@ A RAMIPRIL d00728A C I10 Essential (primary) hypertension A E+@ A ROSUVASTATIN d04851A B E78.0 Pure hypercholesterolemia A E+@ A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A E+P A . . . E+` A . . . E+p A . . . E+ A DEXMETHYLPHENIDATE d04777A B F90 Attention-deficit hyperactivity disorders A E+ A ACETAMINOPHEN; HYDROCODONE d03428A B= G89 M25.5 Pain, not elsewhere classified Pain in joint A0 E+ A INDOMETHACIN d00039A Ap R60.9 Edema, unspecified A0 E+ A MELOXICAM d04532A C M25.5 Pain in joint A0 E+ A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia A E+ A CARVEDILOL d03847A C I21.P Prevent heart attack/myocardial infarction A E+ A CELECOXIB d04380A C T14.9 Unspecified injury A E+ A DILTIAZEM d00045A Ei 99999 A E+ A DORZOLAMIDE OPHTHALMIC d03805A D H40 Glaucoma A E+ A FEBUXOSTAT d07397A D E79.9 Disorder of purine and pyrimidine metabolism, unspecified A E+ A FINASTERIDE d00563A B N42.9 Disorder of prostate, unspecified A E+ A FUROSEMIDE d00070A C R06.9 Unspecified abnormalities of breathing A E+ A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A E+ A ISOSORBIDE DINITRATE d00268A C I51.9 Heart disease, unspecified A E+ A LATANOPROST OPHTHALMIC d04017A D H40 Glaucoma A E+ A LOSARTAN d03821A C I10 Essential (primary) hypertension A E+ A MIRABEGRON d07876A B N42.9 Disorder of prostate, unspecified A E+ A TERAZOSIN d00386A D N42.9 Disorder of prostate, unspecified A E+ A . . . E+ A ALBUTEROL d00749A C J45 Asthma AP E+ A BECLOMETHASONE d00760A B J45 Asthma AP E+ A CETIRIZINE d03827A C T78.40 Allergy, unspecified AP E+ A MONTELUKAST d04289A C R06.2 Wheezing AP E+ A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease AP E+ A ETONOGESTREL d04772A C Z79.3 Long term (current) use of hormonal contraceptives A E+ A . . . E+ A THYROID DESICCATED d00655A C E03.9 Hypothyroidism, unspecified A E, A . . . E, A . . . E, A . . . E,0 A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E,@ A SUMATRIPTAN d03160A BZ G43 Migraine A E,P A ETHINYL ESTRADIOL; NORGESTIMATE d03781A B Z79.3 Long term (current) use of hormonal contraceptives A E,` A ATENOLOL d00004A D1 I10 Essential (primary) hypertension A` E,` A ATORVASTATIN d04105A B* I70.P Prevent atherosclerosis A` E,` A ESOMEPRAZOLE d04749A BK K30 Functional dyspepsia A` E,` A HYDROCHLOROTHIAZIDE d00253A D1 I10 Essential (primary) hypertension A` E,` A PREDNISONE d00350A C1` 55555 A` E,` A TAMSULOSIN d04121A Cr N40 Enlarged prostate A` E,p A . . . E, A . . . E, A . . . E, A AMOXICILLIN; CLAVULANATE d00089A A0 J01.9 Acute sinusitis, unspecified A@ E, A DEXAMETHASONE d00206A A0 J01.9 Acute sinusitis, unspecified A@ E, A LEVOTHYROXINE d00278A A0 E03.9 Hypothyroidism, unspecified A@ E, A SIMVASTATIN d00746A A0 E78.0 Pure hypercholesterolemia A@ E, A . . . E, A . . . E, A . . . E, A . . . E, A . . . E- A . . . E- A . . . E- A DOXAZOSIN d00726A Cr I10 Essential (primary) hypertension A0 E- A HYDROCHLOROTHIAZIDE; OLMESARTAN d04878A Dc I10 Essential (primary) hypertension A0 E- A RALOXIFENE d04261A Cr M81 Osteoporosis without current pathological fracture A0 E-0 A . . . E-@ A CYCLOBENZAPRINE d00963A B M79.1 Myalgia A E-@ A IBUPROFEN d00015A B Z79.1 Long term (current) use of non-steroidal anti-inflammatories (NSAID) A E-P A . . . E-` A . . . E-p A . . . E- A . . . E- A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A0 E- A DICLOFENAC d00848A B M54 Dorsalgia A0 E- A TIZANIDINE d04102A B M62.83 M79.1 Muscle spasm Myalgia A0 E- A . . . E- A . . . E- A . . . E- A . . . E- A . . . E- A . . . E. A . . . E. A . . . E. A ALBUTEROL d00749A D J44.9 J45 Chronic obstructive pulmonary disease, unspecified Asthma A E.0 A . . . E.@ A HYDROCHLOROTHIAZIDE d00253A B I10 Essential (primary) hypertension A E.@ A MIRABEGRON d07876A A R32 Unspecified urinary incontinence A E.P A . . . E.` A ESCITALOPRAM d04812A B F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E.` A TRAZODONE d00395A B F32.9 G47.0 Major depressive disorder, single episode, unspecified Insomnia A E.p A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified AP E.p A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP E.p A LEVOTHYROXINE d00278A D# E03.9 Hypothyroidism, unspecified AP E.p A MECLIZINE d00859A C- R42 Dizziness and giddiness AP E.p A POTASSIUM CHLORIDE d00345A C- 99999 AP E. A . . . E. A . . . E. A . . . E. A SERTRALINE d00880A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E. A . . . E. A . . . E. A . . . E. A . . . E/ A ATENOLOL d00004A C I10 Essential (primary) hypertension A@ E/ A MELOXICAM d04532A C M19.9 Osteoarthritis, unspecified site A@ E/ A PANTOPRAZOLE d04514A D K25 Gastric ulcer A@ E/ A SERTRALINE d00880A Dc F32.9 Major depressive disorder, single episode, unspecified A@ E/ A . . . E/ A OMEPRAZOLE d00325A B[ B96.81 Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere A E/0 A . . . E/@ A AMITRIPTYLINE d00146A Cr M79.2 Neuralgia and neuritis, unspecified A E/@ A CARVEDILOL d03847A C I21.P I50.9 Prevent heart attack/myocardial infarction Heart failure, unspecified A E/@ A CLOPIDOGREL d04258A Cr D75.9P I21 Prevent blood clots ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction A E/@ A DILTIAZEM d00045A Cr I20.9 I21 Angina pectoris, unspecified ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction A E/@ A EZETIMIBE; SIMVASTATIN d05348A B E78.0 Pure hypercholesterolemia A E/@ A FUROSEMIDE d00070A B R60.9 Edema, unspecified A E/@ A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A E/@ A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E/@ A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A E/@ A OMEPRAZOLE d00325A C K21 K30 Gastro-esophageal reflux disease Functional dyspepsia A E/@ A PIOGLITAZONE d04442A C E11 Type 2 diabetes mellitus A E/@ A ROPINIROLE d04215A CDp G25.81 Restless legs syndrome A E/@ A SITAGLIPTIN d05896A B E11 Type 2 diabetes mellitus A E/@ A TOPIRAMATE d04115A C G43 Migraine A E/@ A VENLAFAXINE d03181A C[@ E11.4 Type 2 diabetes mellitus with neurological complications A E/P A . . . E/` A . . . E/p A . . . E/ A ALBUTEROL d00749A Cr J42 Unspecified chronic bronchitis A E/ A ATORVASTATIN d04105A B= E78.0 Pure hypercholesterolemia A E/ A DILTIAZEM d00045A B[ 99999 A E/ A GABAPENTIN d03182A B 99999 A E/ A HYDROCORTISONE TOPICAL d03205A Cr R21 Rash and other nonspecific skin eruption A E/ A HYDROXYZINE d00907A B 99999 A E/ A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A E/ A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A E/ A OMEPRAZOLE d00325A B[ K21 Gastro-esophageal reflux disease A E/ A TRAZODONE d00395A B G43.P Prevent migraine A E/ A TRIAMCINOLONE TOPICAL d03206A Cr R21 Rash and other nonspecific skin eruption A E/ A . . . E/ A . . . E/ A . . . E/ A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A E/ A CARVEDILOL d03847A C I10 Essential (primary) hypertension A E/ A FUROSEMIDE d00070A C- 99999 A E/ A HYDRALAZINE d00132A B[ I10 Essential (primary) hypertension A E/ A IBUPROFEN d00015A C M06.9 Rheumatoid arthritis, unspecified A E/ A ISOSORBIDE DINITRATE d00268A CDp 99999 A E/ A LINAGLIPTIN d07767A C- I10 Essential (primary) hypertension A E/ A PANTOPRAZOLE d04514A C 99999 A E/ A POTASSIUM CHLORIDE d00345A CDp 99999 A E/ A TRAMADOL d03826A C M79.1 Myalgia A E/ A HYDROCHLOROTHIAZIDE d00253A B[ R60.9 Edema, unspecified A0 E/ A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension A0 E/ A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus A0 E/ A AMLODIPINE d00689A0 C I10 Essential (primary) hypertension AP E/ A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A0 C I10 Essential (primary) hypertension AP E/ A LISINOPRIL d00732A0 C I10 Essential (primary) hypertension AP E/ A METOPROLOL d00134A0 C I10 Essential (primary) hypertension AP E/ A SIMVASTATIN d00746A0 C E78.0 Pure hypercholesterolemia AP E/ A . . . E0 A . . . E0 A . . . E0 A . . . E00 A . . . E0@ A . . . E0P A . . . E0` A . . . E0p A . . . E0 A . . . E0 A ALBUTEROL d00749A CDp J45 Asthma AP E0 A AMLODIPINE d00689A A I10 Essential (primary) hypertension AP E0 A BENZTROPINE d00175A CDp F32.9 Major depressive disorder, single episode, unspecified AP E0 A PREDNISONE d00350A A R06.2 Wheezing AP E0 A RISPERIDONE d03180A CDp F32.9 Major depressive disorder, single episode, unspecified AP E0 A . . . E0 A CODEINE; GUAIFENESIN d03393A Ap R05 Cough A E0 A DOXYCYCLINE d00037A Ap I10 Essential (primary) hypertension A E0 A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E0 A OMEPRAZOLE d00325A CDp K30 Functional dyspepsia A E0 A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E0 A . . . E0 A . . . E1 A . . . E1 A ETONOGESTREL d04772A CDp Z79.3 Long term (current) use of hormonal contraceptives A E1 A DILTIAZEM d00045A D I10 Essential (primary) hypertension AP E1 A OMEPRAZOLE d00325A D K21 K30 Gastro-esophageal reflux disease Functional dyspepsia AP E1 A SERTRALINE d00880A D 99999 AP E1 A SODIUM CHLORIDE d00438A B= 55555 AP E1 A WARFARIN d00022A D* D75.9P Prevent blood clots AP E10 A . . . E1@ A . . . E1P A . . . E1` A . . . E1p A . . . E1 A . . . E1 A AMOXICILLIN d00088A Ap J01.9 Acute sinusitis, unspecified A E1 A IBUPROFEN d00015A B M54 Dorsalgia A E1 A ALPRAZOLAM d00168A Cr F41.9 Anxiety disorder, unspecified A0 E1 A CITALOPRAM d04332A Cr F32.9 Major depressive disorder, single episode, unspecified A0 E1 A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A0 E1 A AMLODIPINE d00689A C- I10 Essential (primary) hypertension AP E1 A GLIPIZIDE d00246A D E11 Type 2 diabetes mellitus AP E1 A LISINOPRIL d00732A D ^ I10 Essential (primary) hypertension AP E1 A METFORMIN d03807A D E11 Type 2 diabetes mellitus AP E1 A TAMSULOSIN d04121A B N40 Enlarged prostate AP E1 A GABAPENTIN d03182A C R60.9 Edema, unspecified A E1 A METOPROLOL d00134A Dc I10 Essential (primary) hypertension A E1 A . . . E1 A . . . E2 A ALBUTEROL d00749A C R05 R06.02 R06.2 Cough Shortness of breath Wheezing Ap E2 A AMITRIPTYLINE d00146A C F43.9 G47.0 K92.9 Reaction to severe stress, unspecified Insomnia Disease of digestive system, unspecified Ap E2 A BUDESONIDE; FORMOTEROL d04795A C R06.02 Shortness of breath Ap E2 A IBANDRONATE d05357A CDp M81 Osteoporosis without current pathological fracture Ap E2 A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified Ap E2 A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease Ap E2 A TAVABOROLE TOPICAL d08272A CDp L08.9 Local infection of the skin and subcutaneous tissue, unspecified Ap E2 A . . . E2 A . . . E20 A . . . E2@ A BUSPIRONE d00182A C F41.9 Anxiety disorder, unspecified A@ E2@ A FLUOXETINE d00236A C F32.9 Major depressive disorder, single episode, unspecified A@ E2@ A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A@ E2@ A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E2P A . . . E2` A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A C- Z79.3 Long term (current) use of hormonal contraceptives A E2p A . . . E2 A IBUPROFEN d00015A CDp R50.9 Fever, unspecified A E2 A . . . E2 A . . . E2 A . . . E2 A . . . E2 A GEMFIBROZIL d00245A C- E78.0 Pure hypercholesterolemia A E2 A LOSARTAN d03821A C"0 I10 Essential (primary) hypertension A E2 A . . . E2 A . . . E3 A . . . E3 A ALBUTEROL d00749A B( J20.9 R06.02 Acute bronchitis, unspecified Shortness of breath AP E3 A BENZONATATE d00796A C[@ J00 Acute nasopharyngitis [common cold] AP E3 A BROMPHENIRAMINE; PSEUDOEPHEDRINE d03301A A J00 Acute nasopharyngitis [common cold] AP E3 A IBUPROFEN d00015A A H93.9 Unspecified disorder of ear AP E3 A PROMETHAZINE d00787A B( J40 Bronchitis, not specified as acute or chronic AP E3 A . . . E30 A . . . E3@ A . . . E3P A . . . E3` A . . . E3p A HYDROCHLOROTHIAZIDE d00253A CDp I10 Essential (primary) hypertension A E3 A LATANOPROST OPHTHALMIC d04017A C- H40 Glaucoma A E3 A . . . E3 A PENICILLIN d00116A A K04.7P Prevent tooth infection A E3 A ALBIGLUTIDE d08251A B# E11 Type 2 diabetes mellitus A E3 A ALBUTEROL d00749A C[@ J45 Asthma A E3 A FLUTICASONE d01296A CDp J45 Asthma A E3 A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A E3 A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A E3 A NIFEDIPINE d00051A C I10 Essential (primary) hypertension A E3 A OMEPRAZOLE d00325A C[@ K21 Gastro-esophageal reflux disease A E3 A SERTRALINE d00880A CDp F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E3 A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A E3 A RANITIDINE d00021A B K21 Gastro-esophageal reflux disease A E3 A ALBUTEROL d00749A CDp J44.9 Chronic obstructive pulmonary disease, unspecified AP E3 A BUDESONIDE; FORMOTEROL d04795A CDp R06.9 Unspecified abnormalities of breathing AP E3 A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP E3 A METOPROLOL d00134A C 99999 AP E3 A SIMVASTATIN d00746A C 99999 AP E3 A AMLODIPINE d00689A B[ I10 Essential (primary) hypertension A E3 A HYDROCHLOROTHIAZIDE d00253A B[ I10 Essential (primary) hypertension A E3 A . . . E4 A . . . E4 A ONDANSETRON d00867A Ap R11 Nausea and vomiting A E4 A . . . E40 A ALBUTEROL d00749A C J45 Asthma A E40 A FLUTICASONE; SALMETEROL d04611A CDp J45 Asthma A E4@ A MIRTAZAPINE d04025A C- F32.9 F41.9 G47.0 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Insomnia A E4P A . . . E4` A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A0 E4` A CEFDINIR d04256A Ap H66.9 Otitis media, unspecified A0 E4` A DEXMETHYLPHENIDATE d04777A B= R41 Other symptoms and signs involving cognitive functions and awareness A0 E4p A TRIAMCINOLONE TOPICAL d03206A B[ L20.9 Atopic dermatitis, unspecified A E4 A ACEBUTOLOL d00128A D"8 I10 Essential (primary) hypertension A E4 A ACETAMINOPHEN; HYDROCODONE d03428A CO M54 M79.1 M79.6 Dorsalgia Myalgia Pain in limb, hand, foot, fingers and toes A E4 A APREMILAST d08247A B L40 Psoriasis A E4 A CANDESARTAN d04322A D I10 Essential (primary) hypertension A E4 A CEPHALEXIN d00096A C L08.9 Local infection of the skin and subcutaneous tissue, unspecified A E4 A DILTIAZEM d00045A D"8 I10 Essential (primary) hypertension A E4 A EZETIMIBE d04824A C E78.0 Pure hypercholesterolemia A E4 A HYDROCHLOROTHIAZIDE d00253A C[@ I10 Essential (primary) hypertension A E4 A AMOXICILLIN d00088A A J02 Acute pharyngitis A E4 A . . . E4 A ALBUTEROL d00749A C J45 Asthma A E4 A ACETAMINOPHEN; HYDROCODONE d03428A B M25.5 M54 Pain in joint Dorsalgia A` E4 A CARISOPRODOL d00960A Ei M54 M79.1 Dorsalgia Myalgia A` E4 A CLONAZEPAM d00197A Ei F32.9 Major depressive disorder, single episode, unspecified A` E4 A LOVASTATIN d00280A Cr E78.0 Pure hypercholesterolemia A` E4 A METOCLOPRAMIDE d00298A Ei 99999 A` E4 A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A` E4 A . . . E4 A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia A E4 A . . . E5 A AMLODIPINE d00689A C"@ I10 Essential (primary) hypertension Ap E5 A HYDROCHLOROTHIAZIDE d00253A D ^ I63.P Prevent stroke Ap E5 A IPRATROPIUM d00265A Bz R09.8 Other specified symptoms and signs involving the circulatory and respiratory systems Ap E5 A MELOXICAM d04532A C[@ M79.1 Myalgia Ap E5 A PANTOPRAZOLE d04514A C K30 Functional dyspepsia Ap E5 A PHENTERMINE d00806A A E66 Overweight and obesity Ap E5 A VENLAFAXINE d03181A D F41.9 Anxiety disorder, unspecified Ap E5 A . . . E5 A . . . E50 A . . . E5@ A . . . E5P A METFORMIN d03807A C E11.P Prevent diabetes A E5` A POLYETHYLENE GLYCOL 3350 d05350A C- K59.0 Constipation A E5p A METHYLPHENIDATE d00900A D F90 Attention-deficit hyperactivity disorders A E5 A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified A0 E5 A AMOXICILLIN d00088A Ap N39.0 Urinary tract infection, site not specified A0 E5 A PAROXETINE d03157A Dc F32.9 Major depressive disorder, single episode, unspecified A0 E5 A . . . E5 A . . . E5 A . . . E5 A . . . E5 A . . . E5 A . . . E5 A . . . E6 A . . . E6 A 99999 . . A E6 A DOXAZOSIN d00726A C R39.9 Unspecified symptoms and signs involving the genitourinary system A E6 A . . . E60 A . . . E6@ A 99999 . . A E6P A . . . E6` A ETORICOXIB h00039A C M25.9 Joint disorder, unspecified A E6` A LOSARTAN d03821A D I10 Essential (primary) hypertension A E6p A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A CDp I10 Essential (primary) hypertension A E6 A ROSUVASTATIN d04851A C- E78.0 Pure hypercholesterolemia A E6 A VALSARTAN d04113A C- I10 Essential (primary) hypertension A E6 A . . . E6 A GLIPIZIDE d00246A Ei E11 Type 2 diabetes mellitus A E6 A LISINOPRIL d00732A Ei I10 Essential (primary) hypertension A E6 A ALENDRONATE d03849A Cr M81 Osteoporosis without current pathological fracture A@ E6 A DILTIAZEM d00045A Dc I10 Essential (primary) hypertension A@ E6 A DONEPEZIL d04099A C- G30.9 G31.9 R41 Alzheimer's disease, unspecified Degenerative disease of nervous system, unspecified Other symptoms and signs involving cognitive functions and awareness A@ E6 A MEMANTINE d04899A CDp G30.9 G31.9 R41 Alzheimer's disease, unspecified Degenerative disease of nervous system, unspecified Other symptoms and signs involving cognitive functions and awareness A@ E6 A . . . E6 A . . . E6 A . . . E6 A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP E6 A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E6 A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP E6 A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP E6 A METOPROLOL d00134A C I10 R07.9 Essential (primary) hypertension Chest pain, unspecified AP E7 A . . . E7 A . . . E7 A . . . E70 A . . . E7@ A FINASTERIDE d00563A Dc N40 Enlarged prostate AP E7@ A INDOMETHACIN d00039A D M1A Chronic gout AP E7@ A ISOSORBIDE d00653A Cr I10 Essential (primary) hypertension AP E7@ A METFORMIN d03807A D E11 Type 2 diabetes mellitus AP E7@ A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia AP E7P A . . . E7` A . . . E7p A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified Ap E7p A CITALOPRAM d04332A Dc F32.9 Major depressive disorder, single episode, unspecified Ap E7p A LISINOPRIL d00732A C I10 Essential (primary) hypertension Ap E7p A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease Ap E7p A RIVAROXABAN d07356A C I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified Ap E7p A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia Ap E7p A TRAZODONE d00395A Dc F41.9 Anxiety disorder, unspecified Ap E7 A ETHINYL ESTRADIOL; NORGESTIMATE d03781A B= Z79.3 Long term (current) use of hormonal contraceptives A E7 A . . . E7 A . . . E7 A . . . E7 A . . . E7 A . . . E7 A . . . E7 A . . . E8 A ACETAMINOPHEN; OXYCODONE d03431A C9 M54 Dorsalgia Ap E8 A BENZTROPINE d00175A Dc F32.9 Major depressive disorder, single episode, unspecified Ap E8 A CITALOPRAM d04332A C- F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Ap E8 A CLONIDINE d00044A D# I10 Essential (primary) hypertension Ap E8 A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A C- I10 R60.9 Essential (primary) hypertension Edema, unspecified Ap E8 A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus Ap E8 A TRAZODONE d00395A D F32.9 F41.9 G47.0 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Insomnia Ap E8 A ETHINYL ESTRADIOL; NORGESTIMATE d03781A CDp Z79.3 Long term (current) use of hormonal contraceptives A E8 A . . . E80 A . . . E8@ A FLUTICASONE NASAL d04283A A R09.81 Nasal congestion A E8@ A IBUPROFEN d00015A A@ M06.9 Rheumatoid arthritis, unspecified A E8P A ALBUTEROL d00749A C J45 Asthma AP E8P A ALBUTEROL d00749A C J45 Asthma AP E8P A FLUTICASONE NASAL d04283A CDp J30.2 J30.9 Other seasonal allergic rhinitis Allergic rhinitis, unspecified AP E8P A FLUTICASONE; SALMETEROL d04611A CDp J45 Asthma AP E8P A MONTELUKAST d04289A CDp J45 Asthma AP E8` A RANITIDINE d00021A B= K21 Gastro-esophageal reflux disease A E8p A . . . E8 A . . . E8 A ALBUTEROL d00749A C[@ J45 Asthma A@ E8 A FLUTICASONE d01296A Bz J45 Asthma A@ E8 A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A@ E8 A OMEPRAZOLE d00325A C K21 K30 R12 Gastro-esophageal reflux disease Functional dyspepsia Heartburn A@ E8 A CLOPIDOGREL d04258A C[@ 99999 A E8 A DOXAZOSIN d00726A CDp 99999 A E8 A FUROSEMIDE d00070A C I51.9 Heart disease, unspecified A E8 A INSULIN ASPART d04697A C E11 Type 2 diabetes mellitus A E8 A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A E8 A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E8 A MECLIZINE d00859A C- R42 Dizziness and giddiness A E8 A METOPROLOL d00134A C 99999 A E8 A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A E8 A SERTRALINE d00880A C 99999 A E8 A SIMVASTATIN d00746A C 99999 A E8 A SPIRONOLACTONE d00373A C 99999 A E8 A . . . E8 A LEVOTHYROXINE d00278A CDp E07.9 Disorder of thyroid, unspecified A E8 A NAPROXEN d00019A B R51 Headache A E8 A . . . E8 A . . . E9 A . . . E9 A . . . E9 A IBUPROFEN d00015A B R50.9 Fever, unspecified A E90 A . . . E9@ A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A` E9@ A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A` E9@ A HYDROCHLOROTHIAZIDE d00253A CDp R60.9 Edema, unspecified A` E9@ A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A` E9@ A PANTOPRAZOLE d04514A CDp K25 Gastric ulcer A` E9@ A TRAMADOL d03826A C- M06.9 Rheumatoid arthritis, unspecified A` E9P A . . . E9` A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A0 E9` A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A0 E9` A OMEPRAZOLE d00325A CDp 99999 A0 E9p A ETHINYL ESTRADIOL; NORGESTIMATE d03781A B N92 Excessive, frequent and irregular menstruation A E9p A FLUORIDE TOPICAL d04397A C K08.8 Other specified disorders of teeth and supporting structures A E9 A . . . E9 A . . . E9 A CIPROFLOXACIN d00011A A N30 Cystitis A E9 A GUAIFENESIN d00797A B R05 Cough A E9 A . . . E9 A MONTELUKAST d04289A B= J30.9 R06.9 Allergic rhinitis, unspecified Unspecified abnormalities of breathing A E9 A . . . E9 A . . . E9 A . . . E: A . . . E: A ACYCLOVIR d00001A B A60.9 B00.1 Anogenital herpesviral infection, unspecified Herpesviral vesicular dermatitis A E: A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A A@ L08.9 Local infection of the skin and subcutaneous tissue, unspecified A E:0 A . . . E:@ A METHYLPHENIDATE d00900A B F90 Attention-deficit hyperactivity disorders A E:P A AMLODIPINE d00689A B= I10 Essential (primary) hypertension AP E:P A DICLOFENAC d00848A B G43 Migraine AP E:P A PREDNISONE d00350A A@ T78.40 Allergy, unspecified AP E:P A TIZANIDINE d04102A B= M79.7 Fibromyalgia AP E:P A TOPIRAMATE d04115A B G43 Migraine AP E:` A . . . E:p A FAMOTIDINE d00141A C K30 Functional dyspepsia Ap E:p A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension Ap E:p A LORAZEPAM d00149A C- F41.9 Anxiety disorder, unspecified Ap E:p A METOPROLOL d00134A C I49.9 Cardiac arrhythmia, unspecified Ap E:p A MIRTAZAPINE d04025A CDp G47.0 Insomnia Ap E:p A SUCRALFATE d00377A D K25 Gastric ulcer Ap E:p A WARFARIN d00022A CDp D75.9P Prevent blood clots Ap E: A . . . E: A BUDESONIDE; FORMOTEROL d04795A C- J44.9 Chronic obstructive pulmonary disease, unspecified Ap E: A CELECOXIB d04380A C[@ M13 Other arthritis Ap E: A EZETIMIBE d04824A CDp E78.0 Pure hypercholesterolemia Ap E: A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension Ap E: A METFORMIN d03807A C E11 Type 2 diabetes mellitus Ap E: A PANTOPRAZOLE d04514A Cr K30 Functional dyspepsia Ap E: A TAMSULOSIN d04121A B N40 Enlarged prostate Ap E: A . . . E: A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia A@ E: A INSULIN GLARGINE d04538A C- R73 Elevated blood glucose level A@ E: A LISINOPRIL d00732A D I10 Essential (primary) hypertension A@ E: A METFORMIN d03807A D E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A@ E: A . . . E: A . . . E: A . . . E: A . . . E; A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E; A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E; A . . . E; A . . . E;0 A . . . E;@ A . . . E;P A . . . E;` A . . . E;p A . . . E; A DILTIAZEM d00045A C I10 Essential (primary) hypertension A@ E; A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A B= R60.9 Edema, unspecified A@ E; A PRAVASTATIN d00348A Ei E78.0 Pure hypercholesterolemia A@ E; A TAMSULOSIN d04121A C N40 Enlarged prostate A@ E; A . . . E; A DOXYCYCLINE d00037A B B96.81 Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere A E; A DIAZEPAM d00148A C M62.83 Muscle spasm A@ E; A LOSARTAN d03821A C I10 Essential (primary) hypertension A@ E; A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E; A SIMVASTATIN d00746A C E78.0P Prevent high cholesterol A@ E; A ACETAMINOPHEN; BUTALBITAL; CAFFEINE d03455A D R51 Headache A E; A BACLOFEN d00967A B M62.83 Muscle spasm A E; A DULOXETINE d05355A C- M79.7 Fibromyalgia A E; A GABAPENTIN d03182A Cr M54 Dorsalgia A E; A METFORMIN d03807A C"0 R73 Elevated blood glucose level A E; A METOPROLOL d00134A Bz R00 Abnormalities of heart beat A E; A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease A E; A ONDANSETRON d00867A C R11 Nausea and vomiting A E; A TERAZOSIN d00386A C"0 T88.7P Prevent drug side effect A E; A TRAZODONE d00395A B[ G47.0 Insomnia A E; A . . . E; A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A@ E; A MELOXICAM d04532A C M06.9 Rheumatoid arthritis, unspecified A@ E; A METOPROLOL d00134A C- I21.P Prevent heart attack/myocardial infarction A@ E; A TAMSULOSIN d04121A C N40 Enlarged prostate A@ E; A . . . E< A . . . E< A ALENDRONATE d03849A C[@ M81 Osteoporosis without current pathological fracture A E< A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A E< A DEXAMETHASONE d00206A C R52 Pain, unspecified A E< A FUROSEMIDE d00070A C R60.9 Edema, unspecified A E< A GABAPENTIN d03182A CDp 99999 A E< A LEUCOVORIN d00275A C- M19.9 Osteoarthritis, unspecified site A E< A METFORMIN d03807A Bz R73 Elevated blood glucose level A E< A METHOTREXATE d00060A C- M19.9 Osteoarthritis, unspecified site A E< A SPIRONOLACTONE d00373A C R60.9 Edema, unspecified A E< A VERAPAMIL d00048A C[@ 99999 A E< A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C- F90 Attention-deficit hyperactivity disorders A E<0 A ALBUTEROL d00749A B[ J20.9 J45 R05 Acute bronchitis, unspecified Asthma Cough A E<@ A . . . E
A CETIRIZINE d03827A C T78.40 Allergy, unspecified A0 E> A DICYCLOMINE d00999A D R10 Abdominal and pelvic pain A0 E> A FLUTICASONE NASAL d04283A Cr J30.9 Allergic rhinitis, unspecified A0 E> A AZATHIOPRINE d00024A C K50 Crohn's disease [regional enteritis] AP E> A GABAPENTIN d03182A C K50 Crohn's disease [regional enteritis] AP E> A MESALAMINE d01031A C K50 Crohn's disease [regional enteritis] AP E> A ONDANSETRON d00867A C- K50 Crohn's disease [regional enteritis] AP E> A PREDNISONE d00350A C K50 Crohn's disease [regional enteritis] AP E> A ALBUTEROL d00749A C J44.9 Chronic obstructive pulmonary disease, unspecified A@ E> A ALBUTEROL d00749A0 C J44.9 Chronic obstructive pulmonary disease, unspecified A@ E> A BUDESONIDE; FORMOTEROL d04795A0 C J44.9 Chronic obstructive pulmonary disease, unspecified A@ E> A TIOTROPIUM d04829A0 C J44.9 Chronic obstructive pulmonary disease, unspecified A@ E>0 A AMLODIPINE d00689A Ei I10 Essential (primary) hypertension B E>0 A ATORVASTATIN d04105A Ei E78.0 Pure hypercholesterolemia B E>0 A CETIRIZINE d03827A Ei L29.9 Pruritus, unspecified B E>0 A CLOPIDOGREL d04258A Ei D75.9P Prevent blood clots B E>0 A DOXEPIN TOPICAL d03774A Ei L29.9 Pruritus, unspecified B E>0 A FLUOCINOLONE TOPICAL d01293A Ei L29.9 R21 Pruritus, unspecified Rash and other nonspecific skin eruption B E>0 A LATANOPROST OPHTHALMIC d04017A Ei H40 Glaucoma B E>0 A LEVOTHYROXINE d00278A Ei E07.9 Disorder of thyroid, unspecified B E>0 A LISINOPRIL d00732A Ei I10 I21.P Essential (primary) hypertension Prevent heart attack/myocardial infarction B E>0 A MELOXICAM d04532A Ei 99999 B E>0 A METFORMIN d03807A Ei E11 Type 2 diabetes mellitus B E>0 A METOPROLOL d00134A Ei I10 Essential (primary) hypertension B E>0 A NITROGLYCERIN d00321A Ei I20.9 Angina pectoris, unspecified B E>0 A OMEPRAZOLE d00325A Ei K25.P Prevent gastric ulcer B E>0 A RIVAROXABAN d07356A Ei D75.9P Prevent blood clots B E>0 A TIZANIDINE d04102A Ei M62.83 M79.1 Muscle spasm Myalgia B E>@ A . . . E>P A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A B[ 55555 A E>` A . . . E>p A LOSARTAN d03821A B I10 Essential (primary) hypertension A E>p A OMEPRAZOLE d00325A C K30 Functional dyspepsia A E> A . . . E> A GABAPENTIN d03182A C E11.4 Type 2 diabetes mellitus with neurological complications A0 E> A GLIMEPIRIDE d03864A C E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A0 E> A NAPROXEN d00019A C M79.1 Myalgia A0 E> A . . . E> A . . . E> A . . . E> A GEMFIBROZIL d00245A D* E78.0 Pure hypercholesterolemia A0 E> A LEVOTHYROXINE d00278A D@) E03.9 Hypothyroidism, unspecified A0 E> A PIOGLITAZONE d04442A DNk E11 Type 2 diabetes mellitus A0 E> A 77777 . . Ap E> A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia Ap E> A BENAZEPRIL d00730A A I10 Essential (primary) hypertension Ap E> A BRIMONIDINE OPHTHALMIC d04048A C H26.9 Unspecified cataract Ap E> A HYDROCHLOROTHIAZIDE d00253A B= R60.9 Edema, unspecified Ap E> A LEVOTHYROXINE d00278A Bz E03.9 Hypothyroidism, unspecified Ap E> A WARFARIN d00022A B= D64.9 Anemia, unspecified Ap E> A AMLODIPINE d00689A0 Dc I10 Essential (primary) hypertension A E> A ATENOLOL d00004A0 D# R00 Abnormalities of heart beat A E> A CLOPIDOGREL d04258A0 C Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A E> A INSULIN ASPART d04697A0 Dc R73 Elevated blood glucose level A E> A INSULIN GLARGINE d04538A0 Dc R73 Elevated blood glucose level A E> A LOSARTAN d03821A0 Dc I10 Essential (primary) hypertension A E> A PRAVASTATIN d00348A0 C I51.9 Heart disease, unspecified A E> A RANITIDINE d00021A0 Bz K21 Gastro-esophageal reflux disease A E> A SILODOSIN d07354A0 CDp N40 Enlarged prostate A E? A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A E? A DUTASTERIDE d04788A C N40 Enlarged prostate A E? A . . . E? A . . . E?0 A INSULIN GLARGINE d04538A C R73 Elevated blood glucose level A E?0 A INSULIN LISPRO d04373A C R73 Elevated blood glucose level A E?@ A . . . E?P A . . . E?` A TRAMADOL d03826A CDp M54 Dorsalgia A E?p A . . . E? A . . . E? A AMLODIPINE; VALSARTAN d06662A C I10 Essential (primary) hypertension A E? A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A E? A CITALOPRAM d04332A C- F32.9 Major depressive disorder, single episode, unspecified A E? A NAPROXEN d00019A C- N94 Pain and other conditions associated with female genital organs and menstrual cycle A E? A . . . E? A . . . E? A BROMPHENIRAMINE; DEXTROMETHORPHAN; PSEUDOEPHEDRINE d03368A B J06.9 Acute upper respiratory infection, unspecified A E? A CETIRIZINE d03827A B J06.9 Acute upper respiratory infection, unspecified A E? A AMOXICILLIN; CLAVULANATE d00089A Ap H66.9 Otitis media, unspecified A E? A CETIRIZINE d03827A Ap T78.40 Allergy, unspecified A E? A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A B= I10 Essential (primary) hypertension A E@ A . . . E@ A . . . E@ A . . . E@0 A BECLOMETHASONE d00760A C R05 Cough A E@@ A ATENOLOL d00004A C I10 Essential (primary) hypertension A@ E@@ A BENAZEPRIL d00730A C I10 Essential (primary) hypertension A@ E@@ A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A@ E@@ A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E@P A LEVOTHYROXINE d00278A CP C80.1 Malignant (primary) neoplasm, unspecified A@ E@P A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E@P A METOPROLOL d00134A C I10 Essential (primary) hypertension A@ E@P A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A@ E@` A HYDROCORTISONE TOPICAL d03205A A L20.9 Atopic dermatitis, unspecified A0 E@` A MOMETASONE TOPICAL d01300A A L20.9 Atopic dermatitis, unspecified A0 E@` A MONTELUKAST d04289A Bz J30.9 J45 Allergic rhinitis, unspecified Asthma A0 E@p A . . . E@ A . . . E@ A CEFDINIR d04256A A J01.9 Acute sinusitis, unspecified A E@ A MONTELUKAST d04289A B J30.9 Allergic rhinitis, unspecified A E@ A . . . E@ A HYDROXYPROGESTERONE d00554A B= 55555 A E@ A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A E@ A ESTRADIOL d00537A CDp N95 Z79.890 Menopausal and other perimenopausal disorders Hormone replacement therapy A0 E@ A PROGESTERONE d00550A CDp M81 N95 Osteoporosis without current pathological fracture Menopausal and other perimenopausal disorders A0 E@ A THYROID DESICCATED d00655A C E03.9 Hypothyroidism, unspecified A0 E@ A . . . E@ A ACETAMINOPHEN; HYDROCODONE d03428A C M54 Dorsalgia A E@ A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E@ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E@ A CARVEDILOL d03847A C I10 Essential (primary) hypertension A E@ A CLOPIDOGREL d04258A C D75.9P Prevent blood clots A E@ A EZETIMIBE d04824A C E78.0 Pure hypercholesterolemia A E@ A INSULIN ASPART d04697A D E11 Type 2 diabetes mellitus A E@ A INSULIN GLARGINE d04538A D E11 Type 2 diabetes mellitus A E@ A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E@ A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E@ A LORAZEPAM d00149A C F41.9 Anxiety disorder, unspecified A E@ A VENLAFAXINE d03181A CDp F32.9 Major depressive disorder, single episode, unspecified A EA A . . . EA A . . . EA A . . . EA0 A . . . EA@ A ALENDRONATE d03849A C M81 Osteoporosis without current pathological fracture A EA@ A ALPRAZOLAM d00168A C F43.9 Reaction to severe stress, unspecified A EA@ A CLONIDINE d00044A B I10 Essential (primary) hypertension A EA@ A CYCLOSPORINE OPHTHALMIC d04836A C[@ H04 Disorders of lacrimal system A EA@ A FLUVASTATIN d03183A C- E78.0 Pure hypercholesterolemia A EA@ A FUROSEMIDE d00070A D# R60.9 Edema, unspecified A EA@ A MOMETASONE NASAL d04223A C J34.9 Unspecified disorder of nose and nasal sinuses A EA@ A POTASSIUM CHLORIDE d00345A D# E87.6 Hypokalemia A EA@ A RANITIDINE d00021A CDp K21 Gastro-esophageal reflux disease A EA@ A WARFARIN d00022A D# I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified A EAP A . . . EA` A AMOXICILLIN d00088A A K04.7 Periapical abscess without sinus A@ EA` A CLINDAMYCIN d00043A Ap K04.7 Periapical abscess without sinus A@ EA` A CLONAZEPAM d00197A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A@ EA` A QUETIAPINE d04220A D F32.9 G47.9 Major depressive disorder, single episode, unspecified Sleep disorder, unspecified A@ EAp A ALBIGLUTIDE d08251A0 C E11 Type 2 diabetes mellitus A EAp A ATORVASTATIN d04105A0 D= E78.0 Pure hypercholesterolemia A EAp A ESOMEPRAZOLE d04749A0 D B96.81 Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere A EAp A FLUTICASONE NASAL d04283A0 C R09.81 Nasal congestion A EAp A INSULIN GLARGINE d04538A0 D= E11 Type 2 diabetes mellitus A EAp A IPRATROPIUM d00265A0 C R06.2 Wheezing A EAp A LEVOTHYROXINE d00278A0 Dc E03.9 Hypothyroidism, unspecified A EAp A VALSARTAN d04113A0 D I21.P Prevent heart attack/myocardial infarction A EA A . . . EA A . . . EA A . . . EA A . . . EA A . . . EA A RANITIDINE d00021A B= K21 Gastro-esophageal reflux disease A EA A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A0 EA A BUPROPION d00181A B F32.9 Major depressive disorder, single episode, unspecified A0 EA A FINASTERIDE d00563A C[@ L65.9 Nonscarring hair loss, unspecified A0 EA A PANTOPRAZOLE d04514A B= K25 Gastric ulcer A EB A . . . EB A BUPROPION d00181A Bz F43.1 F90 Post-traumatic stress disorder (PTSD) Attention-deficit hyperactivity disorders A EB A . . . EB0 A . . . EB@ A CEPHALEXIN d00096A Ap L08.9 Local infection of the skin and subcutaneous tissue, unspecified A EB@ A IBUPROFEN d00015A Ap M79.2 Neuralgia and neuritis, unspecified A EBP A . . . EB` A AMLODIPINE d00689A C I10 Essential (primary) hypertension A0 EB` A PHENTERMINE d00806A A E66 Overweight and obesity A0 EB` A RANITIDINE d00021A B K30 Functional dyspepsia A0 EBp A . . . EB A . . . EB A . . . EB A METOPROLOL d00134A C I49.9 Cardiac arrhythmia, unspecified A EB A . . . EB A BUPROPION d00181A CDp F32.9 Major depressive disorder, single episode, unspecified A0 EB A IBANDRONATE d05357A C M85.9 Disorder of bone density and structure, unspecified A0 EB A OMEPRAZOLE d00325A C K30 Functional dyspepsia A0 EB A LISDEXAMFETAMINE d06663A C- F90 Attention-deficit hyperactivity disorders A EB A . . . EB A . . . EC A . . . EC A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ EC A HYDROCHLOROTHIAZIDE; QUINAPRIL d04509A C I10 Essential (primary) hypertension A@ EC A METHOCARBAMOL d00965A B M54 Dorsalgia A@ EC A METOPROLOL d00134A C I10 Essential (primary) hypertension A@ EC A . . . EC0 A . . . EC@ A ACETAMINOPHEN; HYDROCODONE d03428A Cr M19.9 Osteoarthritis, unspecified site AP EC@ A ALLOPURINOL d00023A CDp M1A Chronic gout AP EC@ A FLUTICASONE; SALMETEROL d04611A Dc J44.9 J45 Chronic obstructive pulmonary disease, unspecified Asthma AP EC@ A IPRATROPIUM d00265A Dc J44.9 J45 Chronic obstructive pulmonary disease, unspecified Asthma AP EC@ A OMEGA-3 POLYUNSATURATED FATTY ACIDS d00497A Cr AP ECP A DONEPEZIL d04099A C R41 Other symptoms and signs involving cognitive functions and awareness Ap ECP A LOSARTAN d03821A B I10 Essential (primary) hypertension Ap ECP A MEGESTROL d01348A B= R63 Symptoms and signs concerning food and fluid intake Ap ECP A OXYBUTYNIN d00328A B[ R35 Polyuria Ap ECP A PAROXETINE d03157A B[ R45 Symptoms and signs involving emotional state Ap ECP A TRAMADOL d03826A CDp M25.5 Pain in joint Ap ECP A TRAZODONE d00395A C G47.0 Insomnia Ap EC` A . . . ECp A ACYCLOVIR d00001A C- B34.9P Prevent viral infection A ECp A BUDESONIDE d04276A B R06.9 Unspecified abnormalities of breathing A ECp A GABAPENTIN d03182A C- M79.2 Neuralgia and neuritis, unspecified A ECp A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A Dc I10 Essential (primary) hypertension A ECp A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A ECp A METOPROLOL d00134A Dc I10 Essential (primary) hypertension A ECp A OMEPRAZOLE d00325A Ei K21 Gastro-esophageal reflux disease A ECp A TRAMADOL d03826A C[@ M79.2 Neuralgia and neuritis, unspecified A EC A . . . EC A CEPHALEXIN d00096A A L08.9 Local infection of the skin and subcutaneous tissue, unspecified A EC A LEVOTHYROXINE d00278A D=O E03.9 Hypothyroidism, unspecified A EC A MONTELUKAST d04289A Cr J30.9 Allergic rhinitis, unspecified A EC A ALPRAZOLAM d00168A D G25.81 Restless legs syndrome Ap EC A GABAPENTIN d03182A B M79.2 Neuralgia and neuritis, unspecified Ap EC A HYDROCHLOROTHIAZIDE d00253A D R60.9 Edema, unspecified Ap EC A IBRUTINIB d08170A B= 55555 Ap EC A NITROFURANTOIN d00112A DGJ N39.0 Urinary tract infection, site not specified Ap EC A OMEPRAZOLE d00325A B K21 Gastro-esophageal reflux disease Ap EC A RANITIDINE d00021A C- K30 Functional dyspepsia Ap EC A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A EC A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A EC A LOSARTAN d03821A C I10 Essential (primary) hypertension A EC A ALBUTEROL d00749A C J45 Asthma A EC A CETIRIZINE d03827A B[ T78.40 Allergy, unspecified A EC A . . . ED A . . . ED A AMLODIPINE d00689A Dc I10 Essential (primary) hypertension A ED A SIMVASTATIN d00746A Dc E78.0 Pure hypercholesterolemia A ED A . . . ED0 A . . . ED@ A . . . EDP A CARVEDILOL d03847A D I51.9P Prevent heart disease A` EDP A FUROSEMIDE d00070A D R60.9 Edema, unspecified A` EDP A GLIPIZIDE d00246A D E11 Type 2 diabetes mellitus A` EDP A LOSARTAN d03821A C- E11.2 Type 2 diabetes mellitus with kidney complications A` EDP A METFORMIN d03807A D E11 Type 2 diabetes mellitus A` EDP A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A` ED` A . . . EDp A . . . ED A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C[@ Z79.3 Long term (current) use of hormonal contraceptives A ED A LEVOTHYROXINE d00278A B 99999 A ED A CLINDAMYCIN d00043A B L70 Acne A ED A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A ED A . . . ED A . . . ED A METFORMIN d03807A B E11.P E66 Prevent diabetes Overweight and obesity A ED A VARENICLINE d05807A B* F17.2 Nicotine dependence A ED A . . . ED A COLESEVELAM d04695A CDp E78.0 Pure hypercholesterolemia A@ ED A HYDROCHLOROTHIAZIDE; OLMESARTAN d04878A B[ I10 Essential (primary) hypertension A@ ED A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ ED A ROSUVASTATIN d04851A B[ E78.0 Pure hypercholesterolemia A@ EE A OFLOXACIN OPHTHALMIC d03977A A0 H66.9P Prevent ear infection A EE A . . . EE A CLONAZEPAM d00197A C- F41.9 Anxiety disorder, unspecified AP EE A ESCITALOPRAM d04812A Dc F32.9 Major depressive disorder, single episode, unspecified AP EE A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus AP EE A ROPINIROLE d04215A B G25.81 Restless legs syndrome AP EE A TRAMADOL d03826A C- M79.1 Myalgia AP EE0 A NEBIVOLOL d05265A C I49.9 Cardiac arrhythmia, unspecified A@ EE0 A QUINAPRIL d00365A Dc I10 Essential (primary) hypertension A@ EE0 A RANITIDINE d00021A Cr K30 Functional dyspepsia A@ EE0 A SPIRONOLACTONE d00373A D I10 Essential (primary) hypertension A@ EE@ A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A CDp I10 Essential (primary) hypertension A0 EE@ A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A0 EE@ A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A0 EEP A . . . EE` A CEFDINIR d04256A A H66.9 Otitis media, unspecified A EEp A ALBUTEROL d00749A C- T78.40 Allergy, unspecified AP EEp A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP EEp A CETIRIZINE d03827A C T78.40 Allergy, unspecified AP EEp A FLUTICASONE NASAL d04283A C T78.40 Allergy, unspecified AP EEp A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease AP EE A AMLODIPINE d00689A B[ I10 Essential (primary) hypertension A0 EE A ATENOLOL d00004A C I10 Essential (primary) hypertension A0 EE A HYDROCHLOROTHIAZIDE d00253A B[ R60.9 Edema, unspecified A0 EE A . . . EE A AMOXICILLIN d00088A A K02 Dental caries A@ EE A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Cr I10 Essential (primary) hypertension A@ EE A IBUPROFEN d00015A A K08.8 Other specified disorders of teeth and supporting structures A@ EE A LANSOPRAZOLE d03828A D K21 K46 Gastro-esophageal reflux disease Unspecified abdominal hernia A@ EE A . . . EE A AMLODIPINE d00689A B[ I10 Essential (primary) hypertension A0 EE A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A B= R60.9 Edema, unspecified A0 EE A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A0 EE A . . . EE A 99999 . . A EE A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A EE A . . . EF A . . . EF A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A CDp I10 Essential (primary) hypertension A EF A . . . EF0 A . . . EF@ A . . . EFP A HYDROCHLOROTHIAZIDE; OLMESARTAN d04878A C[@ I10 Essential (primary) hypertension A EF` A . . . EFp A ACETAMINOPHEN; HYDROCODONE d03428A D M54 Dorsalgia A0 EFp A CYCLOBENZAPRINE d00963A D M54 Dorsalgia A0 EFp A IBUPROFEN d00015A D M54 Dorsalgia A0 EF A . . . EF A . . . EF A . . . EF A . . . EF A . . . EF A LEVOTHYROXINE d00278A D9 E03.9 Hypothyroidism, unspecified A@ EF A LOVASTATIN d00280A D E78.0 Pure hypercholesterolemia A@ EF A METOPROLOL d00134A C I10 Essential (primary) hypertension A@ EF A WARFARIN d00022A C I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified A@ EF A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A C I10 Essential (primary) hypertension A EF A POTASSIUM CHLORIDE d00345A C- E87.6 Hypokalemia A EF A . . . EG A GLYBURIDE d00248A C- E11 Type 2 diabetes mellitus A@ EG A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A@ EG A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A@ EG A PRAVASTATIN d00348A C[@ E78.0 Pure hypercholesterolemia A@ EG A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A EG A LEVOTHYROXINE d00278A C E07.9 Disorder of thyroid, unspecified A EG A . . . EG0 A ATORVASTATIN d04105A C- E78.0P Prevent high cholesterol A@ EG0 A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A@ EG0 A LISINOPRIL d00732A CDp E11.8 Type 2 diabetes mellitus with unspecified complications A@ EG0 A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A@ EG@ A ALLOPURINOL d00023A Cr M1A Chronic gout A@ EG@ A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A Cr I10 Essential (primary) hypertension A@ EG@ A METFORMIN d03807A Cr E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A@ EG@ A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A@ EGP A FLUTICASONE NASAL d04283A CDp J30.9 Allergic rhinitis, unspecified A EGP A METHYLPREDNISOLONE d00293A A@ M25.9 R60.9 Joint disorder, unspecified Edema, unspecified A EG` A . . . EGp A . . . EG A . . . EG A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A EG A SPIRONOLACTONE d00373A BZ I10 Essential (primary) hypertension A EG A . . . EG A . . . EG A . . . EG A . . . EG A ACETAMINOPHEN; TRAMADOL d04766A C- R52 Pain, unspecified A EG A AMITRIPTYLINE d00146A C- F39 Unspecified mood [affective] disorder A EG A APIXABAN d07804A C D75.9P Prevent blood clots A EG A CYPROHEPTADINE d00790A C- T78.40 Allergy, unspecified A EG A DILTIAZEM d00045A C- I10 Essential (primary) hypertension A EG A DULOXETINE d05355A C- F39 Unspecified mood [affective] disorder A EG A ESOMEPRAZOLE d04749A CDp K21 Gastro-esophageal reflux disease A EG A GLIPIZIDE d00246A Cr E11 Type 2 diabetes mellitus A EG A INSULIN GLARGINE d04538A B[ E11 Type 2 diabetes mellitus A EG A LINAGLIPTIN d07767A C 99999 A EG A LISINOPRIL d00732A C 99999 A EG A MECLIZINE d00859A C R42 Dizziness and giddiness A EG A MIRTAZAPINE d04025A C- F39 Unspecified mood [affective] disorder A EG A PREGABALIN d05508A C M79.2 Neuralgia and neuritis, unspecified A EG A RANITIDINE d00021A C- K31.9 Disease of stomach and duodenum, unspecified A EG A . . . EH A . . . EH A . . . EH A . . . EH0 A . . . EH@ A IBUPROFEN d00015A Ap M54 Dorsalgia A EHP A . . . EH` A . . . EHp A LEVONORGESTREL d00557A C- Z79.3 Long term (current) use of hormonal contraceptives A EH A . . . EH A . . . EH A . . . EH A . . . EH A . . . EH A . . . EH A IBUPROFEN d00015A C M25.5 M79.1 Pain in joint Myalgia A EH A RANITIDINE d00021A B K30 Functional dyspepsia A EH A . . . EI A . . . EI A . . . EI A ALBUTEROL d00749A Cr J44.9 Chronic obstructive pulmonary disease, unspecified A EI A ALLOPURINOL d00023A C E79.9 M10.9 Disorder of purine and pyrimidine metabolism, unspecified Gout, unspecified A EI A AMLODIPINE d00689A Ei I10 Essential (primary) hypertension A EI A ATORVASTATIN d04105A Ei E78.0 Pure hypercholesterolemia A EI A ESTRADIOL d00537A Dc Z79.890 Hormone replacement therapy A EI A FUROSEMIDE d00070A C R60.9 Edema, unspecified A EI A IPRATROPIUM d00265A C J44.9 Chronic obstructive pulmonary disease, unspecified A EI A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A EI A LORAZEPAM d00149A C- F41.9 G47.0 Anxiety disorder, unspecified Insomnia A EI A POTASSIUM CHLORIDE d00345A Ei E87.6 Hypokalemia A EI0 A . . . EI@ A AMOXICILLIN d00088A A J02.0 Streptococcal pharyngitis A EIP A ATORVASTATIN d04105A Bz E78.0 Pure hypercholesterolemia A@ EIP A CLONIDINE d00044A B I10 Essential (primary) hypertension A@ EIP A LOSARTAN d03821A B[ I10 Essential (primary) hypertension A@ EIP A OMEPRAZOLE d00325A B[ K21 K30 Gastro-esophageal reflux disease Functional dyspepsia A@ EI` A . . . EIp A INSULIN ISOPHANE; INSULIN REGULAR d04374A C[@ E11 Type 2 diabetes mellitus A@ EIp A LOSARTAN d03821A C[@ I10 Essential (primary) hypertension A@ EIp A METFORMIN d03807A C E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A@ EIp A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A@ EI A . . . EI A PANTOPRAZOLE d04514A B K21 Gastro-esophageal reflux disease A EI A . . . EI A BENAZEPRIL; HYDROCHLOROTHIAZIDE d03265A C- I10 Essential (primary) hypertension A0 EI A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A0 EI A TAMSULOSIN d04121A C- N40 Enlarged prostate A0 EI A RANITIDINE d00021A A K21 Gastro-esophageal reflux disease A EI A . . . EI A . . . EI A . . . EJ A CLONAZEPAM d00197A B F33.9 F41.9 Major depressive disorder, recurrent, unspecified Anxiety disorder, unspecified A@ EJ A LAMOTRIGINE d03809A B F33.9 F41.9 Major depressive disorder, recurrent, unspecified Anxiety disorder, unspecified A@ EJ A LOVASTATIN d00280A B E78.0 I99.9 Pure hypercholesterolemia Unspecified disorder of circulatory system A@ EJ A QUETIAPINE d04220A B G47.0 Insomnia A@ EJ A . . . EJ A 77777 . . A EJ0 A . . . EJ@ A IRBESARTAN d04222A C- 99999 A EJ@ A PRAVASTATIN d00348A C- 99999 A EJP A . . . EJ` A . . . EJp A . . . EJ A ATORVASTATIN d04105A B I21.P Prevent heart attack/myocardial infarction A EJ A GABAPENTIN d03182A Cr M79.2 Neuralgia and neuritis, unspecified A EJ A GLIPIZIDE d00246A C[@ E11 Type 2 diabetes mellitus A EJ A INSULIN GLARGINE d04538A C- E11 Type 2 diabetes mellitus A EJ A INSULIN LISPRO d04373A B E11 Type 2 diabetes mellitus A EJ A LINAGLIPTIN d07767A CDp E11 Type 2 diabetes mellitus A EJ A LOSARTAN d03821A A N28.9P Prevent kidney disease A EJ A MELOXICAM d04532A C- M13 Other arthritis A EJ A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A EJ A NORTRIPTYLINE d00144A C- M79.2 Neuralgia and neuritis, unspecified A EJ A OLOPATADINE OPHTHALMIC d04117A B H04 Disorders of lacrimal system A EJ A NIFEDIPINE d00051A CDp I27.9 Pulmonary heart disease, unspecified A EJ A PANTOPRAZOLE d04514A B K21 Gastro-esophageal reflux disease A EJ A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A EJ A CLOPIDOGREL d04258A D Z95 Presence of cardiac and vascular implants and grafts A0 EJ A RIVAROXABAN d07356A B Z95 Presence of cardiac and vascular implants and grafts A0 EJ A SOTALOL d00371A B I10 Essential (primary) hypertension A0 EJ A AMLODIPINE d00689A C I10 Essential (primary) hypertension A0 EJ A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A0 EJ A VALSARTAN d04113A C I10 Essential (primary) hypertension A0 EJ A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ EJ A CALCITONIN d00598A C M81 Osteoporosis without current pathological fracture A@ EJ A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A@ EJ A VALSARTAN d04113A D I10 Essential (primary) hypertension A@ EJ A . . . EJ A AMLODIPINE d00689A B I10 Essential (primary) hypertension A EJ A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C- I10 Essential (primary) hypertension A EK A . . . EK A CLONAZEPAM d00197A D F41.0 Panic disorder [episodic paroxysmal anxiety] without agoraphobia A EK A FLUOXETINE d00236A B F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A EK A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia AP EK A FUROSEMIDE d00070A B R60.9 Edema, unspecified AP EK A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension AP EK A TAMSULOSIN d04121A C- R35 Polyuria AP EK A WARFARIN d00022A Cr D75.9P I80.3 Prevent blood clots Phlebitis and thrombophlebitis of lower extremities, unspecified AP EK0 A ATORVASTATIN d04105A0 C E78.0 Pure hypercholesterolemia Ap EK0 A CARVEDILOL d03847A C[@ I49.9 Cardiac arrhythmia, unspecified Ap EK0 A ESOMEPRAZOLE d04749A0 C K30 Functional dyspepsia Ap EK0 A LOSARTAN d03821A0 C I10 Essential (primary) hypertension Ap EK0 A METFORMIN d03807A0 C E11 Type 2 diabetes mellitus Ap EK0 A METHIMAZOLE d00290A0 C E05 Thyrotoxicosis [hyperthyroidism] Ap EK0 A SITAGLIPTIN d05896A0 C E11 Type 2 diabetes mellitus Ap EK@ A . . . EKP A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A EK` A . . . EKp A . . . EK A ACETAMINOPHEN; OXYCODONE d03431A C- M54 Dorsalgia A EK A AMLODIPINE d00689A C I10 Essential (primary) hypertension A EK A APIXABAN d07804A B D75.9P Prevent blood clots A EK A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A EK A CARVEDILOL d03847A C I49.9 Cardiac arrhythmia, unspecified A EK A GABAPENTIN d03182A C"@ M79.2 Neuralgia and neuritis, unspecified A EK A HYDRALAZINE d00132A C[@ I10 Essential (primary) hypertension A EK A PANTOPRAZOLE d04514A . K21 Gastro-esophageal reflux disease A EK A ZOLPIDEM d00910A B= G47.9 Sleep disorder, unspecified A EK A . . . EK A FUROSEMIDE d00070A CDp R60.9 Edema, unspecified A` EK A LEVOTHYROXINE d00278A C E07.9 Disorder of thyroid, unspecified A` EK A LOSARTAN d03821A C[@ I10 Essential (primary) hypertension A` EK A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` EK A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A` EK A WARFARIN d00022A C Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A` EK A . . . EK A AMPHETAMINE; DEXTROAMPHETAMINE d04035A B= F90 Attention-deficit hyperactivity disorders A EK A LEVOTHYROXINE d00278A C E03.9 Z90 Hypothyroidism, unspecified Acquired absence of organs, not elsewhere classified A EK A ALFUZOSIN d04797A C N32.9 Bladder disorder, unspecified AP EK A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia AP EK A FINASTERIDE d00563A C N40 Enlarged prostate AP EK A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension AP EK A METFORMIN d03807A C- R73 Elevated blood glucose level AP EK A PREDNISONE d00350A C M35 Other systemic involvement of connective tissue A EL A . . . EL A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension AP EL A AZELASTINE NASAL d04068A C- J30.1 R09.81 Allergic rhinitis due to pollen Nasal congestion AP EL A LOSARTAN d03821A CDp I10 Essential (primary) hypertension AP EL A METOPROLOL d00134A C Z79 Long term (current) drug therapy AP EL A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia AP EL A AMLODIPINE d00689A D I10 Essential (primary) hypertension A@ EL A APIXABAN d07804A C I21.P Prevent heart attack/myocardial infarction A@ EL A ATENOLOL d00004A D I10 Essential (primary) hypertension A@ EL A ENALAPRIL d00013A D I10 Essential (primary) hypertension A@ EL0 A . . . EL@ A ALLOPURINOL d00023A Ei M1A Chronic gout B EL@ A CARBIDOPA; LEVODOPA d03473A C G40 Epilepsy and recurrent seizures B EL@ A CITALOPRAM d04332A D M62.83 Muscle spasm B EL@ A CYCLOBENZAPRINE d00963A D I51.9 Heart disease, unspecified B EL@ A FINASTERIDE d00563A D M62.83 Muscle spasm B EL@ A GABAPENTIN d03182A D 99999 B EL@ A GLIPIZIDE d00246A D 99999 B EL@ A INSULIN DETEMIR d05436A B[ E11 Type 2 diabetes mellitus B EL@ A LEVETIRACETAM d04499A D 99999 B EL@ A LISINOPRIL d00732A D 99999 B EL@ A LOVASTATIN d00280A D 99999 B EL@ A METOPROLOL d00134A D 99999 B EL@ A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease B EL@ A POTASSIUM CHLORIDE d00345A D 99999 B EL@ A RANITIDINE d00021A A0 K22 Other diseases of esophagus B EL@ A RIVAROXABAN d07356A D I63 Cerebral infarction B ELP A . . . EL` A MELOXICAM d04532A B T14.9 Unspecified injury A ELp A . . . EL A . . . EL A AMOXICILLIN d00088A Ap H66.9 Otitis media, unspecified A EL A FLUTICASONE TOPICAL d04284A C R21 Rash and other nonspecific skin eruption A EL A FAMOTIDINE d00141A B 99999 A EL A ENALAPRIL d00013A C[@ I21.P Prevent heart attack/myocardial infarction A EL A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A EL A AMLODIPINE d00689A C I10 Essential (primary) hypertension A EL A FLUOXETINE d00236A C- F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A EL A GABAPENTIN d03182A C- M54 Dorsalgia AP EL A GEMFIBROZIL d00245A C- E78.0 Pure hypercholesterolemia AP EL A GLIMEPIRIDE d03864A C- R73 Elevated blood glucose level AP EL A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C- I10 Essential (primary) hypertension AP EL A METFORMIN d03807A C- R73 Elevated blood glucose level AP EL A LISINOPRIL d00732A D% E11.2P Prevent diabetic kidney disease A0 EL A METFORMIN d03807A D% E11 Type 2 diabetes mellitus A0 EL A SIMVASTATIN d00746A D% E78.0 Pure hypercholesterolemia A0 EM A . . . EM A ALBUTEROL d00749A CDp J44.9 Chronic obstructive pulmonary disease, unspecified AP EM A HYDROCODONE d03075A CO J44.9 Chronic obstructive pulmonary disease, unspecified AP EM A METOPROLOL d00134A CDp I10 Essential (primary) hypertension AP EM A PREDNISONE d00350A CDp J44.9 Chronic obstructive pulmonary disease, unspecified AP EM A SERTRALINE d00880A CDp F32.9 Major depressive disorder, single episode, unspecified AP EM A DOXAZOSIN d00726A D N40 Enlarged prostate A0 EM A FINASTERIDE d00563A D N40 Enlarged prostate A0 EM A LATANOPROST OPHTHALMIC d04017A B H40 Glaucoma A0 EM0 A . . . EM@ A . . . EMP A . . . EM` A . . . EMp A . . . EM A . . . EM A . . . EM A . . . EM A . . . EM A . . . EM A . . . EM A . . . EM A . . . EN A . . . EN A . . . EN A ADALIMUMAB d04835A C M06.9 Rheumatoid arthritis, unspecified A EN A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A EN A ESOMEPRAZOLE d04749A Cr K30 Functional dyspepsia A EN A FLUTICASONE; VILANTEROL d08100A CDp J44.9 Chronic obstructive pulmonary disease, unspecified A EN A IBUPROFEN d00015A C M19.9 Osteoarthritis, unspecified site A EN A METHOTREXATE d00060A C M06.9 Rheumatoid arthritis, unspecified A EN A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A EN A PREDNISONE d00350A D M06.9 Rheumatoid arthritis, unspecified A EN A TRAMADOL d03826A CDp M06.9 Rheumatoid arthritis, unspecified A EN0 A . . . EN@ A . . . ENP A . . . EN` A . . . ENp A . . . EN A . . . EN A . . . EN A . . . EN A CARVEDILOL d03847A Dc I51.9 Heart disease, unspecified Ap EN A DIGOXIN d00210A Dc I51.9 Heart disease, unspecified Ap EN A ENALAPRIL d00013A Dc I10 Essential (primary) hypertension Ap EN A FUROSEMIDE d00070A Dc I50.9 I51.9 Heart failure, unspecified Heart disease, unspecified Ap EN A HYDROXYZINE d00907A Dc I10 Essential (primary) hypertension Ap EN A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease Ap EN A POTASSIUM IODIDE d00800A Dc I51.9 Heart disease, unspecified Ap EN A . . . EN A AMLODIPINE d00689A Ei I10 Essential (primary) hypertension A` EN A APIXABAN d07804A Ei D75.9P Prevent blood clots A` EN A DILTIAZEM d00045A Ei I10 Essential (primary) hypertension A` EN A FUROSEMIDE d00070A Ei R60.9 Edema, unspecified A` EN A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A` EN A PHENYTOIN d00143A C G40 Epilepsy and recurrent seizures A` EN A . . . EN A . . . EO A OMEPRAZOLE d00325A C"0 R14 Flatulence and related conditions A EO A . . . EO A . . . EO0 A . . . EO@ A . . . EOP A . . . EO` A DUTASTERIDE d04788A C N40 Enlarged prostate A0 EO` A FENOFIBRATE d04286A D E78.1 Pure hyperglyceridemia A0 EO` A TAMSULOSIN d04121A C N40 Enlarged prostate A0 EOp A AMOXICILLIN d00088A Ap K04.7 Periapical abscess without sinus A0 EOp A GLIPIZIDE d00246A CDp E11 Type 2 diabetes mellitus A0 EOp A IBUPROFEN d00015A D M79.1 Z96 Myalgia Presence of other functional implants A0 EO A . . . EO A LEVONORGESTREL d00557A Cr Z79.3 Long term (current) use of hormonal contraceptives A EO A AMANTADINE d00086A B[ F90 R41 Attention-deficit hyperactivity disorders Other symptoms and signs involving cognitive functions and awareness A EO A ARIPIPRAZOLE d04825A Cr R45 Symptoms and signs involving emotional state A EO A . . . EO A . . . EO A . . . EO A ALBUTEROL d00749A Cr J45 Asthma A` EO A BUDESONIDE; FORMOTEROL d04795A CDp J45 Asthma A` EO A CETIRIZINE d03827A CDp T78.40 Allergy, unspecified A` EO A DEXAMETHASONE d00206A A J45 Asthma A` EO A MONTELUKAST d04289A C J45 T78.40 Asthma Allergy, unspecified A` EO A PREDNISOLONE d00084A AP J45 Asthma A` EO A LAMOTRIGINE d03809A C9 F31.9 Bipolar disorder, unspecified A EP A . . . EP A ABACAVIR; DOLUTEGRAVIR; LAMIVUDINE d08284A C B20 Human immunodeficiency virus [HIV] disease A` EP A CYCLOBENZAPRINE d00963A C- M79.1 T14.9 Myalgia Unspecified injury A` EP A FLUOXETINE d00236A Cr F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A` EP A LISINOPRIL d00732A B I10 Essential (primary) hypertension A` EP A NAPROXEN d00019A C M79.1 Myalgia A` EP A OXYCODONE d00329A C M79.1 T14.9 Myalgia Unspecified injury A` EP A . . . EP0 A . . . EP@ A . . . EPP A AMLODIPINE; OLMESARTAN d06905A C[@ I10 Essential (primary) hypertension A0 EPP A COLCHICINE d00150A C M1A Chronic gout A0 EPP A ROSUVASTATIN d04851A B E78.0 Pure hypercholesterolemia A0 EP` A ALBUTEROL d00749A C R06.02 Shortness of breath A EP` A FENOFIBRATE d04286A CDp E78.0 Pure hypercholesterolemia A EP` A FLUTICASONE NASAL d04283A C J30.2 Other seasonal allergic rhinitis A EP` A GABAPENTIN d03182A C M79.7 Fibromyalgia A EP` A IBUPROFEN d00015A C G43 Migraine A EP` A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A EP` A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A EP` A ROPINIROLE d04215A C G25.81 Restless legs syndrome A EP` A TOPIRAMATE d04115A C"0 E66 Overweight and obesity A EP` A TRIAMTERENE d00396A D R60.9 Edema, unspecified A EP` A VENLAFAXINE d03181A C F31.9 Bipolar disorder, unspecified A EP` A ZOLPIDEM d00910A C G47.0 Insomnia A EPp A . . . EP A . . . EP A . . . EP A . . . EP A . . . EP A . . . EP A AMLODIPINE d00689A D I10 Essential (primary) hypertension Ap EP A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia Ap EP A DONEPEZIL d04099A C R41 Other symptoms and signs involving cognitive functions and awareness Ap EP A GLIMEPIRIDE d03864A D E11 Type 2 diabetes mellitus Ap EP A LEVOTHYROXINE d00278A D E07.9 Disorder of thyroid, unspecified Ap EP A MEMANTINE d04899A B R41 Other symptoms and signs involving cognitive functions and awareness Ap EP A RIVAROXABAN d07356A CDp I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified Ap EP A . . . EP A CITALOPRAM d04332A C[@ F39 Unspecified mood [affective] disorder A EP A MONTELUKAST d04289A A J30.9 Allergic rhinitis, unspecified A EQ A . . . EQ A . . . EQ A GLIPIZIDE d00246A CP E11 Type 2 diabetes mellitus A@ EQ A LISINOPRIL d00732A C I10 N28.9P Essential (primary) hypertension Prevent kidney disease A@ EQ A METFORMIN d03807A CP E11 Type 2 diabetes mellitus A@ EQ A SIMVASTATIN d00746A CP E78.0 Pure hypercholesterolemia A@ EQ0 A AMLODIPINE; BENAZEPRIL d03829A D I10 Essential (primary) hypertension A0 EQ0 A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 EQ0 A TAMSULOSIN d04121A C- R39.1 Other difficulties with micturition A0 EQ@ A AMLODIPINE d00689A Ei 99999 A@ EQ@ A FUROSEMIDE d00070A B R60.9 Edema, unspecified A@ EQ@ A GABAPENTIN d03182A B= 99999 A@ EQ@ A METOPROLOL d00134A C- I10 Essential (primary) hypertension A@ EQP A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A EQ` A LOSARTAN d03821A C I10 Essential (primary) hypertension A@ EQ` A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ EQ` A METOPROLOL d00134A C I10 Essential (primary) hypertension A@ EQ` A SIMVASTATIN d00746A C E78.0P Prevent high cholesterol A@ EQp A . . . EQ A . . . EQ A . . . EQ A CLOTRIMAZOLE TOPICAL d04395A C[@ B35 Dermatophytosis A EQ A ENALAPRIL d00013A C[@ I10 Essential (primary) hypertension A EQ A FUROSEMIDE d00070A Cr R60.9 Edema, unspecified A EQ A GABAPENTIN d03182A Dc M79.2 Neuralgia and neuritis, unspecified A EQ A IBUPROFEN d00015A B R51 Headache A EQ A INSULIN LISPRO d04373A D E11 Type 2 diabetes mellitus A EQ A OMEPRAZOLE d00325A Dc K21 Gastro-esophageal reflux disease A EQ A POTASSIUM CHLORIDE d00345A D# E87.6 Hypokalemia A EQ A SELENIUM SULFIDE TOPICAL d03210A C[@ B35 Dermatophytosis A EQ A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A EQ A BECLOMETHASONE d00760A CDp J45 Asthma A EQ A . . . EQ A ATENOLOL d00004A D I10 Essential (primary) hypertension A EQ A LISINOPRIL d00732A C I10 Essential (primary) hypertension A EQ A ALBUTEROL d00749A D J45 Asthma A0 EQ A FLUTICASONE NASAL d04283A C- J30.9 Allergic rhinitis, unspecified A0 EQ A MONTELUKAST d04289A C J45 Asthma A0 EQ A ALBUTEROL d00749A C[@ J44.9 Chronic obstructive pulmonary disease, unspecified A EQ A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A EQ A ATENOLOL; CHLORTHALIDONE d03258A Cr I10 Essential (primary) hypertension A EQ A ATORVASTATIN d04105A A E78.0 Pure hypercholesterolemia A EQ A CLOBETASOL TOPICAL d01288A A` L20.9 Atopic dermatitis, unspecified A EQ A FUROSEMIDE d00070A C R60.9 Edema, unspecified A EQ A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A EQ A IBUPROFEN d00015A C M19.9 Osteoarthritis, unspecified site A EQ A INDOMETHACIN d00039A B M19.9 Osteoarthritis, unspecified site A EQ A MELOXICAM d04532A A0 M19.9 Osteoarthritis, unspecified site A EQ A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A EQ A OMEPRAZOLE d00325A C K31.9 T88.7P Disease of stomach and duodenum, unspecified Prevent drug side effect A EQ A PREGABALIN d05508A A0 M79.2 Neuralgia and neuritis, unspecified A EQ A TIOTROPIUM d04829A C[@ J44.9 Chronic obstructive pulmonary disease, unspecified A ER A . . . ER A . . . ER A . . . ER0 A . . . ER@ A . . . ERP A . . . ER` A . . . ERp A AMOXICILLIN d00088A Ap J02 Acute pharyngitis A0 ERp A CETIRIZINE d03827A Bz T78.40 Allergy, unspecified A0 ERp A RANITIDINE d00021A C K92.9 Disease of digestive system, unspecified A0 ER A . . . ER A ATORVASTATIN d04105A0 C[@ I21.P Prevent heart attack/myocardial infarction AP ER A CLOPIDOGREL d04258A0 C[@ I21 ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction AP ER A CYANOCOBALAMIN d00413A0 C[@ E63.9 Nutritional deficiency, unspecified AP ER A LISINOPRIL d00732A0 C[@ I21.P Prevent heart attack/myocardial infarction AP ER A METOPROLOL d00134A0 C[@ I21.P Prevent heart attack/myocardial infarction AP ER A . . . ER A AMOXICILLIN d00088A AP J40 Bronchitis, not specified as acute or chronic A ER A 55555 A C G47.9 Sleep disorder, unspecified A ER A . . . ER A . . . ER A FLUTICASONE; VILANTEROL d08100A C J45 Asthma A@ ER A LEVOTHYROXINE d00278A C"0 E03.9 Hypothyroidism, unspecified A@ ER A METFORMIN d03807A C"0 E11 Type 2 diabetes mellitus A@ ER A TIOTROPIUM d04829A C J45 R06.9 Asthma Unspecified abnormalities of breathing A@ ES A MONTELUKAST d04289A B J45 Asthma A ES A NAPROXEN d00019A C T14.9 Unspecified injury AP ES A PROPRANOLOL d00032A B= R25.1 Tremor, unspecified AP ES A SERTRALINE d00880A C- F41.9 Anxiety disorder, unspecified AP ES A SIMVASTATIN d00746A B= E78.0 Pure hypercholesterolemia AP ES A TERAZOSIN d00386A C- N40 Enlarged prostate AP ES A . . . ES0 A CLONIDINE d00044A D I10 Essential (primary) hypertension A` ES0 A LOSARTAN d03821A C"@ I10 Essential (primary) hypertension A` ES0 A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A` ES0 A OXCARBAZEPINE d04513A D F39 Unspecified mood [affective] disorder A` ES0 A SERTRALINE d00880A D F31.9 Bipolar disorder, unspecified A` ES0 A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A` ES@ A . . . ESP A . . . ES` A . . . ESp A . . . ES A . . . ES A . . . ES A HYDROCHLOROTHIAZIDE d00253A Cr I10 Essential (primary) hypertension A ES A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A ES A ALBUTEROL d00749A0 B R07.9 Chest pain, unspecified A ES A APIXABAN d07804A0 Ei D75.9P Prevent blood clots A ES A BUDESONIDE; FORMOTEROL d04795A0 Ei R06.2 Wheezing A ES A DILTIAZEM d00045A0 Ei I10 Essential (primary) hypertension A ES A FLUTICASONE d01296A0 C R07.9 Chest pain, unspecified A ES A FUROSEMIDE d00070A0 DU I51.9 Heart disease, unspecified A ES A LATANOPROST OPHTHALMIC d04017A0 Ei H40 Glaucoma A ES A LEVOTHYROXINE d00278A0 DGJ E03.9 Hypothyroidism, unspecified A ES A MECLIZINE d00859A0 Ei R42 Dizziness and giddiness A ES A METFORMIN d03807A0 DGJ E11 Type 2 diabetes mellitus A ES A METOPROLOL d00134A0 Ei 99999 A ES A POTASSIUM CHLORIDE d00345A0 Ei 99999 A ES A PRAVASTATIN d00348A0 Ei 99999 A ES A TIMOLOL OPHTHALMIC d04037A0 D 99999 A ES A TOPIRAMATE d04115A0 Ei 99999 A ES A . . . ES A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A@ ES A HYDROCHLOROTHIAZIDE d00253A C- I10 Essential (primary) hypertension A@ ES A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A@ ES A NIFEDIPINE d00051A Cr I10 Essential (primary) hypertension A@ ES A ALLOPURINOL d00023A C- M10.9P Prevent gout A` ES A LISINOPRIL d00732A C- E11.2P I10 Prevent diabetic kidney disease Essential (primary) hypertension A` ES A LORAZEPAM d00149A C- F41.9 Anxiety disorder, unspecified A` ES A METFORMIN d03807A B[ R73 Elevated blood glucose level A` ES A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A` ES A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A` ES A ALBUTEROL d00749A C J44.9 Chronic obstructive pulmonary disease, unspecified A ES A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A ES A FLUTICASONE NASAL d04283A C R09.81 Nasal congestion A ES A FUROSEMIDE d00070A C N28.9 Disorder of kidney and ureter, unspecified A ES A GLIPIZIDE d00246A C E11.P Prevent diabetes A ES A INSULIN DETEMIR d05436A Dc E11 Type 2 diabetes mellitus A ES A LISINOPRIL d00732A C E11.2 Type 2 diabetes mellitus with kidney complications A ES A METOPROLOL d00134A C I10 Essential (primary) hypertension A ES A NITROGLYCERIN d00321A D I20.9 Angina pectoris, unspecified A ES A PRAMIPEXOLE d04145A C G25.81 Restless legs syndrome A ES A RANITIDINE d00021A Cr K30 Functional dyspepsia A ET A . . . ET A . . . ET A . . . ET0 A 99999 . . A ET@ A CEFDINIR d04256A Ap H66.9 Otitis media, unspecified A ETP A . . . ET` A . . . ETp A . . . ET A . . . ET A . . . ET A 99999 . . A` ET A ARIPIPRAZOLE d04825A C F32.9 Major depressive disorder, single episode, unspecified A` ET A ESOMEPRAZOLE d04749A Cr K30 Functional dyspepsia A` ET A INSULIN ASPART d04697A C E11 Type 2 diabetes mellitus A` ET A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A` ET A VENLAFAXINE d03181A C F32.9 Major depressive disorder, single episode, unspecified A` ET A RIZATRIPTAN d04328A C- G43 Migraine A ET A ALFUZOSIN d04797A Cr R39.9 Unspecified symptoms and signs involving the genitourinary system A ET A ALPRAZOLAM d00168A C"0 F41.9 Anxiety disorder, unspecified A ET A DALFAMPRIDINE d07546A Cr G99.8 Other specified disorders of nervous system in diseases classified elsewhere A ET A DILTIAZEM d00045A D I10 Essential (primary) hypertension A ET A FLUOXETINE d00236A CDp F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A ET A GALANTAMINE d04750A C- R41 Other symptoms and signs involving cognitive functions and awareness A ET A HYDRALAZINE d00132A CDp I10 Essential (primary) hypertension A ET A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Dc I10 Essential (primary) hypertension A ET A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension A ET A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus A ET A METHENAMINE d00106A C[@ N39.0P Prevent urinary tract infection A ET A ATENOLOL d00004A0 C I10 Essential (primary) hypertension A0 ET A FLUTICASONE NASAL d04283A CDp J30.9 Allergic rhinitis, unspecified A0 ET A HYDROCHLOROTHIAZIDE d00253A0 C I10 Essential (primary) hypertension A0 ET A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A` ET A ATENOLOL d00004A D# I99.9 Unspecified disorder of circulatory system A` ET A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` ET A MONTELUKAST d04289A B[ J30.9 Allergic rhinitis, unspecified A` ET A SERTRALINE d00880A Dc F41.9 Anxiety disorder, unspecified A` ET A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A` ET A GUANFACINE d00717A C- F90 Attention-deficit hyperactivity disorders A ET A LISDEXAMFETAMINE d06663A C[@ F90 Attention-deficit hyperactivity disorders A EU A . . . EU A ETHINYL ESTRADIOL; NORGESTREL d03241A C- N92 Excessive, frequent and irregular menstruation A EU A METFORMIN d03807A B E11 Type 2 diabetes mellitus A EU A . . . EU0 A . . . EU@ A . . . EUP A . . . EU` A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia Ap EU` A CARVEDILOL d03847A C[@ I10 Essential (primary) hypertension Ap EU` A FUROSEMIDE d00070A C- N28.9 Disorder of kidney and ureter, unspecified Ap EU` A INSULIN ASPART d04697A0 D* E11 Type 2 diabetes mellitus Ap EU` A INSULIN GLARGINE d04538A0 D* E11 Type 2 diabetes mellitus Ap EU` A IRBESARTAN d04222A C- I10 Essential (primary) hypertension Ap EU` A PRAMIPEXOLE d04145A C[@ G20 Parkinson's disease Ap EUp A . . . EU A . . . EU A . . . EU A ALPRAZOLAM d00168A CDp F41.9 Anxiety disorder, unspecified Ap EU A CARVEDILOL d03847A Cr I50.9 Heart failure, unspecified Ap EU A FINASTERIDE d00563A CDp N32.9 Bladder disorder, unspecified Ap EU A HYOSCYAMINE; METHENA; MBLUE; PHENYLSAL; SODIUM BIPHOSPHATE d08274A B N32.81 Overactive bladder Ap EU A LANSOPRAZOLE d03828A D K21 Gastro-esophageal reflux disease Ap EU A OXYBUTYNIN d00328A C- N32.81 Overactive bladder Ap EU A WARFARIN d00022A C D75.9P Prevent blood clots Ap EU A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A0 EU A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A0 EU A OMEGA-3 POLYUNSATURATED FATTY ACIDS d00497A C"0 E78.1 Pure hyperglyceridemia A0 EU A DICLOFENAC d00848A C- Z79.1 Long term (current) use of non-steroidal anti-inflammatories (NSAID) A EU A DULOXETINE d05355A A F32.9 Major depressive disorder, single episode, unspecified A EU A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A EU A IBUPROFEN d00015A C T14.9 Unspecified injury A EU A INDOMETHACIN d00039A B Z79.1 Long term (current) use of non-steroidal anti-inflammatories (NSAID) A EU A METHOCARBAMOL d00965A B= M79.1 M79.7 Myalgia Fibromyalgia A EU A PREDNISONE d00350A C Z79 Long term (current) drug therapy A EU A ROSUVASTATIN d04851A B E78.0 Pure hypercholesterolemia A EU A . . . EU A . . . EU A LEVOTHYROXINE d00278A C[@ E03.9 Hypothyroidism, unspecified A EV A AMLODIPINE; BENAZEPRIL d03829A C I10 Essential (primary) hypertension A EV A FLUOXETINE d00236A B= F32.9 Major depressive disorder, single episode, unspecified A EV A FENOFIBRATE d04286A D* E78.0 Pure hypercholesterolemia Ap EV A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus Ap EV A INSULIN LISPRO d04373A D E11 Type 2 diabetes mellitus Ap EV A LANSOPRAZOLE d03828A D* K30 Functional dyspepsia Ap EV A LOSARTAN d03821A D E11.2 Type 2 diabetes mellitus with kidney complications Ap EV A PRAVASTATIN d00348A D E78.0 Pure hypercholesterolemia Ap EV A VILAZODONE d07740A CDp F32.9 Major depressive disorder, single episode, unspecified Ap EV0 A CHOLESTYRAMINE d00193A C E78.0 Pure hypercholesterolemia A` EV0 A MESALAMINE d01031A C- K51 Ulcerative colitis A` EV0 A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A` EV0 A PAROXETINE d03157A C[@ F32.9 Major depressive disorder, single episode, unspecified A` EV0 A RANITIDINE d00021A Ap K21 Gastro-esophageal reflux disease A` EV0 A VERAPAMIL d00048A D' I10 Essential (primary) hypertension A` EV@ A . . . EVP A . . . EV` A . . . EVp A EPINEPHRINE d00699A Cr T78.40 Allergy, unspecified A EVp A METHYLPHENIDATE d00900A C' F90 Attention-deficit hyperactivity disorders A EV A . . . EV A BUPRENORPHINE; NALOXONE d04819A C F11.23 Opioid dependence with withdrawal A0 EV A CITALOPRAM d04332A C F32.9 Major depressive disorder, single episode, unspecified A0 EV A HYDROXYZINE d00907A C- F41.9 Anxiety disorder, unspecified A0 EV A . . . EV A ETHINYL ESTRADIOL; ETONOGESTREL d04773A D N92 Z79.3 Excessive, frequent and irregular menstruation Long term (current) use of hormonal contraceptives A EV A LIFITEGRAST OPHTHALMIC d08472A B[ H04 Disorders of lacrimal system A EV A . . . EV A . . . EV A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension AP EV A ATORVASTATIN d04105A B= E78.0 Pure hypercholesterolemia AP EV A INSULIN LISPRO d04373A C E10 R73 Type 1 diabetes mellitus Elevated blood glucose level AP EV A IRBESARTAN d04222A B I10 Essential (primary) hypertension AP EV A LISDEXAMFETAMINE d06663A C F90 Attention-deficit hyperactivity disorders AP EV A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease A0 EV A SERTRALINE d00880A C[@ F41.9 Anxiety disorder, unspecified A0 EV A TOPIRAMATE d04115A C G43 Migraine A0 EW A . . . EW A . . . EW A CLONIDINE d00044A A I10 Essential (primary) hypertension AP EW A HYDROCHLOROTHIAZIDE d00253A A0 I10 Essential (primary) hypertension AP EW A INSULIN ISOPHANE (NPH) d04370A B E11 Type 2 diabetes mellitus AP EW A LOSARTAN d03821A C I10 Essential (primary) hypertension AP EW A METFORMIN d03807A B[ E11 Type 2 diabetes mellitus AP EW0 A . . . EW@ A ATORVASTATIN d04105A A E78.0 Pure hypercholesterolemia A EWP A . . . EW` A . . . EWp A SERTRALINE d00880A D* F32.9 Major depressive disorder, single episode, unspecified A EWp A TRAZODONE d00395A D* F41.9 Anxiety disorder, unspecified A EW A . . . EW A . . . EW A . . . EW A . . . EW A . . . EW A . . . EW A . . . EW A ASPIRIN d00170A C[@ I63.P Prevent stroke AP EW A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia AP EW A GLIPIZIDE d00246A C- E11 Type 2 diabetes mellitus AP EW A LOSARTAN d03821A C[@ I10 Essential (primary) hypertension AP EW A METFORMIN d03807A C- E11 Type 2 diabetes mellitus AP EX A . . . EX A . . . EX A . . . EX0 A . . . EX@ A . . . EXP A . . . EX` A . . . EXp A ACETAMINOPHEN; OXYCODONE d03431A D M25.5 M54 Pain in joint Dorsalgia A@ EXp A ATENOLOL d00004A Bz I49.9 Cardiac arrhythmia, unspecified A@ EXp A METHIMAZOLE d00290A Bz E05 Thyrotoxicosis [hyperthyroidism] A@ EXp A SUMATRIPTAN d03160A AP G43 Migraine A@ EX A . . . EX A ETHINYL ESTRADIOL; NORGESTIMATE d03781A B[ Z79.3 Long term (current) use of hormonal contraceptives A EX A . . . EX A . . . EX A DIVALPROEX SODIUM d03833A CDp F31.9 Bipolar disorder, unspecified A@ EX A EFAVIRENZ; EMTRICITABINE; TENOFOVIR d05847A C B20 Human immunodeficiency virus [HIV] disease A@ EX A ESCITALOPRAM d04812A Cr F32.9 Major depressive disorder, single episode, unspecified A@ EX A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease A@ EX A . . . EX A ANASTROZOLE d03873A Ei C50.P prevent breast cancer Ap EX A ATORVASTATIN d04105A Ei 99999 Ap EX A CEPHALEXIN d00096A B[ B99.9 Unspecified infectious disease Ap EX A HYDRALAZINE d00132A Ei I10 Essential (primary) hypertension Ap EX A LISINOPRIL d00732A Ei 99999 Ap EX A METOPROLOL d00134A Ei 99999 Ap EX A SERTRALINE d00880A CDp F32.9 Major depressive disorder, single episode, unspecified Ap EX A ATENOLOL d00004A D I10 Essential (primary) hypertension A` EX A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A` EX A NAPROXEN d00019A D M13 Other arthritis A` EX A OMEPRAZOLE d00325A Cr K30 Functional dyspepsia A` EX A ROSUVASTATIN d04851A Cr E78.1 Pure hyperglyceridemia A` EX A TRAZODONE d00395A C G47.9 Sleep disorder, unspecified A` EY A . . . EY A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C- F90 Attention-deficit hyperactivity disorders A EY A . . . EY0 A . . . EY@ A . . . EYP A . . . EY` A . . . EYp A . . . EY A METFORMIN d03807A A E11 Type 2 diabetes mellitus A EY A . . . EY A . . . EY A BECLOMETHASONE d00760A C J45 Asthma A EY A CETIRIZINE d03827A C[@ J45 Asthma A EY A ATORVASTATIN d04105A B* E78.0 Pure hypercholesterolemia A EY A SUMATRIPTAN d03160A D G43 Migraine A EY A ATORVASTATIN d04105A D 99999 A@ EY A FUROSEMIDE d00070A D 99999 A@ EY A METOPROLOL d00134A D 99999 A@ EY A OMEPRAZOLE d00325A D 99999 A@ EY A . . . EY A LEVOTHYROXINE d00278A DR E03.9 Hypothyroidism, unspecified AP EY A LOSARTAN d03821A C I10 Essential (primary) hypertension AP EY A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP EY A PAROXETINE d03157A C[@ F32.9 Major depressive disorder, single episode, unspecified AP EY A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia AP EZ A . . . EZ A DIVALPROEX SODIUM d03833A CDp M54 Dorsalgia A0 EZ A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A0 EZ A SUMATRIPTAN d03160A CDp G43 Migraine A0 EZ A . . . EZ0 A AMIODARONE d00002A D I48.9 I49.9 Unspecified atrial fibrillation and atrial flutter Cardiac arrhythmia, unspecified A EZ0 A AMLODIPINE d00689A C I10 I21.P Essential (primary) hypertension Prevent heart attack/myocardial infarction A EZ0 A CARVEDILOL d03847A C I48.9 I50.9 Unspecified atrial fibrillation and atrial flutter Heart failure, unspecified A EZ0 A DICLOFENAC TOPICAL d04722A B[ M19.9 M25.5 Osteoarthritis, unspecified site Pain in joint A EZ0 A FUROSEMIDE d00070A D R60.9 Edema, unspecified A EZ0 A HYDROCODONE d03075A CDp M25.5 M54 Pain in joint Dorsalgia A EZ0 A LATANOPROST OPHTHALMIC d04017A C H40 Glaucoma A EZ0 A MIRTAZAPINE d04025A B F41.9 Anxiety disorder, unspecified A EZ0 A OMEPRAZOLE d00325A CDp K30 Functional dyspepsia A EZ0 A PRAMIPEXOLE d04145A CDp G25.81 Restless legs syndrome A EZ0 A RIVAROXABAN d07356A C I21 I48.9 I49.9 ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction Unspecified atrial fibrillation and atrial flutter Cardiac arrhythmia, unspecified A EZ@ A . . . EZP A . . . EZ` A . . . EZp A BUPROPION d00181A A F17.2 F32.9 F41.9 Nicotine dependence Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A0 EZp A CETIRIZINE d03827A A T78.40 Allergy, unspecified A0 EZp A FLUTICASONE NASAL d04283A A J30.2 Other seasonal allergic rhinitis A0 EZ A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A EZ A . . . EZ A . . . EZ A . . . EZ A . . . EZ A . . . EZ A LATANOPROST OPHTHALMIC d04017A0 D H40 Glaucoma A0 EZ A SIMVASTATIN d00746A0 Dc E78.0 Pure hypercholesterolemia A0 EZ A VALACYCLOVIR d03838A0 C- B00.1 Herpesviral vesicular dermatitis A0 EZ A . . . E[ A AMLODIPINE d00689A0 Cr I10 Essential (primary) hypertension A0 E[ A HYDROCHLOROTHIAZIDE d00253A0 Cr I10 Essential (primary) hypertension A0 E[ A VALSARTAN d04113A0 Cr I10 Essential (primary) hypertension A0 E[ A 99999 . . A E[ A . . . E[0 A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A E[0 A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E[@ A . . . E[P A ATENOLOL d00004A Cr I10 Essential (primary) hypertension A E[P A NORTRIPTYLINE d00144A Dc G43 Migraine A E[` A CANAGLIFLOZIN; METFORMIN d08280A C- E11 Type 2 diabetes mellitus A0 E[` A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A0 E[` A SERTRALINE d00880A C[@ F41.9 Anxiety disorder, unspecified A0 E[p A . . . E[ A . . . E[ A . . . E[ A LISDEXAMFETAMINE d06663A B= F90 Attention-deficit hyperactivity disorders A E[ A ETHINYL ESTRADIOL; NORETHINDRONE d03238A B N94 Pain and other conditions associated with female genital organs and menstrual cycle A0 E[ A IBUPROFEN d00015A A@ N20.0 Calculus of kidney A0 E[ A NITROFURANTOIN d00112A A@ N39.0 Urinary tract infection, site not specified A0 E[ A RANITIDINE d00021A C K30 Functional dyspepsia A E[ A . . . E[ A LANSOPRAZOLE d03828A C- B96.81 Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere A` E[ A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A` E[ A MELOXICAM d04532A AP M79.1 Myalgia A` E[ A MONTELUKAST d04289A C R06.9 Unspecified abnormalities of breathing A` E[ A NIFEDIPINE d00051A C I10 Essential (primary) hypertension A` E[ A NITROFURANTOIN d00112A A0 N39.0 Urinary tract infection, site not specified A` E[ A . . . E\ A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A` E\ A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A` E\ A INSULIN ISOPHANE (NPH) d04370A CDp E11 Type 2 diabetes mellitus A` E\ A INSULIN REGULAR d04369A CDp E11 Type 2 diabetes mellitus A` E\ A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A` E\ A METFORMIN d03807A D R73 Elevated blood glucose level A` E\ A . . . E\ A . . . E\0 A . . . E\@ A . . . E\P A . . . E\` A . . . E\p A . . . E\ A . . . E\ A APIXABAN d07804A C D75.9P Prevent blood clots Ap E\ A DEXLANSOPRAZOLE d07395A Cr K21 Gastro-esophageal reflux disease Ap E\ A ESTRADIOL d00537A D1 Z79.890 Hormone replacement therapy Ap E\ A OXYBUTYNIN d00328A B N39.4 Other specified urinary incontinence Ap E\ A PITAVASTATIN d07637A CDp E78.0 Pure hypercholesterolemia Ap E\ A SOTALOL d00371A C[@ I48.9 Unspecified atrial fibrillation and atrial flutter Ap E\ A VILAZODONE d07740A C F32.9 Major depressive disorder, single episode, unspecified Ap E\ A 99999 . . A E\ A . . . E\ A . . . E\ A . . . E\ A . . . E\ A . . . E] A METOPROLOL d00134A D I48.9 Unspecified atrial fibrillation and atrial flutter A E] A 55555 . . L30.9 Dermatitis, unspecified A E] A . . . E]0 A ETHINYL ESTRADIOL; NORGESTIMATE d03781A Cr N92 Excessive, frequent and irregular menstruation A E]@ A COLESEVELAM d04695A C K58 Irritable bowel syndrome A@ E]@ A LORAZEPAM d00149A Dc F41.9 Anxiety disorder, unspecified A@ E]@ A OLANZAPINE d04050A Dc F31.9 Bipolar disorder, unspecified A@ E]@ A PROMETHAZINE d00787A B= R11 Nausea and vomiting A@ E]P A LEVOTHYROXINE d00278A C E07.9 Disorder of thyroid, unspecified A0 E]P A OMEPRAZOLE d00325A B K21 Gastro-esophageal reflux disease A0 E]P A TAMSULOSIN d04121A B R35 Polyuria A0 E]` A . . . E]p A . . . E] A . . . E] A . . . E] A METHYLPHENIDATE d00900A C} F90 Attention-deficit hyperactivity disorders A E] A . . . E] A ALBUTEROL d00749A C- J44.9 Chronic obstructive pulmonary disease, unspecified A E] A AMOXICILLIN d00088A Ap K04.7P Prevent tooth infection A E] A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A E] A CARVEDILOL d03847A D I10 Essential (primary) hypertension A E] A CLOPIDOGREL d04258A C I21.P Prevent heart attack/myocardial infarction A E] A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A E] A LISINOPRIL d00732A D I10 Essential (primary) hypertension A E] A SPIRONOLACTONE d00373A CDp R60.9 Edema, unspecified A E] A . . . E] A APIXABAN d07804A B[ I48.9 Unspecified atrial fibrillation and atrial flutter A@ E] A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ E] A CARVEDILOL d03847A B[ I10 Essential (primary) hypertension A@ E] A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 R60.9 Essential (primary) hypertension Edema, unspecified A@ E] A . . . E^ A FAMOTIDINE d00141A C"0 K21 Gastro-esophageal reflux disease A@ E^ A FLUOXETINE d00236A C- F41.9 Anxiety disorder, unspecified A@ E^ A MONTELUKAST d04289A C J30.9 R06.2 Allergic rhinitis, unspecified Wheezing A@ E^ A NAPROXEN d00019A C- R51 Headache A@ E^ A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E^ A ALBUTEROL d00749A C J45 Asthma A0 E^ A FLUTICASONE; SALMETEROL d04611A CDp J45 Asthma A0 E^ A HYDROXYZINE d00907A C J30.9 Allergic rhinitis, unspecified A0 E^0 A . . . E^@ A . . . E^P A . . . E^` A . . . E^p A BENAZEPRIL d00730A Cr I10 Essential (primary) hypertension Ap E^p A FELODIPINE d00231A Cr I10 Essential (primary) hypertension Ap E^p A GLIPIZIDE d00246A Cr E11 Type 2 diabetes mellitus Ap E^p A HYDROCHLOROTHIAZIDE d00253A CDp I10 Essential (primary) hypertension Ap E^p A IBUPROFEN d00015A B M25.5 M54 Pain in joint Dorsalgia Ap E^p A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus Ap E^p A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia Ap E^ A ACETAMINOPHEN; OXYCODONE d03431A B G89 Pain, not elsewhere classified A@ E^ A FLUCONAZOLE d00071A0 A B37 Candidiasis A@ E^ A ONDANSETRON d00867A A R11 Nausea and vomiting A@ E^ A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A B L08.9 Local infection of the skin and subcutaneous tissue, unspecified A@ E^ A . . . E^ A . . . E^ A . . . E^ A ALBUTEROL; IPRATROPIUM d04066A Cr R06.9P Prevent breathing difficulty A E^ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E^ A BETAMETHASONE; CLOTRIMAZOLE TOPICAL d03561A C- B35 Dermatophytosis A E^ A FUROSEMIDE d00070A C I50.9 Heart failure, unspecified A E^ A GABAPENTIN d03182A C- R25.2 Cramp and spasm A E^ A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E^ A METFORMIN d03807A C R73 Elevated blood glucose level A E^ A METOPROLOL d00134A C I48.9 Unspecified atrial fibrillation and atrial flutter A E^ A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A E^ A WARFARIN d00022A C D75.9P Prevent blood clots A E^ A . . . E^ A . . . E^ A . . . E_ A . . . E_ A ALLOPURINOL d00023A D M10.9P Prevent gout AP E_ A AMLODIPINE; BENAZEPRIL d03829A B I10 Essential (primary) hypertension AP E_ A HYDROCHLOROTHIAZIDE d00253A D* I10 Essential (primary) hypertension AP E_ A NEBIVOLOL d05265A B I10 Essential (primary) hypertension AP E_ A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia AP E_ A . . . E_0 A . . . E_@ A . . . E_P A . . . E_` A . . . E_p A . . . E_ A AMOXICILLIN d00088A A J02 Acute pharyngitis A E_ A ALLOPURINOL d00023A Cr M1A N20.0 Chronic gout Calculus of kidney A` E_ A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A` E_ A LEVOTHYROXINE d00278A D# E03.9 Hypothyroidism, unspecified A` E_ A LISINOPRIL d00732A D I10 Essential (primary) hypertension A` E_ A METFORMIN d03807A C R73 Elevated blood glucose level A` E_ A NAPROXEN d00019A Cr 55555 A` E_ A . . . E_ A LEVOTHYROXINE d00278A CYP 55555 A E_ A . . . E_ A ACYCLOVIR d00001A AP B00.1 Herpesviral vesicular dermatitis A E_ A IBUPROFEN d00015A AP B00.1 R52 Herpesviral vesicular dermatitis Pain, unspecified A E_ A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E_ A CLONIDINE d00044A C I10 Essential (primary) hypertension A E_ A ETANERCEPT d04365A B= M06.9 Rheumatoid arthritis, unspecified A E_ A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A B I10 Essential (primary) hypertension A E` A 99999 . . A E` A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E` A . . . E` A LISINOPRIL d00732A CP I10 Essential (primary) hypertension A E`0 A . . . E`@ A . . . E`P A . . . E`` A . . . E`p A . . . E` A ALBUTEROL d00749A Dc J45 Asthma A E` A FLUTICASONE NASAL d04283A B= H93.9 Unspecified disorder of ear A E` A AMOXICILLIN d00088A A0 B00.1 Herpesviral vesicular dermatitis A E` A . . . E` A ALOGLIPTIN d07963A C- E11 Type 2 diabetes mellitus A E` A AMLODIPINE d00689A C 99999 A E` A HYDRALAZINE d00132A C 99999 A E` A HYDROCHLOROTHIAZIDE d00253A C I50.9 Heart failure, unspecified A E` A INSULIN GLARGINE d04538A C[@ E11 Type 2 diabetes mellitus A E` A LOSARTAN d03821A C I10 Essential (primary) hypertension A E` A METOPROLOL d00134A C I10 Essential (primary) hypertension A E` A NATEGLINIDE d04743A Cr R73 Elevated blood glucose level A E` A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia A E` A ROPINIROLE d04215A CDp G20 Parkinson's disease A E` A . . . E` A CEPHALEXIN d00096A A L98.9 Disorder of the skin and subcutaneous tissue, unspecified A E` A APIXABAN d07804A B D75.9P Prevent blood clots A` E` A ATORVASTATIN d04105A C E78.0 I10 Pure hypercholesterolemia Essential (primary) hypertension A` E` A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A` E` A METOPROLOL d00134A B I10 Essential (primary) hypertension A` E` A TORSEMIDE d03189A D R60.9 Edema, unspecified A` E` A VERAPAMIL d00048A D I48.9 Unspecified atrial fibrillation and atrial flutter A` E` A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A Ea A AMLODIPINE d00689A Bz I10 Essential (primary) hypertension A Ea A . . . Ea A LORAZEPAM d00149A CDp F41.9 Anxiety disorder, unspecified AP Ea A QUETIAPINE d04220A C F32.9 Major depressive disorder, single episode, unspecified AP Ea A ROPINIROLE d04215A C G25.81 Restless legs syndrome AP Ea A TADALAFIL d04896A C N32.9 Bladder disorder, unspecified AP Ea A VENLAFAXINE d03181A C F32.9 Major depressive disorder, single episode, unspecified AP Ea0 A . . . Ea@ A . . . EaP A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A B[ Z79.3 Long term (current) use of hormonal contraceptives A EaP A RANITIDINE d00021A B[ T78.40 Allergy, unspecified A Ea` A . . . Eap A ANTIHYPERTENSIVE AGENTS - UNSPECIFIED h00024A CDp I10 Essential (primary) hypertension A Eap A IBUPROFEN d00015A C M1A Chronic gout A Ea A . . . Ea A . . . Ea A AMLODIPINE d00689A B= I10 I63.P Essential (primary) hypertension Prevent stroke A Ea A ATORVASTATIN d04105A B= E78.0 Pure hypercholesterolemia A Ea A BUPROPION d00181A C F32.9 Major depressive disorder, single episode, unspecified A Ea A CYCLOBENZAPRINE d00963A B= M79.1 Myalgia A Ea A FLUOXETINE d00236A C F32.9 Major depressive disorder, single episode, unspecified A Ea A LOSARTAN d03821A C I10 Essential (primary) hypertension A Ea A NORTRIPTYLINE d00144A CDp M79.2 Neuralgia and neuritis, unspecified A Ea A WARFARIN d00022A D D75.9P Prevent blood clots A Ea A . . . Ea A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified Ap Ea A LOSARTAN d03821A C I10 Essential (primary) hypertension Ap Ea A METOPROLOL d00134A C I48.9 Unspecified atrial fibrillation and atrial flutter Ap Ea A NIACIN d00314A C 55555 Ap Ea A RIVAROXABAN d07356A C D75.9P I48.9 Prevent blood clots Unspecified atrial fibrillation and atrial flutter Ap Ea A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia Ap Ea A SPIRONOLACTONE d00373A C I51.9 Heart disease, unspecified Ap Ea A . . . Ea A GABAPENTIN d03182A CDp M54 Dorsalgia A0 Ea A MIRABEGRON d07876A C- N39.4 R32 Other specified urinary incontinence Unspecified urinary incontinence A0 Ea A ZOLPIDEM d00910A C[@ G47.0 Insomnia A0 Ea A . . . Eb A GLYBURIDE d00248A Ap R73 Elevated blood glucose level A Eb A . . . Eb A INSULIN DETEMIR d05436A B E11 Type 2 diabetes mellitus A0 Eb A METFORMIN d03807A B E11 Type 2 diabetes mellitus A0 Eb A SIMVASTATIN d00746A C E11 Type 2 diabetes mellitus A0 Eb0 A . . . Eb@ A . . . EbP A . . . Eb` A ALBUTEROL d00749A B J45 Asthma A Eb` A FLUTICASONE d01296A C J45 Asthma A Ebp A . . . Eb A . . . Eb A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified A Eb A . . . Eb A TRAZODONE d00395A Cr G47.9 Sleep disorder, unspecified A Eb A CARVEDILOL d03847A D I10 Essential (primary) hypertension A Eb A DEXLANSOPRAZOLE d07395A C K21 Gastro-esophageal reflux disease A Eb A DICYCLOMINE d00999A C R12 Heartburn A Eb A DOXYCYCLINE d00037A C- A49.9 Bacterial infection, unspecified A Eb A EMPAGLIFLOZIN d08275A C E11 Type 2 diabetes mellitus A Eb A GEMFIBROZIL d00245A C E78.0 Pure hypercholesterolemia A Eb A GLYBURIDE d00248A C E11 Type 2 diabetes mellitus A Eb A INSULIN DETEMIR d05436A C- E11 Type 2 diabetes mellitus A Eb A RAMIPRIL d00728A Dc I10 Essential (primary) hypertension A Eb A SIMVASTATIN d00746A Dc E78.0 Pure hypercholesterolemia A Eb A SITAGLIPTIN d05896A C E11 Type 2 diabetes mellitus A Eb A . . . Eb A LEVOTHYROXINE d00278A C E04 Other nontoxic goiter A Eb A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C Z79.3 Long term (current) use of hormonal contraceptives A Ec A . . . Ec A AMOXICILLIN; CLAVULANATE d00089A A0 J01.9 Acute sinusitis, unspecified A0 Ec A CETIRIZINE d03827A A0 J01.9 R09.81 Acute sinusitis, unspecified Nasal congestion A0 Ec A PREDNISOLONE d00084A A0 R05 R09.81 Cough Nasal congestion A0 Ec A APIXABAN d07804A C I48.9 Unspecified atrial fibrillation and atrial flutter A0 Ec A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A0 Ec A SIMVASTATIN d00746A Dc E78.0 Pure hypercholesterolemia A0 Ec0 A . . . Ec@ A . . . EcP A ACETAMINOPHEN; BUTALBITAL; CAFFEINE d03455A B G47.9 Sleep disorder, unspecified A0 EcP A NAPROXEN d00019A C ` G89 M25.5 Z96 Pain, not elsewhere classified Pain in joint Presence of other functional implants A0 EcP A TIZANIDINE d04102A B G47.9 Sleep disorder, unspecified A0 Ec` A . . . Ecp A 99999 . . A Ec A . . . Ec A CLONIDINE d00044A C- F90 Attention-deficit hyperactivity disorders A Ec A . . . Ec A MELOXICAM d04532A C- L40 Psoriasis A0 Ec A RANITIDINE d00021A Cr K30 Functional dyspepsia A0 Ec A TRAMADOL d03826A A M13 Other arthritis A0 Ec A ALBUTEROL d00749A D# J45 Asthma A Ec A BROMPHENIRAMINE; DEXTROMETHORPHAN; PSEUDOEPHEDRINE d03368A A R05 Cough A Ec A CELECOXIB d04380A C- M79.2 Neuralgia and neuritis, unspecified A Ec A ESOMEPRAZOLE d04749A C K21 Gastro-esophageal reflux disease A Ec A FLUTICASONE d01296A D# J45 Asthma A Ec A GABAPENTIN d03182A Dc M79.2 Neuralgia and neuritis, unspecified A Ec A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A CDp I10 Essential (primary) hypertension A Ec A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A Ec A . . . Ec A . . . Ec A . . . Ed A MESALAMINE d01031A C K50 Crohn's disease [regional enteritis] A Ed A METHOTREXATE d00060A Cr K50 Crohn's disease [regional enteritis] A Ed A . . . Ed A DUTASTERIDE d04788A C C61.P Prevent prostate cancer AP Ed A GLIPIZIDE d00246A B E11 Type 2 diabetes mellitus AP Ed A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified AP Ed A PANTOPRAZOLE d04514A C"0 K22 Other diseases of esophagus AP Ed A WARFARIN d00022A C D75.9P Prevent blood clots AP Ed0 A ATENOLOL d00004A CDp I49.9 Cardiac arrhythmia, unspecified A` Ed0 A CHLORDIAZEPOXIDE; CLIDINIUM d03492A D K21 Gastro-esophageal reflux disease A` Ed0 A ESOMEPRAZOLE d04749A B R10 Abdominal and pelvic pain A` Ed0 A HYDROXYZINE d00907A C[@ K76.9 L29.9 Liver disease, unspecified Pruritus, unspecified A` Ed0 A MELOXICAM d04532A Dc M19.9 Osteoarthritis, unspecified site A` Ed0 A URSODIOL d01005A D# K87 Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere A` Ed@ A GABAPENTIN d03182A Cr M79.7 Fibromyalgia A@ Ed@ A LEVOTHYROXINE d00278A Dc E03.9 E05 Hypothyroidism, unspecified Thyrotoxicosis [hyperthyroidism] A@ Ed@ A METHOTREXATE d00060A Bz M06.9 Rheumatoid arthritis, unspecified A@ Ed@ A VENLAFAXINE d03181A C F32.9 Major depressive disorder, single episode, unspecified A@ EdP A . . . Ed` A . . . Edp A . . . Ed A . . . Ed A ATORVASTATIN d04105A Ei E78.0 Pure hypercholesterolemia A` Ed A CLOPIDOGREL d04258A C- I21.P Prevent heart attack/myocardial infarction A` Ed A FUROSEMIDE d00070A C R60.9 Edema, unspecified A` Ed A ISOSORBIDE d00653A C- R07.9 Chest pain, unspecified A` Ed A METOPROLOL d00134A C- I10 Essential (primary) hypertension A` Ed A TIZANIDINE d04102A C M62.83 Muscle spasm A` Ed A LISINOPRIL d00732A C I10 Essential (primary) hypertension A Ed A . . . Ed A . . . Ed A . . . Ed A . . . Ed A ABACAVIR; DOLUTEGRAVIR; LAMIVUDINE d08284A C B20 Human immunodeficiency virus [HIV] disease Ap Ed A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia Ap Ed A BETAMETHASONE d00628A C C80.1 Malignant (primary) neoplasm, unspecified Ap Ed A DARUNAVIR d05825A C B20 Human immunodeficiency virus [HIV] disease Ap Ed A RITONAVIR d03984A D B20 Human immunodeficiency virus [HIV] disease Ap Ed A TERAZOSIN d00386A Cr N40 Enlarged prostate Ap Ed A TRIAMCINOLONE TOPICAL d03206A C L20.9 Atopic dermatitis, unspecified Ap Ee A BUPROPION d00181A CDp F32.9 Major depressive disorder, single episode, unspecified A0 Ee A ONDANSETRON d00867A B= R11 Nausea and vomiting A0 Ee A RISPERIDONE d03180A Cr F29 F31.9 F99 Unspecified psychosis not due to a substance or known physiological condition Bipolar disorder, unspecified Mental disorder, not otherwise specified A0 Ee A . . . Ee A DILTIAZEM d00045A Dc I20.9 Angina pectoris, unspecified A@ Ee A MELOXICAM d04532A C- M19.9 Osteoarthritis, unspecified site A@ Ee A NIACIN d00314A CDp E78.0 Pure hypercholesterolemia A@ Ee A PAROXETINE d03157A C F41.9 Anxiety disorder, unspecified A@ Ee0 A . . . Ee@ A ETHINYL ESTRADIOL; NORGESTIMATE d03781A Bz L70 Acne A EeP A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A Ee` A . . . Eep A . . . Ee A . . . Ee A . . . Ee A IBANDRONATE d05357A C- M81 Osteoporosis without current pathological fracture A Ee A METFORMIN d03807A C- R73 Elevated blood glucose level A Ee A . . . Ee A . . . Ee A . . . Ee A KETOCONAZOLE TOPICAL d03202A B[ L30.9 Dermatitis, unspecified A0 Ee A KETOCONAZOLE TOPICAL d03202A B[ L30.9 Dermatitis, unspecified A0 Ee A TOPICAL STEROIDS - UNSPECIFIED c00138A C L30.9 Dermatitis, unspecified A0 Ee A . . . Ef A AMOXICILLIN d00088A AP H66.9 Otitis media, unspecified A Ef A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 Ef A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A0 Ef A METFORMIN d03807A C E11 Type 2 diabetes mellitus A0 Ef A . . . Ef0 A HYDROXYZINE d00907A B= F41.9 Anxiety disorder, unspecified A Ef@ A . . . EfP A PENICILLIN d00116A A K04.7 Periapical abscess without sinus A Ef` A . . . Efp A . . . Ef A AMOXICILLIN d00088A AP J02 Acute pharyngitis AP Ef A BROMPHENIRAMINE; DEXTROMETHORPHAN; PSEUDOEPHEDRINE d03368A Ap R05 Cough AP Ef A CETIRIZINE d03827A Cr T78.40 Allergy, unspecified AP Ef A FLUTICASONE NASAL d04283A C[@ T78.40 Allergy, unspecified AP Ef A MONTELUKAST d04289A C[@ T78.40 Allergy, unspecified AP Ef A ALENDRONATE d03849A CDp M81 Osteoporosis without current pathological fracture Ap Ef A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia Ap Ef A BRIMONIDINE; TIMOLOL OPHTHALMIC d05283A C[@ H40 Glaucoma Ap Ef A GABAPENTIN d03182A C- R52 Pain, unspecified Ap Ef A LATANOPROST OPHTHALMIC d04017A C[@ H40 Glaucoma Ap Ef A LOSARTAN d03821A C I10 Essential (primary) hypertension Ap Ef A NITROFURANTOIN d00112A A N30 Cystitis Ap Ef A ALBUTEROL d00749A B= J20.9 Acute bronchitis, unspecified A Ef A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A Ef A . . . Ef A AMLODIPINE d00689A D# I10 Essential (primary) hypertension A@ Ef A LORAZEPAM d00149A CS R45 Symptoms and signs involving emotional state A@ Ef A LOSARTAN d03821A C I10 Essential (primary) hypertension A@ Ef A MELOXICAM d04532A Cr M79.6 Pain in limb, hand, foot, fingers and toes A@ Ef A . . . Ef A ACETAMINOPHEN; HYDROCODONE d03428A C M54 Dorsalgia A Ef A ALBUTEROL d00749A C9 J44.9 Chronic obstructive pulmonary disease, unspecified A Ef A AMLODIPINE; OLMESARTAN d06905A C I10 Essential (primary) hypertension A Ef A BIMATOPROST OPHTHALMIC d04754A DGJ H40 Glaucoma A Ef A BRIMONIDINE OPHTHALMIC d04048A DGJ H40 Glaucoma A Ef A DORZOLAMIDE OPHTHALMIC d03805A DGJ H40 Glaucoma A Ef A METOPROLOL d00134A C I10 Essential (primary) hypertension A Ef A TRAZODONE d00395A C- G47.9 Sleep disorder, unspecified A Ef A . . . Eg A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A0 Eg A OXAPROZIN d00853A C M06.9 Rheumatoid arthritis, unspecified A0 Eg A POTASSIUM CHLORIDE d00345A Ap E87.6 Hypokalemia A0 Eg A . . . Eg A ATORVASTATIN d04105A D* E78.0 I21.P Pure hypercholesterolemia Prevent heart attack/myocardial infarction A Eg A CELECOXIB d04380A C- M79.1 Myalgia A Eg A INSULIN GLARGINE d04538A D E11 Type 2 diabetes mellitus A Eg A INSULIN LISPRO d04373A D E11 Type 2 diabetes mellitus A Eg A INSULIN LISPRO; INSULIN LISPRO PROTAMINE d04510A D E11 Type 2 diabetes mellitus A Eg A LOSARTAN d03821A C N28.9P Prevent kidney disease A Eg A PIOGLITAZONE d04442A D E11 Type 2 diabetes mellitus A Eg A TAMSULOSIN d04121A CDp N40 Enlarged prostate A Eg0 A . . . Eg@ A . . . EgP A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A0 EgP A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A0 EgP A TIZANIDINE d04102A C- G47.0 Insomnia A0 Eg` A . . . Egp A . . . Eg A . . . Eg A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A Eg A . . . Eg A ALBUTEROL d00749A A R06.9 Unspecified abnormalities of breathing A Eg A . . . Eg A . . . Eg A . . . Eg A . . . Eh A ACYCLOVIR d00001A C"0 B00.1 Herpesviral vesicular dermatitis A Eh A ALBUTEROL d00749A C R06.02 Shortness of breath A@ Eh A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A@ Eh A CYCLOBENZAPRINE d00963A Cr M25.5 Pain in joint A@ Eh A METOPROLOL d00134A C I10 Essential (primary) hypertension A@ Eh A . . . Eh0 A INSULIN ASPART d04697A Cr E10 Type 1 diabetes mellitus A Eh@ A . . . EhP A . . . Eh` A CYCLOBENZAPRINE d00963A C[@ M54 Dorsalgia A0 Eh` A GABAPENTIN d03182A CDp G25.81 Restless legs syndrome A0 Eh` A LORAZEPAM d00149A C[@ F41.9 Anxiety disorder, unspecified A0 Ehp A . . . Eh A . . . Eh A PAROXETINE d03157A C I10 Essential (primary) hypertension A Eh A ZOLPIDEM d00910A C G47.9 Sleep disorder, unspecified A Eh A . . . Eh A . . . Eh A . . . Eh A . . . Eh A . . . Eh A AMITRIPTYLINE d00146A B G47.0 Insomnia AP Eh A CLONIDINE d00044A CDp I10 Essential (primary) hypertension AP Eh A ESCITALOPRAM d04812A C F32.9 Major depressive disorder, single episode, unspecified AP Eh A HYDROXYZINE d00907A B F41.9 Anxiety disorder, unspecified AP Eh A OLANZAPINE d04050A B[ F39 Unspecified mood [affective] disorder AP Ei A ALPRAZOLAM d00168A C- F41.9 Anxiety disorder, unspecified A Ei A ESTRADIOL d00537A C Z79.890 Hormone replacement therapy A Ei A . . . Ei A . . . Ei0 A ALLOPURINOL d00023A C- M1A Chronic gout A@ Ei0 A METHOTREXATE d00060A C- M06.9 Rheumatoid arthritis, unspecified A@ Ei0 A PREDNISONE d00350A C- M06.9 Rheumatoid arthritis, unspecified A@ Ei0 A TENOFOVIR d04774A C- K76.9 Liver disease, unspecified A@ Ei@ A BETAMETHASONE; CALCIPOTRIENE TOPICAL d05044A B= L40 Psoriasis A` Ei@ A CICLOPIROX TOPICAL d01272A C L98.9 Disorder of the skin and subcutaneous tissue, unspecified A` Ei@ A CLOBETASOL TOPICAL d01288A C L98.9 Disorder of the skin and subcutaneous tissue, unspecified A` Ei@ A INSULIN GLARGINE d04538A C- E11 Type 2 diabetes mellitus A` Ei@ A INSULIN GLULISINE d05278A C- E11 Type 2 diabetes mellitus A` Ei@ A TRIAMCINOLONE TOPICAL d03206A C L40 Psoriasis A` EiP A 99999 . . A Ei` A APIXABAN d07804A C D75.9P I48.9 Prevent blood clots Unspecified atrial fibrillation and atrial flutter A` Ei` A ATORVASTATIN d04105A C 99999 A` Ei` A CLINDAMYCIN d00043A D K04.7 Periapical abscess without sinus A` Ei` A DIGOXIN d00210A C I48.9 Unspecified atrial fibrillation and atrial flutter A` Ei` A FINASTERIDE d00563A C[@ 99999 A` Ei` A SOLIFENACIN d05413A C[@ R35 Polyuria A` Eip A . . . Ei A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP Ei A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia AP Ei A CARVEDILOL d03847A C I10 Essential (primary) hypertension AP Ei A HYDRALAZINE d00132A C I10 Essential (primary) hypertension AP Ei A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP Ei A ETHINYL ESTRADIOL; NORELGESTROMIN d04779A C N92 Excessive, frequent and irregular menstruation A Ei A . . . Ei A . . . Ei A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A Ei A ATORVASTATIN d04105A CP E78.0 Pure hypercholesterolemia A Ei A CETIRIZINE d03827A B R09.81 Nasal congestion A Ei A GLIMEPIRIDE d03864A B E11 Type 2 diabetes mellitus A Ei A HYDROCHLOROTHIAZIDE d00253A C[@ I10 Essential (primary) hypertension A Ei A MELOXICAM d04532A B M54 Dorsalgia A Ei A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A Ei A QUETIAPINE d04220A C F31.9 Bipolar disorder, unspecified A Ei A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease A Ei A VENLAFAXINE d03181A C F31.9 Bipolar disorder, unspecified A Ei A AMLODIPINE d00689A D* I10 I51.9 Essential (primary) hypertension Heart disease, unspecified A Ei A ANASTROZOLE d03873A A K31.9 Disease of stomach and duodenum, unspecified A Ei A CETIRIZINE d03827A A K31.9 K87 Disease of stomach and duodenum, unspecified Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere A Ei A HYDROCHLOROTHIAZIDE d00253A D* I10 Essential (primary) hypertension A Ei A IBUPROFEN d00015A A R10 Abdominal and pelvic pain A Ei A OMEPRAZOLE d00325A A K21 K30 Gastro-esophageal reflux disease Functional dyspepsia A Ei A POLYETHYLENE GLYCOL 3350 d05350A B[ K59.0 Constipation A Ei A PRAVASTATIN d00348A B I99.9 Unspecified disorder of circulatory system A Ei A SUCRALFATE d00377A A K25.P Prevent gastric ulcer A Ei A TELMISARTAN d04364A CDp I21.P Prevent heart attack/myocardial infarction A Ei A . . . Ei A . . . Ej A ESCITALOPRAM d04812A Bz F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A Ej A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C"0 N92 Excessive, frequent and irregular menstruation A Ej A AMITRIPTYLINE d00146A C F33.9 M79.2 Major depressive disorder, recurrent, unspecified Neuralgia and neuritis, unspecified Ap Ej A AMLODIPINE d00689A C I10 Essential (primary) hypertension Ap Ej A CHLORTHALIDONE d00192A C I10 Essential (primary) hypertension Ap Ej A CYCLOBENZAPRINE d00963A C M62.83 M79.1 Muscle spasm Myalgia Ap Ej A FLUOXETINE d00236A C F32.9 Major depressive disorder, single episode, unspecified Ap Ej A MELOXICAM d04532A C M25.5 Pain in joint Ap Ej A OMEPRAZOLE d00325A C[@ K21 R12 Gastro-esophageal reflux disease Heartburn Ap Ej A . . . Ej0 A ETHINYL ESTRADIOL; NORGESTIMATE d03781A B Z79.3 Long term (current) use of hormonal contraceptives A Ej@ A LISINOPRIL d00732A B I10 Essential (primary) hypertension A EjP A . . . Ej` A . . . Ejp A . . . Ej A LOSARTAN d03821A C I10 Essential (primary) hypertension A Ej A ETHINYL ESTRADIOL; NORGESTREL d03241A C"0 Z79.3 Long term (current) use of hormonal contraceptives A Ej A NAPROXEN d00019A C M25.9 Joint disorder, unspecified A Ej A DONEPEZIL d04099A D R41 Other symptoms and signs involving cognitive functions and awareness A Ej A MEMANTINE d04899A Dc R41 Other symptoms and signs involving cognitive functions and awareness A Ej A . . . Ej A ASPIRIN d00170A CDp D75.9P Prevent blood clots AP Ej A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP Ej A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP Ej A METFORMIN; SITAGLIPTIN d06720A C E11 Type 2 diabetes mellitus AP Ej A VENLAFAXINE d03181A D 99999 AP Ej A . . . Ej A . . . Ej A NAPROXEN d00019A A M54 Dorsalgia A0 Ej A TIZANIDINE d04102A A M54 Dorsalgia A0 Ej A TRAMADOL d03826A A M54 Dorsalgia A0 Ek A . . . Ek A . . . Ek A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A Ek A FLUTICASONE NASAL d04283A B R09.81 Nasal congestion A Ek0 A . . . Ek@ A AMLODIPINE d00689A0 C- I10 Essential (primary) hypertension A Ek@ A ATORVASTATIN d04105A0 C E78.0 Pure hypercholesterolemia A Ek@ A HYDROCHLOROTHIAZIDE d00253A0 C- I10 Essential (primary) hypertension A Ek@ A INSULIN GLARGINE d04538A0 C R73 Elevated blood glucose level A Ek@ A LISINOPRIL d00732A0 C I10 Essential (primary) hypertension A Ek@ A METFORMIN d03807A0 C- E11 Type 2 diabetes mellitus A Ek@ A METOPROLOL d00134A0 C I10 Essential (primary) hypertension A Ek@ A PIOGLITAZONE d04442A0 C- E11 Type 2 diabetes mellitus A EkP A . . . Ek` A . . . Ekp A . . . Ek A . . . Ek A . . . Ek A . . . Ek A . . . Ek A . . . Ek A . . . Ek A ALBUTEROL d00749A CDp R06.02 Shortness of breath AP Ek A CARVEDILOL d03847A D I10 Essential (primary) hypertension AP Ek A CITALOPRAM d04332A Dc F43.9 Reaction to severe stress, unspecified AP Ek A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension AP Ek A LORAZEPAM d00149A Dc F41.9 Anxiety disorder, unspecified AP Ek A . . . El A . . . El A FENOFIBRATE d04286A C R73 Elevated blood glucose level A@ El A IBUPROFEN d00015A C M25.5 Pain in joint A@ El A LEVOTHYROXINE d00278A B= E03.9 Hypothyroidism, unspecified A@ El A METFORMIN; SAXAGLIPTIN d07709A C R73 Elevated blood glucose level A@ El A . . . El0 A . . . El@ A . . . ElP A ACETAMINOPHEN; HYDROCODONE d03428A C M25.5 M65.9 Pain in joint Synovitis and tenosynovitis, unspecified A@ ElP A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A@ ElP A ATORVASTATIN d04105A C[@ E78.0P Prevent high cholesterol A@ ElP A NAPROXEN d00019A Ap M25.5 Pain in joint A@ El` A . . . Elp A METHADONE d00050A C[@ F11.23 Opioid dependence with withdrawal A El A . . . El A TRAMADOL d03826A B# M54 Dorsalgia A El A . . . El A ACETAMINOPHEN; CODEINE d03423A B= M25.5 M54 Pain in joint Dorsalgia A El A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A El A ESCITALOPRAM d04812A C[@ F32.9 Major depressive disorder, single episode, unspecified A El A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A Dc I10 Essential (primary) hypertension A El A MONTELUKAST d04289A C R09.81 Nasal congestion A El A MORPHINE d00308A Bz M25.5 M54 Pain in joint Dorsalgia A El A NIFEDIPINE d00051A Cr I10 Essential (primary) hypertension A El A TIZANIDINE d04102A B[ M79.1 Myalgia A El A . . . El A . . . El A ALLOPURINOL d00023A D M1A Chronic gout A` El A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A` El A DEXAMETHASONE; TOBRAMYCIN OPHTHALMIC d03536A B[ H57.9 Unspecified disorder of eye and adnexa A` El A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A` El A SPIRONOLACTONE d00373A C I10 Essential (primary) hypertension A` El A VENLAFAXINE d03181A C- F43.9 Reaction to severe stress, unspecified A` El A . . . Em A . . . Em A . . . Em A . . . Em0 A CLONIDINE d00044A C I10 Essential (primary) hypertension A Em0 A DILTIAZEM d00045A C- 99999 A Em0 A DOXAZOSIN d00726A C N28.9 Disorder of kidney and ureter, unspecified A Em0 A FAMOTIDINE d00141A C K21 Gastro-esophageal reflux disease A Em0 A GLIPIZIDE d00246A C- E11 Type 2 diabetes mellitus A Em0 A LOSARTAN d03821A C- 99999 A Em0 A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension A Em0 A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A Em0 A WARFARIN d00022A D* Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A Em@ A FLUTICASONE NASAL d04283A C[@ R09.8 T78.40 Other specified symptoms and signs involving the circulatory and respiratory systems Allergy, unspecified A Em@ A TRIAMCINOLONE TOPICAL d03206A B L20.9 Atopic dermatitis, unspecified A EmP A AMLODIPINE d00689A C I10 Essential (primary) hypertension A` EmP A ATENOLOL d00004A C I10 Essential (primary) hypertension A` EmP A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A` EmP A IRBESARTAN d04222A C I10 Essential (primary) hypertension A` EmP A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease A` EmP A RALOXIFENE d04261A C C50.P prevent breast cancer A` Em` A . . . Emp A BUPROPION d00181A Cr F32.9 Major depressive disorder, single episode, unspecified A Emp A METHYLPHENIDATE d00900A C F90 Attention-deficit hyperactivity disorders A Em A . . . Em A . . . Em A AZELASTINE NASAL d04068A C J30.9 Allergic rhinitis, unspecified A0 Em A BROMPHENIRAMINE; DEXTROMETHORPHAN; PSEUDOEPHEDRINE d03368A A R05 Cough A0 Em A FLUTICASONE d01296A CDp J45 Asthma A0 Em A . . . Em A . . . Em A . . . Em A OSELTAMIVIR d04462A A J09 Influenza due to certain identified influenza viruses A Em A . . . En A LOVASTATIN d00280A Cr E78.0 Pure hypercholesterolemia A En A . . . En A . . . En0 A ATENOLOL d00004A D I48.9 R00 Unspecified atrial fibrillation and atrial flutter Abnormalities of heart beat A En0 A ATORVASTATIN d04105A D E78.0P Prevent high cholesterol A En0 A ETANERCEPT d04365A Dc K50 L40 Crohn's disease [regional enteritis] Psoriasis A En0 A FUROSEMIDE d00070A D I51.9 Heart disease, unspecified A En0 A GLIPIZIDE d00246A D E11 Type 2 diabetes mellitus A En0 A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A En0 A LISINOPRIL d00732A D I10 Essential (primary) hypertension A En0 A METFORMIN d03807A C E11 Type 2 diabetes mellitus A En0 A SPIRONOLACTONE d00373A D I10 R00 Essential (primary) hypertension Abnormalities of heart beat A En0 A SULFASALAZINE d00379A D* K51 Ulcerative colitis A En0 A WARFARIN d00022A D D75.9P I48.9 Prevent blood clots Unspecified atrial fibrillation and atrial flutter A En@ A FLUOXETINE d00236A B F32.9 Major depressive disorder, single episode, unspecified A EnP A . . . En` A AMOXICILLIN d00088A A K04.7 Periapical abscess without sinus A Enp A LATANOPROST OPHTHALMIC d04017A B[ H40 Glaucoma AP Enp A METOPROLOL d00134A C I10 Essential (primary) hypertension AP Enp A PIRFENIDONE d08031A B= J98.9 Respiratory disorder, unspecified AP Enp A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia AP Enp A PREDNISONE d00350A B= J44.9 Chronic obstructive pulmonary disease, unspecified AP En A DULOXETINE d05355A C"0 F32.9 Major depressive disorder, single episode, unspecified A En A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A En A MYCOPHENOLATE MOFETIL d03839A C- T86.9P Prevent transplanted organ and tissue rejection A En A PANCRELIPASE d01002A D/ 55555 A En A PREDNISONE d00350A C T86.9P Prevent transplanted organ and tissue rejection A En A SUMATRIPTAN d03160A C G43 Migraine A En A TACROLIMUS d03752A C- T86.9P Prevent transplanted organ and tissue rejection A En A TRAZODONE d00395A C F41.9 G47.0 Anxiety disorder, unspecified Insomnia A En A VALGANCICLOVIR d04755A C- B35 Dermatophytosis A En A . . . En A CARVEDILOL d03847A C ` G47.0 Insomnia A` En A FUROSEMIDE d00070A C ` R60.9 Edema, unspecified A` En A LISINOPRIL d00732A C ` I10 Essential (primary) hypertension A` En A PANTOPRAZOLE d04514A B[ K21 Gastro-esophageal reflux disease A` En A SPIRONOLACTONE d00373A B< I50.9 Heart failure, unspecified A` En A WARFARIN d00022A C ` D75.9P Prevent blood clots A` En A . . . En A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A0 En A INDAPAMIDE d00260A A I10 Essential (primary) hypertension A0 En A RAMIPRIL d00728A A@ I10 Essential (primary) hypertension A0 En A . . . En A AZITHROMYCIN d00091A A@ J06.9 Acute upper respiratory infection, unspecified A En A ESTRADIOL d00537A C- N95 Menopausal and other perimenopausal disorders A0 En A IRBESARTAN d04222A Cr I10 Essential (primary) hypertension A0 En A ROSUVASTATIN d04851A C- E78.0 Pure hypercholesterolemia A0 Eo A . . . Eo A . . . Eo A ESCITALOPRAM d04812A0 Bz F32.9 Major depressive disorder, single episode, unspecified AP Eo A ESOMEPRAZOLE d04749A0 C R12 Heartburn AP Eo A FAMOTIDINE d00141A0 C K21 Gastro-esophageal reflux disease AP Eo A LEVOTHYROXINE d00278A0 C E03.9 Hypothyroidism, unspecified AP Eo A LURASIDONE d07705A0 C- F31.9 Bipolar disorder, unspecified AP Eo0 A CLONIDINE d00044A C- 99999 A Eo0 A DICYCLOMINE d00999A C- 99999 A Eo@ A . . . EoP A . . . Eo` A . . . Eop A . . . Eo A AMLODIPINE; BENAZEPRIL d03829A C I10 Essential (primary) hypertension A0 Eo A CLOPIDOGREL d04258A B I21.P Prevent heart attack/myocardial infarction A0 Eo A METFORMIN d03807A Bz E11 Type 2 diabetes mellitus A0 Eo A TRIAMCINOLONE TOPICAL d03206A A 55555 A Eo A . . . Eo A . . . Eo A . . . Eo A MONTELUKAST d04289A C J30.9 Allergic rhinitis, unspecified A Eo A AMLODIPINE; HYDROCHLOROTHIAZIDE; OLMESARTAN d07668A Cr I10 Essential (primary) hypertension A` Eo A DOXAZOSIN d00726A Cr I10 Essential (primary) hypertension A` Eo A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A` Eo A METFORMIN; SITAGLIPTIN d06720A C- E11 Type 2 diabetes mellitus A` Eo A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A` Eo A TRAVOPROST OPHTHALMIC d04753A Cr H40 Glaucoma A` Eo A ALBUTEROL d00749A D% J45 Asthma A Eo A BUDESONIDE; FORMOTEROL d04795A C- J45 Asthma A Ep A . . . Ep A . . . Ep A HYDROCODONE d03075A Cr M19.9 M25.5 M54 Osteoarthritis, unspecified site Pain in joint Dorsalgia A Ep A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease A Ep0 A . . . Ep@ A . . . EpP A . . . Ep` A . . . Epp A . . . Ep A . . . Ep A AMLODIPINE d00689A C I10 Essential (primary) hypertension A Ep A . . . Ep A . . . Ep A . . . Ep A . . . Ep A . . . Ep A . . . Eq A ALENDRONATE d03849A C- M81 Osteoporosis without current pathological fracture A Eq A CANAGLIFLOZIN d08080A B= E11 Type 2 diabetes mellitus A Eq A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A Eq A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified A Eq A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A Eq A LISINOPRIL d00732A C E11.2P I10 Prevent diabetic kidney disease Essential (primary) hypertension A Eq A METFORMIN d03807A C E11 Type 2 diabetes mellitus A Eq A METOPROLOL d00134A C I10 I21.P Essential (primary) hypertension Prevent heart attack/myocardial infarction A Eq A TIOTROPIUM d04829A B[ J44.9 Chronic obstructive pulmonary disease, unspecified A Eq A AMLODIPINE d00689A Dc I10 Essential (primary) hypertension A Eq A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension A Eq0 A ESCITALOPRAM d04812A C[@ F32.9 Major depressive disorder, single episode, unspecified A Eq@ A ATORVASTATIN d04105A C[@ E78.0P Prevent high cholesterol A@ Eq@ A ETANERCEPT d04365A CP L40 Psoriasis A@ Eq@ A GABAPENTIN d03182A C- G47.0 Insomnia A@ Eq@ A TAMOXIFEN d00381A C9 55555 A@ EqP A . . . Eq` A ALLOPURINOL d00023A C M1A Chronic gout A Eq` A AMLODIPINE d00689A C I10 Essential (primary) hypertension A Eq` A CARVEDILOL d03847A C I10 Essential (primary) hypertension A Eq` A CLOPIDOGREL d04258A Cr Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A Eq` A DOXAZOSIN d00726A B= R35 Polyuria A Eq` A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A Eq` A LANSOPRAZOLE d03828A Cr K25 Gastric ulcer A Eq` A METFORMIN d03807A C R73 Elevated blood glucose level A Eq` A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A Eqp A . . . Eq A CEFDINIR d04256A A H66.9 Otitis media, unspecified A Eq A IBUPROFEN d00015A AP K08.8 R50.9 Other specified disorders of teeth and supporting structures Fever, unspecified A Eq A MOUTH AND THROAT PRODUCTS - UNSPECIFIED c00146A A@ B00.1 Herpesviral vesicular dermatitis A Eq A MEGESTROL d01348A CDp N95 Menopausal and other perimenopausal disorders A Eq A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A Eq A ACETAMINOPHEN; OXYCODONE d03431A Cr M54 Dorsalgia A Eq A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A Eq A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A D I10 Essential (primary) hypertension A Eq A INDOMETHACIN d00039A D# M10.9 Gout, unspecified A Eq A INSULIN GLARGINE d04538A D E11 Type 2 diabetes mellitus A Eq A METFORMIN d03807A D E11 Type 2 diabetes mellitus A Eq A METOPROLOL d00134A Ei I10 Essential (primary) hypertension A Eq A MORPHINE d00308A Cr M54 Dorsalgia A Eq A . . . Eq A . . . Eq A . . . Eq A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ Eq A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C- I10 Essential (primary) hypertension A@ Eq A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A@ Eq A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A@ Er A WARFARIN d00022A D 55555 A Er A BENAZEPRIL d00730A C N28.9P Prevent kidney disease A@ Er A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A@ Er A METFORMIN d03807A C R73 Elevated blood glucose level A@ Er A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A@ Er A . . . Er0 A . . . Er@ A . . . ErP A . . . Er` A . . . Erp A METHYLPHENIDATE d00900A B[ F90 Attention-deficit hyperactivity disorders A Erp A SERTRALINE d00880A B[ F41.9 Anxiety disorder, unspecified A Er A ACETAMINOPHEN; HYDROCODONE d03428A B M54 M79.6 Dorsalgia Pain in limb, hand, foot, fingers and toes A Er A APIXABAN d07804A C Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A Er A FAMOTIDINE d00141A C 99999 A Er A FINASTERIDE d00563A Ei 99999 A Er A FUROSEMIDE d00070A Ei 99999 A Er A GABAPENTIN d03182A B E11.4 M79.2 Type 2 diabetes mellitus with neurological complications Neuralgia and neuritis, unspecified A Er A INSULIN DETEMIR d05436A B R73 Elevated blood glucose level A Er A ISOSORBIDE MONONITRATE d00269A C 99999 A Er A METOPROLOL d00134A C I10 Essential (primary) hypertension A Er A NITROGLYCERIN d00321A C R07.9 Chest pain, unspecified A Er A POTASSIUM CHLORIDE d00345A C E87.6P Prevent hypokalemia A Er A PRASUGREL d07409A Ei 99999 A Er A SIMVASTATIN d00746A Ei 99999 A Er A TAMSULOSIN d04121A Ei 99999 A Er A TRAMADOL d03826A B M54 M79.6 Dorsalgia Pain in limb, hand, foot, fingers and toes A Er A LAMOTRIGINE d03809A CDp G47.0 Insomnia A0 Er A LITHIUM d00061A C F31.9 Bipolar disorder, unspecified A0 Er A TEMAZEPAM d00384A CDp G47.9 Sleep disorder, unspecified A0 Er A . . . Er A . . . Er A . . . Er A . . . Er A ATORVASTATIN d04105A Cr I21.P Prevent heart attack/myocardial infarction A0 Er A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A0 Er A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A0 Er A CLOPIDOGREL d04258A B[ I63.P Prevent stroke Ap Er A DONEPEZIL; MEMANTINE d08337A CDp R41 Other symptoms and signs involving cognitive functions and awareness Ap Er A ESCITALOPRAM d04812A C[@ F32.9 Major depressive disorder, single episode, unspecified Ap Er A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus Ap Er A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A B= I10 Essential (primary) hypertension Ap Er A LANSOPRAZOLE d03828A D K21 Gastro-esophageal reflux disease Ap Er A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified Ap Es A . . . Es A . . . Es A . . . Es0 A . . . Es@ A DIVALPROEX SODIUM d03833A C- F31.9 Bipolar disorder, unspecified A0 Es@ A HALOPERIDOL d00027A C- G47.0 Insomnia A0 Es@ A MEDROXYPROGESTERONE d00284A Cr Z79.3 Long term (current) use of hormonal contraceptives A0 EsP A THYROID DESICCATED d00655A C E03.9 Hypothyroidism, unspecified A Es` A . . . Esp A . . . Es A . . . Es A . . . Es A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A@ Es A HYDROCHLOROTHIAZIDE d00253A C- I10 Essential (primary) hypertension A@ Es A LISINOPRIL d00732A C- E78.0 Pure hypercholesterolemia A@ Es A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ Es A . . . Es A MONTELUKAST d04289A CDp T78.40 Allergy, unspecified A Es A . . . Es A BUPROPION d00181A CDp F32.9 Major depressive disorder, single episode, unspecified Ap Es A DIVALPROEX SODIUM d03833A Cr F39 Unspecified mood [affective] disorder Ap Es A GLIPIZIDE d00246A C- E11 Type 2 diabetes mellitus Ap Es A INSULIN ISOPHANE (NPH) d04370A B E11 Type 2 diabetes mellitus Ap Es A LITHIUM d00061A C F39 Unspecified mood [affective] disorder Ap Es A METOPROLOL d00134A C- I10 Essential (primary) hypertension Ap Es A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia Ap Es A MONTELUKAST d04289A B J30.9 J45 Allergic rhinitis, unspecified Asthma A Et A . . . Et A CITALOPRAM d04332A C F99 Mental disorder, not otherwise specified A@ Et A DOCUSATE d01021A B[ K92.9 Disease of digestive system, unspecified A@ Et A HALOPERIDOL d00027A B F99 Mental disorder, not otherwise specified A@ Et A QUETIAPINE d04220A C G47.0 Insomnia A@ Et A ACETAMINOPHEN; HYDROCODONE d03428A C T14.9 Unspecified injury AP Et A CYCLOBENZAPRINE d00963A B M79.1 Myalgia AP Et A ROSUVASTATIN d04851A CDp E78.0 Pure hypercholesterolemia AP Et A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified AP Et A TEMAZEPAM d00384A CDp G47.9 Sleep disorder, unspecified AP Et0 A . . . Et@ A . . . EtP A . . . Et` A CIPROFLOXACIN; DEXAMETHASONE OTIC d04890A A0 A49.9P Prevent bacterial infection A Etp A AMLODIPINE d00689A B I21.P Prevent heart attack/myocardial infarction AP Etp A CLOPIDOGREL d04258A B D75.9P Prevent blood clots AP Etp A FINASTERIDE d00563A C N40 R39.9 Enlarged prostate Unspecified symptoms and signs involving the genitourinary system AP Etp A METOPROLOL d00134A D I10 Essential (primary) hypertension AP Etp A ROSUVASTATIN d04851A B I21.P Prevent heart attack/myocardial infarction AP Et A . . . Et A . . . Et A . . . Et A . . . Et A ACETAMINOPHEN; BUTALBITAL; CAFFEINE d03455A C- G43 Migraine Ap Et A AMITRIPTYLINE d00146A C[@ G43 Migraine Ap Et A ESOMEPRAZOLE d04749A A0 K30 Functional dyspepsia Ap Et A ESTRADIOL d00537A C G43.P Prevent migraine Ap Et A ONDANSETRON d00867A Cr R11 Nausea and vomiting Ap Et A PHENDIMETRAZINE d00809A B E66 Overweight and obesity Ap Et A PREDNISONE d00350A B G43 Migraine Ap Et A . . . Et A . . . Et A . . . Eu A 77777 . . A Eu A . . . Eu A FEXOFENADINE d04040A C J30.9 Allergic rhinitis, unspecified Ap Eu A LAMOTRIGINE d03809A B F31.9 F32.9 F41.9 Bipolar disorder, unspecified Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Ap Eu A MONTELUKAST d04289A B J30.9 Allergic rhinitis, unspecified Ap Eu A PANTOPRAZOLE d04514A CDp K31.9 Disease of stomach and duodenum, unspecified Ap Eu A PHENTERMINE d00806A B( E66 Overweight and obesity Ap Eu A PREGABALIN d05508A C M79.7 Fibromyalgia Ap Eu A TOPIRAMATE d04115A C- G43 Migraine Ap Eu0 A . . . Eu@ A . . . EuP A . . . Eu` A . . . Eup A . . . Eu A . . . Eu A AMITRIPTYLINE d00146A C K58 Irritable bowel syndrome A Eu A ATENOLOL d00004A C I48.9 Unspecified atrial fibrillation and atrial flutter A Eu A BUPRENORPHINE d00840A C[@ M54 M79.2 Dorsalgia Neuralgia and neuritis, unspecified A Eu A COLESEVELAM d04695A C E78.0 E78.1 Pure hypercholesterolemia Pure hyperglyceridemia A Eu A FLUTICASONE; UMECLIDINIUM; VILANTEROL d08666A B= J42 J43 J44.9 Unspecified chronic bronchitis Emphysema Chronic obstructive pulmonary disease, unspecified A Eu A HYOSCYAMINE d00985A D K58 Irritable bowel syndrome A Eu A MONTELUKAST d04289A C J42 J44.9 Unspecified chronic bronchitis Chronic obstructive pulmonary disease, unspecified A Eu A PANTOPRAZOLE d04514A B[ K21 K25.P Gastro-esophageal reflux disease Prevent gastric ulcer A Eu A PREGABALIN d05508A D M79.2 Neuralgia and neuritis, unspecified A Eu A ROFLUMILAST d07684A C- J42 J44.9 Unspecified chronic bronchitis Chronic obstructive pulmonary disease, unspecified A Eu A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A Eu A TAMSULOSIN d04121A C- N40 Enlarged prostate A Eu A TRAMADOL d03826A D M25.5 M54 R10 Pain in joint Dorsalgia Abdominal and pelvic pain A Eu A . . . Eu A . . . Eu A HYDROCHLOROTHIAZIDE d00253A C- I10 Essential (primary) hypertension Ap Eu A INSULIN GLARGINE d04538A D E11 Type 2 diabetes mellitus Ap Eu A INSULIN LISPRO d04373A D E11 Type 2 diabetes mellitus Ap Eu A LOSARTAN d03821A D I10 Essential (primary) hypertension Ap Eu A OMEPRAZOLE d00325A B[ K30 Functional dyspepsia Ap Eu A SERTRALINE d00880A B F32.9 Major depressive disorder, single episode, unspecified Ap Eu A TRAZODONE d00395A B= G47.9 Sleep disorder, unspecified Ap Eu A . . . Eu A SULFISOXAZOLE d00120A AP N39.0 Urinary tract infection, site not specified A Eu A . . . Ev A LISINOPRIL d00732A C I10 Essential (primary) hypertension A Ev A METOPROLOL d00134A C- I10 Essential (primary) hypertension A Ev A . . . Ev A 77777 . . A Ev0 A QUETIAPINE d04220A D= F31.9 Bipolar disorder, unspecified A Ev0 A VALPROIC ACID d00083A D= F31.9 Bipolar disorder, unspecified A Ev@ A . . . EvP A . . . Ev` A NYSTATIN TOPICAL d04399A B B37 Candidiasis A Evp A . . . Ev A BUPROPION d00181A C F41.9 Anxiety disorder, unspecified A0 Ev A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia A0 Ev A MELOXICAM d04532A C- M13 Other arthritis A0 Ev A . . . Ev A . . . Ev A . . . Ev A . . . Ev A TAMSULOSIN d04121A C N40 Enlarged prostate A Ev A AMLODIPINE d00689A C I10 Essential (primary) hypertension A Ev A HYDROCHLOROTHIAZIDE d00253A Dc R60.9 Edema, unspecified A Ev A INSULIN GLARGINE d04538A D E11 Type 2 diabetes mellitus A Ev A INSULIN GLULISINE d05278A D E11 Type 2 diabetes mellitus A Ev A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A Ev A LISINOPRIL d00732A C I10 Essential (primary) hypertension A Ev A LOPERAMIDE d01025A D* R19.7 Diarrhea, unspecified A Ev A MERCAPTOPURINE d00289A Cr K50 Crohn's disease [regional enteritis] A Ev A MESALAMINE d01031A C- K50 Crohn's disease [regional enteritis] A Ev A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease A Ev A PAROXETINE d03157A D F32.9 Major depressive disorder, single episode, unspecified A Ev A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A Ev A . . . Ew A . . . Ew A . . . Ew A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ Ew A BACLOFEN d00967A B M79.1 Myalgia A@ Ew A BUSPIRONE d00182A C- F41.9 Anxiety disorder, unspecified A@ Ew A ESCITALOPRAM d04812A C- F41.9 Anxiety disorder, unspecified A@ Ew0 A . . . Ew@ A . . . EwP A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A` EwP A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A` EwP A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A` EwP A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` EwP A TRAMADOL d03826A CDp M79.1 Myalgia A` EwP A ZOLPIDEM d00910A C G47.0 Insomnia A` Ew` A . . . Ewp A . . . Ew A IBUPROFEN d00015A B M25.5 Pain in joint A Ew A HYDROCORTISONE TOPICAL d03205A Cr L20.9 Atopic dermatitis, unspecified A Ew A . . . Ew A DONEPEZIL; MEMANTINE d08337A Cr G31.9 Degenerative disease of nervous system, unspecified A@ Ew A METOPROLOL d00134A Cr I50.9 Heart failure, unspecified A@ Ew A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A@ Ew A QUETIAPINE d04220A Cr G31.9 Degenerative disease of nervous system, unspecified A@ Ew A . . . Ew A ETHINYL ESTRADIOL; NORGESTIMATE d03781A Bz Z79.3 Long term (current) use of hormonal contraceptives A Ew A ALBUTEROL d00749A C J45 Asthma B Ew A ALLOPURINOL d00023A C[@ I51.9 Heart disease, unspecified B Ew A CITALOPRAM d04332A C- F32.9 Major depressive disorder, single episode, unspecified B Ew A COLCHICINE d00150A CDp M1A Chronic gout B Ew A DOCUSATE d01021A C K58 Irritable bowel syndrome B Ew A FEXOFENADINE d04040A CDp R09.81 T78.40 Nasal congestion Allergy, unspecified B Ew A FLUTICASONE NASAL d04283A C- J45 R09.81 Asthma Nasal congestion B Ew A FLUTICASONE; VILANTEROL d08100A B J44.9 J45 R06.9 Chronic obstructive pulmonary disease, unspecified Asthma Unspecified abnormalities of breathing B Ew A GABAPENTIN d03182A B M79.2 Neuralgia and neuritis, unspecified B Ew A INSULIN DEGLUDEC d08054A C E11 Type 2 diabetes mellitus B Ew A INSULIN REGULAR d04369A C- E11 Type 2 diabetes mellitus B Ew A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified B Ew A METOPROLOL d00134A C I50.9 Heart failure, unspecified B Ew A MIRABEGRON d07876A C N28.9 Disorder of kidney and ureter, unspecified B Ew A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease B Ew A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia B Ew A PRIMIDONE d00352A B 55555 B Ew A SACUBITRIL; VALSARTAN d08369A B I50.9 Heart failure, unspecified B Ew A SPIRONOLACTONE d00373A B R60.9 Edema, unspecified B Ew A TORSEMIDE d03189A C R60.9 Edema, unspecified B Ew A VENLAFAXINE d03181A B F41.9 Anxiety disorder, unspecified B Ew A WARFARIN d00022A D* D75.9P Prevent blood clots B Ew A . . . Ex A . . . Ex A DEXMETHYLPHENIDATE d04777A B= R41 Other symptoms and signs involving cognitive functions and awareness A Ex A . . . Ex0 A . . . Ex@ A APIXABAN d07804A B= I48.9 Unspecified atrial fibrillation and atrial flutter A Ex@ A CARVEDILOL d03847A C[@ I50.9 Heart failure, unspecified A Ex@ A DIGOXIN d00210A Cr I50.9 Heart failure, unspecified A Ex@ A FUROSEMIDE d00070A Cr I50.9 Heart failure, unspecified A Ex@ A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus A Ex@ A INSULIN ASPART d04697A C E11 Type 2 diabetes mellitus A Ex@ A INSULIN GLARGINE d04538A C- E11 Type 2 diabetes mellitus A Ex@ A LOSARTAN d03821A C[@ I50.9 Heart failure, unspecified A Ex@ A METFORMIN d03807A C E11 Type 2 diabetes mellitus A Ex@ A OXYBUTYNIN d00328A B R32 Unspecified urinary incontinence A Ex@ A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A Ex@ A VALACYCLOVIR d03838A C A60.9 Anogenital herpesviral infection, unspecified A ExP A ALLOPURINOL d00023A Dc 99999 A` ExP A CARVEDILOL d03847A Dc I50.9 Heart failure, unspecified A` ExP A FUROSEMIDE d00070A Dc I50.9 I51.9 Heart failure, unspecified Heart disease, unspecified A` ExP A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A` ExP A LISINOPRIL d00732A Dc I50.9 Heart failure, unspecified A` ExP A PANTOPRAZOLE d04514A Dc K21 Gastro-esophageal reflux disease A` Ex` A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A Ex` A METFORMIN d03807A C E11 Type 2 diabetes mellitus A Exp A . . . Ex A . . . Ex A ALLOPURINOL d00023A C"@ M25.5 Pain in joint A Ex A AMITRIPTYLINE d00146A AP K31.9 Disease of stomach and duodenum, unspecified A Ex A BUMETANIDE d00179A Cr I10 Essential (primary) hypertension A Ex A DICYCLOMINE d00999A B[ R10 Abdominal and pelvic pain A Ex A LOSARTAN d03821A C"@ I10 Essential (primary) hypertension A Ex A OMEPRAZOLE d00325A B[ K31.9 Disease of stomach and duodenum, unspecified A Ex A PRAVASTATIN d00348A C"@ E78.0 Pure hypercholesterolemia A Ex A TRIAMTERENE d00396A C"@ I10 Essential (primary) hypertension A Ex A 99999 . . A Ex A ATENOLOL d00004A D ^ I49.9 Cardiac arrhythmia, unspecified A` Ex A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A` Ex A CLOPIDOGREL d04258A D ^ D75.9P Prevent blood clots A` Ex A FINASTERIDE d00563A D R39.9 Unspecified symptoms and signs involving the genitourinary system A` Ex A OMEPRAZOLE d00325A C K30 Functional dyspepsia A` Ex A TAMSULOSIN d04121A D R39.9 Unspecified symptoms and signs involving the genitourinary system A` Ex A DICLOFENAC d00848A C M79.1 M79.7 T14.9 Myalgia Fibromyalgia Unspecified injury A Ex A . . . Ex A PRAVASTATIN d00348A CDp E78.0 Pure hypercholesterolemia A Ex A TRAMADOL d03826A Cr M54 Dorsalgia A Ex A . . . Ey A . . . Ey A . . . Ey A . . . Ey0 A CITALOPRAM d04332A C F32.9 Major depressive disorder, single episode, unspecified A Ey0 A ISOSORBIDE d00653A C R60.9 Edema, unspecified A Ey0 A LOSARTAN d03821A A I10 Essential (primary) hypertension A Ey0 A METOPROLOL d00134A C I21.P Prevent heart attack/myocardial infarction A Ey0 A PANTOPRAZOLE d04514A C K57 Diverticular disease of intestine A Ey0 A PRAVASTATIN d00348A C[@ E78.0 Pure hypercholesterolemia A Ey0 A TEMAZEPAM d00384A C- G47.0 G47.9 Insomnia Sleep disorder, unspecified A Ey0 A TRAZODONE d00395A C F39 Unspecified mood [affective] disorder A Ey0 A UMECLIDINIUM; VILANTEROL d08188A Ap J42 J43 J44.9 Unspecified chronic bronchitis Emphysema Chronic obstructive pulmonary disease, unspecified A Ey@ A CITALOPRAM d04332A A G47.0 Insomnia A EyP A . . . Ey` A DROSPIRENONE; ETHINYL ESTRADIOL d04760A B= Z79.3 Long term (current) use of hormonal contraceptives A Eyp A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A@ Eyp A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A@ Eyp A OMEPRAZOLE d00325A C K30 Functional dyspepsia A@ Eyp A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia A@ Ey A . . . Ey A ACETAMINOPHEN; CODEINE d03423A Ap T14.9 Unspecified injury A Ey A IBUPROFEN d00015A A0 T14.9 Unspecified injury A Ey A CIPROFLOXACIN d00011A D N39.0 R09.81 Urinary tract infection, site not specified Nasal congestion A Ey A BUPROPION d00181A B= G47.9 Sleep disorder, unspecified A Ey A QUETIAPINE d04220A Ei F31.9 F32.9 Bipolar disorder, unspecified Major depressive disorder, single episode, unspecified A Ey A METOPROLOL d00134A C I48.9 Unspecified atrial fibrillation and atrial flutter A@ Ey A RIVAROXABAN d07356A C I48.9 Unspecified atrial fibrillation and atrial flutter A@ Ey A TAMSULOSIN d04121A C R39.9 Unspecified symptoms and signs involving the genitourinary system A@ Ey A TORSEMIDE d03189A C R39.9 Unspecified symptoms and signs involving the genitourinary system A@ Ey A . . . Ey A . . . Ey A . . . Ez A . . . Ez A . . . Ez A TRAMADOL d03826A C M54 Dorsalgia A Ez0 A ALBUTEROL d00749A CDp J45 Asthma A Ez0 A BUDESONIDE; FORMOTEROL d04795A CDp J45 Asthma A Ez@ A CLONIDINE d00044A B F41.9 G47.9 Anxiety disorder, unspecified Sleep disorder, unspecified A0 Ez@ A METHYLPHENIDATE d00900A C- F90 Attention-deficit hyperactivity disorders A0 Ez@ A SERTRALINE d00880A C F41.9 Anxiety disorder, unspecified A0 EzP A HYDROCHLOROTHIAZIDE; IRBESARTAN d04245A D I10 Essential (primary) hypertension A EzP A PRAVASTATIN d00348A D E78.0 Pure hypercholesterolemia A Ez` A MINOCYCLINE d00110A B L70 Acne A Ez` A SPIRONOLACTONE d00373A B L70 Acne A Ezp A FUROSEMIDE d00070A Cr R60.9 Edema, unspecified A@ Ezp A GLIMEPIRIDE d03864A Cr R73 Elevated blood glucose level A@ Ezp A PANTOPRAZOLE d04514A Cr K21 Gastro-esophageal reflux disease A@ Ezp A RABEPRAZOLE d04448A C K21 Gastro-esophageal reflux disease A@ Ez A . . . Ez A . . . Ez A PAROXETINE d03157A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A Ez A 99999 . . A Ez A ESTERIFIED ESTROGENS; METHYLTESTOSTERONE d03245A D N95 Menopausal and other perimenopausal disorders A Ez A FAMOTIDINE; IBUPROFEN d07764A B K25.P M19.9 Prevent gastric ulcer Osteoarthritis, unspecified site A Ez A AZITHROMYCIN d00091A A0 J20.9 Acute bronchitis, unspecified A Ez A . . . Ez A . . . E{ A FLUOXETINE d00236A CDp F32.9 Major depressive disorder, single episode, unspecified A E{ A OMEPRAZOLE d00325A C K21 R14 Gastro-esophageal reflux disease Flatulence and related conditions A E{ A ARIPIPRAZOLE d04825A C- F99 Mental disorder, not otherwise specified A` E{ A BUPROPION d00181A C- F32.9 Major depressive disorder, single episode, unspecified A` E{ A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A` E{ A MIRTAZAPINE d04025A C F99 Mental disorder, not otherwise specified A` E{ A PRAVASTATIN d00348A CDp E78.0 Pure hypercholesterolemia A` E{ A TAMSULOSIN d04121A CDp N42.9 Disorder of prostate, unspecified A` E{ A ATENOLOL d00004A Cr I10 I20.9 Essential (primary) hypertension Angina pectoris, unspecified A@ E{ A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A@ E{ A HYDROCHLOROTHIAZIDE d00253A Cr I10 Essential (primary) hypertension A@ E{ A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A@ E{0 A . . . E{@ A . . . E{P A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C"0 Z79.3 Long term (current) use of hormonal contraceptives A E{` A PITAVASTATIN d07637A A E78.0 Pure hypercholesterolemia A0 E{` A SOTALOL d00371A B I48.9 Unspecified atrial fibrillation and atrial flutter A0 E{` A WARFARIN d00022A C[@ I48.9 Unspecified atrial fibrillation and atrial flutter A0 E{p A . . . E{ A ALPRAZOLAM d00168A C F41.0 F41.9 Panic disorder [episodic paroxysmal anxiety] without agoraphobia Anxiety disorder, unspecified A0 E{ A PHENTERMINE d00806A B[ E66 Overweight and obesity A0 E{ A TRAZODONE d00395A B G47.9 Sleep disorder, unspecified A0 E{ A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A E{ A ACETAMINOPHEN; HYDROCODONE d03428A D M54 Dorsalgia A E{ A ALBUTEROL d00749A C J44.9 J45 Chronic obstructive pulmonary disease, unspecified Asthma A E{ A BACLOFEN d00967A C M62.83 Muscle spasm A E{ A FLUTICASONE; SALMETEROL d04611A C J44.9 Chronic obstructive pulmonary disease, unspecified A E{ A LISINOPRIL d00732A C I10 I50.9 Essential (primary) hypertension Heart failure, unspecified A E{ A NAPROXEN d00019A D M54 Dorsalgia A E{ A SERTRALINE d00880A Cr F32.9 Major depressive disorder, single episode, unspecified A E{ A VERAPAMIL d00048A C I10 I49.9 Essential (primary) hypertension Cardiac arrhythmia, unspecified A E{ A ZOLPIDEM d00910A B= G47.0 Insomnia A E{ A . . . E{ A . . . E{ A . . . E{ A ACETAMINOPHEN; HYDROCODONE d03428A C M54 Dorsalgia A` E{ A BUMETANIDE d00179A CDp R60.9 Edema, unspecified A` E{ A CITALOPRAM d04332A Cr F32.9 Major depressive disorder, single episode, unspecified A` E{ A MELOXICAM d04532A C M19.9 Osteoarthritis, unspecified site A` E{ A NICOTINE d00316A Ap F17.2 Nicotine dependence A` E{ A TRAZODONE d00395A Cr F32.9 Major depressive disorder, single episode, unspecified A` E{ A 55555 A Bz Z79.3 Long term (current) use of hormonal contraceptives A E| A . . . E| A ANTIHYPERLIPIDEMIC AGENTS - UNSPECIFIED c00019. . A E| A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A E| A . . . E|0 A AMLODIPINE d00689A B I63 Cerebral infarction A E|@ A . . . E|P A . . . E|` A . . . E|p A . . . E| A . . . E| A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia A E| A SIMVASTATIN d00746A B E78.0 Pure hypercholesterolemia A E| A ALBUTEROL d00749A Cr J42 J45 R06.02 Unspecified chronic bronchitis Asthma Shortness of breath A E| A CETIRIZINE d03827A CDp R06.2 T78.40 Wheezing Allergy, unspecified A E| A EPINEPHRINE d00699A CDp T78.40 Allergy, unspecified A E| A HYDROXYZINE d00907A C- F41.9 T78.40 Anxiety disorder, unspecified Allergy, unspecified A E| A KETOROLAC OPHTHALMIC d03214A B= H10.1 Acute atopic conjunctivitis A E| A MONTELUKAST d04289A C[@ J45 Asthma A E| A PANTOPRAZOLE d04514A CDp K21 Gastro-esophageal reflux disease A E| A SERTRALINE d00880A CDp F32.9 F43.1 N94 Major depressive disorder, single episode, unspecified Post-traumatic stress disorder (PTSD) Pain and other conditions associated with female genital organs and menstrual cycle A E| A . . . E| A ADALIMUMAB d04835A C M06.9 Rheumatoid arthritis, unspecified A0 E| A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease A0 E| A OXYCODONE d00329A CDp M25.5 M79.1 M79.2 Pain in joint Myalgia Neuralgia and neuritis, unspecified A0 E| A . . . E| A AMLODIPINE d00689A D I10 Essential (primary) hypertension A0 E| A FENOFIBRATE d04286A B= E78.0 E78.1 Pure hypercholesterolemia Pure hyperglyceridemia A0 E| A TAMSULOSIN d04121A B= N40 Enlarged prostate A0 E} A . . . E} A . . . E} A . . . E}0 A . . . E}@ A . . . E}P A EZETIMIBE; SIMVASTATIN d05348A C E78.0 Pure hypercholesterolemia AP E}P A FUROSEMIDE d00070A C R60.9 Edema, unspecified AP E}P A LOSARTAN d03821A C I10 Essential (primary) hypertension AP E}P A METOPROLOL d00134A B[ R00 Abnormalities of heart beat AP E}P A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease AP E}` A . . . E}p A . . . E} A . . . E} A BUPROPION d00181A B= F32.9 Major depressive disorder, single episode, unspecified A E} A . . . E} A . . . E} A HYDROXYZINE d00907A A L29.9 Pruritus, unspecified A E} A . . . E} A ALBUTEROL d00749A D* J45 Asthma A` E} A CETIRIZINE d03827A C T78.40 Allergy, unspecified A` E} A DICLOFENAC d00848A C T14.9 Unspecified injury A` E} A LOPERAMIDE d01025A D K51 K58 Ulcerative colitis Irritable bowel syndrome A` E} A OMEPRAZOLE d00325A C K21 K30 Gastro-esophageal reflux disease Functional dyspepsia A` E} A VENLAFAXINE d03181A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A` E} A ATORVASTATIN d04105A B= E78.0 Pure hypercholesterolemia A0 E} A CELECOXIB d04380A A M79.6 Pain in limb, hand, foot, fingers and toes A0 E} A METFORMIN d03807A B E11 Type 2 diabetes mellitus A0 E~ A . . . E~ A . . . E~ A . . . E~0 A . . . E~@ A METFORMIN; SITAGLIPTIN d06720A C[@ E11 Type 2 diabetes mellitus A E~P A . . . E~` A . . . E~p A . . . E~ A . . . E~ A . . . E~ A . . . E~ A . . . E~ A AZITHROMYCIN d00091A AP J40 Bronchitis, not specified as acute or chronic A E~ A . . . E~ A IBUPROFEN d00015A B[ T14.9 Unspecified injury A E~ A . . . E A . . . E A . . . E A 99999 . . A E0 A AMOXICILLIN; CLAVULANATE d00089A AP B99.9 Unspecified infectious disease A E@ A . . . EP A . . . E` A . . . Ep A . . . E A CYPROHEPTADINE d00790A CDp G43 Migraine A E A POLYETHYLENE GLYCOL 3350 d05350A C K59.0 Constipation A E A . . . E A LISINOPRIL d00732A D* I10 Essential (primary) hypertension A E A LOVASTATIN d00280A D* E78.0 Pure hypercholesterolemia A E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A ESTRADIOL TOPICAL d04210A B[ N95 Menopausal and other perimenopausal disorders A E A FLUOROURACIL d00235A B8 C80.1 Malignant (primary) neoplasm, unspecified A E A . . . E A . . . E A . . . E A . . . E A . . . E A ALLOPURINOL d00023A B M10.9P Prevent gout AP E A ATORVASTATIN d04105A B I63.P Prevent stroke AP E A FUROSEMIDE d00070A B M10.9 Gout, unspecified AP E A METOPROLOL d00134A B I10 Essential (primary) hypertension AP E A SERTRALINE d00880A B F32.9 Major depressive disorder, single episode, unspecified AP E0 A CYPROHEPTADINE d00790A C G43 Migraine AP E0 A FLUTICASONE NASAL d04283A B[ T78.40 Allergy, unspecified AP E0 A NAPROXEN d00019A B[ G43 Migraine AP E0 A RIZATRIPTAN d04328A C G43 Migraine AP E0 A TOPIRAMATE d04115A B[ G43 Migraine AP E@ A . . . EP A . . . E` A CARVEDILOL d03847A Bz I10 Essential (primary) hypertension A E` A CLOPIDOGREL d04258A B= I49.9 I63 Cardiac arrhythmia, unspecified Cerebral infarction A E` A DULOXETINE d05355A B F32.9 Major depressive disorder, single episode, unspecified A E` A FUROSEMIDE d00070A A I10 R60.9 Essential (primary) hypertension Edema, unspecified A E` A HYDRALAZINE d00132A C I10 Essential (primary) hypertension A E` A HYDROCHLOROTHIAZIDE; OLMESARTAN d04878A B I10 Essential (primary) hypertension A E` A INSULIN DEGLUDEC d08054A Cr E11 Type 2 diabetes mellitus A E` A LIRAGLUTIDE d07466A B E11 Type 2 diabetes mellitus A E` A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E` A METOPROLOL d00134A B I10 Essential (primary) hypertension A E` A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A E` A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A E` A PREGABALIN d05508A Cr M79.2 Neuralgia and neuritis, unspecified A E` A TRAMADOL d03826A B T14.9 Unspecified injury A Ep A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A . . . E A METHYLPHENIDATE d00900A Cr F90 Attention-deficit hyperactivity disorders A E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A E A . . . E0 A . . . E@ A . . . EP A CLOPIDOGREL d04258A C D75.9P Prevent blood clots A@ EP A EZETIMIBE d04824A C E78.0 Pure hypercholesterolemia A@ EP A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A@ EP A TAMSULOSIN d04121A C N40 Enlarged prostate A@ E` A ALBUTEROL d00749A A R05 Cough A Ep A . . . E A . . . E A . . . E A ALBUTEROL d00749A0 D* J45 Asthma A0 E A AZITHROMYCIN d00091A0 AP J40 Bronchitis, not specified as acute or chronic A0 E A PREDNISONE d00350A0 AP J42 Unspecified chronic bronchitis A0 E A . . . E A CLONAZEPAM d00197A C[@ F41.0 F41.9 G47.9 Panic disorder [episodic paroxysmal anxiety] without agoraphobia Anxiety disorder, unspecified Sleep disorder, unspecified A E A DIVALPROEX SODIUM d03833A C F31.9 F39 F99 Bipolar disorder, unspecified Unspecified mood [affective] disorder Mental disorder, not otherwise specified A E A DIVALPROEX SODIUM d03833A CDp F31.9 F32.9 F99 Bipolar disorder, unspecified Major depressive disorder, single episode, unspecified Mental disorder, not otherwise specified A E A DULOXETINE d05355A C- F32.9 M79.2 Major depressive disorder, single episode, unspecified Neuralgia and neuritis, unspecified A E A FENOFIBRATE d04286A C E78.0 Pure hypercholesterolemia A E A GABAPENTIN d03182A C[@ F41.9 M79.2 Anxiety disorder, unspecified Neuralgia and neuritis, unspecified A E A METHOCARBAMOL d00965A A` M62.83 T14.9 Muscle spasm Unspecified injury A E A MIRTAZAPINE d04025A CDp G47.0 Insomnia A E A MONTELUKAST d04289A B J30.1 J30.9 L50 Allergic rhinitis due to pollen Allergic rhinitis, unspecified Urticaria A E A PANTOPRAZOLE d04514A C- K21 K30 R12 Gastro-esophageal reflux disease Functional dyspepsia Heartburn A E A PROPRANOLOL d00032A C[@ F41.9 I10 Anxiety disorder, unspecified Essential (primary) hypertension A E A SULFAMETHOXAZOLE d00119A Ap A49.9 L08.9 Bacterial infection, unspecified Local infection of the skin and subcutaneous tissue, unspecified A E A . . . E A ALPRAZOLAM d00168A AP F41.9 Anxiety disorder, unspecified A E A ATENOLOL d00004A C I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A E A ESCITALOPRAM d04812A A@ F32.9 Major depressive disorder, single episode, unspecified A E A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified A E A INSULIN GLARGINE d04538A Bz R73 Elevated blood glucose level A E A LOSARTAN d03821A C I10 Essential (primary) hypertension A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A RANITIDINE d00021A Bz K21 Gastro-esophageal reflux disease A E A . . . E A . . . E A ALLOPURINOL d00023A C[@ M19.9 Osteoarthritis, unspecified site A@ E A ATENOLOL d00004A C[@ I10 Essential (primary) hypertension A@ E A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A@ E A WARFARIN d00022A C[@ D75.9P Prevent blood clots A@ E A DOXYLAMINE; PYRIDOXINE d04654A B R11 Nausea and vomiting A@ E A FLUTICASONE NASAL d04283A C J30.2 Other seasonal allergic rhinitis A@ E A FLUTICASONE; SALMETEROL d04611A Dc J45 Asthma A@ E A INSULIN ISOPHANE (NPH) d04370A A 55555 A@ E0 A . . . E@ A AMITRIPTYLINE d00146A D M79.7 Fibromyalgia AP E@ A METOPROLOL d00134A B I10 Essential (primary) hypertension AP E@ A PREDNISONE d00350A A@ M19.9 Osteoarthritis, unspecified site AP E@ A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified AP E@ A SIMVASTATIN d00746A B= E78.0 Pure hypercholesterolemia AP EP A AMOXICILLIN d00088A A A49.9P Prevent bacterial infection AP EP A ATENOLOL d00004A C I10 Essential (primary) hypertension AP EP A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia AP EP A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP EP A TRAMADOL d03826A CDp K08.8 Other specified disorders of teeth and supporting structures AP E` A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A0 E` A DEXLANSOPRAZOLE d07395A C K30 Functional dyspepsia A0 E` A HYDROCHLOROTHIAZIDE d00253A C[@ I10 Essential (primary) hypertension A0 Ep A . . . E A . . . E A ALLOPURINOL d00023A C- E79.9 Disorder of purine and pyrimidine metabolism, unspecified A0 E A ESOMEPRAZOLE d04749A C K21 Gastro-esophageal reflux disease A0 E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A0 E A FLUOCINONIDE TOPICAL d01294A A R21 Rash and other nonspecific skin eruption A E A ALLOPURINOL d00023A Cr M10.9 Gout, unspecified A E A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A E A ASPIRIN; BUTALBITAL; CAFFEINE d03457A A R51 Headache A E A CARBIDOPA; LEVODOPA d03473A B= G20 Parkinson's disease A E A CITALOPRAM d04332A B F32.9 Major depressive disorder, single episode, unspecified A E A CLOPIDOGREL d04258A CP D75.9P Prevent blood clots A E A DAPSONE d00098A C[@ L08.9 Local infection of the skin and subcutaneous tissue, unspecified A E A DONEPEZIL d04099A C G30.9 Alzheimer's disease, unspecified A E A DORZOLAMIDE OPHTHALMIC d03805A C[@ H40 Glaucoma A E A FUROSEMIDE d00070A B R60.9 Edema, unspecified A E A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A E A LATANOPROST OPHTHALMIC d04017A CDp H40 Glaucoma A E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A RAMIPRIL d00728A Cr I10 Essential (primary) hypertension A E A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A E A . . . E A AMOXICILLIN d00088A AP H66.9 J42 Otitis media, unspecified Unspecified chronic bronchitis A E A . . . E A ATORVASTATIN d04105A Cr 99999 A` E A CITALOPRAM d04332A Dc F32.9 Major depressive disorder, single episode, unspecified A` E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C[@ I63.P Prevent stroke A` E A INSULIN GLARGINE d04538A D E11 Type 2 diabetes mellitus A` E A METFORMIN d03807A C[@ 99999 A` E A SPIRONOLACTONE d00373A Cr 99999 A` E A . . . E A . . . E A ATENOLOL d00004A C- I10 Essential (primary) hypertension A` E A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A` E A DULAGLUTIDE d08290A C E11 Type 2 diabetes mellitus A` E A EZETIMIBE d04824A B= E78.0 Pure hypercholesterolemia A` E A INSULIN DETEMIR d05436A CDp E11 Type 2 diabetes mellitus A` E A INSULIN LISPRO d04373A CDp E11 Type 2 diabetes mellitus A` E0 A FLUTICASONE; VILANTEROL d08100A Bz J98.9 Respiratory disorder, unspecified A E0 A MONTELUKAST d04289A C J45 Asthma A E@ A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A` E@ A FENOFIBRATE d04286A D* E78.1 Pure hyperglyceridemia A` E@ A LOSARTAN d03821A C I10 Essential (primary) hypertension A` E@ A METFORMIN d03807A C- R73 Elevated blood glucose level A` E@ A PANTOPRAZOLE d04514A D9 K21 Gastro-esophageal reflux disease A` E@ A PAROXETINE d03157A B F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A` EP A . . . E` A ATORVASTATIN d04105A Cr 99999 A` E` A CLOPIDOGREL d04258A Cr D75.9P Prevent blood clots A` E` A DONEPEZIL d04099A Cr G30.9 Alzheimer's disease, unspecified A` E` A HYDROXYZINE d00907A Cr I51.9 Heart disease, unspecified A` E` A LOSARTAN d03821A Cr I99.9 Unspecified disorder of circulatory system A` E` A MIRTAZAPINE d04025A Cr G47.0 Insomnia A` Ep A GABAPENTIN d03182A C- E11.4 Type 2 diabetes mellitus with neurological complications AP Ep A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus AP Ep A NAPROXEN d00019A Cr M25.5 T14.9 Pain in joint Unspecified injury AP Ep A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia AP Ep A TRAMADOL d03826A B M54 Dorsalgia AP E A . . . E A ACETAMINOPHEN; BUTALBITAL; CAFFEINE d03455A C G43 Migraine Ap E A ACETAMINOPHEN; CODEINE d03423A C G43 Migraine Ap E A CLINDAMYCIN d00043A A L08.9 Local infection of the skin and subcutaneous tissue, unspecified Ap E A IMIPRAMINE d00259A C"0 G43 Migraine Ap E A METHYLPHENIDATE d00900A Bz F90 Attention-deficit hyperactivity disorders Ap E A METHYLPHENIDATE d00900A Bz F90 Attention-deficit hyperactivity disorders Ap E A VENLAFAXINE d03181A B G43.P Prevent migraine Ap E A . . . E A BRIMONIDINE; TIMOLOL OPHTHALMIC d05283A C H40 Glaucoma A E A LATANOPROST OPHTHALMIC d04017A C H40 Glaucoma A E A AMLODIPINE d00689A Dc I10 Essential (primary) hypertension Ap E A ASPIRIN d00170A C I21.P Prevent heart attack/myocardial infarction Ap E A GLIPIZIDE d00246A C 99999 Ap E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A Ei 99999 Ap E A HYDROXYZINE d00907A C F41.9 Anxiety disorder, unspecified Ap E A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus Ap E A SIMVASTATIN d00746A Dc E78.0 Pure hypercholesterolemia Ap E A ANTIHISTAMINES - UNSPECIFIED c00123A B L20.9 Atopic dermatitis, unspecified A E A PIMECROLIMUS TOPICAL d04784A B L20.9 Atopic dermatitis, unspecified A E A APIXABAN d07804A C D75.9P I48.9 I63.P Prevent blood clots Unspecified atrial fibrillation and atrial flutter Prevent stroke AP E A ATORVASTATIN d04105A D# E78.0 Pure hypercholesterolemia AP E A DOXAZOSIN d00726A D I10 Essential (primary) hypertension AP E A LISINOPRIL d00732A D# I10 Essential (primary) hypertension AP E A MEMANTINE d04899A B G31.9 Degenerative disease of nervous system, unspecified AP E A . . . E A . . . E A . . . E A . . . E0 A CETIRIZINE d03827A CDp J30.9 T78.40 Allergic rhinitis, unspecified Allergy, unspecified A E0 A CLONAZEPAM d00197A C F41.9 G25.81 Anxiety disorder, unspecified Restless legs syndrome A E0 A DEXLANSOPRAZOLE d07395A CDp K21 Gastro-esophageal reflux disease A E0 A FLUTICASONE NASAL d04283A B= J30.9 R09.81 Allergic rhinitis, unspecified Nasal congestion A E0 A FLUVOXAMINE d03804A CDp F33.9 F41.9 M79.7 Major depressive disorder, recurrent, unspecified Anxiety disorder, unspecified Fibromyalgia A E0 A OLMESARTAN d04801A Dc I10 Essential (primary) hypertension A E0 A RISPERIDONE d03180A A F33.9 F39 F84 Major depressive disorder, recurrent, unspecified Unspecified mood [affective] disorder Pervasive developmental disorders A E0 A ROPINIROLE d04215A CDp G25.81 Restless legs syndrome A E0 A TESTOSTERONE d00558A C[@ E29.1 Testicular hypofunction A E@ A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A EP A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E` A ATORVASTATIN d04105A C- I70.P Prevent atherosclerosis Ap E` A DILTIAZEM d00045A C- I49.9 Cardiac arrhythmia, unspecified Ap E` A FLECAINIDE d00234A C- I10 Essential (primary) hypertension Ap E` A FLUTICASONE NASAL d04283A C- J30.9 Allergic rhinitis, unspecified Ap E` A FUROSEMIDE d00070A C- E78.0 Pure hypercholesterolemia Ap E` A LISINOPRIL d00732A C9 I10 Essential (primary) hypertension Ap E` A POTASSIUM CHLORIDE d00345A C- I51.9P Prevent heart disease Ap Ep A . . . E A ALENDRONATE d03849A B M81.P Prevent bone loss/osteoporosis A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A DABIGATRAN d07137A B* I49.9 Cardiac arrhythmia, unspecified A E A DONEPEZIL d04099A C G31.9 Degenerative disease of nervous system, unspecified A E A LISINOPRIL d00732A B I21.P Prevent heart attack/myocardial infarction A E A MEMANTINE d04899A C G31.9 Degenerative disease of nervous system, unspecified A E A MESALAMINE d01031A CDp K51 Ulcerative colitis A E A OMEPRAZOLE d00325A C- K51 Ulcerative colitis A E A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A E A AMLODIPINE; BENAZEPRIL d03829A C I10 Essential (primary) hypertension A0 E A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A C I10 Essential (primary) hypertension A0 E A RANITIDINE d00021A B K21 Gastro-esophageal reflux disease A0 E A FLUTICASONE d01296A B[ R06.2 Wheezing A0 E A MONTELUKAST d04289A B R06.2 R06.9 Wheezing Unspecified abnormalities of breathing A0 E A RANITIDINE d00021A B K21 Gastro-esophageal reflux disease A0 E A . . . E A LAMOTRIGINE d03809A C G40 Epilepsy and recurrent seizures A E A SERTRALINE d00880A C[@ G40 Epilepsy and recurrent seizures A E A . . . E A . . . E A . . . E A ALBUTEROL d00749A D J45 Asthma A E A FLUNISOLIDE d00761A C J45 Asthma A E A . . . E A WARFARIN d00022A C 55555 A E0 A . . . E@ A BUSPIRONE d00182A B F32.9 F33.9 F41.9 Major depressive disorder, single episode, unspecified Major depressive disorder, recurrent, unspecified Anxiety disorder, unspecified Ap E@ A DEXLANSOPRAZOLE d07395A C- K21 Gastro-esophageal reflux disease Ap E@ A DULOXETINE d05355A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Ap E@ A FESOTERODINE d07162A C N32.81 Overactive bladder Ap E@ A METOPROLOL d00134A C R00 Abnormalities of heart beat Ap E@ A NORTRIPTYLINE d00144A C- M35 M79.2 M79.7 Other systemic involvement of connective tissue Neuralgia and neuritis, unspecified Fibromyalgia Ap E@ A TRAZODONE d00395A C G47.0 G47.9 Insomnia Sleep disorder, unspecified Ap EP A . . . E` A FLUTICASONE NASAL d04283A C J30.2 Other seasonal allergic rhinitis A E` A MONTELUKAST d04289A B T78.40 Allergy, unspecified A Ep A . . . E A HYDROXYZINE d00907A B= F41.9 Anxiety disorder, unspecified A E A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified A E A . . . E A 77777 . . A E A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A E A . . . E A 99999 . . A E A ROSUVASTATIN d04851A B= E78.0P Prevent high cholesterol A E A ATORVASTATIN d04105A Bz E78.0 Pure hypercholesterolemia A@ E A GLIPIZIDE d00246A Bz R73 Elevated blood glucose level A@ E A LISINOPRIL d00732A Bz I10 Essential (primary) hypertension A@ E A METFORMIN d03807A Bz R73 Elevated blood glucose level A@ E A ESOMEPRAZOLE d04749A C- K30 Functional dyspepsia A E A . . . E A SULFAMETHOXAZOLE d00119A A B99.9 Unspecified infectious disease A E0 A . . . E@ A . . . EP A FLECAINIDE d00234A D I49.9 Cardiac arrhythmia, unspecified A EP A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A E` A ATENOLOL d00004A C I10 Essential (primary) hypertension A E` A PANTOPRAZOLE d04514A A R10 Abdominal and pelvic pain A Ep A CARVEDILOL d03847A C I10 Essential (primary) hypertension A` Ep A FUROSEMIDE d00070A Ap R60.9 Edema, unspecified A` Ep A INSULIN DEGLUDEC d08054A C E11 Type 2 diabetes mellitus A` Ep A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A` Ep A POTASSIUM CHLORIDE d00345A Ap N28.9 Disorder of kidney and ureter, unspecified A` Ep A PRIMIDONE d00352A D R25.1 Tremor, unspecified A` E A . . . E A ETHINYL ESTRADIOL; ETONOGESTREL d04773A A Z79.3 Long term (current) use of hormonal contraceptives A E A PREDNISONE d00350A B[ H57.9 J42 Unspecified disorder of eye and adnexa Unspecified chronic bronchitis A E A . . . E A TRIAMCINOLONE TOPICAL d03206A B L20.9 Atopic dermatitis, unspecified A E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A E A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A B N92 Excessive, frequent and irregular menstruation A E A . . . E A . . . E A OLANZAPINE d04050A B[ F31.9 Bipolar disorder, unspecified A E A . . . E A . . . E0 A . . . E@ A . . . EP A ASPIRIN d00170A B= I21.P I51.9P I63.P Prevent heart attack/myocardial infarction Prevent heart disease Prevent stroke A` EP A ATORVASTATIN d04105A C"0 E78.0 Pure hypercholesterolemia A` EP A GLIPIZIDE d00246A C[@ E11 Type 2 diabetes mellitus A` EP A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10.P Prevent hypertension A` EP A LEVOTHYROXINE d00278A B E07.9 Disorder of thyroid, unspecified A` EP A SAXAGLIPTIN d07467A B E11 Type 2 diabetes mellitus A` E` A . . . Ep A . . . E A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A CLOPIDOGREL d04258A C- Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A E A ESTRADIOL d00537A D N95 Menopausal and other perimenopausal disorders A E A EZETIMIBE d04824A Cr E78.0 Pure hypercholesterolemia A E A IMIPRAMINE d00259A C N20.0 Calculus of kidney A E A LISINOPRIL d00732A C- E11.2P Prevent diabetic kidney disease A E A METFORMIN d03807A B[ R73 Elevated blood glucose level A E A PANTOPRAZOLE d04514A C K25 Gastric ulcer A E A SITAGLIPTIN d05896A B= R73 Elevated blood glucose level A E A . . . E A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified A E A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A A0 N39.0 Urinary tract infection, site not specified A E A . . . E A . . . E A . . . E A . . . E A PANTOPRAZOLE d04514A B K30 Functional dyspepsia A E A VALACYCLOVIR d03838A A B00.1 Herpesviral vesicular dermatitis A E A OXAZEPAM d00040A D# F41.9 Anxiety disorder, unspecified A E A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A E0 A METFORMIN d03807A B= R73 Elevated blood glucose level A E@ A BUDESONIDE; FORMOTEROL d04795A C J43 J44.9 J45 Emphysema Chronic obstructive pulmonary disease, unspecified Asthma A E@ A CEPHALEXIN d00096A B N30 Cystitis A E@ A CLOPIDOGREL d04258A B D75.9P I80.3 Prevent blood clots Phlebitis and thrombophlebitis of lower extremities, unspecified A E@ A DOXEPIN d00217A CDp G47.9 Sleep disorder, unspecified A E@ A GABAPENTIN d03182A Cr M79.2 Neuralgia and neuritis, unspecified A E@ A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A E@ A IPRATROPIUM d00265A Cr R06.9 Unspecified abnormalities of breathing A E@ A LAMOTRIGINE d03809A D F31.9 Bipolar disorder, unspecified A E@ A LITHIUM d00061A CDp F31.9 F99 Bipolar disorder, unspecified Mental disorder, not otherwise specified A E@ A ONDANSETRON d00867A Cr R11 Nausea and vomiting A E@ A PRAZOSIN d00138A C[@ G47.9 Sleep disorder, unspecified A E@ A QUETIAPINE d04220A B F31.9 Bipolar disorder, unspecified A E@ A TIZANIDINE d04102A B M54 Dorsalgia A E@ A TRAMADOL d03826A B M54 Dorsalgia A E@ A ZOLPIDEM d00910A CDp G47.0 Insomnia A EP A . . . E` A ATORVASTATIN d04105A D# E78.0 Pure hypercholesterolemia A0 E` A HYDROCHLOROTHIAZIDE; IRBESARTAN d04245A D"8 I10 Essential (primary) hypertension A0 E` A METOPROLOL d00134A D"8 I49.9 Cardiac arrhythmia, unspecified A0 Ep A . . . E A . . . E A . . . E A ACETAMINOPHEN; TRAMADOL d04766A D M79.7 Fibromyalgia Ap E A ALBUTEROL d00749A B R06.02 Shortness of breath Ap E A AZELASTINE NASAL d04068A B J30.9 Allergic rhinitis, unspecified Ap E A OLODATEROL; TIOTROPIUM d08362A B J44.9 Chronic obstructive pulmonary disease, unspecified Ap E A OMEPRAZOLE d00325A C K30 Functional dyspepsia Ap E A QUETIAPINE d04220A B F41.9 G31.9 Anxiety disorder, unspecified Degenerative disease of nervous system, unspecified Ap E A TRAZODONE d00395A D G47.0 M79.7 Insomnia Fibromyalgia Ap E A . . . E A . . . E A . . . E A . . . E A . . . E A ALBUTEROL d00749A A R06.9P Prevent breathing difficulty A E A BUDESONIDE; FORMOTEROL d04795A CP J45 Asthma A E A CELECOXIB d04380A D M13 Other arthritis A E A ESTROPIPATE d00543A Cr N95 Menopausal and other perimenopausal disorders A E A GABAPENTIN d03182A D M79.2 Neuralgia and neuritis, unspecified A E A LOSARTAN d03821A C I10 Essential (primary) hypertension A E A PRIMIDONE d00352A D R25.1 Tremor, unspecified A E A RABEPRAZOLE d04448A C K30 Functional dyspepsia A E A ROSUVASTATIN d04851A C- E78.0 Pure hypercholesterolemia A E A SERTRALINE d00880A D* F41.9 Anxiety disorder, unspecified A E A . . . E0 A . . . E@ A . . . EP A ACETAMINOPHEN; CODEINE d03423A C T14.9 Unspecified injury A EP A ECONAZOLE TOPICAL d01271A C B35 Dermatophytosis A EP A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A EP A GLIPIZIDE d00246A Dc E11 Type 2 diabetes mellitus A EP A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A EP A INSULIN GLARGINE d04538A C- E11 Type 2 diabetes mellitus A EP A LISINOPRIL d00732A CDp I21.P Prevent heart attack/myocardial infarction A EP A METFORMIN d03807A C E11 Type 2 diabetes mellitus A EP A OMEPRAZOLE d00325A C K21 R12 Gastro-esophageal reflux disease Heartburn A EP A SITAGLIPTIN d05896A Dc E11 Type 2 diabetes mellitus A EP A TAMSULOSIN d04121A C Z79 Long term (current) drug therapy A EP A TRIAMCINOLONE TOPICAL d03206A Dc R21 Rash and other nonspecific skin eruption A E` A AMPHETAMINE d00803A C[@ F90 Attention-deficit hyperactivity disorders A Ep A . . . E A DEXMETHYLPHENIDATE d04777A C F90 Attention-deficit hyperactivity disorders A E A . . . E A . . . E A . . . E A CARVEDILOL d03847A Dc I10 Essential (primary) hypertension A E A CLOPIDOGREL d04258A C Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A E A DONEPEZIL; MEMANTINE d08337A B[ R41 Other symptoms and signs involving cognitive functions and awareness A E A EZETIMIBE; SIMVASTATIN d05348A Dc E78.0 Pure hypercholesterolemia A E A ISOSORBIDE MONONITRATE d00269A C I49.9 Cardiac arrhythmia, unspecified A E A LEVOTHYROXINE d00278A D* E03.9 Hypothyroidism, unspecified A E A LISINOPRIL d00732A C I21.P Prevent heart attack/myocardial infarction A E A NITROGLYCERIN d00321A D I20.9 Angina pectoris, unspecified A E A PANTOPRAZOLE d04514A C T88.7P Prevent drug side effect A E A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A C 99999 AP E A MELOXICAM d04532A C[@ M54 Dorsalgia AP E A METOPROLOL d00134A C I10 Essential (primary) hypertension AP E A POTASSIUM CHLORIDE d00345A Ei Z95 Presence of cardiac and vascular implants and grafts AP E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia AP E A . . . E A MECLIZINE d00859A Cr R42 Dizziness and giddiness A E A . . . E A ARIPIPRAZOLE d04825A B= G47.9 Sleep disorder, unspecified A E A CITALOPRAM d04332A D F32.9 F41.9 R53 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Malaise and fatigue A E A METFORMIN d03807A B E11 Type 2 diabetes mellitus A E0 A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E0 A LOSARTAN d03821A C I10 Essential (primary) hypertension A0 E0 A METHOTREXATE d00060A B M06.9 Rheumatoid arthritis, unspecified A0 E@ A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension AP E@ A FINASTERIDE d00563A CDp N40 Enlarged prostate AP E@ A LOSARTAN d03821A B= I10 Essential (primary) hypertension AP E@ A METFORMIN d03807A B= E11.P Prevent diabetes AP E@ A TAMSULOSIN d04121A CDp N40 Enlarged prostate AP EP A AMOXICILLIN d00088A AP J02 Acute pharyngitis A0 EP A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A0 EP A RAMIPRIL d00728A C I10 Essential (primary) hypertension A0 E` A . . . Ep A . . . E A . . . E A GABAPENTIN d03182A C M54 Dorsalgia A0 E A PREGABALIN d05508A B M79.2 Neuralgia and neuritis, unspecified A0 E A VALSARTAN d04113A Ap I10 Essential (primary) hypertension A0 E A . . . E A . . . E A AMOXICILLIN d00088A A J02 Acute pharyngitis A E A ALBUTEROL d00749A C R06.02 Shortness of breath A E A RANITIDINE d00021A B K30 Functional dyspepsia A E A . . . E A ESCITALOPRAM d04812A D F32.9 Major depressive disorder, single episode, unspecified A E A HYDROXYZINE d00907A D F41.9 T88.7P Anxiety disorder, unspecified Prevent drug side effect A E A HYDROCORTISONE TOPICAL d03205A A0 R21 Rash and other nonspecific skin eruption A E A . . . E0 A . . . E@ A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A EP A HYDROCORTISONE TOPICAL d03205A C[@ L20.9 Atopic dermatitis, unspecified A E` A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A@ E` A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C- I10 Essential (primary) hypertension A@ E` A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A@ E` A RISEDRONATE d04300A B= M81 Osteoporosis without current pathological fracture A@ Ep A FAMOTIDINE d00141A C[@ R14 Flatulence and related conditions AP Ep A FENOFIBRATE d04286A Cr E78.0 Pure hypercholesterolemia AP Ep A HYDROCHLOROTHIAZIDE d00253A Cr R60.9 Edema, unspecified AP Ep A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified AP Ep A LOSARTAN d03821A Cr I10 Essential (primary) hypertension AP E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A Cr I10 Essential (primary) hypertension A E A GABAPENTIN d03182A B M79.6 Pain in limb, hand, foot, fingers and toes A E A IPRATROPIUM d00265A B J45 Asthma A E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A LISINOPRIL d00732A A I10 Essential (primary) hypertension A E A METFORMIN d03807A C 99999 A E A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A E A MONTELUKAST d04289A D J45 Asthma A E A . . . E A . . . E0 A . . . E@ A . . . EP A MELOXICAM d04532A D M79.1 Myalgia A E` A . . . Ep A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A CLOPIDOGREL d04258A C D75.9P Prevent blood clots A E A FUROSEMIDE d00070A C R60.9 Edema, unspecified A E A GLIMEPIRIDE d03864A D E11 Type 2 diabetes mellitus A E A INSULIN GLARGINE d04538A D E11 Type 2 diabetes mellitus A E A INSULIN LISPRO d04373A Dc E11 Type 2 diabetes mellitus A E A ISOSORBIDE d00653A B R07.9 Chest pain, unspecified A E A METFORMIN d03807A D E11 Type 2 diabetes mellitus A E A METOPROLOL d00134A D I50.9 Heart failure, unspecified A E A OMEPRAZOLE d00325A C[@ K21 Gastro-esophageal reflux disease A E A PREGABALIN d05508A C E11.4 Type 2 diabetes mellitus with neurological complications A E A TRAMADOL d03826A Cr M25.5 Pain in joint A E A . . . E A ATORVASTATIN d04105A C 99999 A E A CITALOPRAM d04332A CDp F32.9 Major depressive disorder, single episode, unspecified A E A INSULIN GLARGINE d04538A C- E11 Type 2 diabetes mellitus A E A INSULIN LISPRO d04373A C E11 Type 2 diabetes mellitus A E A MIDODRINE d04047A C 99999 A E A PANTOPRAZOLE d04514A C 99999 A E A PREGABALIN d05508A C- G99.8 Other specified disorders of nervous system in diseases classified elsewhere A E A SPIRONOLACTONE d00373A C 99999 A E A TORSEMIDE d03189A B 99999 A E A . . . E A . . . E A . . . E A ALENDRONATE d03849A C M81 Osteoporosis without current pathological fracture A@ E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A@ E A . . . E A ALBUTEROL d00749A C[@ J45 Asthma A0 E A FLUTICASONE NASAL d04283A C[@ J30.9 Allergic rhinitis, unspecified A0 E A MOMETASONE d05262A C[@ J45 Asthma A0 E0 A ACETAMINOPHEN; OXYCODONE d03431A B M54 Dorsalgia A0 E0 A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A0 E0 A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A0 E@ A . . . EP A CLOPIDOGREL d04258A B- D75.9P Prevent blood clots A0 EP A COLESTIPOL d00744A Ei E78.0 Pure hypercholesterolemia A0 EP A METOPROLOL d00134A B= I10 Essential (primary) hypertension A0 E` A KETOROLAC d00273A A N20.0 Calculus of kidney A E` A TAMSULOSIN d04121A A R32 Unspecified urinary incontinence A Ep A . . . E A . . . E A RANITIDINE d00021A B[ K21 Gastro-esophageal reflux disease A E A GLIPIZIDE d00246A D E11 Type 2 diabetes mellitus AP E A INSULIN ISOPHANE (NPH) d04370A C[@ R73 Elevated blood glucose level AP E A LISINOPRIL d00732A D E11.2 Type 2 diabetes mellitus with kidney complications AP E A METFORMIN d03807A D E11 Type 2 diabetes mellitus AP E A NAPROXEN d00019A Cr M79.1 Myalgia AP E A . . . E A LISINOPRIL d00732A Ap I10 Essential (primary) hypertension A E A . . . E A CELECOXIB d04380A B R52 Pain, unspecified A` E A CETIRIZINE d03827A C[@ T78.40 Allergy, unspecified A` E A CYCLOBENZAPRINE d00963A Cr R52 Pain, unspecified A` E A HYDROXYZINE d00907A Cr L29.9 Pruritus, unspecified A` E A PREGABALIN d05508A C R52 Pain, unspecified A` E A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A` E A FENOFIBRATE d04286A Cr E78.1 Pure hyperglyceridemia A E A LOSARTAN d03821A Ap I10 Essential (primary) hypertension A E A BENAZEPRIL d00730A Dc I10 Essential (primary) hypertension Ap E A DOXAZOSIN d00726A C- R35 Polyuria Ap E A GABAPENTIN d03182A B E11.4 Type 2 diabetes mellitus with neurological complications Ap E A HYDROCHLOROTHIAZIDE d00253A Dc R60.9 Edema, unspecified Ap E A METFORMIN d03807A Dc R73 Elevated blood glucose level Ap E A RANITIDINE d00021A CDp K21 Gastro-esophageal reflux disease Ap E A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia Ap E A . . . E A . . . E0 A . . . E@ A OMEPRAZOLE d00325A C[@ K30 Functional dyspepsia A EP A . . . E` A 99999 . . A Ep A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C[@ Z79.3 Long term (current) use of hormonal contraceptives A E A CLOPIDOGREL d04258A D I21.P Prevent heart attack/myocardial infarction A@ E A METOPROLOL d00134A D I21.P Prevent heart attack/myocardial infarction A@ E A RAMIPRIL d00728A D I21.P Prevent heart attack/myocardial infarction A@ E A SIMVASTATIN d00746A D I21.P Prevent heart attack/myocardial infarction A@ E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia Ap E A LEVOCETIRIZINE d05851A CDp T78.40 Allergy, unspecified Ap E A METFORMIN d03807A C[@ E11 R73 Type 2 diabetes mellitus Elevated blood glucose level Ap E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease Ap E A PROPRANOLOL d00032A Cr R25.1 Tremor, unspecified Ap E A RIOCIGUAT d08140A C- I27.9 Pulmonary heart disease, unspecified Ap E A RIVAROXABAN d07356A Cr D75.9P Prevent blood clots Ap E A . . . E A . . . E A . . . E A CLINDAMYCIN d00043A B K04.7 Periapical abscess without sinus A E A METHOTREXATE d00060A C M06.9 Rheumatoid arthritis, unspecified A E A . . . E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A Cr M13 M79.1 Other arthritis Myalgia A E A ALBUTEROL d00749A Cr J43 J44.9 R06.9P Emphysema Chronic obstructive pulmonary disease, unspecified Prevent breathing difficulty A E A BUDESONIDE; FORMOTEROL d04795A Cr J42 J43 J44.9 Unspecified chronic bronchitis Emphysema Chronic obstructive pulmonary disease, unspecified A E A GABAPENTIN d03182A C[@ M79.2 M79.7 Neuralgia and neuritis, unspecified Fibromyalgia A E A METHOTREXATE d00060A Cr M06.9 Rheumatoid arthritis, unspecified A E A ONDANSETRON d00867A A R11 Nausea and vomiting A E A PANTOPRAZOLE d04514A C- K27 Peptic ulcer, site unspecified A E A SILDENAFIL d04299A CDp N52.9 Male erectile dysfunction, unspecified A E0 A ACETAMINOPHEN; HYDROCODONE d03428A Ap R10 Abdominal and pelvic pain A E@ A . . . EP A 77777 . . A E` A . . . Ep A GLIPIZIDE d00246A D E11 Type 2 diabetes mellitus A0 Ep A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A0 Ep A METFORMIN d03807A D E11 Type 2 diabetes mellitus A0 E A AMOXICILLIN d00088A Ap H10 Conjunctivitis A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia Ap E A FUROSEMIDE d00070A C R60.9 Edema, unspecified Ap E A LOSARTAN d03821A C I10 Essential (primary) hypertension Ap E A METFORMIN d03807A B= E11 Type 2 diabetes mellitus Ap E A MISOPROSTOL d00303A B[ K30 Functional dyspepsia Ap E A PAROXETINE d03157A C F32.9 Major depressive disorder, single episode, unspecified Ap E A VERAPAMIL d00048A C I10 Essential (primary) hypertension Ap E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A ALENDRONATE d03849A Dc M81 Osteoporosis without current pathological fracture A E A AMLODIPINE d00689A C I21.P Prevent heart attack/myocardial infarction A E A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A E A CELECOXIB d04380A D M19.9 Osteoarthritis, unspecified site A E A DEXLANSOPRAZOLE d07395A C K21 Gastro-esophageal reflux disease A E A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A E A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A E A METFORMIN d03807A Dc R73 Elevated blood glucose level A E A METHOTREXATE d00060A C L40 Psoriasis A E A SITAGLIPTIN d05896A Dc R73 Elevated blood glucose level A E A SUCRALFATE d00377A C K21 Gastro-esophageal reflux disease A E A TELMISARTAN d04364A Dc I21.P Prevent heart attack/myocardial infarction A E A . . . E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A D Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A FAMOTIDINE d00141A CDp K21 Gastro-esophageal reflux disease A@ E A PROPRANOLOL d00032A C- F41.9 Anxiety disorder, unspecified A@ E A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A@ E A SERTRALINE d00880A C F42 Obsessive-compulsive disorder A@ E A PROPRANOLOL d00032A C F41.9 Anxiety disorder, unspecified A E A FEXOFENADINE d04040A C L23 R09.81 T78.40 Allergic contact dermatitis Nasal congestion Allergy, unspecified A@ E A MONTELUKAST d04289A Bz J30.9 Allergic rhinitis, unspecified A@ E A PROMETHAZINE d00787A A G43 Migraine A@ E A TRAZODONE d00395A Cr F33.9 F41.9 G47.0 Major depressive disorder, recurrent, unspecified Anxiety disorder, unspecified Insomnia A@ E A . . . E A METFORMIN d03807A C E11.P Prevent diabetes A E A OMEPRAZOLE d00325A C- R12 Heartburn A E A CETIRIZINE d03827A C J30.9 Allergic rhinitis, unspecified A E0 A . . . E@ A AMLODIPINE d00689A C& I10 Essential (primary) hypertension A0 E@ A LOSARTAN d03821A C I10 Essential (primary) hypertension A0 E@ A NEBIVOLOL d05265A C[@ I10 Essential (primary) hypertension A0 EP A EMPAGLIFLOZIN d08275A AP E11 Type 2 diabetes mellitus A@ EP A INSULIN LISPRO d04373A B E11 Type 2 diabetes mellitus A@ EP A METFORMIN d03807A Ei E11 Type 2 diabetes mellitus A@ EP A TRAMADOL d03826A A M25.5 Pain in joint A@ E` A . . . Ep A . . . E A . . . E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A@ E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A@ E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A@ E A . . . E A . . . E A CYCLOBENZAPRINE d00963A0 CDp M62.83 Muscle spasm A E A EMPAGLIFLOZIN d08275A0 C[@ E11 Type 2 diabetes mellitus A E A ENALAPRIL d00013A0 C[@ I10 Essential (primary) hypertension A E A EXENATIDE d05529A0 C E11 Type 2 diabetes mellitus A E A GLYBURIDE; METFORMIN d04703A0 C[@ E11 Type 2 diabetes mellitus A E A IBUPROFEN d00015A0 CDp M54 Dorsalgia A E A PREGABALIN d05508A0 CDp M79.2 Neuralgia and neuritis, unspecified A E A SERTRALINE d00880A B[ F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A B= Z79.3 Long term (current) use of hormonal contraceptives A E A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension Ap E A CYCLOSPORINE d00079A C[@ T86.9P Prevent transplanted organ and tissue rejection Ap E A FLUDROCORTISONE d00608A C[@ I99.9 Unspecified disorder of circulatory system Ap E A LABETALOL d00016A C[@ I10 Essential (primary) hypertension Ap E A LEVOTHYROXINE d00278A C[@ E04 Other nontoxic goiter Ap E A MYCOPHENOLATE MOFETIL d03839A C[@ T86.9P Prevent transplanted organ and tissue rejection Ap E A PANTOPRAZOLE d04514A C[@ 99999 Ap E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 E A MECLIZINE d00859A C[@ R42 Dizziness and giddiness A0 E A TIMOLOL OPHTHALMIC d04037A C H40 Glaucoma A0 E A . . . E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A BRIMONIDINE OPHTHALMIC d04048A CDp H40 Glaucoma A@ E` A DORZOLAMIDE OPHTHALMIC d03805A CDp H40 Glaucoma A@ E` A LATANOPROST OPHTHALMIC d04017A CDp H40 Glaucoma A@ E` A THYROID DESICCATED d00655A CDp E07.9 Disorder of thyroid, unspecified A@ Ep A ACETAZOLAMIDE d00161A Cr H40 Glaucoma Ap Ep A AMMONIUM LACTATE TOPICAL d04049A Ap B35 Dermatophytosis Ap Ep A ARIPIPRAZOLE d04825A C F32.9 Major depressive disorder, single episode, unspecified Ap Ep A BRIMONIDINE OPHTHALMIC d04048A Cr H40 Glaucoma Ap Ep A DESMOPRESSIN d00583A C R32 Unspecified urinary incontinence Ap Ep A DORZOLAMIDE; TIMOLOL OPHTHALMIC d04303A Cr H40 Glaucoma Ap Ep A LATANOPROST OPHTHALMIC d04017A Cr H40 Glaucoma Ap E A . . . E A . . . E A CITALOPRAM d04332A Cr F41.9 Anxiety disorder, unspecified A` E A GABAPENTIN d03182A B= M54 Dorsalgia A` E A LISINOPRIL d00732A B= I10 Essential (primary) hypertension A` E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A` E A RANITIDINE d00021A Cr K21 Gastro-esophageal reflux disease A` E A VALACYCLOVIR d03838A B B00.9 Herpesviral infection, unspecified A` E A . . . E A . . . E A QUETIAPINE d04220A C F32.9 Major depressive disorder, single episode, unspecified A E A VALPROIC ACID d00083A C F39 Unspecified mood [affective] disorder A E A ETODOLAC d00851A B M25.5 Pain in joint A0 E A FESOTERODINE d07162A B N32.81 Overactive bladder A0 E A LEVOTHYROXINE d00278A D* E03.9 Hypothyroidism, unspecified A0 E A ALBUTEROL d00749A Cr J45 R06.2 R07.9 Asthma Wheezing Chest pain, unspecified A E A . . . E A ALLOPURINOL d00023A CDp M10.9 Gout, unspecified A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A GABAPENTIN d03182A B= 99999 A E A GLIPIZIDE d00246A CDp E11 Type 2 diabetes mellitus A E A HYDRALAZINE d00132A CDp I10 Essential (primary) hypertension A E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C- I10 R60.9 Essential (primary) hypertension Edema, unspecified A E A METFORMIN; PIOGLITAZONE d05635A CDp E11 Type 2 diabetes mellitus A E A METOPROLOL d00134A C M79.6 Pain in limb, hand, foot, fingers and toes A E A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A E A . . . E0 A . . . E@ A . . . EP A . . . E` A ESTRADIOL d00537A D"8 Z79.890 Hormone replacement therapy A@ E` A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A@ E` A LISINOPRIL d00732A D I10 Essential (primary) hypertension A@ E` A METFORMIN; SITAGLIPTIN d06720A C E11 Type 2 diabetes mellitus A@ Ep A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A@ Ep A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A@ Ep A TRAZODONE d00395A Dc G47.9 Sleep disorder, unspecified A@ Ep A VENLAFAXINE d03181A C F32.9 Major depressive disorder, single episode, unspecified A@ E A . . . E A . . . E A . . . E A . . . E A . . . E A ETHINYL ESTRADIOL; NORGESTREL d03241A C N92 Excessive, frequent and irregular menstruation A0 E A LISDEXAMFETAMINE d06663A C- F90 Attention-deficit hyperactivity disorders A0 E A NAPROXEN d00019A C N94 Pain and other conditions associated with female genital organs and menstrual cycle A0 E A . . . E A INSULIN GLARGINE d04538A B E10 Type 1 diabetes mellitus A E A INSULIN LISPRO d04373A C E10 Type 1 diabetes mellitus A E A . . . E A . . . E A DEXAMETHASONE d00206A C"@ H57.9 Unspecified disorder of eye and adnexa A@ E A DONEPEZIL d04099A C[@ R41 Other symptoms and signs involving cognitive functions and awareness A@ E A OMEPRAZOLE d00325A CDp K30 Functional dyspepsia A@ E A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia A@ E0 A METFORMIN d03807A Cr R73 Elevated blood glucose level A E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A B G89 Pain, not elsewhere classified A E A ATORVASTATIN d04105A B= E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia A@ E A NAPROXEN d00019A Dc Z79.1 Long term (current) use of non-steroidal anti-inflammatories (NSAID) A@ E A TRIAMCINOLONE TOPICAL d03206A Cr L20.9 Atopic dermatitis, unspecified A@ E A VERAPAMIL d00048A Dc I49.9 Cardiac arrhythmia, unspecified A@ E A ALBUTEROL d00749A C J45 Asthma A E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C- Z79.3 Long term (current) use of hormonal contraceptives A E A OMEGA-3 POLYUNSATURATED FATTY ACIDS d00497A B= E78.1 Pure hyperglyceridemia A E A . . . E A . . . E A . . . E0 A . . . E@ A HYDROCHLOROTHIAZIDE d00253A C- I10 Essential (primary) hypertension A EP A BUPROPION d00181A CDp F32.9 Major depressive disorder, single episode, unspecified AP EP A CITALOPRAM d04332A C F32.9 Major depressive disorder, single episode, unspecified AP EP A IRBESARTAN d04222A Bz I10 Essential (primary) hypertension AP EP A MELOXICAM d04532A A Z79 Long term (current) drug therapy AP EP A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus AP E` A . . . Ep A OFLOXACIN OPHTHALMIC d03977A A H10 Conjunctivitis A E A CARVEDILOL d03847A0 Cr I21.P Prevent heart attack/myocardial infarction Ap E A CETIRIZINE d03827A0 CDp R09.81 Nasal congestion Ap E A DIAZEPAM d00148A C F33.9 Major depressive disorder, recurrent, unspecified Ap E A MONTELUKAST d04289A0 CDp J30.9 Allergic rhinitis, unspecified Ap E A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease Ap E A RAMIPRIL d00728A0 CDp I10 Essential (primary) hypertension Ap E A SIMVASTATIN d00746A0 C E78.0 Pure hypercholesterolemia Ap E A . . . E A . . . E A 99999 . . A E A CETIRIZINE d03827A C- R06.2 T78.40 Wheezing Allergy, unspecified A E A FLUTICASONE NASAL d04283A C- J30.2 Other seasonal allergic rhinitis A E A . . . E A . . . E A . . . E A . . . E A BUPROPION d00181A CDp F17.2 Nicotine dependence A0 E A EZETIMIBE d04824A C- E78.0 Pure hypercholesterolemia A0 E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A0 E A CELECOXIB d04380A C- M06.9 Rheumatoid arthritis, unspecified Ap E A CLINDAMYCIN d00043A B= L08.9 Local infection of the skin and subcutaneous tissue, unspecified Ap E A FUROSEMIDE d00070A B N28.9 R60.9 Disorder of kidney and ureter, unspecified Edema, unspecified Ap E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension Ap E A METOPROLOL d00134A B= I10 Essential (primary) hypertension Ap E A POTASSIUM CHLORIDE d00345A B E87.6 Hypokalemia Ap E A TRIAMCINOLONE TOPICAL d03206A Bz R21 Rash and other nonspecific skin eruption Ap E0 A . . . E@ A CLONIDINE d00044A A F90 Attention-deficit hyperactivity disorders A E@ A DEXMETHYLPHENIDATE d04777A B F90 Attention-deficit hyperactivity disorders A EP A . . . E` A . . . Ep A . . . E A . . . E A EXEMESTANE d04461A B[ C50 Malignant neoplasm of breast A E A ZOLPIDEM d00910A D G47.0 Insomnia A E A . . . E A . . . E A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia A@ E A LEFLUNOMIDE d04349A A M06.9 Rheumatoid arthritis, unspecified A@ E A SUCRALFATE d00377A B K25.P Prevent gastric ulcer A@ E A TELMISARTAN d04364A0 D* I10 Essential (primary) hypertension A@ E A . . . E A . . . E A . . . E A ESCITALOPRAM d04812A0 Bz F32.9 Major depressive disorder, single episode, unspecified A0 E A HYDROCHLOROTHIAZIDE d00253A B[ R60.9 Edema, unspecified A0 E A LISINOPRIL d00732A0 Bz I10 Essential (primary) hypertension A0 E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A` E A FLUTICASONE NASAL d04283A C- J30.9 Allergic rhinitis, unspecified A` E A LEVETIRACETAM d04499A C G31.9 Degenerative disease of nervous system, unspecified A` E A MEMANTINE d04899A C G30.9 Alzheimer's disease, unspecified A` E A MONTELUKAST d04289A C J45 Asthma A` E A SILVER SULFADIAZINE TOPICAL d01259A B T78.40 Allergy, unspecified A` E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C[@ F90 Attention-deficit hyperactivity disorders A@ E A FLUOXETINE d00236A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A@ E A GUANFACINE d00717A C F90 F91 Attention-deficit hyperactivity disorders Conduct disorders A@ E A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease A@ E0 A ATENOLOL d00004A C- I10 Essential (primary) hypertension A E0 A BIMATOPROST OPHTHALMIC d04754A C H40 Glaucoma A E0 A DEXTRANOMER; SODIUM HYALURONATE d08128A C H40 Glaucoma A E0 A DEXTROMETHORPHAN; PROMETHAZINE d03360A C R05 Cough A E0 A DORZOLAMIDE OPHTHALMIC d03805A C H40 Glaucoma A E0 A FLUTICASONE; SALMETEROL d04611A CDp J45 Asthma A E0 A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A E0 A IPRATROPIUM d00265A CDp J45 Asthma A E0 A MECLIZINE d00859A C R42 Dizziness and giddiness A E0 A SIMVASTATIN d00746A Ei E78.0 Pure hypercholesterolemia A E0 A TAMSULOSIN d04121A B= R39.1 Other difficulties with micturition A E0 A TIOTROPIUM d04829A C- J45 Asthma A E@ A . . . EP A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ EP A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ EP A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified A@ EP A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E` A ASPIRIN d00170A C I21.P Prevent heart attack/myocardial infarction AP E` A LOSARTAN d03821A Bz I10 Essential (primary) hypertension AP E` A METFORMIN d03807A C R73 Elevated blood glucose level AP E` A SIMVASTATIN d00746A CP E78.0 Pure hypercholesterolemia AP E` A TEMAZEPAM d00384A C G47.0 Insomnia AP Ep A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A C M54 Dorsalgia A` E A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A` E A GABAPENTIN d03182A C M54 Dorsalgia A` E A MELOXICAM d04532A C Z79 Long term (current) drug therapy A` E A MELOXICAM d04532A C M54 Dorsalgia A` E A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension A` E A . . . E A BUPROPION d00181A CDp F31.9 F41.9 Bipolar disorder, unspecified Anxiety disorder, unspecified A0 E A ESCITALOPRAM d04812A CDp F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A0 E A PANTOPRAZOLE d04514A B K21 Gastro-esophageal reflux disease A0 E A . . . E A . . . E A . . . E A AMOXICILLIN; CLAVULANATE d00089A A H66.9 Otitis media, unspecified A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E A BUSPIRONE d00182A A F41.9 Anxiety disorder, unspecified AP E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension AP E A LOSARTAN d03821A B E87.6 Hypokalemia AP E A RANITIDINE d00021A C- K57 Diverticular disease of intestine AP E A . . . E A . . . E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A CDp E28 Ovarian dysfunction A@ E A LEVOTHYROXINE d00278A B E06 Thyroiditis A@ E A METFORMIN d03807A Cr E28 Ovarian dysfunction A@ E A NAPROXEN d00019A B Z79 Long term (current) drug therapy A@ E0 A CARVEDILOL d03847A C[@ I10 Essential (primary) hypertension A` E0 A CLOPIDOGREL d04258A B[ D75.9P Prevent blood clots A` E0 A DOCUSATE d01021A B[ K59.0 Constipation A` E0 A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A` E0 A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease A` E0 A SIMVASTATIN d00746A Dc E78.0 Pure hypercholesterolemia A` E@ A . . . EP A DESVENLAFAXINE d07113A CDp F32.9 Major depressive disorder, single episode, unspecified A E` A . . . Ep A . . . E A . . . E A . . . E A . . . E A ATENOLOL d00004A C I10 Essential (primary) hypertension A0 E A NAPROXEN d00019A C- M19.9 Osteoarthritis, unspecified site A0 E A PRAVASTATIN d00348A CDp E78.0 Pure hypercholesterolemia A0 E A BENAZEPRIL d00730A B= I10 Essential (primary) hypertension A E A . . . E A CLONAZEPAM d00197A D G25.81 M62.83 Restless legs syndrome Muscle spasm A0 E A FLUOXETINE d00236A D F32.9 Major depressive disorder, single episode, unspecified A0 E A VERAPAMIL d00048A D G43 Migraine A0 E A . . . E A . . . E A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A0 E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A0 E A METOPROLOL d00134A CDp I20.9 Angina pectoris, unspecified A0 E0 A . . . E@ A METOPROLOL d00134A C I10 Essential (primary) hypertension A EP A . . . E` A . . . Ep A . . . E A . . . E A FLUOXETINE d00236A B F41.9 Anxiety disorder, unspecified A E A LOSARTAN d03821A C- I10 Essential (primary) hypertension A E A . . . E A ALBUTEROL d00749A C- J45 Asthma A@ E A ALBUTEROL d00749A Cr J45 Asthma A@ E A BUDESONIDE; FORMOTEROL d04795A B J45 Asthma A@ E A MONTELUKAST d04289A C- J45 Asthma A@ E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A MOXIFLOXACIN OPHTHALMIC d04860A Ap H10 Conjunctivitis A E0 A ANTIGOUT AGENTS - UNSPECIFIED c00194A CDp M10.9 Gout, unspecified A0 E0 A ANTIHYPERLIPIDEMIC AGENTS - UNSPECIFIED c00019A CDp E78.0 Pure hypercholesterolemia A0 E0 A ANTIHYPERTENSIVE AGENTS - UNSPECIFIED h00024A CDp I10 Essential (primary) hypertension A0 E@ A . . . EP A . . . E` A AMIODARONE d00002A B I49.9 Cardiac arrhythmia, unspecified A E` A AMLODIPINE d00689A B I10 R07.9 Essential (primary) hypertension Chest pain, unspecified A E` A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A E` A CLOPIDOGREL d04258A C- D75.9P I63.P Prevent blood clots Prevent stroke A E` A FUROSEMIDE d00070A C R60.9 Edema, unspecified A E` A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus A E` A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A E` A METFORMIN d03807A D E11 Type 2 diabetes mellitus A E` A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A E` A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A Ep A . . . E A . . . E A ALBUTEROL d00749A C J45 Asthma A E A . . . E A . . . E A ALBUTEROL d00749A C[@ J45 Asthma A E A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A E A BUPROPION d00181A Cr F32.9 Major depressive disorder, single episode, unspecified A E A DIAZEPAM d00148A Cr F41.9 Anxiety disorder, unspecified A E A FLUTICASONE; SALMETEROL d04611A C[@ J98.9 Respiratory disorder, unspecified A E A LEVETIRACETAM d04499A C R25.1 Tremor, unspecified A E A MORPHINE d00308A CP M25.5 Pain in joint A E A MORPHINE d00308A CP R52 Pain, unspecified A E A OMEPRAZOLE d00325A C K31.9 Disease of stomach and duodenum, unspecified A E A SERTRALINE d00880A Cr F32.9 Major depressive disorder, single episode, unspecified A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E0 A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C- I10 Essential (primary) hypertension A E@ A . . . EP A . . . E` A AMLODIPINE d00689A B I10 Essential (primary) hypertension A E` A CETIRIZINE d03827A C H10.1 Acute atopic conjunctivitis A Ep A ALBUTEROL d00749A C- J45 Asthma A E A ATENOLOL d00004A C I10 Essential (primary) hypertension A` E A GLIPIZIDE d00246A C- E11 Type 2 diabetes mellitus A` E A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A` E A PRAVASTATIN d00348A C- E78.0 Pure hypercholesterolemia A` E A SITAGLIPTIN d05896A A@ R73 Elevated blood glucose level A` E A SPIRONOLACTONE d00373A Cr I10 Essential (primary) hypertension A` E A . . . E A . . . E A LOSARTAN d03821A C- I10 Essential (primary) hypertension A E A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A E A . . . E A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A@ E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C- I10 Essential (primary) hypertension A@ E A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia A@ E A TOPIRAMATE d04115A CDp G43 Migraine A@ E A . . . E A 77777 . . A E A LOVASTATIN d00280A C E78.0 I21.P Pure hypercholesterolemia Prevent heart attack/myocardial infarction A@ E A METOPROLOL d00134A C I10 Essential (primary) hypertension A@ E A OMEPRAZOLE d00325A C- R11 Nausea and vomiting A@ E A PROPAFENONE d00358A C I49.9 Cardiac arrhythmia, unspecified A@ E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A LOSARTAN d03821A C"0 I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A METFORMIN d03807A C9 E11 Type 2 diabetes mellitus A E0 A . . . E@ A . . . EP A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A@ EP A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A@ EP A TRAMADOL d03826A C- M54 Dorsalgia A@ EP A URSODIOL d01005A CDp 99999 A@ E` A . . . Ep A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A CDp N92 N94 Excessive, frequent and irregular menstruation Pain and other conditions associated with female genital organs and menstrual cycle A E A 99999 . . A E A ARIPIPRAZOLE d04825A D= F32.9 G47.9 Major depressive disorder, single episode, unspecified Sleep disorder, unspecified A@ E A BENZTROPINE d00175A D= G25.81 Restless legs syndrome A@ E A CITALOPRAM d04332A D= F32.9 Major depressive disorder, single episode, unspecified A@ E A TRAZODONE d00395A C F32.9 Major depressive disorder, single episode, unspecified A@ E A BACLOFEN d00967A C[@ M54 Dorsalgia A E A DICLOFENAC d00848A C M19.9 Osteoarthritis, unspecified site A E A DICYCLOMINE d00999A C Z90 Acquired absence of organs, not elsewhere classified A E A DULOXETINE d05355A C M79.2 Neuralgia and neuritis, unspecified A E A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A E A GLIMEPIRIDE d03864A Cr E11 Type 2 diabetes mellitus A E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A E A MINOCYCLINE d00110A C L70 Acne A E A MISOPROSTOL d00303A Cr K25.P Prevent gastric ulcer A E A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease A E A . . . E A AMITRIPTYLINE d00146A C- G43 Migraine A0 E A ESCITALOPRAM d04812A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A0 E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C- Z79.3 Long term (current) use of hormonal contraceptives A0 E0 A . . . E@ A . . . EP A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A EP A AZITHROMYCIN d00091A AP J00 Acute nasopharyngitis [common cold] A EP A CARVEDILOL d03847A CDp I10 Essential (primary) hypertension A EP A GABAPENTIN d03182A B M79.2 Neuralgia and neuritis, unspecified A EP A GLIPIZIDE d00246A D E11 Type 2 diabetes mellitus A EP A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A CDp I10 Essential (primary) hypertension A EP A METFORMIN d03807A D E11 Type 2 diabetes mellitus A EP A NAPROXEN d00019A C- M19.9 Osteoarthritis, unspecified site A EP A PANTOPRAZOLE d04514A C- K21 Gastro-esophageal reflux disease A E` A . . . Ep A . . . E A . . . E A OSELTAMIVIR d04462A AP J09 Influenza due to certain identified influenza viruses A E A AMOXICILLIN d00088A A J01.9 Acute sinusitis, unspecified A E A . . . E A . . . E A . . . E A . . . E A AMLODIPINE d00689A D I10 Essential (primary) hypertension A@ E A GLIMEPIRIDE d03864A D% E11 Type 2 diabetes mellitus A@ E A METFORMIN d03807A D' E11 Type 2 diabetes mellitus A@ E A VALSARTAN d04113A Bz I10 Essential (primary) hypertension A@ E A ACYCLOVIR d00001A CDp A60.9 Anogenital herpesviral infection, unspecified A E A ALBUTEROL d00749A D J45 Asthma A E A LAMOTRIGINE d03809A C[@ F32.9 Major depressive disorder, single episode, unspecified A E A LORAZEPAM d00149A C- F41.9 Anxiety disorder, unspecified A E A LURASIDONE d07705A C[@ F20 Schizophrenia A E A MIRTAZAPINE d04025A CDp G47.0 Insomnia A E A OXYCODONE d00329A A G89 Pain, not elsewhere classified A E A TRAMADOL d03826A A M54 Dorsalgia A E A . . . E A ATENOLOL d00004A C I50.9 Heart failure, unspecified A E A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A E A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A E A HYDRALAZINE d00132A B= I10 Essential (primary) hypertension A E A ISOSORBIDE d00653A C H40 Glaucoma A E A LISINOPRIL d00732A C N19 Unspecified kidney failure A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E0 A . . . E@ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E@ A CANAGLIFLOZIN; METFORMIN d08280A B E11 R73 Type 2 diabetes mellitus Elevated blood glucose level AP E@ A FLUTICASONE NASAL d04283A C H93.9 Unspecified disorder of ear AP E@ A GLIPIZIDE d00246A C R73 Elevated blood glucose level AP E@ A IBUPROFEN d00015A B= M79.6 Pain in limb, hand, foot, fingers and toes AP EP A . . . E` A NORETHINDRONE d00555A C N92 Excessive, frequent and irregular menstruation A Ep A . . . E A HYDROCHLOROTHIAZIDE d00253A C- I10 Essential (primary) hypertension AP E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified AP E A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia AP E A METOPROLOL d00134A CDp I10 Essential (primary) hypertension AP E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease AP E A . . . E A . . . E A AMOXICILLIN d00088A A B34.9 Viral infection, unspecified Ap E A FLUDROCORTISONE d00608A C I99.9 Unspecified disorder of circulatory system Ap E A LAMOTRIGINE d03809A B= F31.9 Bipolar disorder, unspecified Ap E A LIDOCAINE TOPICAL d00683A A J02 Acute pharyngitis Ap E A MIDODRINE d04047A C I99.9 Unspecified disorder of circulatory system Ap E A QUETIAPINE d04220A C F31.9 Bipolar disorder, unspecified Ap E A TOPIRAMATE d04115A C G43 Migraine Ap E A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A@ E A DONEPEZIL d04099A C[@ R41 Other symptoms and signs involving cognitive functions and awareness A@ E A LOSARTAN d03821A C[@ I10 Essential (primary) hypertension A@ E A MEMANTINE d04899A C[@ R41 Other symptoms and signs involving cognitive functions and awareness A@ E A . . . E A . . . E A . . . E A ACETAMINOPHEN; OXYCODONE d03431A C M25.5 Z96 Pain in joint Presence of other functional implants Ap E A ATORVASTATIN d04105A0 C- E78.0P Prevent high cholesterol Ap E A CLOPIDOGREL d04258A C- D75.9P Prevent blood clots Ap E A GABAPENTIN d03182A C- M79.2 Neuralgia and neuritis, unspecified Ap E A INSULIN GLARGINE d04538A CDp E11 Type 2 diabetes mellitus Ap E A LISINOPRIL d00732A C- I10.P Prevent hypertension Ap E A METFORMIN d03807A C E11 Type 2 diabetes mellitus Ap E A . . . E A . . . E0 A CYCLOBENZAPRINE d00963A B[ M62.83 Muscle spasm AP E0 A GABAPENTIN d03182A Bz R25.2 R52 Cramp and spasm Pain, unspecified AP E0 A METFORMIN d03807A D E11 Type 2 diabetes mellitus AP E0 A OXYCODONE d00329A C[@ R52 Pain, unspecified AP E0 A VENLAFAXINE d03181A C F32.9 Major depressive disorder, single episode, unspecified AP E@ A . . . EP A PAZOPANIB d07499A C C80.1 Malignant (primary) neoplasm, unspecified A E` A . . . Ep A . . . E A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A@ E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A@ E A CARVEDILOL d03847A Cr I10 Essential (primary) hypertension A@ E A VALSARTAN d04113A Cr I10 Essential (primary) hypertension A@ E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A CDp K21 Gastro-esophageal reflux disease A@ E A LABETALOL d00016A Cr I10 Essential (primary) hypertension A@ E A LOSARTAN d03821A C[@ I10 Essential (primary) hypertension A@ E A PANTOPRAZOLE d04514A CDp K21 Gastro-esophageal reflux disease A@ E A ATENOLOL d00004A Dc I10 Essential (primary) hypertension A0 E A ATORVASTATIN d04105A Cr I51.9P Prevent heart disease A0 E A ENALAPRIL; HYDROCHLOROTHIAZIDE d03740A CDp I10 Essential (primary) hypertension A0 E0 A . . . E@ A . . . EP A AMOXICILLIN d00088A B H66.9 Otitis media, unspecified A E` A . . . Ep A . . . E A ALENDRONATE d03849A CDp M81 Osteoporosis without current pathological fracture A E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A E A GABAPENTIN d03182A Bz E11.4 Type 2 diabetes mellitus with neurological complications A E A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A E A INSULIN LISPRO d04373A C E11 Type 2 diabetes mellitus A E A LISINOPRIL d00732A B= I10 Essential (primary) hypertension A E A PANTOPRAZOLE d04514A B= K30 Functional dyspepsia A E A RIVAROXABAN d07356A C[@ I48.9 Unspecified atrial fibrillation and atrial flutter A E A TIMOLOL OPHTHALMIC d04037A C[@ H40 Glaucoma A E A MINOCYCLINE d00110A A L70 Acne A E A . . . E A TELMISARTAN d04364A C I10 Essential (primary) hypertension A E A DORZOLAMIDE; TIMOLOL OPHTHALMIC d04303A C H40 Glaucoma Ap E A ESOMEPRAZOLE d04749A C K30 Functional dyspepsia Ap E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified Ap E A MEMANTINE d04899A B G99.8 Other specified disorders of nervous system in diseases classified elsewhere Ap E A OMEGA-3 POLYUNSATURATED FATTY ACIDS d00497A Cr E78.0 I51.9P Pure hypercholesterolemia Prevent heart disease Ap E A PANCRELIPASE d01002A B K30 Functional dyspepsia Ap E A SILODOSIN d07354A C N40 Enlarged prostate Ap E A . . . E A . . . E A METFORMIN d03807A Bz R73 Elevated blood glucose level A E A NAPROXEN d00019A C- M19.9 M54 M79.1 Osteoarthritis, unspecified site Dorsalgia Myalgia A E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A . . . E0 A . . . E@ A . . . EP A . . . E` A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A` E` A CLOPIDOGREL d04258A CDp D75.9P Prevent blood clots A` E` A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus A` E` A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A` E` A QUETIAPINE d04220A C[@ F20 Schizophrenia A` E` A VENLAFAXINE d03181A C F41.9 Anxiety disorder, unspecified A` Ep A OMEPRAZOLE; SODIUM BICARBONATE d05770A CDp K30 Functional dyspepsia A E A BECLOMETHASONE d00760A C- J45 Asthma A E A . . . E A ATORVASTATIN d04105A Bz E78.0 Pure hypercholesterolemia Ap E A BIMATOPROST OPHTHALMIC d04754A B H40 Glaucoma Ap E A BRIMONIDINE; TIMOLOL OPHTHALMIC d05283A B H40 Glaucoma Ap E A BRINZOLAMIDE OPHTHALMIC d04301A B H40 Glaucoma Ap E A CLOPIDOGREL d04258A C I51.9P Z79.0 Prevent heart disease Long term (current) use of anticoagulants and antithrombotics/antiplatelets Ap E A DICLOFENAC d00848A C M13 M25.5 Other arthritis Pain in joint Ap E A METOPROLOL d00134A C I10 Essential (primary) hypertension Ap E A . . . E A . . . E A CIMETIDINE d00140A B B34.9 Viral infection, unspecified A0 E A HYDROCORTISONE TOPICAL d03205A C B34.9 Viral infection, unspecified A0 E A INSULIN LISPRO d04373A C- E11 Type 2 diabetes mellitus A0 E A . . . E A ATENOLOL d00004A C I10 Essential (primary) hypertension A0 E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A0 E A OMEPRAZOLE d00325A C R12 Heartburn A0 E A ACETAMINOPHEN; CODEINE d03423A A N94 Pain and other conditions associated with female genital organs and menstrual cycle A E A . . . E A ADALIMUMAB d04835A B L40 Psoriasis A E0 A . . . E@ A . . . EP A NORETHINDRONE d00555A C Z79.3 Long term (current) use of hormonal contraceptives A E` A ALCLOMETASONE TOPICAL d01282A A@ L20.9 Atopic dermatitis, unspecified A Ep A . . . E A . . . E A ATORVASTATIN d04105A C I21.P Prevent heart attack/myocardial infarction A@ E A CLONAZEPAM d00197A D M79.2 Neuralgia and neuritis, unspecified A@ E A GABAPENTIN d03182A Cr M79.2 Neuralgia and neuritis, unspecified A@ E A TAMSULOSIN d04121A Cr R39.9 Unspecified symptoms and signs involving the genitourinary system A@ E A CLOTRIMAZOLE TOPICAL d04395A A0 B35 Dermatophytosis A E A . . . E A . . . E A CLOPIDOGREL d04258A Cr D75.9P Prevent blood clots Ap E A FUROSEMIDE d00070A C[@ I51.9 Heart disease, unspecified Ap E A POTASSIUM CHLORIDE d00345A Cr E87.6 Hypokalemia Ap E A PREDNISONE d00350A C J44.9 Chronic obstructive pulmonary disease, unspecified Ap E A RAMIPRIL d00728A C I10 Essential (primary) hypertension Ap E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia Ap E A TAMSULOSIN d04121A C R35 R39.1 Polyuria Other difficulties with micturition Ap E A IRBESARTAN d04222A B= I10 Essential (primary) hypertension A E A . . . E A AZELASTINE; FLUTICASONE NASAL d07868A C- J30.2 Other seasonal allergic rhinitis A E A ACETAMINOPHEN; HYDROCODONE d03428A B M54 Dorsalgia A E A LEVOTHYROXINE d00278A D= E03.9 Hypothyroidism, unspecified A E A LOSARTAN d03821A D I10 Essential (primary) hypertension A E0 A LOSARTAN d03821A C I10 Essential (primary) hypertension A E0 A METOPROLOL d00134A C I10 I21.P Essential (primary) hypertension Prevent heart attack/myocardial infarction A E@ A . . . EP A ARIPIPRAZOLE d04825A B[ F29 Unspecified psychosis not due to a substance or known physiological condition A EP A ZONISAMIDE d04527A B G40 Epilepsy and recurrent seizures A E` A . . . Ep A AMLODIPINE d00689A D ^ I10 I20.9 R07.9 Essential (primary) hypertension Angina pectoris, unspecified Chest pain, unspecified AP Ep A BENAZEPRIL d00730A D ^ I10 Essential (primary) hypertension AP Ep A BETAMETHASONE; CLOTRIMAZOLE TOPICAL d03561A D@) B35 Dermatophytosis AP Ep A CARVEDILOL d03847A D ^ I10 Essential (primary) hypertension AP Ep A SIMVASTATIN d00746A D ^ E78.0P I21.P Prevent high cholesterol Prevent heart attack/myocardial infarction AP E A CITALOPRAM d04332A D F32.9 Major depressive disorder, single episode, unspecified A0 E A THYROID DESICCATED d00655A C E03.9 Hypothyroidism, unspecified A0 E A TRIAMTERENE d00396A D' I10 Essential (primary) hypertension A0 E A . . . E A . . . E A . . . E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A CLONAZEPAM d00197A D F41.9 Anxiety disorder, unspecified A@ E A CONJUGATED ESTROGENS d00541A Dc Z79.890 Hormone replacement therapy A@ E A IBUPROFEN d00015A CDp M13 Other arthritis A@ E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A@ E A . . . E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A . . . EP A DESLORATADINE d04785A B R06.2 Wheezing A EP A RANITIDINE d00021A B= K21 Gastro-esophageal reflux disease A E` A BUPROPION d00181A CDp F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A@ E` A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A CDp Z79.3 Long term (current) use of hormonal contraceptives A@ E` A FLUTICASONE NASAL d04283A C- J30.9 Allergic rhinitis, unspecified A@ E` A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease A@ Ep A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A 99999 . . A` E A AMLODIPINE d00689A D I10 Essential (primary) hypertension A` E A CHLORTHALIDONE d00192A Dc R60.9 Edema, unspecified A` E A HYDROXYCHLOROQUINE d00817A B* M06.9 Rheumatoid arthritis, unspecified A` E A METHOTREXATE d00060A B M06.9 Rheumatoid arthritis, unspecified A` E A PREDNISONE d00350A Cr M06.9 Rheumatoid arthritis, unspecified A` E A . . . E A . . . E A . . . E A . . . E A . . . E0 A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Cr I10 Essential (primary) hypertension A E@ A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A0 E@ A RAMIPRIL d00728A C[@ I10.P Prevent hypertension A0 E@ A SIMVASTATIN d00746A B* E78.0 Pure hypercholesterolemia A0 EP A LISINOPRIL d00732A B I10 Essential (primary) hypertension A E` A . . . Ep A ALBUTEROL d00749A0 C J44.9 Chronic obstructive pulmonary disease, unspecified A Ep A ATORVASTATIN d04105A0 Cr E78.0 Pure hypercholesterolemia A Ep A BUDESONIDE d04276A0 B J44.9 Chronic obstructive pulmonary disease, unspecified A Ep A CARVEDILOL d03847A0 C- I50.9 Heart failure, unspecified A Ep A DICLOFENAC d00848A0 B M25.5 Pain in joint A Ep A FOSINOPRIL d00242A0 B[ I50.9 Heart failure, unspecified A Ep A FUROSEMIDE d00070A0 C- R60.9 Edema, unspecified A Ep A HYDROXYCHLOROQUINE d00817A0 Cr M06.9 Rheumatoid arthritis, unspecified A Ep A INSULIN d00262A0 Cr E11 Type 2 diabetes mellitus A Ep A TIOTROPIUM d04829A0 B J44.9 Chronic obstructive pulmonary disease, unspecified A Ep A TRIAMCINOLONE TOPICAL d03206A0 B[ R21 Rash and other nonspecific skin eruption A E A BUPRENORPHINE; NALOXONE d04819A Ap F11.23 Opioid dependence with withdrawal Ap E A CLONIDINE d00044A Ap F11.23 Opioid dependence with withdrawal Ap E A DESVENLAFAXINE d07113A Bz F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Ap E A DEXLANSOPRAZOLE d07395A C K21 Gastro-esophageal reflux disease Ap E A GUANFACINE d00717A Ap F11.23 Opioid dependence with withdrawal Ap E A LISDEXAMFETAMINE d06663A B[ F90 Attention-deficit hyperactivity disorders Ap E A PHENOBARBITAL d00340A Ap F11.23 Opioid dependence with withdrawal Ap E A AMOXICILLIN d00088A A0 J40 Bronchitis, not specified as acute or chronic A E A . . . E A ACETAMINOPHEN; OXYCODONE d03431A Dc G89 M25.5 Pain, not elsewhere classified Pain in joint A0 E A DIAZEPAM d00148A C G47.9 Sleep disorder, unspecified A0 E A OXYCODONE d00329A C G89 M25.5 Pain, not elsewhere classified Pain in joint A0 E A . . . E A . . . E A . . . E A FLUTICASONE NASAL d04283A C[@ T78.40 Allergy, unspecified A E A . . . E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A B Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E0 A AMLODIPINE d00689A C- I10 Essential (primary) hypertension Ap E0 A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia Ap E0 A CLOPIDOGREL d04258A C D75.9P Prevent blood clots Ap E0 A HYDRALAZINE d00132A C- I10 Essential (primary) hypertension Ap E0 A INSULIN ASPART d04697A CDp E11 Type 2 diabetes mellitus Ap E0 A INSULIN DETEMIR d05436A CDp E11 Type 2 diabetes mellitus Ap E0 A POLYETHYLENE GLYCOL 3350 d05350A C K59.0 Constipation Ap E@ A . . . EP A . . . E` A 77777 . . A Ep A . . . E A ATENOLOL d00004A C I10 Essential (primary) hypertension A E A DEXLANSOPRAZOLE d07395A CDp R12 Heartburn A E A GLIPIZIDE d00246A C[@ E11 Type 2 diabetes mellitus A E A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified A E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia A E A MELOXICAM d04532A C M25.5 Pain in joint A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A PAROXETINE d03157A C F32.9 Major depressive disorder, single episode, unspecified A E A AMLODIPINE; BENAZEPRIL d03829A Ap N28.9 R60.9 Disorder of kidney and ureter, unspecified Edema, unspecified A E A CLONAZEPAM d00197A Cr F41.0 M62.83 R45 Panic disorder [episodic paroxysmal anxiety] without agoraphobia Muscle spasm Symptoms and signs involving emotional state A E A FUROSEMIDE d00070A C[@ N18.9 N28.9 R60.9 Chronic kidney disease, unspecified Disorder of kidney and ureter, unspecified Edema, unspecified A E A GLIMEPIRIDE d03864A CDp E11 Type 2 diabetes mellitus A E A OMEGA-3 POLYUNSATURATED FATTY ACIDS d00497A C 99999 A E A OXYCODONE d00329A B M54 M79.2 M79.7 Dorsalgia Neuralgia and neuritis, unspecified Fibromyalgia A E A SUCRALFATE d00377A CDp K25 Gastric ulcer A E A TAMSULOSIN d04121A A R35 Polyuria A E A FLUTICASONE NASAL d04283A C J30.2 Other seasonal allergic rhinitis A E A MONTELUKAST d04289A B J42 R06.2 Unspecified chronic bronchitis Wheezing A E A AMLODIPINE d00689A Bz I10 Essential (primary) hypertension A E A MEDROXYPROGESTERONE d00284A Bz E28 Ovarian dysfunction A E A IBUPROFEN d00015A B M54 Dorsalgia A E A . . . E A DEXMETHYLPHENIDATE d04777A C R41 Other symptoms and signs involving cognitive functions and awareness A E A . . . E A FLUTICASONE NASAL d04283A B T78.40 Allergy, unspecified A E A OLOPATADINE OPHTHALMIC d04117A B R09.81 Nasal congestion A E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A AMOXICILLIN d00088A A@ H66.9 Otitis media, unspecified A E A . . . E A BENAZEPRIL d00730A C I10 Essential (primary) hypertension A E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A CDp M54 Dorsalgia A E A ALLOPURINOL d00023A C M1A Chronic gout A E A APREMILAST d08247A C- L40 Psoriasis A E A FUROSEMIDE d00070A CDp I51.9 Heart disease, unspecified A E A GABAPENTIN d03182A C M54 Dorsalgia A E A OLMESARTAN d04801A A I10 Essential (primary) hypertension A E A RIVAROXABAN d07356A C I48.9 Unspecified atrial fibrillation and atrial flutter A E A ROSUVASTATIN d04851A Cr E78.0 Pure hypercholesterolemia A E A TAMSULOSIN d04121A CDp R35 Polyuria A E A TAPENTADOL d07453A C M54 Dorsalgia A E A ALBUTEROL d00749A C- J44.9 Chronic obstructive pulmonary disease, unspecified AP E A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension AP E A ATENOLOL d00004A C I10 Essential (primary) hypertension AP E A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A C I10 Essential (primary) hypertension AP E A VARENICLINE d05807A B F17.2 Nicotine dependence AP E A . . . E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A CYCLOBENZAPRINE d00963A C- M62.83 Muscle spasm A0 E@ A TIZANIDINE d04102A B= M54 Dorsalgia A0 E@ A TRAMADOL d03826A C- M54 Dorsalgia A0 EP A ATENOLOL d00004A C R00 Abnormalities of heart beat A@ EP A ENALAPRIL d00013A C I10 Essential (primary) hypertension A@ EP A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A@ EP A SERTRALINE d00880A C F41.9 Anxiety disorder, unspecified A@ E` A . . . Ep A LEVONORGESTREL d00557A C9 Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A . . . E A . . . E A . . . E A BUPROPION d00181A C"0 F39 F41.9 Unspecified mood [affective] disorder Anxiety disorder, unspecified A E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A C M25.5 M79.1 Pain in joint Myalgia A0 E A LACTULOSE d01024A C K76.9 Liver disease, unspecified A0 E A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A B= A49.9P Prevent bacterial infection A0 E A IBUPROFEN d00015A CDp M79.1 Myalgia A E A . . . E A . . . E A CLOPIDOGREL d04258A C D75.9P Prevent blood clots A@ E A LISINOPRIL d00732A C I21.P Prevent heart attack/myocardial infarction A@ E A METOPROLOL d00134A C I21.P Prevent heart attack/myocardial infarction A@ E A SIMVASTATIN d00746A C I21.P Prevent heart attack/myocardial infarction A@ E0 A . . . E@ A . . . EP A 99999 . . A E` A . . . Ep A AMANTADINE d00086A CDp G25.81 Restless legs syndrome Ap Ep A BETHANECHOL d01427A C[@ R39.1 Other difficulties with micturition Ap Ep A GABAPENTIN d03182A CDp M54 Dorsalgia Ap Ep A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified Ap Ep A PANTOPRAZOLE d04514A C- R12 Heartburn Ap Ep A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia Ap Ep A TRAZODONE d00395A C M54 Dorsalgia Ap E A AMOXICILLIN d00088A A` N30 Cystitis A E A LABETALOL d00016A C I10 Essential (primary) hypertension A E A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease A E A ATORVASTATIN d04105A D I21.P Prevent heart attack/myocardial infarction A E A CILOSTAZOL d04382A D I70 Atherosclerosis A E A GABAPENTIN d03182A C[@ R25.2 Cramp and spasm A E A INSULIN GLARGINE d04538A C- R73 Elevated blood glucose level A E A LEVOTHYROXINE d00278A C C80.1 Malignant (primary) neoplasm, unspecified A E A NATEGLINIDE d04743A C- E11 Type 2 diabetes mellitus A E A NORTRIPTYLINE d00144A A0 R25.2 Cramp and spasm A E A PIOGLITAZONE d04442A C- E11 Type 2 diabetes mellitus A E A INSULIN GLARGINE d04538A CDp E11 Type 2 diabetes mellitus A E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C"0 F90 Attention-deficit hyperactivity disorders A E A FLUOXETINE d00236A C"0 F32.9 Major depressive disorder, single episode, unspecified A E A . . . E A AMLODIPINE d00689A C- R07.9 Chest pain, unspecified A E A CEFPODOXIME d00095A C R10 Abdominal and pelvic pain A E A FUROSEMIDE d00070A C R10 Abdominal and pelvic pain A E A HYDRALAZINE d00132A C R10 Abdominal and pelvic pain A E A LOSARTAN d03821A C- R11 Nausea and vomiting A E A METOPROLOL d00134A C- R11 Nausea and vomiting A E A PANTOPRAZOLE d04514A C R10 Abdominal and pelvic pain A E A POTASSIUM CHLORIDE d00345A C- R10 Abdominal and pelvic pain A E A TIOTROPIUM d04829A A R06.9 Unspecified abnormalities of breathing A E A FINASTERIDE d00563A D L65.9 Nonscarring hair loss, unspecified A E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A0 E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A0 E A OLANZAPINE d04050A D"8 F29 Unspecified psychosis not due to a substance or known physiological condition A0 E A CITALOPRAM d04332A CDp F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C[@ Z79.3 Long term (current) use of hormonal contraceptives A E A SIMVASTATIN d00746A Ap E78.0 Pure hypercholesterolemia A E0 A ALBUTEROL d00749A B J44.9 Chronic obstructive pulmonary disease, unspecified A@ E0 A ATORVASTATIN d04105A B[ E78.0 Pure hypercholesterolemia A@ E0 A INSULIN GLARGINE d04538A B E11 Type 2 diabetes mellitus A@ E0 A METFORMIN d03807A B[ E11 Type 2 diabetes mellitus A@ E@ A . . . EP A . . . E` A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A Ep A . . . E A . . . E A DORZOLAMIDE; TIMOLOL OPHTHALMIC d04303A Dc H40 Glaucoma A E A FLUNISOLIDE NASAL d04279A C J30.9 Allergic rhinitis, unspecified A@ E A GLATIRAMER d04111A D G99.8 Other specified disorders of nervous system in diseases classified elsewhere A@ E A MODAFINIL d04378A C R53 Malaise and fatigue A@ E A PAROXETINE d03157A C F41.9 Anxiety disorder, unspecified A@ E A ESCITALOPRAM d04812A B= F32.9 Major depressive disorder, single episode, unspecified A E A ATORVASTATIN d04105A DGJ E63.9 Nutritional deficiency, unspecified A@ E A LEVOTHYROXINE d00278A DGJ E03.9 Hypothyroidism, unspecified A@ E A LISINOPRIL d00732A DGJ E03.9 Hypothyroidism, unspecified A@ E A METFORMIN d03807A DGJ E11 Type 2 diabetes mellitus A@ E A ESCITALOPRAM d04812A B[ F41.9 Anxiety disorder, unspecified A0 E A GABAPENTIN d03182A C B02 G25.81 M79.2 Zoster [herpes zoster] Restless legs syndrome Neuralgia and neuritis, unspecified A0 E A TRAZODONE d00395A B G47.9 Sleep disorder, unspecified A0 E A . . . E A ALBUTEROL d00749A CDp J45 Asthma A E A FLUTICASONE NASAL d04283A CDp J30.2 Other seasonal allergic rhinitis A E A ARIPIPRAZOLE d04825A B[ F32.9 F39 Major depressive disorder, single episode, unspecified Unspecified mood [affective] disorder Ap E A ETODOLAC d00851A B M79.1 Myalgia Ap E A GLIPIZIDE d00246A CDp R73 Elevated blood glucose level Ap E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension Ap E A HYDROXYZINE d00907A C- G47.0 Insomnia Ap E A METFORMIN d03807A C E11 Type 2 diabetes mellitus Ap E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia Ap E A . . . E A AMOXICILLIN; CLAVULANATE d00089A AP J02 Acute pharyngitis A E0 A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A` E0 A FINASTERIDE d00563A C R39.9 Unspecified symptoms and signs involving the genitourinary system A` E0 A LISINOPRIL d00732A C I10 Essential (primary) hypertension A` E0 A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A` E0 A TAMSULOSIN d04121A Dc R39.1 Other difficulties with micturition A` E0 A VERAPAMIL d00048A D I10 Essential (primary) hypertension A` E@ A . . . EP A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C Z79.3 Long term (current) use of hormonal contraceptives A E` A ACARBOSE d03846A C"@ E11 Type 2 diabetes mellitus Ap E` A DOXAZOSIN d00726A C N42.9 Disorder of prostate, unspecified Ap E` A GABAPENTIN d03182A D M79.2 Neuralgia and neuritis, unspecified Ap E` A GLIPIZIDE d00246A D E11 Type 2 diabetes mellitus Ap E` A LISINOPRIL d00732A C I10 Essential (primary) hypertension Ap E` A METFORMIN d03807A D E11 Type 2 diabetes mellitus Ap E` A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia Ap Ep A . . . E A DOXYCYCLINE d00037A B= B99.9 Unspecified infectious disease A E A ACETAMINOPHEN; HYDROCODONE d03428A C- M79.6 Pain in limb, hand, foot, fingers and toes A E A ALBUTEROL d00749A B= J20.9 J42 Acute bronchitis, unspecified Unspecified chronic bronchitis A E A ALBUTEROL d00749A C J42 Unspecified chronic bronchitis A E A CITALOPRAM d04332A C F32.9 Major depressive disorder, single episode, unspecified A E A DICLOFENAC d00848A Cr M79.6 Pain in limb, hand, foot, fingers and toes A E A FLUTICASONE NASAL d04283A CDp J45 Asthma A E A GLYBURIDE d00248A D E11 Type 2 diabetes mellitus A E A LISINOPRIL d00732A CDp I51.9P Prevent heart disease A E A LORAZEPAM d00149A C F41.9 G47.9 Anxiety disorder, unspecified Sleep disorder, unspecified A E A METFORMIN d03807A D E11 Type 2 diabetes mellitus A E A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease A E A BECLOMETHASONE d00760A CDp R05 R06.2 Cough Wheezing A E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A0 E A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A0 E A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A0 E A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A D I10 Essential (primary) hypertension A E A NIFEDIPINE d00051A D I10 Essential (primary) hypertension A E A . . . E A . . . E A METHYLPHENIDATE d00900A B F90 Attention-deficit hyperactivity disorders A E A . . . E A METHYLPHENIDATE d00900A Cr F90 Attention-deficit hyperactivity disorders A E A METHYLPHENIDATE d00900A Cr F90 Attention-deficit hyperactivity disorders A E A . . . E0 A . . . E@ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E@ A GABAPENTIN d03182A Dc M79.2 Neuralgia and neuritis, unspecified AP E@ A LOSARTAN d03821A C E11.2 I10 Type 2 diabetes mellitus with kidney complications Essential (primary) hypertension AP E@ A METFORMIN d03807A D E11 Type 2 diabetes mellitus AP E@ A OXYBUTYNIN d00328A C- N32.81 Overactive bladder AP EP A 77777 . . A E` A . . . Ep A DILTIAZEM d00045A DGJ I10 Essential (primary) hypertension A0 Ep A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A0 Ep A OMEPRAZOLE d00325A A K21 Gastro-esophageal reflux disease A0 E A . . . E A . . . E A . . . E A . . . E A ALBUTEROL d00749A D9 J45 Asthma A E A . . . E A . . . E A ATROPINE OPHTHALMIC d03212A B= H57.9 Unspecified disorder of eye and adnexa A E A . . . E A . . . E A . . . E0 A ATORVASTATIN d04105A0 D E78.0 Pure hypercholesterolemia A@ E0 A LOSARTAN d03821A0 D* I10 Essential (primary) hypertension A@ E0 A METFORMIN d03807A0 C E11 Type 2 diabetes mellitus A@ E0 A OMEPRAZOLE d00325A0 D* K21 Gastro-esophageal reflux disease A@ E@ A SERTRALINE d00880A B* F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A EP A ACETAMINOPHEN; HYDROCODONE d03428A Ap K08.8 Other specified disorders of teeth and supporting structures A0 EP A FAMOTIDINE d00141A B- K30 R12 Functional dyspepsia Heartburn A0 EP A PENICILLIN V POTASSIUM d07730A Ap K04.7 Periapical abscess without sinus A0 E` A BICALUTAMIDE d03850A0 C9 C61 Malignant neoplasm of prostate AP E` A LEUPROLIDE d01353A0 CDp C61 Malignant neoplasm of prostate AP E` A MORPHINE d00308A0 B[ G89 Pain, not elsewhere classified AP E` A NYSTATIN; TRIAMCINOLONE TOPICAL d03562A B[ L29.9 Pruritus, unspecified AP E` A TRIPTORELIN d04696A0 C9 C61 Malignant neoplasm of prostate AP Ep A . . . E A . . . E A ALBUTEROL d00749A C J20.9 J45 R06.2 Acute bronchitis, unspecified Asthma Wheezing A@ E A ALBUTEROL d00749A C J20.9 J45 R06.2 Acute bronchitis, unspecified Asthma Wheezing A@ E A FLUTICASONE d01296A Cr J45 R06.2 R07.9 Asthma Wheezing Chest pain, unspecified A@ E A FLUTICASONE NASAL d04283A C J30.2 J30.9 R09.81 Other seasonal allergic rhinitis Allergic rhinitis, unspecified Nasal congestion A@ E A . . . E A . . . E A BETAMETHASONE TOPICAL d03197A D# L40 Psoriasis A E A FLUTICASONE; VILANTEROL d08100A Bz J45 Asthma A E A . . . E A ALBUTEROL; IPRATROPIUM d04066A C- J44.9 R05 R06.9P Chronic obstructive pulmonary disease, unspecified Cough Prevent breathing difficulty A E A FLUTICASONE; VILANTEROL d08100A B J44.9 R05 Chronic obstructive pulmonary disease, unspecified Cough A E A LISINOPRIL d00732A C- I10 I63.P Essential (primary) hypertension Prevent stroke A E A LOVASTATIN d00280A B E78.0 I21.P Pure hypercholesterolemia Prevent heart attack/myocardial infarction A E A OXCARBAZEPINE d04513A B G40 Epilepsy and recurrent seizures A E A PAROXETINE d03157A C F39 F43.1 N95 Unspecified mood [affective] disorder Post-traumatic stress disorder (PTSD) Menopausal and other perimenopausal disorders A E A PRAZOSIN d00138A B F43.1 G47.9 I10 Post-traumatic stress disorder (PTSD) Sleep disorder, unspecified Essential (primary) hypertension A E A PROPRANOLOL d00032A C I10 R07.9 Essential (primary) hypertension Chest pain, unspecified A E A TRAZODONE d00395A C- F41.9 F43.1 G47.0 Anxiety disorder, unspecified Post-traumatic stress disorder (PTSD) Insomnia A E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A C 99999 A E A FLUOXETINE d00236A C F39 Unspecified mood [affective] disorder A E A FUROSEMIDE d00070A C R60.9 Edema, unspecified A E A GABAPENTIN d03182A C- E11.4 Type 2 diabetes mellitus with neurological complications A E A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus A E A LOSARTAN d03821A C I10 Essential (primary) hypertension A E A WARFARIN d00022A C D75.9P Prevent blood clots A E A . . . E A . . . E0 A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A E0 A BRIMONIDINE OPHTHALMIC d04048A CDp H40 Glaucoma A E0 A FLUOXETINE d00236A D F32.9 Major depressive disorder, single episode, unspecified A E0 A ISOSORBIDE MONONITRATE d00269A A` I10 I21.P Essential (primary) hypertension Prevent heart attack/myocardial infarction A E0 A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E0 A MELOXICAM d04532A B M54 Dorsalgia A E0 A METOPROLOL d00134A C R07.9 Chest pain, unspecified A E0 A NIFEDIPINE d00051A D' I10 Essential (primary) hypertension A E0 A PREDNISONE d00350A D 55555 A E0 A TIZANIDINE d04102A B[ M54 Dorsalgia A E0 A TRAZODONE d00395A CDp G47.0 Insomnia A E0 A TROSPIUM d04929A C- R35 Polyuria A E@ A . . . EP A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A E` A . . . Ep A . . . E A ACETAMINOPHEN; OXYCODONE d03431A B[ M25.5 M54 Pain in joint Dorsalgia A0 E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A0 E A OMEPRAZOLE d00325A B R12 Heartburn A0 E A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A E A . . . E A . . . E A . . . E A . . . E A GABAPENTIN d03182A C F41.9 Anxiety disorder, unspecified A E A ROPINIROLE d04215A C F29 Unspecified psychosis not due to a substance or known physiological condition A E A GLIPIZIDE d00246A C I10 Essential (primary) hypertension A` E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A` E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` E A METOPROLOL d00134A D I10 Essential (primary) hypertension A` E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A` E A SITAGLIPTIN d05896A C E11 Type 2 diabetes mellitus A` E A . . . E A METHYLPHENIDATE d00900A Bz F90 Attention-deficit hyperactivity disorders A E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E0 A . . . E@ A ALPRAZOLAM d00168A D F41.0 F41.9 Panic disorder [episodic paroxysmal anxiety] without agoraphobia Anxiety disorder, unspecified A` E@ A CYCLOBENZAPRINE d00963A C M62.83 Muscle spasm A` E@ A DIAZEPAM d00148A D1 G47.9 M62.83 Sleep disorder, unspecified Muscle spasm A` E@ A HYDROCODONE d03075A D% M54 M79.2 Dorsalgia Neuralgia and neuritis, unspecified A` E@ A LETROZOLE d04156A B C50 Malignant neoplasm of breast A` E@ A PREGABALIN d05508A C- M79.2 Neuralgia and neuritis, unspecified A` EP A AMLODIPINE d00689A C I10 Essential (primary) hypertension A EP A AMOXICILLIN d00088A A K04.7 Periapical abscess without sinus A EP A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A EP A CHLORTHALIDONE d00192A C I10 Essential (primary) hypertension A EP A GLIMEPIRIDE d03864A D E11 Type 2 diabetes mellitus A EP A HYDRALAZINE d00132A C I10 Essential (primary) hypertension A EP A METFORMIN d03807A B E11 Type 2 diabetes mellitus A EP A OLMESARTAN d04801A C I10 Essential (primary) hypertension A E` A . . . Ep A . . . E A CARVEDILOL d03847A CDp I10 Essential (primary) hypertension A E A MYCOPHENOLATE MOFETIL d03839A CDp T86.9P Prevent transplanted organ and tissue rejection A E A MYCOPHENOLIC ACID d05217A CDp T86.9P Prevent transplanted organ and tissue rejection A E A NIFEDIPINE d00051A CDp I10 Essential (primary) hypertension A E A PREDNISONE d00350A CDp T86.9P Prevent transplanted organ and tissue rejection A E A RANITIDINE d00021A CDp K21 Gastro-esophageal reflux disease A E A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A E A TACROLIMUS d03752A CDp T86.9P Prevent transplanted organ and tissue rejection A E A . . . E A . . . E A . . . E A AMOXICILLIN d00088A A J20.9 Acute bronchitis, unspecified A E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A Cr 99999 AP E A DONEPEZIL d04099A Ei R41 Other symptoms and signs involving cognitive functions and awareness AP E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A Cr I10 Essential (primary) hypertension AP E A MEMANTINE d04899A Ei R41 Other symptoms and signs involving cognitive functions and awareness AP E A MONTELUKAST d04289A Cr J45 Asthma AP E A . . . E A . . . E0 A ALBUTEROL d00749A Cr J44.9 Chronic obstructive pulmonary disease, unspecified A E0 A ALBUTEROL d00749A Cr J44.9 Chronic obstructive pulmonary disease, unspecified A E0 A BUSPIRONE d00182A C- F41.9 Anxiety disorder, unspecified A E0 A FORMOTEROL; MOMETASONE d07660A C[@ J44.9 Chronic obstructive pulmonary disease, unspecified A E0 A OXYBUTYNIN d00328A C R32 Unspecified urinary incontinence A E0 A ROPINIROLE d04215A C- G25.81 Restless legs syndrome A E0 A THEOPHYLLINE d00142A CDp J44.9 Chronic obstructive pulmonary disease, unspecified A E0 A TIOTROPIUM d04829A Cr J44.9 Chronic obstructive pulmonary disease, unspecified A E@ A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified A@ E@ A LISINOPRIL d00732A C- E11.2P Prevent diabetic kidney disease A@ E@ A LOVASTATIN d00280A D E78.0 Pure hypercholesterolemia A@ E@ A METFORMIN d03807A B= E11 Type 2 diabetes mellitus A@ EP A SERTRALINE d00880A Bz F43.1 Post-traumatic stress disorder (PTSD) A E` A BUPROPION d00181A CDp F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A` E` A BUSPIRONE d00182A CDp F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A` E` A HYDROCHLOROTHIAZIDE d00253A CDp I10 Essential (primary) hypertension A` E` A IBUPROFEN d00015A A M1A Chronic gout A` E` A INDOMETHACIN d00039A Ap M1A Chronic gout A` E` A TRAMADOL d03826A A M1A Chronic gout A` Ep A . . . E A . . . E A . . . E A DESOGESTREL; ETHINYL ESTRADIOL d03782A B Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A . . . E A . . . E A DROSPIRENONE; ETHINYL ESTRADIOL d04760A CP Z79.3 Long term (current) use of hormonal contraceptives A E A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A E A . . . E A DESMOPRESSIN d00583A B G47.0 Insomnia A E A FOSINOPRIL d00242A D I10 Essential (primary) hypertension A E A HYDROCODONE d03075A B M25.5 Pain in joint A E A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A E A MIRABEGRON d07876A B R35 Polyuria A E A OMEPRAZOLE d00325A Cr K30 Functional dyspepsia A E A PRAMIPEXOLE d04145A C[@ G25.81 Restless legs syndrome A E A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A E A TAMSULOSIN d04121A C R35 Polyuria A E A TEMAZEPAM d00384A C- G47.0 Insomnia A E A TIZANIDINE d04102A C M54 Dorsalgia A E A . . . E A . . . E0 A VALSARTAN d04113A C< N28.9P Prevent kidney disease A E@ A . . . EP A . . . E` A . . . Ep A ATENOLOL d00004A D I10 Essential (primary) hypertension A Ep A FUROSEMIDE d00070A D R60.9 Edema, unspecified A Ep A GEMFIBROZIL d00245A C E78.0 Pure hypercholesterolemia A Ep A LISINOPRIL d00732A D I10 Essential (primary) hypertension A Ep A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus A Ep A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A Ep A TERAZOSIN d00386A D N40 Enlarged prostate A Ep A WARFARIN d00022A C D75.9P Prevent blood clots A E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A A0 E78.0 Pure hypercholesterolemia A E A ADALIMUMAB d04835A Cr M06.9 Rheumatoid arthritis, unspecified Ap E A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension Ap E A DENOSUMAB d07640A Cr M81 Osteoporosis without current pathological fracture Ap E A EZETIMIBE d04824A Cr E78.0 Pure hypercholesterolemia Ap E A LOSARTAN d03821A Cr I10 Essential (primary) hypertension Ap E A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia Ap E A RIFAMPIN d00047A Cr 99999 Ap E A ATORVASTATIN d04105A CDp 99999 A E A BUPROPION d00181A C- F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A CARISOPRODOL d00960A D M79.1 T14.9 Myalgia Unspecified injury A E A ESCITALOPRAM d04812A C[@ 99999 A E A FUROSEMIDE d00070A CDp 99999 A E A GLIMEPIRIDE d03864A C- 99999 A E A HYDROCODONE d03075A D M54 Dorsalgia A E A LOSARTAN d03821A C- 99999 A E A MONTELUKAST d04289A C[@ J45 Asthma A E A OMEPRAZOLE d00325A C[@ K30 Functional dyspepsia A E A TERAZOSIN d00386A C[@ N40 Enlarged prostate A E A . . . E A 99999 . . A E A . . . E A . . . E A AMOXICILLIN d00088A A H66.9 J18.9 Otitis media, unspecified Pneumonia, unspecified organism A E0 A ALBUTEROL d00749A C- J45 Asthma A` E0 A AMLODIPINE d00689A D I10 Essential (primary) hypertension A` E0 A ETRAVIRINE d07076A D B20 Human immunodeficiency virus [HIV] disease A` E0 A FLUTICASONE NASAL d04283A C- R09.81 Nasal congestion A` E0 A RALTEGRAVIR d07048A D B20 Human immunodeficiency virus [HIV] disease A` E0 A ZIDOVUDINE d00034A D B20 Human immunodeficiency virus [HIV] disease A` E@ A . . . EP A . . . E` A . . . Ep A . . . E A ALBUTEROL d00749A C9 R06.2 Wheezing A0 E A FLUTICASONE NASAL d04283A C9 J30.9 Allergic rhinitis, unspecified A0 E A LEVOCETIRIZINE d05851A C9 T78.40 Allergy, unspecified A0 E A . . . E A AMLODIPINE d00689A C I63.P Prevent stroke A` E A CHLORTHALIDONE d00192A Cr I10 Essential (primary) hypertension A` E A LINAGLIPTIN d07767A C E11 Type 2 diabetes mellitus A` E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A` E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` E A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A` E A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension Ap E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia Ap E A DOXEPIN TOPICAL d03774A Cr M19.9 Osteoarthritis, unspecified site Ap E A GLIPIZIDE d00246A Cr E11 Type 2 diabetes mellitus Ap E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A Cr I10 Essential (primary) hypertension Ap E A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus Ap E A OMEPRAZOLE d00325A B K21 Gastro-esophageal reflux disease Ap E A . . . E A . . . E A ETHINYL ESTRADIOL; GESTODENE h00015A C Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C N92 Excessive, frequent and irregular menstruation A E A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A E A PAROXETINE d03157A CDp F41.9 N95 Anxiety disorder, unspecified Menopausal and other perimenopausal disorders A E A . . . E0 A SERTRALINE d00880A CDp F41.9 Anxiety disorder, unspecified A E@ A IBUPROFEN d00015A C M79.2 Neuralgia and neuritis, unspecified A EP A . . . E` A . . . Ep A PRAZOSIN d00138A C- F29 F43.1 G47.9 Unspecified psychosis not due to a substance or known physiological condition Post-traumatic stress disorder (PTSD) Sleep disorder, unspecified A0 Ep A QUETIAPINE d04220A CDp F31.9 Bipolar disorder, unspecified A0 Ep A TRAZODONE d00395A Cr F41.9 Anxiety disorder, unspecified A0 E A TRIAMTERENE d00396A Cr I10 Essential (primary) hypertension A E A TELMISARTAN d04364A C I10 Essential (primary) hypertension A E A . . . E A OMEPRAZOLE d00325A CDp K21 K27 Gastro-esophageal reflux disease Peptic ulcer, site unspecified A E A LATANOPROST OPHTHALMIC d04017A Dc H40 Glaucoma A E A OMEPRAZOLE d00325A C[@ K21 K30 Gastro-esophageal reflux disease Functional dyspepsia A E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A0 E A NABUMETONE d00310A B M54 M79.2 Dorsalgia Neuralgia and neuritis, unspecified A0 E A FUROSEMIDE d00070A Cr I51.9 Heart disease, unspecified A E A GABAPENTIN d03182A Cr M79.2 Neuralgia and neuritis, unspecified A E A GLIPIZIDE d00246A Cr R73 Elevated blood glucose level A E A ISOSORBIDE MONONITRATE d00269A Cr I20.9 I21.P Angina pectoris, unspecified Prevent heart attack/myocardial infarction A E A LATANOPROST OPHTHALMIC d04017A Cr H40 Glaucoma A E A LEVOTHYROXINE d00278A Cr E78.0 Pure hypercholesterolemia A E A LOSARTAN d03821A Cr 99999 A E A METOPROLOL d00134A Cr I63.P Prevent stroke A E A OMEPRAZOLE d00325A Cr R10 Abdominal and pelvic pain A E A POTASSIUM CHLORIDE d00345A Cr E87.6 Hypokalemia A E A WARFARIN d00022A Cr I48.9 Unspecified atrial fibrillation and atrial flutter A E A . . . E A ATORVASTATIN d04105A0 C E78.0 Pure hypercholesterolemia A0 E A DICLOFENAC d00848A0 C M25.5 Pain in joint A0 E A METFORMIN d03807A0 C E11 Type 2 diabetes mellitus A0 E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A AMOXICILLIN d00088A A K04.7 Periapical abscess without sinus A Ep A SERTRALINE d00880A B1 F41.9 Anxiety disorder, unspecified A E A . . . E A FEXOFENADINE d04040A D T78.40 Allergy, unspecified A0 E A HYDROCHLOROTHIAZIDE d00253A C N42.9 Disorder of prostate, unspecified A0 E A TRAMADOL d03826A C M19.9 Osteoarthritis, unspecified site A0 E A METHIMAZOLE d00290A B E05 Thyrotoxicosis [hyperthyroidism] A E A ALPRAZOLAM d00168A Cr F41.9 Anxiety disorder, unspecified A0 E A ATENOLOL d00004A C I10 Essential (primary) hypertension A0 E A FAMOTIDINE d00141A C K30 Functional dyspepsia A0 E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A E A CILOSTAZOL d04382A CDp I70 Atherosclerosis A E A CLOPIDOGREL d04258A CDp D75.9P Prevent blood clots A E A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A E A ISOSORBIDE MONONITRATE d00269A Cr R07.9 Chest pain, unspecified A E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A MELOXICAM d04532A C M06.9 Rheumatoid arthritis, unspecified A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A E A OXYBUTYNIN d00328A Cr N32.81 R35 Overactive bladder Polyuria A E A PANTOPRAZOLE d04514A Cr K21 Gastro-esophageal reflux disease A E A PIOGLITAZONE d04442A C[@ E11 Type 2 diabetes mellitus A E A . . . E A . . . E A . . . E A AMLODIPINE d00689A B I10 Essential (primary) hypertension AP E A CLONIDINE d00044A B I10 Essential (primary) hypertension AP E A HYDRALAZINE d00132A B I10 Essential (primary) hypertension AP E A METOPROLOL d00134A C I10 Essential (primary) hypertension AP E A ROSUVASTATIN d04851A B E78.0 Pure hypercholesterolemia AP E A INSULIN GLARGINE d04538A B= E11 Type 2 diabetes mellitus A0 E A LOSARTAN d03821A B= I10 Essential (primary) hypertension A0 E A TENOFOVIR d04774A B= K76.9 Liver disease, unspecified A0 E A . . . E0 A ALBUTEROL d00749A B J45 Asthma A E@ A DONEPEZIL d04099A B R41 Other symptoms and signs involving cognitive functions and awareness A E@ A FLUCONAZOLE d00071A B B35 Dermatophytosis A EP A . . . E` A . . . Ep A AMANTADINE d00086A CP R25 Abnormal involuntary movements A Ep A ATORVASTATIN d04105A C"0 E78.0 Pure hypercholesterolemia A Ep A BACLOFEN d00967A D G99.8 M25.9 Other specified disorders of nervous system in diseases classified elsewhere Joint disorder, unspecified A Ep A BENZONATATE d00796A B0 J40 R05 Bronchitis, not specified as acute or chronic Cough A Ep A FAMOTIDINE d00141A C"0 R12 Heartburn A Ep A GLATIRAMER d04111A B G99.8 Other specified disorders of nervous system in diseases classified elsewhere A Ep A HYDROCHLOROTHIAZIDE d00253A C"0 Z79 Long term (current) drug therapy A Ep A LOSARTAN d03821A C I10 Essential (primary) hypertension A Ep A POTASSIUM CHLORIDE d00345A Bz E87.6 Hypokalemia A E A . . . E A . . . E A . . . E A METHOTREXATE d00060A C M06.9 Rheumatoid arthritis, unspecified A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A0 E A LOSARTAN d03821A C I10 Essential (primary) hypertension A0 E A AMLODIPINE d00689A Cr 99999 B E A ARIPIPRAZOLE d04825A0 C[@ F32.9 Major depressive disorder, single episode, unspecified B E A ATORVASTATIN d04105A0 Cr 99999 B E A BENZTROPINE d00175A0 Cr F32.9 Major depressive disorder, single episode, unspecified B E A CLOPIDOGREL d04258A0 Cr I70 Atherosclerosis B E A DIPHENHYDRAMINE d00212A0 B= F32.9 Major depressive disorder, single episode, unspecified B E A ESCITALOPRAM d04812A0 Cr 99999 B E A ESCITALOPRAM d04812A0 Cr F32.9 Major depressive disorder, single episode, unspecified B E A GABAPENTIN d03182A0 Cr M54 Dorsalgia B E A LEVOTHYROXINE d00278A0 Cr 99999 B E A LISINOPRIL d00732A0 Cr 99999 B E A METFORMIN d03807A0 C E11 Type 2 diabetes mellitus B E A METOPROLOL d00134A0 Cr M54 Dorsalgia B E A PANTOPRAZOLE d04514A0 Cr K92.9 Disease of digestive system, unspecified B E A POTASSIUM CHLORIDE d00345A0 Cr F32.9 Major depressive disorder, single episode, unspecified B E A RISPERIDONE d03180A0 Cr F32.9 Major depressive disorder, single episode, unspecified B E A TRAZODONE d00395A0 C[@ G47.0 Insomnia B E A . . . E A . . . E A ALBUTEROL d00749A C J44.9 Chronic obstructive pulmonary disease, unspecified A` E A APIXABAN d07804A B[ Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A` E A DILTIAZEM d00045A Bz I10 Essential (primary) hypertension A` E A FORMOTEROL; MOMETASONE d07660A C J44.9 Chronic obstructive pulmonary disease, unspecified A` E A FUROSEMIDE d00070A B I51.9 Heart disease, unspecified A` E A METOPROLOL d00134A B[ I10 Essential (primary) hypertension A` E A LOSARTAN d03821A C- I10 Essential (primary) hypertension A E A DIPHENHYDRAMINE d00212A CDp 99999 Ap E A DONEPEZIL d04099A CDp 99999 Ap E A FINASTERIDE d00563A Cr 99999 Ap E A FLUTICASONE NASAL d04283A CDp 99999 Ap E A PRAVASTATIN d00348A C9 99999 Ap E A RISPERIDONE d03180A C- 99999 Ap E A TAMSULOSIN d04121A B 99999 Ap E0 A . . . E@ A . . . EP A . . . E` A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A0 E` A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C- I10 Essential (primary) hypertension A0 E` A PRAVASTATIN d00348A C- E78.0P Prevent high cholesterol A0 Ep A . . . E A METHYLPHENIDATE d00900A B F90 Attention-deficit hyperactivity disorders A E A . . . E A IBUPROFEN d00015A A T14.9 Unspecified injury A0 E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 E A MONTELUKAST d04289A C- J30.9 Allergic rhinitis, unspecified A0 E A ACETAMINOPHEN; HYDROCODONE d03428A C M25.5 Pain in joint A` E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A` E A GABAPENTIN d03182A Cr F32.9 Major depressive disorder, single episode, unspecified A` E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A` E A IBUPROFEN d00015A C G89 T14.9 Pain, not elsewhere classified Unspecified injury A` E A SERTRALINE d00880A Cr F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A` E A AMITRIPTYLINE d00146A B R19.7 Diarrhea, unspecified A E A . . . E A FLUOXETINE d00236A B F32.9 Major depressive disorder, single episode, unspecified A E A AMOXICILLIN d00088A B J42 Unspecified chronic bronchitis A E A BROMPHENIRAMINE; PSEUDOEPHEDRINE d03301A A J42 Unspecified chronic bronchitis A E A ALPRAZOLAM d00168A D* F41.0 F41.9 Panic disorder [episodic paroxysmal anxiety] without agoraphobia Anxiety disorder, unspecified Ap E A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia Ap E A BUPROPION d00181A C[@ F31.9 Bipolar disorder, unspecified Ap E A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension Ap E A OMEGA-3 POLYUNSATURATED FATTY ACIDS d00497A C[@ I51.9 Heart disease, unspecified Ap E A OXCARBAZEPINE d04513A CDp F39 Unspecified mood [affective] disorder Ap E A PRAMIPEXOLE d04145A C"0 G25.81 Restless legs syndrome Ap E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A ESTRADIOL TOPICAL d04210A B Z79.890 Hormone replacement therapy A E A . . . E A . . . E A ALBUTEROL d00749A C J44.9 Chronic obstructive pulmonary disease, unspecified A E A BUDESONIDE; FORMOTEROL d04795A CDp J44.9 Chronic obstructive pulmonary disease, unspecified A E A BUPROPION d00181A B F17.2 Nicotine dependence A E A FLUTICASONE d01296A C[@ J44.9 Chronic obstructive pulmonary disease, unspecified A E A FLUTICASONE NASAL d04283A C 99999 A E A METOPROLOL d00134A CP R00 Abnormalities of heart beat A E A MONTELUKAST d04289A CP J44.9 Chronic obstructive pulmonary disease, unspecified A E A OXYBUTYNIN d00328A B N32.81 Overactive bladder A E A PREDNISONE d00350A CDp J44.9 Chronic obstructive pulmonary disease, unspecified A E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A VENLAFAXINE d03181A C F41.9 Anxiety disorder, unspecified A E A . . . E A . . . E A BUPROPION d00181A C[@ F32.9 Major depressive disorder, single episode, unspecified A` E A GABAPENTIN d03182A B M79.2 Neuralgia and neuritis, unspecified A` E A GLIPIZIDE d00246A Ap E11 Type 2 diabetes mellitus A` E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A` E A METFORMIN d03807A B E11 Type 2 diabetes mellitus A` E A TRAMADOL d03826A C M79.2 Neuralgia and neuritis, unspecified A` E A . . . E A . . . E A HYDROCHLOROTHIAZIDE d00253A CDp I10 Essential (primary) hypertension A E A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A E A . . . E0 A 99999 . . A E0 A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A A L08.9 Local infection of the skin and subcutaneous tissue, unspecified A E@ A . . . EP A METOPROLOL d00134A D= I10 Essential (primary) hypertension A E` A . . . Ep A AMITRIPTYLINE d00146A C- N95 Menopausal and other perimenopausal disorders A` Ep A HYDROCHLOROTHIAZIDE d00253A C- I10 Essential (primary) hypertension A` Ep A HYDROXYCHLOROQUINE d00817A C- L93 Lupus erythematosus A` Ep A LOSARTAN d03821A C- I10 Essential (primary) hypertension A` Ep A METHOTREXATE d00060A C- L93 Lupus erythematosus A` Ep A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A` E A . . . E A IBUPROFEN d00015A C[@ Z90 Acquired absence of organs, not elsewhere classified A E A GLIPIZIDE d00246A CDp R73 Elevated blood glucose level A E A INSULIN GLARGINE d04538A B E11 Type 2 diabetes mellitus A E A FLUTICASONE NASAL d04283A C- J30.9 Allergic rhinitis, unspecified A0 E A FORMOTEROL; MOMETASONE d07660A C- J45 Asthma A0 E A MONTELUKAST d04289A C- J45 Asthma A0 E A OMEPRAZOLE d00325A Ei K21 Gastro-esophageal reflux disease A@ E A SERTRALINE d00880A C& F32.9 Major depressive disorder, single episode, unspecified A@ E A SIMVASTATIN d00746A Ei E78.0 Pure hypercholesterolemia A@ E A TRAMADOL d03826A B M25.5 Pain in joint A@ E A . . . E A . . . E A . . . E A OMEPRAZOLE d00325A B[ R12 Heartburn A E A 99999 . . A E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified AP E A LOSARTAN d03821A C E87.6 Hypokalemia AP E A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP E A OMEPRAZOLE d00325A C[@ K21 Gastro-esophageal reflux disease AP E A ROSUVASTATIN d04851A Cr E78.0 Pure hypercholesterolemia AP E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A LATANOPROST OPHTHALMIC d04017A C- H40 Glaucoma A E A AMLODIPINE d00689A Dc I10 Essential (primary) hypertension A E A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease A E A AMLODIPINE d00689A C9 I10 Essential (primary) hypertension A0 E A CHLORTHALIDONE d00192A C9 I10 Essential (primary) hypertension A0 E A LEVOTHYROXINE d00278A B E03.9 Hypothyroidism, unspecified A0 E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C- F90 Attention-deficit hyperactivity disorders A E A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia Ap E A CLOPIDOGREL d04258A D D75.9P Prevent blood clots Ap E A EZETIMIBE d04824A Dc I21.P Prevent heart attack/myocardial infarction Ap E A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified Ap E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension Ap E A PANTOPRAZOLE d04514A Dc K21 Gastro-esophageal reflux disease Ap E A TAMSULOSIN d04121A B= R39.9 Unspecified symptoms and signs involving the genitourinary system Ap E A ACETAMINOPHEN; HYDROCODONE d03428A B N20.0 Calculus of kidney A@ E A CETIRIZINE d03827A Cr T78.40 Allergy, unspecified A@ E A IBUPROFEN d00015A B N20.0 Calculus of kidney A@ E A ONDANSETRON d00867A B N20.0 Calculus of kidney A@ E A ALBUTEROL d00749A C- J45 Asthma A E A LEVOTHYROXINE d00278A C[@ C80.1 E03.9 Malignant (primary) neoplasm, unspecified Hypothyroidism, unspecified A E A . . . E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A E0 A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E0 A SPIRONOLACTONE d00373A C[@ R60.9 Edema, unspecified A E@ A DULAGLUTIDE d08290A CDp E11 Type 2 diabetes mellitus A E@ A GLIPIZIDE d00246A D E11 Type 2 diabetes mellitus A EP A . . . E` A CARVEDILOL d03847A C- I21.P Prevent heart attack/myocardial infarction Ap E` A FUROSEMIDE d00070A C R60.9 Edema, unspecified Ap E` A LOSARTAN d03821A C- I50.9 Heart failure, unspecified Ap E` A PAROXETINE d03157A C- F41.9 Anxiety disorder, unspecified Ap E` A POTASSIUM CHLORIDE d00345A C- E87.6 Hypokalemia Ap E` A SPIRONOLACTONE d00373A C I51.9 Heart disease, unspecified Ap E` A ZOLPIDEM d00910A B G47.0 Insomnia Ap Ep A . . . E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A D I10 Essential (primary) hypertension A E A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease A E A . . . E A . . . E A BETHANECHOL d01427A B K30 Functional dyspepsia A E A CARVEDILOL d03847A CDp I10 Essential (primary) hypertension A E A CLONIDINE d00044A CDp I10 Essential (primary) hypertension A E A HYDRALAZINE d00132A C- I10 Essential (primary) hypertension A E A LISINOPRIL d00732A B I10 Essential (primary) hypertension A E A LORAZEPAM d00149A B F41.9 Anxiety disorder, unspecified A E A NIFEDIPINE d00051A CDp I10 Essential (primary) hypertension A E A PANTOPRAZOLE d04514A B[ K21 Gastro-esophageal reflux disease A E A PREGABALIN d05508A C M79.2 Neuralgia and neuritis, unspecified A E A TRAMADOL d03826A CDp M54 Dorsalgia A E A TRAZODONE d00395A A F41.9 Anxiety disorder, unspecified A E A ZOLPIDEM d00910A C- G47.0 Insomnia A E A . . . E A . . . E A . . . E A . . . E A . . . E A CLONIDINE d00044A C[@ G47.0 Insomnia A E A METHYLPHENIDATE d00900A Cr F90 Attention-deficit hyperactivity disorders A E A ALPRAZOLAM d00168A Cr F41.9 Anxiety disorder, unspecified A@ E A CETIRIZINE d03827A Dc L50 Urticaria A@ E A FLUOXETINE d00236A D F32.9 Major depressive disorder, single episode, unspecified A@ E A RANITIDINE d00021A B L50 Urticaria A@ E0 A . . . E@ A . . . EP A . . . E` A CETIRIZINE d03827A C- T78.40 Allergy, unspecified A Ep A ALBUTEROL d00749A B J45 Asthma A Ep A BECLOMETHASONE d00760A B J45 Asthma A E A FLUTICASONE NASAL d04283A C J30.1 Allergic rhinitis due to pollen A E A MONTELUKAST d04289A C J30.1 Allergic rhinitis due to pollen A E A BROMPHENIRAMINE; DEXTROMETHORPHAN; PSEUDOEPHEDRINE d03368A Ap R05 Cough A E A CEFDINIR d04256A A@ J42 Unspecified chronic bronchitis A E A CETIRIZINE d03827A A J30.9 T78.40 Allergic rhinitis, unspecified Allergy, unspecified A E A 99999 . . A E A . . . E A . . . E A . . . E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A0 E A FERRIC CITRATE d08336A C 55555 A0 E A METOPROLOL d00134A C- I10 Essential (primary) hypertension A0 E A EZETIMIBE d04824A C E78.0 Pure hypercholesterolemia A E A . . . E A DEXMETHYLPHENIDATE d04777A B[ R41 Other symptoms and signs involving cognitive functions and awareness A E0 A . . . E@ A . . . EP A . . . E` A AMOXICILLIN d00088A B H10 Conjunctivitis A Ep A . . . E A FLUTICASONE NASAL d04283A0 C J30.9 Allergic rhinitis, unspecified A@ E A POLYETHYLENE GLYCOL 3350 d05350A0 C- K59.0 Constipation A@ E A PRAVASTATIN d00348A0 Cr E78.0 Pure hypercholesterolemia A@ E A RANITIDINE d00021A0 Dc K21 Gastro-esophageal reflux disease A@ E A . . . E A 99999 . . A E A AMLODIPINE d00689A D I10 Essential (primary) hypertension A E A ATENOLOL d00004A D I10 Essential (primary) hypertension A E A DOXYCYCLINE d00037A Ap L08.9 Local infection of the skin and subcutaneous tissue, unspecified A E A FLUOXETINE d00236A D* F32.9 Major depressive disorder, single episode, unspecified A E A FUROSEMIDE d00070A Cr R60.9 Edema, unspecified A E A GABAPENTIN d03182A Cr M54 Dorsalgia A E A LISINOPRIL d00732A D I10 Essential (primary) hypertension A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A METHIMAZOLE d00290A C- E05 Thyrotoxicosis [hyperthyroidism] A E A POTASSIUM CHLORIDE d00345A D E87.6P Prevent hypokalemia A E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A . . . E A ACYCLOVIR d00001A C- A60.9 Anogenital herpesviral infection, unspecified AP E A ASPIRIN d00170A C I63.P N94 Prevent stroke Pain and other conditions associated with female genital organs and menstrual cycle AP E A FLUOXETINE d00236A D F42 Obsessive-compulsive disorder AP E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension AP E A METHOCARBAMOL d00965A C M62.83 M79.1 Muscle spasm Myalgia AP E A METFORMIN d03807A B= E11 Type 2 diabetes mellitus A E A . . . E A DESOGESTREL; ETHINYL ESTRADIOL d03782A A Z79.3 Long term (current) use of hormonal contraceptives A E0 A CARBIDOPA d00184A Ei G20 Parkinson's disease A E0 A DIGOXIN d00210A Ei I49.9 Cardiac arrhythmia, unspecified A E0 A FAMOTIDINE d00141A Ei K21 Gastro-esophageal reflux disease A E0 A FUROSEMIDE d00070A Ei R60.9 Edema, unspecified A E0 A GABAPENTIN d03182A Ei M79.2 Neuralgia and neuritis, unspecified A E0 A GLIPIZIDE d00246A Ei E11 Type 2 diabetes mellitus A E0 A LEVETIRACETAM d04499A Ei G40 Epilepsy and recurrent seizures A E0 A LEVOTHYROXINE d00278A Ei E03.9 Hypothyroidism, unspecified A E0 A POTASSIUM CHLORIDE d00345A Ei E87.6 Hypokalemia A E@ A . . . EP A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A Cr I10 Essential (primary) hypertension A0 EP A HYDROXYCHLOROQUINE d00817A D# L40 Psoriasis A0 EP A METHOTREXATE d00060A D"8 L40 Psoriasis A0 E` A . . . Ep A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension AP Ep A ATENOLOL d00004A Cr I50.9 Heart failure, unspecified AP Ep A CLOPIDOGREL d04258A C[@ 99999 AP Ep A MONTELUKAST d04289A C J45 Asthma AP Ep A SIMVASTATIN d00746A Ei 99999 AP E A ALBUTEROL d00749A C J45 Asthma AP E A DESLORATADINE d04785A C J45 Asthma AP E A EZETIMIBE d04824A C E78.0 Pure hypercholesterolemia AP E A FLUVASTATIN d03183A Dc E78.0 Pure hypercholesterolemia AP E A OLODATEROL; TIOTROPIUM d08362A A J45 Asthma AP E A . . . E A ALBUTEROL d00749A C R06.2 Wheezing A E A GLIPIZIDE d00246A0 C R20 Disturbances of skin sensation A@ E A LEVOTHYROXINE d00278A0 D E03.9 Hypothyroidism, unspecified A@ E A LISINOPRIL d00732A0 C- I10 Essential (primary) hypertension A@ E A METFORMIN d03807A0 C E11.P Prevent diabetes A@ E A AMIODARONE d00002A Dc I51.9 Heart disease, unspecified Ap E A ASPIRIN d00170A D D75.9P Prevent blood clots Ap E A CLOPIDOGREL d04258A D 99999 Ap E A ISOSORBIDE d00653A B I51.9 Heart disease, unspecified Ap E A LISINOPRIL d00732A Cr I51.9 Heart disease, unspecified Ap E A METOPROLOL d00134A B I49.9 R07.9 Cardiac arrhythmia, unspecified Chest pain, unspecified Ap E A RANOLAZINE d05719A B I51.9 Heart disease, unspecified Ap E A ALBUTEROL d00749A C- J45 Asthma A E A . . . E A BICALUTAMIDE d03850A B C61 Malignant neoplasm of prostate Ap E A CLONAZEPAM d00197A D* G25.81 Restless legs syndrome Ap E A DONEPEZIL d04099A B R41 Other symptoms and signs involving cognitive functions and awareness Ap E A EZETIMIBE d04824A D E78.0 Pure hypercholesterolemia Ap E A SPIRONOLACTONE d00373A C[@ E03.9 Hypothyroidism, unspecified Ap E A SPIRONOLACTONE d00373A D I10 Essential (primary) hypertension Ap E A VALSARTAN d04113A C I10 Essential (primary) hypertension Ap E A . . . E A . . . E A . . . E0 A . . . E@ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A` E@ A FEBUXOSTAT d07397A C M1A Chronic gout A` E@ A FUROSEMIDE d00070A C I10 Essential (primary) hypertension A` E@ A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A` E@ A GLIMEPIRIDE d03864A C R73 Elevated blood glucose level A` E@ A LOSARTAN d03821A C E87.6 Hypokalemia A` EP A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A0 EP A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 EP A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus A0 E` A ALBUTEROL d00749A B R06.9P Prevent breathing difficulty A@ E` A BUPRENORPHINE; NALOXONE d04819A B[ F11.23 Opioid dependence with withdrawal A@ E` A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A@ E` A IBUPROFEN d00015A B M54 T14.9 Dorsalgia Unspecified injury A@ Ep A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A` Ep A BENZONATATE d00796A B R05 Cough A` Ep A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A Cr I10 Essential (primary) hypertension A` Ep A OMEPRAZOLE d00325A C- K21 R12 Gastro-esophageal reflux disease Heartburn A` Ep A RALOXIFENE d04261A C- M81 Osteoporosis without current pathological fracture A` Ep A ROPINIROLE d04215A B G25.81 Restless legs syndrome A` E A . . . E A . . . E A CLONIDINE d00044A C G47.0 Insomnia AP E A DEXMETHYLPHENIDATE d04777A C F90 Attention-deficit hyperactivity disorders AP E A FLUTICASONE NASAL d04283A C R09.81 Nasal congestion AP E A ONDANSETRON d00867A C R11 Nausea and vomiting AP E A SERTRALINE d00880A C F90 Attention-deficit hyperactivity disorders AP E A . . . E A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A A N39.0 Urinary tract infection, site not specified A@ E A SUMATRIPTAN d03160A D* G43 Migraine A@ E A TIZANIDINE d04102A Dc G43 Migraine A@ E A TOPIRAMATE d04115A Dc G43 Migraine A@ E A GABAPENTIN d03182A Bz M25.5 M54 Pain in joint Dorsalgia A@ E A OXYCODONE d00329A B M54 Dorsalgia A@ E A TRAZODONE d00395A Cr G47.0 Insomnia A@ E A VALSARTAN d04113A B I10 Essential (primary) hypertension A@ E A . . . E A . . . E A . . . E A . . . E A CITALOPRAM d04332A D F32.9 Major depressive disorder, single episode, unspecified A@ E A GABAPENTIN d03182A D F41.9 Anxiety disorder, unspecified A@ E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A@ E A LOVASTATIN d00280A D E78.0 Pure hypercholesterolemia A@ E0 A ATENOLOL d00004A C I10 Essential (primary) hypertension A@ E0 A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ E0 A LORAZEPAM d00149A Cr F43.9 R45 Reaction to severe stress, unspecified Symptoms and signs involving emotional state A@ E0 A OMEPRAZOLE d00325A C K25 Gastric ulcer A@ E@ A . . . EP A LEVOTHYROXINE d00278A B[ E03.9 Hypothyroidism, unspecified A E` A HYDROCHLOROTHIAZIDE; OLMESARTAN d04878A Ap I10 Essential (primary) hypertension A0 E` A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A0 E` A VALSARTAN d04113A Cr I10 Essential (primary) hypertension A0 Ep A . . . E A FLUTICASONE NASAL d04283A B8 H93.9 Unspecified disorder of ear A E A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension AP E A CARVEDILOL d03847A CDp I10 Essential (primary) hypertension AP E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension AP E A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus AP E A PRAVASTATIN d00348A CDp E78.0 Pure hypercholesterolemia AP E A . . . E A . . . E A . . . E A . . . E A AMOXICILLIN d00088A AP H66.9 Otitis media, unspecified A E A . . . E A . . . E A . . . E A . . . E0 A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension AP E0 A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C- I10 Essential (primary) hypertension AP E0 A MIRTAZAPINE d04025A C- 99999 AP E0 A NITROFURANTOIN d00112A C- 99999 AP E0 A QUETIAPINE d04220A C F31.9 Bipolar disorder, unspecified AP E@ A . . . EP A . . . E` A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia A@ E` A FLUOXETINE d00236A C F32.9 Major depressive disorder, single episode, unspecified A@ E` A METOPROLOL d00134A C- R00 Abnormalities of heart beat A@ E` A VALSARTAN d04113A Dc I10 Essential (primary) hypertension A@ Ep A . . . E A . . . E A FAMOTIDINE d00141A C K21 Gastro-esophageal reflux disease A0 E A IBUPROFEN d00015A CDp M54 Dorsalgia A0 E A METFORMIN d03807A C R73 Elevated blood glucose level A0 E A FLUOXETINE d00236A CDp F32.9 Major depressive disorder, single episode, unspecified A0 E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A0 E A LORAZEPAM d00149A C- F41.9 Anxiety disorder, unspecified A0 E A AMLODIPINE d00689A D I10 Essential (primary) hypertension A E A . . . E A ALLOPURINOL d00023A D E79.9 Disorder of purine and pyrimidine metabolism, unspecified A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A CANAGLIFLOZIN; METFORMIN d08280A C- E11.P R73 Prevent diabetes Elevated blood glucose level A E A FENOFIBRATE d04286A C[@ E78.0 E78.1 Pure hypercholesterolemia Pure hyperglyceridemia A E A LISINOPRIL d00732A C- K76.9P Prevent liver disease A E A RANITIDINE d00021A CDp K30 Functional dyspepsia A E A USTEKINUMAB d07396A C L40 Psoriasis A E A ZOLPIDEM d00910A Cr G47.0 Insomnia A E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C- I10 Essential (primary) hypertension A E A LEVOTHYROXINE d00278A D9 Z90 Acquired absence of organs, not elsewhere classified A0 E A LISINOPRIL d00732A D I10 Essential (primary) hypertension A0 E A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A D/ N30 Cystitis A0 E A . . . E A AMLODIPINE d00689A Dc I10.P Prevent hypertension A E A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A E A . . . E0 A . . . E@ A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A E@ A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A E@ A DICLOFENAC; MISOPROSTOL d04271A C M25.5 Pain in joint A E@ A INDAPAMIDE d00260A Dc I10 Essential (primary) hypertension A E@ A INSULIN GLARGINE d04538A Dc E11 Type 2 diabetes mellitus A E@ A INSULIN LISPRO d04373A D E11 Type 2 diabetes mellitus A E@ A LABETALOL d00016A Dc I10 Essential (primary) hypertension A E@ A VALSARTAN d04113A D I10 Essential (primary) hypertension A EP A . . . E` A AMLODIPINE d00689A Ei I10 Essential (primary) hypertension A E` A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E` A GABAPENTIN d03182A Bz M54 Dorsalgia A E` A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Ei 99999 A E` A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E` A METOPROLOL d00134A D ^ I21.P Prevent heart attack/myocardial infarction A E` A NAPROXEN d00019A B M25.5 M54 Pain in joint Dorsalgia A E` A OMEPRAZOLE d00325A B K21 K30 Gastro-esophageal reflux disease Functional dyspepsia A E` A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A E` A ROPINIROLE d04215A C G25.81 Restless legs syndrome A E` A SERTRALINE d00880A C- F32.9 Major depressive disorder, single episode, unspecified A Ep A . . . E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease A E A . . . E A GLIPIZIDE d00246A Cr E11 Type 2 diabetes mellitus A0 E A METOPROLOL d00134A Cr I10 Essential (primary) hypertension A0 E A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A0 E A . . . E A . . . E A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A E A . . . E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A Cr F90 Attention-deficit hyperactivity disorders A E A DESVENLAFAXINE d07113A C[@ F32.9 Major depressive disorder, single episode, unspecified A E A FLUTICASONE NASAL d04283A Cr R09.81 Nasal congestion A E A GABAPENTIN d03182A C- M25.5 Pain in joint A E A HYDROCHLOROTHIAZIDE d00253A C- R60.9 Edema, unspecified A E A HYDROCODONE d03075A D G43 Migraine A E A KETOROLAC d00273A B G43 Migraine A E A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A E A LOSARTAN d03821A C- I10 Essential (primary) hypertension A E A MELOXICAM d04532A C- M25.5 Pain in joint A E A ROSUVASTATIN d04851A Dc E78.0 Pure hypercholesterolemia A E A SUMATRIPTAN d03160A D* G43 Migraine A E A . . . E A 55555 A CDp 55555 A E A 55555 A CP 55555 A E A ALBUTEROL d00749A C 55555 A E A ALBUTEROL d00749A CP 55555 A E A AZITHROMYCIN d00091A C T78.40 Allergy, unspecified A E A CETIRIZINE d03827A C[@ T78.40 Allergy, unspecified A E A OMEPRAZOLE d00325A CP K21 Gastro-esophageal reflux disease A E A PANCRELIPASE d01002A CP 55555 A E A TOBRAMYCIN d00069A C[@ 55555 A E A . . . E0 A DIVALPROEX SODIUM d03833A Bz F20 F32.9 Schizophrenia Major depressive disorder, single episode, unspecified A0 E0 A PALIPERIDONE d06297A C F31.9 Bipolar disorder, unspecified A0 E0 A TRIHEXYPHENIDYL d00970A C T88.7P Prevent drug side effect A0 E@ A . . . EP A . . . E` A AMITRIPTYLINE d00146A C F32.9 Major depressive disorder, single episode, unspecified A E` A PHENYTOIN d00143A C G40 Epilepsy and recurrent seizures A Ep A DULOXETINE d05355A B F32.9 M54 Major depressive disorder, single episode, unspecified Dorsalgia A0 Ep A FLUOXETINE d00236A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A0 Ep A GABAPENTIN d03182A C"0 M54 Dorsalgia A0 E A . . . E A . . . E A . . . E° A ALBUTEROL d00749A A J20.9 Acute bronchitis, unspecified A E° A CEFDINIR d04256A A H66.9 Otitis media, unspecified A E A . . . E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A D I10 Essential (primary) hypertension A E A METOPROLOL d00134A D I10 Essential (primary) hypertension A E A . . . E A GLIPIZIDE d00246A D E11 Type 2 diabetes mellitus A E A METFORMIN d03807A D E11 Type 2 diabetes mellitus A E A . . . E A . . . E A . . . E0 A . . . E@ A AMOXICILLIN; CLAVULANATE d00089A A H66.9 Otitis media, unspecified A EP A ETHINYL ESTRADIOL; NORGESTIMATE d03781A B[ N92 Excessive, frequent and irregular menstruation A E` A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A Ep A . . . EÀ A PAROXETINE d03157A D* F32.9 F41.0 Major depressive disorder, single episode, unspecified Panic disorder [episodic paroxysmal anxiety] without agoraphobia A EÐ A . . . Eà A CHLORTHALIDONE d00192A B I10 Essential (primary) hypertension A0 Eà A LOSARTAN d03821A C I10 Essential (primary) hypertension A0 Eà A PRAVASTATIN d00348A C[@ E78.0 Pure hypercholesterolemia A0 Eð A . . . E A ATENOLOL d00004A C I10 Essential (primary) hypertension A0 E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E A MELOXICAM d04532A Dc M19.9 Osteoarthritis, unspecified site A0 E A . . . E A . . . E A . . . E A . . . E A INSULIN LISPRO d04373A B E10 Type 1 diabetes mellitus A E A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia AP E A BUPROPION d00181A D- F32.9 Major depressive disorder, single episode, unspecified AP E A FLUOXETINE d00236A D- F32.9 Major depressive disorder, single episode, unspecified AP E A LEVOTHYROXINE d00278A D1 E03.9 Hypothyroidism, unspecified AP E A MONTELUKAST d04289A D- J45 Asthma AP E0 A HYDROCODONE d03075A A R05 Cough A E0 A PREDNISONE d00350A A J18.9 J42 Pneumonia, unspecified organism Unspecified chronic bronchitis A E@ A . . . EP A . . . E` A ETHINYL ESTRADIOL; NORETHINDRONE d03238A Dc Z79.3 Long term (current) use of hormonal contraceptives A E` A LISINOPRIL d00732A B I10 Essential (primary) hypertension A Ep A . . . EĀ A ACETAMINOPHEN; OXYCODONE d03431A CDp M79.2 Neuralgia and neuritis, unspecified A EĀ A CLONAZEPAM d00197A C F41.9 Anxiety disorder, unspecified A EĀ A MELOXICAM d04532A C- M54 Dorsalgia A EĀ A METHOCARBAMOL d00965A B M25.5 Pain in joint A EĀ A MUPIROCIN TOPICAL d01267A B[ L08.9 Local infection of the skin and subcutaneous tissue, unspecified A EĀ A SUMATRIPTAN d03160A C"0 G43 Migraine A EĀ A TOPIRAMATE d04115A C[@ G43 Migraine A EĀ A TRAMADOL d03826A C9 M79.1 Myalgia A EĐ A METFORMIN d03807A Cr E11.P R73 Prevent diabetes Elevated blood glucose level A EĠ A . . . Eİ A . . . E A . . . E A PENICILLIN d00116A C 55555 A E A . . . E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A@ E A CLONIDINE d00044A C[@ I10 Essential (primary) hypertension A@ E A CLOPIDOGREL d04258A C I63 Cerebral infarction A@ E A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A@ E0 A . . . E@ A . . . EP A HYDROCHLOROTHIAZIDE d00253A CDp 99999 A` EP A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A` EP A INSULIN LISPRO d04373A C R73 Elevated blood glucose level A` EP A LISINOPRIL d00732A C- 99999 A` EP A METFORMIN d03807A Cr R73 Elevated blood glucose level A` EP A OMEPRAZOLE d00325A A0 99999 A` E` A BUPROPION d00181A C- F32.9 F39 F41.9 Major depressive disorder, single episode, unspecified Unspecified mood [affective] disorder Anxiety disorder, unspecified A0 E` A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C E28 N92 Z79.3 Ovarian dysfunction Excessive, frequent and irregular menstruation Long term (current) use of hormonal contraceptives A0 E` A METFORMIN d03807A C- E11.P E28 R73 Prevent diabetes Ovarian dysfunction Elevated blood glucose level A0 Ep A CITALOPRAM d04332A C- F41.9 Anxiety disorder, unspecified A@ Ep A CLONAZEPAM d00197A C- 99999 A@ Ep A MIRABEGRON d07876A Bz R35 Polyuria A@ Ep A PANTOPRAZOLE d04514A B[ K30 Functional dyspepsia A@ Eŀ A . . . EŐ A . . . EŠ A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia A` EŠ A FLECAINIDE d00234A D I48.9 Unspecified atrial fibrillation and atrial flutter A` EŠ A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A` EŠ A MONTELUKAST d04289A D J30.9 Allergic rhinitis, unspecified A` EŠ A OLMESARTAN d04801A C- I10 Essential (primary) hypertension A` EŠ A VERAPAMIL d00048A D I10 Essential (primary) hypertension A` EŰ A DIVALPROEX SODIUM d03833A C- F33.9 F43.1 Major depressive disorder, recurrent, unspecified Post-traumatic stress disorder (PTSD) A@ EŰ A LITHIUM d00061A B F31.9 Bipolar disorder, unspecified A@ EŰ A LOSARTAN d03821A C I10 Essential (primary) hypertension A@ EŰ A VENLAFAXINE d03181A C F32.9 F41.9 F43.1 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Post-traumatic stress disorder (PTSD) A@ E A AMLODIPINE d00689A C E78.0 Pure hypercholesterolemia A E A DAPAGLIFLOZIN d07928A C E11 Type 2 diabetes mellitus A E A GLIMEPIRIDE d03864A D E11 Type 2 diabetes mellitus A E A LISINOPRIL d00732A Cr 99999 A E A LOSARTAN d03821A C E78.0 Pure hypercholesterolemia A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A METOPROLOL d00134A C I10 Essential (primary) hypertension A E A RANITIDINE d00021A C[@ K21 Gastro-esophageal reflux disease A E A . . . E A ATENOLOL d00004A D# I10 Essential (primary) hypertension Ap E A CYCLOBENZAPRINE d00963A B M62.83 Muscle spasm Ap E A HYDROCHLOROTHIAZIDE d00253A Cr R60.9 Edema, unspecified Ap E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified Ap E A LOVASTATIN d00280A Dc E78.0 Pure hypercholesterolemia Ap E A MELOXICAM d04532A B= M13 Other arthritis Ap E A POTASSIUM CHLORIDE d00345A Dc E87.6 Hypokalemia Ap E A . . . E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E A . . . E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C[@ F90 Attention-deficit hyperactivity disorders A E0 A FUROSEMIDE d00070A B= I10 Essential (primary) hypertension Ap E0 A GABAPENTIN d03182A Ei M54 Dorsalgia Ap E0 A INSULIN DETEMIR d05436A Ei E11 Type 2 diabetes mellitus Ap E0 A LISINOPRIL d00732A Ei 55555 Ap E0 A METFORMIN d03807A Ei E11 Type 2 diabetes mellitus Ap E0 A SIMVASTATIN d00746A Ei E78.0 Pure hypercholesterolemia Ap E0 A SITAGLIPTIN d05896A Ei E11 Type 2 diabetes mellitus Ap E@ A . . . EP A . . . E` A OXYCODONE d00329A C M79.6 T14.9 Pain in limb, hand, foot, fingers and toes Unspecified injury A E` A ROSUVASTATIN d04851A B[ M85.9 Disorder of bone density and structure, unspecified A Ep A ANASTROZOLE d03873A CDp C50.P prevent breast cancer A@ Ep A OMEPRAZOLE d00325A Cr K30 Functional dyspepsia A@ Ep A PROPRANOLOL d00032A D:u I10 I49.9 Essential (primary) hypertension Cardiac arrhythmia, unspecified A@ Ep A TRAMADOL d03826A C M19.9 M79.1 Osteoarthritis, unspecified site Myalgia A@ Eƀ A AMLODIPINE d00689A C I10 Essential (primary) hypertension A EƐ A ETHINYL ESTRADIOL; NORGESTIMATE d03781A C Z79.3 Long term (current) use of hormonal contraceptives A EƠ A . . . Eư A AMLODIPINE d00689A Ei 99999 A Eư A ATORVASTATIN d04105A Ei 99999 A Eư A CARBIDOPA; LEVODOPA d03473A Ei 99999 A Eư A CARVEDILOL d03847A Ei 99999 A Eư A ESOMEPRAZOLE d04749A Ei 99999 A Eư A INSULIN ASPART; INSULIN ASPART PROTAMINE d04839A C E11 Type 2 diabetes mellitus A Eư A LEVOTHYROXINE d00278A Ei 99999 A Eư A LISINOPRIL d00732A Ei 99999 A Eư A METFORMIN d03807A Ei 99999 A Eư A TRIHEXYPHENIDYL d00970A Ei 99999 A E A FINASTERIDE d00563A Dc L65.9 Nonscarring hair loss, unspecified A E A . . . E A MIRTAZAPINE d04025A CDp F32.9 G47.0 Major depressive disorder, single episode, unspecified Insomnia A E A RISPERIDONE d03180A CDp F29 Unspecified psychosis not due to a substance or known physiological condition A E A . . . E A CITALOPRAM d04332A D= F32.9 Major depressive disorder, single episode, unspecified A0 E A IBUPROFEN d00015A C- M25.5 Pain in joint A0 E A TRAZODONE d00395A CDp G47.9 Sleep disorder, unspecified A0 E A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A@ E A GLIPIZIDE d00246A B R73 Elevated blood glucose level A@ E A LINAGLIPTIN d07767A B E11 Type 2 diabetes mellitus A@ E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E A BACLOFEN d00967A B= M54 Dorsalgia A0 E A CITALOPRAM d04332A C F41.9 Anxiety disorder, unspecified A0 E A OXYBUTYNIN d00328A C N32.81 Overactive bladder A0 E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . Eǀ A . . . Eǐ A . . . EǠ A 99999 . . A Eǰ A POLYETHYLENE GLYCOL 3350 d05350A C K59.0 Constipation A E A LEVOTHYROXINE d00278A C 99999 A0 E A METFORMIN d03807A C E11.P Prevent diabetes A0 E A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A0 E A . . . E A AMLODIPINE d00689A Ei I10 Essential (primary) hypertension A E A APIXABAN d07804A B I48.9 Unspecified atrial fibrillation and atrial flutter A E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A Cr I10 Essential (primary) hypertension A E A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A METOPROLOL d00134A Ei I10 Essential (primary) hypertension A E A MONTELUKAST d04289A B J30.9 R06.9 Allergic rhinitis, unspecified Unspecified abnormalities of breathing A E A . . . E A . . . E A . . . E A . . . E0 A ALBUTEROL d00749A B J45 Asthma A E@ A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A E@ A ENALAPRIL d00013A C I10 Essential (primary) hypertension A EP A . . . E` A AMIODARONE d00002A B= I49.9 Cardiac arrhythmia, unspecified A E` A ASPIRIN d00170A C- I21.P Prevent heart attack/myocardial infarction A E` A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A E` A BUPROPION d00181A C F32.9 Major depressive disorder, single episode, unspecified A E` A CARVEDILOL d03847A C- I10 Essential (primary) hypertension A E` A DOCUSATE d01021A C- K59.0 Constipation A E` A FINASTERIDE d00563A Bz N40 Enlarged prostate A E` A GABAPENTIN d03182A CDp M79.2 Neuralgia and neuritis, unspecified A E` A LOSARTAN d03821A C- I10 Essential (primary) hypertension A E` A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A E` A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease A E` A RIVAROXABAN d07356A Bz D75.9P Prevent blood clots A Ep A . . . EȀ A . . . EȐ A AMITRIPTYLINE d00146A B= G47.0 Insomnia A EȐ A GABAPENTIN d03182A B[ G25.81 M79.2 Restless legs syndrome Neuralgia and neuritis, unspecified A EȠ A . . . EȰ A . . . E A . . . E A . . . E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A AZITHROMYCIN d00091A AP J02.0 Streptococcal pharyngitis A E A . . . E A . . . E A FLUDROCORTISONE d00608A D- E27.9 Disorder of adrenal gland, unspecified A` E A HYDROCORTISONE d00254A D- E27.9 Disorder of adrenal gland, unspecified A` E A LATANOPROST OPHTHALMIC d04017A CDp H40 Glaucoma A` E A LEVOTHYROXINE d00278A D1 E03.9 Hypothyroidism, unspecified A` E A SILDENAFIL d04299A Bz N42.9 Disorder of prostate, unspecified A` E A SIMVASTATIN d00746A Dc E78.0 Pure hypercholesterolemia A` E0 A AMLODIPINE d00689A C I10 Essential (primary) hypertension A` E0 A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A` E0 A HYDROCHLOROTHIAZIDE d00253A C I10 R60.9 Essential (primary) hypertension Edema, unspecified A` E0 A INSULIN LISPRO; INSULIN LISPRO PROTAMINE d04510A C E11 Type 2 diabetes mellitus A` E0 A LISINOPRIL d00732A C I10 Essential (primary) hypertension A` E0 A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` E@ A . . . EP A . . . E` A . . . Ep A ALBUTEROL d00749A C J20.9 Acute bronchitis, unspecified A0 Ep A BUDESONIDE; FORMOTEROL d04795A C J20.9 Acute bronchitis, unspecified A0 Ep A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A0 Eɀ A BETAMETHASONE; CLOTRIMAZOLE TOPICAL d03561A B L20.9 Atopic dermatitis, unspecified A Eɐ A . . . Eɠ A 99999 . . A Eɰ A ACETAMINOPHEN; HYDROCODONE d03428A C M25.5 M54 Pain in joint Dorsalgia A Eɰ A ALBUTEROL d00749A D4 J45 Asthma A Eɰ A ALPRAZOLAM d00168A C"0 F41.9 G47.0 Anxiety disorder, unspecified Insomnia A Eɰ A ANASTROZOLE d03873A C- C50 Malignant neoplasm of breast A Eɰ A DULOXETINE d05355A B F32.9 Major depressive disorder, single episode, unspecified A Eɰ A HYDROCHLOROTHIAZIDE d00253A C I10 R60.9 Essential (primary) hypertension Edema, unspecified A Eɰ A INSULIN DETEMIR d05436A CDp E11 Type 2 diabetes mellitus A Eɰ A LOSARTAN d03821A C I10 Essential (primary) hypertension A Eɰ A METFORMIN d03807A C E11 Type 2 diabetes mellitus A Eɰ A NIFEDIPINE d00051A D I10 Essential (primary) hypertension A Eɰ A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A . . . E A ALPRAZOLAM d00168A C F41.9 G47.0 Anxiety disorder, unspecified Insomnia A E A ANASTROZOLE d03873A Ap R52 Pain, unspecified A E A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A E A CILOSTAZOL d04382A C- I70 Atherosclerosis A E A GABAPENTIN d03182A C[@ M79.2 Neuralgia and neuritis, unspecified A E A GLIMEPIRIDE d03864A D E11 Type 2 diabetes mellitus A E A LISINOPRIL d00732A Dc I10 Essential (primary) hypertension A E A METFORMIN; SAXAGLIPTIN d07709A D E11 Type 2 diabetes mellitus A E A . . . E A OMEPRAZOLE d00325A D R12 Heartburn A E A INSULIN LISPRO d04373A C[@ E10 Type 1 diabetes mellitus A E0 A . . . E@ A . . . EP A ESOMEPRAZOLE d04749A B[ K30 Functional dyspepsia A E` A . . . Ep A . . . Eʀ A ESCITALOPRAM d04812A CDp F41.9 Anxiety disorder, unspecified A Eʀ A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A Eʐ A . . . Eʠ A GABAPENTIN d03182A B 99999 A Eʰ A . . . E A AMLODIPINE d00689A D I10 Essential (primary) hypertension A` E A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A` E A LATANOPROST OPHTHALMIC d04017A B[ H40 Glaucoma A` E A LEVOTHYROXINE d00278A D1 E03.9 Hypothyroidism, unspecified A` E A LISINOPRIL d00732A D I10 Essential (primary) hypertension A` E A METRONIDAZOLE TOPICAL d03208A D L71 Rosacea A` E A ESTRADIOL d00537A C N95 Menopausal and other perimenopausal disorders A E A . . . E A CLONAZEPAM d00197A C- F41.9 Anxiety disorder, unspecified A E A PAROXETINE d03157A C- F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A . . . E A . . . E A . . . E0 A 99999 . . A E@ A . . . EP A . . . E` A . . . Ep A . . . Eˀ A . . . Eː A . . . Eˠ A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A Cr I10 Essential (primary) hypertension A E˰ A . . . E A . . . E A . . . E A DROSPIRENONE; ETHINYL ESTRADIOL d04760A Cr Z79.3 Long term (current) use of hormonal contraceptives A E A FLUOXETINE d00236A C F41.9 Anxiety disorder, unspecified A E A . . . E A . . . E A . . . E A . . . E0 A AMLODIPINE d00689A C- I10 Essential (primary) hypertension AP E0 A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E0 A CLOPIDOGREL d04258A C- D75.9P Prevent blood clots AP E0 A GLIPIZIDE d00246A C- E11 Type 2 diabetes mellitus AP E0 A LOSARTAN d03821A C- I10 Essential (primary) hypertension AP E@ A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A EP A . . . E` A . . . Ep A . . . È A . . . E̐ A . . . E̠ A . . . Ḛ A AMLODIPINE d00689A Dc I10 Essential (primary) hypertension A` Ḛ A FLUTICASONE NASAL d04283A C J30.2 Other seasonal allergic rhinitis A` Ḛ A IBUPROFEN d00015A D M54 M79.1 R51 Dorsalgia Myalgia Headache A` Ḛ A RABEPRAZOLE d04448A C K21 Gastro-esophageal reflux disease A` Ḛ A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A` Ḛ A TELMISARTAN d04364A Dc I10 Essential (primary) hypertension A` E A CLOPIDOGREL d04258A C[@ I63 Cerebral infarction Ap E A DULAGLUTIDE d08290A C- E11.P Prevent diabetes Ap E A LOSARTAN d03821A C I63.P Prevent stroke Ap E A METFORMIN d03807A C- E11 Type 2 diabetes mellitus Ap E A METOPROLOL d00134A C I10 Essential (primary) hypertension Ap E A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia Ap E A TAMSULOSIN d04121A C N40 Enlarged prostate Ap E A CALCIUM ACETATE d03689A Cr N19 Unspecified kidney failure A E A . . . E A . . . E A . . . E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A B= Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E0 A AMLODIPINE d00689A B[ I10 Essential (primary) hypertension AP E0 A FUROSEMIDE d00070A B I10 Essential (primary) hypertension AP E0 A HYDRALAZINE d00132A B I10 Essential (primary) hypertension AP E0 A LOSARTAN d03821A B I10 Essential (primary) hypertension AP E0 A SPIRONOLACTONE d00373A B I10 Essential (primary) hypertension AP E@ A . . . EP A TRIAMCINOLONE TOPICAL d03206A D9 L29.9 R21 Pruritus, unspecified Rash and other nonspecific skin eruption A E` A . . . Ep A . . . È A . . . E͐ A . . . E͠ A CIPROFLOXACIN d00011A Ap H66.9 Otitis media, unspecified A E͠ A TOBRAMYCIN d00069A AP H66.9 Otitis media, unspecified A EͰ A . . . E A LOSARTAN d03821A C I10 Essential (primary) hypertension A E A 77777 . . A E A ALBUTEROL d00749A B J45 Asthma A0 E A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A0 E A PREDNISONE d00350A AP J45 Asthma A0 E A . . . E A . . . E A FLUORIDE TOPICAL d04397A B[ K02 Dental caries A E A GENTAMICIN d00014A A H10 Conjunctivitis A E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A AMLODIPINE d00689A0 C I10 Essential (primary) hypertension A` E A GABAPENTIN d03182A0 C- I99.9 Unspecified disorder of circulatory system A` E A HYDROCHLOROTHIAZIDE d00253A0 C I10 Essential (primary) hypertension A` E A METFORMIN d03807A0 C R73 Elevated blood glucose level A` E A METOPROLOL d00134A0 C I10 Essential (primary) hypertension A` E A TAMSULOSIN d04121A0 C- N40 Enlarged prostate A` Eΐ A . . . EΠ A . . . Eΰ A 99999 . . A E A . . . E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A ADAPALENE; BENZOYL PEROXIDE TOPICAL d07382A Ap L70 Acne A E A DAPSONE TOPICAL d05543A Ap L70 Acne A E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A ALLOPURINOL d00023A D M1A Chronic gout AP Ep A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP Ep A CLOPIDOGREL d04258A C D75.9P Prevent blood clots AP Ep A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP Ep A METOPROLOL d00134A D I10 Essential (primary) hypertension AP Eπ A CETIRIZINE d03827A B[ T78.40 Allergy, unspecified A Eϐ A . . . EϠ A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A0 EϠ A DULOXETINE d05355A C F41.9 Anxiety disorder, unspecified A0 EϠ A METOPROLOL d00134A C I99.9 Unspecified disorder of circulatory system A0 Eϰ A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP Eϰ A CLONIDINE d00044A C I10 Essential (primary) hypertension AP Eϰ A FUROSEMIDE d00070A C I10 Essential (primary) hypertension AP Eϰ A METOPROLOL d00134A C I10 Essential (primary) hypertension AP Eϰ A POTASSIUM CHLORIDE d00345A C I10 Essential (primary) hypertension AP E A . . . E A FLUOXETINE d00236A C F32.9 Major depressive disorder, single episode, unspecified A0 E A GUANFACINE d00717A C[@ F90 Attention-deficit hyperactivity disorders A0 E A LISDEXAMFETAMINE d06663A C"0 F90 Attention-deficit hyperactivity disorders A0 E A . . . E A CALCITONIN d00598A Cr M81 Osteoporosis without current pathological fracture A@ E A CYCLOBENZAPRINE d00963A Cr M62.83 Muscle spasm A@ E A OMEPRAZOLE d00325A D K21 K46 Gastro-esophageal reflux disease Unspecified abdominal hernia A@ E A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A@ E A . . . E A . . . E A ALENDRONATE d03849A C M81 Osteoporosis without current pathological fracture A0 E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E A LOSARTAN d03821A D I10 Essential (primary) hypertension A0 E0 A ESCITALOPRAM d04812A D F32.9 Major depressive disorder, single episode, unspecified AP E0 A LAMOTRIGINE d03809A D F32.9 Major depressive disorder, single episode, unspecified AP E0 A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified AP E0 A LORAZEPAM d00149A D F41.9 Anxiety disorder, unspecified AP E0 A LURASIDONE d07705A B F32.9 Major depressive disorder, single episode, unspecified AP E@ A . . . EP A . . . E` A LOSARTAN d03821A D# I10 Essential (primary) hypertension A Ep A . . . EЀ A AMITRIPTYLINE d00146A A F32.9 Major depressive disorder, single episode, unspecified A@ EЀ A CIPROFLOXACIN d00011A A B96.81 Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere A@ EЀ A IBUPROFEN d00015A A R10 Abdominal and pelvic pain A@ EЀ A PENTOSAN POLYSULFATE SODIUM d04052A A K25.P Prevent gastric ulcer A@ EА A . . . EР A GLIPIZIDE d00246A CDp E11 Type 2 diabetes mellitus A0 EР A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A CDp I10 Essential (primary) hypertension A0 EР A PRAVASTATIN d00348A C- E78.0 Pure hypercholesterolemia A0 Eа A . . . E A . . . E A ALFUZOSIN d04797A C[@ N40 Enlarged prostate AP E A FUROSEMIDE d00070A C R60.9 Edema, unspecified AP E A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP E A OMEPRAZOLE d00325A C K21 K25 Gastro-esophageal reflux disease Gastric ulcer AP E A ONDANSETRON d00867A B R11 Nausea and vomiting AP E A CETIRIZINE d03827A C- T78.40 Allergy, unspecified A E A FLUTICASONE NASAL d04283A C- J30.2 Other seasonal allergic rhinitis A E A . . . E A . . . E A . . . E A BACLOFEN d00967A D M54 Dorsalgia Ap E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A D E11 Type 2 diabetes mellitus Ap E A LATANOPROST OPHTHALMIC d04017A CDp H40 Glaucoma Ap E A METFORMIN d03807A D E11 Type 2 diabetes mellitus Ap E A METOPROLOL d00134A Cr I10 Essential (primary) hypertension Ap E A PIOGLITAZONE d04442A D E11 Type 2 diabetes mellitus Ap E A SIMVASTATIN d00746A D E11 Type 2 diabetes mellitus Ap E0 A . . . E@ A ACETAMINOPHEN; OXYCODONE d03431A A K08.8 Other specified disorders of teeth and supporting structures A E@ A PENICILLIN V POTASSIUM d07730A A K04.7 Periapical abscess without sinus A EP A BENAZEPRIL; HYDROCHLOROTHIAZIDE d03265A C I10 Essential (primary) hypertension A0 EP A LEVETIRACETAM d04499A D G40 Epilepsy and recurrent seizures A0 EP A TRAZODONE d00395A D G47.0 Insomnia A0 E` A ALBUTEROL d00749A0 C J44.9 Chronic obstructive pulmonary disease, unspecified B E` A AMLODIPINE d00689A0 Cr I10 Essential (primary) hypertension B E` A ATORVASTATIN d04105A0 C E78.0 Pure hypercholesterolemia B E` A BUDESONIDE d04276A0 C J44.9 Chronic obstructive pulmonary disease, unspecified B E` A CARBAMAZEPINE d00058A0 D G40 Epilepsy and recurrent seizures B E` A CETIRIZINE d03827A0 C T78.40 Allergy, unspecified B E` A DICLOFENAC d00848A0 Cr M19.9 Osteoarthritis, unspecified site B E` A FENOFIBRATE d04286A0 C E78.1 Pure hyperglyceridemia B E` A FINASTERIDE d00563A0 C N40 Enlarged prostate B E` A FLUTICASONE NASAL d04283A0 Cr J30.2 Other seasonal allergic rhinitis B E` A GLIPIZIDE d00246A0 Dc E11 Type 2 diabetes mellitus B E` A HYDROCHLOROTHIAZIDE d00253A0 D I10 Essential (primary) hypertension B E` A LISINOPRIL d00732A0 C I10 Essential (primary) hypertension B E` A METFORMIN d03807A0 Dc E11 Type 2 diabetes mellitus B E` A METOPROLOL d00134A0 D"8 I21.P Prevent heart attack/myocardial infarction B E` A PANTOPRAZOLE d04514A0 CDp K21 Gastro-esophageal reflux disease B E` A SILDENAFIL d04299A0 C N42.9 Disorder of prostate, unspecified B E` A TAMSULOSIN d04121A0 Cr N40 Enlarged prostate B E` A TROSPIUM d04929A0 Cr N42.9 Disorder of prostate, unspecified B Ep A . . . Eр A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A@ Eр A BISOPROLOL d00709A C I10 Essential (primary) hypertension A@ Eр A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A C I10 Essential (primary) hypertension A@ Eр A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ Eѐ A . . . EѠ A . . . EѰ A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C Z79.3 Long term (current) use of hormonal contraceptives A EѰ A FLUTICASONE NASAL d04283A Cr J30.2 Other seasonal allergic rhinitis A E A METFORMIN d03807A B E11 Type 2 diabetes mellitus A0 E A METOPROLOL d00134A D I10 Essential (primary) hypertension A0 E A ROSUVASTATIN d04851A D E78.0 Pure hypercholesterolemia A0 E A . . . E A AMLODIPINE; BENAZEPRIL d03829A C I10 Essential (primary) hypertension A0 E A DESVENLAFAXINE d07113A Dc F32.9 Major depressive disorder, single episode, unspecified A0 E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A0 E A . . . E A . . . E A . . . E A . . . E0 A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ E0 A ATENOLOL d00004A D I10 Essential (primary) hypertension A@ E0 A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A@ E0 A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A@ E@ A . . . EP A . . . E` A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A E` A METFORMIN d03807A CDp E28 Ovarian dysfunction A Ep A 99999 . . A EҀ A . . . EҐ A . . . EҠ A ETHINYL ESTRADIOL; NORGESTIMATE d03781A B= L70 Acne A EҰ A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A` EҰ A FENOFIBRATE d04286A C E78.0 Pure hypercholesterolemia A` EҰ A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A` EҰ A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease A` EҰ A RAMIPRIL d00728A C"0 I10 Essential (primary) hypertension A` EҰ A SITAGLIPTIN d05896A C E11 Type 2 diabetes mellitus A` E A ATENOLOL; CHLORTHALIDONE d03258A C- I10 Essential (primary) hypertension A E A BUDESONIDE d04276A C J45 Asthma A E A MONTELUKAST d04289A D$ J45 Asthma A E A GUANFACINE d00717A C- F39 Unspecified mood [affective] disorder A E A METHYLPHENIDATE d00900A Cr F90 Attention-deficit hyperactivity disorders A E A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A` E A GABAPENTIN d03182A C F41.9 Anxiety disorder, unspecified A` E A LOSARTAN d03821A C- I10 Essential (primary) hypertension A` E A MONTELUKAST d04289A DO J45 Asthma A` E A OMEGA-3 POLYUNSATURATED FATTY ACIDS d00497A C ` M81.P Prevent bone loss/osteoporosis A` E A PHENOBARBITAL d00340A DO G40 Epilepsy and recurrent seizures A` E A . . . E A . . . E A ARIPIPRAZOLE d04825A C- F32.9 F43.1 Major depressive disorder, single episode, unspecified Post-traumatic stress disorder (PTSD) A` E A BUPROPION d00181A Dc F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A` E A CETIRIZINE d03827A C T78.40 Allergy, unspecified A` E A MELOXICAM d04532A B[ M79.1 Myalgia A` E A OXYBUTYNIN d00328A B N32.81 Overactive bladder A` E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A` E0 A . . . E@ A . . . EP A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP EP A FLUTICASONE NASAL d04283A B J30.2 Other seasonal allergic rhinitis AP EP A LOSARTAN d03821A C I10 Essential (primary) hypertension AP EP A METOPROLOL d00134A C I10 Essential (primary) hypertension AP EP A NIFEDIPINE d00051A C I10 Essential (primary) hypertension AP E` A . . . Ep A . . . EӀ A . . . EӐ A ALLOPURINOL d00023A D M1A Chronic gout A EӐ A CLOPIDOGREL d04258A C- D75.9P Prevent blood clots A EӐ A COLESTIPOL d00744A Dc K31.9 Disease of stomach and duodenum, unspecified A EӐ A FUROSEMIDE d00070A D R60.9 Edema, unspecified A EӐ A METOPROLOL d00134A C- I49.9 Cardiac arrhythmia, unspecified A EӐ A OMEPRAZOLE d00325A C K25 Gastric ulcer A EӐ A ROPINIROLE d04215A C G25.81 Restless legs syndrome A EӐ A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A EӠ A ALLOPURINOL d00023A D* M10.9P Prevent gout A EӠ A ATORVASTATIN d04105A Cr I21.P Prevent heart attack/myocardial infarction A EӠ A DILTIAZEM d00045A C I10 Essential (primary) hypertension A EӠ A LEVOTHYROXINE d00278A D9 E03.9 Hypothyroidism, unspecified A EӠ A METOPROLOL d00134A D* I10 I21.P Essential (primary) hypertension Prevent heart attack/myocardial infarction A EӠ A OMEPRAZOLE d00325A Dc K21 K30 Gastro-esophageal reflux disease Functional dyspepsia A EӠ A ROPINIROLE d04215A C G25.81 Restless legs syndrome A EӠ A SPIRONOLACTONE d00373A D& R60.9 Edema, unspecified A EӠ A TAMSULOSIN d04121A C[@ R39.1 Other difficulties with micturition A EӰ A . . . E A . . . E A . . . E A ASPIRIN d00170A CDp I21.P Prevent heart attack/myocardial infarction A` E A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A` E A CARVEDILOL d03847A CDp I10 Essential (primary) hypertension A` E A CLOPIDOGREL d04258A CDp 99999 A` E A LISINOPRIL d00732A CDp I50.9 Heart failure, unspecified A` E A PANTOPRAZOLE d04514A CDp K21 Gastro-esophageal reflux disease A` E A BUTALBITAL d03061A D# G43 Migraine A E A FLUTICASONE NASAL d04283A D R09.81 Nasal congestion A E A FLUTICASONE; SALMETEROL d04611A D# J45 Asthma A E A GABAPENTIN d03182A D# G43 Migraine A E A LISINOPRIL d00732A C"0 I10 Essential (primary) hypertension A E A NAPROXEN d00019A D Z79 Long term (current) drug therapy A E A OLANZAPINE d04050A D F20 F32.9 Schizophrenia Major depressive disorder, single episode, unspecified A E A PERPHENAZINE d00855A B F20 Schizophrenia A E A SERTRALINE d00880A D F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A TRAZODONE d00395A D G47.9 Sleep disorder, unspecified A E A BRIMONIDINE OPHTHALMIC d04048A Ei 99999 AP E A CLOPIDOGREL d04258A Ei 99999 AP E A METOPROLOL d00134A Ei 99999 AP E A OLOPATADINE OPHTHALMIC d04117A Ei 99999 AP E A ROSUVASTATIN d04851A Ei 99999 AP E A COLESEVELAM d04695A C E11 Type 2 diabetes mellitus A@ E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E A VENLAFAXINE d03181A C G43.P Prevent migraine A@ E A ARIPIPRAZOLE d04825A B F31.9 Bipolar disorder, unspecified A E A SERTRALINE d00880A C F31.9 Bipolar disorder, unspecified A E0 A RANITIDINE d00021A B K21 Gastro-esophageal reflux disease A E@ A MIRABEGRON d07876A B= N32.81 Overactive bladder A EP A . . . E` A ALLOPURINOL d00023A C- E79.9 Disorder of purine and pyrimidine metabolism, unspecified A E` A BUMETANIDE d00179A C I50.9 Heart failure, unspecified A E` A CARVEDILOL d03847A C"@ I10 Essential (primary) hypertension A E` A FLUORIDE TOPICAL d04397A C"0 K02 Dental caries A E` A GLIPIZIDE d00246A C"@ E11 Type 2 diabetes mellitus A E` A HYDROXYCHLOROQUINE d00817A Dc M06.9 Rheumatoid arthritis, unspecified A E` A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E` A OMEPRAZOLE d00325A C- K30 Functional dyspepsia A E` A ROFLUMILAST d07684A C- J44.9 Chronic obstructive pulmonary disease, unspecified A E` A SIMVASTATIN d00746A Dc I21.P Prevent heart attack/myocardial infarction A E` A SITAGLIPTIN d05896A C[@ E11 Type 2 diabetes mellitus A E` A TRAZODONE d00395A C- F32.9 G47.0 Major depressive disorder, single episode, unspecified Insomnia A Ep A . . . EԀ A ATORVASTATIN d04105A D@) E78.0 Pure hypercholesterolemia A EԀ A BENAZEPRIL d00730A D@) I10 Essential (primary) hypertension A EԀ A CELECOXIB d04380A D@) M06.9 Rheumatoid arthritis, unspecified A EԀ A DONEPEZIL d04099A D@) G31.9 Degenerative disease of nervous system, unspecified A EԀ A FINASTERIDE d00563A D@) N40 Enlarged prostate A EԀ A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A EԀ A POTASSIUM CHLORIDE d00345A D@) E87.6 Hypokalemia A EԀ A RANITIDINE d00021A D@) K21 Gastro-esophageal reflux disease A EԐ A . . . EԠ A . . . E A ALBUTEROL d00749A CDp J45 Asthma A E A ATORVASTATIN d04105A C 99999 A E A BRIMONIDINE; TIMOLOL OPHTHALMIC d05283A B[ H40 Glaucoma A E A CARVEDILOL d03847A C 99999 A E A CETIRIZINE d03827A B T78.40 Allergy, unspecified A E A ESCITALOPRAM d04812A C 99999 A E A ESTRADIOL d00537A C[@ 99999 A E A GABAPENTIN d03182A C- M54 Dorsalgia A E A LEVOTHYROXINE d00278A C 99999 A E A MONTELUKAST d04289A B 99999 A E A RIVAROXABAN d07356A C- I51.9 Heart disease, unspecified A E A INSULIN ASPART d04697A Ap R73 Elevated blood glucose level A0 E A INSULIN GLARGINE d04538A B E11 Type 2 diabetes mellitus A0 E A METFORMIN d03807A A E11 Type 2 diabetes mellitus A0 E A . . . E A BUPROPION d00181A0 Cr 99999 Ap E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A0 Ei I10 Essential (primary) hypertension Ap E A LEVOTHYROXINE d00278A0 D* E03.9 Hypothyroidism, unspecified Ap E A METOPROLOL d00134A0 Cr I48.9 Unspecified atrial fibrillation and atrial flutter Ap E A MOMETASONE NASAL d04223A0 Dc J30.9 Allergic rhinitis, unspecified Ap E A SIMVASTATIN d00746A0 Cr E78.0 Pure hypercholesterolemia Ap E A WARFARIN d00022A0 C I48.9 Unspecified atrial fibrillation and atrial flutter Ap E A . . . E A . . . E A RANITIDINE d00021A B= K21 Gastro-esophageal reflux disease A E A . . . E0 A ALBUTEROL d00749A C[@ R06.2 R07.9 Wheezing Chest pain, unspecified A E@ A AZITHROMYCIN d00091A A@ J42 Unspecified chronic bronchitis A E@ A DEXTROMETHORPHAN; PROMETHAZINE d03360A A0 J09 Influenza due to certain identified influenza viruses A EP A . . . E` A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A E` A ZOLPIDEM d00910A Cr G47.0 Insomnia A Ep A . . . EՀ A . . . EՐ A . . . Eՠ A 99999 . . A Eհ A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A E A . . . E A . . . E A ATENOLOL; CHLORTHALIDONE d03258A C[@ I10 Essential (primary) hypertension A@ E A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A@ E A GLIPIZIDE d00246A C[@ E11 Type 2 diabetes mellitus A@ E A LISINOPRIL d00732A C[@ E11.2P I10 Prevent diabetic kidney disease Essential (primary) hypertension A@ E A . . . E A AMLODIPINE d00689A Bz I10 Essential (primary) hypertension A0 E A LISINOPRIL d00732A Bz I10 Essential (primary) hypertension A0 E A METFORMIN d03807A B[ R73 Elevated blood glucose level A0 E A . . . E A ALBUTEROL d00749A C[@ J44.9 Chronic obstructive pulmonary disease, unspecified A0 E A FLUTICASONE; SALMETEROL d04611A C[@ J44.9 Chronic obstructive pulmonary disease, unspecified A0 E A MERCAPTOPURINE d00289A C[@ K50 Crohn's disease [regional enteritis] A0 E0 A . . . E@ A INSULIN LISPRO d04373A D E10 Type 1 diabetes mellitus A EP A . . . E` A AMOXICILLIN d00088A A J01.9 Acute sinusitis, unspecified A Ep A IBUPROFEN d00015A C J02.0 Streptococcal pharyngitis A Eր A . . . E A ALBUTEROL d00749A C J44.9 R06.02 R06.9P Chronic obstructive pulmonary disease, unspecified Shortness of breath Prevent breathing difficulty AP E A ALBUTEROL d00749A C J43 J44.9 R06.9P Emphysema Chronic obstructive pulmonary disease, unspecified Prevent breathing difficulty AP E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E A FLUTICASONE; VILANTEROL d08100A C J42 J43 J44.9 Unspecified chronic bronchitis Emphysema Chronic obstructive pulmonary disease, unspecified AP E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension AP E֠ A FLUTICASONE TOPICAL d04284A B L20.9 Atopic dermatitis, unspecified A Eְ A . . . E A . . . E A . . . E A ATENOLOL d00004A C I10 Essential (primary) hypertension AP E A FUROSEMIDE d00070A C R60.9 Edema, unspecified AP E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension AP E A MONTELUKAST d04289A C J30.9 Allergic rhinitis, unspecified AP E A PANTOPRAZOLE d04514A C[@ K21 Gastro-esophageal reflux disease AP E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A E A BENZONATATE d00796A B R05 R06.2 Cough Wheezing A E A DABIGATRAN d07137A A D75.9P Prevent blood clots A E A FINASTERIDE d00563A C"0 R39.1 Other difficulties with micturition A E A FLECAINIDE d00234A A I49.9 Cardiac arrhythmia, unspecified A E A LEVOTHYROXINE d00278A C- E07.9 Disorder of thyroid, unspecified A E A LISINOPRIL d00732A B I21.P Prevent heart attack/myocardial infarction A E A MEMANTINE d04899A C"0 R41 Other symptoms and signs involving cognitive functions and awareness A E A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A E A RAMIPRIL d00728A C- I10 Essential (primary) hypertension A E A TAMSULOSIN d04121A C"0 R32 Unspecified urinary incontinence A E A . . . E A . . . E A . . . E0 A CEFUROXIME d00056A A N30 Cystitis A E0 A DEXMETHYLPHENIDATE d04777A B= R41 Other symptoms and signs involving cognitive functions and awareness A E@ A . . . EP A . . . E` A CELECOXIB d04380A B M1A Chronic gout A0 E` A HYDROCHLOROTHIAZIDE d00253A C[@ I10 Essential (primary) hypertension A0 E` A ROSUVASTATIN d04851A C[@ E78.0 Pure hypercholesterolemia A0 Ep A . . . E׀ A . . . Eא A . . . Eנ A . . . Eװ A CLONAZEPAM d00197A C[@ F41.9 Anxiety disorder, unspecified A@ Eװ A FAMOTIDINE d00141A C K21 Gastro-esophageal reflux disease A@ Eװ A LATANOPROST OPHTHALMIC d04017A C- H40 Glaucoma A@ Eװ A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A@ E A HYDRALAZINE d00132A Ei I10 Essential (primary) hypertension AP E A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A Ei I10 Essential (primary) hypertension AP E A LEVOTHYROXINE d00278A C E07.9 Disorder of thyroid, unspecified AP E A MELOXICAM d04532A Ei M19.9 Osteoarthritis, unspecified site AP E A PANTOPRAZOLE d04514A C[@ K21 Gastro-esophageal reflux disease AP E A LEVETIRACETAM d04499A CDp G40 Epilepsy and recurrent seizures A E A . . . E A . . . E A . . . E A ALPRAZOLAM d00168A0 C- F41.9 Anxiety disorder, unspecified Ap E A CARVEDILOL d03847A0 C I10 Essential (primary) hypertension Ap E A CLOPIDOGREL d04258A0 C I21.P Prevent heart attack/myocardial infarction Ap E A INSULIN DETEMIR d05436A0 C E11 Type 2 diabetes mellitus Ap E A LISINOPRIL d00732A0 C I10 Essential (primary) hypertension Ap E A SIMVASTATIN d00746A0 C 99999 Ap E A SITAGLIPTIN d05896A0 C- E11 Type 2 diabetes mellitus Ap E A . . . E0 A ACETAMINOPHEN; OXYCODONE d03431A C M54 Dorsalgia B E0 A ALPRAZOLAM d00168A C- F41.9 Anxiety disorder, unspecified B E0 A AZELASTINE NASAL d04068A B J30.9 Allergic rhinitis, unspecified B E0 A BACLOFEN d00967A C M79.1 Myalgia B E0 A BUPROPION d00181A Dc F32.9 Major depressive disorder, single episode, unspecified B E0 A CLOPIDOGREL d04258A C D75.9P Prevent blood clots B E0 A ESCITALOPRAM d04812A Dc F41.9 Anxiety disorder, unspecified B E0 A FUROSEMIDE d00070A B I51.9 Heart disease, unspecified B E0 A ISOSORBIDE MONONITRATE d00269A C I20.9 Angina pectoris, unspecified B E0 A LISINOPRIL d00732A C I10 Essential (primary) hypertension B E0 A METOPROLOL d00134A C I20.9 Angina pectoris, unspecified B E0 A MONTELUKAST d04289A C J44.9 Chronic obstructive pulmonary disease, unspecified B E0 A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease B E0 A OXYMORPHONE d00833A Cr M79.1 Myalgia B E0 A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia B E0 A PREGABALIN d05508A D M79.7 Fibromyalgia B E0 A ZOLPIDEM d00910A C G47.0 Insomnia B E@ A ALBUTEROL d00749A B- J45 Asthma A E@ A ALBUTEROL d00749A B- J45 Asthma A E@ A CINACALCET d05218A B N18.9 Chronic kidney disease, unspecified A E@ A FEBUXOSTAT d07397A C M10.9 Gout, unspecified A E@ A FLUTICASONE d01296A B= J45 Asthma A E@ A METOPROLOL d00134A Dc I10 Essential (primary) hypertension A E@ A PREDNISOLONE d00084A Ap J45 Asthma A E@ A PREDNISONE d00350A D= T86.9P Prevent transplanted organ and tissue rejection A E@ A SEVELAMER d04363A C9 N19 Unspecified kidney failure A E@ A VALSARTAN d04113A Dc I10 Essential (primary) hypertension A EP A . . . E` A ATORVASTATIN d04105A C- I21.P Prevent heart attack/myocardial infarction A0 E` A LOSARTAN d03821A C E11.2 Type 2 diabetes mellitus with kidney complications A0 E` A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A0 Ep A . . . E A . . . Eؐ A FLUORIDE TOPICAL d04397A C K02 Dental caries A Eؠ A . . . Eذ A AMLODIPINE d00689A C I10 Essential (primary) hypertension A Eذ A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A E A 99999 . . A0 E A CLOPIDOGREL d04258A D I63.P Prevent stroke A0 E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A0 E A . . . E A DICLOFENAC d00848A B= M65.9 Synovitis and tenosynovitis, unspecified A@ E A KETOROLAC d00273A A M65.9 Synovitis and tenosynovitis, unspecified A@ E A LEVOTHYROXINE d00278A Bz E03.9 Hypothyroidism, unspecified A@ E A SERTRALINE d00880A Bz F32.9 Major depressive disorder, single episode, unspecified A@ E A . . . E A . . . E A . . . E A CEVIMELINE d04512A B= M35 Other systemic involvement of connective tissue A E A HYDROXYCHLOROQUINE d00817A B= M35 Other systemic involvement of connective tissue A E0 A LAMOTRIGINE d03809A Bz G47.0 Insomnia A E0 A SERTRALINE d00880A Bz F41.9 Anxiety disorder, unspecified A E@ A ESTRADIOL d00537A D* N95 Menopausal and other perimenopausal disorders AP E@ A LEVOTHYROXINE d00278A D# E03.9 Hypothyroidism, unspecified AP E@ A QUINAPRIL d00365A D I10 Essential (primary) hypertension AP E@ A SERTRALINE d00880A D# F32.9 Major depressive disorder, single episode, unspecified AP E@ A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia AP EP A MELOXICAM d04532A A M54 Dorsalgia A E` A . . . Ep A ALPRAZOLAM d00168A0 D# F32.9 R45 Major depressive disorder, single episode, unspecified Symptoms and signs involving emotional state B Ep A AMLODIPINE d00689A0 D I21.P Prevent heart attack/myocardial infarction B Ep A ASPIRIN d00170A0 D I21.P I51.9P Prevent heart attack/myocardial infarction Prevent heart disease B Ep A GABAPENTIN d03182A0 B M79.2 Neuralgia and neuritis, unspecified B Ep A GLIPIZIDE d00246A0 Cr E11 Type 2 diabetes mellitus B Ep A INSULIN ASPART d04697A B E11 R73 Type 2 diabetes mellitus Elevated blood glucose level B Ep A INSULIN GLARGINE d04538A B E11 Type 2 diabetes mellitus B Ep A LISINOPRIL d00732A0 D I10 Essential (primary) hypertension B Ep A METFORMIN d03807A0 Cr E11 Type 2 diabetes mellitus B Ep A METHYLPHENIDATE d00900A C F90 Attention-deficit hyperactivity disorders B Ep A METOPROLOL d00134A0 Ei I10 I20.9 Essential (primary) hypertension Angina pectoris, unspecified B Ep A NITROGLYCERIN d00321A D I20.9 R07.9 Angina pectoris, unspecified Chest pain, unspecified B Ep A OLANZAPINE d04050A0 D F32.9 F39 G47.0 Major depressive disorder, single episode, unspecified Unspecified mood [affective] disorder Insomnia B Ep A OMEPRAZOLE d00325A0 Dc K21 Gastro-esophageal reflux disease B Ep A OXYCODONE d00329A Cr M25.5 M54 T14.9 Pain in joint Dorsalgia Unspecified injury B Ep A PAROXETINE d03157A D F32.9 R45 Major depressive disorder, single episode, unspecified Symptoms and signs involving emotional state B Ep A SIMVASTATIN d00746A0 D E78.0 Pure hypercholesterolemia B Eـ A . . . Eِ A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A Eِ A LEVOTHYROXINE d00278A D4 E03.9 Hypothyroidism, unspecified A Eِ A LOSARTAN d03821A C I51.9P Z95 Prevent heart disease Presence of cardiac and vascular implants and grafts A Eِ A MEMANTINE d04899A C[@ R41 Other symptoms and signs involving cognitive functions and awareness A Eِ A PAROXETINE d03157A Cr F41.9 Anxiety disorder, unspecified A Eِ A TROSPIUM d04929A C N32.81 Overactive bladder A Eِ A WARFARIN d00022A A I49.9 Cardiac arrhythmia, unspecified A Eِ A ZOLPIDEM d00910A A G47.0 Insomnia A E٠ A 99999 . . A0 E٠ A FLUOXETINE d00236A C"0 F32.9 Major depressive disorder, single episode, unspecified A0 E٠ A GABAPENTIN d03182A B M79.2 Neuralgia and neuritis, unspecified A0 Eٰ A . . . E A . . . E A . . . E A METHIMAZOLE d00290A B E05 Thyrotoxicosis [hyperthyroidism] A E A . . . E A . . . E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C- I10 Essential (primary) hypertension A E A LEVOTHYROXINE d00278A D9 E03.9 Hypothyroidism, unspecified A E A GLIMEPIRIDE d03864A C[@ E11 Type 2 diabetes mellitus A@ E A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A@ E A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension A@ E A SIMVASTATIN d00746A A E78.0 Pure hypercholesterolemia A@ E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A ETONOGESTREL d04772A B Z79.3 Long term (current) use of hormonal contraceptives A Eڀ A . . . Eڐ A . . . Eڠ A AZITHROMYCIN d00091A AP H66.9 J20.9 Otitis media, unspecified Acute bronchitis, unspecified A@ Eڠ A CODEINE; GUAIFENESIN d03393A B J20.9 R05 Acute bronchitis, unspecified Cough A@ Eڠ A FLUVOXAMINE d03804A C F41.9 Anxiety disorder, unspecified A@ Eڠ A MONTELUKAST d04289A B J20.9 Acute bronchitis, unspecified A@ Eڰ A ALBUTEROL d00749A B J45 Asthma A0 Eڰ A ALBUTEROL d00749A C J45 Asthma A0 Eڰ A BUDESONIDE d04276A C J45 Asthma A0 E A . . . E A ALENDRONATE d03849A0 C M81 Osteoporosis without current pathological fracture A E A AMOXICILLIN; CLAVULANATE d00089A AP J01.9 J02 J06.9 Acute sinusitis, unspecified Acute pharyngitis Acute upper respiratory infection, unspecified A E A APIXABAN d07804A0 C I63.P Prevent stroke A E A ATORVASTATIN d04105A C I10 Essential (primary) hypertension A E A BACLOFEN d00967A B M62.83 Muscle spasm A E A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A E A PANTOPRAZOLE d04514A C K27 Peptic ulcer, site unspecified A E A RANITIDINE d00021A C K27 Peptic ulcer, site unspecified A E A SPIRONOLACTONE d00373A C I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A CDp M54 Dorsalgia A@ E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A@ E A . . . E0 A AMLODIPINE d00689A D I10 Essential (primary) hypertension A E0 A CILOSTAZOL d04382A B[ I70 Atherosclerosis A E0 A ENALAPRIL d00013A D I10 Essential (primary) hypertension A E0 A FLUOXETINE d00236A B[ F32.9 Major depressive disorder, single episode, unspecified A E0 A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A E0 A METOPROLOL d00134A CDp I50.9 Heart failure, unspecified A E0 A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease A E0 A ROSUVASTATIN d04851A CDp E78.0 Pure hypercholesterolemia A E@ A . . . EP A . . . E` A AMPHETAMINE; DEXTROAMPHETAMINE d04035A CDp F90 Attention-deficit hyperactivity disorders A Ep A . . . Eۀ A . . . Eې A AZELASTINE NASAL d04068A B[ J02 Acute pharyngitis AP Eې A FLUOXETINE d00236A C- F32.9 Major depressive disorder, single episode, unspecified AP Eې A FLUTICASONE NASAL d04283A B J02 Acute pharyngitis AP Eې A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A Dc I10 Essential (primary) hypertension AP Eې A QUINAPRIL d00365A Dc I10 Essential (primary) hypertension AP E۠ A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A E۰ A . . . E A . . . E A . . . E A . . . E A . . . E A CYCLOBENZAPRINE d00963A C M79.1 Myalgia AP E A ESCITALOPRAM d04812A C F32.9 Major depressive disorder, single episode, unspecified AP E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension AP E A MELOXICAM d04532A C M19.9 Osteoarthritis, unspecified site AP E A ONDANSETRON d00867A C R11 Nausea and vomiting AP E A . . . E A . . . E0 A . . . E@ A . . . EP A AMLODIPINE; BENAZEPRIL d03829A D I10 Essential (primary) hypertension A@ EP A HYDROCHLOROTHIAZIDE d00253A Dc R60.9 Edema, unspecified A@ EP A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus A@ EP A TAMSULOSIN d04121A C- R35 Polyuria A@ E` A LISINOPRIL d00732A C I10 Essential (primary) hypertension A Ep A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E܀ A PHENTERMINE d00806A B E66 Overweight and obesity A Eܐ A . . . Eܠ A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A Eܠ A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A Eܰ A . . . E A . . . E A CHLORTHALIDONE d00192A CDp R60.9 Edema, unspecified A@ E A HYDROCHLOROTHIAZIDE; TELMISARTAN d04737A C I10 Essential (primary) hypertension A@ E A METFORMIN d03807A CDp E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A@ E A PROPRANOLOL d00032A C I10 Essential (primary) hypertension A@ E A INSULIN ASPART d04697A B E10 Type 1 diabetes mellitus A0 E A INSULIN GLARGINE d04538A Cr E10 Type 1 diabetes mellitus A0 E A PANTOPRAZOLE d04514A B R12 Heartburn A0 E A FUROSEMIDE d00070A C I10 Essential (primary) hypertension A@ E A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus A@ E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia AP E A FLUTICASONE; SALMETEROL d04611A D R06.9 Unspecified abnormalities of breathing AP E A GLIPIZIDE d00246A D R73 Elevated blood glucose level AP E A METFORMIN d03807A D E11 Type 2 diabetes mellitus AP E A TIOTROPIUM d04829A D J44.9 Chronic obstructive pulmonary disease, unspecified AP E A HYDROCHLOROTHIAZIDE d00253A D I10 Essential (primary) hypertension A E A . . . E0 A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A E@ A . . . EP A ACETAMINOPHEN; HYDROCODONE d03428A C M79.1 Myalgia A EP A BUMETANIDE d00179A B= R60.9 Edema, unspecified A EP A DOXEPIN d00217A B= L50 Urticaria A EP A PANTOPRAZOLE d04514A C- K21 Gastro-esophageal reflux disease A EP A TADALAFIL d04896A CDp I27.9 Pulmonary heart disease, unspecified A EP A TIZANIDINE d04102A C[@ M62.83 M79.1 Muscle spasm Myalgia A EP A TREPROSTINIL d04802A C[@ I27.9 Pulmonary heart disease, unspecified A EP A WARFARIN d00022A C[@ I27.9 Pulmonary heart disease, unspecified A E` A . . . Ep A CYCLOBENZAPRINE d00963A A M79.1 Myalgia A0 Ep A RANITIDINE d00021A C K25 Gastric ulcer A0 Ep A TRAMADOL d03826A B M25.5 Pain in joint A0 E݀ A . . . Eݐ A . . . Eݠ A . . . Eݰ A . . . E A . . . E A . . . E A . . . E A . . . E A ASPIRIN d00170A C- I99.9 Unspecified disorder of circulatory system A0 E A METFORMIN d03807A C- E11 Type 2 diabetes mellitus A0 E A METOPROLOL d00134A C- I10 Essential (primary) hypertension A0 E A . . . E A ATOMOXETINE d04827A C"0 F90 Attention-deficit hyperactivity disorders A@ E A CLONIDINE d00044A C F90 Attention-deficit hyperactivity disorders A@ E A DEXMETHYLPHENIDATE d04777A C F90 Attention-deficit hyperactivity disorders A@ E A GUANFACINE d00717A C F90 Attention-deficit hyperactivity disorders A@ E0 A ALPRAZOLAM d00168A C- F41.0 F41.9 Panic disorder [episodic paroxysmal anxiety] without agoraphobia Anxiety disorder, unspecified Ap E0 A CELECOXIB d04380A C- M13 Other arthritis Ap E0 A HYDROCHLOROTHIAZIDE; OLMESARTAN d04878A D I10 Essential (primary) hypertension Ap E0 A ONDANSETRON d00867A B R11 Nausea and vomiting Ap E0 A PREGABALIN d05508A C- M79.2 Neuralgia and neuritis, unspecified Ap E0 A RANITIDINE d00021A D# K21 Gastro-esophageal reflux disease Ap E0 A SERTRALINE d00880A B F41.9 Anxiety disorder, unspecified Ap E@ A CLONIDINE d00044A Cr 99999 A E@ A CLOPIDOGREL d04258A Cr I49.9 Cardiac arrhythmia, unspecified A E@ A GLIPIZIDE d00246A Cr E11 Type 2 diabetes mellitus A E@ A HYDRALAZINE; ISOSORBIDE DINITRATE d05540A Cr 99999 A E@ A METFORMIN d03807A B= E11 Type 2 diabetes mellitus A E@ A METOPROLOL d00134A Cr 99999 A E@ A OLMESARTAN d04801A CDp 99999 A E@ A ROSUVASTATIN d04851A C"0 E78.0 Pure hypercholesterolemia A EP A LEVOTHYROXINE d00278A Cr E06 Thyroiditis A E` A . . . Ep A . . . Eހ A . . . Eސ A HYDROXYZINE d00907A C- F41.9 Anxiety disorder, unspecified A Eސ A VENLAFAXINE d03181A C- F32.9 Major depressive disorder, single episode, unspecified A Eޠ A AMLODIPINE d00689A C- I63.P Prevent stroke AP Eޠ A GABAPENTIN d03182A C- M79.2 Neuralgia and neuritis, unspecified AP Eޠ A HYDROCHLOROTHIAZIDE d00253A C- I10 Essential (primary) hypertension AP Eޠ A LEVETIRACETAM d04499A C- G40 Epilepsy and recurrent seizures AP Eޠ A METOPROLOL d00134A C- I10 Essential (primary) hypertension AP Eް A . . . E A . . . E A . . . E A . . . E A . . . E A LISDEXAMFETAMINE d06663A Bz F90 Attention-deficit hyperactivity disorders A E A . . . E A RALOXIFENE d04261A Cr M85.9 Disorder of bone density and structure, unspecified A0 E A SIMVASTATIN d00746A C- I21.P Prevent heart attack/myocardial infarction A0 E A VALSARTAN d04113A D I10 Essential (primary) hypertension A0 E0 A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E@ A HYDROXYCHLOROQUINE d00817A B[ M35 Other systemic involvement of connective tissue AP E@ A HYDROXYZINE d00907A C L29.9 Pruritus, unspecified AP E@ A PANTOPRAZOLE d04514A C- K21 Gastro-esophageal reflux disease AP E@ A RITUXIMAB d04255A C"0 M35 Other systemic involvement of connective tissue AP E@ A RIVAROXABAN d07356A C7 55555 AP EP A . . . E` A FLUOXETINE d00236A B F41.9 Anxiety disorder, unspecified AP E` A GABAPENTIN d03182A CDp M54 Dorsalgia AP E` A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C[@ I10 Essential (primary) hypertension AP E` A IBUPROFEN d00015A C[@ N94 Pain and other conditions associated with female genital organs and menstrual cycle AP E` A OXYCODONE d00329A C- M25.5 M54 R52 Pain in joint Dorsalgia Pain, unspecified AP Ep A . . . E߀ A . . . Eߐ A ALBUTEROL d00749A C J20.9 Acute bronchitis, unspecified A Eߠ A . . . E߰ A ALLOPURINOL d00023A C M1A Chronic gout A E߰ A AMOXICILLIN d00088A D K04.7P Prevent tooth infection A E߰ A BETAXOLOL OPHTHALMIC d04038A Cr H40 Glaucoma A E߰ A BRIMONIDINE; BRINZOLAMIDE OPHTHALMIC d08086A Cr H40 Glaucoma A E߰ A CYCLOSPORINE OPHTHALMIC d04836A D H04 Disorders of lacrimal system A E߰ A DUTASTERIDE d04788A C R39.9 Unspecified symptoms and signs involving the genitourinary system A E߰ A FLUTICASONE NASAL d04283A Ei T78.40 Allergy, unspecified A E߰ A FUROSEMIDE d00070A C R60.9 Edema, unspecified A E߰ A LEVOTHYROXINE d00278A B E07.9 Disorder of thyroid, unspecified A E߰ A LOSARTAN d03821A Ei I10 Essential (primary) hypertension A E߰ A METOPROLOL d00134A D I51.9 Heart disease, unspecified A E߰ A TAMSULOSIN d04121A Ei R39.1 Other difficulties with micturition A E߰ A ZOLPIDEM d00910A C G47.0 Insomnia A E A LEVOTHYROXINE d00278A D* E03.9 Hypothyroidism, unspecified A E A SIMVASTATIN d00746A D* E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A . . . E A ALBUTEROL d00749A C[@ R06.02 Shortness of breath A E A BECLOMETHASONE d00760A C- R06.02 Shortness of breath A E A . . . E A . . . E0 A CETIRIZINE d03827A CDp T78.40 Allergy, unspecified AP E0 A FUROSEMIDE d00070A Cr J98.9 R60.9 Respiratory disorder, unspecified Edema, unspecified AP E0 A NEBIVOLOL d05265A C I50.9 Heart failure, unspecified AP E0 A POTASSIUM CHLORIDE d00345A Cr E87.6 Hypokalemia AP E0 A VALSARTAN d04113A Cr I10 Essential (primary) hypertension AP E@ A ALBUTEROL d00749A CDp J45 Asthma A EP A . . . E` A . . . Ep A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A Ep A ATENOLOL d00004A C- I10 Essential (primary) hypertension A E A IBUPROFEN d00015A Bz M85.9 Disorder of bone density and structure, unspecified A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A TRIAMCINOLONE TOPICAL d03206A A R21 Rash and other nonspecific skin eruption A E A . . . E A . . . E A . . . E0 A . . . E@ A . . . EP A RANITIDINE d00021A B K21 Gastro-esophageal reflux disease A E` A APIXABAN d07804A B I48.9 Unspecified atrial fibrillation and atrial flutter A` E` A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A` E` A LINAGLIPTIN d07767A C E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A` E` A METFORMIN d03807A D E11 R73 Type 2 diabetes mellitus Elevated blood glucose level A` E` A METOPROLOL d00134A Cr I48.9 Unspecified atrial fibrillation and atrial flutter A` E` A VALSARTAN d04113A CDp I10 Essential (primary) hypertension A` Ep A FLUTICASONE; SALMETEROL d04611A C J45 Asthma A E A . . . E A . . . E A . . . E A HYDROCHLOROTHIAZIDE d00253A D I10 Essential (primary) hypertension A E A METOPROLOL d00134A D I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A . . . E A . . . E A AMLODIPINE d00689A C I21.P Prevent heart attack/myocardial infarction A E A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A E A CLOPIDOGREL d04258A CDp Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A E A GABAPENTIN d03182A C 99999 A E A GLIPIZIDE d00246A D' E11 Type 2 diabetes mellitus A E A INSULIN d00262A CDp E11 Type 2 diabetes mellitus A E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A E A METOPROLOL d00134A Dc I10 Essential (primary) hypertension A E A OXYBUTYNIN d00328A C R35 Polyuria A E A TAMSULOSIN d04121A C N40 Enlarged prostate A E A ROSUVASTATIN d04851A C I21.P Prevent heart attack/myocardial infarction A E0 A . . . E@ A ALLOPURINOL d00023A C 99999 A E@ A AMLODIPINE d00689A C 99999 A E@ A FENOFIBRATE d04286A C 99999 A E@ A FUROSEMIDE d00070A C 99999 A E@ A GABAPENTIN d03182A C 99999 A E@ A HYDRALAZINE d00132A C 99999 A E@ A INSULIN ASPART d04697A C E11 Type 2 diabetes mellitus A E@ A SUCRALFATE d00377A C 99999 A EP A . . . E` A . . . Ep A . . . E A . . . E A . . . E A . . . E A . . . E A FLUTICASONE NASAL d04283A B J30.2 Other seasonal allergic rhinitis A E A . . . E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A E A . . . E A ALLOPURINOL d00023A D M10.9P Prevent gout Ap E A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia Ap E A FUROSEMIDE d00070A D0z R60.9 Edema, unspecified Ap E A GABAPENTIN d03182A D M79.2 Neuralgia and neuritis, unspecified Ap E A OXYCODONE d00329A C M25.5 Pain in joint Ap E A POTASSIUM CHLORIDE d00345A Dc E87.6 Hypokalemia Ap E A WARFARIN d00022A D0z Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets Ap E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A ALBUTEROL d00749A C J43 J44.9 Emphysema Chronic obstructive pulmonary disease, unspecified A E A ALBUTEROL d00749A C J43 J44.9 Emphysema Chronic obstructive pulmonary disease, unspecified A E A ARFORMOTEROL d05893A C J43 J44.9 Emphysema Chronic obstructive pulmonary disease, unspecified A E A BUDESONIDE d04276A C J43 J44.9 Emphysema Chronic obstructive pulmonary disease, unspecified A E A COLESTIPOL d00744A D9 E78.0 R19.7 Pure hypercholesterolemia Diarrhea, unspecified A E A CYANOCOBALAMIN d00413A D9 55555 A E A DONEPEZIL d04099A CDp G30.9 Alzheimer's disease, unspecified A E A MEMANTINE d04899A C[@ G30.9 Alzheimer's disease, unspecified A E A PANTOPRAZOLE d04514A CDp K21 Gastro-esophageal reflux disease A E A SELEGILINE d00976A C[@ G31.9 Degenerative disease of nervous system, unspecified A E A SODIUM CHLORIDE d00438A C J43 J44.9 Emphysema Chronic obstructive pulmonary disease, unspecified A E A THEOPHYLLINE d00142A C J42 J43 J44.9 Unspecified chronic bronchitis Emphysema Chronic obstructive pulmonary disease, unspecified A E A TIOTROPIUM d04829A C J43 J44.9 Emphysema Chronic obstructive pulmonary disease, unspecified A E A TRAZODONE d00395A D# G47.0 Insomnia A E A WARFARIN d00022A D9 I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified A E A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E A 55555 A B 55555 Ap E A ALLOPURINOL d00023A C M1A Chronic gout Ap E A CHLORTHALIDONE d00192A C 99999 Ap E A GLIPIZIDE d00246A C- E11 Type 2 diabetes mellitus Ap E A LOSARTAN d03821A C 99999 Ap E A METFORMIN d03807A C E11 Type 2 diabetes mellitus Ap E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease Ap E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified Ap Ep A DULOXETINE d05355A CDp F32.9 M79.1 Major depressive disorder, single episode, unspecified Myalgia Ap Ep A ESTRADIOL d00537A C Z79.890 Hormone replacement therapy Ap Ep A METHOCARBAMOL d00965A CP M54 M79.1 Dorsalgia Myalgia Ap Ep A PRAMIPEXOLE d04145A C- G25.81 Restless legs syndrome Ap Ep A TRAMADOL d03826A CDp M54 Dorsalgia Ap Ep A TRAZODONE d00395A CDp G47.0 Insomnia Ap E A . . . E A . . . E A COLCHICINE d00150A C M10.9 Gout, unspecified A E A INSULIN ISOPHANE (NPH) d04370A C E11 Type 2 diabetes mellitus A E A INSULIN REGULAR d04369A C[@ E11 Type 2 diabetes mellitus A E A LISINOPRIL d00732A D I10 Essential (primary) hypertension A E A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia A E A METFORMIN d03807A D R73 Elevated blood glucose level A E A METOPROLOL d00134A C I50.9 Heart failure, unspecified A E A PRAMIPEXOLE d04145A C G25.81 Restless legs syndrome A E A TEMAZEPAM d00384A C- G47.9 Sleep disorder, unspecified A E A AMOXICILLIN d00088A A J01.9 J02 Acute sinusitis, unspecified Acute pharyngitis A E A . . . E A . . . E A . . . E A . . . E A BACLOFEN d00967A Bz M62.83 Muscle spasm A0 E A CLONAZEPAM d00197A B M62.83 Muscle spasm A0 E A LEVETIRACETAM d04499A Bz G40 Epilepsy and recurrent seizures A0 E A . . . E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A . . . E A CYCLOBENZAPRINE d00963A B= M79.1 T14.9 Myalgia Unspecified injury A@ E A HYDROCHLOROTHIAZIDE d00253A CDp I10 Essential (primary) hypertension A@ E A IBUPROFEN d00015A B[ T14.9 Unspecified injury A@ E A LISINOPRIL d00732A B= I10 Essential (primary) hypertension A@ E A . . . E A . . . E A . . . E A CARBAMAZEPINE d00058A D% G40 Epilepsy and recurrent seizures A E A . . . E A . . . E A . . . E A CONTRACEPTIVES - UNSPECIFIED c00102A C- N92 Excessive, frequent and irregular menstruation A E0 A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A E@ A . . . EP A GEMFIBROZIL d00245A Dc E78.0 Pure hypercholesterolemia A` EP A ISOSORBIDE MONONITRATE d00269A C[@ 99999 A` EP A METOPROLOL d00134A C[@ I10 Essential (primary) hypertension A` EP A OMEPRAZOLE d00325A C[@ 99999 A` EP A PIOGLITAZONE d04442A C- E11 Type 2 diabetes mellitus A` EP A SIMVASTATIN d00746A CDp I21.P Prevent heart attack/myocardial infarction A` E` A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A Ep A ALBUTEROL d00749A Ap R05 Cough A@ Ep A AZITHROMYCIN d00091A Ap J01.9 Acute sinusitis, unspecified A@ Ep A FLUTICASONE NASAL d04283A Ap J30.9 Allergic rhinitis, unspecified A@ Ep A IBUPROFEN d00015A Ap R60.9 Edema, unspecified A@ E A . . . E A ALENDRONATE d03849A CDp M81 Osteoporosis without current pathological fracture AP E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia AP E A ESTRADIOL d00537A C- N95 Menopausal and other perimenopausal disorders AP E A MELOXICAM d04532A B= M79.1 Myalgia AP E A MONTELUKAST d04289A CDp J45 Asthma AP E A . . . E A BACLOFEN d00967A C- M54 T14.9 Dorsalgia Unspecified injury A0 E A PANTOPRAZOLE d04514A C[@ K25 Gastric ulcer A0 E A ZOLPIDEM d00910A C[@ G47.0 Insomnia A0 E A . . . E A . . . E A . . . E A . . . E A . . . E A FAMOTIDINE d00141A C K30 Functional dyspepsia A E A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A E A FENOFIBRATE d04286A0 D E78.1 Pure hyperglyceridemia AP E A LISINOPRIL d00732A0 D I10 Essential (primary) hypertension AP E A METFORMIN d03807A0 D E11 Type 2 diabetes mellitus AP E A OXYBUTYNIN d00328A0 B N32.81 Overactive bladder AP E A SIMVASTATIN d00746A0 D* E78.0 Pure hypercholesterolemia AP E0 A . . . E@ A . . . EP A ATENOLOL d00004A C[@ R00 Abnormalities of heart beat A EP A FLUOXETINE d00236A C"0 F41.9 Anxiety disorder, unspecified A E` A . . . Ep A AMLODIPINE d00689A D I10 Essential (primary) hypertension A Ep A LEVOTHYROXINE d00278A D# E03.9 Hypothyroidism, unspecified A E A METHADONE d00050A C- F11.23 Opioid dependence with withdrawal A E A SIMVASTATIN d00746A B[ E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ E A BENAZEPRIL d00730A C I10 Essential (primary) hypertension A@ E A HYDROCODONE d03075A B M25.5 Pain in joint A@ E A OMEPRAZOLE d00325A D* K21 Gastro-esophageal reflux disease A@ E0 A . . . E@ A . . . EP A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A0 EP A IBUPROFEN d00015A C M25.5 Pain in joint A0 EP A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A0 E` A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A Ep A . . . E A . . . E A . . . E A DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE d07697A Cr L70 N92 Z79.3 Acne Excessive, frequent and irregular menstruation Long term (current) use of hormonal contraceptives A E A ACETAMINOPHEN; HYDROCODONE d03428A Cr T14.9 Unspecified injury Ap E A BACLOFEN d00967A B= M62.83 Muscle spasm Ap E A ENALAPRIL d00013A Cr I10 Essential (primary) hypertension Ap E A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus Ap E A INSULIN LISPRO d04373A C- R73 Elevated blood glucose level Ap E A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia Ap E A TRAZODONE d00395A C- G47.0 Insomnia Ap E A . . . E A . . . E A LISINOPRIL d00732A D I10 Essential (primary) hypertension AP E A METFORMIN d03807A D E11 Type 2 diabetes mellitus AP E A PRAVASTATIN d00348A D E78.0 Pure hypercholesterolemia AP E A SITAGLIPTIN d05896A Cr E11 Type 2 diabetes mellitus AP E A TERBINAFINE d04012A A B35 Dermatophytosis AP E A AMLODIPINE d00689A Dc I10 Essential (primary) hypertension AP E A DICLOFENAC; MISOPROSTOL d04271A Cr M13 M54 Other arthritis Dorsalgia AP E A ESOMEPRAZOLE d04749A C- K30 Functional dyspepsia AP E A LEVOTHYROXINE d00278A D# E03.9 Hypothyroidism, unspecified AP E A LOSARTAN d03821A Dc I10 Essential (primary) hypertension AP E A ACETAMINOPHEN; OXYCODONE d03431A Cr L93 M54 Lupus erythematosus Dorsalgia A E A AMLODIPINE d00689A D' I10 Essential (primary) hypertension A E A BROMFENAC OPHTHALMIC d05518A A H57.9 Unspecified disorder of eye and adnexa A E A DIFLUPREDNATE OPHTHALMIC d07298A A H57.9 Unspecified disorder of eye and adnexa A E A FUROSEMIDE d00070A D' I51.9 Heart disease, unspecified A E A HYDROXYCHLOROQUINE d00817A D' L93 Lupus erythematosus A E A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A E A LOSARTAN d03821A D' I10 Essential (primary) hypertension A E A METHYLDOPA d00133A D' I10 Essential (primary) hypertension A E A METOPROLOL d00134A D' I10 Essential (primary) hypertension A E A MOXIFLOXACIN OPHTHALMIC d04860A A H26.9 Unspecified cataract A E A NAPROXEN d00019A D' L93 Lupus erythematosus A E A POTASSIUM CHLORIDE d00345A CDp E87.6 Hypokalemia A E A PREDNISONE d00350A D' L93 Lupus erythematosus A E A . . . E A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E0 A BUPROPION d00181A D F32.9 Major depressive disorder, single episode, unspecified AP E0 A BUSPIRONE d00182A C- F41.9 Anxiety disorder, unspecified AP E0 A LEVOMILNACIPRAN d08114A C F32.9 Major depressive disorder, single episode, unspecified AP E0 A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified AP E0 A TOPIRAMATE d04115A C[@ F31.9 Bipolar disorder, unspecified AP E@ A ALBUTEROL d00749A CP J45 Asthma A EP A FLUCONAZOLE d00071A B B37 Candidiasis A E` A . . . Ep A . . . E A . . . E A . . . E A . . . E A CEFPROZIL d00073A AP J06.9 Acute upper respiratory infection, unspecified A E A . . . E A . . . E A . . . E A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A E A THYROID DESICCATED d00655A Cr E03.9 Hypothyroidism, unspecified A E A ALENDRONATE d03849A C M81 Osteoporosis without current pathological fracture Ap E A AMLODIPINE d00689A C I10 Essential (primary) hypertension Ap E A CARVEDILOL d03847A C I10 Essential (primary) hypertension Ap E A FLUTICASONE d01296A C- R06.2 Wheezing Ap E A LEVOCETIRIZINE d05851A B J30.9 Allergic rhinitis, unspecified Ap E A OMEPRAZOLE d00325A C- K25 Gastric ulcer Ap E A VALSARTAN d04113A C I10 Essential (primary) hypertension Ap E A . . . E A . . . E0 A . . . E@ A ACETAMINOPHEN; HYDROCODONE d03428A Cr M79.1 Myalgia A` E@ A AMLODIPINE d00689A C I10 Essential (primary) hypertension A` E@ A ESOMEPRAZOLE d04749A C K30 Functional dyspepsia A` E@ A GABAPENTIN d03182A C 99999 A` E@ A PREDNISONE d00350A Ei M19.9 Osteoarthritis, unspecified site A` E@ A VALSARTAN d04113A C I10 Essential (primary) hypertension A` EP A . . . E` A CYCLOBENZAPRINE d00963A0 D M54 Dorsalgia A E` A ESOMEPRAZOLE d04749A0 D K30 Functional dyspepsia A E` A GABAPENTIN d03182A0 C M79.2 Neuralgia and neuritis, unspecified A E` A INSULIN d00262A C E11 Type 2 diabetes mellitus A E` A ISOSORBIDE MONONITRATE d00269A0 Dc R07.9 Chest pain, unspecified A E` A LEVOTHYROXINE d00278A0 Dc E03.9 Hypothyroidism, unspecified A E` A METOPROLOL d00134A0 Dc I10 Essential (primary) hypertension A E` A NITROGLYCERIN d00321A0 D R07.9 Chest pain, unspecified A Ep A ALENDRONATE d03849A C M81 Osteoporosis without current pathological fracture A@ Ep A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 R60.9 Essential (primary) hypertension Edema, unspecified A@ Ep A METOPROLOL d00134A C- I10 Essential (primary) hypertension A@ Ep A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A@ E A LISDEXAMFETAMINE d06663A C F90 Attention-deficit hyperactivity disorders A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease A0 E A TAMSULOSIN d04121A C N40 Enlarged prostate A0 E A . . . E A DONEPEZIL d04099A C R41 Other symptoms and signs involving cognitive functions and awareness AP E A LOSARTAN d03821A Cr I10 Essential (primary) hypertension AP E A METOPROLOL d00134A C I10 I49.9 Essential (primary) hypertension Cardiac arrhythmia, unspecified AP E A PANTOPRAZOLE d04514A Cr K21 Gastro-esophageal reflux disease AP E A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia AP E A APIXABAN d07804A B D75.9P Prevent blood clots A` E A CITALOPRAM d04332A C 99999 A` E A LEVOTHYROXINE d00278A C"0 99999 A` E A LOSARTAN d03821A C 99999 A` E A METOPROLOL d00134A B 99999 A` E A SIMVASTATIN d00746A C 99999 A` E A CLINDAMYCIN TOPICAL d01241A C- L70 Acne A E A TRETINOIN d03863A C- L70 Acne A E A . . . E A . . . E A . . . E A . . . E A . . . E0 A INSULIN GLARGINE d04538A B E11 Type 2 diabetes mellitus AP E0 A METFORMIN d03807A B E11 Type 2 diabetes mellitus AP E0 A PANTOPRAZOLE d04514A B K21 Gastro-esophageal reflux disease AP E0 A PIOGLITAZONE d04442A B E11 Type 2 diabetes mellitus AP E0 A SIMVASTATIN d00746A B E78.0 Pure hypercholesterolemia AP E@ A MELOXICAM d04532A CDp M54 Dorsalgia A0 E@ A MIRABEGRON d07876A C R35 Polyuria A0 E@ A OMEPRAZOLE d00325A C[@ K21 Gastro-esophageal reflux disease A0 EP A . . . E` A . . . Ep A FLUTICASONE; SALMETEROL d04611A CDp J45 Asthma A Ep A LEVALBUTEROL d04427A Cr J45 Asthma A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A IBUPROFEN d00015A Ap K08.8 Other specified disorders of teeth and supporting structures A E A . . . E A . . . E A BUDESONIDE; FORMOTEROL d04795A C- T78.40 Allergy, unspecified A E A FLUTICASONE NASAL d04283A C T78.40 Allergy, unspecified A E A NAPROXEN d00019A A G43 Migraine A E A . . . E A CETIRIZINE d03827A B R09.81 Nasal congestion A E A HYDROCHLOROTHIAZIDE d00253A B I10 Essential (primary) hypertension A E A . . . E A ADALIMUMAB d04835A C"0 L40 Psoriasis A E A ALBUTEROL d00749A A J45 Asthma A E A BUSPIRONE d00182A C[@ F32.9 Major depressive disorder, single episode, unspecified A E A CITALOPRAM d04332A Cr F41.9 Anxiety disorder, unspecified A E A DICLOFENAC d00848A C- L40 Psoriasis A E A GABAPENTIN d03182A C M79.7 Fibromyalgia A E A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A E A METOPROLOL d00134A CDp I10 Essential (primary) hypertension A E A MOMETASONE d05262A A J45 Asthma A E A PANTOPRAZOLE d04514A C K21 Gastro-esophageal reflux disease A E A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A E A ALBUTEROL d00749A CP J45 Asthma A E A AMIODARONE d00002A C I49.9 Cardiac arrhythmia, unspecified A E A APIXABAN d07804A Cr D75.9P Prevent blood clots A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A CARVEDILOL d03847A C I49.9 Cardiac arrhythmia, unspecified A E A DULAGLUTIDE d08290A C[@ E11 Type 2 diabetes mellitus A E A FLUTICASONE; VILANTEROL d08100A A J42 J44.9 Unspecified chronic bronchitis Chronic obstructive pulmonary disease, unspecified A E A FUROSEMIDE d00070A C R60.9 Edema, unspecified A E A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A E A HYDROCHLOROTHIAZIDE d00253A Ei I10 Essential (primary) hypertension A E A LOSARTAN d03821A C- I10 Essential (primary) hypertension A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E0 A METHYLPHENIDATE d00900A B F90 Attention-deficit hyperactivity disorders A E@ A AMOXICILLIN d00088A B J20.9 Acute bronchitis, unspecified A E@ A FLUTICASONE NASAL d04283A B J30.2 R09.81 Other seasonal allergic rhinitis Nasal congestion A EP A ALBUTEROL d00749A D J45 Asthma A EP A FLUTICASONE; SALMETEROL d04611A C J45 Asthma A E` A AMPHETAMINE; DEXTROAMPHETAMINE d04035A A F90 Attention-deficit hyperactivity disorders A Ep A . . . E A . . . E A . . . E A . . . E A DOXYCYCLINE d00037A B L08.9 Local infection of the skin and subcutaneous tissue, unspecified A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E0 A BUPROPION d00181A B F32.9 Major depressive disorder, single episode, unspecified A E@ A ALENDRONATE d03849A Cr M81 Osteoporosis without current pathological fracture A@ E@ A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A CDp I10 Essential (primary) hypertension A@ E@ A LOVASTATIN d00280A C- E78.0 Pure hypercholesterolemia A@ E@ A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease A@ EP A . . . E` A MECLIZINE d00859A B R42 Dizziness and giddiness A Ep A ALBUTEROL d00749A B J45 Asthma A Ep A ENTECAVIR d05525A B K76.9 Liver disease, unspecified A E A ATORVASTATIN d04105A CDp I21.P Prevent heart attack/myocardial infarction A E A CARBAMAZEPINE d00058A CDp 99999 A E A DILTIAZEM d00045A CDp I48.9 Unspecified atrial fibrillation and atrial flutter A E A FUROSEMIDE d00070A Cr I51.9 Heart disease, unspecified A E A LEVOTHYROXINE d00278A D9 E03.9 Hypothyroidism, unspecified A E A METOPROLOL d00134A CDp R00 Abnormalities of heart beat A E A POTASSIUM CHLORIDE d00345A Cr E87.6 Hypokalemia A E A WARFARIN d00022A CDp I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified A E A . . . E A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A E A RAMIPRIL d00728A Cr I10 Essential (primary) hypertension A E A . . . E A ALBUTEROL d00749A B J42 Unspecified chronic bronchitis A E A BUDESONIDE d04276A B J40 Bronchitis, not specified as acute or chronic A E A . . . E A LEVOCETIRIZINE d05851A B T78.40 Allergy, unspecified A E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E A SERTRALINE d00880A B F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A . . . E A . . . E0 A . . . E@ A ACETAMINOPHEN; BUTALBITAL; CAFFEINE d03455A0 C R51 Headache A` E@ A AMLODIPINE; BENAZEPRIL d03829A0 C- I10 Essential (primary) hypertension A` E@ A DICLOFENAC d00848A0 C[@ M19.9 Osteoarthritis, unspecified site A` E@ A ETODOLAC d00851A0 C[@ I10 Essential (primary) hypertension A` E@ A HYDROCHLOROTHIAZIDE d00253A0 C[@ I10 Essential (primary) hypertension A` E@ A METFORMIN d03807A0 C E11 Type 2 diabetes mellitus A` EP A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A E` A . . . Ep A HYDROXYZINE d00907A B= F39 F41.9 Unspecified mood [affective] disorder Anxiety disorder, unspecified A E A . . . E A . . . E A . . . E A 99999 . . A E A . . . E A . . . E A CEPHALEXIN d00096A B L08.9 Local infection of the skin and subcutaneous tissue, unspecified A E A CLOTRIMAZOLE TOPICAL d04395A B L08.9 Local infection of the skin and subcutaneous tissue, unspecified A E A . . . E A . . . E A . . . E A ALLOPURINOL d00023A Cr M10.9 Gout, unspecified A E A MELOXICAM d04532A Cr Z79.1 Long term (current) use of non-steroidal anti-inflammatories (NSAID) A E0 A METOPROLOL d00134A B[ I10 Essential (primary) hypertension A E@ A . . . EP A . . . E` A MEDROXYPROGESTERONE d00284A CDp Z79.3 Long term (current) use of hormonal contraceptives A Ep A . . . E A CEFDINIR d04256A Ap T78.40 Allergy, unspecified A E A FLUTICASONE NASAL d04283A Ap J30.9 Allergic rhinitis, unspecified A E A ATORVASTATIN d04105A0 B E78.0 Pure hypercholesterolemia Ap E A FLUTICASONE NASAL d04283A0 C R09.81 Nasal congestion Ap E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A0 C I10 Essential (primary) hypertension Ap E A KETOCONAZOLE TOPICAL d03202A0 B= B35 R21 Dermatophytosis Rash and other nonspecific skin eruption Ap E A METOPROLOL d00134A0 C I10 Essential (primary) hypertension Ap E A NIFEDIPINE d00051A B I10 Essential (primary) hypertension Ap E A TADALAFIL d04896A0 C N40 Enlarged prostate Ap E A . . . E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A B F90 Attention-deficit hyperactivity disorders A E A PHENTERMINE d00806A C E66 R41 Overweight and obesity Other symptoms and signs involving cognitive functions and awareness A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E0 A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C- I10 Essential (primary) hypertension A E0 A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A E@ A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A D I10 Essential (primary) hypertension A E@ A ROSUVASTATIN d04851A C- E78.0 Pure hypercholesterolemia A EP A . . . E` A . . . Ep A . . . E A . . . E A ATENOLOL d00004A C I10 Essential (primary) hypertension A0 E A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified A0 E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A0 E A . . . E A . . . E A . . . E A . . . E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A AMOXICILLIN; CLAVULANATE d00089A A0 J01.9 Acute sinusitis, unspecified A E A . . . E A CETIRIZINE d03827A D T78.40 Allergy, unspecified A E A FLUTICASONE NASAL d04283A D J30.9 Allergic rhinitis, unspecified A E A ALPRAZOLAM d00168A C G47.0 Insomnia Ap E A CARVEDILOL d03847A Cr I49.9 Cardiac arrhythmia, unspecified Ap E A CYCLOBENZAPRINE d00963A C M62.83 Muscle spasm Ap E A DICLOFENAC d00848A B[ M79.1 Myalgia Ap E A LEVOTHYROXINE d00278A C- 99999 Ap E A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease Ap E A SIMVASTATIN d00746A Cr 99999 Ap E0 A . . . E@ A FLUCONAZOLE d00071A Ap B37 Candidiasis A EP A CITALOPRAM d04332A C F39 F84 F90 Unspecified mood [affective] disorder Pervasive developmental disorders Attention-deficit hyperactivity disorders AP EP A FLUTICASONE; SALMETEROL d04611A Cr J45 Asthma AP EP A GUANFACINE d00717A Cr F90 F91 R41 Attention-deficit hyperactivity disorders Conduct disorders Other symptoms and signs involving cognitive functions and awareness AP EP A METHYLPHENIDATE d00900A C F90 Attention-deficit hyperactivity disorders AP EP A MONTELUKAST d04289A Cr J30.9 J45 Allergic rhinitis, unspecified Asthma AP E` A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C- R41 Other symptoms and signs involving cognitive functions and awareness A E` A QUETIAPINE d04220A C[@ F90 Attention-deficit hyperactivity disorders A Ep A . . . E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A METOPROLOL d00134A Bz I10 Essential (primary) hypertension A E A AMLODIPINE d00689A D I10 Essential (primary) hypertension A0 E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E A BENAZEPRIL d00730A D E11.2 Type 2 diabetes mellitus with kidney complications A0 E A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A E A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus A E A AMLODIPINE d00689A B 99999 A0 E A ATORVASTATIN d04105A C 99999 A0 E A LOSARTAN d03821A C I10 Essential (primary) hypertension A0 E A . . . E A ALPRAZOLAM d00168A Cr F33.9 F41.9 Major depressive disorder, recurrent, unspecified Anxiety disorder, unspecified Ap E A ESCITALOPRAM d04812A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Ap E A LISINOPRIL d00732A C I10 Essential (primary) hypertension Ap E A METOPROLOL d00134A C I10 Essential (primary) hypertension Ap E A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease Ap E A OXYBUTYNIN d00328A C N32.9 Bladder disorder, unspecified Ap E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia Ap E A . . . E A . . . E A . . . E A . . . E A BUMETANIDE d00179A B R60.9 Edema, unspecified A E A FEXOFENADINE d04040A Bz R09.81 Nasal congestion A E A INSULIN ASPART d04697A C[@ E11 Type 2 diabetes mellitus A E A INSULIN DETEMIR d05436A C[@ E11 Type 2 diabetes mellitus A E A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A E A METFORMIN d03807A C"0 E11 Type 2 diabetes mellitus A E A METOPROLOL d00134A C"0 I10 Essential (primary) hypertension A E A PRAVASTATIN d00348A C"0 E78.0 Pure hypercholesterolemia A E A PREGABALIN d05508A C- M79.2 Neuralgia and neuritis, unspecified A E0 A ATORVASTATIN d04105A B I10 Essential (primary) hypertension A E0 A METFORMIN d03807A B E11 Type 2 diabetes mellitus A E@ A . . . EP A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A0 EP A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C- I10 Essential (primary) hypertension A0 EP A SERTRALINE d00880A C F41.9 Anxiety disorder, unspecified A0 E` A LEVOTHYROXINE d00278A C[@ E03.9 Hypothyroidism, unspecified A Ep A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A0 Ep A LOSARTAN d03821A C I51.9P Prevent heart disease A0 Ep A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A0 E A . . . E A . . . E A DESVENLAFAXINE d07113A C"0 F32.9 Major depressive disorder, single episode, unspecified A0 E A OMEGA-3 POLYUNSATURATED FATTY ACIDS d00497A C F90 Attention-deficit hyperactivity disorders A0 E A TRAMADOL d03826A Ap M54 R51 Dorsalgia Headache A0 E A . . . E A . . . E A . . . E A . . . E A . . . E A CLONIDINE d00044A C- I10 Essential (primary) hypertension Ap E A GLIMEPIRIDE d03864A D R73 Elevated blood glucose level Ap E A LISINOPRIL d00732A D I10 Essential (primary) hypertension Ap E A METFORMIN d03807A D R73 Elevated blood glucose level Ap E A METOPROLOL d00134A D I50.9 Heart failure, unspecified Ap E A TAMSULOSIN d04121A C N40 Enlarged prostate Ap E A TRAZODONE d00395A C G47.0 Insomnia Ap E A METOPROLOL d00134A B= I10 Essential (primary) hypertension A E A . . . E0 A . . . E@ A . . . EP A . . . E` A PAROXETINE d03157A C F41.9 Anxiety disorder, unspecified A Ep A AMLODIPINE d00689A C I10 Essential (primary) hypertension A Ep A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A ALLOPURINOL d00023A B E79.9 Disorder of purine and pyrimidine metabolism, unspecified A@ E A ATENOLOL d00004A C I10 Essential (primary) hypertension A@ E A BENAZEPRIL d00730A C I10 Essential (primary) hypertension A@ E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E A PRAVASTATIN d00348A B E78.0 Pure hypercholesterolemia A E A . . . E A AMOXICILLIN d00088A Ap J02.0 Streptococcal pharyngitis A E A ATENOLOL d00004A C I10 Essential (primary) hypertension A E A . . . E A . . . E A INSULIN ASPART d04697A Cr E11 Type 2 diabetes mellitus A0 E A INSULIN GLARGINE d04538A Cr E11 Type 2 diabetes mellitus A0 E A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A0 E0 A ACETAMINOPHEN; BUTALBITAL; CAFFEINE d03455A C- G43 R51 Migraine Headache A@ E0 A ALPRAZOLAM d00168A C- M62.83 Muscle spasm A@ E0 A OMEPRAZOLE d00325A B[ K21 Gastro-esophageal reflux disease A@ E0 A URSODIOL d01005A Ap K87 Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere A@ E@ A . . . EP A . . . E` A AMOXICILLIN d00088A A K04.7 Periapical abscess without sinus AP E` A ATORVASTATIN d04105A C I70.P Prevent atherosclerosis AP E` A LOSARTAN d03821A C I10 Essential (primary) hypertension AP E` A SOTALOL d00371A Cr I49.9 Cardiac arrhythmia, unspecified AP E` A WARFARIN d00022A C I48.9 Unspecified atrial fibrillation and atrial flutter AP Ep A METHOCARBAMOL d00965A B M54 Dorsalgia A E A NYSTATIN d01233A A0 B37 Candidiasis A E A . . . E A ATENOLOL d00004A B I10 Essential (primary) hypertension A E A CYPROHEPTADINE d00790A D T78.40 Allergy, unspecified A E A COBICISTAT; DARUNAVIR d08305A Cr B20 Human immunodeficiency virus [HIV] disease A E A EMTRICITABINE; TENOFOVIR d05352A Cr B20 Human immunodeficiency virus [HIV] disease A E A . . . E A . . . E A . . . E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A CDp 55555 A E A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A E A . . . E A . . . E A . . . E0 A . . . E@ A LAMOTRIGINE d03809A C- G40 Epilepsy and recurrent seizures A EP A AMLODIPINE d00689A C[@ 99999 A@ EP A ATORVASTATIN d04105A Ei 99999 A@ EP A HYDROCHLOROTHIAZIDE d00253A C[@ 99999 A@ EP A LISINOPRIL d00732A C[@ 99999 A@ E` A ALBUTEROL d00749A CDp J45 Asthma AP E` A ALBUTEROL d00749A CDp J45 Asthma AP E` A FLUTICASONE d01296A CDp J45 Asthma AP E` A POLYETHYLENE GLYCOL 3350 d05350A Bz K92.9 Disease of digestive system, unspecified AP E` A PREDNISOLONE d00084A B R06.9 Unspecified abnormalities of breathing AP Ep A BUPROPION d00181A C F32.9 Major depressive disorder, single episode, unspecified A Ep A SERTRALINE d00880A CDp F41.9 Anxiety disorder, unspecified A E A BREXPIPRAZOLE d08373A C9 F31.9 Bipolar disorder, unspecified A E A OLANZAPINE d04050A CDp F31.9 Bipolar disorder, unspecified A E A . . . E A FLUTICASONE NASAL d04283A C J30.2 Other seasonal allergic rhinitis A0 E A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A D I10 Essential (primary) hypertension A0 E A PANTOPRAZOLE d04514A D K21 Gastro-esophageal reflux disease A0 E A . . . E A . . . E A . . . E A BUPROPION d00181A D F32.9 Major depressive disorder, single episode, unspecified Ap E A DULOXETINE d05355A Ei F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Ap E A GABAPENTIN d03182A B G25.81 Restless legs syndrome Ap E A IBUPROFEN d00015A A M25.5 T14.9 Pain in joint Unspecified injury Ap E A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified Ap E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension Ap E A RANITIDINE d00021A C- K21 Gastro-esophageal reflux disease Ap E A . . . E A HYDROCHLOROTHIAZIDE d00253A B I10 Essential (primary) hypertension AP E A METOPROLOL d00134A B I10 Essential (primary) hypertension AP E A OMEPRAZOLE d00325A B R12 Heartburn AP E A PRAVASTATIN d00348A B E78.0 Pure hypercholesterolemia AP E A TRAZODONE d00395A B G47.0 Insomnia AP E A . . . E A . . . E0 A . . . E@ A . . . EP A CLOPIDOGREL d04258A Dc E78.0 Pure hypercholesterolemia A EP A DULOXETINE d05355A Dc F32.9 Major depressive disorder, single episode, unspecified A EP A GABAPENTIN d03182A Dc M79.2 Neuralgia and neuritis, unspecified A EP A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A EP A METOPROLOL d00134A Ei I10 Essential (primary) hypertension A EP A OMEPRAZOLE d00325A Ei R12 Heartburn A EP A TOPIRAMATE d04115A Dc R51 Headache A EP A TRAZODONE d00395A Dc G47.9 Sleep disorder, unspecified A E` A . . . Ep A . . . E A . . . E A . . . E A CLINDAMYCIN d00043A AP K04.7 Periapical abscess without sinus A0 E A PREDNISONE d00350A0 AP B02 R52 Zoster [herpes zoster] Pain, unspecified A0 E A VALACYCLOVIR d03838A0 A B02 Zoster [herpes zoster] A0 E A BENAZEPRIL; HYDROCHLOROTHIAZIDE d03265A Cr I10 Essential (primary) hypertension A E A . . . E A . . . E A ETHINYL ESTRADIOL; NORGESTREL d03241A C N92 Z79.3 Excessive, frequent and irregular menstruation Long term (current) use of hormonal contraceptives A E A . . . E A . . . E A AMOXICILLIN; CLAVULANATE d00089A A A49.9 Bacterial infection, unspecified A E A . . . E0 A . . . E@ A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia A E@ A LEVOTHYROXINE d00278A D* E03.9 Hypothyroidism, unspecified A EP A . . . E` A . . . Ep A DIGOXIN d00210A CDp I48.9 I49.9 Unspecified atrial fibrillation and atrial flutter Cardiac arrhythmia, unspecified A Ep A GABAPENTIN d03182A B[ M79.2 Neuralgia and neuritis, unspecified A Ep A GLIMEPIRIDE d03864A Cr E11 Type 2 diabetes mellitus A Ep A INSULIN GLARGINE d04538A Cr E11 Type 2 diabetes mellitus A Ep A METOPROLOL d00134A Cr I48.9 I50.9 Unspecified atrial fibrillation and atrial flutter Heart failure, unspecified A Ep A SACUBITRIL; VALSARTAN d08369A B I50.9 Heart failure, unspecified A Ep A SERTRALINE d00880A Cr F32.9 Major depressive disorder, single episode, unspecified A Ep A SIMVASTATIN d00746A CP E78.0 Pure hypercholesterolemia A Ep A WARFARIN d00022A Cr I48.9 Unspecified atrial fibrillation and atrial flutter A E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A Bz N92 Excessive, frequent and irregular menstruation A E A . . . E A . . . E A ALBUTEROL d00749A C J44.9 J45 Chronic obstructive pulmonary disease, unspecified Asthma A E A ALBUTEROL d00749A D* J45 Asthma A E A ALLOPURINOL d00023A C- M10.9 Gout, unspecified A E A CITALOPRAM d04332A C F41.9 Anxiety disorder, unspecified A E A CLONIDINE d00044A C I10 Essential (primary) hypertension A E A FLUTICASONE d01296A D* J44.9 J45 Chronic obstructive pulmonary disease, unspecified Asthma A E A KETOCONAZOLE TOPICAL d03202A C B35 Dermatophytosis A E A LATANOPROST OPHTHALMIC d04017A Dc H40 Glaucoma A E A METOPROLOL d00134A C I10 Essential (primary) hypertension A E A RISPERIDONE d03180A CDp F32.9 Major depressive disorder, single episode, unspecified A E A SPIRONOLACTONE d00373A C- I10 Essential (primary) hypertension A E A TORSEMIDE d03189A D I10 Essential (primary) hypertension A E A . . . E A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension A E A . . . E A AMLODIPINE; BENAZEPRIL d03829A C- I10 R52 Essential (primary) hypertension Pain, unspecified A@ E A BICALUTAMIDE d03850A C C61 Malignant neoplasm of prostate A@ E A CLOPIDOGREL d04258A C D75.9P I21.P Prevent blood clots Prevent heart attack/myocardial infarction A@ E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A@ E A . . . E A . . . E A . . . E0 A . . . E@ A ALBUTEROL d00749A C J45 Asthma A E@ A BRIMONIDINE OPHTHALMIC d04048A C H40 Glaucoma A E@ A DICLOFENAC TOPICAL d04722A B M54 Dorsalgia A E@ A FLUTICASONE; SALMETEROL d04611A C J45 Asthma A E@ A HYDRALAZINE d00132A C I10 Essential (primary) hypertension A E@ A HYDROCHLOROTHIAZIDE d00253A CDp I50.9 Heart failure, unspecified A E@ A LIDOCAINE TOPICAL d00683A A M54 Dorsalgia A E@ A LOSARTAN d03821A C I21.P Prevent heart attack/myocardial infarction A E@ A LOTEPREDNOL OPHTHALMIC d04292A Cr H10.1 Acute atopic conjunctivitis A EP A . . . E` A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ E` A GLIPIZIDE d00246A B= E11 Type 2 diabetes mellitus A@ E` A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A@ E` A PIOGLITAZONE d04442A CDp E11 Type 2 diabetes mellitus A@ Ep A . . . E A AMOXICILLIN; CLAVULANATE d00089A A H66.9 Otitis media, unspecified A E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A@ E A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A@ E A GLIPIZIDE d00246A Cr E11 Type 2 diabetes mellitus A@ E A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A@ E A . . . E A PROMETHAZINE d00787A C[@ R11 Nausea and vomiting A E A QUETIAPINE d04220A CDp G47.0 Insomnia A E A . . . E A . . . E A RANITIDINE d00021A B K21 Gastro-esophageal reflux disease A E A . . . E A 77777 . . A E A AMITRIPTYLINE d00146A B G47.0 Insomnia AP E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A B N92 N94 Excessive, frequent and irregular menstruation Pain and other conditions associated with female genital organs and menstrual cycle AP E A FLUOXETINE d00236A B F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified AP E A METFORMIN d03807A C- E11 Type 2 diabetes mellitus AP E A NAPROXEN d00019A B G43 Migraine AP E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A CYCLOBENZAPRINE d00963A CD` M79.1 Myalgia A E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C R60.9 Edema, unspecified A E A MELOXICAM d04532A B[ M54 Dorsalgia A E A METFORMIN; SITAGLIPTIN d06720A CD` E11 Type 2 diabetes mellitus A E A MONTELUKAST d04289A C J45 Asthma A E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E A AMOXICILLIN d00088A A J01.9 Acute sinusitis, unspecified A E A . . . E A . . . E A EZETIMIBE d04824A D* E78.0 Pure hypercholesterolemia A E A PANTOPRAZOLE d04514A D1 K21 Gastro-esophageal reflux disease A E A DILTIAZEM d00045A C I10 Essential (primary) hypertension AP E A GEMFIBROZIL d00245A Cr E78.0 Pure hypercholesterolemia AP E A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus AP E A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia AP E A TAMSULOSIN d04121A C N40 Enlarged prostate AP E A . . . E A . . . E A . . . E A LISDEXAMFETAMINE d06663A CP F90 Attention-deficit hyperactivity disorders A E A ATORVASTATIN d04105A B[ E78.0 Pure hypercholesterolemia AP E A CARVEDILOL d03847A CDp I10 Essential (primary) hypertension AP E A ITRACONAZOLE d00102A B= B35 Dermatophytosis AP E A METHYLPHENIDATE d00900A C- F43.1 Post-traumatic stress disorder (PTSD) AP E A TEMAZEPAM d00384A Cr G47.0 Insomnia AP E0 A AMITRIPTYLINE d00146A Ei 99999 A E0 A LEVOTHYROXINE d00278A Ei 99999 A E0 A LOSARTAN d03821A Ei 99999 A E0 A MELOXICAM d04532A Ei 99999 A E0 A MEMANTINE d04899A Ei 99999 A E0 A METFORMIN d03807A Ei 99999 A E0 A METHYLPREDNISOLONE d00293A Ei 99999 A E0 A MONTELUKAST d04289A Ei 99999 A E0 A NITROFURANTOIN d00112A Ei 99999 A E0 A OMEGA-3 POLYUNSATURATED FATTY ACIDS d00497A Ei 99999 A E0 A RIVASTIGMINE d04537A Ei 99999 A E0 A ROPINIROLE d04215A Ei 99999 A E0 A SIMVASTATIN d00746A Ei 99999 A E@ A . . . EP A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A E` A . . . Ep A MONTELUKAST d04289A B J30.9 R06.2 Allergic rhinitis, unspecified Wheezing A Ep A VARENICLINE d05807A B[ F17.2 Nicotine dependence A E A . . . E A FINASTERIDE d00563A C"0 99999 A0 E A OMEPRAZOLE d00325A C"0 99999 A0 E A TAMSULOSIN d04121A C"0 99999 A0 E A BENZOYL PEROXIDE; ERYTHROMYCIN TOPICAL d03857A Bz L70 Acne A E A CETIRIZINE d03827A C T78.40 Allergy, unspecified A E A . . . E A ALBUTEROL; IPRATROPIUM d04066A C J45 Asthma A E A BACLOFEN d00967A CDp M62.83 Muscle spasm A E A CARVEDILOL d03847A D I21.P Prevent heart attack/myocardial infarction A E A CLOPIDOGREL d04258A D I21.P Prevent heart attack/myocardial infarction A E A FLUTICASONE NASAL d04283A C J30.9 Allergic rhinitis, unspecified A E A FUROSEMIDE d00070A D I51.9 Heart disease, unspecified A E A GLIPIZIDE d00246A CP E11 Type 2 diabetes mellitus A E A INSULIN DETEMIR d05436A C E11 Type 2 diabetes mellitus A E A LISINOPRIL d00732A D I10 Essential (primary) hypertension A E A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia A E A METFORMIN d03807A CP E11 Type 2 diabetes mellitus A E A TRAMADOL d03826A Cr M54 Dorsalgia A E A ASPIRIN; DIPYRIDAMOLE d04497A0 C[@ D75.9P I63 Prevent blood clots Cerebral infarction Ap E A ATORVASTATIN d04105A0 C[@ E78.0 Pure hypercholesterolemia Ap E A ESCITALOPRAM d04812A0 B[ F32.9 Major depressive disorder, single episode, unspecified Ap E A GLIPIZIDE d00246A0 C[@ 99999 Ap E A INSULIN DETEMIR d05436A Ap E11 Type 2 diabetes mellitus Ap E A METOPROLOL d00134A0 B[ I10 Essential (primary) hypertension Ap E A SITAGLIPTIN d05896A0 C[@ R73 Elevated blood glucose level Ap E A DEXMETHYLPHENIDATE d04777A B F90 Attention-deficit hyperactivity disorders A E A CARVEDILOL d03847A C I10 I21.P I50.9 Essential (primary) hypertension Prevent heart attack/myocardial infarction Heart failure, unspecified AP E A METHIMAZOLE d00290A C E05 Thyrotoxicosis [hyperthyroidism] AP E A MONTELUKAST d04289A C J45 R06.9 R07.9 Asthma Unspecified abnormalities of breathing Chest pain, unspecified AP E A PREGABALIN d05508A C Z79 Long term (current) drug therapy AP E A SIMVASTATIN d00746A C I21.P I63.P Prevent heart attack/myocardial infarction Prevent stroke AP E A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A E A ROSUVASTATIN d04851A CDp E78.0 Pure hypercholesterolemia A E A . . . E0 A FLUTICASONE NASAL d04283A B= J30.2 R09.8 Other seasonal allergic rhinitis Other specified symptoms and signs involving the circulatory and respiratory systems A E@ A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C Z79.3 Long term (current) use of hormonal contraceptives A E@ A MOMETASONE d05262A B R06.2 Wheezing A EP A FLUTICASONE NASAL d04283A A J30.9 Allergic rhinitis, unspecified A E` A ALENDRONATE d03849A CP M81 Osteoporosis without current pathological fracture A0 E` A GLIMEPIRIDE d03864A CDp R73 Elevated blood glucose level A0 E` A SIMVASTATIN d00746A Ei E78.0 Pure hypercholesterolemia A0 Ep A . . . E A . . . E A DOCUSATE d01021A C K92.9 Disease of digestive system, unspecified Ap E A FINASTERIDE d00563A C- N40 Enlarged prostate Ap E A HYDROCHLOROTHIAZIDE d00253A D I51.9 Heart disease, unspecified Ap E A METOPROLOL d00134A D I10 Essential (primary) hypertension Ap E A SERTRALINE d00880A D F41.9 Anxiety disorder, unspecified Ap E A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia Ap E A TAMSULOSIN d04121A C9 N40 Enlarged prostate Ap E A . . . E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A E A GRISEOFULVIN d00100A B B35 Dermatophytosis A E A BUPROPION; NALTREXONE d08288A CDp E66 Overweight and obesity A0 E A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A0 E A LOSARTAN d03821A C I10 Essential (primary) hypertension A0 E A . . . E A . . . E A ALBUTEROL d00749A D& J45 Asthma A E A TAMSULOSIN d04121A C N40 Enlarged prostate A E A . . . E0 A . . . E@ A . . . EP A FLUOXETINE d00236A C ` F41.9 Anxiety disorder, unspecified A E` A ATORVASTATIN d04105A B E78.0P Prevent high cholesterol A E` A NABUMETONE d00310A C M79.1 Myalgia A Ep A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A Ep A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia A E A OXYBUTYNIN d00328A CDp R35 Polyuria A E A . . . E A AMITRIPTYLINE d00146A C- F41.9 Anxiety disorder, unspecified A E A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A E A INSULIN DETEMIR d05436A Cr E11 Type 2 diabetes mellitus A E A LABETALOL d00016A C[@ I10 Essential (primary) hypertension A E A LEVOTHYROXINE d00278A Cr E03.9 Hypothyroidism, unspecified A E A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A E A RANITIDINE d00021A C[@ R12 Heartburn A E A SUMATRIPTAN d03160A CDp G43 Migraine A E A DIVALPROEX SODIUM d03833A0 B F32.9 Major depressive disorder, single episode, unspecified Ap E A LEVETIRACETAM d04499A0 B F32.9 Major depressive disorder, single episode, unspecified Ap E A MIRTAZAPINE d04025A0 B F32.9 Major depressive disorder, single episode, unspecified Ap E A PHENYTOIN d00143A0 C G40 Epilepsy and recurrent seizures Ap E A RISPERIDONE d03180A0 B G40 Epilepsy and recurrent seizures Ap E A RISPERIDONE d03180A0 C F32.9 Major depressive disorder, single episode, unspecified Ap E A SERTRALINE d00880A0 C G40 Epilepsy and recurrent seizures Ap E A NORETHINDRONE d00555A B Z79.3 Long term (current) use of hormonal contraceptives A E A IRBESARTAN d04222A C I10 Essential (primary) hypertension A E A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A . . . E A 77777 . . A E A . . . E0 A . . . E@ A . . . EP A . . . E` A AMOXICILLIN; CLAVULANATE d00089A A J01.9 Acute sinusitis, unspecified A Ep A . . . E A . . . E A . . . E A ATORVASTATIN d04105A Dc E78.0 Pure hypercholesterolemia A@ E A CITALOPRAM d04332A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A@ E A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A@ E A TAMSULOSIN d04121A C R35 Polyuria A@ E A . . . E A . . . E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ E A HYDRALAZINE d00132A C I10 Essential (primary) hypertension A@ E A INSULIN DEGLUDEC d08054A B E11 Type 2 diabetes mellitus A@ E A TRAMADOL d03826A B R52 Pain, unspecified A@ E A FLUTICASONE NASAL d04283A Dc J30.2 Other seasonal allergic rhinitis AP E A LOSARTAN d03821A C I10 Essential (primary) hypertension AP E A OMEGA-3 POLYUNSATURATED FATTY ACIDS d00497A C I51.9P Prevent heart disease AP E A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease AP E A ROSUVASTATIN d04851A C E78.0P Prevent high cholesterol AP E A . . . E A AMIODARONE d00002A D I51.9 Heart disease, unspecified A E A AMLODIPINE d00689A B I10 Essential (primary) hypertension A E A APIXABAN d07804A C- I51.9P Prevent heart disease A E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A E A BENZONATATE d00796A A R05 R09.3 Cough Abnormal sputum A E A DICLOFENAC TOPICAL d04722A C M25.5 M79.6 Pain in joint Pain in limb, hand, foot, fingers and toes A E A DONEPEZIL d04099A C R41 Other symptoms and signs involving cognitive functions and awareness A E A GABAPENTIN d03182A A M25.5 M79.6 Pain in joint Pain in limb, hand, foot, fingers and toes A E A HYDROCHLOROTHIAZIDE d00253A C I51.9 Heart disease, unspecified A E A PANTOPRAZOLE d04514A C K31.9 Disease of stomach and duodenum, unspecified A E A POTASSIUM CHLORIDE d00345A C- R60.9 Edema, unspecified A E0 A ALLOPURINOL d00023A CDp M10.9P Prevent gout A E0 A CARVEDILOL d03847A Cr I10 Essential (primary) hypertension A E0 A FLUTICASONE NASAL d04283A C[@ J30.2 Other seasonal allergic rhinitis A E0 A HYDRALAZINE d00132A Cr I10 Essential (primary) hypertension A E0 A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A E0 A MONTELUKAST d04289A C[@ H10 J30.9 L29.9 Conjunctivitis Allergic rhinitis, unspecified Pruritus, unspecified A E0 A ROSUVASTATIN d04851A C[@ E78.0 Pure hypercholesterolemia A E0 A TORSEMIDE d03189A CDp R60.9 Edema, unspecified A E@ A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A0 E@ A LISINOPRIL d00732A C I21.P Prevent heart attack/myocardial infarction A0 E@ A METOPROLOL d00134A C- I10 Essential (primary) hypertension A0 EP A ACETAMINOPHEN; HYDROCODONE d03428A CP K51 Ulcerative colitis A@ EP A ALPRAZOLAM d00168A CDp F41.9 Anxiety disorder, unspecified A@ EP A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified A@ EP A SULFASALAZINE d00379A Cr K51 Ulcerative colitis A@ E` A . . . Ep A . . . E A ALBUTEROL d00749A C J45 R06.2 R07.9 Asthma Wheezing Chest pain, unspecified A E A FLUTICASONE NASAL d04283A Cr J30.2 J30.9 R09.81 Other seasonal allergic rhinitis Allergic rhinitis, unspecified Nasal congestion A E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A E A . . . E A ALENDRONATE d03849A C- M81 Osteoporosis without current pathological fracture A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A BUPROPION d00181A C F32.9 Major depressive disorder, single episode, unspecified A E A EZETIMIBE d04824A C 99999 A E A HYDROCHLOROTHIAZIDE d00253A C R60.9 Edema, unspecified A E A MECLIZINE d00859A C R42 Dizziness and giddiness A E A MEMANTINE d04899A C R41 Other symptoms and signs involving cognitive functions and awareness A E A OMEPRAZOLE d00325A C K25 Gastric ulcer A E A . . . E A ESCITALOPRAM d04812A C"0 F41.9 Anxiety disorder, unspecified A E A . . . E A . . . E A . . . E A METHYLPHENIDATE d00900A Cr F90 Attention-deficit hyperactivity disorders A0 E A MINOCYCLINE d00110A B[ L70 Acne A0 E A RISPERIDONE d03180A Cr F31.9 R45 Bipolar disorder, unspecified Symptoms and signs involving emotional state A0 E A . . . E0 A GABAPENTIN d03182A Cr R20 Disturbances of skin sensation A0 E0 A HYDROXYCHLOROQUINE d00817A C[@ L93 Lupus erythematosus A0 E0 A TAMSULOSIN d04121A Cr N40 Enlarged prostate A0 E@ A ALBUTEROL d00749A Ap R06.2 Wheezing A E@ A PREDNISOLONE d00084A AP B34.9 Viral infection, unspecified A EP A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ EP A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified A@ EP A IBUPROFEN d00015A C M13 Other arthritis A@ EP A METOPROLOL d00134A C I10 Essential (primary) hypertension A@ E` A . . . Ep A DIVALPROEX SODIUM d03833A C G40 Epilepsy and recurrent seizures AP Ep A FAMOTIDINE d00141A C- R63 Symptoms and signs concerning food and fluid intake AP Ep A MYCOPHENOLATE MOFETIL d03839A C T86.9P Prevent transplanted organ and tissue rejection AP Ep A PREDNISONE d00350A C 99999 AP Ep A TACROLIMUS d03752A C T86.9P Prevent transplanted organ and tissue rejection AP E A ATENOLOL d00004A C I10 Essential (primary) hypertension A0 E A HYDROCHLOROTHIAZIDE d00253A D I10 Essential (primary) hypertension A0 E A SIMVASTATIN d00746A D E78.0 Pure hypercholesterolemia A0 E A . . . E A DOXYCYCLINE d00037A C L70 Acne A@ E A ETHINYL ESTRADIOL; NORGESTIMATE d03781A B N92 Excessive, frequent and irregular menstruation A@ E A FLUTICASONE NASAL d04283A C- J30.2 R09.81 Other seasonal allergic rhinitis Nasal congestion A@ E A METRONIDAZOLE TOPICAL d03208A C L70 Acne A@ E A . . . E A CLONIDINE d00044A C G47.0 Insomnia A` E A DIAZEPAM d00148A C F41.9 Anxiety disorder, unspecified A` E A FLUOXETINE d00236A CP F32.9 Major depressive disorder, single episode, unspecified A` E A GABAPENTIN d03182A Cr F41.9 Anxiety disorder, unspecified A` E A RISPERIDONE d03180A C F43.1 G47.9 Post-traumatic stress disorder (PTSD) Sleep disorder, unspecified A` E A TRAZODONE d00395A CDp F43.1 G47.9 Post-traumatic stress disorder (PTSD) Sleep disorder, unspecified A` E A CONJUGATED ESTROGENS TOPICAL d04396A CDp N95 Menopausal and other perimenopausal disorders A E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A . . . E A PREDNISONE d00350A D- 55555 A E A . . . E 0 A . . . E @ A METHYLPHENIDATE d00900A C F90 Attention-deficit hyperactivity disorders A E P A . . . E ` A ALBUTEROL d00749A C[@ J45 Asthma A0 E ` A ALBUTEROL d00749A C J45 Asthma A0 E ` A BUDESONIDE d04276A0 C J45 Asthma A0 E p A AMLODIPINE d00689A D& I10 Essential (primary) hypertension AP E p A LEVOTHYROXINE d00278A D& E04 Other nontoxic goiter AP E p A LOSARTAN d03821A D= I10 Essential (primary) hypertension AP E p A METOPROLOL d00134A D& I10 Essential (primary) hypertension AP E p A OMEPRAZOLE d00325A D K21 Gastro-esophageal reflux disease AP E A . . . E A . . . E A . . . E A CLOPIDOGREL d04258A C Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets A` E A FUROSEMIDE d00070A B 99999 A` E A IMIPRAMINE d00259A C R52 Pain, unspecified A` E A METOPROLOL d00134A B 99999 A` E A POTASSIUM CHLORIDE d00345A B 99999 A` E A TOPIRAMATE d04115A B R52 Pain, unspecified A` E A . . . E A . . . E A . . . E A INSULIN ASPART d04697A C E11 Type 2 diabetes mellitus A0 E A INSULIN GLARGINE d04538A C E11 Type 2 diabetes mellitus A0 E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A0 E A . . . E A ACETAMINOPHEN; BUTALBITAL; CAFFEINE d03455A Ei M54 Dorsalgia A@ E A CYCLOBENZAPRINE d00963A B 99999 A@ E A HYDROCHLOROTHIAZIDE d00253A Ei 99999 A@ E A HYDROXYCHLOROQUINE d00817A C L93 Lupus erythematosus A@ E A CARVEDILOL d03847A C[@ I10 Essential (primary) hypertension A0 E A FENOFIBRATE d04286A C[@ E63.9 Nutritional deficiency, unspecified A0 E A HYDROCHLOROTHIAZIDE; SPIRONOLACTONE d03247A Cr I10 Essential (primary) hypertension A0 E0 A METHYLPHENIDATE d00900A B[ F90 Attention-deficit hyperactivity disorders A E0 A METHYLPHENIDATE d00900A B[ F90 Attention-deficit hyperactivity disorders A E@ A CARVEDILOL d03847A C 99999 A` E@ A ESOMEPRAZOLE d04749A B[ K30 Functional dyspepsia A` E@ A FUROSEMIDE d00070A C 99999 A` E@ A LOSARTAN d03821A C 99999 A` E@ A NITROGLYCERIN d00321A C I21 ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction A` E@ A SIMVASTATIN d00746A C 99999 A` EP A ATORVASTATIN d04105A Cr E78.0 Pure hypercholesterolemia A EP A PAROXETINE d03157A CDp F32.9 Major depressive disorder, single episode, unspecified A E` A . . . Ep A HYDROCHLOROTHIAZIDE d00253A C- I10 R60.9 Essential (primary) hypertension Edema, unspecified A Ep A OMEPRAZOLE d00325A C- K21 Gastro-esophageal reflux disease A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A CETIRIZINE d03827A A R05 Cough A E A . . . E A . . . E A . . . E A OMEPRAZOLE d00325A C[@ K21 K30 K57 Gastro-esophageal reflux disease Functional dyspepsia Diverticular disease of intestine A E A PANTOPRAZOLE d04514A Ap K21 Gastro-esophageal reflux disease A E0 A . . . E@ A ACETAMINOPHEN; HYDROCODONE d03428A A M54 Dorsalgia A@ E@ A METOPROLOL d00134A C I10 Essential (primary) hypertension A@ E@ A OLMESARTAN d04801A C I10 Essential (primary) hypertension A@ E@ A SPIRONOLACTONE d00373A C I10 Essential (primary) hypertension A@ EP A . . . E` A . . . Ep A . . . E A BENZOYL PEROXIDE; CLINDAMYCIN TOPICAL d04742A B[ L70 Acne A E A FLUORIDE TOPICAL d04397A B= K02 Dental caries A E A 55555 A Cr 55555 A E A 55555 A D R63 Symptoms and signs concerning food and fluid intake A E A 55555 A D 55555 A E A ALBUTEROL d00749A CDp 55555 A E A ALBUTEROL d00749A D 55555 A E A AZITHROMYCIN d00091A C T78.40 Allergy, unspecified A E A PANCRELIPASE d01002A D 55555 A E A SODIUM CHLORIDE d00438A D 55555 A E A TOBRAMYCIN d00069A CDp 55555 A E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ E A ATENOLOL d00004A C I10 Essential (primary) hypertension A@ E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A@ E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A E A VALACYCLOVIR d03838A C B00.1 Herpesviral vesicular dermatitis A E A . . . E A HYDROXYCHLOROQUINE d00817A C- M19.9 Osteoarthritis, unspecified site A@ E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A@ E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A@ E A PENTOSAN POLYSULFATE SODIUM d04052A Dc N32.9 Bladder disorder, unspecified A@ E A . . . E A CLONIDINE d00044A C I10 Essential (primary) hypertension A0 E A IMATINIB d04758A C C80.1P Prevent cancer A0 E A VALSARTAN d04113A Cr I10 Essential (primary) hypertension A0 E A AMOXICILLIN d00088A Ap J09 Influenza due to certain identified influenza viruses A E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A` E A ASPIRIN d00170A C I21.P Prevent heart attack/myocardial infarction A` E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A` E A FUROSEMIDE d00070A C R60.9 Edema, unspecified A` E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A` E A METOPROLOL d00134A C R00 Abnormalities of heart beat A` E0 A ALBUTEROL d00749A C J45 Asthma A E@ A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A E@ A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A EP A . . . E` A . . . Ep A . . . E A LISINOPRIL d00732A B= N39.0 Urinary tract infection, site not specified A E A METFORMIN d03807A B= E11 Type 2 diabetes mellitus A E A GABAPENTIN d03182A B F41.9 M79.2 Anxiety disorder, unspecified Neuralgia and neuritis, unspecified A E A . . . E A MOMETASONE NASAL d04223A CDp R09.8 Other specified symptoms and signs involving the circulatory and respiratory systems A E A . . . E A . . . E A AMOXICILLIN d00088A A@ K04.7 Periapical abscess without sinus A E A . . . E A CLONAZEPAM d00197A B G25.81 Restless legs syndrome A E A FINASTERIDE d00563A CDp N40 Enlarged prostate A E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E A TAMSULOSIN d04121A CDp N40 Enlarged prostate A E A . . . E0 A ACETAMINOPHEN; HYDROCODONE d03428A B# T14.9 Unspecified injury AP E0 A CITALOPRAM d04332A B F32.9 Major depressive disorder, single episode, unspecified AP E0 A ELUXADOLINE d08401A B[ K58 Irritable bowel syndrome AP E0 A OMEPRAZOLE d00325A Cr K21 Gastro-esophageal reflux disease AP E0 A ROSUVASTATIN d04851A C- E78.0 Pure hypercholesterolemia AP E@ A . . . EP A . . . E` A LANSOPRAZOLE d03828A B K21 Gastro-esophageal reflux disease A E` A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease A Ep A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A Ep A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A CDp I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A . . . E A . . . E A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E A CETIRIZINE d03827A A T78.40 Allergy, unspecified A E A CLONIDINE d00044A C I10 Essential (primary) hypertension A` E A FINASTERIDE d00563A C N40 Enlarged prostate A` E A FLUOXETINE d00236A C F32.9 Major depressive disorder, single episode, unspecified A` E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A` E A METOPROLOL d00134A C I10 R00 Essential (primary) hypertension Abnormalities of heart beat A` E A TAMSULOSIN d04121A C N40 Enlarged prostate A` E A . . . E A ATORVASTATIN d04105A Cr I21.P Prevent heart attack/myocardial infarction A@ E A CANAGLIFLOZIN d08080A B E11 Type 2 diabetes mellitus A@ E A INSULIN DETEMIR d05436A B[ E11 Type 2 diabetes mellitus A@ E A METFORMIN d03807A B E11 Type 2 diabetes mellitus A@ E A . . . E A . . . E0 A ATORVASTATIN d04105A B[ E78.0 Pure hypercholesterolemia A0 E0 A LOSARTAN d03821A B I10 Essential (primary) hypertension A0 E0 A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified A0 E@ A . . . EP A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A0 EP A PRAVASTATIN d00348A Cr E78.0 Pure hypercholesterolemia A0 EP A TRAZODONE d00395A D G47.0 Insomnia A0 E` A . . . Ep A . . . E A . . . E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E A HYDROCHLOROTHIAZIDE d00253A C[@ I10 Essential (primary) hypertension A E A . . . E A . . . E A AMLODIPINE d00689A C 99999 A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A ESCITALOPRAM d04812A C F41.9 Anxiety disorder, unspecified A E A FAMOTIDINE d00141A Cr K21 Gastro-esophageal reflux disease A E A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A E A LOSARTAN d03821A CDp 99999 A E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A METOPROLOL d00134A C I10 Essential (primary) hypertension A E A TAMSULOSIN d04121A Cr N40 R39.1 Enlarged prostate Other difficulties with micturition A E A CARVEDILOL d03847A C I49.9 Cardiac arrhythmia, unspecified A@ E A EZETIMIBE d04824A C- E78.0 Pure hypercholesterolemia A@ E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A@ E A PITAVASTATIN d07637A C- E78.0 Pure hypercholesterolemia A@ E A HYDROCODONE d03075A A M79.6 Pain in limb, hand, foot, fingers and toes A E A . . . E A ALLOPURINOL d00023A C[@ M10.9P Prevent gout A0 E A HYDROCHLOROTHIAZIDE d00253A D* I10 Essential (primary) hypertension A0 E A LISINOPRIL d00732A D* I10 Essential (primary) hypertension A0 E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A ALPRAZOLAM d00168A Cr G47.0 Insomnia A@ E A AMLODIPINE d00689A C G47.0 Insomnia A@ E A NADOLOL d00018A C I10 Essential (primary) hypertension A@ E A POTASSIUM CHLORIDE d00345A Cr 99999 A@ E A . . . E A . . . E A . . . E A DILTIAZEM d00045A C- I10 Essential (primary) hypertension A E A FUROSEMIDE d00070A Ei R60.9 R73 Edema, unspecified Elevated blood glucose level A E A GABAPENTIN d03182A C- R52 Pain, unspecified A E A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A E A LINACLOTIDE d07902A Bz K59.0 Constipation A E A LOVASTATIN d00280A C[@ E78.0 Pure hypercholesterolemia A E A METHOTREXATE d00060A B= R21 Rash and other nonspecific skin eruption A E A QUINAPRIL d00365A C[@ I10 Essential (primary) hypertension A E A SITAGLIPTIN d05896A C"@ E11 Type 2 diabetes mellitus A E A TIZANIDINE d04102A CDp M62.83 Muscle spasm A E A . . . E A CETIRIZINE d03827A C T78.40 Allergy, unspecified A E A MONTELUKAST d04289A CDp J30.9 Allergic rhinitis, unspecified A E A ALPRAZOLAM d00168A C F41.9 G47.0 Anxiety disorder, unspecified Insomnia A E A LOSARTAN d03821A C[@ I10 Essential (primary) hypertension A E A . . . E A . . . E0 A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E@ A . . . EP A ATENOLOL d00004A C[@ I10 Essential (primary) hypertension Ap EP A GLIPIZIDE d00246A CDp E11 Type 2 diabetes mellitus Ap EP A HYDROCHLOROTHIAZIDE d00253A C[@ I10 Essential (primary) hypertension Ap EP A INSULIN ISOPHANE (NPH) d04370A A E11 Type 2 diabetes mellitus Ap EP A LOSARTAN d03821A B I10 Essential (primary) hypertension Ap EP A LOVASTATIN d00280A C[@ E78.0 Pure hypercholesterolemia Ap EP A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus Ap E` A . . . Ep A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A A K08.8 Other specified disorders of teeth and supporting structures A E A AMOXICILLIN d00088A A K04.7 Periapical abscess without sinus A E A . . . E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 E A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus A0 E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A0 E A . . . E A . . . E A . . . E A HYDROCHLOROTHIAZIDE d00253A C- I10 Essential (primary) hypertension A E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A` E A CARVEDILOL d03847A C I10 Essential (primary) hypertension A` E A FUROSEMIDE d00070A C R60.9 Edema, unspecified A` E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A` E A LOVASTATIN d00280A C E78.0 Pure hypercholesterolemia A` E A MORPHINE d00308A B= M54 Dorsalgia A` E A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E A GABAPENTIN d03182A C M79.6 Pain in limb, hand, foot, fingers and toes AP E A METOPROLOL d00134A C I10 Essential (primary) hypertension AP E A MIRTAZAPINE d04025A C G47.0 Insomnia AP E A . . . E0 A . . . E@ A PHENDIMETRAZINE d00809A B E66 Overweight and obesity A EP A LEVOTHYROXINE d00278A Ei E07.9 Disorder of thyroid, unspecified AP EP A LISINOPRIL d00732A A I10 Essential (primary) hypertension AP EP A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP EP A OLANZAPINE d04050A B F32.9 Major depressive disorder, single episode, unspecified AP EP A SIMVASTATIN d00746A B[ E78.0 Pure hypercholesterolemia AP E` A . . . Ep A . . . E A . . . E A ALBUTEROL d00749A A J20.9 Acute bronchitis, unspecified A E A OSELTAMIVIR d04462A AP J09 Influenza due to certain identified influenza viruses A E A . . . E A . . . E A . . . E A . . . E A AMLODIPINE d00689A Ei I10 Essential (primary) hypertension A0 E A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A0 E A ILOPERIDONE d07441A CDp F20 Schizophrenia A0 E A . . . E A GABAPENTIN d03182A C 99999 A` E A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A` E A OXYBUTYNIN d00328A C N39.4 Other specified urinary incontinence A` E A RIVAROXABAN d07356A Cr D75.9P Prevent blood clots A` E A SOTALOL d00371A C I51.9 Heart disease, unspecified A` E A TAMSULOSIN d04121A C N40 Enlarged prostate A` E A . . . E A . . . E 0 A . . . E @ A ETHINYL ESTRADIOL; NORETHINDRONE d03238A CDp Z79.3 Long term (current) use of hormonal contraceptives A E P A . . . E ` A ALBUTEROL d00749A C J45 Asthma A E ` A MONTELUKAST d04289A Cr J45 Asthma A E p A . . . E A . . . E A . . . E A HALOPERIDOL d00027A C P G31.9 R25 Degenerative disease of nervous system, unspecified Abnormal involuntary movements Ap E A HYOSCYAMINE d00985A B R09.3 Abnormal sputum Ap E A LACTULOSE d01024A B K59.0 Constipation Ap E A LISINOPRIL d00732A C I10 Essential (primary) hypertension Ap E A LORAZEPAM d00149A C F41.9 Anxiety disorder, unspecified Ap E A MORPHINE d00308A B M79.1 R52 Myalgia Pain, unspecified Ap E A OXYCODONE d00329A B5 M79.1 Myalgia Ap E A ALPRAZOLAM d00168A C F41.9 Anxiety disorder, unspecified A E A CARVEDILOL d03847A C- I10 Essential (primary) hypertension A E A CYCLOBENZAPRINE d00963A B M62.83 Muscle spasm A E A GABAPENTIN d03182A CDp M54 Dorsalgia A E A GLIPIZIDE d00246A C E11 Type 2 diabetes mellitus A E A LEVOTHYROXINE d00278A C E05 Thyrotoxicosis [hyperthyroidism] A E A MONTELUKAST d04289A C J30.9 Allergic rhinitis, unspecified A E A NITROGLYCERIN d00321A C- I51.9 Heart disease, unspecified A E A PREDNISONE d00350A C J44.9 Chronic obstructive pulmonary disease, unspecified A E A ROFLUMILAST d07684A Bz J44.9 Chronic obstructive pulmonary disease, unspecified A E A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A E A SPIRONOLACTONE d00373A C- R60.9 Edema, unspecified A E A TORSEMIDE d03189A C- R60.9 Edema, unspecified A E A . . . E A . . . E A AMOXICILLIN d00088A A H66.9 Otitis media, unspecified A E A GLIPIZIDE d00246A B E11.P Prevent diabetes A E A NAPROXEN d00019A CDp Z79 Long term (current) drug therapy A E A . . . E A . . . E 0 A . . . E @ A . . . E P A . . . E ` A . . . E p A . . . E A . . . E A . . . E A . . . E A . . . E A ALLOPURINOL d00023A D# M10.9P Prevent gout Ap E A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia Ap E A CARVEDILOL d03847A D I10 I50.9 Essential (primary) hypertension Heart failure, unspecified Ap E A DABIGATRAN d07137A B D75.9P Z79.0 Prevent blood clots Long term (current) use of anticoagulants and antithrombotics/antiplatelets Ap E A FUROSEMIDE d00070A CDp R60.9 Edema, unspecified Ap E A LOSARTAN d03821A D* I10 Essential (primary) hypertension Ap E A SOTALOL d00371A C"0 I49.9 Cardiac arrhythmia, unspecified Ap E A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A E A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A E A BACLOFEN d00967A C M54 Dorsalgia A E A CLONIDINE d00044A C I10 Essential (primary) hypertension A E A HYDRALAZINE d00132A Bz I10 Essential (primary) hypertension A E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A E A INSULIN DETEMIR d05436A C- E11 Type 2 diabetes mellitus A E A RANITIDINE d00021A C K30 Functional dyspepsia A E A SERTRALINE d00880A C F32.9 Major depressive disorder, single episode, unspecified A E A AMLODIPINE d00689A C I10 Essential (primary) hypertension AP E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E A INSULIN ISOPHANE; INSULIN REGULAR d04374A C E11 Type 2 diabetes mellitus AP E A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP E A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP E A . . . E A ALLOPURINOL d00023A C M1A Chronic gout A@ E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A C I10 Essential (primary) hypertension A@ E A METFORMIN d03807A C R73 Elevated blood glucose level A@ E A . . . E A CEFUROXIME d00056A A J40 Bronchitis, not specified as acute or chronic A@ E A LOSARTAN d03821A C I10 Essential (primary) hypertension A@ E A MESALAMINE d01031A C K51 Ulcerative colitis A@ E A METFORMIN d03807A D E11 Type 2 diabetes mellitus A@ E 0 A . . . E @ A . . . E P A CEPHALEXIN d00096A A K04.7P Prevent tooth infection A E ` A AMPHETAMINE; DEXTROAMPHETAMINE d04035A C F90 Attention-deficit hyperactivity disorders A E p A ALBUTEROL d00749A CDp J45 Asthma A` E p A FLUTICASONE NASAL d04283A C- J30.2 Other seasonal allergic rhinitis A` E p A FLUTICASONE; SALMETEROL d04611A CDp J45 Asthma A` E p A LISDEXAMFETAMINE d06663A B[ F90 Attention-deficit hyperactivity disorders A` E p A OLOPATADINE NASAL d07132A C- R09.81 Nasal congestion A` E p A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A C- J01.9 Acute sinusitis, unspecified A` E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E A SPIRONOLACTONE d00373A CDp I10 Essential (primary) hypertension A0 E A VALSARTAN d04113A D I10 Essential (primary) hypertension A0 E A . . . E A . . . E A CLOPIDOGREL d04258A Cr I51.9P Z79.0 Prevent heart disease Long term (current) use of anticoagulants and antithrombotics/antiplatelets A@ E A LOSARTAN d03821A C- I10 Essential (primary) hypertension A@ E A METOPROLOL d00134A Cr I51.9 Heart disease, unspecified A@ E A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A@ E A . . . E A ASPIRIN d00170A B- M79.1 Myalgia A E A DONEPEZIL d04099A B- R41 Other symptoms and signs involving cognitive functions and awareness A E A GABAPENTIN d03182A B- M79.2 Neuralgia and neuritis, unspecified A E A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A E A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A E A NORTRIPTYLINE d00144A B M79.2 Neuralgia and neuritis, unspecified A E A SERTRALINE d00880A B F90 Attention-deficit hyperactivity disorders A E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E A SULFASALAZINE d00379A C K51 Ulcerative colitis A E A TAMSULOSIN d04121A C N40 Enlarged prostate A E A TRAMADOL d03826A B= 99999 A E A ZOLPIDEM d00910A B G47.0 Insomnia A E A AMPHETAMINE; DEXTROAMPHETAMINE d04035A CDp F90 Attention-deficit hyperactivity disorders A E A CETIRIZINE d03827A C- T78.40 Allergy, unspecified A E A CIPROFLOXACIN; DEXAMETHASONE OTIC d04890A A H60 Otitis externa A E A FAMOTIDINE d00141A C K92.9 Disease of digestive system, unspecified A E A FLUOXETINE d00236A C F39 F91 Unspecified mood [affective] disorder Conduct disorders A E A FLUTICASONE NASAL d04283A C J30.9 Allergic rhinitis, unspecified A E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C N19 Unspecified kidney failure A E A LAMOTRIGINE d03809A C- F39 F91 Unspecified mood [affective] disorder Conduct disorders A E A NITROFURANTOIN d00112A C- N39.0P Prevent urinary tract infection A E A POLYETHYLENE GLYCOL 3350 d05350A C K59.0 Constipation A E A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A E A . . . E 0 A ETHINYL ESTRADIOL; NORETHINDRONE d03238A B N92 Excessive, frequent and irregular menstruation A E @ A . . . E P A APIXABAN d07804A C- I48.9 Unspecified atrial fibrillation and atrial flutter Ap E P A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia Ap E P A DILTIAZEM d00045A Cr I48.9 Unspecified atrial fibrillation and atrial flutter Ap E P A ESCITALOPRAM d04812A C F41.9 Anxiety disorder, unspecified Ap E P A LISINOPRIL d00732A C I10 Essential (primary) hypertension Ap E P A METOPROLOL d00134A C- I48.9 Unspecified atrial fibrillation and atrial flutter Ap E P A PANTOPRAZOLE d04514A Cr K25 Gastric ulcer Ap E ` A LEVOTHYROXINE d00278A Dc E03.9 Z90 Hypothyroidism, unspecified Acquired absence of organs, not elsewhere classified A E p A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A PANTOPRAZOLE d04514A C- K21 R12 Gastro-esophageal reflux disease Heartburn A E A . . . E A . . . E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A` E A DILTIAZEM d00045A Bz 99999 A` E A ENALAPRIL d00013A C 99999 A` E A FUROSEMIDE d00070A Bz 99999 A` E A POTASSIUM CHLORIDE d00345A Bz 99999 A` E A SOTALOL d00371A B I49.9 Cardiac arrhythmia, unspecified A` E A . . . E 0 A APIXABAN d07804A B Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets Ap E 0 A GLIMEPIRIDE d03864A C- E11.P R73 Prevent diabetes Elevated blood glucose level Ap E 0 A LEVETIRACETAM d04499A C[@ G40 Epilepsy and recurrent seizures Ap E 0 A LEVOTHYROXINE d00278A CDp E07.9 Disorder of thyroid, unspecified Ap E 0 A LOSARTAN d03821A C I10 Essential (primary) hypertension Ap E 0 A METOPROLOL d00134A C I10 Essential (primary) hypertension Ap E 0 A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia Ap E @ A CLARITHROMYCIN d00097A A K04.7 Periapical abscess without sinus A E P A . . . E ` A . . . E p A GABAPENTIN d03182A Cr M79.2 Neuralgia and neuritis, unspecified AP E p A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP E p A OMEPRAZOLE d00325A B K92.9 Disease of digestive system, unspecified AP E p A SIMVASTATIN d00746A Cr E78.0 Pure hypercholesterolemia AP E p A TIOTROPIUM d04829A C J44.9 R06.9 Chronic obstructive pulmonary disease, unspecified Unspecified abnormalities of breathing AP E A SULFAMETHOXAZOLE; TRIMETHOPRIM d00124A A` A49.9 Bacterial infection, unspecified A E A BISOPROLOL; HYDROCHLOROTHIAZIDE d03744A D* I51.9P Z79 Prevent heart disease Long term (current) drug therapy AP E A CYCLOBENZAPRINE d00963A C- M79.1 Myalgia AP E A ESCITALOPRAM d04812A D N95 Z90 Menopausal and other perimenopausal disorders Acquired absence of organs, not elsewhere classified AP E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified AP E A LOSARTAN d03821A D I10 Essential (primary) hypertension AP E A APIXABAN d07804A C D75.9P I48.9 Prevent blood clots Unspecified atrial fibrillation and atrial flutter A0 E A PANTOPRAZOLE d04514A CDp K27 Peptic ulcer, site unspecified A0 E A VERAPAMIL d00048A C- I49.9 Cardiac arrhythmia, unspecified A0 E A CARVEDILOL d03847A CDp I10 Essential (primary) hypertension A0 E A CLOPIDOGREL d04258A CD` I21 ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction A0 E A PITAVASTATIN d07637A C- E78.0 Pure hypercholesterolemia A0 E A . . . E A ALLOPURINOL d00023A B M10.9 Gout, unspecified A E A INDOMETHACIN d00039A A@ M1A Chronic gout A E A . . . E A FLUTICASONE; SALMETEROL d04611A C J43 J44.9 Emphysema Chronic obstructive pulmonary disease, unspecified A` E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A` E A LOVASTATIN d00280A D E78.0 Pure hypercholesterolemia A` E A RANITIDINE d00021A CDp K21 Gastro-esophageal reflux disease A` E A RISPERIDONE d03180A C F20 Schizophrenia A` E A TRAZODONE d00395A D' F29 G47.0 G47.9 Unspecified psychosis not due to a substance or known physiological condition Insomnia Sleep disorder, unspecified A` E A AMLODIPINE d00689A D% I10 Essential (primary) hypertension AP E A FLUTICASONE NASAL d04283A C J30.1 Allergic rhinitis due to pollen AP E A LISINOPRIL d00732A D% I10 Essential (primary) hypertension AP E A METHOCARBAMOL d00965A B M79.1 Myalgia AP E A OXYMORPHONE d00833A C[@ M54 Dorsalgia AP E A LISINOPRIL d00732A C- I10 Essential (primary) hypertension A E A OMEPRAZOLE d00325A Dc K21 Gastro-esophageal reflux disease A E A . . . E0 A METHYLPHENIDATE d00900A CDp F90 Attention-deficit hyperactivity disorders A E@ A ALPRAZOLAM d00168A CDp F41.9 Anxiety disorder, unspecified Ap E@ A ESCITALOPRAM d04812A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Ap E@ A ESOMEPRAZOLE d04749A Cr 55555 Ap E@ A EZETIMIBE d04824A C- E78.0 Pure hypercholesterolemia Ap E@ A HOMATROPINE; HYDROCODONE d03340A A@ R05 Cough Ap E@ A LISINOPRIL d00732A C I10 Essential (primary) hypertension Ap E@ A VALACYCLOVIR d03838A D B00.1 Herpesviral vesicular dermatitis Ap EP A ALBUTEROL d00749A D* J45 Asthma A EP A BUDESONIDE; FORMOTEROL d04795A C[@ J45 Asthma A EP A FENOFIBRATE d04286A C- E78.0 Pure hypercholesterolemia A EP A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A EP A LOSARTAN d03821A C I10 Essential (primary) hypertension A EP A MEMANTINE d04899A C- R41 Other symptoms and signs involving cognitive functions and awareness A EP A MONTELUKAST d04289A Cr J42 J45 R06.9 Unspecified chronic bronchitis Asthma Unspecified abnormalities of breathing A EP A PREDNISONE d00350A D* J45 Asthma A E` A . . . Ep A . . . E A FLUTICASONE; SALMETEROL d04611A Cr J45 Asthma A E A . . . E A GABAPENTIN d03182A CDp M79.2 Neuralgia and neuritis, unspecified A0 E A LATANOPROST OPHTHALMIC d04017A C H40 Glaucoma A0 E A TIMOLOL d00139A D I49.9 Cardiac arrhythmia, unspecified A0 E A . . . E A . . . E A CARVEDILOL d03847A C I10 Essential (primary) hypertension A E A CITALOPRAM d04332A C F32.9 Major depressive disorder, single episode, unspecified A E A CLOPIDOGREL d04258A C D75.9P Prevent blood clots A E A FAMOTIDINE d00141A C R12 Heartburn A E A FUROSEMIDE d00070A C I51.9 Heart disease, unspecified A E A GABAPENTIN d03182A C- M79.2 Neuralgia and neuritis, unspecified A E A HYDRALAZINE d00132A C I50.9 Heart failure, unspecified A E A INSULIN ASPART d04697A C R73 Elevated blood glucose level A E A INSULIN GLARGINE d04538A C R73 Elevated blood glucose level A E A ISOSORBIDE MONONITRATE d00269A C I21.P Prevent heart attack/myocardial infarction A E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A OMEGA-3 POLYUNSATURATED FATTY ACIDS d00497A C I51.9P Prevent heart disease A E A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A . . . E A AMITRIPTYLINE d00146A C G47.0 Insomnia A E A AMLODIPINE d00689A C- I10 Essential (primary) hypertension A E A DICYCLOMINE d00999A C R10 Abdominal and pelvic pain A E A HYDROCHLOROTHIAZIDE d00253A B I10 Essential (primary) hypertension A E A METHOCARBAMOL d00965A C T14.9 Unspecified injury A E A PAROXETINE d03157A C- F32.9 Major depressive disorder, single episode, unspecified A E A PROPRANOLOL d00032A C R07.9 Chest pain, unspecified A E A ROPINIROLE d04215A C G25.81 Restless legs syndrome A E A TOPIRAMATE d04115A C G43 Migraine A E A TRAMADOL d03826A B= M25.5 Pain in joint A E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A0 E A DORZOLAMIDE; TIMOLOL OPHTHALMIC d04303A C H40 Glaucoma A0 E A LATANOPROST OPHTHALMIC d04017A C H40 Glaucoma A0 E A DICLOFENAC; MISOPROSTOL d04271A Cr M19.9 Osteoarthritis, unspecified site AP E A FUROSEMIDE d00070A D# R60.9 Edema, unspecified AP E A GABAPENTIN d03182A C- M79.2 Neuralgia and neuritis, unspecified AP E A METOPROLOL d00134A D I10 Essential (primary) hypertension AP E A POTASSIUM CHLORIDE d00345A Cr E87.6 Hypokalemia AP E A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A E A BUPROPION d00181A C F32.9 Major depressive disorder, single episode, unspecified A E A CITALOPRAM d04332A B F32.9 Major depressive disorder, single episode, unspecified A E A DESONIDE TOPICAL d01290A CDp B35 Dermatophytosis A E A DICLOFENAC d00848A C M19.9 Osteoarthritis, unspecified site A E A DONEPEZIL d04099A CDp R41 Other symptoms and signs involving cognitive functions and awareness A E A KETOCONAZOLE TOPICAL d03202A CDp B35 Dermatophytosis A E A LEVOTHYROXINE d00278A DJ$ E03.9 Hypothyroidism, unspecified A E A LORAZEPAM d00149A CDp F41.9 Anxiety disorder, unspecified A E A METRONIDAZOLE TOPICAL d03208A C"0 L71 Rosacea A E A TRAZODONE d00395A Dc G47.0 Insomnia A E A TRIAMCINOLONE TOPICAL d03206A C- L98.9 Disorder of the skin and subcutaneous tissue, unspecified A E A ZOLPIDEM d00910A Dc G47.0 Insomnia A E A . . . E A . . . E A . . . E A . . . E A . . . E A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension AP E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified AP E A MONTELUKAST d04289A D J30.1 J45 Allergic rhinitis due to pollen Asthma AP E A SERTRALINE d00880A D# F32.9 Major depressive disorder, single episode, unspecified AP E A . . . E0 A FORMOTEROL; MOMETASONE d07660A C- T78.40 Allergy, unspecified A E@ A ONDANSETRON d00867A B R11 Nausea and vomiting A EP A DICLOFENAC d00848A B< M54 Dorsalgia A@ EP A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A@ EP A LISINOPRIL d00732A BZ E11.2P Prevent diabetic kidney disease A@ EP A OLOPATADINE OPHTHALMIC d04117A Cr H10.1 Acute atopic conjunctivitis A@ E` A . . . Ep A . . . E A . . . E A ALBUTEROL; IPRATROPIUM d04066A C- J44.9 Chronic obstructive pulmonary disease, unspecified Ap E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia Ap E A BECLOMETHASONE d00760A D J44.9 Chronic obstructive pulmonary disease, unspecified Ap E A HYDROCHLOROTHIAZIDE d00253A Dc R60.9 Edema, unspecified Ap E A LOSARTAN d03821A C E11.2 Type 2 diabetes mellitus with kidney complications Ap E A NORTRIPTYLINE d00144A D F32.9 I10 Major depressive disorder, single episode, unspecified Essential (primary) hypertension Ap E A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease Ap E A ESCITALOPRAM d04812A B F41.9 Anxiety disorder, unspecified A E A . . . E A . . . E A . . . E A . . . E A ALLOPURINOL d00023A C G20 Parkinson's disease A E A AMANTADINE d00086A Ei G20 Parkinson's disease A E A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A E A CARBIDOPA; LEVODOPA d03473A Cr G20 Parkinson's disease A E A CHLORHEXIDINE TOPICAL d01231A B= L08.9 Local infection of the skin and subcutaneous tissue, unspecified A E A DONEPEZIL d04099A C- R41 Other symptoms and signs involving cognitive functions and awareness A E A ESCITALOPRAM d04812A Ei G20 Parkinson's disease A E A POLYETHYLENE GLYCOL 3350 d05350A C 99999 A E A TROSPIUM d04929A Cr N32.81 Overactive bladder A E A AZELAIC ACID TOPICAL d03848A C- L70 Acne A E A ETHINYL ESTRADIOL; NORETHINDRONE d03238A C- N92 Excessive, frequent and irregular menstruation A E A OMEPRAZOLE d00325A Cr K21 R12 Gastro-esophageal reflux disease Heartburn A E A . . . E0 A . . . E@ A FAMOTIDINE d00141A Ap R10 Abdominal and pelvic pain A E@ A TRAZODONE d00395A Ap R51 Headache A EP A CARVEDILOL d03847A CDp I10 Essential (primary) hypertension Ap EP A DIVALPROEX SODIUM d03833A CDp F31.9 Bipolar disorder, unspecified Ap EP A DOXAZOSIN d00726A CDp R35 Polyuria Ap EP A ESCITALOPRAM d04812A D/ F31.9 F41.9 Bipolar disorder, unspecified Anxiety disorder, unspecified Ap EP A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified Ap EP A SIMVASTATIN d00746A B[ E78.0 Pure hypercholesterolemia Ap EP A TRAZODONE d00395A CDp G47.9 Sleep disorder, unspecified Ap E` A . . . Ep A ALLOPURINOL d00023A Cr M25.5 Pain in joint A@ Ep A APIXABAN d07804A C[@ I48.9 Unspecified atrial fibrillation and atrial flutter A@ Ep A LOSARTAN d03821A C I10 Essential (primary) hypertension A@ Ep A METOPROLOL d00134A C I10 Essential (primary) hypertension A@ E A SIMVASTATIN d00746A Dc E78.0 Pure hypercholesterolemia A E A . . . E A ONDANSETRON d00867A B[ R11 Nausea and vomiting A E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A0 E A PRAVASTATIN d00348A C E78.0 Pure hypercholesterolemia A0 E A PRAZOSIN d00138A C N40 Enlarged prostate A0 E A . . . E A . . . E A . . . E A 77777 . . A E A AMLODIPINE d00689A B I10 Essential (primary) hypertension A@ E A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension A@ E A PREGABALIN d05508A B= M79.7 Fibromyalgia A@ E A RANITIDINE d00021A Cr R12 Heartburn A@ E A . . . E A . . . E0 A CIPROFLOXACIN; DEXAMETHASONE OTIC d04890A A H60 Otitis externa A E@ A ALBUTEROL d00749A C J45 Asthma A E@ A MONTELUKAST d04289A C J45 T78.40 Asthma Allergy, unspecified A EP A . . . E` A CITALOPRAM d04332A Ap F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A@ E` A CLOTRIMAZOLE TOPICAL d04395A B[ B35 Dermatophytosis A@ E` A SERTRALINE d00880A Cr F32.9 F41.0 F41.9 Major depressive disorder, single episode, unspecified Panic disorder [episodic paroxysmal anxiety] without agoraphobia Anxiety disorder, unspecified A@ E` A TRIAMCINOLONE TOPICAL d03206A B[ L23 L29.9 R21 Allergic contact dermatitis Pruritus, unspecified Rash and other nonspecific skin eruption A@ Ep A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E A ATENOLOL d00004A C I10 Essential (primary) hypertension A E A CLONIDINE d00044A B M79.2 Neuralgia and neuritis, unspecified A E A CLOPIDOGREL d04258A C- I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified A E A GABAPENTIN d03182A A F41.9 Anxiety disorder, unspecified A E A LOSARTAN d03821A C I10 Essential (primary) hypertension A E A NORTRIPTYLINE d00144A C- M79.2 Neuralgia and neuritis, unspecified A E A TAMSULOSIN d04121A C R35 Polyuria A E A TRIAMCINOLONE TOPICAL d03206A C L20.9 R21 Atopic dermatitis, unspecified Rash and other nonspecific skin eruption A E A HYDROCHLOROTHIAZIDE; TRIAMTERENE d03052A C"0 R60.9 Edema, unspecified A E A . . . E A . . . E A . . . E A ROSUVASTATIN d04851A C E78.0 Pure hypercholesterolemia A E A THYROID DESICCATED d00655A C E03.9 Hypothyroidism, unspecified A E A AMLODIPINE d00689A Cr I10 Essential (primary) hypertension Ap E A BICALUTAMIDE d03850A C C61 Malignant neoplasm of prostate Ap E A LISINOPRIL d00732A D* I10 Essential (primary) hypertension Ap E A METFORMIN d03807A C[@ E11 Type 2 diabetes mellitus Ap E A NEBIVOLOL d05265A Cr I10 Essential (primary) hypertension Ap E A ROSUVASTATIN d04851A D E78.0 Pure hypercholesterolemia Ap E A SERTRALINE d00880A C- F32.9 Major depressive disorder, single episode, unspecified Ap E A . . . E A INSULIN GLARGINE d04538A D& E11 Type 2 diabetes mellitus A@ E A INSULIN LISPRO d04373A D)Y E11 Type 2 diabetes mellitus A@ E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A@ E A POTASSIUM CHLORIDE d00345A B E87.6 Hypokalemia A@ E A DEXMETHYLPHENIDATE d04777A C F90 R41 Attention-deficit hyperactivity disorders Other symptoms and signs involving cognitive functions and awareness A@ E A DOXEPIN d00217A C G47.9 Sleep disorder, unspecified A@ E A MIRTAZAPINE d04025A C F31.9 G47.9 Bipolar disorder, unspecified Sleep disorder, unspecified A@ E A PRAZOSIN d00138A C G47.9 Sleep disorder, unspecified A@ E A OMEPRAZOLE d00325A C"0 K21 R12 Gastro-esophageal reflux disease Heartburn A E0 A . . . E@ A METFORMIN d03807A D"8 E11 Type 2 diabetes mellitus A0 E@ A SAXAGLIPTIN d07467A CDp E11 Type 2 diabetes mellitus A0 E@ A SIMVASTATIN d00746A C E78.0 I21.P Pure hypercholesterolemia Prevent heart attack/myocardial infarction A0 EP A . . . E` A ALENDRONATE d03849A A M81 Osteoporosis without current pathological fracture A@ E` A BISOPROLOL d00709A C I10 Essential (primary) hypertension A@ E` A CITALOPRAM d04332A CDp F41.9 Anxiety disorder, unspecified A@ E` A MELOXICAM d04532A C R52 Pain, unspecified A@ Ep A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A ATENOLOL d00004A D I10 Essential (primary) hypertension AP E A FUROSEMIDE d00070A Dc R60.9 Edema, unspecified AP E A METOCLOPRAMIDE d00298A C 99999 AP E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease AP E A POLYETHYLENE GLYCOL 3350 d05350A C K59.0 Constipation AP E A . . . E A AMOXICILLIN d00088A Ap J06.9 Acute upper respiratory infection, unspecified A0 E A FLUTICASONE NASAL d04283A C[@ T78.40 Allergy, unspecified A0 E A PHENYLEPHRINE; THONZYLAMINE d08091A A J06.9 Acute upper respiratory infection, unspecified A0 E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A@ E A CANAGLIFLOZIN d08080A C- E11 Type 2 diabetes mellitus A@ E A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A D I10 Essential (primary) hypertension A@ E A ICOSAPENT d07891A C- E78.1 Pure hyperglyceridemia A@ E A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia AP E A GABAPENTIN d03182A B= R10 Abdominal and pelvic pain AP E A LISINOPRIL d00732A C I10 Essential (primary) hypertension AP E A METFORMIN d03807A C E11 Type 2 diabetes mellitus AP E A METOPROLOL d00134A C I10 Essential (primary) hypertension AP E0 A ATENOLOL d00004A C- R06.9 Unspecified abnormalities of breathing A` E0 A FAMOTIDINE d00141A C K21 Gastro-esophageal reflux disease A` E0 A LOSARTAN d03821A C"0 I10 Essential (primary) hypertension A` E0 A METFORMIN d03807A C E11 Type 2 diabetes mellitus A` E0 A PHENYTOIN d00143A Cr G40 Epilepsy and recurrent seizures A` E0 A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A` E@ A . . . EP A . . . E` A . . . Ep A . . . E A . . . E A ATORVASTATIN d04105A C[@ E78.0P Prevent high cholesterol A` E A BACLOFEN d00967A C[@ M62.83 Muscle spasm A` E A LEVETIRACETAM d04499A C[@ G40 Epilepsy and recurrent seizures A` E A LEVOTHYROXINE d00278A C[@ E03.9 Hypothyroidism, unspecified A` E A MELOXICAM d04532A C[@ M19.9 Osteoarthritis, unspecified site A` E A ZOLPIDEM d00910A Cr G47.0 Insomnia A` E A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A@ E A INSULIN ISOPHANE (NPH) d04370A B= E11 Type 2 diabetes mellitus A@ E A METFORMIN d03807A D E11 Type 2 diabetes mellitus A@ E A TAMSULOSIN d04121A B[ N40 Enlarged prostate A@ E A 77777 . . A E A ALENDRONATE d03849A CDp M19.9 Osteoarthritis, unspecified site A E A APIXABAN d07804A C"@ D75.9P Prevent blood clots A E A ATORVASTATIN d04105A CDp E78.0 Pure hypercholesterolemia A E A CARVEDILOL d03847A C I49.9 Cardiac arrhythmia, unspecified A E A DULOXETINE d05355A C- M79.2 Neuralgia and neuritis, unspecified A E A FUROSEMIDE d00070A D I50.9 Heart failure, unspecified A E A GABAPENTIN d03182A D M79.2 Neuralgia and neuritis, unspecified A E A LISINOPRIL d00732A D# I10 Essential (primary) hypertension A E A NITROGLYCERIN d00321A D I21.P Prevent heart attack/myocardial infarction A E A SPIRONOLACTONE d00373A D I50.9 Heart failure, unspecified A E A AMLODIPINE d00689A B 99999 A E A ATORVASTATIN d04105A B[ E78.0 Pure hypercholesterolemia A E A LOSARTAN d03821A Cr I10 Essential (primary) hypertension A E A METAXALONE d00964A Bz 99999 A E A METFORMIN d03807A CDp R73 Elevated blood glucose level A E A METOPROLOL d00134A C 99999 A E A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A E A UMECLIDINIUM d08187A B= J45 Asthma A E A . . . E A DESOGESTREL; ETHINYL ESTRADIOL d03782A B* Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A ACYCLOVIR d00001A Ap B00.1 Herpesviral vesicular dermatitis Ap E A FLUOXETINE d00236A C F32.9 Major depressive disorder, single episode, unspecified Ap E A FLUTICASONE NASAL d04283A C J30.9 Allergic rhinitis, unspecified Ap E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension Ap E A MONTELUKAST d04289A C J30.9 Allergic rhinitis, unspecified Ap E A OMEPRAZOLE d00325A CDp K21 Gastro-esophageal reflux disease Ap E A PREDNISONE d00350A Ap T78.40 Allergy, unspecified Ap E A CEPHALEXIN d00096A B= J42 Unspecified chronic bronchitis A@ E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A B I10 Essential (primary) hypertension A@ E A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A@ E A PANTOPRAZOLE d04514A B K21 Gastro-esophageal reflux disease A@ E0 A . . . E@ A CARVEDILOL d03847A C I10 Essential (primary) hypertension A E@ A LISINOPRIL d00732A D I10 Essential (primary) hypertension A EP A . . . E` A . . . Ep A CLONIDINE d00044A CDp F31.9 Bipolar disorder, unspecified A` Ep A INSULIN DEGLUDEC d08054A B E10 Type 1 diabetes mellitus A` Ep A LAMOTRIGINE d03809A CDp F31.9 Bipolar disorder, unspecified A` Ep A LITHIUM d00061A Cr F31.9 Bipolar disorder, unspecified A` Ep A SITAGLIPTIN d05896A B E10 Type 1 diabetes mellitus A` Ep A TRAZODONE d00395A B G47.0 Insomnia A` E A ALBUTEROL d00749A C J45 Asthma A E A ALBUTEROL d00749A C J45 Asthma A E A . . . E A . . . E A PROPRANOLOL d00032A C I10 Essential (primary) hypertension A E A SUMATRIPTAN d03160A D# G43 Migraine A E A . . . E A . . . E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A0 E A METFORMIN d03807A C- M19.9 Osteoarthritis, unspecified site A0 E A SIMVASTATIN d00746A C[@ E78.0 Pure hypercholesterolemia A0 E A ETHINYL ESTRADIOL; LEVONORGESTREL d03242A CDp N92 Z79.3 Excessive, frequent and irregular menstruation Long term (current) use of hormonal contraceptives A E A . . . E A . . . E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A0 E A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C I10 Essential (primary) hypertension A0 E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A0 E0 A . . . E@ A CARIPRAZINE d08379A B[ F31.9 Bipolar disorder, unspecified A E@ A VORTIOXETINE d08125A Ap F32.9 Major depressive disorder, single episode, unspecified A EP A FLUTICASONE d01296A B[ T78.40 Allergy, unspecified A EP A FLUTICASONE NASAL d04283A B J30.2 Other seasonal allergic rhinitis A E` A . . . Ep A DESOGESTREL; ETHINYL ESTRADIOL d03782A D& Z79.3 Long term (current) use of hormonal contraceptives A E A . . . E A . . . E A . . . E A LANSOPRAZOLE d03828A C K30 Functional dyspepsia A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E0 A METFORMIN d03807A0 D E11 Type 2 diabetes mellitus A E0 A PRAVASTATIN d00348A0 D E78.0 Pure hypercholesterolemia A E@ A . . . EP A THYROID DESICCATED d00655A D E03.9 Hypothyroidism, unspecified A E` A . . . Ep A ALBUTEROL d00749A C J44.9 J45 Chronic obstructive pulmonary disease, unspecified Asthma A Ep A ALBUTEROL d00749A C J45 Asthma A Ep A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A Ep A CANAGLIFLOZIN d08080A CDp E11 Type 2 diabetes mellitus A Ep A FLUOXETINE d00236A C F32.9 Major depressive disorder, single episode, unspecified A Ep A HYDROCHLOROTHIAZIDE d00253A C I10 Essential (primary) hypertension A Ep A INSULIN DETEMIR d05436A C[@ E11 Type 2 diabetes mellitus A Ep A LISINOPRIL d00732A C I10 Essential (primary) hypertension A Ep A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A Ep A PREGABALIN d05508A C E11.4 Type 2 diabetes mellitus with neurological complications A Ep A UMECLIDINIUM; VILANTEROL d08188A A J44.9 Chronic obstructive pulmonary disease, unspecified A E A . . . E A CYCLOSPORINE OPHTHALMIC d04836A B= H04 Disorders of lacrimal system AP E A LORAZEPAM d00149A B[ F41.9 Anxiety disorder, unspecified AP E A MELOXICAM d04532A B[ M06.9 M19.9 Rheumatoid arthritis, unspecified Osteoarthritis, unspecified site AP E A OLOPATADINE OPHTHALMIC d04117A B H40 Glaucoma AP E A TRAZODONE d00395A C G47.0 Insomnia AP E A ALBUTEROL d00749A C[@ J44.9 Chronic obstructive pulmonary disease, unspecified A E A ALLOPURINOL d00023A CDp M10.9P Prevent gout A E A FUROSEMIDE d00070A Bz I10 Essential (primary) hypertension A E A INSULIN ASPART d04697A C- E11 Type 2 diabetes mellitus A E A INSULIN GLARGINE d04538A CDp E11 Type 2 diabetes mellitus A E A OMEPRAZOLE d00325A C- B96.81 Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere A E A OXYBUTYNIN d00328A C N32.81 Overactive bladder A E A PRIMIDONE d00352A C[@ G20 Parkinson's disease A E A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E A FLUTICASONE; SALMETEROL d04611A Dc J45 Asthma A E A LOSARTAN d03821A C[@ I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A E A SIMVASTATIN d00746A C- E78.0 Pure hypercholesterolemia A E A . . . E A ACETAMINOPHEN; HYDROCODONE d03428A C M54 Dorsalgia A E A GLYBURIDE d00248A C- E11 Type 2 diabetes mellitus A E A PROGESTERONE d00550A C[@ 55555 A E0 A . . . E@ A . . . EP A . . . E` A LISINOPRIL d00732A Cr I50.9 Heart failure, unspecified A Ep A CLONIDINE d00044A Bz F84 I10 Pervasive developmental disorders Essential (primary) hypertension A@ Ep A HYDRALAZINE d00132A C I10 Essential (primary) hypertension A@ Ep A METFORMIN d03807A BK R73 Elevated blood glucose level A@ Ep A OLMESARTAN d04801A Bz I10 Essential (primary) hypertension A@ E A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A E A LOVASTATIN d00280A CDp E78.0 Pure hypercholesterolemia A E A . . . E A . . . E A . . . E A . . . E A . . . E A ALENDRONATE d03849A C- M81 Osteoporosis without current pathological fracture A E A ALPRAZOLAM d00168A C- F41.9 Anxiety disorder, unspecified A E A AMITRIPTYLINE d00146A C G47.0 Insomnia A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A BUPROPION d00181A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A CITALOPRAM d04332A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A E A CYCLOBENZAPRINE d00963A B M62.83 Muscle spasm A E A DICYCLOMINE d00999A C- K58 Irritable bowel syndrome A E A DIVALPROEX SODIUM d03833A C G43 Migraine A E A DULOXETINE d05355A A R25.1 Tremor, unspecified A E A INDOMETHACIN d00039A A M19.9 Osteoarthritis, unspecified site A E A METOCLOPRAMIDE d00298A C K21 Gastro-esophageal reflux disease A E A PANTOPRAZOLE d04514A C K30 Functional dyspepsia A E A TIMOLOL OPHTHALMIC d04037A C- H40 Glaucoma A E A LOSARTAN d03821A B E11.8 Type 2 diabetes mellitus with unspecified complications A0 E A METFORMIN d03807A CP E11 Type 2 diabetes mellitus A0 E A PRAVASTATIN d00348A CP E78.0 Pure hypercholesterolemia A0 E A ATORVASTATIN d04105A C E78.0 E78.1 Pure hypercholesterolemia Pure hyperglyceridemia A@ E A CILOSTAZOL d04382A B[ I70 Atherosclerosis A@ E A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus A@ E A METOPROLOL d00134A Dc I49.9 Cardiac arrhythmia, unspecified A@ E A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A E A CLONIDINE d00044A C I10 Essential (primary) hypertension A E A ESCITALOPRAM d04812A B F32.9 Major depressive disorder, single episode, unspecified A E A HYDRALAZINE d00132A C[@ I10 Essential (primary) hypertension A E A INSULIN ISOPHANE (NPH) d04370A C[@ E11 Type 2 diabetes mellitus A E A LISINOPRIL d00732A C[@ I10 Essential (primary) hypertension A E A METFORMIN d03807A Cr E11 Type 2 diabetes mellitus A E A METOPROLOL d00134A C I10 Essential (primary) hypertension A E A MONTELUKAST d04289A C J45 Asthma A E A OMEPRAZOLE d00325A C K31.9 Disease of stomach and duodenum, unspecified A E A POTASSIUM CHLORIDE d00345A C E87.6 Hypokalemia A E A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A E A . . . E0 A . . . E@ A . . . EP A . . . E` A . . . Ep A ALLOPURINOL d00023A C M10.9 Gout, unspecified A Ep A ATORVASTATIN d04105A D E78.0 Pure hypercholesterolemia A Ep A FUROSEMIDE d00070A C- R60.9 Edema, unspecified A Ep A GLIPIZIDE d00246A D# E11 Type 2 diabetes mellitus A Ep A HYDRALAZINE; ISOSORBIDE DINITRATE d05540A C- R60.9 Edema, unspecified A Ep A METOPROLOL d00134A C[@ I51.9 Heart disease, unspecified A Ep A SITAGLIPTIN d05896A C- E11 Type 2 diabetes mellitus A Ep A UMECLIDINIUM; VILANTEROL d08188A B R06.02 Shortness of breath A E A CITALOPRAM d04332A CDp I10 Essential (primary) hypertension A E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E0 A . . . E@ A HYDROCHLOROTHIAZIDE; LISINOPRIL d03266A C- I10 Essential (primary) hypertension A E@ A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A EP A . . . E` A . . . Ep A LISINOPRIL d00732A CDp I10 Essential (primary) hypertension AP Ep A MELOXICAM d04532A A M54 Dorsalgia AP Ep A METOPROLOL d00134A B R00 Abnormalities of heart beat AP Ep A PRAVASTATIN d00348A C- E78.0 Pure hypercholesterolemia AP Ep A TIZANIDINE d04102A B M54 Dorsalgia AP E A . . . E A ALPRAZOLAM d00168A D M62.83 Muscle spasm A E A CARVEDILOL d03847A CDp I10 Essential (primary) hypertension A E A CITALOPRAM d04332A B F32.9 Major depressive disorder, single episode, unspecified A E A FLUDROCORTISONE d00608A C- 55555 A E A GLIMEPIRIDE d03864A C E11 Type 2 diabetes mellitus A E A LEVOTHYROXINE d00278A C- E03.9 Hypothyroidism, unspecified A E A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A E A METFORMIN d03807A C- R73 Elevated blood glucose level A E A NIFEDIPINE d00051A CDp I10 Essential (primary) hypertension A E A ROSUVASTATIN d04851A CDp E78.0 Pure hypercholesterolemia A E A . . . E A TERBINAFINE d04012A B B35 Dermatophytosis A E A AMLODIPINE d00689A0 Cr I10 Essential (primary) hypertension Ap E A ATENOLOL d00004A D I10 Essential (primary) hypertension Ap E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia Ap E A BENAZEPRIL d00730A C I10 Essential (primary) hypertension Ap E A DOXAZOSIN d00726A D Z79.0 Long term (current) use of anticoagulants and antithrombotics/antiplatelets Ap E A INSULIN GLARGINE d04538A C- E11 Type 2 diabetes mellitus Ap E A SITAGLIPTIN d05896A C R73 Elevated blood glucose level Ap E A . . . E A . . . E A . . . E A . . . E A . . . E A . . . E0 A AMLODIPINE d00689A C[@ I10 Essential (primary) hypertension A0 E0 A ATORVASTATIN d04105A B[ E78.0 Pure hypercholesterolemia A0 E0 A HYDROCHLOROTHIAZIDE d00253A C[@ I10 Essential (primary) hypertension A0 E@ A . . . EP A . . . E` A ATORVASTATIN d04105A C"@ E78.0 Pure hypercholesterolemia A0 E` A DIVALPROEX SODIUM d03833A CDp F39 Unspecified mood [affective] disorder A0 E` A METFORMIN d03807A C"@ E11 Type 2 diabetes mellitus A0 Ep A . . . E A . . . E A DOXAZOSIN d00726A C[@ N40 Enlarged prostate A0 E A FAMOTIDINE d00141A B R39.9 Unspecified symptoms and signs involving the genitourinary system A0 E A IBUPROFEN d00015A Bz M25.5 Pain in joint A0 E A . . . E A . . . E A . . . E A ACYCLOVIR d00001A D T86.9P Prevent transplanted organ and tissue rejection A E A ASPIRIN d00170A D I99.9 Unspecified disorder of circulatory system A E A LOPERAMIDE d01025A Ap R19.7 Diarrhea, unspecified A E A METOPROLOL d00134A D ^ I10 Essential (primary) hypertension A E A MYCOPHENOLATE MOFETIL d03839A D T86.9P Prevent transplanted organ and tissue rejection A E A OMEPRAZOLE d00325A C K59.0 Constipation A E A PREDNISONE d00350A D N18.9 Chronic kidney disease, unspecified A E A SIMVASTATIN d00746A D 99999 A E A TACROLIMUS d03752A D N19 Unspecified kidney failure A E A ACYCLOVIR d00001A Dc B00.9 Herpesviral infection, unspecified A E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A Cr I10 Essential (primary) hypertension A E A CIPROFLOXACIN d00011A Ap N39.0 Urinary tract infection, site not specified A E A TRAMADOL d03826A A@ N94 Pain and other conditions associated with female genital organs and menstrual cycle A E A . . . E A . . . E A BENZTROPINE d00175A C T88.7P Prevent drug side effect A E A BUPROPION; NALTREXONE d08288A C- E66 Overweight and obesity A E A CLONAZEPAM d00197A C F41.9 Anxiety disorder, unspecified A E A DIVALPROEX SODIUM d03833A D F39 Unspecified mood [affective] disorder A E A GABAPENTIN d03182A C F39 Unspecified mood [affective] disorder A E A GUANFACINE d00717A C- F90 Attention-deficit hyperactivity disorders A E A PROPRANOLOL d00032A Cr R25.1 Tremor, unspecified A E A TAMSULOSIN d04121A C- N40 Enlarged prostate A E A ZIPRASIDONE d04747A D F31.9 Bipolar disorder, unspecified A E 0 A . . . E @ A . . . E P A CLINDAMYCIN d00043A B 55555 A@ E P A CLONAZEPAM d00197A CDp F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified A@ E P A LEVOFLOXACIN d04109A Ap L08.9 Local infection of the skin and subcutaneous tissue, unspecified A@ E P A METOPROLOL d00134A B[ I48.9 Unspecified atrial fibrillation and atrial flutter A@ E ` A SIMVASTATIN d00746A C E78.0 Pure hypercholesterolemia A E p A ATORVASTATIN d04105A B E78.0 Pure hypercholesterolemia A E p A METFORMIN d03807A C E11 Type 2 diabetes mellitus A E A PREDNISOLONE OPHTHALMIC d03221A B H57.9 Unspecified disorder of eye and adnexa A E A . . . E A BENZTROPINE d00175A C- F32.9 Major depressive disorder, single episode, unspecified A E A . . . E A ALLOPURINOL d00023A D"8 M1A Chronic gout AP E A GLIPIZIDE d00246A B E11 Type 2 diabetes mellitus AP E A LISINOPRIL d00732A D E11.2P Prevent diabetic kidney disease AP E A METFORMIN d03807A Dc E11 Type 2 diabetes mellitus AP E A SIMVASTATIN d00746A Dc E78.0 Pure hypercholesterolemia AP E A . . . E A . . . E A ATORVASTATIN d04105A C& E78.0 Pure hypercholesterolemia A0 E A GLIPIZIDE d00246A C& E11 Type 2 diabetes mellitus A0 E A METFORMIN d03807A C& E11 Type 2 diabetes mellitus A0 E A . . . E A FENOFIBRATE d04286A C E78.1 Pure hyperglyceridemia A@ E A HYDROCHLOROTHIAZIDE; LOSARTAN d03830A CDp I10 Essential (primary) hypertension A@ E A LEVOTHYROXINE d00278A C E03.9 Hypothyroidism, unspecified A@ E A METOPROLOL d00134A C I10 Essential (primary) hypertension A@ E A AMLODIPINE d00689A C I10 Essential (primary) hypertension A@ E A LISINOPRIL d00732A D I10 Essential (primary) hypertension A@ E A LOVASTATIN d00280A D I51.9 R07.9 Heart disease, unspecified Chest pain, unspecified A@ E A METFORMIN d03807A C E11 Type 2 diabetes mellitus A@ E 0 A . . . E @ A PANTOPRAZOLE d04514A C R12 Heartburn A E P A ALLOPURINOL d00023A B E79.9 Disorder of purine and pyrimidine metabolism, unspecified A@ E P A METHOTREXATE d00060A C M06.9 Rheumatoid arthritis, unspecified A@ E P A NEBIVOLOL d05265A CDp I10 Essential (primary) hypertension A@ E P A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease A@ E ` A ATORVASTATIN d04105A C- E78.0 Pure hypercholesterolemia A E ` A IRBESARTAN d04222A C- I10 Essential (primary) hypertension A E p A ALENDRONATE d03849A C M81.P Prevent bone loss/osteoporosis A E p A METFORMIN d03807A D E11 Type 2 diabetes mellitus A E A . . . E A AMOXICILLIN d00088A CDp K04.7P Prevent tooth infection A E A ATORVASTATIN d04105A C[@ E78.0 Pure hypercholesterolemia A E A CARVEDILOL d03847A C[@ I51.9 Heart disease, unspecified A E A COLCHICINE d00150A C M1A Chronic gout A E A FUROSEMIDE d00070A C[@ I51.9 Heart disease, unspecified A E A INSULIN GLARGINE d04538A CDp E11 Type 2 diabetes mellitus A E A INSULIN LISPRO d04373A C- E11 Type 2 diabetes mellitus A E A LEVOFLOXACIN d04109A A R05 Cough A E A LOSARTAN d03821A C[@ I10 Essential (primary) hypertension A E A OMEPRAZOLE d00325A C[@ K21 Gastro-esophageal reflux disease A E A . . . E A CANAGLIFLOZIN d08080A B E11 Type 2 diabetes mellitus A E A HYDROCHLOROTHIAZIDE; VALSARTAN d04293A C I10 Essential (primary) hypertension A E A . . . E A CARVEDILOL d03847A CDp I51.9 Heart disease, unspecified A E A CYCLOBENZAPRINE d00963A C[@ M62.83 Muscle spasm A E A DAPAGLIFLOZIN d07928A CDp E11 Type 2 diabetes mellitus A E A HYDROCHLOROTHIAZIDE d00253A CDp R60.9 Edema, unspecified A E A LISINOPRIL d00732A C I10 Essential (primary) hypertension A E A METFORMIN; SITAGLIPTIN d06720A C- E11 Type 2 diabetes mellitus A E A NISOLDIPINE d03825A C I10 Essential (primary) hypertension A E A ROSUVASTATIN d04851A C[@ E78.0 Pure hypercholesterolemia A E A TESTOSTERONE d00558A C[@ E29.1 Testicular hypofunction A E A . . . E A ESTRADIOL d00537A C- Z79.890 Hormone replacement therapy A E A RIZATRIPTAN d04328A Bz G43 Migraine A E A . . . E A ALBUTEROL d00749A Cr J45 Asthma A E 0 A ATORVASTATIN d04105A C I21.P Prevent heart attack/myocardial infarction Ap E 0 A DILTIAZEM d00045A C I48.9 Unspecified atrial fibrillation and atrial flutter Ap E 0 A ISOSORBIDE MONONITRATE d00269A C I21.P Prevent heart attack/myocardial infarction Ap E 0 A LANSOPRAZOLE d03828A C K21 Gastro-esophageal reflux disease Ap E 0 A METFORMIN; SITAGLIPTIN d06720A C R73 Elevated blood glucose level Ap E 0 A METOPROLOL d00134A C I21.P Prevent heart attack/myocardial infarction Ap E 0 A WARFARIN d00022A C D75.9P Prevent blood clots Ap E @ A . . . E P A PANTOPRAZOLE d04514A Cr K30 Functional dyspepsia A E ` A IRBESARTAN d04222A C I10 Essential (primary) hypertension A0 E ` A LEVOTHYROXINE d00278A Dc E03.9 Hypothyroidism, unspecified A0 E ` A METFORMIN d03807A CDp E11 Type 2 diabetes mellitus A0 E p A BRIMONIDINE OPHTHALMIC d04048A B H40 Glaucoma A E A . . . E A BIMATOPROST OPHTHALMIC d04754A C H40 Glaucoma A E A TIMOLOL OPHTHALMIC d04037A C H40 Glaucoma A E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A0 E A LOSARTAN d03821A CDp I10 Essential (primary) hypertension A0 E A SPIRONOLACTONE d00373A B E87.6 Hypokalemia A0 E A . . . E A . . . E A . . . E A . . . E A AMLODIPINE d00689A B I10 Essential (primary) hypertension A0 E A LISINOPRIL d00732A B I10 Essential (primary) hypertension A0 E A METFORMIN; SITAGLIPTIN d06720A B E11 Type 2 diabetes mellitus A0 E A ALBUTEROL d00749A C- J45 R06.02 R06.2 Asthma Shortness of breath Wheezing A E A ASPIRIN d00170A C"0 55555 AP E A ENALAPRIL d00013A B 55555 AP E A LEVOTHYROXINE d00278A C$ E03.9 Hypothyroidism, unspecified AP E A OMEPRAZOLE d00325A C K21 Gastro-esophageal reflux disease AP E A RANITIDINE d00021A C K21 Gastro-esophageal reflux disease AP E A . . . E 0 A DROSPIRENONE; ETHINYL ESTRADIOL d04760A C L70 N92 Z79.3 Acne Excessive, frequent and irregular menstruation Long term (current) use of hormonal contraceptives A E @ A . . . E P A LISINOPRIL d00732A Cr I10 Essential (primary) hypertension A E P A METFORMIN d03807A CDp E11.P Prevent diabetes A E ` A . . . E p A . . . E A . . . E A . . . E A . . . E A . . . E A AMOXICILLIN d00088A A J02 Acute pharyngitis A E A AMOXICILLIN d00088A Ap Z79 Long term (current) drug therapy A E A 77777 . . A E A ACETAMINOPHEN; HYDROCODONE d03428A C M54 Dorsalgia Ap E A BUPRENORPHINE d00840A B[ M54 M79.2 M79.7 Dorsalgia Neuralgia and neuritis, unspecified Fibromyalgia Ap E A CLOBETASOL TOPICAL d01288A Dc L40 Psoriasis Ap E A GABAPENTIN d03182A C M54 M79.2 Dorsalgia Neuralgia and neuritis, unspecified Ap E A IBUPROFEN d00015A Dc M54 M79.7 Dorsalgia Fibromyalgia Ap E A LIDOCAINE TOPICAL d00683A C M54 M79.7 Dorsalgia Fibromyalgia Ap E A VENLAFAXINE d03181A C F32.9 F41.9 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Ap E A . . . E A . . . E A ATORVASTATIN d04105A C E78.0 Pure hypercholesterolemia A E A METHIMAZOLE d00290A B E05 Thyrotoxicosis [hyperthyroidism] A E 0 A . . . E @ A ATENOLOL d00004A D I10 Essential (primary) hypertension Ap E @ A ATORVASTATIN d04105A D E78.0P Prevent high cholesterol Ap E @ A BECLOMETHASONE d00760A C- J44.9 Chronic obstructive pulmonary disease, unspecified Ap E @ A BUPROPION d00181A D F41.9 Anxiety disorder, unspecified Ap E @ A LOSARTAN d03821A D I10 Essential (primary) hypertension Ap E @ A TIOTROPIUM d04829A C- J44.9 Chronic obstructive pulmonary disease, unspecified Ap E @ A TRAZODONE d00395A D F41.0 Panic disorder [episodic paroxysmal anxiety] without agoraphobia Ap E P A LEVOTHYROXINE d00278A D E03.9 Hypothyroidism, unspecified A E ` A . . . E p A . . . E A ARIPIPRAZOLE d04825A Dc F32.9 Major depressive disorder, single episode, unspecified A@ E A FLUOXETINE d00236A C F32.9 Major depressive disorder, single episode, unspecified A@ E A LAMOTRIGINE d03809A Cr F32.9 Major depressive disorder, single episode, unspecified A@ E A LISDEXAMFETAMINE d06663A C- R53 Malaise and fatigue A@ E A FUROSEMIDE d00070A B M79.2 Neuralgia and neuritis, unspecified A` E A METOPROLOL d00134A B R51 Headache A` E A NAPROXEN d00019A B= 99999 A` E A NITROGLYCERIN d00321A A R07.9 Chest pain, unspecified A` E A OMEPRAZOLE d00325A A R10 Abdominal and pelvic pain A` E A POTASSIUM CHLORIDE d00345A B= M62.83 Muscle spasm A` E A . . . E A ACETAMINOPHEN; BUTALBITAL; CAFFEINE d03455A Cr G43 Migraine A E A ACYCLOVIR d00001A C- B02 Zoster [herpes zoster] A E A DULOXETINE d05355A C- M79.7 Fibromyalgia A E A ESOMEPRAZOLE d04749A C K21 Gastro-esophageal reflux disease A E A FENOFIBRATE d04286A Cr E78.1 Pure hyperglyceridemia A E A LEVOTHYROXINE d00278A CDp E03.9 Hypothyroidism, unspecified A E A METAXALONE d00964A A M54 Dorsalgia A E A TIZANIDINE d04102A CDp M62.83 Muscle spasm A E A WARFARIN d00022A C D75.9P Prevent blood clots A E A COLESTIPOL d00744A B R19.7 Diarrhea, unspecified AP E A DABIGATRAN d07137A C[@ D75.9P Prevent blood clots AP E A LEVOTHYROXINE d00278A Dc E07.9 Disorder of thyroid, unspecified AP E A METFORMIN d03807A D R73 Elevated blood glucose level AP E A METOPROLOL d00134A C[@ I49.9 Cardiac arrhythmia, unspecified AP E A AMOXICILLIN d00088A AP J02 Acute pharyngitis A E A . . . E A . . . E! A . . . E! A AMLODIPINE d00689A CDp I10 Essential (primary) hypertension A@ E! A BENAZEPRIL; HYDROCHLOROTHIAZIDE d03265A CDp I10 Essential (primary) hypertension A@ E! A SIMVASTATIN d00746A CDp E78.0 Pure hypercholesterolemia A@ E! A TAMSULOSIN d04121A C- N40 Enlarged prostate A@ E! A . . . E!0 A . . . E!@ A . . . E!P A . . . E!` A . . . E!p A ACETAMINOPHEN; CODEINE d03423A CDp M13 M25.5 M54 Other arthritis Pain in joint Dorsalgia AP E!p A BUPROPION d00181A CDp F32.9 F41.9 F90 Major depressive disorder, single episode, unspecified Anxiety disorder, unspecified Attention-deficit hyperactivity disorders AP E!p A LEVONORGESTREL d00557A C- N92 Z79.3 Excessive, frequent and irregular menstruation Long term (current) use of hormonal contraceptives AP E!p A MELOXICAM d04532A CDp M13 M79.1 M79.7 Other arthritis Myalgia Fibromyalgia AP E!p A METHOTREXATE d00060A B* M06.9 Rheumatoid arthritis, unspecified AP E! A RANITIDINE d00021A C K21 R12 Gastro-esophageal reflux disease Heartburn A E! A . . . E! A . . . E! A . . . E! A CLOPIDOGREL d04258A C I63.P Prevent stroke AP E! A GABAPENTIN d03182A CDp I63 Cerebral infarction AP E! A LEVETIRACETAM d04499A CDp G47.0 Insomnia AP E! A OMEPRAZOLE d00325A Dc T88.7P Prevent drug side effect AP E! A ZONISAMIDE d04527A CDp I63 Cerebral infarction AP E! A . . . E! A NYSTATIN TOPICAL d04399A B[ B37 Candidiasis A E! A METOPROLOL d00134A C I10 Essential (primary) hypertension A E" A AMLODIPINE d00689A C I10 Essential (primary) hypertension A E" A . . . E" A 99999 . . A E"0 A BRIMONIDINE OPHTHALMIC d04048A C H40 Glaucoma A@ E"0 A DORZOLAMIDE; TIMOLOL OPHTHALMIC d04303A C H40 Glaucoma A@ E"0 A LATANOPROST OPHTHALMIC d04017A C H40 Glaucoma A@ E"0 A LOSARTAN d03821A C"0 E78.0 Pure hypercholesterolemia A@ E"@ A . . . E"P A . . . E"` A 99999 . . A` E"` A DABIGATRAN d07137A C D75.9P Prevent blood clots A` E"` A ENALAPRIL d00013A D I10 Essential (primary) hypertension A` E"` A NIFEDIPINE d00051A D I10 Essential (primary) hypertension A` E"` A POTASSIUM CITRATE d01423A C E87.6 Hypokalemia A` E"` A TRIAMTERENE d00396A C R60.9 Edema, unspecified A` E"p A EPINEPHRINE d00699A C- 55555 A E" A DABIGATRAN d07137A C I49.9 Cardiac arrhythmia, unspecified A E" A ALBUTEROL d00749A Bz R06.2 Wheezing A E" A BECLOMETHASONE d00760A B= J45 Asthma A E" A . . . E" A . . . E" A CETIRIZINE d03827A A@ T78.40 Allergy, unspecified AP E" A DULOXETINE d05355A C F41.9 M79.2 Anxiety disorder, unspecified Neuralgia and neuritis, unspecified AP E" A FLUTICASONE NASAL d04283A A@ J30.2 Other seasonal allergic rhinitis AP E" A GABAPENTIN d03182A C M79.2 Neuralgia and neuritis, unspecified AP E" A NORTRIPTYLINE d00144A C M79.2 Neuralgia and neuritis, unspecified AP